Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	json	split
Consistent with this, the ARU - GFP translational fusion protein driven by the endogenous promoter ( pARU :: ARU - GFP) is highly expressed in wild - type synergids ( Supplementary Fig. 7 ), suggesting an important role for ARU in these cells.	ARU,26,29,Gene/Protein	GFP,32,35,Gene/Protein	ARU,102,105,Gene/Protein	GFP,115,118,Gene/Protein	ARU,224,227,Gene/Protein	"[{""token"": ""ARU"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""ARU"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""ARU"", ""start_span"": 224, ""end_span"": 227, ""type"": ""Gene/Protein""}]"	test
SALK - lines were obtained from NASC: SALK_067271 ( At1g61790, aru - 1 ), SALK_137883C ( At1g61780 ), SALK_052207C and SALK_026074C ( At1g61795 ), SALK_104077 ( At1g61810 ).	At1g61790,52,61,Gene/Protein	aru - 1,63,70,Gene/Protein	At1g61780,89,98,Gene/Protein	At1g61795,134,143,Gene/Protein	At1g61810,161,170,Gene/Protein	"[{""token"": ""At1g61790"", ""start_span"": 52, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""aru - 1"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""At1g61780"", ""start_span"": 89, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""At1g61795"", ""start_span"": 134, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""At1g61810"", ""start_span"": 161, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	test
The FER promoter was amplified from the pFER :: FER - GFP construct13 using specific primers 5 ′- TTTGGTAAGCTTCGATTTAAGCGAG - 3 ′ and 5 ′- TTTTCTAGACGATCAAGAGCACTTCTCCGGG - 3 ′, which introduce HindIII and XbaI restriction sites as well.	FER,4,7,Gene/Protein	FER,41,44,Gene/Protein	GFP,54,57,Gene/Protein	HindIII,194,201,Gene/Protein	XbaI,206,210,Gene/Protein	"[{""token"": ""FER"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""FER"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""HindIII"", ""start_span"": 194, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""XbaI"", ""start_span"": 206, ""end_span"": 210, ""type"": ""Gene/Protein""}]"	test
For the constructs with ARU under the control of its endogenous promoter, the ARU fragment ( including 1, 492 bp of upstream, ARU CDS, and 865 bp of downstream sequence) was amplified from Col - 0 and Ga - 0 genomic DNA using primers 5 ′- TTTTACTAGTAGGCAATTCCATCAGTTGTT - 3 ′ and 5 ′- TTTTGGTACCGTTACTTCACTTTCTCGAGT - 3 ′, introducing a SpeI and a KpnI restriction site, respectively.	ARU,24,27,Gene/Protein	ARU,78,81,Gene/Protein	ARU,126,129,Gene/Protein	SpeI,337,341,Gene/Protein	KpnI,348,352,Gene/Protein	"[{""token"": ""ARU"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""ARU"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""ARU"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""SpeI"", ""start_span"": 337, ""end_span"": 341, ""type"": ""Gene/Protein""}, {""token"": ""KpnI"", ""start_span"": 348, ""end_span"": 352, ""type"": ""Gene/Protein""}]"	test
We further demonstrate that it regulates cell survival via a signaling mechanism involving MEK - ERK via TLR4 and CD11B / CD18.	MEK,91,94,Gene/Protein	ERK,97,100,Gene/Protein	TLR4,105,109,Gene/Protein	CD11B,114,119,Gene/Protein	CD18,122,126,Gene/Protein	"[{""token"": ""MEK"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""TLR4"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""CD11B"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""CD18"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Gene/Protein""}]"	test
Furthermore, neutrophils do not express survivin, an inhibitor - of - apoptosis protein ( IAP ), unless expression is induced by GCSF and GMCSF or in inflammatory conditions [ 16 ].	survivin,40,48,Gene/Protein	inhibitor - of - apoptosis protein,53,87,Gene/Protein	IAP,90,93,Gene/Protein	GCSF,129,133,Gene/Protein	GMCSF,138,143,Gene/Protein	"[{""token"": ""survivin"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""inhibitor - of - apoptosis protein"", ""start_span"": 53, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""IAP"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""GCSF"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""GMCSF"", ""start_span"": 138, ""end_span"": 143, ""type"": ""Gene/Protein""}]"	test
We sought to verify S100A8 and A9 mediation of the community anti - apoptotic effect using recombinant human S100A8 and A9 ( kindly provided by Philippe A.	S100A8,20,26,Gene/Protein	A9,31,33,Gene/Protein	human,103,108,Organism/Species	S100A8,109,115,Gene/Protein	A9,120,122,Gene/Protein	"[{""token"": ""S100A8"", ""start_span"": 20, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""A9"", ""start_span"": 31, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Organism/Species""}, {""token"": ""S100A8"", ""start_span"": 109, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""A9"", ""start_span"": 120, ""end_span"": 122, ""type"": ""Gene/Protein""}]"	test
Neutrophils undergoing spontaneous constitutive PCD at a concentration of 0. 5 × 106 / ml for 12h, with rabbit polyclonal antibody dilutions of 1 ∶ 100, 1 ∶ 1000, and 1 ∶ 10, 000 against S100A9 and S100A8, were then treated with 2 µg / ml S100A8 / 9 complex.	rabbit,104,110,Organism/Species	antibody,122,130,Gene/Protein	S100A9,187,193,Gene/Protein	S100A8,198,204,Gene/Protein	S100A8,239,245,Gene/Protein	"[{""token"": ""rabbit"", ""start_span"": 104, ""end_span"": 110, ""type"": ""Organism/Species""}, {""token"": ""antibody"", ""start_span"": 122, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""S100A9"", ""start_span"": 187, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""S100A8"", ""start_span"": 198, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""S100A8"", ""start_span"": 239, ""end_span"": 245, ""type"": ""Gene/Protein""}]"	test
S100A8 / 9 does not mediate the community effect via McL1, A1, the bcl - 2 protein family, or survivin	S100A8,0,6,Gene/Protein	McL1,53,57,Gene/Protein	A1,59,61,Gene/Protein	bcl - 2,67,74,Gene/Protein	survivin,94,102,Gene/Protein	"[{""token"": ""S100A8"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""McL1"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""A1"", ""start_span"": 59, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""bcl - 2"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""survivin"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Gene/Protein""}]"	test
Apoptosis was assessed by Annexin V - PI staining. E. The survival effect induced by the complex S100A8 / 9 in the presence of pertussis toxin. Bordetella pertussis toxin at 100 and 500 ng / ml were added to neutrophils 45 min before adding S100A8 / 9.	Annexin V,26,35,Gene/Protein	S100A8,97,103,Gene/Protein	pertussis toxin,127,142,Gene/Protein	Bordetella pertussis,144,164,Organism/Species	S100A8,241,247,Gene/Protein	"[{""token"": ""Annexin V"", ""start_span"": 26, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""S100A8"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""pertussis toxin"", ""start_span"": 127, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""Bordetella pertussis"", ""start_span"": 144, ""end_span"": 164, ""type"": ""Organism/Species""}, {""token"": ""S100A8"", ""start_span"": 241, ""end_span"": 247, ""type"": ""Gene/Protein""}]"	test
However, when we examined the effect of recombinant S100A8 / 9 on CD11b / CD18 - deficient neutrophils from a leukocyte adhesion deficiency ( LAD) patient, results were less clear.	S100A8,52,58,Gene/Protein	CD11b,66,71,Gene/Protein	CD18,74,78,Gene/Protein	leukocyte adhesion deficiency,110,139,Disease/Disorder	LAD,142,145,Disease/Disorder	"[{""token"": ""S100A8"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""CD11b"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""CD18"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""leukocyte adhesion deficiency"", ""start_span"": 110, ""end_span"": 139, ""type"": ""Disease/Disorder""}, {""token"": ""LAD"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Disease/Disorder""}]"	test
Inhibiting TLR4 abrogated the survival effect of S100A8 / 9 by 25 − 60% ( Fig. 5F ), suggesting that both CD11b / CD18 and TLR4 may be involved in the pathway enabling these proteins to affect neutrophil PCD.	TLR4,11,15,Gene/Protein	S100A8,49,55,Gene/Protein	CD11b,106,111,Gene/Protein	CD18,114,118,Gene/Protein	TLR4,123,127,Gene/Protein	"[{""token"": ""TLR4"", ""start_span"": 11, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""S100A8"", ""start_span"": 49, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""CD11b"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""CD18"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""TLR4"", ""start_span"": 123, ""end_span"": 127, ""type"": ""Gene/Protein""}]"	test
In particular, overexpression of JMJD2B exhibits oncogenic activity in various human cancers, including prostate, breast, colon and gastric cancers. 13, 14, 15, 16, 17 In addition, JMJD2B was found to be necessary for self - renewal of embryonic stem cells and induced pluripotent stem cell generation. 18	JMJD2B,33,39,Gene/Protein	human,79,84,Organism/Species	cancers,85,92,Disease/Disorder	gastric cancers,132,147,Disease/Disorder	JMJD2B,181,187,Gene/Protein	"[{""token"": ""JMJD2B"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Organism/Species""}, {""token"": ""cancers"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Disease/Disorder""}, {""token"": ""gastric cancers"", ""start_span"": 132, ""end_span"": 147, ""type"": ""Disease/Disorder""}, {""token"": ""JMJD2B"", ""start_span"": 181, ""end_span"": 187, ""type"": ""Gene/Protein""}]"	test
JMJD2B gene expression was barely detectable in the brains of tau - Cre; Jmj2b flox / flox mice as determined by reverse transcription – PCR ( P = 0. 009; Figure 2a, left ).	JMJD2B,0,6,Gene/Protein	tau,62,65,Gene/Protein	Cre,68,71,Gene/Protein	Jmj2b,73,78,Gene/Protein	mice,91,95,Organism/Species	"[{""token"": ""JMJD2B"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""tau"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""Cre"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""Jmj2b"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Organism/Species""}]"	test
A previous report demonstrated that G9a histone methyltransferase elevates the density of dendritic spines in nucleus accumbens neurons by reducing H3K9me2 levels on exposure to cocaine. 45 In addition, mutation of MeCP2, the causative gene of Rett syndrome and an epigenetic regulator that acts by binding to methylated DNA, also causes a decrease in the number of dendritic spines. 46 Thus, there is increasing evidence that epigenetic mechanisms affect the development and plasticity of dendritic spines.	G9a,36,39,Gene/Protein	histone methyltransferase,40,65,Gene/Protein	cocaine,178,185,Chemical/Drug	MeCP2,215,220,Gene/Protein	Rett syndrome,244,257,Disease/Disorder	"[{""token"": ""G9a"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""histone methyltransferase"", ""start_span"": 40, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""cocaine"", ""start_span"": 178, ""end_span"": 185, ""type"": ""Chemical/Drug""}, {""token"": ""MeCP2"", ""start_span"": 215, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""Rett syndrome"", ""start_span"": 244, ""end_span"": 257, ""type"": ""Disease/Disorder""}]"	test
Variables that were shown in some studies to be associated with less favorable treatment response included • demographic variables such as male sex ( Blain, Galovski, & Robinson, 2010 ), younger age ( Rizvi et al ., 2009; Taylor, Fedoroff, & Koch, 1999 ), higher level of education ( Ehlers et al ., 2005) or ethnic minority ( Walling, Suvak, Howard, Taft, & Murphy, 2012 );• comorbidity with other anxiety disorders or high symptoms of anxiety and arousal ( Rosenkranz & Muller, 2011; Tarrier et al ., 2000; but see van Minnen et al ., 2002; Richardson et al ., 2011; for negative findings ); with depression or suicidal ideation ( Duffy et al ., 2007; Tarrier et al ., 2000; but see van Minnen et al ., 2002; Richardson et al ., 2011; for negative findings ); substance abuse ( van Minnen et al ., 2002; but see Richardson et al ., 2011; for negative findings ); personality disorders ( Clarke, Rizvi, & Resick, 2008; Feeny et al ., 2002 ); use of psychotropic medication ( van Minnen et al ., 2002 ), and permanent physical disability resulting from the trauma ( Gillespie et al ., 2002; but see Duffy et al ., 2007; for negative findings );• trauma characteristics such as multiple trauma ( van Minnen et al ., 2002 ), childhood trauma ( van Minnen et al ., 2002; but also see Jaycox, Foa, & Morral, 1998; for negative findings ), interpersonal trauma committed by a perpetrator ( van Minnen et al ., 2002 ), longer time since the trauma ( Duffy et al ., 2007; but see Ehlers et al ., 2005; Rizvi et al ., 2009; for negative findings ).	anxiety disorders,399,416,Disease/Disorder	anxiety,437,444,Disease/Disorder	depression,599,609,Disease/Disorder	substance abuse,762,777,Disease/Disorder	personality disorders,865,886,Disease/Disorder	"[{""token"": ""anxiety disorders"", ""start_span"": 399, ""end_span"": 416, ""type"": ""Disease/Disorder""}, {""token"": ""anxiety"", ""start_span"": 437, ""end_span"": 444, ""type"": ""Disease/Disorder""}, {""token"": ""depression"", ""start_span"": 599, ""end_span"": 609, ""type"": ""Disease/Disorder""}, {""token"": ""substance abuse"", ""start_span"": 762, ""end_span"": 777, ""type"": ""Disease/Disorder""}, {""token"": ""personality disorders"", ""start_span"": 865, ""end_span"": 886, ""type"": ""Disease/Disorder""}]"	test
Increased Cxcr4 ( ANOVA, * P < 0. 0001) and Cd38 ( ANOVA, * P < 0. 05) expression was found in MOG 91 - 108 in CFA - immunized rats compared to naive and CFA - alone - immunized rats.	Cxcr4,10,15,Gene/Protein	Cd38,44,48,Gene/Protein	MOG,95,98,Gene/Protein	rats,127,131,Organism/Species	rats,178,182,Organism/Species	"[{""token"": ""Cxcr4"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""Cd38"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""MOG"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""rats"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 178, ""end_span"": 182, ""type"": ""Organism/Species""}]"	test
There was an upregulation of Cxcr4 and Cxcl12 mRNA in DA ( RT1av1) rats immunized with MOG 1 - 125 in CFA compared to DA ( RT1av1) rats immunized with CFA alone ( ANOVA, * P < 0. 01 ).	Cxcr4,29,34,Gene/Protein	Cxcl12,39,45,Gene/Protein	rats,67,71,Organism/Species	MOG,87,90,Gene/Protein	rats,131,135,Organism/Species	"[{""token"": ""Cxcr4"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""Cxcl12"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""rats"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Organism/Species""}, {""token"": ""MOG"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""rats"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Organism/Species""}]"	test
B6. 129P2 - Cd38tm1Lnd / J mice ( white bars, n = 4) had reduced IgG and IgG1 antibodies compared to C57BL / 6J 000664 mice ( black bars, n = 4) ( ANOVA, * P < 0. 05) on day 12 p. i.	mice,27,31,Organism/Species	IgG,65,68,Gene/Protein	IgG1,73,77,Gene/Protein	antibodies,78,88,Gene/Protein	mice,119,123,Organism/Species	"[{""token"": ""mice"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""IgG1"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 78, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Organism/Species""}]"	test
FTY720 treatment ( n = 9) compared to controls ( n = 9) led to the downregulation of mRNA expression of its receptor, S1p1 ( ANOVA, P < 0. 0001 ), and of Akt2 ( ANOVA, P < 0. 0001 ), one of the genes involved in the intracellular signaling cascade connected to S1P1 and CXCR4, on day 14 p. i.	FTY720,0,6,Chemical/Drug	S1p1,118,122,Gene/Protein	Akt2,154,158,Gene/Protein	S1P1,261,265,Gene/Protein	CXCR4,270,275,Gene/Protein	"[{""token"": ""FTY720"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical/Drug""}, {""token"": ""S1p1"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""Akt2"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""S1P1"", ""start_span"": 261, ""end_span"": 265, ""type"": ""Gene/Protein""}, {""token"": ""CXCR4"", ""start_span"": 270, ""end_span"": 275, ""type"": ""Gene/Protein""}]"	test
In contrast, the expression of Cxcr4 was not altered ( ANOVA, not significant) ( Fig. 5D ). Fig. 5. Influence of FTY720 in EAE. ( A) Female LEW. 1AV1 ( RT1av1) rats were immunized with MOG 1 - 125 in CFA.	Cxcr4,31,36,Gene/Protein	FTY720,113,119,Chemical/Drug	EAE,123,126,Disease/Disorder	rats,160,164,Organism/Species	MOG,185,188,Gene/Protein	"[{""token"": ""Cxcr4"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""FTY720"", ""start_span"": 113, ""end_span"": 119, ""type"": ""Chemical/Drug""}, {""token"": ""EAE"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Disease/Disorder""}, {""token"": ""rats"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Organism/Species""}, {""token"": ""MOG"", ""start_span"": 185, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	test
CXCR4 ( CD184) is a seven - transmembrane G - coupled receptor expressed by a number of tissues, including cells of the immune system ( Campbell et al ., 2003 ). Cxcr4 - knockout mice die in utero or perinatally and do not only have defects in the hematopoietic system ( impairment of myeloid and B - cell generation, reduced proliferation of triple - negative and double - positive lymphocytes ), but also in the circulatory system and in the CNS ( Zou et al ., 1998; Tachibana et al ., 1998 ).	CXCR4,0,5,Gene/Protein	CD184,8,13,Gene/Protein	seven - transmembrane G - coupled receptor,20,62,Gene/Protein	Cxcr4,162,167,Gene/Protein	mice,179,183,Organism/Species	"[{""token"": ""CXCR4"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""CD184"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""seven - transmembrane G - coupled receptor"", ""start_span"": 20, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""Cxcr4"", ""start_span"": 162, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 179, ""end_span"": 183, ""type"": ""Organism/Species""}]"	test
CXCL12 activates numerous signaling pathways, such as receptor - associated trimeric G proteins, phospholipase Cγ, PI3K and small G proteins ( Pawig et al ., 2015 ).	CXCL12,0,6,Gene/Protein	G proteins,85,95,Gene/Protein	phospholipase Cγ,97,113,Gene/Protein	PI3K,115,119,Gene/Protein	small G proteins,124,140,Gene/Protein	"[{""token"": ""CXCL12"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""G proteins"", ""start_span"": 85, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""phospholipase C\u03b3"", ""start_span"": 97, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""PI3K"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""small G proteins"", ""start_span"": 124, ""end_span"": 140, ""type"": ""Gene/Protein""}]"	test
Our data indicate that, also in MOG - induced EAE and possibly in MS, the interaction of CXCR4 and CXCL12 is of paramount importance for disease development.	MOG,32,35,Gene/Protein	EAE,46,49,Disease/Disorder	MS,66,68,Disease/Disorder	CXCR4,89,94,Gene/Protein	CXCL12,99,105,Gene/Protein	"[{""token"": ""MOG"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""EAE"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Disease/Disorder""}, {""token"": ""MS"", ""start_span"": 66, ""end_span"": 68, ""type"": ""Disease/Disorder""}, {""token"": ""CXCR4"", ""start_span"": 89, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""CXCL12"", ""start_span"": 99, ""end_span"": 105, ""type"": ""Gene/Protein""}]"	test
CD38 ligation in T cells results in phosphorylation of the Raf - 1 / MAP kinase and CD3 - ζ / ZAP - 70 signaling pathway ( Zubiaur et al ., 1997 ).	CD38,0,4,Gene/Protein	Raf - 1,59,66,Gene/Protein	MAP kinase,69,79,Gene/Protein	CD3 - ζ,84,91,Gene/Protein	ZAP - 70,94,102,Gene/Protein	"[{""token"": ""CD38"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""Raf - 1"", ""start_span"": 59, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""MAP kinase"", ""start_span"": 69, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""CD3 - \u03b6"", ""start_span"": 84, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""ZAP - 70"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Gene/Protein""}]"	test
These pathways might be valuable targets of therapeutic approaches as we have shown attenuation of EAE after treatment with FTY720 or reduced EAE severity in CD38 - deficient mice.	EAE,99,102,Disease/Disorder	FTY720,124,130,Chemical/Drug	EAE,142,145,Disease/Disorder	CD38,158,162,Gene/Protein	mice,175,179,Organism/Species	"[{""token"": ""EAE"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Disease/Disorder""}, {""token"": ""FTY720"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Chemical/Drug""}, {""token"": ""EAE"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Disease/Disorder""}, {""token"": ""CD38"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 175, ""end_span"": 179, ""type"": ""Organism/Species""}]"	test
Smoking is the leading cause of death in high income countries such as Canada [ 1] and is a major risk factor for cardiovascular disease and cancer. [ 2 ], [ 3] In Canada, approximately 20% of all deaths are attributable smoking according to 2005 estimates. [ 4] The majority of these deaths are due to the following causes: lung cancer, chronic obstructive pulmonary disease and ischemic heart disease. [ 5] About 50% of smokers die of smoking - related diseases and smokers who die between the ages of 35 and 69 in Canada lose on average more than 20 years of life .[ 6 ]–[ 8] Importantly, however, smoking cessation can reverse the risk for mortality; quitting by age 50 can halve the lifetime risk, while quitting by age 30 can reduce the risk close to that of never smokers. [ 9 ], [ 10 ].	cardiovascular disease,114,136,Disease/Disorder	cancer,141,147,Disease/Disorder	lung cancer,325,336,Disease/Disorder	chronic obstructive pulmonary disease,338,375,Disease/Disorder	ischemic heart disease,380,402,Disease/Disorder	"[{""token"": ""cardiovascular disease"", ""start_span"": 114, ""end_span"": 136, ""type"": ""Disease/Disorder""}, {""token"": ""cancer"", ""start_span"": 141, ""end_span"": 147, ""type"": ""Disease/Disorder""}, {""token"": ""lung cancer"", ""start_span"": 325, ""end_span"": 336, ""type"": ""Disease/Disorder""}, {""token"": ""chronic obstructive pulmonary disease"", ""start_span"": 338, ""end_span"": 375, ""type"": ""Disease/Disorder""}, {""token"": ""ischemic heart disease"", ""start_span"": 380, ""end_span"": 402, ""type"": ""Disease/Disorder""}]"	test
Here, we investigated the roles of two RNA - binding proteins of the Puf - family, Plasmodium Puf1 and Puf2, during sporozoite stage conversion.	RNA - binding proteins,39,61,Gene/Protein	Puf,69,72,Gene/Protein	Plasmodium,83,93,Organism/Species	Puf1,94,98,Gene/Protein	Puf2,103,107,Gene/Protein	"[{""token"": ""RNA - binding proteins"", ""start_span"": 39, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""Puf"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""Plasmodium"", ""start_span"": 83, ""end_span"": 93, ""type"": ""Organism/Species""}, {""token"": ""Puf1"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""Puf2"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Gene/Protein""}]"	test
Recently however, a family of genes related to the plant Apetala - 2 ( AP2) transcription factors has been identified in Plasmodium and related apicomplexan parasites [ 6 ], [ 7 ], and proposed to play a central role during life cycle progression.	plant,51,56,Organism/Species	Apetala - 2,57,68,Gene/Protein	AP2,71,74,Gene/Protein	transcription factors,76,97,Gene/Protein	Plasmodium,121,131,Organism/Species	"[{""token"": ""plant"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Organism/Species""}, {""token"": ""Apetala - 2"", ""start_span"": 57, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""AP2"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 76, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""Plasmodium"", ""start_span"": 121, ""end_span"": 131, ""type"": ""Organism/Species""}]"	test
Puf proteins typically bind to the 3 ′ UTR of target mRNAs and repress their translation or induce their degradation ( reviewed in [ 18] and [ 19 ]). Plasmodium parasites possess two genes encoding proteins with Puf domains, Puf1 and Puf2 [ 20 ].	Puf,0,3,Gene/Protein	Plasmodium,150,160,Organism/Species	Puf,212,215,Gene/Protein	Puf1,225,229,Gene/Protein	Puf2,234,238,Gene/Protein	"[{""token"": ""Puf"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""Plasmodium"", ""start_span"": 150, ""end_span"": 160, ""type"": ""Organism/Species""}, {""token"": ""Puf"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""Puf1"", ""start_span"": 225, ""end_span"": 229, ""type"": ""Gene/Protein""}, {""token"": ""Puf2"", ""start_span"": 234, ""end_span"": 238, ""type"": ""Gene/Protein""}]"	test
Interestingly, microarray data indicate that Puf2 is most highly expressed in P. falciparum sporozoites [ 23 ], and in P. berghei, expression of both Puf1 ( PBANKA_123350) and Puf2 ( PBANKA_071920) has been reported in sporozoites, where Puf1 was initially identified as UIS9 [ 4 ], [ 24 ].	Puf2,45,49,Gene/Protein	Puf1,150,154,Gene/Protein	Puf2,176,180,Gene/Protein	Puf1,238,242,Gene/Protein	UIS9,271,275,Gene/Protein	"[{""token"": ""Puf2"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""Puf1"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""Puf2"", ""start_span"": 176, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""Puf1"", ""start_span"": 238, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""UIS9"", ""start_span"": 271, ""end_span"": 275, ""type"": ""Gene/Protein""}]"	test
Moreover, puf2 (-) sporozoites isolated late after mosquito infection ( at day 25) were not capable of inducing a blood stage infection in mice.	puf2,10,14,Gene/Protein	mosquito,51,59,Organism/Species	infection,60,69,Disease/Disorder	infection,126,135,Disease/Disorder	mice,139,143,Organism/Species	"[{""token"": ""puf2"", ""start_span"": 10, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""mosquito"", ""start_span"": 51, ""end_span"": 59, ""type"": ""Organism/Species""}, {""token"": ""infection"", ""start_span"": 60, ""end_span"": 69, ""type"": ""Disease/Disorder""}, {""token"": ""infection"", ""start_span"": 126, ""end_span"": 135, ""type"": ""Disease/Disorder""}, {""token"": ""mice"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Organism/Species""}]"	test
Altogether, these data indicate that Puf2 regulates a subset of genes in P. berghei sporozoites, including Puf1 and the kinase UIS1 / IK2.	Puf2,37,41,Gene/Protein	Puf1,107,111,Gene/Protein	kinase,120,126,Gene/Protein	UIS1,127,131,Gene/Protein	IK2,134,137,Gene/Protein	"[{""token"": ""Puf2"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""Puf1"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""kinase"", ""start_span"": 120, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""UIS1"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""IK2"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene/Protein""}]"	test
Biochemical data, such as in vitro binding assays using recombinant Puf domains expressed in bacteria and heterologous in vivo studies using the yeast three - hybrid system, have demonstrated intrinsic binding activity of the P. falciparum PfPuf1 and PfPuf2 to the NRE sequence [ 20 ], [ 21 ].	Puf,68,71,Gene/Protein	bacteria,93,101,Organism/Species	yeast,145,150,Organism/Species	PfPuf1,240,246,Gene/Protein	PfPuf2,251,257,Gene/Protein	"[{""token"": ""Puf"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""bacteria"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Organism/Species""}, {""token"": ""yeast"", ""start_span"": 145, ""end_span"": 150, ""type"": ""Organism/Species""}, {""token"": ""PfPuf1"", ""start_span"": 240, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""PfPuf2"", ""start_span"": 251, ""end_span"": 257, ""type"": ""Gene/Protein""}]"	test
Indeed, using RT - qPCR, we found a 4 - fold reduction of Spect and Spect2 mRNA levels in puf2 (-) sporozoites, whereas actin and AMA1 were not affected ( unpublished data ).	Spect,58,63,Gene/Protein	Spect2,68,74,Gene/Protein	puf2,90,94,Gene/Protein	actin,120,125,Gene/Protein	AMA1,130,134,Gene/Protein	"[{""token"": ""Spect"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""Spect2"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""puf2"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""actin"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""AMA1"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	test
In 1991, an eight months treatment regimen composed of 2 months intensive with Isoniazid ( H ), Rifampicin ( R ), Pyrazinamide ( Z) and Ethambutol ( E) ( 2RHZE / S) and 6 months continuation ( 6HE) phases were recommended for all new cases of TB across the world [ 6 ].	Isoniazid,79,88,Chemical/Drug	Rifampicin,96,106,Chemical/Drug	Pyrazinamide,114,126,Chemical/Drug	Ethambutol,136,146,Chemical/Drug	TB,243,245,Disease/Disorder	"[{""token"": ""Isoniazid"", ""start_span"": 79, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""Rifampicin"", ""start_span"": 96, ""end_span"": 106, ""type"": ""Chemical/Drug""}, {""token"": ""Pyrazinamide"", ""start_span"": 114, ""end_span"": 126, ""type"": ""Chemical/Drug""}, {""token"": ""Ethambutol"", ""start_span"": 136, ""end_span"": 146, ""type"": ""Chemical/Drug""}, {""token"": ""TB"", ""start_span"": 243, ""end_span"": 245, ""type"": ""Disease/Disorder""}]"	test
The following standard case and outcome definitions were adopted and used for the study [ 11, 19 ]. New case of TB a patient who never had treatment for TB, or had been on anti - TB treatment for less than four weeks in the past Other cases are those patients who do not fulfill the criteria for new, relapse, and return after default or treatment after failure. Cured: a patient whose sputum smear or culture was positive at the beginning of the treatment but who was smear or culture - negative in the last month of treatment and on at least one previous occasion. Treatment completed: completed treatment but does not have a negative sputum smear or culture result in the last month of treatment and on at least one previous occasion. Treatment failure: a patient whose sputum smear or culture is positive at 5 months or later during treatment or patients found to harbor Multidrug Resistant ( MDR) TB strain at any point of time during the treatment, whether they are smear - negative or - positive. Died: a patient who dies for any reason during the course of TB treatment. Defaulter / loss to follow - up: a patient who has been on treatment for at least 4 weeks and interrupted treatment for eight or more consecutive weeks. Successful treatment: a treatment that ends up in cure or treatment completion Unsuccessful treatment: a treatment that end up in treatment default or loss to follow up, treatment failure or death.	TB,112,114,Disease/Disorder	TB,153,155,Disease/Disorder	TB,179,181,Disease/Disorder	TB,902,904,Disease/Disorder	TB,1065,1067,Disease/Disorder	"[{""token"": ""TB"", ""start_span"": 112, ""end_span"": 114, ""type"": ""Disease/Disorder""}, {""token"": ""TB"", ""start_span"": 153, ""end_span"": 155, ""type"": ""Disease/Disorder""}, {""token"": ""TB"", ""start_span"": 179, ""end_span"": 181, ""type"": ""Disease/Disorder""}, {""token"": ""TB"", ""start_span"": 902, ""end_span"": 904, ""type"": ""Disease/Disorder""}, {""token"": ""TB"", ""start_span"": 1065, ""end_span"": 1067, ""type"": ""Disease/Disorder""}]"	test
Among those tested HIV positives, 44 ( 57. 1 %) received either Cotrimoxazole Prophylactic Therapy ( CPT) or Antiretroviral Therapy ( ART) with no statistically significant difference among the regimens 24 ( 64. 9 %) from 6EH and 20 ( 50 %), p = 0. 2. Table 1Demographic and clinical characteristics of the tuberculosis patients registered between, 2008 – 2014, Southwest EthiopiaVariableContinuation phase treatment regimenTotal P value6EH ( n = 395) n (%) 4RH ( n = 395) n (%) Age ( years) Mean ± SDa 31. 1 ± 12. 930. 5 ± 11. 930. 8 ± 12. 40. 5GenderMale221 ( 55. 9) 226 ( 57. 2) 447 ( 56. 6) 0. 7Female174 ( 44. 1) 169 ( 42. 8) 343 ( 43. 4) ResidenceUrban175 ( 44. 3) 175 ( 44. 3) 350 ( 44. 3) 1Rural220 ( 55. 7) 220 ( 55. 7) 440 ( 55. 7) ZoneKaffa106 ( 26. 8) 104 ( 26. 3) 210 ( 26. 6) 0. 9Bench Maji206 ( 52. 2) 203 ( 26. 3) 409 ( 51. 8) Sheka83 ( 21. 0) 88 ( 22. 3) 171 ( 21. 6) Treatment centerHospital55 ( 13. 9) 49 ( 12. 4) 104 ( 13. 2) 0. 5Health center340 ( 86. 1) 346 ( 87. 6) 686 ( 86. 8) Baseline weightMean ± SDa 47. 6 ± 8. 648. 4 ± 8. 548 ± 8. 50. 2Baseline sputum smearPositive186 ( 47. 1) 173 ( 43. 8) 359 ( 45. 4) 0. 6Negative151 ( 38. 2) 165 ( 41. 8) 316 ( 40) Unknown58 ( 14. 7) 57 ( 14. 4) 115 ( 14. 6) Type of TBPulmonary303 ( 76. 7305 ( 77. 2) 608 ( 77. 0) 0. 9Positive186 ( 47. 1) 173 ( 43. 8) 359 ( 45. 4) Negative117 ( 30. 4) 132 ( 33. 4) 252 ( 31. 9) Extra pulmonary92 ( 23. 3) 90 ( 22. 8) 179 ( 23) HIV statusPositive37 ( 9. 4) 40 ( 10. 1) 77 ( 9. 7 )< 0. 001Negative246 ( 62. 3) 289 ( 73. 2) 535 ( 67. 7) Unknown112 ( 28. 4) 66 ( 16. 7) 178 ( 22. 5) Received CPTb ( n = 77) Yes18 ( 48. 6) 17 ( 42. 5) 35 ( 45. 5) 0. 6Received CPT or ARTc ( n = 77) Yes6 ( 16. 2) 6 ( 15. 0) 12 ( 15. 6) 0. 8Received ART ( n = 77) Yes12 ( 32. 4) 9 ( 22. 5) 21 ( 27. 3) 0. 3Baseline sputum smearPositive186 ( 47. 1) 173 ( 43. 8) 359 ( 45. 4) 0. 6Negative151 ( 38. 2) 165 ( 41. 8) 316 ( 40) Unknown58 ( 14. 7) 57 ( 14. 4) 115 ( 14. 6) aStandard deviation, b CPT Cotrimoxazole prophylactic therapy, c ART antiretroviral therapy	HIV,19,22,Organism/Species	Cotrimoxazole,64,77,Chemical/Drug	tuberculosis,307,319,Disease/Disorder	HIV,1428,1431,Organism/Species	Cotrimoxazole,1971,1984,Chemical/Drug	"[{""token"": ""HIV"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Organism/Species""}, {""token"": ""Cotrimoxazole"", ""start_span"": 64, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""tuberculosis"", ""start_span"": 307, ""end_span"": 319, ""type"": ""Disease/Disorder""}, {""token"": ""HIV"", ""start_span"": 1428, ""end_span"": 1431, ""type"": ""Organism/Species""}, {""token"": ""Cotrimoxazole"", ""start_span"": 1971, ""end_span"": 1984, ""type"": ""Chemical/Drug""}]"	test
Besides, statistically significant differences in successful outcomes, 64 ( 83. 1 %), 482 ( 90. 1 %) and 149 ( 83. 7 %, p = 0. 005 were also found among HIV positive, HIV negatives and unknown HIV status TB cases, respectively. Table 2Patient follow - up measures and treatment outcomes of TB patients registered during 2008 – 2014, Southwest EthiopiaVariablesContinuation phase treatment regimen6EH ( n = 395) n (%) 4RH ( n = 395) n (%) Total N (%) P valueWeight at 2nd monthMean ± SD49. 9 ± 8. 950. 8 ± 8. 250. 4 ± 8. 60. 2Weight at 5th monthMean ± SD51. 4 ± 8. 651. 3 ± 7. 351. 3 ± 7. 90. 9Weight at 6 / 7th monthMean ± SD51. 1 ± 8. 952. 5 ± 6. 551. 7 ± 7. 90. 3Change in weight at 2nd monthNot increased49 ( 12. 4) 61 ( 15. 4) 110 ( 13. 9) 0. 4Increased191 ( 48. 4) 177 ( 44. 8) 368 ( 46. 6) Unknown155 ( 39. 2) 157 ( 39. 7) 312 ( 39. 5) Sputum smear end of 2nd month ( n = 359) Positive4 ( 2. 2) 2 ( 1. 2) 6 ( 1. 7) 0. 09Negative130 ( 69. 9) 138 ( 79. 8) 268 ( 74. 7) Unknown52 ( 28) 33 ( 19. 1) 85 ( 23. 7) Sputum smear end of 5th month ( n = 359) Positive1 ( 0. 5) 0 ( 0) 1 ( 0. 3) 0. 03Negative83 ( 44. 6) 100 ( 57. 8) 183 ( 51) Unknown102 ( 54. 8) 73 ( 42. 2) 175 ( 48. 7) Sputum smear end of 6 / 7th month ( n = 359) Positive0000. 8Negative94 ( 50. 5) 85 ( 49. 1) 179 ( 49. 9) Unknown92 ( 49. 5) 88 ( 50. 9) 180 ( 50. 1) Sputum smear done during treatment ( n = 359) No44 ( 23. 7) 33 ( 19. 1) 77 ( 21. 4) 0. 3At least once142 ( 76. 3) 140 ( 80. 9) 282 ( 78. 6) Continuation phase visitMean ± SD5. 8 ± 1. 15. 4 ± 3. 10. 09Treatment outcomeSuccessful337 ( 85. 3) 358 ( 90. 6) 695 ( 88) 0. 02Cured77 ( 19. 5) 85 ( 21. 5) 162 ( 20. 5) Completed260 ( 65. 8) 273 ( 69. 1) 533 ( 67) Unsuccessful58 ( 14. 7) 37 ( 9. 4) 95 ( 12) Died28 ( 7. 1) 18 ( 4. 6) 46 ( 5. 8) Defaulted29 ( 7. 3) 19 ( 4. 8) 48 ( 6. 1) Failure1 ( 0. 3) 01 ( 0. 1)	HIV,153,156,Organism/Species	HIV,167,170,Organism/Species	HIV,193,196,Organism/Species	TB,204,206,Disease/Disorder	TB,290,292,Disease/Disorder	"[{""token"": ""HIV"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Organism/Species""}, {""token"": ""TB"", ""start_span"": 204, ""end_span"": 206, ""type"": ""Disease/Disorder""}, {""token"": ""TB"", ""start_span"": 290, ""end_span"": 292, ""type"": ""Disease/Disorder""}]"	test
Similarly, type II and V secretion systems generally transport proteins to the surface of the host cell and are involved in the extracellular release of various toxins and hydrolytic enzymes such as exotoxin A, Las A, Las B, protease and elastase [ 21 ], [ 22 ].	exotoxin A,199,209,Gene/Protein	Las A,211,216,Gene/Protein	Las B,218,223,Gene/Protein	protease,225,233,Gene/Protein	elastase,238,246,Gene/Protein	"[{""token"": ""exotoxin A"", ""start_span"": 199, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""Las A"", ""start_span"": 211, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""Las B"", ""start_span"": 218, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""protease"", ""start_span"": 225, ""end_span"": 233, ""type"": ""Gene/Protein""}, {""token"": ""elastase"", ""start_span"": 238, ""end_span"": 246, ""type"": ""Gene/Protein""}]"	test
The mitogen - activated protein kinase ( MAPK) and the NF - κB signalling pathways are implicated in the production of TNF - α and IL - 6 in macrophages [ 48 ].	mitogen - activated protein kinase,4,38,Gene/Protein	MAPK,41,45,Gene/Protein	NF - κB,55,62,Gene/Protein	TNF - α,119,126,Gene/Protein	IL - 6,131,137,Gene/Protein	"[{""token"": ""mitogen - activated protein kinase"", ""start_span"": 4, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""NF - \u03baB"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""TNF - \u03b1"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 131, ""end_span"": 137, ""type"": ""Gene/Protein""}]"	test
One of the ways to activate NF - κB by extracellular stimuli involves the rapid degradation of IκB - α as a consequence of IκB - α phosphorylation at Ser32 by IκB kinase, which corresponds to IKK in the so - called canonical pathway.	NF - κB,28,35,Gene/Protein	IκB - α,95,102,Gene/Protein	IκB - α,123,130,Gene/Protein	IκB kinase,159,169,Gene/Protein	IKK,192,195,Gene/Protein	"[{""token"": ""NF - \u03baB"", ""start_span"": 28, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""I\u03baB - \u03b1"", ""start_span"": 95, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""I\u03baB - \u03b1"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""I\u03baB kinase"", ""start_span"": 159, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""IKK"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	test
We studied the effect of inulin and FOS on the activation ( phosphorylation) of IκB - α and MAPK, ERK, JNK and p38 by Western blot analysis in macrophages infected with P. aeruginosa.	IκB - α,80,87,Gene/Protein	MAPK,92,96,Gene/Protein	ERK,98,101,Gene/Protein	JNK,103,106,Gene/Protein	p38,111,114,Gene/Protein	"[{""token"": ""I\u03baB - \u03b1"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""MAPK"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""p38"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}]"	test
We used mutants deficient in PtxS and PtxR, two transcriptional regulators that control the expression of the toxA gene, encoding the exotoxin A virulence factor [ 50 ].	PtxS,29,33,Gene/Protein	PtxR,38,42,Gene/Protein	transcriptional regulators,48,74,Gene/Protein	toxA,110,114,Gene/Protein	exotoxin A,134,144,Gene/Protein	"[{""token"": ""PtxS"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""PtxR"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional regulators"", ""start_span"": 48, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""toxA"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""exotoxin A"", ""start_span"": 134, ""end_span"": 144, ""type"": ""Gene/Protein""}]"	test
C) The macrophage mortality induced by WT P. aeruginosa and its ptxS and ptxR mutants was measured by the total release of cytoplasmic lactate dehydrogenase ( LDH ). * P < 0. 05 vs macrophage without bacteria and & P < 0. 05 vs macrophage with WT ( ANOVA followed by least significance tests ).	ptxS,64,68,Gene/Protein	ptxR,73,77,Gene/Protein	lactate dehydrogenase,135,156,Gene/Protein	LDH,159,162,Gene/Protein	bacteria,200,208,Organism/Species	"[{""token"": ""ptxS"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""ptxR"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""lactate dehydrogenase"", ""start_span"": 135, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""LDH"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""bacteria"", ""start_span"": 200, ""end_span"": 208, ""type"": ""Organism/Species""}]"	test
Remarkably, treatment with FOS attenuated significantly all the steps of this response, i. e. secretion of IL - 6, IL - 10 and TNF - α, IκB - α phosphorylation and p65 nuclear translocation ( Figs.	IL - 6,107,113,Gene/Protein	IL - 10,115,122,Gene/Protein	TNF - α,127,134,Gene/Protein	IκB - α,136,143,Gene/Protein	p65,164,167,Gene/Protein	"[{""token"": ""IL - 6"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 115, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""TNF - \u03b1"", ""start_span"": 127, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""I\u03baB - \u03b1"", ""start_span"": 136, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	test
These changes correlated with toxA expression, since the highest cytokine secretion / toxA transcription was observed in the ptxS mutant, followed by the WT strain and the ptxR mutant [ 51 ].	toxA,30,34,Gene/Protein	cytokine,65,73,Gene/Protein	toxA,86,90,Gene/Protein	ptxS,125,129,Gene/Protein	ptxR,172,176,Gene/Protein	"[{""token"": ""toxA"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 65, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""toxA"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""ptxS"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""ptxR"", ""start_span"": 172, ""end_span"": 176, ""type"": ""Gene/Protein""}]"	test
Several classes of antibiotics including cephalosporins, penicillins, carbapenems, quinolones and aminoglycosides are currently been used to combat P. aeruginosa clinically, but specific sensitivity testing is mandatory [ 66 ].	cephalosporins,41,55,Chemical/Drug	penicillins,57,68,Chemical/Drug	carbapenems,70,81,Chemical/Drug	quinolones,83,93,Chemical/Drug	aminoglycosides,98,113,Chemical/Drug	"[{""token"": ""cephalosporins"", ""start_span"": 41, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""penicillins"", ""start_span"": 57, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""carbapenems"", ""start_span"": 70, ""end_span"": 81, ""type"": ""Chemical/Drug""}, {""token"": ""quinolones"", ""start_span"": 83, ""end_span"": 93, ""type"": ""Chemical/Drug""}, {""token"": ""aminoglycosides"", ""start_span"": 98, ""end_span"": 113, ""type"": ""Chemical/Drug""}]"	test
To remove lymphocytes, CD161. 1 - biotin ( 1 ∶ 200 ), CD45RA - PE ( 1 ∶ 200) and CD3 ( 1 ∶ 150) ( Biosciences ), were added and incubated at 4 ° C for 30 min.	CD161,23,28,Gene/Protein	biotin,34,40,Chemical/Drug	CD45RA,54,60,Gene/Protein	PE,63,65,Gene/Protein	CD3,81,84,Gene/Protein	"[{""token"": ""CD161"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""biotin"", ""start_span"": 34, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""CD45RA"", ""start_span"": 54, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""PE"", ""start_span"": 63, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene/Protein""}]"	test
Phosphoproteomic analysis of anaplastic lymphoma kinase ( ALK) downstream signaling pathways identifies signal transducer and activator of transcription 3 as a functional target of activated ALK in neuroblastoma cells	anaplastic lymphoma kinase,29,55,Gene/Protein	ALK,58,61,Gene/Protein	signal transducer and activator of transcription 3,104,154,Gene/Protein	ALK,191,194,Gene/Protein	neuroblastoma,198,211,Disease/Disorder	"[{""token"": ""anaplastic lymphoma kinase"", ""start_span"": 29, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""signal transducer and activator of transcription 3"", ""start_span"": 104, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 191, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""neuroblastoma"", ""start_span"": 198, ""end_span"": 211, ""type"": ""Disease/Disorder""}]"	test
In the majority of cases, ALK is activated by fusion with a dimerizing partner protein as a result of chromosomal translocation events, most studied in the case of the nucleophosmin – ALK and echinoderm microtubule - associated protein - like 4 – ALK oncoproteins.	ALK,26,29,Gene/Protein	nucleophosmin,168,181,Gene/Protein	ALK,184,187,Gene/Protein	echinoderm microtubule - associated protein - like 4,192,244,Gene/Protein	ALK oncoproteins,247,263,Gene/Protein	"[{""token"": ""ALK"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""nucleophosmin"", ""start_span"": 168, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 184, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""echinoderm microtubule - associated protein - like 4"", ""start_span"": 192, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""ALK oncoproteins"", ""start_span"": 247, ""end_span"": 263, ""type"": ""Gene/Protein""}]"	test
Many of the tyrosine kinases in the human kinome are implicated in human cancers 1, and provide important targets for cancer treatment, as well as biomarkers for patient stratification.	tyrosine kinases,12,28,Gene/Protein	human,36,41,Organism/Species	human,67,72,Organism/Species	cancers,73,80,Disease/Disorder	cancer,118,124,Disease/Disorder	"[{""token"": ""tyrosine kinases"", ""start_span"": 12, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Organism/Species""}, {""token"": ""cancers"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Disease/Disorder""}, {""token"": ""cancer"", ""start_span"": 118, ""end_span"": 124, ""type"": ""Disease/Disorder""}]"	test
Presented and compared side - by - side with our phosphotyrosine mapping of activated full - length ALK are the global surveys of phosphotyrosine peptides identified in EML4 – ALK and NPM – ALK 29, 30.	ALK,100,103,Gene/Protein	EML4,169,173,Gene/Protein	ALK,176,179,Gene/Protein	NPM,184,187,Gene/Protein	ALK,190,193,Gene/Protein	"[{""token"": ""ALK"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""EML4"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""NPM"", ""start_span"": 184, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 190, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	test
Interestingly, whereas long - term stimulation of the wild - type ALK receptor did lead to visible tyrosine phosphorylation of STAT3, this was not prominently observed after 30 min of stimulation, a time point when ALK and ERK1 / 2 were highly phosphorylated ( Fig. 2A, compare lanes 3 and 4 ).	ALK receptor,66,78,Gene/Protein	tyrosine,99,107,Chemical/Drug	STAT3,127,132,Gene/Protein	ALK,215,218,Gene/Protein	ERK1,223,227,Gene/Protein	"[{""token"": ""ALK receptor"", ""start_span"": 66, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""tyrosine"", ""start_span"": 99, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""STAT3"", ""start_span"": 127, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 215, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""ERK1"", ""start_span"": 223, ""end_span"": 227, ""type"": ""Gene/Protein""}]"	test
( B, C) PC12 cells were transfected with either wild - type ALK or the ALKF1174S mutant together with FLAG - tagged STAT3 prior to stimulation with 1 μg · mL − 1 ALK - activating mAb ( mAb46) for 24 h, in the presence or absence of 250 nm crizotinib, as indicated.	ALK,60,63,Gene/Protein	FLAG,102,106,Gene/Protein	STAT3,116,121,Gene/Protein	ALK,162,165,Gene/Protein	crizotinib,239,249,Chemical/Drug	"[{""token"": ""ALK"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""FLAG"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 162, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""crizotinib"", ""start_span"": 239, ""end_span"": 249, ""type"": ""Chemical/Drug""}]"	test
Lysates were immunoprecipitated ( IP) with either antibody against FLAG ( M2) ( B) or with antibody against ALK ( mAb31) ( C ), and this was followed by immunoblotting for ALK, FLAG, and STAT3, as indicated.	FLAG,67,71,Gene/Protein	ALK,108,111,Gene/Protein	ALK,172,175,Gene/Protein	FLAG,177,181,Gene/Protein	STAT3,187,192,Gene/Protein	"[{""token"": ""FLAG"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 172, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""FLAG"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 187, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	test
These neuroblastoma cell lines are all ALK gain - of - function in nature, containing either an activated ALK mutation ( ALKR1275Q, CBL - GA; ALKF1174V, CLB - GE; ALKF1174L, Kelly) or overexpressing an ALK receptor with an extracellular domain deletion ( CLB - BARΔexon 4 – 12 ), and express different levels of MYCN ( Fig. S3) 38, 39.	neuroblastoma,6,19,Disease/Disorder	ALK,39,42,Gene/Protein	ALK,106,109,Gene/Protein	ALK receptor,202,214,Gene/Protein	MYCN,312,316,Gene/Protein	"[{""token"": ""neuroblastoma"", ""start_span"": 6, ""end_span"": 19, ""type"": ""Disease/Disorder""}, {""token"": ""ALK"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""ALK receptor"", ""start_span"": 202, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""MYCN"", ""start_span"": 312, ""end_span"": 316, ""type"": ""Gene/Protein""}]"	test
We investigated ALK, STAT3 and MYCN levels in CLB - GE, CLB - BAR, Kelly and CLB - GA neuroblastoma cell lines upon treatment with STAT3 inhibitors ( Fig. 4A – D ).	ALK,16,19,Gene/Protein	STAT3,21,26,Gene/Protein	MYCN,31,35,Gene/Protein	neuroblastoma,86,99,Disease/Disorder	STAT3,131,136,Gene/Protein	"[{""token"": ""ALK"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""MYCN"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""neuroblastoma"", ""start_span"": 86, ""end_span"": 99, ""type"": ""Disease/Disorder""}, {""token"": ""STAT3"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Gene/Protein""}]"	test
In keeping with the results obtained with STAT3 siRNA treatment, both inhibitors reduced MYCN levels ( Fig. 4A – D, compare lanes 3 and 4 with lane 1 ), suggesting that STAT3 may act between the ALK receptor and expression of MYCN.	STAT3,42,47,Gene/Protein	MYCN,89,93,Gene/Protein	STAT3,169,174,Gene/Protein	ALK receptor,195,207,Gene/Protein	MYCN,226,230,Gene/Protein	"[{""token"": ""STAT3"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""MYCN"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 169, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""ALK receptor"", ""start_span"": 195, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""MYCN"", ""start_span"": 226, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	test
To investigate further whether STAT3 is involved in ALK - activated initiation of MYCN transcription, we employed an MYCNP – luciferase assay in two independent neuroblastoma cell lines 36.	STAT3,31,36,Gene/Protein	ALK,52,55,Gene/Protein	MYCN,82,86,Gene/Protein	luciferase,125,135,Gene/Protein	neuroblastoma,161,174,Disease/Disorder	"[{""token"": ""STAT3"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""MYCN"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""luciferase"", ""start_span"": 125, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""neuroblastoma"", ""start_span"": 161, ""end_span"": 174, ""type"": ""Disease/Disorder""}]"	test
It is interesting to compare the results of this study with earlier phosphoproteomics analysis on oncogenic ALK fusion proteins, such as EML4 – ALK and NPM – ALK 29, 30.	ALK,108,111,Gene/Protein	EML4,137,141,Gene/Protein	ALK,144,147,Gene/Protein	NPM,152,155,Gene/Protein	ALK,158,161,Gene/Protein	"[{""token"": ""ALK"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""EML4"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""NPM"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""ALK"", ""start_span"": 158, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	test
However, serine / threonine phosphorylation is known to have important regulatory functions for, for example, fibroblast growth factor receptor, epidermal growth factor receptor 50 – 51, and Kit 52, to name but a few.	serine,9,15,Chemical/Drug	threonine,18,27,Chemical/Drug	fibroblast growth factor receptor,110,143,Gene/Protein	epidermal growth factor receptor,145,177,Gene/Protein	Kit,191,194,Gene/Protein	"[{""token"": ""serine"", ""start_span"": 9, ""end_span"": 15, ""type"": ""Chemical/Drug""}, {""token"": ""threonine"", ""start_span"": 18, ""end_span"": 27, ""type"": ""Chemical/Drug""}, {""token"": ""fibroblast growth factor receptor"", ""start_span"": 110, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""epidermal growth factor receptor"", ""start_span"": 145, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""Kit"", ""start_span"": 191, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	test
Third, hBD3 markedly inhibited NF - κB activation by decreasing the phosphorylation of IKK - α / β, IκB, and p65 subunit within 30 min.	hBD3,7,11,Gene/Protein	NF - κB,31,38,Gene/Protein	IKK - α,87,94,Gene/Protein	IκB,100,103,Gene/Protein	p65,109,112,Gene/Protein	"[{""token"": ""hBD3"", ""start_span"": 7, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""NF - \u03baB"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""IKK - \u03b1"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""I\u03baB"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}]"	test
Endothelial cells stimulated with TNF - α produce proinflammatory mediators, including interleukin - ( IL -) 6, IL - 8, and monocyte chemoattractant protein - 1 ( MCP - 1 ), which cause more monocytes to be recruited.	TNF - α,34,41,Gene/Protein	interleukin - ( IL -) 6,87,110,Gene/Protein	IL - 8,112,118,Gene/Protein	monocyte chemoattractant protein - 1,124,160,Gene/Protein	MCP - 1,163,170,Gene/Protein	"[{""token"": ""TNF - \u03b1"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - ( IL -) 6"", ""start_span"": 87, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 112, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""monocyte chemoattractant protein - 1"", ""start_span"": 124, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""MCP - 1"", ""start_span"": 163, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	test
In addition, hBD3 treatment dose - dependently prevented the upregulation of ICAM - 1, VCAM - 1, and E - selectin levels by TNF - α.	hBD3,13,17,Gene/Protein	ICAM - 1,77,85,Gene/Protein	VCAM - 1,87,95,Gene/Protein	E - selectin,101,113,Gene/Protein	TNF - α,124,131,Gene/Protein	"[{""token"": ""hBD3"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 77, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 87, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""E - selectin"", ""start_span"": 101, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""TNF - \u03b1"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Gene/Protein""}]"	test
The protein levels of MBP, Olig1, GFAP, GS, and GAPDH determined by Western blot analysis ( d ).	MBP,22,25,Gene/Protein	Olig1,27,32,Gene/Protein	GFAP,34,38,Gene/Protein	GS,40,42,Gene/Protein	GAPDH,48,53,Gene/Protein	"[{""token"": ""MBP"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""Olig1"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""GFAP"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""GS"", ""start_span"": 40, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""GAPDH"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Gene/Protein""}]"	test
Glycogen is a polysaccharide and the main storage form of glucose from bacteria such as Escherichia coli to yeasts and mammals.	glucose,58,65,Chemical/Drug	bacteria,71,79,Organism/Species	Escherichia coli,88,104,Organism/Species	yeasts,108,114,Organism/Species	mammals,119,126,Organism/Species	"[{""token"": ""glucose"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Chemical/Drug""}, {""token"": ""bacteria"", ""start_span"": 71, ""end_span"": 79, ""type"": ""Organism/Species""}, {""token"": ""Escherichia coli"", ""start_span"": 88, ""end_span"": 104, ""type"": ""Organism/Species""}, {""token"": ""yeasts"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Organism/Species""}, {""token"": ""mammals"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Organism/Species""}]"	test
Transcription of CsrB and CsrC is activated by the BarA / UvrY two - component system ( 23, 25, 28) and is repressed by cAMP - CRP ( 29 ).	CsrB,17,21,Gene/Protein	CsrC,26,30,Gene/Protein	BarA,51,55,Gene/Protein	UvrY,58,62,Gene/Protein	CRP,127,130,Gene/Protein	"[{""token"": ""CsrB"", ""start_span"": 17, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""CsrC"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""BarA"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""UvrY"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""CRP"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Gene/Protein""}]"	test
The beads were cultured in six - well plates under conditions of 5% O2 with DMEM / F12 medium containing 1% insulin, transferrin and selenous ( ITS) ( Sigma - Aldrich ), 100 nM dexamethasone ( Sigma - Aldrich) and 10 ng / ml transforming growth factor - β1 ( TGF - β1) ( PeproTech Rocky Hill, NJ, USA ).	insulin,108,115,Gene/Protein	transferrin,117,128,Gene/Protein	dexamethasone,177,190,Chemical/Drug	transforming growth factor - β1,225,256,Gene/Protein	TGF - β1,259,267,Gene/Protein	"[{""token"": ""insulin"", ""start_span"": 108, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""transferrin"", ""start_span"": 117, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""dexamethasone"", ""start_span"": 177, ""end_span"": 190, ""type"": ""Chemical/Drug""}, {""token"": ""transforming growth factor - \u03b21"", ""start_span"": 225, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""TGF - \u03b21"", ""start_span"": 259, ""end_span"": 267, ""type"": ""Gene/Protein""}]"	test
Nicotine had an obvious adverse effect on cell morphology of the regenerated tissue and synthesis of cartilage matrix. Fig. 1Effects of nicotine on the repair of the cartilage defect with BMSCs transplantation in a rat model after 12 weeks. a and b Macroscopic observation of cartilage repair (× 100 ). c Macroscopic scores of cartilage repair. d and e Safranin - O and fast green staining of cartilage repair (× 100 ). f Histological scores of cartilage repair.	Nicotine,0,8,Chemical/Drug	nicotine,136,144,Chemical/Drug	rat,215,218,Organism/Species	Safranin - O,353,365,Chemical/Drug	fast green,370,380,Chemical/Drug	"[{""token"": ""Nicotine"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine"", ""start_span"": 136, ""end_span"": 144, ""type"": ""Chemical/Drug""}, {""token"": ""rat"", ""start_span"": 215, ""end_span"": 218, ""type"": ""Organism/Species""}, {""token"": ""Safranin - O"", ""start_span"": 353, ""end_span"": 365, ""type"": ""Chemical/Drug""}, {""token"": ""fast green"", ""start_span"": 370, ""end_span"": 380, ""type"": ""Chemical/Drug""}]"	test
We found that 10μM methyllycaconitine ( MLA ), the specific antagonist of α7 - nAChR, conversely eliminated the nicotine - induced calcium influx ( Fig. 3d ), implying that the effect of nicotine on BMSCs was fulfilled through α7 - nAChR.	methyllycaconitine,19,37,Chemical/Drug	α7 - nAChR,74,84,Gene/Protein	nicotine,112,120,Chemical/Drug	nicotine,187,195,Chemical/Drug	α7 - nAChR,227,237,Gene/Protein	"[{""token"": ""methyllycaconitine"", ""start_span"": 19, ""end_span"": 37, ""type"": ""Chemical/Drug""}, {""token"": ""\u03b17 - nAChR"", ""start_span"": 74, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""nicotine"", ""start_span"": 112, ""end_span"": 120, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine"", ""start_span"": 187, ""end_span"": 195, ""type"": ""Chemical/Drug""}, {""token"": ""\u03b17 - nAChR"", ""start_span"": 227, ""end_span"": 237, ""type"": ""Gene/Protein""}]"	test
Nicotine suppressed Sox9 by activating the Ca2 +/ calcineurin / NFATc2 signaling pathway through α7 - nAChR	Nicotine,0,8,Chemical/Drug	Sox9,20,24,Gene/Protein	calcineurin,50,61,Gene/Protein	NFATc2,64,70,Gene/Protein	α7 - nAChR,97,107,Gene/Protein	"[{""token"": ""Nicotine"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical/Drug""}, {""token"": ""Sox9"", ""start_span"": 20, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""calcineurin"", ""start_span"": 50, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""NFATc2"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""\u03b17 - nAChR"", ""start_span"": 97, ""end_span"": 107, ""type"": ""Gene/Protein""}]"	test
Then, NFATc2 and HDAC1 bound on the Sox9 promoter reduced the levels of H3K9ac and H3K14ac on the Sox9 promoter and decreased Sox9 expression.	NFATc2,6,12,Gene/Protein	HDAC1,17,22,Gene/Protein	Sox9,36,40,Gene/Protein	Sox9,98,102,Gene/Protein	Sox9,126,130,Gene/Protein	"[{""token"": ""NFATc2"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""HDAC1"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Gene/Protein""}]"	test
The result showed that the interaction of NFATc2 with HDAC1 was enhanced in a concentration - dependent manner after nicotine exposure ( Fig. 6a ), and no significant change of interaction was observed when Si - NFATc2 and MLA were used before nicotine treatment ( Fig. 6b ).	NFATc2,42,48,Gene/Protein	HDAC1,54,59,Gene/Protein	nicotine,117,125,Chemical/Drug	NFATc2,212,218,Gene/Protein	nicotine,244,252,Chemical/Drug	"[{""token"": ""NFATc2"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""HDAC1"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""nicotine"", ""start_span"": 117, ""end_span"": 125, ""type"": ""Chemical/Drug""}, {""token"": ""NFATc2"", ""start_span"": 212, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""nicotine"", ""start_span"": 244, ""end_span"": 252, ""type"": ""Chemical/Drug""}]"	test
Histone acetyltransferases ( HATs) and HDACs are two classes of histone acetylation enzymes, which determine the acetylation status of histones of genes.	Histone acetyltransferases,0,26,Gene/Protein	HATs,29,33,Gene/Protein	HDACs,39,44,Gene/Protein	histone,64,71,Gene/Protein	histones,135,143,Gene/Protein	"[{""token"": ""Histone acetyltransferases"", ""start_span"": 0, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""HATs"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""HDACs"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""histone"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""histones"", ""start_span"": 135, ""end_span"": 143, ""type"": ""Gene/Protein""}]"	test
Our in vitro data are consistent with the in vivo results where nicotine directly decreased the expression of Sox9 through α7 - nAChR by suppressing the histone acetylation of the Sox9 promoter during the process of BMSCs chondrogenic differentiation.	nicotine,64,72,Chemical/Drug	Sox9,110,114,Gene/Protein	α7 - nAChR,123,133,Gene/Protein	histone,153,160,Gene/Protein	Sox9,180,184,Gene/Protein	"[{""token"": ""nicotine"", ""start_span"": 64, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""Sox9"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""\u03b17 - nAChR"", ""start_span"": 123, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""histone"", ""start_span"": 153, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""Sox9"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	test
NFAT is a family of transcription factors critical in regulating early gene transcription in response to T cell receptor - mediated signals in lymphocytes [ 42 ]. NFATc2 is a repressor of chondrogenesis [ 21] and can induce gene silencing through interaction with HDAC [ 22 ].	NFAT,0,4,Gene/Protein	transcription factors,20,41,Gene/Protein	T cell receptor,105,120,Gene/Protein	NFATc2,163,169,Gene/Protein	HDAC,264,268,Gene/Protein	"[{""token"": ""NFAT"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 20, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""T cell receptor"", ""start_span"": 105, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""NFATc2"", ""start_span"": 163, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""HDAC"", ""start_span"": 264, ""end_span"": 268, ""type"": ""Gene/Protein""}]"	test
Furthermore, depression is a risk factor for the onset of type 2 diabetes mellitus, hypertension, coronary heart disease, cancer, and so on [ 1 ], which is projected to become the second biggest contributor to the global burden of disease and disability by 2020 according to WHO ' s prediction.	depression,13,23,Disease/Disorder	type 2 diabetes mellitus,58,82,Disease/Disorder	hypertension,84,96,Disease/Disorder	coronary heart disease,98,120,Disease/Disorder	cancer,122,128,Disease/Disorder	"[{""token"": ""depression"", ""start_span"": 13, ""end_span"": 23, ""type"": ""Disease/Disorder""}, {""token"": ""type 2 diabetes mellitus"", ""start_span"": 58, ""end_span"": 82, ""type"": ""Disease/Disorder""}, {""token"": ""hypertension"", ""start_span"": 84, ""end_span"": 96, ""type"": ""Disease/Disorder""}, {""token"": ""coronary heart disease"", ""start_span"": 98, ""end_span"": 120, ""type"": ""Disease/Disorder""}, {""token"": ""cancer"", ""start_span"": 122, ""end_span"": 128, ""type"": ""Disease/Disorder""}]"	test
Using the circadian mouse mutant ClockΔ19 / Δ19, we also showed that a functional circadian clock, known to modulate C / EBP and CPS1 expression, was required for NOB induction of CPS1 under the HFD condition.	mouse,20,25,Organism/Species	clock,92,97,Gene/Protein	C / EBP,117,124,Gene/Protein	CPS1,129,133,Gene/Protein	CPS1,180,184,Gene/Protein	"[{""token"": ""mouse"", ""start_span"": 20, ""end_span"": 25, ""type"": ""Organism/Species""}, {""token"": ""clock"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""C / EBP"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""CPS1"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""CPS1"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	test
Carbamoyl phosphate synthetase 1 ( CPS1) catalyzes the first reaction wherein ammonia and bicarbonate combine to form carbamoyl phosphate, and mice deficient in Cps1 suffered pronounced hyperammonemia and neonatal lethality [ 9 ].	Carbamoyl phosphate synthetase 1,0,32,Gene/Protein	CPS1,35,39,Gene/Protein	mice,143,147,Organism/Species	Cps1,161,165,Gene/Protein	hyperammonemia,186,200,Disease/Disorder	"[{""token"": ""Carbamoyl phosphate synthetase 1"", ""start_span"": 0, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""CPS1"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Organism/Species""}, {""token"": ""Cps1"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""hyperammonemia"", ""start_span"": 186, ""end_span"": 200, ""type"": ""Disease/Disorder""}]"	test
Under RC, NOB treatment showed only modest effects on expression of the four other urea cycle genes ( Otc, Ass1, Asl, Arg1) relative to Veh controls ( Fig. 5b - e ).	urea,83,87,Chemical/Drug	Otc,102,105,Gene/Protein	Ass1,107,111,Gene/Protein	Asl,113,116,Gene/Protein	Arg1,118,122,Gene/Protein	"[{""token"": ""urea"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Chemical/Drug""}, {""token"": ""Otc"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""Ass1"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""Asl"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""Arg1"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene/Protein""}]"	test
Besides transcriptional regulation ( C / EBP, glucocorticoid receptor, CREB and HNF3) and the allosteric cofactor NAG [ 7, 17 ], recent mechanistic studies have also underscored the importance of post - translational modifications ( PTMs) for CPS1 protein activity [ 11 – 13, 47 ].	C / EBP,37,44,Gene/Protein	glucocorticoid receptor,46,69,Gene/Protein	CREB,71,75,Gene/Protein	HNF3,80,84,Gene/Protein	CPS1,243,247,Gene/Protein	"[{""token"": ""C / EBP"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""glucocorticoid receptor"", ""start_span"": 46, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""HNF3"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""CPS1"", ""start_span"": 243, ""end_span"": 247, ""type"": ""Gene/Protein""}]"	test
Herpes zoster ( HZ ), also known as shingles, is caused by the reactivation of the varicella zoster virus ( VZV ).	Herpes zoster,0,13,Disease/Disorder	HZ,16,18,Disease/Disorder	shingles,36,44,Disease/Disorder	varicella zoster virus,83,105,Organism/Species	VZV,108,111,Organism/Species	"[{""token"": ""Herpes zoster"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Disease/Disorder""}, {""token"": ""HZ"", ""start_span"": 16, ""end_span"": 18, ""type"": ""Disease/Disorder""}, {""token"": ""shingles"", ""start_span"": 36, ""end_span"": 44, ""type"": ""Disease/Disorder""}, {""token"": ""varicella zoster virus"", ""start_span"": 83, ""end_span"": 105, ""type"": ""Organism/Species""}, {""token"": ""VZV"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Organism/Species""}]"	test
Evidence for the efficacy of a VZV vaccine in the prevention of HZ and PHN episodes and attenuation of the severity of HZ and PHN episodes and associated impact has been documented in recent years [ 11, 33 ].	VZV,31,34,Organism/Species	HZ,64,66,Disease/Disorder	PHN,71,74,Disease/Disorder	HZ,119,121,Disease/Disorder	PHN,126,129,Disease/Disorder	"[{""token"": ""VZV"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Organism/Species""}, {""token"": ""HZ"", ""start_span"": 64, ""end_span"": 66, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Disease/Disorder""}, {""token"": ""HZ"", ""start_span"": 119, ""end_span"": 121, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Disease/Disorder""}]"	test
Nonetheless, recent research indicates that both HZ and PHN patients demonstrate statistically significant and clinically relevant deficits in HRQoL when scores for validated measures of HRQoL ( e. g. SF - 36 and EQ - 5D) among these populations are compared to those from aged - matched normative samples ( Figures 3 and 4) [ 14, 50 ]. Figure 3 Comparison of SF - 36 domain and component scores for HZ patients compared to age - matched norms [ 50 ]. No * s p ≥ 0. 05, * p < 0. 05; ** p > 0. 01; *** p < 0. 001. † = clinically meaningful PF = Physical functioning, R - P = Role - physical, BP = Bodily pain, GH = General health, V = Vitality, SF = Social functioning, R - E = Role - emotional, MH = Mental health, PCS = Physical component summary, MCS = Mental component summary. Note: Data collected on initial presentation of HZ to healthcare professional and then again 7 - 14 days later ( follow - up ). Figure 4 Comparison of SF - 36 domain and component scores for PHN patients compared to age - matched norms [ 14 ]. No * s p ≥ 0. 05, * p < 0. 05; ** p < 0. 01; *** p < 0. 001. † = clinically meaningful PF = Physical functioning, R - P = Role - physical, BP = Bodily pain, GH = General health, V = Vitality, SF = Social functioning, R - E = Role - emotional, MH = Mental health, PCS = Physical component summary, MCS = Mental component summary.	HZ,49,51,Disease/Disorder	PHN,56,59,Disease/Disorder	HZ,400,402,Disease/Disorder	HZ,829,831,Disease/Disorder	PHN,972,975,Disease/Disorder	"[{""token"": ""HZ"", ""start_span"": 49, ""end_span"": 51, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Disease/Disorder""}, {""token"": ""HZ"", ""start_span"": 400, ""end_span"": 402, ""type"": ""Disease/Disorder""}, {""token"": ""HZ"", ""start_span"": 829, ""end_span"": 831, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 972, ""end_span"": 975, ""type"": ""Disease/Disorder""}]"	test
To investigate the role of the P7 - 1 protein in virus pathogenicity, transgenic Arabidopsis thaliana plants were generated in which the P7 - 1 gene was expressed under the control of the 35S promoter.	P7 - 1,31,37,Gene/Protein	virus,49,54,Organism/Species	Arabidopsis thaliana,81,101,Organism/Species	plants,102,108,Organism/Species	P7 - 1,137,143,Gene/Protein	"[{""token"": ""P7 - 1"", ""start_span"": 31, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""virus"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Organism/Species""}, {""token"": ""Arabidopsis thaliana"", ""start_span"": 81, ""end_span"": 101, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Organism/Species""}, {""token"": ""P7 - 1"", ""start_span"": 137, ""end_span"": 143, ""type"": ""Gene/Protein""}]"	test
The RBSDV P7 - 1 - transgenic Arabidopsis plants ( named P7 - 1 - OE) were male sterility.	RBSDV,4,9,Organism/Species	P7 - 1,10,16,Gene/Protein	Arabidopsis,30,41,Organism/Species	plants,42,48,Organism/Species	P7 - 1,57,63,Gene/Protein	"[{""token"": ""RBSDV"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Organism/Species""}, {""token"": ""P7 - 1"", ""start_span"": 10, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""Arabidopsis"", ""start_span"": 30, ""end_span"": 41, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Organism/Species""}, {""token"": ""P7 - 1"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Gene/Protein""}]"	test
Tubule - forming and plasmodesmatal localization of RBSDV P7 - 1 are usually thought to be involved in cell - to - cell movement of the virus in plant and insect cells.	RBSDV,52,57,Organism/Species	P7 - 1,58,64,Gene/Protein	virus,136,141,Organism/Species	plant,145,150,Organism/Species	insect,155,161,Organism/Species	"[{""token"": ""RBSDV"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Organism/Species""}, {""token"": ""P7 - 1"", ""start_span"": 58, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""virus"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Organism/Species""}, {""token"": ""plant"", ""start_span"": 145, ""end_span"": 150, ""type"": ""Organism/Species""}, {""token"": ""insect"", ""start_span"": 155, ""end_span"": 161, ""type"": ""Organism/Species""}]"	test
Young instar nymphs of SBPHs ( small brown planthopper, L. striatellus) were fed RBSDV - infected rice plants for 2 days to acquire the virus.	SBPHs,23,28,Organism/Species	small brown planthopper,31,54,Organism/Species	RBSDV,81,86,Organism/Species	rice plants,98,109,Organism/Species	virus,136,141,Organism/Species	"[{""token"": ""SBPHs"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Organism/Species""}, {""token"": ""small brown planthopper"", ""start_span"": 31, ""end_span"": 54, ""type"": ""Organism/Species""}, {""token"": ""RBSDV"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Organism/Species""}, {""token"": ""rice plants"", ""start_span"": 98, ""end_span"": 109, ""type"": ""Organism/Species""}, {""token"": ""virus"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Organism/Species""}]"	test
But in transgenic plants, siliques remained small, producing no seeds, indicating the high degree of sterility of Arabidopsis plants ectopically expressing RBSDV P7 - 1 ( Figure 2B and 2C ).	plants,18,24,Organism/Species	Arabidopsis,114,125,Organism/Species	plants,126,132,Organism/Species	RBSDV,156,161,Organism/Species	P7 - 1,162,168,Gene/Protein	"[{""token"": ""plants"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Organism/Species""}, {""token"": ""Arabidopsis"", ""start_span"": 114, ""end_span"": 125, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 126, ""end_span"": 132, ""type"": ""Organism/Species""}, {""token"": ""RBSDV"", ""start_span"": 156, ""end_span"": 161, ""type"": ""Organism/Species""}, {""token"": ""P7 - 1"", ""start_span"": 162, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	test
For example, at flowers development 13 stage, the relative expression level of 4CL, CCoAOMT were 0. 8, 0. 3 in P7 - 1 - OE plants but 1. 3, 0. 7 in wild - type plants.	4CL,79,82,Gene/Protein	CCoAOMT,84,91,Gene/Protein	P7 - 1,111,117,Gene/Protein	plants,123,129,Organism/Species	plants,160,166,Organism/Species	"[{""token"": ""4CL"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""CCoAOMT"", ""start_span"": 84, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""P7 - 1"", ""start_span"": 111, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""plants"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 160, ""end_span"": 166, ""type"": ""Organism/Species""}]"	test
Furthermore, overexpressing RBSDV P7 - 1 in Arabidopsis produced plants with male sterility resulting from non - dehiscent anthers ( Figure 2 ), which approximately mimicked the disease symptoms observed in rice anthers.	RBSDV,28,33,Organism/Species	P7 - 1,34,40,Gene/Protein	Arabidopsis,44,55,Organism/Species	plants,65,71,Organism/Species	rice,207,211,Organism/Species	"[{""token"": ""RBSDV"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Organism/Species""}, {""token"": ""P7 - 1"", ""start_span"": 34, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""Arabidopsis"", ""start_span"": 44, ""end_span"": 55, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 65, ""end_span"": 71, ""type"": ""Organism/Species""}, {""token"": ""rice"", ""start_span"": 207, ""end_span"": 211, ""type"": ""Organism/Species""}]"	test
RBSDV P7 - 1 characteristics of tubule - forming and plasmodesmata localization suggest that this protein might be involved in virus intercellular movement, in infected insect and plant cells.	RBSDV,0,5,Organism/Species	P7 - 1,6,12,Gene/Protein	virus,127,132,Organism/Species	insect,169,175,Organism/Species	plant,180,185,Organism/Species	"[{""token"": ""RBSDV"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism/Species""}, {""token"": ""P7 - 1"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""virus"", ""start_span"": 127, ""end_span"": 132, ""type"": ""Organism/Species""}, {""token"": ""insect"", ""start_span"": 169, ""end_span"": 175, ""type"": ""Organism/Species""}, {""token"": ""plant"", ""start_span"": 180, ""end_span"": 185, ""type"": ""Organism/Species""}]"	test
The pathogenesis of tubular proteins during viral morphogenesis has been reported in studies of other members of the family Reoviridae. For example, BTV ( bluetongue virus) nonstructural tubular protein NS1 plays a direct role in cellular pathogenesis [ 25 ].	tubular proteins,20,36,Gene/Protein	Reoviridae,124,134,Organism/Species	BTV,149,152,Organism/Species	bluetongue virus,155,171,Organism/Species	nonstructural tubular protein NS1,173,206,Gene/Protein	"[{""token"": ""tubular proteins"", ""start_span"": 20, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""Reoviridae"", ""start_span"": 124, ""end_span"": 134, ""type"": ""Organism/Species""}, {""token"": ""BTV"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Organism/Species""}, {""token"": ""bluetongue virus"", ""start_span"": 155, ""end_span"": 171, ""type"": ""Organism/Species""}, {""token"": ""nonstructural tubular protein NS1"", ""start_span"": 173, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	test
In support of this notion, our data show that overexpression of RBSDV tubular protein P7 - 1 in Arabidopsis causes male sterility, which mimics the phenotype observed in rice flowers infected with the virus.	RBSDV,64,69,Organism/Species	tubular protein P7 - 1,70,92,Gene/Protein	Arabidopsis,96,107,Organism/Species	rice,170,174,Organism/Species	virus,201,206,Organism/Species	"[{""token"": ""RBSDV"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Organism/Species""}, {""token"": ""tubular protein P7 - 1"", ""start_span"": 70, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""Arabidopsis"", ""start_span"": 96, ""end_span"": 107, ""type"": ""Organism/Species""}, {""token"": ""rice"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Organism/Species""}, {""token"": ""virus"", ""start_span"": 201, ""end_span"": 206, ""type"": ""Organism/Species""}]"	test
Activated microglia, in turn, secrete cytokines and chemokines, generate oxidative stress molecules and alter local metabolic processes. 11 Disruption in the balance of tryptophan metabolism along the kynurenine pathway is a putative mechanism linking inflammation, microglia and depression.	cytokines,38,47,Gene/Protein	chemokines,52,62,Gene/Protein	tryptophan,169,179,Chemical/Drug	kynurenine,201,211,Chemical/Drug	depression,280,290,Disease/Disorder	"[{""token"": ""cytokines"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""chemokines"", ""start_span"": 52, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""tryptophan"", ""start_span"": 169, ""end_span"": 179, ""type"": ""Chemical/Drug""}, {""token"": ""kynurenine"", ""start_span"": 201, ""end_span"": 211, ""type"": ""Chemical/Drug""}, {""token"": ""depression"", ""start_span"": 280, ""end_span"": 290, ""type"": ""Disease/Disorder""}]"	test
A neurotoxic shift in kynurenine metabolism favoring the production of KMO - dependent metabolites is hypothesized to mediate inflammation - associated behavior changes. 27 Increased levels of cerebrospinal fluid ( CSF) QA in patients undergoing interferon - α immunotherapy were positively correlated to more severe depression scores. 19 A similar elevation in central QA and its neurotoxic precursor, 3 - hydroxykynurenine ( 3 - HK ), was measured in mice injected peripherally with lipopolysaccharide ( LPS ).	kynurenine,22,32,Chemical/Drug	KMO,71,74,Gene/Protein	interferon - α,246,260,Gene/Protein	severe depression,310,327,Disease/Disorder	mice,453,457,Organism/Species	"[{""token"": ""kynurenine"", ""start_span"": 22, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""KMO"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""interferon - \u03b1"", ""start_span"": 246, ""end_span"": 260, ""type"": ""Gene/Protein""}, {""token"": ""severe depression"", ""start_span"": 310, ""end_span"": 327, ""type"": ""Disease/Disorder""}, {""token"": ""mice"", ""start_span"": 453, ""end_span"": 457, ""type"": ""Organism/Species""}]"	test
Inflammation - induced depressive behaviors were precipitated in control or transgenic mice using the well - established peripheral LPS challenge model. 29, 30 3 - HK, the initial substrate for neurotoxic kynurenine pathway metabolism, was directly administered to naive mice to determine the behavioral consequences of increased KMO - dependent kynurenine metabolites.	mice,87,91,Organism/Species	kynurenine,205,215,Chemical/Drug	mice,271,275,Organism/Species	KMO,330,333,Gene/Protein	kynurenine,346,356,Chemical/Drug	"[{""token"": ""mice"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Organism/Species""}, {""token"": ""kynurenine"", ""start_span"": 205, ""end_span"": 215, ""type"": ""Chemical/Drug""}, {""token"": ""mice"", ""start_span"": 271, ""end_span"": 275, ""type"": ""Organism/Species""}, {""token"": ""KMO"", ""start_span"": 330, ""end_span"": 333, ""type"": ""Gene/Protein""}, {""token"": ""kynurenine"", ""start_span"": 346, ""end_span"": 356, ""type"": ""Chemical/Drug""}]"	test
HAAO −/− mice had similar LPS treatment responses as WT mice when assessed for anhedonia and anxiety - like behavior.	HAAO,0,4,Gene/Protein	mice,9,13,Organism/Species	mice,56,60,Organism/Species	anhedonia,79,88,Disease/Disorder	anxiety,93,100,Disease/Disorder	"[{""token"": ""HAAO"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Organism/Species""}, {""token"": ""anhedonia"", ""start_span"": 79, ""end_span"": 88, ""type"": ""Disease/Disorder""}, {""token"": ""anxiety"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Disease/Disorder""}]"	test
3 - HK ( μM, Row 3) was not detected in the brain of KMO −/− mice, and was higher in HAAO −/− mice relative to WT mice.	KMO,53,56,Gene/Protein	mice,61,65,Organism/Species	HAAO,85,89,Gene/Protein	mice,94,98,Organism/Species	mice,114,118,Organism/Species	"[{""token"": ""KMO"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Organism/Species""}, {""token"": ""HAAO"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Organism/Species""}]"	test
These findings are consistent with the contemporary hypothesis that disrupting the metabolic balance of the kynurenine pathway, rather than simply increasing overall kynurenine metabolism, defines the functional pathogenic context by which kynurenine metabolism mediates the behavioral effects of inflammation. 27, 28 Further, these data support recent findings from our laboratory, demonstrating that peripheral LPS induces brain region - dependent changes in the balance of kynurenine metabolites, specifically favoring neurotoxic metabolite production in the hippocampus. 34 Recent data characterizing the regional characteristics of microglia throughout the brain demonstrated that not all microglia express the same functional expression markers. 54 Specifically, it was noted that microglia in the hippocampus were more responsive to pro - inflammatory stimuli, earning them the label ‘ immunovigilant '. 54 This hyper - responsive state of hippocampal microglia could underlie the region - specific elevation in neurotoxic kynurenine metabolism described in Table 2.	kynurenine,108,118,Chemical/Drug	kynurenine,166,176,Chemical/Drug	kynurenine,240,250,Chemical/Drug	kynurenine,476,486,Chemical/Drug	kynurenine,1030,1040,Chemical/Drug	"[{""token"": ""kynurenine"", ""start_span"": 108, ""end_span"": 118, ""type"": ""Chemical/Drug""}, {""token"": ""kynurenine"", ""start_span"": 166, ""end_span"": 176, ""type"": ""Chemical/Drug""}, {""token"": ""kynurenine"", ""start_span"": 240, ""end_span"": 250, ""type"": ""Chemical/Drug""}, {""token"": ""kynurenine"", ""start_span"": 476, ""end_span"": 486, ""type"": ""Chemical/Drug""}, {""token"": ""kynurenine"", ""start_span"": 1030, ""end_span"": 1040, ""type"": ""Chemical/Drug""}]"	test
Direct administration of exogenous kynurenine has been utilized in a number of contexts that result in behavioral changes. 40, 41, 59 Our previous work demonstrated that exogenous kynurenine acutely precipitates a depressive - like phenotype similar to LPS. 16 Chronic administration of kynurenine during early development or to adult mice has also been used to elevate KA levels in the brain, resulting in deficits in sensorimotor gating, attentional processing of environmental stimuli, spatial working memory and contextual learning memory. 40, 41, 61 The data here are the first to demonstrate that exogenously administered peripheral 3 - HK is able to precipitate the development of behavioral despair in the TST, impair working memory in the Y - maze and induce anxiety - like behavior assessed in the OF.	kynurenine,35,45,Chemical/Drug	kynurenine,180,190,Chemical/Drug	kynurenine,287,297,Chemical/Drug	mice,335,339,Organism/Species	anxiety,768,775,Disease/Disorder	"[{""token"": ""kynurenine"", ""start_span"": 35, ""end_span"": 45, ""type"": ""Chemical/Drug""}, {""token"": ""kynurenine"", ""start_span"": 180, ""end_span"": 190, ""type"": ""Chemical/Drug""}, {""token"": ""kynurenine"", ""start_span"": 287, ""end_span"": 297, ""type"": ""Chemical/Drug""}, {""token"": ""mice"", ""start_span"": 335, ""end_span"": 339, ""type"": ""Organism/Species""}, {""token"": ""anxiety"", ""start_span"": 768, ""end_span"": 775, ""type"": ""Disease/Disorder""}]"	test
In the kynurenine pathway, tryptophan is metabolized to kynurenine by indoleamine 2, 3 - dioxygenase ( IDO ), an enzyme that is upregulated by pro - inflammatory cytokines.	kynurenine,7,17,Chemical/Drug	tryptophan,27,37,Chemical/Drug	kynurenine,56,66,Chemical/Drug	IDO,103,106,Gene/Protein	pro - inflammatory cytokines,143,171,Gene/Protein	"[{""token"": ""kynurenine"", ""start_span"": 7, ""end_span"": 17, ""type"": ""Chemical/Drug""}, {""token"": ""tryptophan"", ""start_span"": 27, ""end_span"": 37, ""type"": ""Chemical/Drug""}, {""token"": ""kynurenine"", ""start_span"": 56, ""end_span"": 66, ""type"": ""Chemical/Drug""}, {""token"": ""IDO"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""pro - inflammatory cytokines"", ""start_span"": 143, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	test
Then, further metabolism occurs to 3 - hydroxyanthranilic acid ( 3 - HAA) by kynureninase ( KYNU ), and then 3 - HAA is metabolized to quinolinic acid ( QA, red) by 3 - hydroxyanthranilic acid dioxygenase ( HAAO, purple ).	kynureninase,77,89,Gene/Protein	KYNU,92,96,Gene/Protein	quinolinic acid,135,150,Chemical/Drug	3 - hydroxyanthranilic acid dioxygenase,165,204,Gene/Protein	HAAO,207,211,Gene/Protein	"[{""token"": ""kynureninase"", ""start_span"": 77, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""KYNU"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""quinolinic acid"", ""start_span"": 135, ""end_span"": 150, ""type"": ""Chemical/Drug""}, {""token"": ""3 - hydroxyanthranilic acid dioxygenase"", ""start_span"": 165, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""HAAO"", ""start_span"": 207, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	test
A study by Leon et al. [ 8] suggested that compared with that of healthy individuals, the concentration of ccfDNA was significantly increased in cancer patients; furthermore, this phenomenon was confirmed by other studies on breast tumors [ 9 ], colorectal cancer [ 10 ], lung cancer [ 11 ], and other cancer types [ 12 ].	cancer,145,151,Disease/Disorder	breast tumors,225,238,Disease/Disorder	colorectal cancer,246,263,Disease/Disorder	lung cancer,272,283,Disease/Disorder	cancer,302,308,Disease/Disorder	"[{""token"": ""cancer"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Disease/Disorder""}, {""token"": ""breast tumors"", ""start_span"": 225, ""end_span"": 238, ""type"": ""Disease/Disorder""}, {""token"": ""colorectal cancer"", ""start_span"": 246, ""end_span"": 263, ""type"": ""Disease/Disorder""}, {""token"": ""lung cancer"", ""start_span"": 272, ""end_span"": 283, ""type"": ""Disease/Disorder""}, {""token"": ""cancer"", ""start_span"": 302, ""end_span"": 308, ""type"": ""Disease/Disorder""}]"	test
Among the included lymphoma cases, 126 were B cell non - Hodgkin lymphoma ( B - NHL ), with diffuse large B cell lymphoma ( DLBCL, n = 98) as the most common subtype.	lymphoma,19,27,Disease/Disorder	B cell non - Hodgkin lymphoma,44,73,Disease/Disorder	B - NHL,76,83,Disease/Disorder	diffuse large B cell lymphoma,92,121,Disease/Disorder	DLBCL,124,129,Disease/Disorder	"[{""token"": ""lymphoma"", ""start_span"": 19, ""end_span"": 27, ""type"": ""Disease/Disorder""}, {""token"": ""B cell non - Hodgkin lymphoma"", ""start_span"": 44, ""end_span"": 73, ""type"": ""Disease/Disorder""}, {""token"": ""B - NHL"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Disease/Disorder""}, {""token"": ""diffuse large B cell lymphoma"", ""start_span"": 92, ""end_span"": 121, ""type"": ""Disease/Disorder""}, {""token"": ""DLBCL"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Disease/Disorder""}]"	test
There were 18, 9, and 21 patients diagnosed with HL, T cell non - HL ( T - NHL ), and extranodal NK / T cell lymphoma ( NK / TCL ), respectively.	HL,49,51,Disease/Disorder	T cell non - HL,53,68,Disease/Disorder	T - NHL,71,78,Disease/Disorder	extranodal NK / T cell lymphoma,86,117,Disease/Disorder	NK / TCL,120,128,Disease/Disorder	"[{""token"": ""HL"", ""start_span"": 49, ""end_span"": 51, ""type"": ""Disease/Disorder""}, {""token"": ""T cell non - HL"", ""start_span"": 53, ""end_span"": 68, ""type"": ""Disease/Disorder""}, {""token"": ""T - NHL"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Disease/Disorder""}, {""token"": ""extranodal NK / T cell lymphoma"", ""start_span"": 86, ""end_span"": 117, ""type"": ""Disease/Disorder""}, {""token"": ""NK / TCL"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Disease/Disorder""}]"	test
Elevated DII values were observed in patients with HL ( median 0. 37, mean 0. 40, P < 0. 0001 ), DLBCL ( median 0. 43, mean 0. 46, P < 0. 0001 ), other types of B - NHL ( median 0. 34, mean 0. 35, P = 0. 002 ), T - NHL ( median 0. 42, mean 0. 41, P = 0. 008 ), and NK / TCL ( median 0. 33, mean 0. 38, P = 0. 001 ), respectively ( Fig. 1b ).	HL,51,53,Disease/Disorder	DLBCL,97,102,Disease/Disorder	B - NHL,161,168,Disease/Disorder	T - NHL,211,218,Disease/Disorder	NK / TCL,265,273,Disease/Disorder	"[{""token"": ""HL"", ""start_span"": 51, ""end_span"": 53, ""type"": ""Disease/Disorder""}, {""token"": ""DLBCL"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Disease/Disorder""}, {""token"": ""B - NHL"", ""start_span"": 161, ""end_span"": 168, ""type"": ""Disease/Disorder""}, {""token"": ""T - NHL"", ""start_span"": 211, ""end_span"": 218, ""type"": ""Disease/Disorder""}, {""token"": ""NK / TCL"", ""start_span"": 265, ""end_span"": 273, ""type"": ""Disease/Disorder""}]"	test
Black lines indicate admixture between wisent and cattle / aurochs, yellow lines / arrow — between Caucasian and founding or modern wisent respectively, and the blue arrow — from founders to modern wisent.	wisent,39,45,Organism/Species	cattle,50,56,Organism/Species	aurochs,59,66,Organism/Species	wisent,132,138,Organism/Species	wisent,198,204,Organism/Species	"[{""token"": ""wisent"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Organism/Species""}, {""token"": ""cattle"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Organism/Species""}, {""token"": ""aurochs"", ""start_span"": 59, ""end_span"": 66, ""type"": ""Organism/Species""}, {""token"": ""wisent"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Organism/Species""}, {""token"": ""wisent"", ""start_span"": 198, ""end_span"": 204, ""type"": ""Organism/Species""}]"	test
Although sometimes controversial, the concept of de - extinction has generated considerable interest ( Sherkow and Greely 2013 ), and attempts are currently underway to generate animals that, at least superficially, resemble the quagga ( Equus quagga; Heywood 2013 ), an extinct subspecies of plains zebra, and also the aurochs ( van Vuure 2005 ), by careful selective breeding of their living relatives.	animals,178,185,Organism/Species	quagga,229,235,Organism/Species	Equus quagga,238,250,Organism/Species	plains zebra,293,305,Organism/Species	aurochs,320,327,Organism/Species	"[{""token"": ""animals"", ""start_span"": 178, ""end_span"": 185, ""type"": ""Organism/Species""}, {""token"": ""quagga"", ""start_span"": 229, ""end_span"": 235, ""type"": ""Organism/Species""}, {""token"": ""Equus quagga"", ""start_span"": 238, ""end_span"": 250, ""type"": ""Organism/Species""}, {""token"": ""plains zebra"", ""start_span"": 293, ""end_span"": 305, ""type"": ""Organism/Species""}, {""token"": ""aurochs"", ""start_span"": 320, ""end_span"": 327, ""type"": ""Organism/Species""}]"	test
Wisent sequences were aligned with those of 12 other bovin taxa, including the extinct steppe bison ( Bison priscus) and aurochs ( Bos primigenius) ( supplementary table S1, Supplementary Material online ).	Wisent,0,6,Organism/Species	steppe bison,87,99,Organism/Species	Bison priscus,102,115,Organism/Species	aurochs,121,128,Organism/Species	Bos primigenius,131,146,Organism/Species	"[{""token"": ""Wisent"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Organism/Species""}, {""token"": ""steppe bison"", ""start_span"": 87, ""end_span"": 99, ""type"": ""Organism/Species""}, {""token"": ""Bison priscus"", ""start_span"": 102, ""end_span"": 115, ""type"": ""Organism/Species""}, {""token"": ""aurochs"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Organism/Species""}, {""token"": ""Bos primigenius"", ""start_span"": 131, ""end_span"": 146, ""type"": ""Organism/Species""}]"	test
CD4 + T Cells Expressing PD - 1, TIGIT and LAG - 3 Contribute to HIV Persistence during ART	CD4,0,3,Gene/Protein	PD - 1,25,31,Gene/Protein	TIGIT,33,38,Gene/Protein	LAG - 3,43,50,Gene/Protein	HIV,65,68,Organism/Species	"[{""token"": ""CD4"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 25, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Organism/Species""}]"	test
The frequency of CD4 + T cells co - expressing PD - 1, TIGIT and LAG - 3 independently predicted the frequency of cells harboring integrated HIV DNA.	CD4,17,20,Gene/Protein	PD - 1,47,53,Gene/Protein	TIGIT,55,60,Gene/Protein	LAG - 3,65,72,Gene/Protein	HIV,141,144,Organism/Species	"[{""token"": ""CD4"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 47, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Organism/Species""}]"	test
Our data provide evidence that CD4 + T cells expressing PD - 1, TIGIT and LAG - 3 alone or in combination are enriched for persistent HIV during ART and suggest that immune checkpoint blockers directed against these receptors may represent valuable tools to target latently infected cells in virally suppressed individuals.	CD4,31,34,Gene/Protein	PD - 1,56,62,Gene/Protein	TIGIT,64,69,Gene/Protein	LAG - 3,74,81,Gene/Protein	HIV,134,137,Organism/Species	"[{""token"": ""CD4"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 56, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Organism/Species""}]"	test
The functional and homing capacities of CD4 + T cells also dictate their capacity to serve as persistent reservoirs for HIV: Th17 and Th1 / Th17 CD4 + T cells as well as cells expressing CCR6 and CXCR3 show increasing contribution to the viral reservoir with duration of ART [ 11, 12 ].	CD4,40,43,Gene/Protein	HIV,120,123,Organism/Species	CD4,145,148,Gene/Protein	CCR6,187,191,Gene/Protein	CXCR3,196,201,Gene/Protein	"[{""token"": ""CD4"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Organism/Species""}, {""token"": ""CD4"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""CCR6"", ""start_span"": 187, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""CXCR3"", ""start_span"": 196, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	test
We hypothesized that ICs, through their ability to inhibit T - cell activation, will favour HIV latency during ART, and that CD4 + T cells expressing ICs would be enriched for persistent HIV in individuals receiving ART.	ICs,21,24,Gene/Protein	HIV,92,95,Organism/Species	CD4,125,128,Gene/Protein	ICs,150,153,Gene/Protein	HIV,187,190,Organism/Species	"[{""token"": ""ICs"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Organism/Species""}, {""token"": ""CD4"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""ICs"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 187, ""end_span"": 190, ""type"": ""Organism/Species""}]"	test
PD - 1, a member of the B7 - CD28 superfamily, enforces an inhibitory program that blocks further TCR - induced T - cell proliferation and cytokine production [ 18, 19 ].	PD - 1,0,6,Gene/Protein	B7,24,26,Gene/Protein	CD28,29,33,Gene/Protein	TCR,98,101,Gene/Protein	cytokine,139,147,Gene/Protein	"[{""token"": ""PD - 1"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""B7"", ""start_span"": 24, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 139, ""end_span"": 147, ""type"": ""Gene/Protein""}]"	test
CTLA - 4, a CD28 homolog, regulates the amplitude of T - cell activation by both outcompeting CD28 in binding CD80 and CD86, as well as actively delivering inhibitory signals to T cells [ 13 ].	CTLA - 4,0,8,Gene/Protein	CD28 homolog,12,24,Gene/Protein	CD28,94,98,Gene/Protein	CD80,110,114,Gene/Protein	CD86,119,123,Gene/Protein	"[{""token"": ""CTLA - 4"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""CD28 homolog"", ""start_span"": 12, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""CD28"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""CD80"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene/Protein""}]"	test
The expression of 2B4 ( CD244 ), a member of the signalling lymphocyte activation molecule ( SLAM) is also modulated on T cells during HIV infection [ 17, 25 ].	2B4,18,21,Gene/Protein	CD244,24,29,Gene/Protein	signalling lymphocyte activation molecule,49,90,Gene/Protein	SLAM,93,97,Gene/Protein	HIV infection,135,148,Disease/Disorder	"[{""token"": ""2B4"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""CD244"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""signalling lymphocyte activation molecule"", ""start_span"": 49, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""SLAM"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""HIV infection"", ""start_span"": 135, ""end_span"": 148, ""type"": ""Disease/Disorder""}]"	test
TIM - 3 is also an immunoglobulin superfamily member and its expression is increased on HIV - specific CD8 + and CD4 + T cells [ 29, 30 ].	TIM - 3,0,7,Gene/Protein	immunoglobulin,19,33,Gene/Protein	HIV,88,91,Organism/Species	CD8,103,106,Gene/Protein	CD4,113,116,Gene/Protein	"[{""token"": ""TIM - 3"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin"", ""start_span"": 19, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 88, ""end_span"": 91, ""type"": ""Organism/Species""}, {""token"": ""CD8"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene/Protein""}]"	test
( B) Size of the HIV reservoir measured by integrated HIV DNA, total HIV DNA, 2 - LTR circles represented as copies per million CD4 + T cells and cell - associated US HIV RNA represented as copies per million copies of 18S.	HIV,17,20,Organism/Species	HIV,54,57,Organism/Species	HIV,69,72,Organism/Species	CD4,128,131,Gene/Protein	HIV,167,170,Organism/Species	"[{""token"": ""HIV"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Organism/Species""}, {""token"": ""CD4"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Organism/Species""}]"	test
The size of the HIV reservoir was determined by measuring the frequencies of CD4 + T cells harboring integrated HIV DNA, total HIV DNA and 2 - LTR circles as well as cell - associated unspliced ( CA - US) HIV RNA ( Fig 1B and S1 Table ).	HIV,16,19,Organism/Species	CD4,77,80,Gene/Protein	HIV,112,115,Organism/Species	HIV,127,130,Organism/Species	HIV,205,208,Organism/Species	"[{""token"": ""HIV"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Organism/Species""}, {""token"": ""CD4"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 205, ""end_span"": 208, ""type"": ""Organism/Species""}]"	test
The frequency of PD - 1 expressing CD4 + T cells was also associated with the frequency of CD4 + T cells harboring total HIV DNA ( S3 Table ), but only marginally ( 1. 23 - fold effect, p = 0. 07) when the model was adjusted for current CD4 + T - cell count.	PD - 1,17,23,Gene/Protein	CD4,35,38,Gene/Protein	CD4,91,94,Gene/Protein	HIV,121,124,Organism/Species	CD4,237,240,Gene/Protein	"[{""token"": ""PD - 1"", ""start_span"": 17, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Organism/Species""}, {""token"": ""CD4"", ""start_span"": 237, ""end_span"": 240, ""type"": ""Gene/Protein""}]"	test
Using a Boolean gating strategy, we determined the frequency of CD4 + T cells co - expressing PD - 1 and / or TIGIT and / or LAG - 3 in our cohort of 48 HIV - infected participants receiving suppressive ART ( Fig 2A and 2B ).	CD4,64,67,Gene/Protein	PD - 1,94,100,Gene/Protein	TIGIT,110,115,Gene/Protein	LAG - 3,125,132,Gene/Protein	HIV,153,156,Organism/Species	"[{""token"": ""CD4"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 94, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Organism/Species""}]"	test
Although several of these associations were less or no longer statistically significant when the model was adjusted for the current CD4 + T - cell count, the association between the size of the HIV reservoir and the frequency of triple positive cells ( PD - 1 +, LAG - 3 + and TIGIT +) remained statistically significant after adjustment ( p = 0. 038 ).	CD4,132,135,Gene/Protein	HIV,194,197,Organism/Species	PD - 1,253,259,Gene/Protein	LAG - 3,263,270,Gene/Protein	TIGIT,277,282,Gene/Protein	"[{""token"": ""CD4"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 194, ""end_span"": 197, ""type"": ""Organism/Species""}, {""token"": ""PD - 1"", ""start_span"": 253, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 263, ""end_span"": 270, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 277, ""end_span"": 282, ""type"": ""Gene/Protein""}]"	test
All together, these results indicate that the co - expression of PD - 1, TIGIT and LAG - 3 identifies a unique subset of CD4 + T cells that strongly predicts the frequency of cells harboring integrated HIV DNA during ART.	PD - 1,65,71,Gene/Protein	TIGIT,73,78,Gene/Protein	LAG - 3,83,90,Gene/Protein	CD4,121,124,Gene/Protein	HIV,202,205,Organism/Species	"[{""token"": ""PD - 1"", ""start_span"": 65, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 202, ""end_span"": 205, ""type"": ""Organism/Species""}]"	test
Negative binomial regression models to assess the relationship between Integrated HIV DNA and the frequency of CD4 + T cells expressing PD - 1 and / or TIGIT and / or LAG - 3.	HIV,82,85,Organism/Species	CD4,111,114,Gene/Protein	PD - 1,136,142,Gene/Protein	TIGIT,152,157,Gene/Protein	LAG - 3,167,174,Gene/Protein	"[{""token"": ""HIV"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Organism/Species""}, {""token"": ""CD4"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 136, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 167, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	test
Expressions of PD - 1, TIGIT and LAG - 3 are associated with HIV - infected cells in distinct memory CD4 + T - cell subsets during ART	PD - 1,15,21,Gene/Protein	TIGIT,23,28,Gene/Protein	LAG - 3,33,40,Gene/Protein	HIV,61,64,Organism/Species	CD4,101,104,Gene/Protein	"[{""token"": ""PD - 1"", ""start_span"": 15, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Organism/Species""}, {""token"": ""CD4"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}]"	test
PD - 1, TIGIT and LAG - 3 identify HIV - infected cells in distinct memory CD4 + T - cell subsets during ART.	PD - 1,0,6,Gene/Protein	TIGIT,8,13,Gene/Protein	LAG - 3,18,25,Gene/Protein	HIV,35,38,Organism/Species	CD4,75,78,Gene/Protein	"[{""token"": ""PD - 1"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Organism/Species""}, {""token"": ""CD4"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene/Protein""}]"	test
( D ), ( E ), ( F) Frequencies of cells harboring integrated HIV DNA in TCM, TTM and TEM CD4 + T - cell subsets sorted based on their expression of PD - 1 ( n = 12 ), TIGIT ( n = 9) or LAG - 3 ( n = 7 ), respectively.	HIV,61,64,Organism/Species	CD4,89,92,Gene/Protein	PD - 1,148,154,Gene/Protein	TIGIT,167,172,Gene/Protein	LAG - 3,185,192,Gene/Protein	"[{""token"": ""HIV"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Organism/Species""}, {""token"": ""CD4"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 148, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 167, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 185, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	test
We calculated the contribution of cells expressing PD - 1, TIGIT or LAG - 3 to the total reservoir by taking into account the frequency of these subsets within the CD4 compartment and their relative infection frequencies.	PD - 1,51,57,Gene/Protein	TIGIT,59,64,Gene/Protein	LAG - 3,68,75,Gene/Protein	CD4,164,167,Gene/Protein	infection,199,208,Disease/Disorder	"[{""token"": ""PD - 1"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""infection"", ""start_span"": 199, ""end_span"": 208, ""type"": ""Disease/Disorder""}]"	test
Co - expression of PD - 1, TIGIT and LAG - 3 highly enriches in HIV - infected memory CD4 + T cells during ART	PD - 1,19,25,Gene/Protein	TIGIT,27,32,Gene/Protein	LAG - 3,37,44,Gene/Protein	HIV,64,67,Organism/Species	CD4,86,89,Gene/Protein	"[{""token"": ""PD - 1"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Organism/Species""}, {""token"": ""CD4"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene/Protein""}]"	test
We then determined if the combination of PD - 1, TIGIT and LAG - 3 would further enrich memory CD4 + T cells for HIV - infected cells during ART.	PD - 1,41,47,Gene/Protein	TIGIT,49,54,Gene/Protein	LAG - 3,59,66,Gene/Protein	CD4,95,98,Gene/Protein	HIV,113,116,Organism/Species	"[{""token"": ""PD - 1"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 59, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Organism/Species""}]"	test
As the majority of HIV genomes, even when integrated, are defective [ 40 ], we assessed if PD - 1, TIGIT and LAG - 3 identify cells in which HIV production can be induced.	HIV,19,22,Organism/Species	PD - 1,91,97,Gene/Protein	TIGIT,99,104,Gene/Protein	LAG - 3,109,116,Gene/Protein	HIV,141,144,Organism/Species	"[{""token"": ""HIV"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Organism/Species""}, {""token"": ""PD - 1"", ""start_span"": 91, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Organism/Species""}]"	test
As the frequency of triple positive cells was too low to perform this experiment, we sorted memory CD4 + T cells ( CD45RA -) expressing any ( i. e. at least one) versus none of PD - 1, TIGIT or LAG - 3 ( mLPT + and mLPT - respectively ).	CD4,99,102,Gene/Protein	CD45RA,115,121,Gene/Protein	PD - 1,177,183,Gene/Protein	TIGIT,185,190,Gene/Protein	LAG - 3,194,201,Gene/Protein	"[{""token"": ""CD4"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""CD45RA"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 177, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 185, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 194, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	test
We found positive associations between the expression of PD - 1, LAG - 3 and TIGIT in CD4 + T cells and the frequency of cells harboring integrated HIV DNA.	PD - 1,57,63,Gene/Protein	LAG - 3,65,72,Gene/Protein	TIGIT,77,82,Gene/Protein	CD4,86,89,Gene/Protein	HIV,148,151,Organism/Species	"[{""token"": ""PD - 1"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Organism/Species""}]"	test
By sorting TCM, TTM and TEM cells expressing PD - 1, TIGIT and LAG - 3, we observed that cells expressing these markers were enriched for HIV - infected cells in different memory CD4 + T - cells subsets during ART.	PD - 1,45,51,Gene/Protein	TIGIT,53,58,Gene/Protein	LAG - 3,63,70,Gene/Protein	HIV,138,141,Organism/Species	CD4,179,182,Gene/Protein	"[{""token"": ""PD - 1"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Organism/Species""}, {""token"": ""CD4"", ""start_span"": 179, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	test
While LAG - 3 enriched for integrated HIV DNA in all memory subsets ( TCM, TTM, and TEM ), PD - 1 and TIGIT enriched for HIV genomes exclusively in TTM and TEM cells, respectively.	LAG - 3,6,13,Gene/Protein	HIV,38,41,Organism/Species	PD - 1,91,97,Gene/Protein	TIGIT,102,107,Gene/Protein	HIV,121,124,Organism/Species	"[{""token"": ""LAG - 3"", ""start_span"": 6, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Organism/Species""}, {""token"": ""PD - 1"", ""start_span"": 91, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Organism/Species""}]"	test
Indeed, LAG - 3 and PD - 1 are commonly co - expressed on exhausted or dysfunctional T cells in models of chronic infections [ 45 ], autoimmune diseases [ 46 ], and cancers [ 47, 48 ].	LAG - 3,8,15,Gene/Protein	PD - 1,20,26,Gene/Protein	chronic infections,106,124,Disease/Disorder	autoimmune diseases,133,152,Disease/Disorder	cancers,165,172,Disease/Disorder	"[{""token"": ""LAG - 3"", ""start_span"": 8, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 20, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""chronic infections"", ""start_span"": 106, ""end_span"": 124, ""type"": ""Disease/Disorder""}, {""token"": ""autoimmune diseases"", ""start_span"": 133, ""end_span"": 152, ""type"": ""Disease/Disorder""}, {""token"": ""cancers"", ""start_span"": 165, ""end_span"": 172, ""type"": ""Disease/Disorder""}]"	test
Additionally, TIGIT is co - expressed with PD - 1 on activated CD8 + tumor - infiltrating lymphocytes from patients with melanoma [ 50 ].	TIGIT,14,19,Gene/Protein	PD - 1,43,49,Gene/Protein	CD8,63,66,Gene/Protein	tumor,69,74,Disease/Disorder	melanoma,121,129,Disease/Disorder	"[{""token"": ""TIGIT"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 43, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""CD8"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Disease/Disorder""}, {""token"": ""melanoma"", ""start_span"": 121, ""end_span"": 129, ""type"": ""Disease/Disorder""}]"	test
Blockages of TIGIT and PD - 1 synergize to improve T cell proliferation, cytokines production and degranulation in vivo in melanoma treatment and in vitro in HIV infection [ 24, 50 ].	TIGIT,13,18,Gene/Protein	PD - 1,23,29,Gene/Protein	cytokines,73,82,Gene/Protein	melanoma,123,131,Disease/Disorder	HIV infection,158,171,Disease/Disorder	"[{""token"": ""TIGIT"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 73, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""melanoma"", ""start_span"": 123, ""end_span"": 131, ""type"": ""Disease/Disorder""}, {""token"": ""HIV infection"", ""start_span"": 158, ""end_span"": 171, ""type"": ""Disease/Disorder""}]"	test
The expression of PD - 1, LAG - 3 and TIM - 3 on CD4 + and CD8 + T cells prior to ART was recently identified as a strong predictor of time to viral rebound after treatment interruption in the SPARTAC study [ 43 ].	PD - 1,18,24,Gene/Protein	LAG - 3,26,33,Gene/Protein	TIM - 3,38,45,Gene/Protein	CD4,49,52,Gene/Protein	CD8,59,62,Gene/Protein	"[{""token"": ""PD - 1"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""TIM - 3"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""CD8"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene/Protein""}]"	test
In our study, we identified a discrete subset of CD4 + T cells co - expressing PD - 1, TIGIT and LAG - 3 as an important predictor of the frequency of cells harboring integrated HIV DNA during ART.	CD4,49,52,Gene/Protein	PD - 1,79,85,Gene/Protein	TIGIT,87,92,Gene/Protein	LAG - 3,97,104,Gene/Protein	HIV,178,181,Organism/Species	"[{""token"": ""CD4"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 79, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Organism/Species""}]"	test
( A ), ( B ), ( C) Associations between the current CD4 + T cell counts and the frequency of CD4 + T cells expressing PD - 1, TIGIT and LAG - 3, respectively.	CD4,52,55,Gene/Protein	CD4,93,96,Gene/Protein	PD - 1,118,124,Gene/Protein	TIGIT,126,131,Gene/Protein	LAG - 3,136,143,Gene/Protein	"[{""token"": ""CD4"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 118, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 136, ""end_span"": 143, ""type"": ""Gene/Protein""}]"	test
Simultaneously, we also observed a significant decrease in the population of Closrtridium coccoides subgroup ( p = 0. 002 ), Clostridium leptum subgroup ( p = 0. 0001 ), Lactobacillus ( p = 0. 037 ), Campylobacter ( p = 0. 0014) and Eubacterium ( p = 0. 038) in E. histolytica positive samples in comparison to control ( Figure 4B, C, D, E and F respectively ).	Closrtridium coccoides,77,99,Organism/Species	Clostridium leptum,125,143,Organism/Species	Lactobacillus,170,183,Organism/Species	Campylobacter,200,213,Organism/Species	Eubacterium,233,244,Organism/Species	"[{""token"": ""Closrtridium coccoides"", ""start_span"": 77, ""end_span"": 99, ""type"": ""Organism/Species""}, {""token"": ""Clostridium leptum"", ""start_span"": 125, ""end_span"": 143, ""type"": ""Organism/Species""}, {""token"": ""Lactobacillus"", ""start_span"": 170, ""end_span"": 183, ""type"": ""Organism/Species""}, {""token"": ""Campylobacter"", ""start_span"": 200, ""end_span"": 213, ""type"": ""Organism/Species""}, {""token"": ""Eubacterium"", ""start_span"": 233, ""end_span"": 244, ""type"": ""Organism/Species""}]"	test
Members of both Bifidobacteria and Ruminococcus - Ruminococcus torques and Bifidobacterium bifidum are thought to ferment mucin and compete to colonise this substrate for their energy source [ 33 ].	Bifidobacteria,16,30,Organism/Species	Ruminococcus,35,47,Organism/Species	Ruminococcus torques,50,70,Organism/Species	Bifidobacterium bifidum,75,98,Organism/Species	mucin,122,127,Gene/Protein	"[{""token"": ""Bifidobacteria"", ""start_span"": 16, ""end_span"": 30, ""type"": ""Organism/Species""}, {""token"": ""Ruminococcus"", ""start_span"": 35, ""end_span"": 47, ""type"": ""Organism/Species""}, {""token"": ""Ruminococcus torques"", ""start_span"": 50, ""end_span"": 70, ""type"": ""Organism/Species""}, {""token"": ""Bifidobacterium bifidum"", ""start_span"": 75, ""end_span"": 98, ""type"": ""Organism/Species""}, {""token"": ""mucin"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Gene/Protein""}]"	test
As a result, the intestinal epithelial cells tend to produce more of mucin for protection that promotes colonization of Bifidobacteria in one hand and on the other hand the parasite competes to more release of mucin for its adhesion to epithelial layer. Bifidobacteria longum are known to protect the gut from enteropathogenic infection through production of acetate [ 32] and acetate is major energy source for colonocytes but a fine balance in population of different bacterial genera of gut is needed for healthy colon.	mucin,69,74,Gene/Protein	Bifidobacteria,120,134,Organism/Species	mucin,210,215,Gene/Protein	Bifidobacteria longum,254,275,Organism/Species	infection,327,336,Disease/Disorder	"[{""token"": ""mucin"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""Bifidobacteria"", ""start_span"": 120, ""end_span"": 134, ""type"": ""Organism/Species""}, {""token"": ""mucin"", ""start_span"": 210, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""Bifidobacteria longum"", ""start_span"": 254, ""end_span"": 275, ""type"": ""Organism/Species""}, {""token"": ""infection"", ""start_span"": 327, ""end_span"": 336, ""type"": ""Disease/Disorder""}]"	test
It has been suggested that the low and variable prevalence of Methanobrevibacter smithii and Methanosphaera stadtmanae DNA in human stool contrasts with the paramount role of these methanogenic archaea in digestion processes and hypothesized that this contrast is a consequence of the inefficiencies of current protocols for archaea DNA extraction [ 41 ].	Methanobrevibacter smithii,62,88,Organism/Species	Methanosphaera stadtmanae,93,118,Organism/Species	human,126,131,Organism/Species	methanogenic archaea,181,201,Organism/Species	archaea,325,332,Organism/Species	"[{""token"": ""Methanobrevibacter smithii"", ""start_span"": 62, ""end_span"": 88, ""type"": ""Organism/Species""}, {""token"": ""Methanosphaera stadtmanae"", ""start_span"": 93, ""end_span"": 118, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Organism/Species""}, {""token"": ""methanogenic archaea"", ""start_span"": 181, ""end_span"": 201, ""type"": ""Organism/Species""}, {""token"": ""archaea"", ""start_span"": 325, ""end_span"": 332, ""type"": ""Organism/Species""}]"	test
Intestinal SRB ’ s growth and resultant hydrogen sulfide production have been implicated to damage the gastrointestinal tract and thereby contribute to chronic intestinal disorders [ 42 ]. Desulfovibrio fairfieldensis and D. desulfuricans have been associated with incidence of bacteremia and D. vulgaris has been associated with intra - abdominal infections [ 43 ].	SRB,11,14,Organism/Species	intestinal disorders,160,180,Disease/Disorder	Desulfovibrio fairfieldensis,189,217,Organism/Species	bacteremia,278,288,Disease/Disorder	intra - abdominal infections,330,358,Disease/Disorder	"[{""token"": ""SRB"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Organism/Species""}, {""token"": ""intestinal disorders"", ""start_span"": 160, ""end_span"": 180, ""type"": ""Disease/Disorder""}, {""token"": ""Desulfovibrio fairfieldensis"", ""start_span"": 189, ""end_span"": 217, ""type"": ""Organism/Species""}, {""token"": ""bacteremia"", ""start_span"": 278, ""end_span"": 288, ""type"": ""Disease/Disorder""}, {""token"": ""intra - abdominal infections"", ""start_span"": 330, ""end_span"": 358, ""type"": ""Disease/Disorder""}]"	test
The genus Campylobacter is notorious for causing gastroenritis by C. jejuni but uncultured Campylobacter species e. g. Campylobacter hominis whose role is not clear yet, do exist in lower gastrointestinal tract of healthy humans [ 44 ].	Campylobacter,10,23,Organism/Species	gastroenritis,49,62,Disease/Disorder	Campylobacter,91,104,Organism/Species	Campylobacter hominis,119,140,Organism/Species	humans,222,228,Organism/Species	"[{""token"": ""Campylobacter"", ""start_span"": 10, ""end_span"": 23, ""type"": ""Organism/Species""}, {""token"": ""gastroenritis"", ""start_span"": 49, ""end_span"": 62, ""type"": ""Disease/Disorder""}, {""token"": ""Campylobacter"", ""start_span"": 91, ""end_span"": 104, ""type"": ""Organism/Species""}, {""token"": ""Campylobacter hominis"", ""start_span"": 119, ""end_span"": 140, ""type"": ""Organism/Species""}, {""token"": ""humans"", ""start_span"": 222, ""end_span"": 228, ""type"": ""Organism/Species""}]"	test
Several species of Bacteroides are known to harbor nim genes e. g. B. fragilis, B. distasonis, B. thetaiotaomicron, B. vulgatus, B. ovatus but wide differences in MIC values of metronidazole are observed, ranging from 1. 5 to > 256 mg / L and some are also found above the therapeutic breakpoint of 16 mg / L [ 45 ]. Though the population of Bacteroides is decreased significantly in E. histolytica positive patients however we have observed high copy no. of nimE gene in the same.	Bacteroides,19,30,Organism/Species	nim,51,54,Gene/Protein	metronidazole,177,190,Chemical/Drug	Bacteroides,342,353,Organism/Species	nimE,459,463,Gene/Protein	"[{""token"": ""Bacteroides"", ""start_span"": 19, ""end_span"": 30, ""type"": ""Organism/Species""}, {""token"": ""nim"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""metronidazole"", ""start_span"": 177, ""end_span"": 190, ""type"": ""Chemical/Drug""}, {""token"": ""Bacteroides"", ""start_span"": 342, ""end_span"": 353, ""type"": ""Organism/Species""}, {""token"": ""nimE"", ""start_span"": 459, ""end_span"": 463, ""type"": ""Gene/Protein""}]"	test
"It has been also demonstrated that CMV - seropositive offspring of long - lived people have reduced levels of CD8 + T cells expressing CD57 and KLRG1, sometimes referred as """""""" marker of senescence """""","" when compared to their CMV - infected age - matched controls."	CMV,35,38,Organism/Species	CD8,110,113,Gene/Protein	CD57,135,139,Gene/Protein	KLRG1,144,149,Gene/Protein	CMV,228,231,Organism/Species	"[{""token"": ""CMV"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Organism/Species""}, {""token"": ""CD8"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""CD57"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""KLRG1"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""CMV"", ""start_span"": 228, ""end_span"": 231, ""type"": ""Organism/Species""}]"	test
Alterations in insulin pathway are known to be involved in metabolic disease, such as metabolic syndrome, insulin resistance and type 2 diabetes.	insulin,15,22,Gene/Protein	metabolic disease,59,76,Disease/Disorder	metabolic syndrome,86,104,Disease/Disorder	insulin resistance,106,124,Disease/Disorder	type 2 diabetes,129,144,Disease/Disorder	"[{""token"": ""insulin"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""metabolic disease"", ""start_span"": 59, ""end_span"": 76, ""type"": ""Disease/Disorder""}, {""token"": ""metabolic syndrome"", ""start_span"": 86, ""end_span"": 104, ""type"": ""Disease/Disorder""}, {""token"": ""insulin resistance"", ""start_span"": 106, ""end_span"": 124, ""type"": ""Disease/Disorder""}, {""token"": ""type 2 diabetes"", ""start_span"": 129, ""end_span"": 144, ""type"": ""Disease/Disorder""}]"	test
The amino acid sequence of the products predicted from GmPT1 and GmPT2 share 61% and 63% identity, respectively, with the PHO84 in amino acid sequence.	amino acid,4,14,Chemical/Drug	GmPT1,55,60,Gene/Protein	GmPT2,65,70,Gene/Protein	PHO84,122,127,Gene/Protein	amino acid,131,141,Chemical/Drug	"[{""token"": ""amino acid"", ""start_span"": 4, ""end_span"": 14, ""type"": ""Chemical/Drug""}, {""token"": ""GmPT1"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""GmPT2"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""PHO84"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""amino acid"", ""start_span"": 131, ""end_span"": 141, ""type"": ""Chemical/Drug""}]"	test
GmPT1 shows 76% and 61% and GmPT2 shows 76% and 63% amino acid sequence identity with GvPT ( accession number Q00908) and PHO84 ( accession number P25297 ), respectively.	GmPT1,0,5,Gene/Protein	GmPT2,28,33,Gene/Protein	amino acid,52,62,Chemical/Drug	GvPT,86,90,Gene/Protein	PHO84,122,127,Gene/Protein	"[{""token"": ""GmPT1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""GmPT2"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""amino acid"", ""start_span"": 52, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""GvPT"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""PHO84"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Gene/Protein""}]"	test
Images showing onion epidermal cells expressing GmPT1 / GFP ( A – C ), empty vector ( D – F) and GmPT2 / GFP ( G – I) fusion protein examined under fluorescent - field illumination ( A, D and G) to examine GFP fluorescence; under bright - field illumination ( B, E and H) and by confocal microscopy for the overlay of bright and fluorescent illumination ( C, F and I ).	GmPT1,48,53,Gene/Protein	GFP,56,59,Gene/Protein	GmPT2,97,102,Gene/Protein	GFP,105,108,Gene/Protein	GFP,206,209,Gene/Protein	"[{""token"": ""GmPT1"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""GmPT2"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 206, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	test
The rate of uptake was reduced to 77% ( GmPT1) and 80% ( GmPT2) by 100 µM CCCP and, to 82% ( GmPT1) and 83% ( GmPT2) by 100 µM Vanadate, an inhibitor of P - type H +- ATPases.	GmPT1,40,45,Gene/Protein	GmPT2,57,62,Gene/Protein	GmPT1,93,98,Gene/Protein	GmPT2,110,115,Gene/Protein	P - type H +- ATPases,153,174,Gene/Protein	"[{""token"": ""GmPT1"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""GmPT2"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""GmPT1"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""GmPT2"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""P - type H +- ATPases"", ""start_span"": 153, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	test
The expression of GmPT1 and GmPT2 in seedling tissues was increased during the 3 h after the Pi - sufficient treated seedlings were transferred to a Pi - deficient solution at 48 h compared to the expression measured in Pi - sufficient plants ( Figure 7A, C and E for GmPT1 and G, I and K for GmPT2 ).	GmPT1,18,23,Gene/Protein	GmPT2,28,33,Gene/Protein	plants,236,242,Organism/Species	GmPT1,268,273,Gene/Protein	GmPT2,293,298,Gene/Protein	"[{""token"": ""GmPT1"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""GmPT2"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""plants"", ""start_span"": 236, ""end_span"": 242, ""type"": ""Organism/Species""}, {""token"": ""GmPT1"", ""start_span"": 268, ""end_span"": 273, ""type"": ""Gene/Protein""}, {""token"": ""GmPT2"", ""start_span"": 293, ""end_span"": 298, ""type"": ""Gene/Protein""}]"	test
A decrease in the transcript abundance of GmPT1 and GmPT2 in the leaf, stem and root of hydroponically grown soybean seedlings was apparent within 3 h of Pi deprivation ( Figure 7 B, D and F for GmPT1 and H, J and L for GmPT2 ).	GmPT1,42,47,Gene/Protein	GmPT2,52,57,Gene/Protein	soybean,109,116,Organism/Species	GmPT1,195,200,Gene/Protein	GmPT2,220,225,Gene/Protein	"[{""token"": ""GmPT1"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""GmPT2"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""soybean"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Organism/Species""}, {""token"": ""GmPT1"", ""start_span"": 195, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""GmPT2"", ""start_span"": 220, ""end_span"": 225, ""type"": ""Gene/Protein""}]"	test
By complementation of a knock - out of endogenous high - affinity Pi transporters of various yeast mutants, or by measuring the increase of Pi uptake in transformed plant cells, several Pi transporters of many plant species have shown common properties, indicating that there is an electrochemical proton gradient across the plasma membrane [ 6 ], [ 20 ], [ 26 ], [ 27 ], [ 30 ], [ 31 ], [ 45 ].	Pi transporters,66,81,Gene/Protein	yeast,93,98,Organism/Species	plant,165,170,Organism/Species	Pi transporters,186,201,Gene/Protein	plant,210,215,Organism/Species	"[{""token"": ""Pi transporters"", ""start_span"": 66, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""yeast"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Organism/Species""}, {""token"": ""plant"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Organism/Species""}, {""token"": ""Pi transporters"", ""start_span"": 186, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""plant"", ""start_span"": 210, ""end_span"": 215, ""type"": ""Organism/Species""}]"	test
Over - expression of OsPT2 ( PT2 ( O )) in transgenic plants resulted in accumulation of excess shoot Pi and growth retardation similar to that of rice pho2 mutants under Pi - sufficient conditions.	OsPT2,21,26,Gene/Protein	PT2,29,32,Gene/Protein	plants,54,60,Organism/Species	rice,147,151,Organism/Species	pho2,152,156,Gene/Protein	"[{""token"": ""OsPT2"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""PT2"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""plants"", ""start_span"": 54, ""end_span"": 60, ""type"": ""Organism/Species""}, {""token"": ""rice"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Organism/Species""}, {""token"": ""pho2"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	test
The presence or absence of different DGK isozymes in members from different kingdoms and main phyla of eukaryotes was assessed by carrying out Blastp searches on sequences of different DGK isozymes from human and mouse species against annotated members of specific kingdoms or phyla present in the NCBI nr database.	DGK,37,40,Gene/Protein	eukaryotes,103,113,Organism/Species	DGK,185,188,Gene/Protein	human,203,208,Organism/Species	mouse,213,218,Organism/Species	"[{""token"": ""DGK"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""eukaryotes"", ""start_span"": 103, ""end_span"": 113, ""type"": ""Organism/Species""}, {""token"": ""DGK"", ""start_span"": 185, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 203, ""end_span"": 208, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 213, ""end_span"": 218, ""type"": ""Organism/Species""}]"	test
In addition, somework has been carried out on documenting and studying the functions of DGK isozymes in other eukaryotic organisms such as Drosophila, nematodes, slime molds and plants [ 3, 6, 10, 14 – 16, 33 – 35 ].	DGK,88,91,Gene/Protein	Drosophila,139,149,Organism/Species	nematodes,151,160,Organism/Species	slime molds,162,173,Organism/Species	plants,178,184,Organism/Species	"[{""token"": ""DGK"", ""start_span"": 88, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""Drosophila"", ""start_span"": 139, ""end_span"": 149, ""type"": ""Organism/Species""}, {""token"": ""nematodes"", ""start_span"": 151, ""end_span"": 160, ""type"": ""Organism/Species""}, {""token"": ""slime molds"", ""start_span"": 162, ""end_span"": 173, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 178, ""end_span"": 184, ""type"": ""Organism/Species""}]"	test
Retrograde labeling and functional tests showed that LM + MP. NGF / NT3 increased the number of regenerated sensory neurons and improved sensory functional recovery, whereas FN + MP. BDNF preferentially increased regenerated motoneurons and enhanced motor functional recovery.	LM,53,55,Gene/Protein	NGF,62,65,Gene/Protein	NT3,68,71,Gene/Protein	FN,174,176,Gene/Protein	BDNF,183,187,Gene/Protein	"[{""token"": ""LM"", ""start_span"": 53, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""NGF"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""NT3"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""FN"", ""start_span"": 174, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 183, ""end_span"": 187, ""type"": ""Gene/Protein""}]"	test
On the other hand, the interaction between NTFs and their different receptors, such as Trk / p75 receptors or GDNFR / RET receptors, promotes survival and axonal regeneration of different neuronal populations.	NTFs,43,47,Gene/Protein	Trk,87,90,Gene/Protein	p75,93,96,Gene/Protein	GDNFR,110,115,Gene/Protein	RET,118,121,Gene/Protein	"[{""token"": ""NTFs"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""Trk"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""p75"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""GDNFR"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""RET"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene/Protein""}]"	test
Briefly, addition of both LM and NGF / NT3 or FN and BDNF increased the amount of sensory and motor neurite outgrowth, respectively, in culture models.	LM,26,28,Gene/Protein	NGF,33,36,Gene/Protein	NT3,39,42,Gene/Protein	FN,46,48,Gene/Protein	BDNF,53,57,Gene/Protein	"[{""token"": ""LM"", ""start_span"": 26, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""NGF"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""NT3"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""FN"", ""start_span"": 46, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene/Protein""}]"	test
It is noteworthy that only LM + NGF / NT3 group showed differences in maximum neurite length with respect to all the other culture conditions except with LM + BDNF.	LM,27,29,Gene/Protein	NGF,32,35,Gene/Protein	NT3,38,41,Gene/Protein	LM,154,156,Gene/Protein	BDNF,159,163,Gene/Protein	"[{""token"": ""LM"", ""start_span"": 27, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""NGF"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""NT3"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""LM"", ""start_span"": 154, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 159, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	test
The addition of NGF and NT3 enhanced significantly the density of neurites in all the substrates, being LM + NGF / NT3 the most prominent.	NGF,16,19,Gene/Protein	NT3,24,27,Gene/Protein	LM,104,106,Gene/Protein	NGF,109,112,Gene/Protein	NT3,115,118,Gene/Protein	"[{""token"": ""NGF"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""NT3"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""LM"", ""start_span"": 104, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""NGF"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""NT3"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene/Protein""}]"	test
These results indicate that combination of FN + BDNF shows synergistic effects on motor neurons promoting neurite elongation and arborization, with weaker effect on sensory elongation, whereas LM + NGF / NT3 is the only condition that exhibits a synergistic effects on sensory but not on motor neurons based on the enhancement observed in neurite elongation and arborization.	FN,43,45,Gene/Protein	BDNF,48,52,Gene/Protein	LM,193,195,Gene/Protein	NGF,198,201,Gene/Protein	NT3,204,207,Gene/Protein	"[{""token"": ""FN"", ""start_span"": 43, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""LM"", ""start_span"": 193, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""NGF"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""NT3"", ""start_span"": 204, ""end_span"": 207, ""type"": ""Gene/Protein""}]"	test
Regarding the number of regenerated motor neurons, all groups with addition of ECM and NTFs showed significant differences with respect to the COL group ( p < 0. 001, Figure 3G ), being the FN + MP. BDNF group the one with the highest effect, that was also significantly higher compared to all other groups except with FN.	NTFs,87,91,Gene/Protein	COL,143,146,Gene/Protein	FN,190,192,Gene/Protein	BDNF,199,203,Gene/Protein	FN,319,321,Gene/Protein	"[{""token"": ""NTFs"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""COL"", ""start_span"": 143, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""FN"", ""start_span"": 190, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 199, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""FN"", ""start_span"": 319, ""end_span"": 321, ""type"": ""Gene/Protein""}]"	test
Despite the preferential effects observed in vitro appear less marked in vivo, these results indicate that FN + MP. BDNF mainly favors motor axon regeneration, whereas LM + MP. NGF / NT3 is more effective to promote sensory axon regeneration.	FN,107,109,Gene/Protein	BDNF,116,120,Gene/Protein	LM,168,170,Gene/Protein	NGF,177,180,Gene/Protein	NT3,183,186,Gene/Protein	"[{""token"": ""FN"", ""start_span"": 107, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""LM"", ""start_span"": 168, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""NGF"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""NT3"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	test
Similarly, the number of reinnervated SGs was highest in group LM + MP. NGF / NT3, although only significantly from groups COL and LM ( Figure 4L ).	LM,63,65,Gene/Protein	NGF,72,75,Gene/Protein	NT3,78,81,Gene/Protein	COL,123,126,Gene/Protein	LM,131,133,Gene/Protein	"[{""token"": ""LM"", ""start_span"": 63, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""NGF"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""NT3"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""COL"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""LM"", ""start_span"": 131, ""end_span"": 133, ""type"": ""Gene/Protein""}]"	test
To corroborate the preferential effect of NGF, NT - 3 and LM on sensory neurons and BDNF and FN on motor neurons [ 15, 24, 25, 26, 27 ], we cultured DRG explants and spinal cord slices.	NGF,42,45,Gene/Protein	NT - 3,47,53,Gene/Protein	LM,58,60,Gene/Protein	BDNF,84,88,Gene/Protein	FN,93,95,Gene/Protein	"[{""token"": ""NGF"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""NT - 3"", ""start_span"": 47, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""LM"", ""start_span"": 58, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""FN"", ""start_span"": 93, ""end_span"": 95, ""type"": ""Gene/Protein""}]"	test
However, the preferential effect mediated by LM + MP. NGF / NT3 and FN + MP. BDNF treatments was more modest compared to the in vitro experiments.	LM,45,47,Gene/Protein	NGF,54,57,Gene/Protein	NT3,60,63,Gene/Protein	FN,68,70,Gene/Protein	BDNF,77,81,Gene/Protein	"[{""token"": ""LM"", ""start_span"": 45, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""NGF"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""NT3"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""FN"", ""start_span"": 68, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene/Protein""}]"	test
In conclusion, this study demonstrates that the interaction between FN + BDNF and between LM + NGF / NT3 has synergistic effects to preferentially enhance motor and sensory axon regeneration, respectively, in vitro.	FN,68,70,Gene/Protein	BDNF,73,77,Gene/Protein	LM,90,92,Gene/Protein	NGF,95,98,Gene/Protein	NT3,101,104,Gene/Protein	"[{""token"": ""FN"", ""start_span"": 68, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""LM"", ""start_span"": 90, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""NGF"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""NT3"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}]"	test
Plasmids were propagated in Escherichia. coli JM109. S. cerevisiae CEN. PK2 - 1D ( MATα, Δura3 - 52; Δtrp1 - 289; Δleu2 - 3, 112; Δhis3 - 1; MAL2 - 8C; SUC2) from EUROSARF ( Frankfurt, Germany) and the pY13 - TEF1 plasmid was used for heterologous expression of potential transporters.	MATα,83,87,Gene/Protein	MAL2,141,145,Gene/Protein	SUC2,152,156,Gene/Protein	TEF1,209,213,Gene/Protein	transporters,272,284,Gene/Protein	"[{""token"": ""MAT\u03b1"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""MAL2"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""SUC2"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""TEF1"", ""start_span"": 209, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""transporters"", ""start_span"": 272, ""end_span"": 284, ""type"": ""Gene/Protein""}]"	test
MATα Δura3 - 52; Δtrp1 - 289; Δleu2 - 3, 112; Δhis3 - 1; MAL2 - 8C; SUC2; Δjen1 :: URA3; Δady2 :: LEU2	MATα,0,4,Gene/Protein	MAL2,57,61,Gene/Protein	SUC2,68,72,Gene/Protein	URA3,83,87,Gene/Protein	LEU2,98,102,Gene/Protein	"[{""token"": ""MAT\u03b1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""MAL2"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""SUC2"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""URA3"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""LEU2"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}]"	test
To determine whether the cMSCs could promote human tumor growth, we injected the cMSCs into immune deficient mice with human carcinoma cells, while untreated MSCs were used as controls.	human,45,50,Organism/Species	tumor,51,56,Disease/Disorder	mice,109,113,Organism/Species	human,119,124,Organism/Species	carcinoma,125,134,Disease/Disorder	"[{""token"": ""human"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Organism/Species""}, {""token"": ""tumor"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Disease/Disorder""}, {""token"": ""mice"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 119, ""end_span"": 124, ""type"": ""Organism/Species""}, {""token"": ""carcinoma"", ""start_span"": 125, ""end_span"": 134, ""type"": ""Disease/Disorder""}]"	test
A previous study reported a new MSCs paradigm by specific TLR - priming: TLR4 - primed MSC1 and TLR3 - primed MSC2 [ 17 ].	TLR,58,61,Gene/Protein	TLR4,73,77,Gene/Protein	MSC1,87,91,Gene/Protein	TLR3,96,100,Gene/Protein	MSC2,110,114,Gene/Protein	"[{""token"": ""TLR"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""TLR4"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""MSC1"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""TLR3"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""MSC2"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}]"	test
To determine whether monocytes / macrophages mediated the tumor - promoting effect of the cMSCs, we depleted systemic monocytes / macrophages with clodronate liposomes ( Clo - Lip) followed by injecting mixtures of cMSCs or MSCs with 4T1 tumor cells into mice 14 days after transplantation which detected the tumor growth by BLI.	tumor,58,63,Disease/Disorder	clodronate,147,157,Chemical/Drug	tumor,238,243,Disease/Disorder	mice,255,259,Organism/Species	tumor,309,314,Disease/Disorder	"[{""token"": ""tumor"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Disease/Disorder""}, {""token"": ""clodronate"", ""start_span"": 147, ""end_span"": 157, ""type"": ""Chemical/Drug""}, {""token"": ""tumor"", ""start_span"": 238, ""end_span"": 243, ""type"": ""Disease/Disorder""}, {""token"": ""mice"", ""start_span"": 255, ""end_span"": 259, ""type"": ""Organism/Species""}, {""token"": ""tumor"", ""start_span"": 309, ""end_span"": 314, ""type"": ""Disease/Disorder""}]"	test
To establish the role of cMSCs - expressed MCP1 in tumor growth promotion and macrophage infiltration in vivo, we co - transplanted MCP1 siRNA treated cMSCs and 4T1 - FLUC tumor cells into C57BL / 6 mice.	MCP1,43,47,Gene/Protein	tumor,51,56,Disease/Disorder	MCP1,132,136,Gene/Protein	tumor,172,177,Disease/Disorder	C57BL / 6 mice,189,203,Organism/Species	"[{""token"": ""MCP1"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Disease/Disorder""}, {""token"": ""MCP1"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 172, ""end_span"": 177, ""type"": ""Disease/Disorder""}, {""token"": ""C57BL / 6 mice"", ""start_span"": 189, ""end_span"": 203, ""type"": ""Organism/Species""}]"	test
We found that an MCP1 deficiency led to a significant reduction in CD206 positive macrophages in both tumor tissues and peripheral blood ( Figure 4D ), indicating that MCP1 is critical for trafficking CD206 + macrophages.	MCP1,17,21,Gene/Protein	CD206,67,72,Gene/Protein	tumor,102,107,Disease/Disorder	MCP1,168,172,Gene/Protein	CD206,201,206,Gene/Protein	"[{""token"": ""MCP1"", ""start_span"": 17, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""CD206"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Disease/Disorder""}, {""token"": ""MCP1"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""CD206"", ""start_span"": 201, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	test
We showed that the addition of neutralizing antibodies specific for IL - 6 significantly decreased the mRNA expression of FIZZ - 1, MCP1, SIRPα, and reduced the percentage of CD206 positive cells, as compared with the co - culture control treated with nonspecific antibodies ( Figure 5C, 5D ).	IL - 6,68,74,Gene/Protein	FIZZ - 1,122,130,Gene/Protein	MCP1,132,136,Gene/Protein	SIRPα,138,143,Gene/Protein	CD206,175,180,Gene/Protein	"[{""token"": ""IL - 6"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""FIZZ - 1"", ""start_span"": 122, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""MCP1"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""SIRP\u03b1"", ""start_span"": 138, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""CD206"", ""start_span"": 175, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	test
A previous study found that the concomitant presence of TNF - α and IFN - γ could induce the immunosuppressive functions of the MSCs, as these cytokine combinations provoke the expression of high levels of CXCL9, CXCL10 and iNOS [ 18 ].	TNF - α,56,63,Gene/Protein	IFN - γ,68,75,Gene/Protein	CXCL9,206,211,Gene/Protein	CXCL10,213,219,Gene/Protein	iNOS,224,228,Gene/Protein	"[{""token"": ""TNF - \u03b1"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""IFN - \u03b3"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""CXCL9"", ""start_span"": 206, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""CXCL10"", ""start_span"": 213, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""iNOS"", ""start_span"": 224, ""end_span"": 228, ""type"": ""Gene/Protein""}]"	test
Animals were divided into two groups ( n = 6 per group ): the si - iNOS / cMSCs group, in which mice received 1 × 106 iNOS siRNA treated cMSCs and 2 × 106 4T1 - FLUC cells in 100 μl of PBS; and the control ( si - control / cMSCs) group also received 1 × 106 control siRNA treated cMSCs and 2 × 106 tumor cells in 100 μl of PBS.	Animals,0,7,Organism/Species	iNOS,67,71,Gene/Protein	mice,96,100,Organism/Species	iNOS,118,122,Gene/Protein	tumor,298,303,Disease/Disorder	"[{""token"": ""Animals"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Organism/Species""}, {""token"": ""iNOS"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Organism/Species""}, {""token"": ""iNOS"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 298, ""end_span"": 303, ""type"": ""Disease/Disorder""}]"	test
Animals were divided into two groups ( n = 6 per group ): the si - MCP1 / cMSCs group, in which mice received 1 × 106 MCP1 siRNA treated cMSCs and 2 × 106 4T1 - FLUC cells in 100 μl of PBS; and the control ( si - control / cMSCs) group also received 1 × 106 control siRNA treated cMSCs and 2 × 106 tumor cells in 100 μl of PBS.	Animals,0,7,Organism/Species	MCP1,67,71,Gene/Protein	mice,96,100,Organism/Species	MCP1,118,122,Gene/Protein	tumor,298,303,Disease/Disorder	"[{""token"": ""Animals"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Organism/Species""}, {""token"": ""MCP1"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Organism/Species""}, {""token"": ""MCP1"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 298, ""end_span"": 303, ""type"": ""Disease/Disorder""}]"	test
For macrophage surface marker analysis, macrophages were incubated with fluorescent labeled rat anti - mouse CD11b, iNOS, and CD206 antibodies ( BD Biosciences Pharmingen, San Diego, CA ).	rat,92,95,Organism/Species	mouse,103,108,Organism/Species	CD11b,109,114,Gene/Protein	iNOS,116,120,Gene/Protein	CD206,126,131,Gene/Protein	"[{""token"": ""rat"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Organism/Species""}, {""token"": ""CD11b"", ""start_span"": 109, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""iNOS"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""CD206"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene/Protein""}]"	test
The remaining 20% of AMLs develop in association with tuberosclerosis complex ( TSC) or pulmonary lymphangioleiomyomatosis ( LAM) [ 12 ].	AMLs,21,25,Disease/Disorder	tuberosclerosis complex,54,77,Disease/Disorder	TSC,80,83,Disease/Disorder	pulmonary lymphangioleiomyomatosis,88,122,Disease/Disorder	LAM,125,128,Disease/Disorder	"[{""token"": ""AMLs"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Disease/Disorder""}, {""token"": ""tuberosclerosis complex"", ""start_span"": 54, ""end_span"": 77, ""type"": ""Disease/Disorder""}, {""token"": ""TSC"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Disease/Disorder""}, {""token"": ""pulmonary lymphangioleiomyomatosis"", ""start_span"": 88, ""end_span"": 122, ""type"": ""Disease/Disorder""}, {""token"": ""LAM"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Disease/Disorder""}]"	test
TSC is caused by mutations in one of two genes, TSC1 and TSC2, which encode the proteins hamartin and tuberin, respectively.	TSC,0,3,Disease/Disorder	TSC1,48,52,Gene/Protein	TSC2,57,61,Gene/Protein	hamartin,89,97,Gene/Protein	tuberin,102,109,Gene/Protein	"[{""token"": ""TSC"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Disease/Disorder""}, {""token"": ""TSC1"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""TSC2"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""hamartin"", ""start_span"": 89, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""tuberin"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Gene/Protein""}]"	test
However, distinction of epithelioid AMLs from RCC is possible by the presence of immunohistochemistry markers, such as smooth muscle markers ( caldesmon and smooth muscle actin) and melanocytic markers ( HMB - 45 antigen and melan - A) [ 2345 ].	AMLs,36,40,Disease/Disorder	RCC,46,49,Disease/Disorder	caldesmon,143,152,Gene/Protein	smooth muscle actin,157,176,Gene/Protein	melan - A,225,234,Gene/Protein	"[{""token"": ""AMLs"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Disease/Disorder""}, {""token"": ""RCC"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Disease/Disorder""}, {""token"": ""caldesmon"", ""start_span"": 143, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""smooth muscle actin"", ""start_span"": 157, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""melan - A"", ""start_span"": 225, ""end_span"": 234, ""type"": ""Gene/Protein""}]"	test
a Abbreviations: BP: blood pressure; CASM: computer - assisted self - management; CASP: computer - assisted self - management + problem solving treatment; CV: cardiovascular; DM: diabetes mellitus; DM2: type 2 diabetes mellitus; GP: general practitioner; HbA1c; glycated hemoglobin A1c; HDL: high - density lipoprotein; LDL: low - density lipoprotein.	DM,175,177,Disease/Disorder	diabetes mellitus,179,196,Disease/Disorder	DM2,198,201,Disease/Disorder	type 2 diabetes mellitus,203,227,Disease/Disorder	hemoglobin,271,281,Gene/Protein	"[{""token"": ""DM"", ""start_span"": 175, ""end_span"": 177, ""type"": ""Disease/Disorder""}, {""token"": ""diabetes mellitus"", ""start_span"": 179, ""end_span"": 196, ""type"": ""Disease/Disorder""}, {""token"": ""DM2"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Disease/Disorder""}, {""token"": ""type 2 diabetes mellitus"", ""start_span"": 203, ""end_span"": 227, ""type"": ""Disease/Disorder""}, {""token"": ""hemoglobin"", ""start_span"": 271, ""end_span"": 281, ""type"": ""Gene/Protein""}]"	test
GR3027 antagonizes GABAA receptor - potentiating neurosteroids and restores spatial learning and motor coordination in rats with chronic hyperammonemia and hepatic encephalopathy	GR3027,0,6,Chemical/Drug	GABAA receptor,19,33,Gene/Protein	rats,119,123,Organism/Species	hyperammonemia,137,151,Disease/Disorder	hepatic encephalopathy,156,178,Disease/Disorder	"[{""token"": ""GR3027"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical/Drug""}, {""token"": ""GABAA receptor"", ""start_span"": 19, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""rats"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Organism/Species""}, {""token"": ""hyperammonemia"", ""start_span"": 137, ""end_span"": 151, ""type"": ""Disease/Disorder""}, {""token"": ""hepatic encephalopathy"", ""start_span"": 156, ""end_span"": 178, ""type"": ""Disease/Disorder""}]"	train
GR3027 was administered subcutaneously to two main models of HE: rats with chronic hyperammonemia due to ammonia feeding and rats with portacaval shunts ( PCS ).	GR3027,0,6,Chemical/Drug	HE,61,63,Disease/Disorder	rats,65,69,Organism/Species	hyperammonemia,83,97,Disease/Disorder	rats,125,129,Organism/Species	"[{""token"": ""GR3027"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical/Drug""}, {""token"": ""HE"", ""start_span"": 61, ""end_span"": 63, ""type"": ""Disease/Disorder""}, {""token"": ""rats"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Organism/Species""}, {""token"": ""hyperammonemia"", ""start_span"": 83, ""end_span"": 97, ""type"": ""Disease/Disorder""}, {""token"": ""rats"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Organism/Species""}]"	train
Studies in animal HE models have identified cerebral mechanisms responsible for cognitive and motor alterations and brain targets modulation of which reverses cognitive and motor alterations in rats with HE, while hyperammonemia and inflammation remain present ( 15 ).	animal,11,17,Organism/Species	HE,18,20,Disease/Disorder	rats,194,198,Organism/Species	HE,204,206,Disease/Disorder	hyperammonemia,214,228,Disease/Disorder	"[{""token"": ""animal"", ""start_span"": 11, ""end_span"": 17, ""type"": ""Organism/Species""}, {""token"": ""HE"", ""start_span"": 18, ""end_span"": 20, ""type"": ""Disease/Disorder""}, {""token"": ""rats"", ""start_span"": 194, ""end_span"": 198, ""type"": ""Organism/Species""}, {""token"": ""HE"", ""start_span"": 204, ""end_span"": 206, ""type"": ""Disease/Disorder""}, {""token"": ""hyperammonemia"", ""start_span"": 214, ""end_span"": 228, ""type"": ""Disease/Disorder""}]"	train
Increased GABAergic tone induces motor incoordination, and extracellular GABA in cerebellum correlates with motor incoordination in rats ( 9 ). α1 - Containing GABAA receptors are likely involved in the motor incoordination since benzodiazepines induce ataxia by enhancing activation of α1 - containing GABAA receptors ( 27 ).	rats,132,136,Organism/Species	GABAA receptors,160,175,Gene/Protein	benzodiazepines,230,245,Chemical/Drug	ataxia,253,259,Disease/Disorder	GABAA receptors,303,318,Gene/Protein	"[{""token"": ""rats"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Organism/Species""}, {""token"": ""GABAA receptors"", ""start_span"": 160, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""benzodiazepines"", ""start_span"": 230, ""end_span"": 245, ""type"": ""Chemical/Drug""}, {""token"": ""ataxia"", ""start_span"": 253, ""end_span"": 259, ""type"": ""Disease/Disorder""}, {""token"": ""GABAA receptors"", ""start_span"": 303, ""end_span"": 318, ""type"": ""Gene/Protein""}]"	train
GABAergic tone is increased in the cerebellum of rats with chronic hyperammonemia and HE because of increased extracellular GABA and increased levels of neurosteroids acting as positive modulators of GABAA receptors ( allopregnanolone, THDOC) ( 12 ).	rats,49,53,Organism/Species	hyperammonemia,67,81,Disease/Disorder	HE,86,88,Disease/Disorder	GABAA receptors,200,215,Gene/Protein	allopregnanolone,218,234,Chemical/Drug	"[{""token"": ""rats"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Organism/Species""}, {""token"": ""hyperammonemia"", ""start_span"": 67, ""end_span"": 81, ""type"": ""Disease/Disorder""}, {""token"": ""HE"", ""start_span"": 86, ""end_span"": 88, ""type"": ""Disease/Disorder""}, {""token"": ""GABAA receptors"", ""start_span"": 200, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""allopregnanolone"", ""start_span"": 218, ""end_span"": 234, ""type"": ""Chemical/Drug""}]"	train
Allopregnanolone is increased in the brain of cirrhotic patients who die in HE ( 3 ), and allopregnanolone and THDOC are increased in rats with hyperammonemia ( 12) or portacaval anastomosis ( 4, 5 ).	Allopregnanolone,0,16,Chemical/Drug	HE,76,78,Disease/Disorder	allopregnanolone,90,106,Chemical/Drug	rats,134,138,Organism/Species	hyperammonemia,144,158,Disease/Disorder	"[{""token"": ""Allopregnanolone"", ""start_span"": 0, ""end_span"": 16, ""type"": ""Chemical/Drug""}, {""token"": ""HE"", ""start_span"": 76, ""end_span"": 78, ""type"": ""Disease/Disorder""}, {""token"": ""allopregnanolone"", ""start_span"": 90, ""end_span"": 106, ""type"": ""Chemical/Drug""}, {""token"": ""rats"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Organism/Species""}, {""token"": ""hyperammonemia"", ""start_span"": 144, ""end_span"": 158, ""type"": ""Disease/Disorder""}]"	train
The aims were to assess whether GR3027 improves motor incoordination and spatial learning in rats with chronic hyperammonemia or with portacaval anastomosis, two main models of HE recommended by the International Society for Hepatic Encephalopathy ( 10 ).	GR3027,32,38,Chemical/Drug	rats,93,97,Organism/Species	hyperammonemia,111,125,Disease/Disorder	HE,177,179,Disease/Disorder	Hepatic Encephalopathy,225,247,Disease/Disorder	"[{""token"": ""GR3027"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Chemical/Drug""}, {""token"": ""rats"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Organism/Species""}, {""token"": ""hyperammonemia"", ""start_span"": 111, ""end_span"": 125, ""type"": ""Disease/Disorder""}, {""token"": ""HE"", ""start_span"": 177, ""end_span"": 179, ""type"": ""Disease/Disorder""}, {""token"": ""Hepatic Encephalopathy"", ""start_span"": 225, ""end_span"": 247, ""type"": ""Disease/Disorder""}]"	train
In the second set of experiments five groups of rats were used: 1) control rats injected with vehicle, 2) hyperammonemic rats injected with vehicle, and hyperammonemic rats injected with 3) 3, 4) 10, or 5) 20 mg / kg GR3027.	rats,48,52,Organism/Species	rats,75,79,Organism/Species	rats,121,125,Organism/Species	rats,168,172,Organism/Species	GR3027,217,223,Chemical/Drug	"[{""token"": ""rats"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Organism/Species""}, {""token"": ""GR3027"", ""start_span"": 217, ""end_span"": 223, ""type"": ""Chemical/Drug""}]"	train
The reason that the doses used in the studies with hyperammonemic and PCS rats are different is that GR3027 is metabolized by the liver in rats and we expected a reduced metabolism of GR3027 in PCS compared with control or hyperammonemic rats.	rats,74,78,Organism/Species	GR3027,101,107,Chemical/Drug	rats,139,143,Organism/Species	GR3027,184,190,Chemical/Drug	rats,238,242,Organism/Species	"[{""token"": ""rats"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Organism/Species""}, {""token"": ""GR3027"", ""start_span"": 101, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""rats"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Organism/Species""}, {""token"": ""GR3027"", ""start_span"": 184, ""end_span"": 190, ""type"": ""Chemical/Drug""}, {""token"": ""rats"", ""start_span"": 238, ""end_span"": 242, ""type"": ""Organism/Species""}]"	train
Ambulatory counts ( A – D) and vertical activity ( E – H) were assessed in control ( C) and hyperammonemic ( HA) rats ( A, C, E, G) treated with vehicle ( V) or with 20 mg / kg GR3027 and in sham - operated control rats ( SMV) or PCS rats ( B, D, F, H) treated with vehicle ( PCSV) or with 0. 7 ( PCS0. 7) or 2. 5 ( PCS2. 5) mg / kg GR3027.	rats,113,117,Organism/Species	GR3027,177,183,Chemical/Drug	rats,215,219,Organism/Species	rats,234,238,Organism/Species	GR3027,333,339,Chemical/Drug	"[{""token"": ""rats"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Organism/Species""}, {""token"": ""GR3027"", ""start_span"": 177, ""end_span"": 183, ""type"": ""Chemical/Drug""}, {""token"": ""rats"", ""start_span"": 215, ""end_span"": 219, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 234, ""end_span"": 238, ""type"": ""Organism/Species""}, {""token"": ""GR3027"", ""start_span"": 333, ""end_span"": 339, ""type"": ""Chemical/Drug""}]"	train
GR3027 exposures in plasma and in the brain at time for behavioral testing. A and B: in hyperammonemic ( A) and PCS ( B) rats, the total plasma concentrations of GR3027 are shown in μM. C and D: in hyperammonemic ( C) and PCS ( D) rats, the unbound brain concentrations of GR3027 are shown in nmol / kg.	GR3027,0,6,Chemical/Drug	rats,121,125,Organism/Species	GR3027,162,168,Chemical/Drug	rats,231,235,Organism/Species	GR3027,273,279,Chemical/Drug	"[{""token"": ""GR3027"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical/Drug""}, {""token"": ""rats"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Organism/Species""}, {""token"": ""GR3027"", ""start_span"": 162, ""end_span"": 168, ""type"": ""Chemical/Drug""}, {""token"": ""rats"", ""start_span"": 231, ""end_span"": 235, ""type"": ""Organism/Species""}, {""token"": ""GR3027"", ""start_span"": 273, ""end_span"": 279, ""type"": ""Chemical/Drug""}]"	train
Anti - band 3 and anti - spectrin antibodies are increased in Plasmodium vivax infection and are associated with anemia	band 3,7,13,Gene/Protein	spectrin,25,33,Gene/Protein	antibodies,34,44,Gene/Protein	Plasmodium vivax infection,62,88,Disease/Disorder	anemia,113,119,Disease/Disorder	"[{""token"": ""band 3"", ""start_span"": 7, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""spectrin"", ""start_span"": 25, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 34, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""Plasmodium vivax infection"", ""start_span"": 62, ""end_span"": 88, ""type"": ""Disease/Disorder""}, {""token"": ""anemia"", ""start_span"": 113, ""end_span"": 119, ""type"": ""Disease/Disorder""}]"	train
Evidences in this line are given by studies that have shown an inverse association between hemoglobin levels and anti - phosphatidylserine antibodies in humans with late post - anemia due to P. falciparum infection14.	hemoglobin,91,101,Gene/Protein	phosphatidylserine,120,138,Chemical/Drug	antibodies,139,149,Gene/Protein	humans,153,159,Organism/Species	anemia,177,183,Disease/Disorder	"[{""token"": ""hemoglobin"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""phosphatidylserine"", ""start_span"": 120, ""end_span"": 138, ""type"": ""Chemical/Drug""}, {""token"": ""antibodies"", ""start_span"": 139, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""humans"", ""start_span"": 153, ""end_span"": 159, ""type"": ""Organism/Species""}, {""token"": ""anemia"", ""start_span"": 177, ""end_span"": 183, ""type"": ""Disease/Disorder""}]"	train
To determine whether IgG antibodies recognizing nRBC antigens are increased during acute P. vivax malaria, median levels of such immunoglobulins were assessed by ELISA in plasma from patients with patent P. vivax infection presenting ( n = 24) or not ( n = 24) anemia, as well as in plasma from healthy individuals never exposed to malaria ( n = 8 ).	IgG,21,24,Gene/Protein	antibodies,25,35,Gene/Protein	immunoglobulins,129,144,Gene/Protein	anemia,261,267,Disease/Disorder	malaria,332,339,Disease/Disorder	"[{""token"": ""IgG"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 25, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulins"", ""start_span"": 129, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""anemia"", ""start_span"": 261, ""end_span"": 267, ""type"": ""Disease/Disorder""}, {""token"": ""malaria"", ""start_span"": 332, ""end_span"": 339, ""type"": ""Disease/Disorder""}]"	train
Anti - band 3 and anti - spectrin antibodies correlate with anemia in patients with vivax malaria	band 3,7,13,Gene/Protein	spectrin,25,33,Gene/Protein	antibodies,34,44,Gene/Protein	anemia,60,66,Disease/Disorder	vivax malaria,84,97,Disease/Disorder	"[{""token"": ""band 3"", ""start_span"": 7, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""spectrin"", ""start_span"": 25, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 34, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""anemia"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Disease/Disorder""}, {""token"": ""vivax malaria"", ""start_span"": 84, ""end_span"": 97, ""type"": ""Disease/Disorder""}]"	train
( B) Heat map of IgG antibody profile against band 3 and spectrin in plasma from anemic and non - anemic patients with vivax malaria.	IgG,17,20,Gene/Protein	antibody,21,29,Gene/Protein	band 3,46,52,Gene/Protein	spectrin,57,65,Gene/Protein	vivax malaria,119,132,Disease/Disorder	"[{""token"": ""IgG"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 21, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""band 3"", ""start_span"": 46, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""spectrin"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""vivax malaria"", ""start_span"": 119, ""end_span"": 132, ""type"": ""Disease/Disorder""}]"	train
The other four parasite proteins found to be mimetic to human RBC proteins ( PVX_123515, PVX_099980, PVX_101610 and PVX_099980) were membrane surface - related proteins.	human,56,61,Organism/Species	PVX_123515,77,87,Gene/Protein	PVX_099980,89,99,Gene/Protein	PVX_101610,101,111,Gene/Protein	PVX_099980,116,126,Gene/Protein	"[{""token"": ""human"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Organism/Species""}, {""token"": ""PVX_123515"", ""start_span"": 77, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""PVX_099980"", ""start_span"": 89, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""PVX_101610"", ""start_span"": 101, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""PVX_099980"", ""start_span"": 116, ""end_span"": 126, ""type"": ""Gene/Protein""}]"	train
Shibuya et al. ( 2018) proposed a model for antibody assess to the cytoplasmic domain of band 3 in hereditary spherocytosis, which was attributed to the hydrolysis of spectrin and ankyrin.	antibody,44,52,Gene/Protein	band 3,89,95,Gene/Protein	hereditary spherocytosis,99,123,Disease/Disorder	spectrin,167,175,Gene/Protein	ankyrin,180,187,Gene/Protein	"[{""token"": ""antibody"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""band 3"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""hereditary spherocytosis"", ""start_span"": 99, ""end_span"": 123, ""type"": ""Disease/Disorder""}, {""token"": ""spectrin"", ""start_span"": 167, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""ankyrin"", ""start_span"": 180, ""end_span"": 187, ""type"": ""Gene/Protein""}]"	train
Wells were rewashed and incubated with horseradish peroxidase conjugated polyclonal anti - human IgG diluted 1: 8000 in PBS / BSA for 90 minutes at 37 ° C.	horseradish,39,50,Organism/Species	peroxidase,51,61,Gene/Protein	human,91,96,Organism/Species	IgG,97,100,Gene/Protein	BSA,126,129,Gene/Protein	"[{""token"": ""horseradish"", ""start_span"": 39, ""end_span"": 50, ""type"": ""Organism/Species""}, {""token"": ""peroxidase"", ""start_span"": 51, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""BSA"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Gene/Protein""}]"	train
Briefly, plates were coated overnight at 4 ºC with 5 ng of band 3 or 50 ng of spectrin, blocked with 3% BSA, and incubated with sera samples diluted 1: 100 in PBS containing 1% BSA ( PBS. 1% BSA) for 2 h at 37 ºC.	band 3,59,65,Gene/Protein	spectrin,78,86,Gene/Protein	BSA,104,107,Gene/Protein	BSA,177,180,Gene/Protein	BSA,191,194,Gene/Protein	"[{""token"": ""band 3"", ""start_span"": 59, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""spectrin"", ""start_span"": 78, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""BSA"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""BSA"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""BSA"", ""start_span"": 191, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
Therefore, we aimed to evaluate the distribution of circulating amylin and its association with metabolic syndrome ( MetS) and explore if this association is influenced by obesity, inflammatory markers or insulin resistance in apparently healthy Chinese.	amylin,64,70,Gene/Protein	metabolic syndrome,96,114,Disease/Disorder	MetS,117,121,Disease/Disorder	obesity,172,179,Disease/Disorder	insulin resistance,205,223,Disease/Disorder	"[{""token"": ""amylin"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""metabolic syndrome"", ""start_span"": 96, ""end_span"": 114, ""type"": ""Disease/Disorder""}, {""token"": ""MetS"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Disease/Disorder""}, {""token"": ""obesity"", ""start_span"": 172, ""end_span"": 179, ""type"": ""Disease/Disorder""}, {""token"": ""insulin resistance"", ""start_span"": 205, ""end_span"": 223, ""type"": ""Disease/Disorder""}]"	train
The amylin - MetS association is independent of established risk factors of MetS, including obesity, inflammatory markers and insulin resistance.	amylin,4,10,Gene/Protein	MetS,13,17,Disease/Disorder	MetS,76,80,Disease/Disorder	obesity,92,99,Disease/Disorder	insulin resistance,126,144,Disease/Disorder	"[{""token"": ""amylin"", ""start_span"": 4, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""MetS"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Disease/Disorder""}, {""token"": ""MetS"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Disease/Disorder""}, {""token"": ""obesity"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Disease/Disorder""}, {""token"": ""insulin resistance"", ""start_span"": 126, ""end_span"": 144, ""type"": ""Disease/Disorder""}]"	train
Amylin, also named islet amyloid polypeptide ( IAPP ), is a 37 amino acid polypeptide initially isolated from amyloid deposit in pancreatic islets of type 2 diabetes patients [ 1 ], [ 2 ].	Amylin,0,6,Gene/Protein	islet amyloid polypeptide,19,44,Gene/Protein	IAPP,47,51,Gene/Protein	amino acid,63,73,Chemical/Drug	type 2 diabetes,150,165,Disease/Disorder	"[{""token"": ""Amylin"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""islet amyloid polypeptide"", ""start_span"": 19, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""IAPP"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""amino acid"", ""start_span"": 63, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""type 2 diabetes"", ""start_span"": 150, ""end_span"": 165, ""type"": ""Disease/Disorder""}]"	train
During past decades, accumulating evidence has highlighted chronic low - grade inflammation as one of the important mechanisms involving in pathogenesis of obesity and related metabolic disorders such as metabolic syndrome, type 2 diabetes and cardiovascular diseases [ 21 ].	obesity,156,163,Disease/Disorder	metabolic disorders,176,195,Disease/Disorder	metabolic syndrome,204,222,Disease/Disorder	type 2 diabetes,224,239,Disease/Disorder	cardiovascular diseases,244,267,Disease/Disorder	"[{""token"": ""obesity"", ""start_span"": 156, ""end_span"": 163, ""type"": ""Disease/Disorder""}, {""token"": ""metabolic disorders"", ""start_span"": 176, ""end_span"": 195, ""type"": ""Disease/Disorder""}, {""token"": ""metabolic syndrome"", ""start_span"": 204, ""end_span"": 222, ""type"": ""Disease/Disorder""}, {""token"": ""type 2 diabetes"", ""start_span"": 224, ""end_span"": 239, ""type"": ""Disease/Disorder""}, {""token"": ""cardiovascular diseases"", ""start_span"": 244, ""end_span"": 267, ""type"": ""Disease/Disorder""}]"	train
MetS was defined based on the updated National Cholesterol Education Program Adult Treatment Panel III criteria for Asian - Americans [ 17 ], including at least three of the following components: 1) waist circumference ≥ 90 cm in men or ≥ 80 cm in women; 2) triglycerides ≥ 1. 7 mmol / l; 3) HDL cholesterol < 1. 03 mmol / l in men, or < 1. 30 mmol / l in women; 4) blood pressure ≥ 130 / 85 mm Hg, or current use of antihypertensive medications; and 5) fasting plasma glucose ≥ 5. 6 mmol / l.	MetS,0,4,Disease/Disorder	Cholesterol,47,58,Chemical/Drug	triglycerides,258,271,Chemical/Drug	cholesterol,296,307,Chemical/Drug	glucose,469,476,Chemical/Drug	"[{""token"": ""MetS"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Disease/Disorder""}, {""token"": ""Cholesterol"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""triglycerides"", ""start_span"": 258, ""end_span"": 271, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 296, ""end_span"": 307, ""type"": ""Chemical/Drug""}, {""token"": ""glucose"", ""start_span"": 469, ""end_span"": 476, ""type"": ""Chemical/Drug""}]"	train
Although further adjustment of insulin based on model 2 decrease the magnitude of the amylin - MetS association ( with an OR of 1. 85, 95% CI: 1. 21 – 2. 85 ), the association of amylin with MetS is still statistically significant ( P = 0. 001 for trend ).	insulin,31,38,Gene/Protein	amylin,86,92,Gene/Protein	MetS,95,99,Disease/Disorder	amylin,179,185,Gene/Protein	MetS,191,195,Disease/Disorder	"[{""token"": ""insulin"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""amylin"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""MetS"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Disease/Disorder""}, {""token"": ""amylin"", ""start_span"": 179, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""MetS"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Disease/Disorder""}]"	train
However, little is known whether high circulating amylin is an independent risk factor for MetS, a preclinical condition associated with a 2 - fold increase in risk of CVD, CVD mortality, and stroke [ 18 ].	amylin,50,56,Gene/Protein	MetS,91,95,Disease/Disorder	CVD,168,171,Disease/Disorder	CVD,173,176,Disease/Disorder	stroke,192,198,Disease/Disorder	"[{""token"": ""amylin"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""MetS"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Disease/Disorder""}, {""token"": ""CVD"", ""start_span"": 168, ""end_span"": 171, ""type"": ""Disease/Disorder""}, {""token"": ""CVD"", ""start_span"": 173, ""end_span"": 176, ""type"": ""Disease/Disorder""}, {""token"": ""stroke"", ""start_span"": 192, ""end_span"": 198, ""type"": ""Disease/Disorder""}]"	train
While it is still waiting to be verified whether the findings from the in vitro and animal studies are biologically relevant to humans, our data, however, showed that elevated amylin was significantly correlated with increased plasma CRP and IL - 6.	animal,84,90,Organism/Species	humans,128,134,Organism/Species	amylin,176,182,Gene/Protein	CRP,234,237,Gene/Protein	IL - 6,242,248,Gene/Protein	"[{""token"": ""animal"", ""start_span"": 84, ""end_span"": 90, ""type"": ""Organism/Species""}, {""token"": ""humans"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Organism/Species""}, {""token"": ""amylin"", ""start_span"": 176, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""CRP"", ""start_span"": 234, ""end_span"": 237, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 242, ""end_span"": 248, ""type"": ""Gene/Protein""}]"	train
Interestingly, the association between amylin and hypertriglyceridemia was particularly strong and also independent of BMI, a well recognized risk factor for hypertriglyceridemia [ 35 ], whereas the associations between amylin and the rest of the MetS components were largely explained by BMI ( Table 4 ).	amylin,39,45,Gene/Protein	hypertriglyceridemia,50,70,Disease/Disorder	hypertriglyceridemia,158,178,Disease/Disorder	amylin,220,226,Gene/Protein	MetS,247,251,Disease/Disorder	"[{""token"": ""amylin"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""hypertriglyceridemia"", ""start_span"": 50, ""end_span"": 70, ""type"": ""Disease/Disorder""}, {""token"": ""hypertriglyceridemia"", ""start_span"": 158, ""end_span"": 178, ""type"": ""Disease/Disorder""}, {""token"": ""amylin"", ""start_span"": 220, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""MetS"", ""start_span"": 247, ""end_span"": 251, ""type"": ""Disease/Disorder""}]"	train
In another study, Ye et al showed that amylin infusion in rats increased not only circulating levels of non - esterified fatty acids and glycerol, but also hepatic triglyceride content [ 37 ].	amylin,39,45,Gene/Protein	rats,58,62,Organism/Species	fatty acids,121,132,Chemical/Drug	glycerol,137,145,Chemical/Drug	triglyceride,164,176,Chemical/Drug	"[{""token"": ""amylin"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""rats"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Organism/Species""}, {""token"": ""fatty acids"", ""start_span"": 121, ""end_span"": 132, ""type"": ""Chemical/Drug""}, {""token"": ""glycerol"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Chemical/Drug""}, {""token"": ""triglyceride"", ""start_span"": 164, ""end_span"": 176, ""type"": ""Chemical/Drug""}]"	train
To unravel the functional properties of one specific high capacity plasma membrane sucrose transporter in detail, we expressed the sucrose / H + co - transporter from maize ZmSUT1 in Xenopus oocytes.	sucrose transporter,83,102,Gene/Protein	sucrose / H + co - transporter,131,161,Gene/Protein	maize,167,172,Organism/Species	ZmSUT1,173,179,Gene/Protein	Xenopus,183,190,Organism/Species	"[{""token"": ""sucrose transporter"", ""start_span"": 83, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""sucrose / H + co - transporter"", ""start_span"": 131, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""maize"", ""start_span"": 167, ""end_span"": 172, ""type"": ""Organism/Species""}, {""token"": ""ZmSUT1"", ""start_span"": 173, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""Xenopus"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Organism/Species""}]"	train
Transporters both from animal ( SGLT1, PepT1, [ 24 ], [ 34 ]) and plant kingdoms ( STP1, [ 35 ]) are characterized by presteady - state currents which are apparent in the absence of external substrate and disappear under substrate saturation.	animal,23,29,Organism/Species	SGLT1,32,37,Gene/Protein	PepT1,39,44,Gene/Protein	plant,66,71,Organism/Species	STP1,83,87,Gene/Protein	"[{""token"": ""animal"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Organism/Species""}, {""token"": ""SGLT1"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""PepT1"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""plant"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Organism/Species""}, {""token"": ""STP1"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}]"	train
In a phylogenetic analysis of human, rat, and mouse iGluR subunits, each of the three different subtypes formed a monophyletic clade, with functional iGluR proteins made only with subunits within each individual clade [ 6 ].	human,30,35,Organism/Species	rat,37,40,Organism/Species	mouse,46,51,Organism/Species	iGluR,52,57,Gene/Protein	iGluR,150,155,Gene/Protein	"[{""token"": ""human"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Organism/Species""}, {""token"": ""rat"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Organism/Species""}, {""token"": ""iGluR"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""iGluR"", ""start_span"": 150, ""end_span"": 155, ""type"": ""Gene/Protein""}]"	train
To address this question we have conducted a phylogenetic analysis spanning all three Bilateria superclades in order to identify iGluR genes in invertebrate model species that are orthologous with vertebrate iGluR, and thus more likely to be functionally similar.	Bilateria,86,95,Organism/Species	iGluR,129,134,Gene/Protein	invertebrate,144,156,Organism/Species	vertebrate,197,207,Organism/Species	iGluR,208,213,Gene/Protein	"[{""token"": ""Bilateria"", ""start_span"": 86, ""end_span"": 95, ""type"": ""Organism/Species""}, {""token"": ""iGluR"", ""start_span"": 129, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""invertebrate"", ""start_span"": 144, ""end_span"": 156, ""type"": ""Organism/Species""}, {""token"": ""vertebrate"", ""start_span"": 197, ""end_span"": 207, ""type"": ""Organism/Species""}, {""token"": ""iGluR"", ""start_span"": 208, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
Identification of Protostomia iGluR genes homologous to vertebrate NMDAR and AMPAR subunits can allow for predictions of subunits that may be involved in observed synaptic plasticity.	Protostomia,18,29,Organism/Species	iGluR,30,35,Gene/Protein	vertebrate,56,66,Organism/Species	NMDAR,67,72,Gene/Protein	AMPAR,77,82,Gene/Protein	"[{""token"": ""Protostomia"", ""start_span"": 18, ""end_span"": 29, ""type"": ""Organism/Species""}, {""token"": ""iGluR"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""vertebrate"", ""start_span"": 56, ""end_span"": 66, ""type"": ""Organism/Species""}, {""token"": ""NMDAR"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""AMPAR"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Gene/Protein""}]"	train
In this study we clarified the evolution of bilaterian iGluR using phylogenetic analysis, investigated iGluR genes in Aplysia, and determined expression levels in ganglia of the Aplysia nervous system to place this model into an appropriate context with other iGluR model species.	iGluR,55,60,Gene/Protein	iGluR,103,108,Gene/Protein	Aplysia,118,125,Organism/Species	Aplysia,178,185,Organism/Species	iGluR,260,265,Gene/Protein	"[{""token"": ""iGluR"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""iGluR"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""Aplysia"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Organism/Species""}, {""token"": ""Aplysia"", ""start_span"": 178, ""end_span"": 185, ""type"": ""Organism/Species""}, {""token"": ""iGluR"", ""start_span"": 260, ""end_span"": 265, ""type"": ""Gene/Protein""}]"	train
iGluR sequences for phylogenetic analysis were obtained from NCBI for all species except Branchiostoma belcheri ( lancelet ), which were obtained from the Chinese Lancelet Genome Project (< genome. bucm. edu. cn / lancelet >).	iGluR,0,5,Gene/Protein	Branchiostoma belcheri,89,111,Organism/Species	lancelet,114,122,Organism/Species	Lancelet,163,171,Organism/Species	lancelet,214,222,Organism/Species	"[{""token"": ""iGluR"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""Branchiostoma belcheri"", ""start_span"": 89, ""end_span"": 111, ""type"": ""Organism/Species""}, {""token"": ""lancelet"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Organism/Species""}, {""token"": ""Lancelet"", ""start_span"": 163, ""end_span"": 171, ""type"": ""Organism/Species""}, {""token"": ""lancelet"", ""start_span"": 214, ""end_span"": 222, ""type"": ""Organism/Species""}]"	train
Previously described iGluR in both Aplysia and chordates were obtained from the NCBI database, and analyzed using tools at the SMART [ 41] and Interpro [ 42] protein databases for potential binding sites and transmembrane domains to identify all iGluR subunits in Aplysia.	iGluR,21,26,Gene/Protein	Aplysia,35,42,Organism/Species	chordates,47,56,Organism/Species	iGluR,246,251,Gene/Protein	Aplysia,264,271,Organism/Species	"[{""token"": ""iGluR"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""Aplysia"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Organism/Species""}, {""token"": ""chordates"", ""start_span"": 47, ""end_span"": 56, ""type"": ""Organism/Species""}, {""token"": ""iGluR"", ""start_span"": 246, ""end_span"": 251, ""type"": ""Gene/Protein""}, {""token"": ""Aplysia"", ""start_span"": 264, ""end_span"": 271, ""type"": ""Organism/Species""}]"	train
The Kite / Doolittle hydrophobicity scale was used to determine the hydrophobicity of each amino acid for the last 450 amino acids in both human and Aplysia Grin1 subunits, which contains the ligand binding, transmembrane, and intracellular C - terminal domains.	amino acid,91,101,Chemical/Drug	amino acids,119,130,Chemical/Drug	human,139,144,Organism/Species	Aplysia,149,156,Organism/Species	Grin1,157,162,Gene/Protein	"[{""token"": ""amino acid"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Chemical/Drug""}, {""token"": ""amino acids"", ""start_span"": 119, ""end_span"": 130, ""type"": ""Chemical/Drug""}, {""token"": ""human"", ""start_span"": 139, ""end_span"": 144, ""type"": ""Organism/Species""}, {""token"": ""Aplysia"", ""start_span"": 149, ""end_span"": 156, ""type"": ""Organism/Species""}, {""token"": ""Grin1"", ""start_span"": 157, ""end_span"": 162, ""type"": ""Gene/Protein""}]"	train
To describe quantitative expression of identified iGluR in Aplysia nervous system ganglia, six sexually mature Aplysia californica from a single egg mass of wild - caught animals were obtained from the National Resource for Aplysia at the University of Miami.	iGluR,50,55,Gene/Protein	Aplysia,59,66,Organism/Species	Aplysia californica,111,130,Organism/Species	animals,171,178,Organism/Species	Aplysia,224,231,Organism/Species	"[{""token"": ""iGluR"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""Aplysia"", ""start_span"": 59, ""end_span"": 66, ""type"": ""Organism/Species""}, {""token"": ""Aplysia californica"", ""start_span"": 111, ""end_span"": 130, ""type"": ""Organism/Species""}, {""token"": ""animals"", ""start_span"": 171, ""end_span"": 178, ""type"": ""Organism/Species""}, {""token"": ""Aplysia"", ""start_span"": 224, ""end_span"": 231, ""type"": ""Organism/Species""}]"	train
NMDAR genes form three orthologous groups corresponding to Grin1, Grin2, and Grin3 subunits, providing evidence that all three ancestral Grin subunits were present in the most recent bilaterian ancestor ( Fig. 2 ).	NMDAR,0,5,Gene/Protein	Grin1,59,64,Gene/Protein	Grin2,66,71,Gene/Protein	Grin3,77,82,Gene/Protein	Grin,137,141,Gene/Protein	"[{""token"": ""NMDAR"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""Grin1"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""Grin2"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""Grin3"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""Grin"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Gene/Protein""}]"	train
For AMPAR genes there is a monophyletic clade of all vertebrate AMPAR sequences and several orthologous protostome genes, pointing to an AMPAR gene copy present in the common bilaterian ancestor ( Fig. 2 ).	AMPAR,4,9,Gene/Protein	vertebrate,53,63,Organism/Species	AMPAR,64,69,Gene/Protein	protostome,104,114,Organism/Species	AMPAR,137,142,Gene/Protein	"[{""token"": ""AMPAR"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""vertebrate"", ""start_span"": 53, ""end_span"": 63, ""type"": ""Organism/Species""}, {""token"": ""AMPAR"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""protostome"", ""start_span"": 104, ""end_span"": 114, ""type"": ""Organism/Species""}, {""token"": ""AMPAR"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Gene/Protein""}]"	train
For example, in the Lophotrochozoa, Aplysia has 6 paralogous AMPAR genes, Octopus has 1, and Lingula has 2.	Lophotrochozoa,20,34,Organism/Species	Aplysia,36,43,Organism/Species	AMPAR,61,66,Gene/Protein	Octopus,74,81,Organism/Species	Lingula,93,100,Organism/Species	"[{""token"": ""Lophotrochozoa"", ""start_span"": 20, ""end_span"": 34, ""type"": ""Organism/Species""}, {""token"": ""Aplysia"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Organism/Species""}, {""token"": ""AMPAR"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""Octopus"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Organism/Species""}, {""token"": ""Lingula"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Organism/Species""}]"	train
Through genomic searches, the number of iGluR genes identified in chordates was greater than the number of genes in any protostome ( Table 2 ), although it must be noted that for some protostome species the number of iGluR genes may not be accurate due to limited availability of genomic information and annotation.	iGluR,40,45,Gene/Protein	chordates,66,75,Organism/Species	protostome,120,130,Organism/Species	protostome,184,194,Organism/Species	iGluR,217,222,Gene/Protein	"[{""token"": ""iGluR"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""chordates"", ""start_span"": 66, ""end_span"": 75, ""type"": ""Organism/Species""}, {""token"": ""protostome"", ""start_span"": 120, ""end_span"": 130, ""type"": ""Organism/Species""}, {""token"": ""protostome"", ""start_span"": 184, ""end_span"": 194, ""type"": ""Organism/Species""}, {""token"": ""iGluR"", ""start_span"": 217, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	train
This motif contributes to formation of the channel outer pore and its activation gate [ 48 ], and amino acid substitutions in this motif are reported to alter channel gating and permeability [ 49, 50 ]. Aplysia showed a greater number of iGluR subunits compared to other protostomes, primarily due to several gene duplications of AMPAR genes, as discussed above.	amino acid,98,108,Chemical/Drug	Aplysia,203,210,Organism/Species	iGluR,238,243,Gene/Protein	protostomes,271,282,Organism/Species	AMPAR,330,335,Gene/Protein	"[{""token"": ""amino acid"", ""start_span"": 98, ""end_span"": 108, ""type"": ""Chemical/Drug""}, {""token"": ""Aplysia"", ""start_span"": 203, ""end_span"": 210, ""type"": ""Organism/Species""}, {""token"": ""iGluR"", ""start_span"": 238, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""protostomes"", ""start_span"": 271, ""end_span"": 282, ""type"": ""Organism/Species""}, {""token"": ""AMPAR"", ""start_span"": 330, ""end_span"": 335, ""type"": ""Gene/Protein""}]"	train
Hydrophobicity plays a crucial role in receptor binding domains [ 54 ], and this lack of conservation may reflect the diminished role for glycine as a co - agonist in Aplysia NMDAR [ 55 ]. Fig. 4Hydrophobicity plot of Grin1 in H. sapiens and Aplysia.	glycine,138,145,Chemical/Drug	Aplysia,167,174,Organism/Species	NMDAR,175,180,Gene/Protein	Grin1,218,223,Gene/Protein	Aplysia,242,249,Organism/Species	"[{""token"": ""glycine"", ""start_span"": 138, ""end_span"": 145, ""type"": ""Chemical/Drug""}, {""token"": ""Aplysia"", ""start_span"": 167, ""end_span"": 174, ""type"": ""Organism/Species""}, {""token"": ""NMDAR"", ""start_span"": 175, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""Grin1"", ""start_span"": 218, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""Aplysia"", ""start_span"": 242, ""end_span"": 249, ""type"": ""Organism/Species""}]"	train
Despite the utility of protostomes for iGluR mediated responses in the nervous system, identification of iGluR subunits that are orthologous to chordate iGluR has so far not been thoroughly studied.	protostomes,23,34,Organism/Species	iGluR,39,44,Gene/Protein	iGluR,105,110,Gene/Protein	chordate,144,152,Organism/Species	iGluR,153,158,Gene/Protein	"[{""token"": ""protostomes"", ""start_span"": 23, ""end_span"": 34, ""type"": ""Organism/Species""}, {""token"": ""iGluR"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""iGluR"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""chordate"", ""start_span"": 144, ""end_span"": 152, ""type"": ""Organism/Species""}, {""token"": ""iGluR"", ""start_span"": 153, ""end_span"": 158, ""type"": ""Gene/Protein""}]"	train
We conducted a phylogenetic analysis of iGluR spanning all three superclades of bilaterians; Deuterostomia ( including Chordata ), and their sisterclade Protostomia, consisting of Ecdysozoa and Lophotrochozoa.	iGluR,40,45,Gene/Protein	Deuterostomia,93,106,Organism/Species	Protostomia,153,164,Organism/Species	Ecdysozoa,180,189,Organism/Species	Lophotrochozoa,194,208,Organism/Species	"[{""token"": ""iGluR"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""Deuterostomia"", ""start_span"": 93, ""end_span"": 106, ""type"": ""Organism/Species""}, {""token"": ""Protostomia"", ""start_span"": 153, ""end_span"": 164, ""type"": ""Organism/Species""}, {""token"": ""Ecdysozoa"", ""start_span"": 180, ""end_span"": 189, ""type"": ""Organism/Species""}, {""token"": ""Lophotrochozoa"", ""start_span"": 194, ""end_span"": 208, ""type"": ""Organism/Species""}]"	train
Whether AMPAR physiology in protostomes will bear the same resemblance to chordate AMPAR, as is the case with NMDAR, is uncertain.	AMPAR,8,13,Gene/Protein	protostomes,28,39,Organism/Species	chordate,74,82,Organism/Species	AMPAR,83,88,Gene/Protein	NMDAR,110,115,Gene/Protein	"[{""token"": ""AMPAR"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""protostomes"", ""start_span"": 28, ""end_span"": 39, ""type"": ""Organism/Species""}, {""token"": ""chordate"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Organism/Species""}, {""token"": ""AMPAR"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""NMDAR"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Gene/Protein""}]"	train
Our analysis of Aplysia only iGluR genes indicated that NMDAR and AMPAR subunits form well - defined clades and thus may be capable of forming functional iGluR channels.	Aplysia,16,23,Organism/Species	iGluR,29,34,Gene/Protein	NMDAR,56,61,Gene/Protein	AMPAR,66,71,Gene/Protein	iGluR,154,159,Gene/Protein	"[{""token"": ""Aplysia"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Organism/Species""}, {""token"": ""iGluR"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""NMDAR"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""AMPAR"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""iGluR"", ""start_span"": 154, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
Grin1 expression was highest in nearly all Aplysia ganglia, with its two splice variants Grin1 - 1 and Grin1 - 2 together comprising ~ 75% of total NMDAR expression.	Grin1,0,5,Gene/Protein	Aplysia,43,50,Organism/Species	Grin1,89,94,Gene/Protein	Grin1,103,108,Gene/Protein	NMDAR,148,153,Gene/Protein	"[{""token"": ""Grin1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""Aplysia"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Organism/Species""}, {""token"": ""Grin1"", ""start_span"": 89, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""Grin1"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""NMDAR"", ""start_span"": 148, ""end_span"": 153, ""type"": ""Gene/Protein""}]"	train
NMDAR and AMPAR subunits form monophyletic clades, while kainate receptor subunits did not form a clade. Figure S2: NMDAR only subtype tree using sequences identified as NMDAR in the full phylogeny.	NMDAR,0,5,Gene/Protein	AMPAR,10,15,Gene/Protein	kainate receptor,57,73,Gene/Protein	NMDAR,116,121,Gene/Protein	NMDAR,170,175,Gene/Protein	"[{""token"": ""NMDAR"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""AMPAR"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""kainate receptor"", ""start_span"": 57, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""NMDAR"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""NMDAR"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Gene/Protein""}]"	train
Viral capsids are formed of at least one virus - encoded capsid protein ( CP ), which is often multifunctional, playing additional non - structural roles during the infection cycle.	Viral capsids,0,13,Gene/Protein	virus,41,46,Organism/Species	capsid protein,57,71,Gene/Protein	CP,74,76,Gene/Protein	infection,165,174,Disease/Disorder	"[{""token"": ""Viral capsids"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""virus"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Organism/Species""}, {""token"": ""capsid protein"", ""start_span"": 57, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 74, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""infection"", ""start_span"": 165, ""end_span"": 174, ""type"": ""Disease/Disorder""}]"	train
In animal viruses, there are examples of differential localization of CPs associated to the progression of the infection and / or enabled by other viral proteins; these changes in the distribution of CPs may ultimately regulate the involvement of these proteins in different viral functions.	animal,3,9,Organism/Species	viruses,10,17,Organism/Species	CPs,70,73,Gene/Protein	infection,111,120,Disease/Disorder	CPs,200,203,Gene/Protein	"[{""token"": ""animal"", ""start_span"": 3, ""end_span"": 9, ""type"": ""Organism/Species""}, {""token"": ""viruses"", ""start_span"": 10, ""end_span"": 17, ""type"": ""Organism/Species""}, {""token"": ""CPs"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""infection"", ""start_span"": 111, ""end_span"": 120, ""type"": ""Disease/Disorder""}, {""token"": ""CPs"", ""start_span"": 200, ""end_span"": 203, ""type"": ""Gene/Protein""}]"	train
Expression of the viral replication - associated protein, Rep, is sufficient to exclude the CP from the nucleolus, but the localization of the CP in the characteristic patterns induced by the virus cannot be recapitulated by co - expression with any individual viral protein.	viral replication - associated protein,18,56,Gene/Protein	Rep,58,61,Gene/Protein	CP,92,94,Gene/Protein	CP,143,145,Gene/Protein	virus,192,197,Organism/Species	"[{""token"": ""viral replication - associated protein"", ""start_span"": 18, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""Rep"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 92, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 143, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""virus"", ""start_span"": 192, ""end_span"": 197, ""type"": ""Organism/Species""}]"	train
Expression of the viral replication - associated protein, Rep, is sufficient to exclude the CP from the nucleolus, but the localization of the CP in the characteristic patterns induced by TYLCV requires more than a single viral protein.	viral replication - associated protein,18,56,Gene/Protein	Rep,58,61,Gene/Protein	CP,92,94,Gene/Protein	CP,143,145,Gene/Protein	TYLCV,188,193,Organism/Species	"[{""token"": ""viral replication - associated protein"", ""start_span"": 18, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""Rep"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 92, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 143, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""TYLCV"", ""start_span"": 188, ""end_span"": 193, ""type"": ""Organism/Species""}]"	train
This effect of the presence of the virus on the localization of the CP can also be detected in N. benthamiana and tomato upon transient expression of a RFP - CP fusion protein ( Figure 1C and Supplementary Figure S1 ).	virus,35,40,Organism/Species	CP,68,70,Gene/Protein	tomato,114,120,Organism/Species	RFP,152,155,Gene/Protein	CP,158,160,Gene/Protein	"[{""token"": ""virus"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Organism/Species""}, {""token"": ""CP"", ""start_span"": 68, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""tomato"", ""start_span"": 114, ""end_span"": 120, ""type"": ""Organism/Species""}, {""token"": ""RFP"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 158, ""end_span"": 160, ""type"": ""Gene/Protein""}]"	train
As shown in Figure 3, in the absence of the virus the CP – CP interaction can be detected as YFP signal strongly in the nucleolus and weakly in the nucleoplasm, mirroring the distribution of the CP.	virus,44,49,Organism/Species	CP,54,56,Gene/Protein	CP,59,61,Gene/Protein	YFP,93,96,Gene/Protein	CP,195,197,Gene/Protein	"[{""token"": ""virus"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Organism/Species""}, {""token"": ""CP"", ""start_span"": 54, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 59, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""YFP"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 195, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
In the presence of the virus, however, the sites of CP – CP interaction shift, weakening in or disappearing from the nucleolus, and appearing as distinct speckles in the nucleoplasm ( Figure 3B ), which correlates with the observed localization of CP in TYLCV - infected cells ( Figure 1B ).	virus,23,28,Organism/Species	CP,52,54,Gene/Protein	CP,57,59,Gene/Protein	CP,248,250,Gene/Protein	TYLCV,254,259,Organism/Species	"[{""token"": ""virus"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Organism/Species""}, {""token"": ""CP"", ""start_span"": 52, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 57, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 248, ""end_span"": 250, ""type"": ""Gene/Protein""}, {""token"": ""TYLCV"", ""start_span"": 254, ""end_span"": 259, ""type"": ""Organism/Species""}]"	train
Gray columns show the virus gene expression level when each viral gene is independently co - expressed with CP - GFP ( left) or GFP - CP ( right) from a binary vector.	virus,22,27,Organism/Species	CP,108,110,Gene/Protein	GFP,113,116,Gene/Protein	GFP,128,131,Gene/Protein	CP,134,136,Gene/Protein	"[{""token"": ""virus"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Organism/Species""}, {""token"": ""CP"", ""start_span"": 108, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 134, ""end_span"": 136, ""type"": ""Gene/Protein""}]"	train
In the case of the geminivirus TYLCV, subcellular localization of the CP has been previously studied ( Rojas et al ., 2001 ); however, in these experiments the CP was expressed in isolation, and therefore in the absence of other viral proteins, the viral genome, and the cellular changes triggered by the viral infection.	geminivirus,19,30,Organism/Species	TYLCV,31,36,Organism/Species	CP,70,72,Gene/Protein	CP,160,162,Gene/Protein	viral infection,305,320,Disease/Disorder	"[{""token"": ""geminivirus"", ""start_span"": 19, ""end_span"": 30, ""type"": ""Organism/Species""}, {""token"": ""TYLCV"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Organism/Species""}, {""token"": ""CP"", ""start_span"": 70, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 160, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""viral infection"", ""start_span"": 305, ""end_span"": 320, ""type"": ""Disease/Disorder""}]"	train
Interestingly, our results are reminiscent of those obtained by Wistuba et al. ( 1997) when studying the subnuclear localization of the capsid proteins from AAV - 2, which show a redistribution from the nucleolus to nuclear bodies following the progression of the infection and an influence of Rep proteins in the distribution of viral capsids.	capsid proteins,136,151,Gene/Protein	AAV - 2,157,164,Organism/Species	infection,264,273,Disease/Disorder	Rep,294,297,Gene/Protein	viral capsids,330,343,Gene/Protein	"[{""token"": ""capsid proteins"", ""start_span"": 136, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""AAV - 2"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Organism/Species""}, {""token"": ""infection"", ""start_span"": 264, ""end_span"": 273, ""type"": ""Disease/Disorder""}, {""token"": ""Rep"", ""start_span"": 294, ""end_span"": 297, ""type"": ""Gene/Protein""}, {""token"": ""viral capsids"", ""start_span"": 330, ""end_span"": 343, ""type"": ""Gene/Protein""}]"	train
It is interesting to note that changes in the localization of ALY proteins, including ALY4, have been reported upon co - expression with Tomato bushy stunt virus p19 protein ( Uhrig et al ., 2004 ); in this case, ALY4 relocalizes from the nucleus to the cytoplasm.	ALY,62,65,Gene/Protein	ALY4,86,90,Gene/Protein	Tomato bushy stunt virus,137,161,Organism/Species	p19,162,165,Gene/Protein	ALY4,213,217,Gene/Protein	"[{""token"": ""ALY"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""ALY4"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""Tomato bushy stunt virus"", ""start_span"": 137, ""end_span"": 161, ""type"": ""Organism/Species""}, {""token"": ""p19"", ""start_span"": 162, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""ALY4"", ""start_span"": 213, ""end_span"": 217, ""type"": ""Gene/Protein""}]"	train
In the second scenario, host miRNAs interact with viral RNAs, thereby inhibiting virus replication, e. g ., miR - 32 can limit the replication of the retrovirus primate foamy virus ( PFV) in cell culture through an interaction with PFV mRNAs [ 19 ].	virus,81,86,Organism/Species	retrovirus,150,160,Organism/Species	primate foamy virus,161,180,Organism/Species	PFV,183,186,Organism/Species	PFV,232,235,Organism/Species	"[{""token"": ""virus"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Organism/Species""}, {""token"": ""retrovirus"", ""start_span"": 150, ""end_span"": 160, ""type"": ""Organism/Species""}, {""token"": ""primate foamy virus"", ""start_span"": 161, ""end_span"": 180, ""type"": ""Organism/Species""}, {""token"": ""PFV"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Organism/Species""}, {""token"": ""PFV"", ""start_span"": 232, ""end_span"": 235, ""type"": ""Organism/Species""}]"	train
Nevertheless, EBV infection has oncogenic potential, which can result in a number of malignancies, including Burkitt ' s lymphoma, Hodgkin ' s lymphoma, nasopharyngeal carcinoma, and lymphoproliferative diseases, especially among immunocompromised individuals [ 45 ].	EBV infection,14,27,Disease/Disorder	Burkitt ' s lymphoma,109,129,Disease/Disorder	Hodgkin ' s lymphoma,131,151,Disease/Disorder	nasopharyngeal carcinoma,153,177,Disease/Disorder	lymphoproliferative diseases,183,211,Disease/Disorder	"[{""token"": ""EBV infection"", ""start_span"": 14, ""end_span"": 27, ""type"": ""Disease/Disorder""}, {""token"": ""Burkitt ' s lymphoma"", ""start_span"": 109, ""end_span"": 129, ""type"": ""Disease/Disorder""}, {""token"": ""Hodgkin ' s lymphoma"", ""start_span"": 131, ""end_span"": 151, ""type"": ""Disease/Disorder""}, {""token"": ""nasopharyngeal carcinoma"", ""start_span"": 153, ""end_span"": 177, ""type"": ""Disease/Disorder""}, {""token"": ""lymphoproliferative diseases"", ""start_span"": 183, ""end_span"": 211, ""type"": ""Disease/Disorder""}]"	train
The relative proportion of neutrophils was significantly increased whereas the fraction of lymphocytes declined in tamoxifen treated Thoc1F / F: Rosa26CreERT2 test mice compared to tamoxifen treated Thoc1 +/+: Rosa26CreERT2 control mice ( Fig. 1G, H ).	tamoxifen,115,124,Chemical/Drug	mice,164,168,Organism/Species	tamoxifen,181,190,Chemical/Drug	Thoc1,199,204,Gene/Protein	mice,232,236,Organism/Species	"[{""token"": ""tamoxifen"", ""start_span"": 115, ""end_span"": 124, ""type"": ""Chemical/Drug""}, {""token"": ""mice"", ""start_span"": 164, ""end_span"": 168, ""type"": ""Organism/Species""}, {""token"": ""tamoxifen"", ""start_span"": 181, ""end_span"": 190, ""type"": ""Chemical/Drug""}, {""token"": ""Thoc1"", ""start_span"": 199, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 232, ""end_span"": 236, ""type"": ""Organism/Species""}]"	train
To explore the possible regulatory role of miRNAs in PKD, the PKD / Mhm ( cy /+) rat, served as a model to study human ADPKD.	PKD,53,56,Disease/Disorder	PKD,62,65,Disease/Disorder	rat,81,84,Organism/Species	human,113,118,Organism/Species	ADPKD,119,124,Disease/Disorder	"[{""token"": ""PKD"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Disease/Disorder""}, {""token"": ""PKD"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Disease/Disorder""}, {""token"": ""rat"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Organism/Species""}, {""token"": ""ADPKD"", ""start_span"": 119, ""end_span"": 124, ""type"": ""Disease/Disorder""}]"	train
According to the ciliary hypothesis most of the proteins of cystic kidney diseases in humans, rats, mice, or zebrafish are expressed in primary cilia or centrosomes of the renal epithelial cells [ 7 ].	cystic kidney diseases,60,82,Disease/Disorder	humans,86,92,Organism/Species	rats,94,98,Organism/Species	mice,100,104,Organism/Species	zebrafish,109,118,Organism/Species	"[{""token"": ""cystic kidney diseases"", ""start_span"": 60, ""end_span"": 82, ""type"": ""Disease/Disorder""}, {""token"": ""humans"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Organism/Species""}, {""token"": ""rats"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Organism/Species""}, {""token"": ""zebrafish"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Organism/Species""}]"	train
Interestingly, the knocking out of aquaporins ( such as AQP11) results in cysts formation and finally leads to renal failure, which is similar to PKD [ 15 ].	aquaporins,35,45,Gene/Protein	AQP11,56,61,Gene/Protein	cysts,74,79,Disease/Disorder	renal failure,111,124,Disease/Disorder	PKD,146,149,Disease/Disorder	"[{""token"": ""aquaporins"", ""start_span"": 35, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""AQP11"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""cysts"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Disease/Disorder""}, {""token"": ""renal failure"", ""start_span"": 111, ""end_span"": 124, ""type"": ""Disease/Disorder""}, {""token"": ""PKD"", ""start_span"": 146, ""end_span"": 149, ""type"": ""Disease/Disorder""}]"	train
ADPKD datasets with mutation in PKD1: Pkd1L3 / L3 [ 29 ], human ADPKD [ 28 ], Pkd1 −/− [ 30] and Pandey et al [ 34] were downloaded from 4 published studies.	ADPKD,0,5,Disease/Disorder	PKD1,32,36,Gene/Protein	human,58,63,Organism/Species	ADPKD,64,69,Disease/Disorder	Pkd1,78,82,Gene/Protein	"[{""token"": ""ADPKD"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Disease/Disorder""}, {""token"": ""PKD1"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Organism/Species""}, {""token"": ""ADPKD"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Disease/Disorder""}, {""token"": ""Pkd1"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene/Protein""}]"	train
Moreover, the significantly regulated genes in cystic kidneys of PKD / Mhm rats were also compared with two other studies that were conducted on Hnf1α - deficient mice [ 24] and Glis2lacZ / lacZ model [ 25 ].	cystic kidneys,47,61,Disease/Disorder	PKD,65,68,Disease/Disorder	rats,75,79,Organism/Species	Hnf1α,145,150,Gene/Protein	mice,163,167,Organism/Species	"[{""token"": ""cystic kidneys"", ""start_span"": 47, ""end_span"": 61, ""type"": ""Disease/Disorder""}, {""token"": ""PKD"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Disease/Disorder""}, {""token"": ""rats"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Organism/Species""}, {""token"": ""Hnf1\u03b1"", ""start_span"": 145, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Organism/Species""}]"	train
We compared the significantly regulated genes of PKD / Mhm ( cy /+) rat models with data obtained from 3 other published studies which include, PKD1L3 / L3 [ 29 ], PKD1 −/− [ 30] and human ADPKD [ 28 ].	PKD,49,52,Disease/Disorder	rat,68,71,Organism/Species	PKD1,144,148,Gene/Protein	human,183,188,Organism/Species	ADPKD,189,194,Disease/Disorder	"[{""token"": ""PKD"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Disease/Disorder""}, {""token"": ""rat"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Organism/Species""}, {""token"": ""PKD1"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 183, ""end_span"": 188, ""type"": ""Organism/Species""}, {""token"": ""ADPKD"", ""start_span"": 189, ""end_span"": 194, ""type"": ""Disease/Disorder""}]"	train
On the other hand, up - regulation of genes i. e. Bmp1, Tgfβ1, Tgfβ2, Tgfβr1 and Tgfβr2 suggest epithelial - mesenchymal transition ( EMT ).	Bmp1,50,54,Gene/Protein	Tgfβ1,56,61,Gene/Protein	Tgfβ2,63,68,Gene/Protein	Tgfβr1,70,76,Gene/Protein	Tgfβr2,81,87,Gene/Protein	"[{""token"": ""Bmp1"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""Tgf\u03b21"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""Tgf\u03b22"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""Tgf\u03b2r1"", ""start_span"": 70, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""Tgf\u03b2r2"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Gene/Protein""}]"	train
MYC gene is often found up - regulated in human ADPKD [ 17] and we also detected the similar expression in our study. MYC is known to be involved in cell proliferation, apoptosis, differentiation and neoplasia [ 18 ].	MYC,0,3,Gene/Protein	human,42,47,Organism/Species	ADPKD,48,53,Disease/Disorder	MYC,118,121,Gene/Protein	neoplasia,200,209,Disease/Disorder	"[{""token"": ""MYC"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Organism/Species""}, {""token"": ""ADPKD"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Disease/Disorder""}, {""token"": ""MYC"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""neoplasia"", ""start_span"": 200, ""end_span"": 209, ""type"": ""Disease/Disorder""}]"	train
The implications of miR - 146a ( but not miR - 146b) have been shown in chronic renal inflammation [ 48 ], human renal cell carcinoma [ 49] and retinoic acid induction in acute promyelocytic leukemia [ 50 ].	chronic renal inflammation,72,98,Disease/Disorder	human,107,112,Organism/Species	renal cell carcinoma,113,133,Disease/Disorder	retinoic acid,144,157,Chemical/Drug	acute promyelocytic leukemia,171,199,Disease/Disorder	"[{""token"": ""chronic renal inflammation"", ""start_span"": 72, ""end_span"": 98, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Organism/Species""}, {""token"": ""renal cell carcinoma"", ""start_span"": 113, ""end_span"": 133, ""type"": ""Disease/Disorder""}, {""token"": ""retinoic acid"", ""start_span"": 144, ""end_span"": 157, ""type"": ""Chemical/Drug""}, {""token"": ""acute promyelocytic leukemia"", ""start_span"": 171, ""end_span"": 199, ""type"": ""Disease/Disorder""}]"	train
Once an inhibitor ( e. g ., Hnf1α, Hnf4α, Glis2 and Sip1) of signaling networks is down - regulated by one or more miRNAs, these miRNAs then act as a positive regulator which further amplifies the expression of many genes engaged with human pathologies.	Hnf1α,28,33,Gene/Protein	Hnf4α,35,40,Gene/Protein	Glis2,42,47,Gene/Protein	Sip1,52,56,Gene/Protein	human,235,240,Organism/Species	"[{""token"": ""Hnf1\u03b1"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""Hnf4\u03b1"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""Glis2"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""Sip1"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 235, ""end_span"": 240, ""type"": ""Organism/Species""}]"	train
The p27 is a CDKs ( cyclin - dependent kinases) inhibitor of the cell cycle at G1 phase ( Cdk2 / Ccne2 complex ).	p27,4,7,Gene/Protein	CDKs,13,17,Gene/Protein	cyclin - dependent kinases,20,46,Gene/Protein	Cdk2,90,94,Gene/Protein	Ccne2,97,102,Gene/Protein	"[{""token"": ""p27"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""CDKs"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""cyclin - dependent kinases"", ""start_span"": 20, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""Cdk2"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""Ccne2"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Gene/Protein""}]"	train
Interestingly, several potential interactions between 8 up - regulated miRNAs and 6 down - regulated aquaporins ( AQPs) genes were observed for examples: miR - 199a - 5p, - 214 and - 503 can anneal to Aqp1 and Aqp12a with octamer seeds; and Aqp4 has multiple 9nt long binding sites for miR - 132.	aquaporins,101,111,Gene/Protein	AQPs,114,118,Gene/Protein	Aqp1,201,205,Gene/Protein	Aqp12a,210,216,Gene/Protein	Aqp4,241,245,Gene/Protein	"[{""token"": ""aquaporins"", ""start_span"": 101, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""AQPs"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""Aqp1"", ""start_span"": 201, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""Aqp12a"", ""start_span"": 210, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""Aqp4"", ""start_span"": 241, ""end_span"": 245, ""type"": ""Gene/Protein""}]"	train
Comparison between PKD / Mhm rat and 2 published studies. This table shows the common genes obtained by comparing PKD / Mhm rat and Hnf1α - deficient [ 24] and Glis2lacZ / lacZ [ 25] datasets.	PKD,19,22,Disease/Disorder	rat,29,32,Organism/Species	PKD,114,117,Disease/Disorder	rat,124,127,Organism/Species	Hnf1α,132,137,Gene/Protein	"[{""token"": ""PKD"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Disease/Disorder""}, {""token"": ""rat"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Organism/Species""}, {""token"": ""PKD"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Disease/Disorder""}, {""token"": ""rat"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Organism/Species""}, {""token"": ""Hnf1\u03b1"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Gene/Protein""}]"	train
NAFLD can lead to nonalcoholic steatohepatitis ( NASH ), eventual cirrhosis, and HCC [ 26 ].	NAFLD,0,5,Disease/Disorder	nonalcoholic steatohepatitis,18,46,Disease/Disorder	NASH,49,53,Disease/Disorder	cirrhosis,66,75,Disease/Disorder	HCC,81,84,Disease/Disorder	"[{""token"": ""NAFLD"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Disease/Disorder""}, {""token"": ""nonalcoholic steatohepatitis"", ""start_span"": 18, ""end_span"": 46, ""type"": ""Disease/Disorder""}, {""token"": ""NASH"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Disease/Disorder""}, {""token"": ""cirrhosis"", ""start_span"": 66, ""end_span"": 75, ""type"": ""Disease/Disorder""}, {""token"": ""HCC"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Disease/Disorder""}]"	train
Carcinoembryonic antigen ( CEA ), alpha - fetoprotein ( AFP ), and carbohydrate antigen 19 - 9 ( CA19 - 9) should be obtained.	Carcinoembryonic antigen,0,24,Gene/Protein	CEA,27,30,Gene/Protein	alpha - fetoprotein,34,53,Gene/Protein	AFP,56,59,Gene/Protein	carbohydrate,67,79,Chemical/Drug	"[{""token"": ""Carcinoembryonic antigen"", ""start_span"": 0, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""CEA"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""alpha - fetoprotein"", ""start_span"": 34, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""AFP"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""carbohydrate"", ""start_span"": 67, ""end_span"": 79, ""type"": ""Chemical/Drug""}]"	train
Reports of more specific serum marks such as CYFRA21 - 1, claudin - 4, insulin - like growth factor binding protein 5 ( IGFBP - 5 ), and biglycan exist; however, none of these are routinely clinically used [ 39, 40 ].	CYFRA21 - 1,45,56,Gene/Protein	claudin - 4,58,69,Gene/Protein	insulin - like growth factor binding protein 5,71,117,Gene/Protein	IGFBP - 5,120,129,Gene/Protein	biglycan,137,145,Gene/Protein	"[{""token"": ""CYFRA21 - 1"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""claudin - 4"", ""start_span"": 58, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""insulin - like growth factor binding protein 5"", ""start_span"": 71, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""IGFBP - 5"", ""start_span"": 120, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""biglycan"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Gene/Protein""}]"	train
Taking these four prognostic factors into account, Okaybayashi et al. proposed a staging system irrespective of tumor size: Stage I: solitary tumor without vascular invasion; Stage II: solitary tumor with the presence of vascular invasion; Stage IIIa: multiple tumors with or without the presence of invasion; Stage IIIb: any tumor with involvement of regional lymph nodes; Stage IV: distant metastases [ 48 ].	tumor,112,117,Disease/Disorder	solitary tumor,133,147,Disease/Disorder	solitary tumor,185,199,Disease/Disorder	multiple tumors,252,267,Disease/Disorder	tumor,326,331,Disease/Disorder	"[{""token"": ""tumor"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Disease/Disorder""}, {""token"": ""solitary tumor"", ""start_span"": 133, ""end_span"": 147, ""type"": ""Disease/Disorder""}, {""token"": ""solitary tumor"", ""start_span"": 185, ""end_span"": 199, ""type"": ""Disease/Disorder""}, {""token"": ""multiple tumors"", ""start_span"": 252, ""end_span"": 267, ""type"": ""Disease/Disorder""}, {""token"": ""tumor"", ""start_span"": 326, ""end_span"": 331, ""type"": ""Disease/Disorder""}]"	train
The T classification is defined as follows: T1: solitary tumors without vascular invasion, T2: multiple tumors ( multifocal disease, intrahepatic metastasis, or satellite lesions) and any tumor with vascular invasion, T3: any tumor with direct invasion of adjacent organs, and T4: tumors with any periductal - infiltrating component on histology.	solitary tumors,48,63,Disease/Disorder	multiple tumors,95,110,Disease/Disorder	tumor,188,193,Disease/Disorder	tumor,226,231,Disease/Disorder	tumors,281,287,Disease/Disorder	"[{""token"": ""solitary tumors"", ""start_span"": 48, ""end_span"": 63, ""type"": ""Disease/Disorder""}, {""token"": ""multiple tumors"", ""start_span"": 95, ""end_span"": 110, ""type"": ""Disease/Disorder""}, {""token"": ""tumor"", ""start_span"": 188, ""end_span"": 193, ""type"": ""Disease/Disorder""}, {""token"": ""tumor"", ""start_span"": 226, ""end_span"": 231, ""type"": ""Disease/Disorder""}, {""token"": ""tumors"", ""start_span"": 281, ""end_span"": 287, ""type"": ""Disease/Disorder""}]"	train
Ongoing study of these pathways as well as others found to be implicated in cholangiocarcinoma including map kinase pathway, hepatocyte growth factor, BRAF, and platelet derived growth factor hopefully will lead to effective targeted therapy ( Figure 3) [ 97 ].	cholangiocarcinoma,76,94,Disease/Disorder	map kinase,105,115,Gene/Protein	hepatocyte growth factor,125,149,Gene/Protein	BRAF,151,155,Gene/Protein	platelet derived growth factor,161,191,Gene/Protein	"[{""token"": ""cholangiocarcinoma"", ""start_span"": 76, ""end_span"": 94, ""type"": ""Disease/Disorder""}, {""token"": ""map kinase"", ""start_span"": 105, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""hepatocyte growth factor"", ""start_span"": 125, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""BRAF"", ""start_span"": 151, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""platelet derived growth factor"", ""start_span"": 161, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
Wound exudate has been shown to contain elevated levels of immunosuppressive and proinflammatory cytokines, such as interleukin - 1β, interleukin - 2, interleukin - 6, and tumor necrosis factor alpha [ 163 ].	proinflammatory cytokines,81,106,Gene/Protein	interleukin - 1β,116,132,Gene/Protein	interleukin - 2,134,149,Gene/Protein	interleukin - 6,151,166,Gene/Protein	tumor necrosis factor alpha,172,199,Gene/Protein	"[{""token"": ""proinflammatory cytokines"", ""start_span"": 81, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 1\u03b2"", ""start_span"": 116, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 2"", ""start_span"": 134, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 6"", ""start_span"": 151, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor alpha"", ""start_span"": 172, ""end_span"": 199, ""type"": ""Gene/Protein""}]"	train
Most importantly, we detected 4 missense mutations in 3 candidate genes including Sidt1 ( P172R ), Spice1 ( R708S ), Boc ( Q1051R) and Boc ( S450 - insertion in B6 allele) in the liver of SWR homozygous congenic mice.	Sidt1,82,87,Gene/Protein	Spice1,99,105,Gene/Protein	Boc,117,120,Gene/Protein	Boc,135,138,Gene/Protein	mice,212,216,Organism/Species	"[{""token"": ""Sidt1"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""Spice1"", ""start_span"": 99, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""Boc"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""Boc"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 212, ""end_span"": 216, ""type"": ""Organism/Species""}]"	train
Among these genes, Zdhhc23 ( zinc finger, DHHC domain containing 23) is a palmitoyl - transferase involved in protein palmitoylation. Zdhhc23 is reported to control the palmitoylation of calcium - activated potassium channels, which is important for the surface expression of these ion channels [ 27 ].	Zdhhc23,19,26,Gene/Protein	palmitoyl - transferase,74,97,Gene/Protein	Zdhhc23,134,141,Gene/Protein	calcium - activated potassium channels,187,225,Gene/Protein	ion channels,282,294,Gene/Protein	"[{""token"": ""Zdhhc23"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""palmitoyl - transferase"", ""start_span"": 74, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""Zdhhc23"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""calcium - activated potassium channels"", ""start_span"": 187, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""ion channels"", ""start_span"": 282, ""end_span"": 294, ""type"": ""Gene/Protein""}]"	train
Although we did not find significant changes in the expression levels of genes involved in iron absorption ( DMT - 1, Dcytb, Hephestin, Ferroportin1 and H - Ferritin) between Chr16s / s congenics and Chr16b / b controls, we still could not rule out the possibility that changes in intestinal iron absorption may partially contribute to the elevated hepatic iron accumulation.	DMT - 1,109,116,Gene/Protein	Dcytb,118,123,Gene/Protein	Hephestin,125,134,Gene/Protein	Ferroportin1,136,148,Gene/Protein	H - Ferritin,153,165,Gene/Protein	"[{""token"": ""DMT - 1"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""Dcytb"", ""start_span"": 118, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""Hephestin"", ""start_span"": 125, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""Ferroportin1"", ""start_span"": 136, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""H - Ferritin"", ""start_span"": 153, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
Mouse heme oxygenase 1 ( Hmox1) catabolizes cellular heme to biliverdin, carbon monoxide, and free iron [ 48 ].	Mouse,0,5,Organism/Species	heme oxygenase 1,6,22,Gene/Protein	Hmox1,25,30,Gene/Protein	heme,53,57,Chemical/Drug	biliverdin,61,71,Chemical/Drug	"[{""token"": ""Mouse"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism/Species""}, {""token"": ""heme oxygenase 1"", ""start_span"": 6, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""Hmox1"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""heme"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""biliverdin"", ""start_span"": 61, ""end_span"": 71, ""type"": ""Chemical/Drug""}]"	train
This process is crucial for the expulsion of iron from tissue stores. Hmox1 KO mice showed low serum iron and anemia while they had mild iron loading in liver and kidney at 50 weeks of age [ 49 ]. Hmox1 expression is regulated by heme, iron, oxidative stress and inflammatory stimuli [ 22 ].	Hmox1,70,75,Gene/Protein	mice,79,83,Organism/Species	anemia,110,116,Disease/Disorder	Hmox1,197,202,Gene/Protein	heme,230,234,Chemical/Drug	"[{""token"": ""Hmox1"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Organism/Species""}, {""token"": ""anemia"", ""start_span"": 110, ""end_span"": 116, ""type"": ""Disease/Disorder""}, {""token"": ""Hmox1"", ""start_span"": 197, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""heme"", ""start_span"": 230, ""end_span"": 234, ""type"": ""Chemical/Drug""}]"	train
The Community HIV and AIDS prevention ( CHAPS) policy ( led by the Terrence Higgins Trust) identifies post - exposure prophylaxis following sexual exposure ( PEPSE) to the human immunodeficiency virus ( HIV) as one method of preventing HIV infection in the UK [ 4 ].	HIV,14,17,Organism/Species	AIDS,22,26,Disease/Disorder	human immunodeficiency virus,172,200,Organism/Species	HIV,203,206,Organism/Species	HIV infection,236,249,Disease/Disorder	"[{""token"": ""HIV"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Organism/Species""}, {""token"": ""AIDS"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Disease/Disorder""}, {""token"": ""human immunodeficiency virus"", ""start_span"": 172, ""end_span"": 200, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 203, ""end_span"": 206, ""type"": ""Organism/Species""}, {""token"": ""HIV infection"", ""start_span"": 236, ""end_span"": 249, ""type"": ""Disease/Disorder""}]"	train
The same methods were applied in Juglans regia L [ 28 ], Malus domestica Borkh [ 35 ], Caragana korshinskii [ 11 ], Caragana microphylla [ 12] and Populus euphratica [ 24 ], and it was found that T a, VPD, and RH were the three major factors affecting sap flow rate on clear days, but the role of the three factors varied according to the growth stages.	Juglans regia L,33,48,Organism/Species	Malus domestica Borkh,57,78,Organism/Species	Caragana korshinskii,87,107,Organism/Species	Caragana microphylla,116,136,Organism/Species	Populus euphratica,147,165,Organism/Species	"[{""token"": ""Juglans regia L"", ""start_span"": 33, ""end_span"": 48, ""type"": ""Organism/Species""}, {""token"": ""Malus domestica Borkh"", ""start_span"": 57, ""end_span"": 78, ""type"": ""Organism/Species""}, {""token"": ""Caragana korshinskii"", ""start_span"": 87, ""end_span"": 107, ""type"": ""Organism/Species""}, {""token"": ""Caragana microphylla"", ""start_span"": 116, ""end_span"": 136, ""type"": ""Organism/Species""}, {""token"": ""Populus euphratica"", ""start_span"": 147, ""end_span"": 165, ""type"": ""Organism/Species""}]"	train
In the current study we describe another PTEN isoform designated PTENβ, which comprises an extended N - terminal extension of 146 amino acids ( Homo sapiens) as compared with canonical PTEN protein.	PTEN,41,45,Gene/Protein	PTENβ,65,70,Gene/Protein	amino acids,130,141,Chemical/Drug	Homo sapiens,144,156,Organism/Species	PTEN,185,189,Gene/Protein	"[{""token"": ""PTEN"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b2"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""amino acids"", ""start_span"": 130, ""end_span"": 141, ""type"": ""Chemical/Drug""}, {""token"": ""Homo sapiens"", ""start_span"": 144, ""end_span"": 156, ""type"": ""Organism/Species""}, {""token"": ""PTEN"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
We observed that a full length PTEN antibody reacted with an unidentified protein of molecular weight lower than PTENα ( around 70 kDa ), and expression of this protein showed dose dependent variation under acriflavin treatment parallel to that of PTENα ( Fig. 1a ).	PTEN,31,35,Gene/Protein	antibody,36,44,Gene/Protein	PTENα,113,118,Gene/Protein	acriflavin,207,217,Chemical/Drug	PTENα,248,253,Gene/Protein	"[{""token"": ""PTEN"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 36, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b1"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""acriflavin"", ""start_span"": 207, ""end_span"": 217, ""type"": ""Chemical/Drug""}, {""token"": ""PTEN\u03b1"", ""start_span"": 248, ""end_span"": 253, ""type"": ""Gene/Protein""}]"	train
In order to confirm this, we examined cancer cell lines with an anti - PTENα antibody raised in our laboratory by immunization with purified recombinant protein composed of the 173 N - terminal amino acids of PTENα ( ref. 25 ).	cancer,38,44,Disease/Disorder	PTENα,71,76,Gene/Protein	antibody,77,85,Gene/Protein	amino acids,194,205,Chemical/Drug	PTENα,209,214,Gene/Protein	"[{""token"": ""cancer"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Disease/Disorder""}, {""token"": ""PTEN\u03b1"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 77, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""amino acids"", ""start_span"": 194, ""end_span"": 205, ""type"": ""Chemical/Drug""}, {""token"": ""PTEN\u03b1"", ""start_span"": 209, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
UBF that is a well - known nucleolar marker was used to evaluate for co - localization of C - terminal GFP tagged PTENα, PTENβ or PTEN within the nucleolus.	UBF,0,3,Gene/Protein	GFP,103,106,Gene/Protein	PTENα,114,119,Gene/Protein	PTENβ,121,126,Gene/Protein	PTEN,130,134,Gene/Protein	"[{""token"": ""UBF"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b1"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b2"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""PTEN"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
Moreover, missense mutations in the phosphatase domain of PTENβ ( G275E, analogous to PTEN ( G129E )) and ( C270S, analogous to PTEN ( C124S )) both eliminated the lipid phosphatase activity of the protein ( Supplementary Fig. 6b ).	phosphatase,36,47,Gene/Protein	PTENβ,58,63,Gene/Protein	PTEN,86,90,Gene/Protein	PTEN,128,132,Gene/Protein	lipid phosphatase,164,181,Gene/Protein	"[{""token"": ""phosphatase"", ""start_span"": 36, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b2"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""PTEN"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""PTEN"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""lipid phosphatase"", ""start_span"": 164, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	train
In order to clarify the relationship of PTENβ with nucleolin and evaluate PTENβ function in the nucleolus, somatic PTENβ knockout was established with CRISPR - Cas9.	PTENβ,40,45,Gene/Protein	nucleolin,51,60,Gene/Protein	PTENβ,74,79,Gene/Protein	PTENβ,115,120,Gene/Protein	Cas9,160,164,Gene/Protein	"[{""token"": ""PTEN\u03b2"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""nucleolin"", ""start_span"": 51, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b2"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b2"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""Cas9"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
CRISPR - Cas9 - mediated gene targeting eliminated PTENα and PTENβ without affecting canonical PTEN expression, and we also designed a specific target sequence for sole knockout of PTENα as a control ( Fig. 5f, g ).	Cas9,9,13,Gene/Protein	PTENα,51,56,Gene/Protein	PTENβ,61,66,Gene/Protein	PTEN,95,99,Gene/Protein	PTENα,181,186,Gene/Protein	"[{""token"": ""Cas9"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b1"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b2"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""PTEN"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b1"", ""start_span"": 181, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
We found that PTENα and PTENβ double knockout led to elevation of nucleolin phosphorylation levels at Thr84, which is one of the XTPXKKXX motifs located in the nucleolin N - terminal region important for nucleolin function ( Fig. 5h ).	PTENα,14,19,Gene/Protein	PTENβ,24,29,Gene/Protein	nucleolin,66,75,Gene/Protein	nucleolin,160,169,Gene/Protein	nucleolin,204,213,Gene/Protein	"[{""token"": ""PTEN\u03b1"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b2"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""nucleolin"", ""start_span"": 66, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""nucleolin"", ""start_span"": 160, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""nucleolin"", ""start_span"": 204, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
The PTENβ coding sequence overlaps the sequence of full - length canonical PTEN and PTENβ can be efficiently recognized by PTEN antibodies.	PTENβ,4,9,Gene/Protein	PTEN,75,79,Gene/Protein	PTENβ,84,89,Gene/Protein	PTEN,123,127,Gene/Protein	antibodies,128,138,Gene/Protein	"[{""token"": ""PTEN\u03b2"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""PTEN"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b2"", ""start_span"": 84, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""PTEN"", ""start_span"": 123, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 128, ""end_span"": 138, ""type"": ""Gene/Protein""}]"	train
For in vitro PTENβ identification experiments, the PTENβ coding sequence ( CUG513 - UGA2240, PTENα initiation codon CUG513 mutated to CUC and canonical PTEN initiation codon AUG1032 mutated to AUA) was subcloned with a C - terminal His - tag into a pFastBac1 vector for expression in Sf9 insect cells.	PTENβ,13,18,Gene/Protein	PTENβ,51,56,Gene/Protein	PTENα,93,98,Gene/Protein	PTEN,152,156,Gene/Protein	insect,288,294,Organism/Species	"[{""token"": ""PTEN\u03b2"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b2"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b1"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""PTEN"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""insect"", ""start_span"": 288, ""end_span"": 294, ""type"": ""Organism/Species""}]"	train
Control FLAG peptides, FLAG - CDK1 and FLAG - PTENβ were purified with ANTI - FLAG M2 Affinity Gel ( F2426) and 3 × FLAG Peptide ( F4799) from HEK 293T cells after transfection with pCMV vector, pCMV - CDK1 or pCMV - PTENβ for 30 h.	CDK1,30,34,Gene/Protein	PTENβ,46,51,Gene/Protein	F2426,101,106,Chemical/Drug	CDK1,202,206,Gene/Protein	PTENβ,217,222,Gene/Protein	"[{""token"": ""CDK1"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b2"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""F2426"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Chemical/Drug""}, {""token"": ""CDK1"", ""start_span"": 202, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""PTEN\u03b2"", ""start_span"": 217, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	train
Thus, if the horizontally infected individuals die for a second round of horizontal transmission, the parasite has switched from uninucleate to binucleate and then back to uninucleate spores. Fig. 1Life cycle of the microsporidia Edhazardia aedis infecting the mosquito Aedes aegypti.	parasite,102,110,Organism/Species	microsporidia,216,229,Organism/Species	Edhazardia aedis,230,246,Organism/Species	mosquito,261,269,Organism/Species	Aedes aegypti,270,283,Organism/Species	"[{""token"": ""parasite"", ""start_span"": 102, ""end_span"": 110, ""type"": ""Organism/Species""}, {""token"": ""microsporidia"", ""start_span"": 216, ""end_span"": 229, ""type"": ""Organism/Species""}, {""token"": ""Edhazardia aedis"", ""start_span"": 230, ""end_span"": 246, ""type"": ""Organism/Species""}, {""token"": ""mosquito"", ""start_span"": 261, ""end_span"": 269, ""type"": ""Organism/Species""}, {""token"": ""Aedes aegypti"", ""start_span"": 270, ""end_span"": 283, ""type"": ""Organism/Species""}]"	train
Genetic variation of a host for the transmission mode of a parasite has also been detected in the grass Elymus hystrix infected by the endophyte Epichloë elymi [ 27 ].	parasite,59,67,Organism/Species	grass,98,103,Organism/Species	Elymus hystrix,104,118,Organism/Species	endophyte,135,144,Organism/Species	Epichloë elymi,145,159,Organism/Species	"[{""token"": ""parasite"", ""start_span"": 59, ""end_span"": 67, ""type"": ""Organism/Species""}, {""token"": ""grass"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Organism/Species""}, {""token"": ""Elymus hystrix"", ""start_span"": 104, ""end_span"": 118, ""type"": ""Organism/Species""}, {""token"": ""endophyte"", ""start_span"": 135, ""end_span"": 144, ""type"": ""Organism/Species""}, {""token"": ""Epichlo\u00eb elymi"", ""start_span"": 145, ""end_span"": 159, ""type"": ""Organism/Species""}]"	train
To develop insights useful for potential structure - based design of ligands for HPV E6, a series of 2, 6 - disubstituted benzopyranones were prepared and tested as competitive antagonists of E6 - E6AP helix - groove interactions.	HPV,81,84,Organism/Species	E6,85,87,Gene/Protein	benzopyranones,122,136,Chemical/Drug	E6,192,194,Gene/Protein	E6AP,197,201,Gene/Protein	"[{""token"": ""HPV"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Organism/Species""}, {""token"": ""E6"", ""start_span"": 85, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""benzopyranones"", ""start_span"": 122, ""end_span"": 136, ""type"": ""Chemical/Drug""}, {""token"": ""E6"", ""start_span"": 192, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""E6AP"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Gene/Protein""}]"	train
The high risk E6 protein binds to the HECT domain ubiquitin ligase, E6AP / UBE3A and this complex is responsible for ubiquitinylation of the p53 protein, a major suppressor of tumorigenesis, resulting in its degradation by the cellular proteasome [ 7, 8 ].	E6 protein,14,24,Gene/Protein	ubiquitin ligase,50,66,Gene/Protein	E6AP,68,72,Gene/Protein	UBE3A,75,80,Gene/Protein	p53,141,144,Gene/Protein	"[{""token"": ""E6 protein"", ""start_span"": 14, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitin ligase"", ""start_span"": 50, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""E6AP"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""UBE3A"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Gene/Protein""}]"	train
This effect can be reversed in HPV - driven tumor cells by reduced expression of HPV E6, which reactivates p53 expression and leads to senescence or apoptosis [ 9 – 11 ].	HPV,31,34,Organism/Species	tumor,44,49,Disease/Disorder	HPV,81,84,Organism/Species	E6,85,87,Gene/Protein	p53,107,110,Gene/Protein	"[{""token"": ""HPV"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Organism/Species""}, {""token"": ""tumor"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Disease/Disorder""}, {""token"": ""HPV"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Organism/Species""}, {""token"": ""E6"", ""start_span"": 85, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene/Protein""}]"	train
( E, F) Thermal stability profiles of MBP, MBP - E6 and MBP - E6 L50G.	MBP,38,41,Gene/Protein	MBP,43,46,Gene/Protein	E6,49,51,Gene/Protein	MBP,56,59,Gene/Protein	E6,62,64,Gene/Protein	"[{""token"": ""MBP"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""MBP"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""E6"", ""start_span"": 49, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""MBP"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""E6"", ""start_span"": 62, ""end_span"": 64, ""type"": ""Gene/Protein""}]"	train
These in vitro p53 degradation activities are in agreement with previously published results for the HPV - 16 E6 protein containing four cysteine to serine mutations 4C4S [ 39 ].	p53,15,18,Gene/Protein	HPV - 16,101,109,Organism/Species	E6 protein,110,120,Gene/Protein	cysteine,137,145,Chemical/Drug	serine,149,155,Chemical/Drug	"[{""token"": ""p53"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""HPV - 16"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Organism/Species""}, {""token"": ""E6 protein"", ""start_span"": 110, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""cysteine"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Chemical/Drug""}, {""token"": ""serine"", ""start_span"": 149, ""end_span"": 155, ""type"": ""Chemical/Drug""}]"	train
Further evaluation of these E6 mutants was also investigated using a cell - based assay with a p53 - luciferase ( p53 - luc) reporter construct [ 40 ].	E6,28,30,Gene/Protein	p53,95,98,Gene/Protein	luciferase,101,111,Gene/Protein	p53,114,117,Gene/Protein	luc,120,123,Gene/Protein	"[{""token"": ""E6"", ""start_span"": 28, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""luciferase"", ""start_span"": 101, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene/Protein""}]"	train
( C) C33a cells transiently transfected with p53 - luc, firefly luciferase and increasing DNA concentrations of 16E6 and mutants analyzed for luciferase activities at 24 hrs.	p53,45,48,Gene/Protein	luc,51,54,Gene/Protein	firefly,56,63,Organism/Species	luciferase,64,74,Gene/Protein	luciferase,142,152,Gene/Protein	"[{""token"": ""p53"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""firefly"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Organism/Species""}, {""token"": ""luciferase"", ""start_span"": 64, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""luciferase"", ""start_span"": 142, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
E6AP - BAP was eluted with 5 successive elutions of ice - cold 0. 1 M glycine pH 2. 0 into 250 μl of Neutralization buffer ( 50% ( v / v) glycerol, 200 NaCl, 200 mM Tris - HCl pH 8. 0, 2x protease inhibitor cocktail ).	E6AP,0,4,Gene/Protein	BAP,7,10,Gene/Protein	glycine,70,77,Chemical/Drug	glycerol,138,146,Chemical/Drug	protease,188,196,Gene/Protein	"[{""token"": ""E6AP"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""BAP"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""glycine"", ""start_span"": 70, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""glycerol"", ""start_span"": 138, ""end_span"": 146, ""type"": ""Chemical/Drug""}, {""token"": ""protease"", ""start_span"": 188, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
Human p53 proteins were expressed in High 5 cells using human p53 baculovirus that was a kind gift from Carol Prives.	Human,0,5,Organism/Species	p53,6,9,Gene/Protein	human,56,61,Organism/Species	p53,62,65,Gene/Protein	baculovirus,66,77,Organism/Species	"[{""token"": ""Human"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism/Species""}, {""token"": ""p53"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Organism/Species""}, {""token"": ""p53"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""baculovirus"", ""start_span"": 66, ""end_span"": 77, ""type"": ""Organism/Species""}]"	train
In vitro p53 degradation assays were performed in a 30 μL reaction in assay buffer ( 25 mM Tris HCl pH 7. 5, 100 mM NaCl, 2 mM DTT, 2. 5 mM ATP) containing 1 μl rabbit reticulocyte lysate ( RRL ), p53, E6 proteins or E6 buffer.	p53,9,12,Gene/Protein	rabbit,161,167,Organism/Species	p53,197,200,Gene/Protein	E6 proteins,202,213,Gene/Protein	E6,217,219,Gene/Protein	"[{""token"": ""p53"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 161, ""end_span"": 167, ""type"": ""Organism/Species""}, {""token"": ""p53"", ""start_span"": 197, ""end_span"": 200, ""type"": ""Gene/Protein""}, {""token"": ""E6 proteins"", ""start_span"": 202, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""E6"", ""start_span"": 217, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
p53 and MBP - E6 proteins were analyzed by blotting with anti - p53 and anti - E6, respectively.	p53,0,3,Gene/Protein	MBP,8,11,Gene/Protein	E6 proteins,14,25,Gene/Protein	p53,64,67,Gene/Protein	E6,79,81,Gene/Protein	"[{""token"": ""p53"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""MBP"", ""start_span"": 8, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""E6 proteins"", ""start_span"": 14, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""E6"", ""start_span"": 79, ""end_span"": 81, ""type"": ""Gene/Protein""}]"	train
p53 and MBP - E6 ( WT, R102A) proteins were analyzed by blotting with anti - p53 and anti - E6, respectively.	p53,0,3,Gene/Protein	MBP,8,11,Gene/Protein	E6,14,16,Gene/Protein	p53,77,80,Gene/Protein	E6,92,94,Gene/Protein	"[{""token"": ""p53"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""MBP"", ""start_span"": 8, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""E6"", ""start_span"": 14, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""E6"", ""start_span"": 92, ""end_span"": 94, ""type"": ""Gene/Protein""}]"	train
Besides, momL - suf gene cluster, consisting of quorum quenching enzyme coding gene momL and iron - sulfur biosynthetic genes suf, were involved in indole - induced stress response pathway.	momL,9,13,Gene/Protein	suf,16,19,Gene/Protein	quorum quenching enzyme,48,71,Gene/Protein	momL,84,88,Gene/Protein	suf,126,129,Gene/Protein	"[{""token"": ""momL"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""suf"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""quorum quenching enzyme"", ""start_span"": 48, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""momL"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""suf"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Gene/Protein""}]"	train
SufS and SufE are desulfurase homologs, whereas SufC is an ATPase.	SufS,0,4,Gene/Protein	SufE,9,13,Gene/Protein	desulfurase,18,29,Gene/Protein	SufC,48,52,Gene/Protein	ATPase,59,65,Gene/Protein	"[{""token"": ""SufS"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""SufE"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""desulfurase"", ""start_span"": 18, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""SufC"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""ATPase"", ""start_span"": 59, ""end_span"": 65, ""type"": ""Gene/Protein""}]"	train
Transcriptional analysis showed that there were no marked changes in the levels of oxyR2, oxyR3, fur, or himA in the presence of indole, whereas oxyR1 expression increased significantly at 3. 2 - fold over normal conditions ( Fig. 2D ).	oxyR2,83,88,Gene/Protein	oxyR3,90,95,Gene/Protein	fur,97,100,Gene/Protein	himA,105,109,Gene/Protein	oxyR1,145,150,Gene/Protein	"[{""token"": ""oxyR2"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""oxyR3"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""fur"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""himA"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""oxyR1"", ""start_span"": 145, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
Geminiviruses are emerging plant pathogens that infect a wide variety of crops including cotton, cassava, vegetables, ornamental plants and cereals.	Geminiviruses,0,13,Organism/Species	plant,27,32,Organism/Species	cotton,89,95,Organism/Species	cassava,97,104,Organism/Species	plants,129,135,Organism/Species	"[{""token"": ""Geminiviruses"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Organism/Species""}, {""token"": ""plant"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Organism/Species""}, {""token"": ""cotton"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Organism/Species""}, {""token"": ""cassava"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 129, ""end_span"": 135, ""type"": ""Organism/Species""}]"	train
SAB showed 68% nucleotide sequence identity with A. thaliana putative Rieske iron - sulfur protein ( RISP) and 73% with P. sativum RISP.	SAB,0,3,Gene/Protein	nucleotide,15,25,Chemical/Drug	putative Rieske iron - sulfur protein,61,98,Gene/Protein	RISP,101,105,Gene/Protein	RISP,131,135,Gene/Protein	"[{""token"": ""SAB"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""nucleotide"", ""start_span"": 15, ""end_span"": 25, ""type"": ""Chemical/Drug""}, {""token"": ""putative Rieske iron - sulfur protein"", ""start_span"": 61, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""RISP"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""RISP"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene/Protein""}]"	train
Transcript SA3 showed 92% nucleotide sequence identity with the polynucleotide nucleotidyltransferase from P. cryohalolentis K5 ( PNPase; encoded by the pnp gene ).	SA3,11,14,Gene/Protein	nucleotide,26,36,Chemical/Drug	polynucleotide nucleotidyltransferase,64,101,Gene/Protein	PNPase,130,136,Gene/Protein	pnp,153,156,Gene/Protein	"[{""token"": ""SA3"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""nucleotide"", ""start_span"": 26, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""polynucleotide nucleotidyltransferase"", ""start_span"": 64, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""PNPase"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""pnp"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
SA4 shows 90% nucleotide sequence identity with the chromosomal replication initiator protein DnaA. βC1 induces cell proliferation ( enations) and a requirement for DnaA during cell division is thus consistent with this finding.	SA4,0,3,Gene/Protein	nucleotide,14,24,Chemical/Drug	chromosomal replication initiator protein DnaA,52,98,Gene/Protein	βC1,100,103,Gene/Protein	DnaA,165,169,Gene/Protein	"[{""token"": ""SA4"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""nucleotide"", ""start_span"": 14, ""end_span"": 24, ""type"": ""Chemical/Drug""}, {""token"": ""chromosomal replication initiator protein DnaA"", ""start_span"": 52, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2C1"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""DnaA"", ""start_span"": 165, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	train
A set of primers ( ChβC135S ( F) 5 '- GCAAGCTTATGCACCACGTATATGAATTATGTCC - 3 '/ ChβC135S ( R) 5 '- GCGAATTCTCACACACACACATTCGTACATAC - 3 '; having EcoRI and HindIII restriction sites, respectively) were designed to the reported sequence ( accession no. AJ316032) to amplify a 450 bp DNA fragment containing the ChLCB βC1 gene.	EcoRI,146,151,Gene/Protein	HindIII,156,163,Gene/Protein	AJ316032,252,260,Chemical/Drug	ChLCB,310,315,Organism/Species	βC1,316,319,Gene/Protein	"[{""token"": ""EcoRI"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""HindIII"", ""start_span"": 156, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""AJ316032"", ""start_span"": 252, ""end_span"": 260, ""type"": ""Chemical/Drug""}, {""token"": ""ChLCB"", ""start_span"": 310, ""end_span"": 315, ""type"": ""Organism/Species""}, {""token"": ""\u03b2C1"", ""start_span"": 316, ""end_span"": 319, ""type"": ""Gene/Protein""}]"	train
It has been reported that chronic respiratory inflammation are caused by arsenic - induced respiratory diseases [ 3 ], and peripheral neuropathy, encephalopathy, and polyneuropathy are caused by nervous system diseases [ 4 ].	respiratory diseases,91,111,Disease/Disorder	peripheral neuropathy,123,144,Disease/Disorder	encephalopathy,146,160,Disease/Disorder	polyneuropathy,166,180,Disease/Disorder	nervous system diseases,195,218,Disease/Disorder	"[{""token"": ""respiratory diseases"", ""start_span"": 91, ""end_span"": 111, ""type"": ""Disease/Disorder""}, {""token"": ""peripheral neuropathy"", ""start_span"": 123, ""end_span"": 144, ""type"": ""Disease/Disorder""}, {""token"": ""encephalopathy"", ""start_span"": 146, ""end_span"": 160, ""type"": ""Disease/Disorder""}, {""token"": ""polyneuropathy"", ""start_span"": 166, ""end_span"": 180, ""type"": ""Disease/Disorder""}, {""token"": ""nervous system diseases"", ""start_span"": 195, ""end_span"": 218, ""type"": ""Disease/Disorder""}]"	train
Antibodies against collagen type I ( 1: 500, clone I - 8H5, MP Biomedicals, Cambridge, UK) or type II ( 1: 10, clone CIIC1, Developmental Studies Hybridoma Bank, IA, USA) were incubated for 60 minutes prior to the secondary goat anti - mouse biotinylated antibody for 60 minuntes ( Vectastain Elite ABC kit, Vector Laboratories, Peterborough, UK ).	Antibodies,0,10,Gene/Protein	collagen type I,19,34,Gene/Protein	goat,224,228,Organism/Species	mouse,236,241,Organism/Species	antibody,255,263,Gene/Protein	"[{""token"": ""Antibodies"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""collagen type I"", ""start_span"": 19, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""goat"", ""start_span"": 224, ""end_span"": 228, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 236, ""end_span"": 241, ""type"": ""Organism/Species""}, {""token"": ""antibody"", ""start_span"": 255, ""end_span"": 263, ""type"": ""Gene/Protein""}]"	train
Accordingly, using human and mouse fetal intestinal models, we have shown that B. fragilis with PSA and PSA alone inhibits IL - 1β - induced IL - 8 inflammation in fetal and NEC intestine.	human,19,24,Organism/Species	mouse,29,34,Organism/Species	IL - 1β,123,130,Gene/Protein	IL - 8,141,147,Gene/Protein	NEC,174,177,Disease/Disorder	"[{""token"": ""human"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Organism/Species""}, {""token"": ""IL - 1\u03b2"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 141, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""NEC"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Disease/Disorder""}]"	train
We have shown that B. fragilis PSA anti - inflammation requires both the TLR2 and TLR4 receptor and is in part mediated by the AP1 transcription factor ( TLR2) which is developmentally regulated.	TLR2,73,77,Gene/Protein	TLR4 receptor,82,95,Gene/Protein	AP1,127,130,Gene/Protein	transcription factor,131,151,Gene/Protein	TLR2,154,158,Gene/Protein	"[{""token"": ""TLR2"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""TLR4 receptor"", ""start_span"": 82, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""AP1"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 131, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""TLR2"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene/Protein""}]"	train
PSA also interacts with TLR2 receptor molecules on CD4 lymphocytes to preferentially stimulate T - regulatory cells to produce IL - 10 [ 16] which prevents experimental induced colitis via IL - 17 stimulation [ 17, 18 ].	TLR2 receptor,24,37,Gene/Protein	CD4,51,54,Gene/Protein	IL - 10,127,134,Gene/Protein	colitis,177,184,Disease/Disorder	IL - 17,189,196,Gene/Protein	"[{""token"": ""TLR2 receptor"", ""start_span"": 24, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 127, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""colitis"", ""start_span"": 177, ""end_span"": 184, ""type"": ""Disease/Disorder""}, {""token"": ""IL - 17"", ""start_span"": 189, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
H4 cells, were cultured in Dulbeco ’ modified Eagle ’ s medium ( DMEM) ( Gibco Thermofisher, Woburn, MA) with 10% fetal bovine serum ( FBS) ( Mediatech, Manassa, VA ), 0. 2 u / ml insulin ( Eli Lilly and Company, Indianapolis, IN ), 2 mM L - glutamine, 0. 1 mM MEM nonessential amino acids, 10 mM Hepes buffer, 100 units / ml penicillin and 100 μg / ml streptomycin ( all purchased from Gibco Thermofisher ).	insulin,180,187,Gene/Protein	L - glutamine,238,251,Chemical/Drug	amino acids,278,289,Chemical/Drug	penicillin,326,336,Chemical/Drug	streptomycin,353,365,Chemical/Drug	"[{""token"": ""insulin"", ""start_span"": 180, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""L - glutamine"", ""start_span"": 238, ""end_span"": 251, ""type"": ""Chemical/Drug""}, {""token"": ""amino acids"", ""start_span"": 278, ""end_span"": 289, ""type"": ""Chemical/Drug""}, {""token"": ""penicillin"", ""start_span"": 326, ""end_span"": 336, ""type"": ""Chemical/Drug""}, {""token"": ""streptomycin"", ""start_span"": 353, ""end_span"": 365, ""type"": ""Chemical/Drug""}]"	train
TLR4 and TLR2 are required for PSA reduction of IL - 1β - induced IL8 in fetal mouse small intestinal organ cultures.	TLR4,0,4,Gene/Protein	TLR2,9,13,Gene/Protein	IL - 1β,48,55,Gene/Protein	IL8,66,69,Gene/Protein	mouse,79,84,Organism/Species	"[{""token"": ""TLR4"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""TLR2"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1\u03b2"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""IL8"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Organism/Species""}]"	train
TLR2 has been specifically implicated in the stimulation of FOXP3 + Tregs cells to produce IL - 10 which leads to the suppression of the release of IL - 17 cytokines implemented in intestinal inflammation [ 16 ].	TLR2,0,4,Gene/Protein	FOXP3,60,65,Gene/Protein	IL - 10,91,98,Gene/Protein	IL - 17,148,155,Gene/Protein	cytokines,156,165,Gene/Protein	"[{""token"": ""TLR2"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""FOXP3"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""IL - 17"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 156, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
PSA attenuated IL - 8 induction in response to IL - 1β in control but not in TLR2 -/- and TLR4 -/- mice.	IL - 8,15,21,Gene/Protein	IL - 1β,47,54,Gene/Protein	TLR2,77,81,Gene/Protein	TLR4,90,94,Gene/Protein	mice,99,103,Organism/Species	"[{""token"": ""IL - 8"", ""start_span"": 15, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1\u03b2"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""TLR2"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""TLR4"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 99, ""end_span"": 103, ""type"": ""Organism/Species""}]"	train
We have previously reported that AP - 1 is a specific nuclear transcriptional factor for IL - 1β induced IL - 6 / IL - 8 secretions, but only in immature enterocytes [ 36 ].	AP - 1,33,39,Gene/Protein	nuclear transcriptional factor,54,84,Gene/Protein	IL - 1β,89,96,Gene/Protein	IL - 6,105,111,Gene/Protein	IL - 8,114,120,Gene/Protein	"[{""token"": ""AP - 1"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""nuclear transcriptional factor"", ""start_span"": 54, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1\u03b2"", ""start_span"": 89, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 105, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 114, ""end_span"": 120, ""type"": ""Gene/Protein""}]"	train
With the increasing development of LED technology and its use in horticultural production systems in protected environments, plant producers are now able to create specific light scenarios for influencing plant growth and quality and also plant metabolites so as to protect plants against herbivorous insects [ 14 – 15 ].	plant,125,130,Organism/Species	plant,205,210,Organism/Species	plant,239,244,Organism/Species	plants,274,280,Organism/Species	insects,301,308,Organism/Species	"[{""token"": ""plant"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Organism/Species""}, {""token"": ""plant"", ""start_span"": 205, ""end_span"": 210, ""type"": ""Organism/Species""}, {""token"": ""plant"", ""start_span"": 239, ""end_span"": 244, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 274, ""end_span"": 280, ""type"": ""Organism/Species""}, {""token"": ""insects"", ""start_span"": 301, ""end_span"": 308, ""type"": ""Organism/Species""}]"	train
Treatment of Brassica rapa ssp. pekinensis ( Brassicaceae; Chinese cabbage) with blue LED light also increased the biosynthesis of phenylpropanoids including quercetin and kaempferol glycosides [ 11 ].	Brassicaceae,45,57,Organism/Species	Chinese cabbage,59,74,Organism/Species	phenylpropanoids,131,147,Chemical/Drug	quercetin,158,167,Chemical/Drug	kaempferol glycosides,172,193,Chemical/Drug	"[{""token"": ""Brassicaceae"", ""start_span"": 45, ""end_span"": 57, ""type"": ""Organism/Species""}, {""token"": ""Chinese cabbage"", ""start_span"": 59, ""end_span"": 74, ""type"": ""Organism/Species""}, {""token"": ""phenylpropanoids"", ""start_span"": 131, ""end_span"": 147, ""type"": ""Chemical/Drug""}, {""token"": ""quercetin"", ""start_span"": 158, ""end_span"": 167, ""type"": ""Chemical/Drug""}, {""token"": ""kaempferol glycosides"", ""start_span"": 172, ""end_span"": 193, ""type"": ""Chemical/Drug""}]"	train
Concentrations of secondary plant metabolites ( such as glucosinolates and flavonol glycosides) in broccoli plants grown in a climate chamber with specific UV - B, UV - A, and violet light treatments were greater with more red light in the background spectrum [ 6] than with more blue light in the background spectrum ( as in the current study ).	plant,28,33,Organism/Species	glucosinolates,56,70,Chemical/Drug	flavonol glycosides,75,94,Chemical/Drug	broccoli,99,107,Organism/Species	plants,108,114,Organism/Species	"[{""token"": ""plant"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Organism/Species""}, {""token"": ""glucosinolates"", ""start_span"": 56, ""end_span"": 70, ""type"": ""Chemical/Drug""}, {""token"": ""flavonol glycosides"", ""start_span"": 75, ""end_span"": 94, ""type"": ""Chemical/Drug""}, {""token"": ""broccoli"", ""start_span"": 99, ""end_span"": 107, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Organism/Species""}]"	train
To better define the role of binding affinity in forming a protein - ligand complex, a structural characterization for putative human off - targets was recently performed on Nelfinavir, a potent HIV - protease inhibitor with pleiotropic effects in cancer cells [ 2 ].	human,128,133,Organism/Species	Nelfinavir,174,184,Chemical/Drug	HIV,195,198,Organism/Species	protease,201,209,Gene/Protein	cancer,248,254,Disease/Disorder	"[{""token"": ""human"", ""start_span"": 128, ""end_span"": 133, ""type"": ""Organism/Species""}, {""token"": ""Nelfinavir"", ""start_span"": 174, ""end_span"": 184, ""type"": ""Chemical/Drug""}, {""token"": ""HIV"", ""start_span"": 195, ""end_span"": 198, ""type"": ""Organism/Species""}, {""token"": ""protease"", ""start_span"": 201, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""cancer"", ""start_span"": 248, ""end_span"": 254, ""type"": ""Disease/Disorder""}]"	train
482T polymorph has a lower affinity towards substrates, such as Caffeine, Diltiazem, Raloxifene, Quinidine and Verapamil.	Caffeine,64,72,Chemical/Drug	Diltiazem,74,83,Chemical/Drug	Raloxifene,85,95,Chemical/Drug	Quinidine,97,106,Chemical/Drug	Verapamil,111,120,Chemical/Drug	"[{""token"": ""Caffeine"", ""start_span"": 64, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""Diltiazem"", ""start_span"": 74, ""end_span"": 83, ""type"": ""Chemical/Drug""}, {""token"": ""Raloxifene"", ""start_span"": 85, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""Quinidine"", ""start_span"": 97, ""end_span"": 106, ""type"": ""Chemical/Drug""}, {""token"": ""Verapamil"", ""start_span"": 111, ""end_span"": 120, ""type"": ""Chemical/Drug""}]"	train
Recently, a drug class called poly ADP ribose polymerase ( PARP) inhibitors that targets cancers caused by BRCA mutations have shown promise in clinical trials treating breast cancer [ 52 ].	poly ADP ribose polymerase,30,56,Gene/Protein	PARP,59,63,Gene/Protein	cancers,89,96,Disease/Disorder	BRCA,107,111,Gene/Protein	breast cancer,169,182,Disease/Disorder	"[{""token"": ""poly ADP ribose polymerase"", ""start_span"": 30, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""PARP"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""cancers"", ""start_span"": 89, ""end_span"": 96, ""type"": ""Disease/Disorder""}, {""token"": ""BRCA"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""breast cancer"", ""start_span"": 169, ""end_span"": 182, ""type"": ""Disease/Disorder""}]"	train
Therefore, we focused on the Miwi2 ( Piwil4) gene, the ortholog of HIWI2, which has previously shown to be the most ubiquitously expressed human PIWI homolog [ 18 ].	Miwi2,29,34,Gene/Protein	Piwil4,37,43,Gene/Protein	HIWI2,67,72,Gene/Protein	human,139,144,Organism/Species	PIWI,145,149,Gene/Protein	"[{""token"": ""Miwi2"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""Piwil4"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""HIWI2"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 139, ""end_span"": 144, ""type"": ""Organism/Species""}, {""token"": ""PIWI"", ""start_span"": 145, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
The identified risk factors included; demographic features such as increasing age and female sex, and comorbidities such as a previous history of falls and atrial fibrillation, which were associated with increased risk of both events at various points during follow - up, additionally, chronic kidney disease and hyperlipidemia were associated with an increased risk of falls only, while previous stroke / TIA increased fracture risk.	atrial fibrillation,156,175,Disease/Disorder	chronic kidney disease,286,308,Disease/Disorder	hyperlipidemia,313,327,Disease/Disorder	stroke,397,403,Disease/Disorder	TIA,406,409,Disease/Disorder	"[{""token"": ""atrial fibrillation"", ""start_span"": 156, ""end_span"": 175, ""type"": ""Disease/Disorder""}, {""token"": ""chronic kidney disease"", ""start_span"": 286, ""end_span"": 308, ""type"": ""Disease/Disorder""}, {""token"": ""hyperlipidemia"", ""start_span"": 313, ""end_span"": 327, ""type"": ""Disease/Disorder""}, {""token"": ""stroke"", ""start_span"": 397, ""end_span"": 403, ""type"": ""Disease/Disorder""}, {""token"": ""TIA"", ""start_span"": 406, ""end_span"": 409, ""type"": ""Disease/Disorder""}]"	train
After a stroke, there is also muscle wasting ( 25 ), which further contributes toward fall risk, with there being many shared risk factors between stroke and chronic kidney disease and an additional association with chronic kidney disease patients being at increased risk of stroke ( 26 ).	stroke,8,14,Disease/Disorder	stroke,147,153,Disease/Disorder	chronic kidney disease,158,180,Disease/Disorder	chronic kidney disease,216,238,Disease/Disorder	stroke,275,281,Disease/Disorder	"[{""token"": ""stroke"", ""start_span"": 8, ""end_span"": 14, ""type"": ""Disease/Disorder""}, {""token"": ""stroke"", ""start_span"": 147, ""end_span"": 153, ""type"": ""Disease/Disorder""}, {""token"": ""chronic kidney disease"", ""start_span"": 158, ""end_span"": 180, ""type"": ""Disease/Disorder""}, {""token"": ""chronic kidney disease"", ""start_span"": 216, ""end_span"": 238, ""type"": ""Disease/Disorder""}, {""token"": ""stroke"", ""start_span"": 275, ""end_span"": 281, ""type"": ""Disease/Disorder""}]"	train
All other reagents and chemicals were molecular biology grade or obtained at the highest purity available from Sangon Biotech ( Shanghai, China ). Staphylococcus aureus, E. coli, Bacillus megaterium, B. subtilis, B. thuringiensis, Klebsiella pneumoniae, Pseudomonas aeruginosa and Vibrio anguillarum were obtained from Shandong University Organism Culture Collection ( SDMCC ), and cultured in our laboratory in Luria - Bertani medium.	Staphylococcus aureus,147,168,Organism/Species	Bacillus megaterium,179,198,Organism/Species	Klebsiella pneumoniae,231,252,Organism/Species	Pseudomonas aeruginosa,254,276,Organism/Species	Vibrio anguillarum,281,299,Organism/Species	"[{""token"": ""Staphylococcus aureus"", ""start_span"": 147, ""end_span"": 168, ""type"": ""Organism/Species""}, {""token"": ""Bacillus megaterium"", ""start_span"": 179, ""end_span"": 198, ""type"": ""Organism/Species""}, {""token"": ""Klebsiella pneumoniae"", ""start_span"": 231, ""end_span"": 252, ""type"": ""Organism/Species""}, {""token"": ""Pseudomonas aeruginosa"", ""start_span"": 254, ""end_span"": 276, ""type"": ""Organism/Species""}, {""token"": ""Vibrio anguillarum"", ""start_span"": 281, ""end_span"": 299, ""type"": ""Organism/Species""}]"	train
For recombinant expression of MjGal, the sequence was amplified using the primers Gal exF ( 5 ′- TAC TCA CAT ATG ( Nde I) ATG TCA GCA CCA GTG TAC AAC - 3 ′) and Gal exR ( 5 ′- TAC TCA CTC GAG ( Xho I) TCA TAT ACC CTC CTC CAG CAA GGG - 3 ′).	MjGal,30,35,Gene/Protein	Gal,82,85,Gene/Protein	Nde I,115,120,Gene/Protein	Gal,161,164,Gene/Protein	Xho I,194,199,Gene/Protein	"[{""token"": ""MjGal"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""Gal"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""Nde I"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""Gal"", ""start_span"": 161, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""Xho I"", ""start_span"": 194, ""end_span"": 199, ""type"": ""Gene/Protein""}]"	train
Fifty µl of the rMjGal - coated bacteria ( which included a total of 2 × 107 cfu of V. anguillarum together with 15 µg rMjGal) or controls ( 2 × 107 cfu of V. anguillarum together with 15 µg Trx - His, or PBS alone) were injected into the third abdominal segment of each shrimp from experimental or control groups.	rMjGal,16,22,Gene/Protein	bacteria,32,40,Organism/Species	rMjGal,119,125,Gene/Protein	Trx,191,194,Gene/Protein	shrimp,271,277,Organism/Species	"[{""token"": ""rMjGal"", ""start_span"": 16, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""bacteria"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Organism/Species""}, {""token"": ""rMjGal"", ""start_span"": 119, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""Trx"", ""start_span"": 191, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""shrimp"", ""start_span"": 271, ""end_span"": 277, ""type"": ""Organism/Species""}]"	train
After blocking with 3% BSA in PBS for 5 min, FITC - conjugated horse anti - mouse IgG ( 1 ∶ 1000 in PBS containing 3% BSA) was added to the glass slide and incubated for 1 h at 37 ° C in the dark, washed six times with PBS for 10 min each, stained with DAPI ( 1 / 1000 dilution in PBS) for 10 min, washed again six times with PBS for 10 min each, and examined under fluorescence microscope ( Olympus BX51, Tokyo, Japan ).	BSA,23,26,Gene/Protein	horse,63,68,Organism/Species	mouse,76,81,Organism/Species	IgG,82,85,Gene/Protein	BSA,118,121,Gene/Protein	"[{""token"": ""BSA"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""horse"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""BSA"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene/Protein""}]"	train
( C) Purified rMjGal ( 500 µg / ml) was pre - incubated with either lactose ( 200 mM ), glucose ( 200 mM ), or TBS alone for 1 h, and suspensions of four Gram - positive ( G +) bacteria ( S. aureus, B. subtilis, B. megaterium and B. thuringiensis) and four Gram - negative ( G −) bacteria ( V. anguillarum, K. pneumoniae, E. coli and P. aeruginosa) were added and incubated at room temperature for 1 h.	rMjGal,14,20,Gene/Protein	lactose,68,75,Chemical/Drug	glucose,88,95,Chemical/Drug	bacteria,177,185,Organism/Species	bacteria,280,288,Organism/Species	"[{""token"": ""rMjGal"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""lactose"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Chemical/Drug""}, {""token"": ""glucose"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""bacteria"", ""start_span"": 177, ""end_span"": 185, ""type"": ""Organism/Species""}, {""token"": ""bacteria"", ""start_span"": 280, ""end_span"": 288, ""type"": ""Organism/Species""}]"	train
To investigate the clearance activity of rMjGal, the shrimp were injected with V. anguillarum that had been pre - incubated with either rMjGal, Trx - His, or PBS, and the bacteria remaining in the hemolymph were counted at different time points after injection.	rMjGal,41,47,Gene/Protein	shrimp,53,59,Organism/Species	rMjGal,136,142,Gene/Protein	Trx,144,147,Gene/Protein	bacteria,171,179,Organism/Species	"[{""token"": ""rMjGal"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""shrimp"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Organism/Species""}, {""token"": ""rMjGal"", ""start_span"": 136, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""Trx"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""bacteria"", ""start_span"": 171, ""end_span"": 179, ""type"": ""Organism/Species""}]"	train
To verify if the in vitro rMjGal - shrimp hemocyte interactions above also occurred in vivo, shrimp were injected with rMjGal, and after 30 min the hemocytes collected as described above, and the presence of surface - bound rMjGal examined by immunocytochemistry.	rMjGal,26,32,Gene/Protein	shrimp,35,41,Organism/Species	shrimp,93,99,Organism/Species	rMjGal,119,125,Gene/Protein	rMjGal,224,230,Gene/Protein	"[{""token"": ""rMjGal"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""shrimp"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Organism/Species""}, {""token"": ""shrimp"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Organism/Species""}, {""token"": ""rMjGal"", ""start_span"": 119, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""rMjGal"", ""start_span"": 224, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
( D) RNA interference assay: shrimp were injected with dsRNAs twice to silence MjGal expression, and or with GFP dsRNAs as control. Vibrio anguillarum ( 2 × 107 cells) were injected into shrimp after the second injection.	shrimp,29,35,Organism/Species	MjGal,79,84,Gene/Protein	GFP,109,112,Gene/Protein	Vibrio anguillarum,132,150,Organism/Species	shrimp,187,193,Organism/Species	"[{""token"": ""shrimp"", ""start_span"": 29, ""end_span"": 35, ""type"": ""Organism/Species""}, {""token"": ""MjGal"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""Vibrio anguillarum"", ""start_span"": 132, ""end_span"": 150, ""type"": ""Organism/Species""}, {""token"": ""shrimp"", ""start_span"": 187, ""end_span"": 193, ""type"": ""Organism/Species""}]"	train
In contrast, the organization of the MjGal transcript is quite similar to the galectin DpGal - 2, from the water flea D. pulex that houses a 127 - amino acid long CRD linked to a low complexity region.	MjGal,37,42,Gene/Protein	galectin,78,86,Gene/Protein	DpGal - 2,87,96,Gene/Protein	water flea,107,117,Organism/Species	amino acid,147,157,Chemical/Drug	"[{""token"": ""MjGal"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""galectin"", ""start_span"": 78, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""DpGal - 2"", ""start_span"": 87, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""water flea"", ""start_span"": 107, ""end_span"": 117, ""type"": ""Organism/Species""}, {""token"": ""amino acid"", ""start_span"": 147, ""end_span"": 157, ""type"": ""Chemical/Drug""}]"	train
Analysis of the nucleotide and deduced amino acid sequences indicated a closest similarity to galectins identified in the shrimp L. vannamei and the crab E. sinensis, but in spite of the similar transcript organization, a significantly lower sequence similarity.	nucleotide,16,26,Chemical/Drug	amino acid,39,49,Chemical/Drug	galectins,94,103,Gene/Protein	shrimp,122,128,Organism/Species	crab,149,153,Organism/Species	"[{""token"": ""nucleotide"", ""start_span"": 16, ""end_span"": 26, ""type"": ""Chemical/Drug""}, {""token"": ""amino acid"", ""start_span"": 39, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""galectins"", ""start_span"": 94, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""shrimp"", ""start_span"": 122, ""end_span"": 128, ""type"": ""Organism/Species""}, {""token"": ""crab"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Organism/Species""}]"	train
In contrast, MjGal also bound strongly to the hemocyte surface, but the binding could be inhibited ( at least partially) by lactose, thereby confirming that like most galectins described to date, MjGal binds to galactosyl moieties.	MjGal,13,18,Gene/Protein	lactose,124,131,Chemical/Drug	galectins,167,176,Gene/Protein	MjGal,196,201,Gene/Protein	galactosyl,211,221,Chemical/Drug	"[{""token"": ""MjGal"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""lactose"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Chemical/Drug""}, {""token"": ""galectins"", ""start_span"": 167, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""MjGal"", ""start_span"": 196, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""galactosyl"", ""start_span"": 211, ""end_span"": 221, ""type"": ""Chemical/Drug""}]"	train
This opsonic effect of MjGal for bacteria that may have invaded the shrimp internal milieu became the rationale to propose the hypothesis that MjGal - mediated opsonization might be the mechanism by which MjGal enhances the clearance of potential microbial pathogens from circulation as initially observed.	MjGal,23,28,Gene/Protein	bacteria,33,41,Organism/Species	shrimp,68,74,Organism/Species	MjGal,143,148,Gene/Protein	MjGal,205,210,Gene/Protein	"[{""token"": ""MjGal"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""bacteria"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Organism/Species""}, {""token"": ""shrimp"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Organism/Species""}, {""token"": ""MjGal"", ""start_span"": 143, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""MjGal"", ""start_span"": 205, ""end_span"": 210, ""type"": ""Gene/Protein""}]"	train
We also took medical co - morbidities including hyperlipidemia ( ICD - 9 - CM codes 272. 0 – 272. 4 ), diabetes ( ICD - 9 - CM codes 250 ), hypertension ( ICD - 9 - CM codes 401 – 405 ), coronary heart disease ( ICD - 9 - CM codes 410 – 414 or 429. 2) and obesity ( ICD - 9 - CM codes 278, 278. 0, 278, 00 or 278. 01) into consideration in the regression models.	hyperlipidemia,48,62,Disease/Disorder	diabetes,103,111,Disease/Disorder	hypertension,140,152,Disease/Disorder	coronary heart disease,187,209,Disease/Disorder	obesity,256,263,Disease/Disorder	"[{""token"": ""hyperlipidemia"", ""start_span"": 48, ""end_span"": 62, ""type"": ""Disease/Disorder""}, {""token"": ""diabetes"", ""start_span"": 103, ""end_span"": 111, ""type"": ""Disease/Disorder""}, {""token"": ""hypertension"", ""start_span"": 140, ""end_span"": 152, ""type"": ""Disease/Disorder""}, {""token"": ""coronary heart disease"", ""start_span"": 187, ""end_span"": 209, ""type"": ""Disease/Disorder""}, {""token"": ""obesity"", ""start_span"": 256, ""end_span"": 263, ""type"": ""Disease/Disorder""}]"	train
The stratified Cox proportional analysis ( stratified by age, sex, and the year of the index date) suggested that the HR for gallstones during the 5 - year follow - up period was 1. 79 ( 95% CI = 1. 29 ~ 2. 48) for patients who underwent an appendectomy compared to unexposed patients after censoring individuals who died during the follow - up period and adjusting for patients ’ monthly income, geographic region, hypertension, coronary heart disease, hyperlipidemia, and diabetes.	gallstones,125,135,Disease/Disorder	hypertension,416,428,Disease/Disorder	coronary heart disease,430,452,Disease/Disorder	hyperlipidemia,454,468,Disease/Disorder	diabetes,474,482,Disease/Disorder	"[{""token"": ""gallstones"", ""start_span"": 125, ""end_span"": 135, ""type"": ""Disease/Disorder""}, {""token"": ""hypertension"", ""start_span"": 416, ""end_span"": 428, ""type"": ""Disease/Disorder""}, {""token"": ""coronary heart disease"", ""start_span"": 430, ""end_span"": 452, ""type"": ""Disease/Disorder""}, {""token"": ""hyperlipidemia"", ""start_span"": 454, ""end_span"": 468, ""type"": ""Disease/Disorder""}, {""token"": ""diabetes"", ""start_span"": 474, ""end_span"": 482, ""type"": ""Disease/Disorder""}]"	train
After adjusting for age, sex, year, monthly income, geographic region, hypertension, coronary heart disease, hyperlipidemia, and diabetes, patients who underwent an appendectomy were independently associated with a 1. 79 - fold increased risk of having been diagnosed with gallstones during the 5 - year follow - up period.	hypertension,71,83,Disease/Disorder	coronary heart disease,85,107,Disease/Disorder	hyperlipidemia,109,123,Disease/Disorder	diabetes,129,137,Disease/Disorder	gallstones,273,283,Disease/Disorder	"[{""token"": ""hypertension"", ""start_span"": 71, ""end_span"": 83, ""type"": ""Disease/Disorder""}, {""token"": ""coronary heart disease"", ""start_span"": 85, ""end_span"": 107, ""type"": ""Disease/Disorder""}, {""token"": ""hyperlipidemia"", ""start_span"": 109, ""end_span"": 123, ""type"": ""Disease/Disorder""}, {""token"": ""diabetes"", ""start_span"": 129, ""end_span"": 137, ""type"": ""Disease/Disorder""}, {""token"": ""gallstones"", ""start_span"": 273, ""end_span"": 283, ""type"": ""Disease/Disorder""}]"	train
However, the differences between these two groups were minimal ( only 2 – 3 %) and the results of increasing risks of following gallstones among patients with appendectomy remained significant after the diseases of hypertension, coronary heart disease, hyperlipidemia and diabetes were considered in the multivariate regression models for adjustment.	gallstones,128,138,Disease/Disorder	hypertension,215,227,Disease/Disorder	coronary heart disease,229,251,Disease/Disorder	hyperlipidemia,253,267,Disease/Disorder	diabetes,272,280,Disease/Disorder	"[{""token"": ""gallstones"", ""start_span"": 128, ""end_span"": 138, ""type"": ""Disease/Disorder""}, {""token"": ""hypertension"", ""start_span"": 215, ""end_span"": 227, ""type"": ""Disease/Disorder""}, {""token"": ""coronary heart disease"", ""start_span"": 229, ""end_span"": 251, ""type"": ""Disease/Disorder""}, {""token"": ""hyperlipidemia"", ""start_span"": 253, ""end_span"": 267, ""type"": ""Disease/Disorder""}, {""token"": ""diabetes"", ""start_span"": 272, ""end_span"": 280, ""type"": ""Disease/Disorder""}]"	train
Due to exposure to estrogen and progesterone, women indeed present a higher prevalence of gallstones than men [ 20 ].	estrogen,19,27,Chemical/Drug	progesterone,32,44,Chemical/Drug	women,46,51,Organism/Species	gallstones,90,100,Disease/Disorder	men,106,109,Organism/Species	"[{""token"": ""estrogen"", ""start_span"": 19, ""end_span"": 27, ""type"": ""Chemical/Drug""}, {""token"": ""progesterone"", ""start_span"": 32, ""end_span"": 44, ""type"": ""Chemical/Drug""}, {""token"": ""women"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Organism/Species""}, {""token"": ""gallstones"", ""start_span"": 90, ""end_span"": 100, ""type"": ""Disease/Disorder""}, {""token"": ""men"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Organism/Species""}]"	train
In addition, we found appendectomy cases were more likely to have clinical diagnoses of hypertension, diabetes, coronary heart disease, and hyperlipidemia that might also be associated with gallstone disease.	hypertension,88,100,Disease/Disorder	diabetes,102,110,Disease/Disorder	coronary heart disease,112,134,Disease/Disorder	hyperlipidemia,140,154,Disease/Disorder	gallstone,190,199,Disease/Disorder	"[{""token"": ""hypertension"", ""start_span"": 88, ""end_span"": 100, ""type"": ""Disease/Disorder""}, {""token"": ""diabetes"", ""start_span"": 102, ""end_span"": 110, ""type"": ""Disease/Disorder""}, {""token"": ""coronary heart disease"", ""start_span"": 112, ""end_span"": 134, ""type"": ""Disease/Disorder""}, {""token"": ""hyperlipidemia"", ""start_span"": 140, ""end_span"": 154, ""type"": ""Disease/Disorder""}, {""token"": ""gallstone"", ""start_span"": 190, ""end_span"": 199, ""type"": ""Disease/Disorder""}]"	train
Indeed, we found that striatal mTORC1 activity, as measured by mTOR S2448 phosphorylation, was significantly decreased in the Shank3 TG mice compared to wild - type ( WT) mice.	mTORC1,31,37,Gene/Protein	mTOR,63,67,Gene/Protein	Shank3,126,132,Gene/Protein	mice,136,140,Organism/Species	mice,171,175,Organism/Species	"[{""token"": ""mTORC1"", ""start_span"": 31, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""mTOR"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 126, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 171, ""end_span"": 175, ""type"": ""Organism/Species""}]"	train
By comparing with the gene sets of psychiatric disorders, we also observed that the 94 proteins of Shank3 - mTORC1 interactome were significantly associated with bipolar disorder ( BD ).	psychiatric disorders,35,56,Disease/Disorder	Shank3,99,105,Gene/Protein	mTORC1,108,114,Gene/Protein	bipolar disorder,162,178,Disease/Disorder	BD,181,183,Disease/Disorder	"[{""token"": ""psychiatric disorders"", ""start_span"": 35, ""end_span"": 56, ""type"": ""Disease/Disorder""}, {""token"": ""Shank3"", ""start_span"": 99, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""bipolar disorder"", ""start_span"": 162, ""end_span"": 178, ""type"": ""Disease/Disorder""}, {""token"": ""BD"", ""start_span"": 181, ""end_span"": 183, ""type"": ""Disease/Disorder""}]"	train
Altogether, our results suggest a protein interaction - mediated connectivity between Shank3 and certain upstream regulators of mTORC1 that might contribute to the abnormal striatal mTORC1 activity and to the manic - like behaviors of Shank3 TG mice.	Shank3,86,92,Gene/Protein	mTORC1,128,134,Gene/Protein	mTORC1,182,188,Gene/Protein	Shank3,235,241,Gene/Protein	mice,245,249,Organism/Species	"[{""token"": ""Shank3"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 182, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 235, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 245, ""end_span"": 249, ""type"": ""Organism/Species""}]"	train
The serine / threonine kinase mTOR forms two protein complexes, mTOR complex 1 ( mTORC1) and mTORC2, which have different subunit compositions and cellular functions.	serine / threonine kinase,4,29,Gene/Protein	mTOR,30,34,Gene/Protein	mTOR complex 1,64,78,Gene/Protein	mTORC1,81,87,Gene/Protein	mTORC2,93,99,Gene/Protein	"[{""token"": ""serine / threonine kinase"", ""start_span"": 4, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""mTOR"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""mTOR complex 1"", ""start_span"": 64, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""mTORC2"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Gene/Protein""}]"	train
As the active ( GTP - bound) form of Rheb directly binds and activates mTORC1, TSC1 / TSC2 complex is a negative regulator of mTORC1 pathway.	Rheb,37,41,Gene/Protein	mTORC1,71,77,Gene/Protein	TSC1,79,83,Gene/Protein	TSC2,86,90,Gene/Protein	mTORC1,126,132,Gene/Protein	"[{""token"": ""Rheb"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""TSC1"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""TSC2"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 126, ""end_span"": 132, ""type"": ""Gene/Protein""}]"	train
The activity of Rhes is regulated by Ras guanyl releasing protein 1 ( RasGRP1 ), a guanine nucleotide exchange factor ( GEF ), in the striatum ( Shahani et al ., 2016 ).	Rhes,16,20,Gene/Protein	Ras guanyl releasing protein 1,37,67,Gene/Protein	RasGRP1,70,77,Gene/Protein	guanine nucleotide exchange factor,83,117,Gene/Protein	GEF,120,123,Gene/Protein	"[{""token"": ""Rhes"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""Ras guanyl releasing protein 1"", ""start_span"": 37, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""RasGRP1"", ""start_span"": 70, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""guanine nucleotide exchange factor"", ""start_span"": 83, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""GEF"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene/Protein""}]"	train
We recently reported that EGFP - Shank3 ( SH3 and multiple ankyrin repeat domains 3 )- overexpressing transgenic ( TG) mice display manic - like behaviors at the adult stage ( 8 to 12 - week - old ), such as locomotor hyperactivity, hypersensitivity to amphetamine, increased acoustic startle response, reduced prepulse inhibition and abnormal circadian rhythms.	EGFP,26,30,Gene/Protein	Shank3,33,39,Gene/Protein	SH3 and multiple ankyrin repeat domains 3,42,83,Gene/Protein	mice,119,123,Organism/Species	amphetamine,253,264,Chemical/Drug	"[{""token"": ""EGFP"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""SH3 and multiple ankyrin repeat domains 3"", ""start_span"": 42, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Organism/Species""}, {""token"": ""amphetamine"", ""start_span"": 253, ""end_span"": 264, ""type"": ""Chemical/Drug""}]"	train
It is also notable that SHANK3 duplications have been identified in patients with some other disorders including Asperger ’ s syndrome, SCZ, and attention deficit hyperactivity disorder ( ADHD; Durand et al ., 2007; Failla et al ., 2007; Moessner et al ., 2007 ).	SHANK3,24,30,Gene/Protein	Asperger ’ s syndrome,113,134,Disease/Disorder	SCZ,136,139,Disease/Disorder	attention deficit hyperactivity disorder,145,185,Disease/Disorder	ADHD,188,192,Disease/Disorder	"[{""token"": ""SHANK3"", ""start_span"": 24, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""Asperger \u2019 s syndrome"", ""start_span"": 113, ""end_span"": 134, ""type"": ""Disease/Disorder""}, {""token"": ""SCZ"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Disease/Disorder""}, {""token"": ""attention deficit hyperactivity disorder"", ""start_span"": 145, ""end_span"": 185, ""type"": ""Disease/Disorder""}, {""token"": ""ADHD"", ""start_span"": 188, ""end_span"": 192, ""type"": ""Disease/Disorder""}]"	train
To understand the potential underlying mechanisms, we re - analyzed the previously reported protein interactome data, which revealed that 94 interactors were shared between Shank3 and upstream regulators of mTORC1 ( TSC1, TSC2 and Rhes ).	Shank3,173,179,Gene/Protein	mTORC1,207,213,Gene/Protein	TSC1,216,220,Gene/Protein	TSC2,222,226,Gene/Protein	Rhes,231,235,Gene/Protein	"[{""token"": ""Shank3"", ""start_span"": 173, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 207, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""TSC1"", ""start_span"": 216, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""TSC2"", ""start_span"": 222, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""Rhes"", ""start_span"": 231, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	train
Altogether, our results suggest a protein interaction - mediated connectivity between Shank3 and certain upstream regulators of mTORC1 that might contribute to the abnormal striatal mTORC1 activity and, at least in part, to the manic - like behaviors of Shank3 TG mice.	Shank3,86,92,Gene/Protein	mTORC1,128,134,Gene/Protein	mTORC1,182,188,Gene/Protein	Shank3,254,260,Gene/Protein	mice,264,268,Organism/Species	"[{""token"": ""Shank3"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 182, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 254, ""end_span"": 260, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 264, ""end_span"": 268, ""type"": ""Organism/Species""}]"	train
The following antibodies were used: GFP ( Abcam, ab290, 1: 500 ), neuronal nuclei ( NeuN; Millipore, MAB377, 1: 1000 ), rhodamine phalloidin ( Molecular Probes, R415, 1 unit / 200 μl ), and Alexa Fluor - conjugated secondary antibodies ( Jackson Immunoresearch, 111 - 585 - 003 and 115 - 585 - 003, 1: 500 ).	GFP,36,39,Gene/Protein	neuronal nuclei,66,81,Gene/Protein	NeuN,84,88,Gene/Protein	rhodamine phalloidin,120,140,Chemical/Drug	R415,161,165,Chemical/Drug	"[{""token"": ""GFP"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""neuronal nuclei"", ""start_span"": 66, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""NeuN"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""rhodamine phalloidin"", ""start_span"": 120, ""end_span"": 140, ""type"": ""Chemical/Drug""}, {""token"": ""R415"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Chemical/Drug""}]"	train
We found that the phosphorylation level of mTOR S2448 normalized to total mTOR expression was significantly decreased by approximately 15% in the striatum of Shank3 TG mice compared to that of WT mice ( Figure 1E ).	mTOR,43,47,Gene/Protein	mTOR,74,78,Gene/Protein	Shank3,158,164,Gene/Protein	mice,168,172,Organism/Species	mice,196,200,Organism/Species	"[{""token"": ""mTOR"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""mTOR"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 158, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 196, ""end_span"": 200, ""type"": ""Organism/Species""}]"	train
This result prompted us to test whether the levels of polymerized actin ( actin filament or F - actin) were increased in the striatum of Shank3 TG mice.	actin,66,71,Gene/Protein	actin,74,79,Gene/Protein	F - actin,92,101,Gene/Protein	Shank3,137,143,Gene/Protein	mice,147,151,Organism/Species	"[{""token"": ""actin"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""actin"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""F - actin"", ""start_span"": 92, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 137, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Organism/Species""}]"	train
As a control, the intensity of NeuN staining in the three subareas of the dorsal striatum in Shank3 TG mice was comparable to that in WT mice, suggesting a normal neuronal density in the Shank3 TG striatum ( Supplementary Figure S3 ).	NeuN,31,35,Gene/Protein	Shank3,93,99,Gene/Protein	mice,103,107,Organism/Species	mice,137,141,Organism/Species	Shank3,187,193,Gene/Protein	"[{""token"": ""NeuN"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Organism/Species""}, {""token"": ""Shank3"", ""start_span"": 187, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
Therefore, we also tested for the existence of the in vivo protein complex consisting of Shank3, Rhes and WAVE1 in the synaptosomal lysate from Shank3 TG mice.	Shank3,89,95,Gene/Protein	Rhes,97,101,Gene/Protein	WAVE1,106,111,Gene/Protein	Shank3,144,150,Gene/Protein	mice,154,158,Organism/Species	"[{""token"": ""Shank3"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""Rhes"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""WAVE1"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 144, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Organism/Species""}]"	train
This result is consistent with the previous study of “ Rhesactome ”, in which the authors performed IP using Rhes antibodies to pull down endogenous Rhes proteins from the striatal lysate of WT mice, and identified Shank3 and WAVE1 proteins in the complex using mass spectrometry analysis ( Shahani et al ., 2016 ).	Rhes,55,59,Gene/Protein	Rhes,109,113,Gene/Protein	mice,194,198,Organism/Species	Shank3,215,221,Gene/Protein	WAVE1,226,231,Gene/Protein	"[{""token"": ""Rhes"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""Rhes"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 194, ""end_span"": 198, ""type"": ""Organism/Species""}, {""token"": ""Shank3"", ""start_span"": 215, ""end_span"": 221, ""type"": ""Gene/Protein""}, {""token"": ""WAVE1"", ""start_span"": 226, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
In this regard, we reasoned that neuropsychiatric disorders affected by pathological Shank3 - mTORC1 interactions might be identified as those significantly associated with the 94 proteins connecting Shank3 and the upstream regulators of mTORC1.	neuropsychiatric disorders,33,59,Disease/Disorder	Shank3,85,91,Gene/Protein	mTORC1,94,100,Gene/Protein	Shank3,200,206,Gene/Protein	mTORC1,238,244,Gene/Protein	"[{""token"": ""neuropsychiatric disorders"", ""start_span"": 33, ""end_span"": 59, ""type"": ""Disease/Disorder""}, {""token"": ""Shank3"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 94, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 200, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 238, ""end_span"": 244, ""type"": ""Gene/Protein""}]"	train
We found that among the eight major classes of psychiatric disorders in the PsyGeNET, “ BDs and related disorders ” and “ SCZ spectrum and other psychiatric disorders ” were significantly associated with the 94 genes of Shank3 - mTORC1 interactome ( adjusted P = 0. 000186 for both, hypergeometric test; Figures 4A, B and Supplementary Table S8 ).	psychiatric disorders,47,68,Disease/Disorder	SCZ,122,125,Disease/Disorder	psychiatric disorders,145,166,Disease/Disorder	Shank3,220,226,Gene/Protein	mTORC1,229,235,Gene/Protein	"[{""token"": ""psychiatric disorders"", ""start_span"": 47, ""end_span"": 68, ""type"": ""Disease/Disorder""}, {""token"": ""SCZ"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Disease/Disorder""}, {""token"": ""psychiatric disorders"", ""start_span"": 145, ""end_span"": 166, ""type"": ""Disease/Disorder""}, {""token"": ""Shank3"", ""start_span"": 220, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 229, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	train
Associations of the Shank3 - mTORC1 interactome and Shank3 TG striatal transcriptome with the disease. ( A) Disease association analysis for the 94 genes in Shank3 - mTORC1 interactome.	Shank3,20,26,Gene/Protein	mTORC1,29,35,Gene/Protein	Shank3,52,58,Gene/Protein	Shank3,157,163,Gene/Protein	mTORC1,166,172,Gene/Protein	"[{""token"": ""Shank3"", ""start_span"": 20, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 29, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 157, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 166, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	train
Together, these results suggest that both Shank3 - mTORC1 interactome and striatal transcriptome of Shank3 TG mice may be associated with BD.	Shank3,42,48,Gene/Protein	mTORC1,51,57,Gene/Protein	Shank3,100,106,Gene/Protein	mice,110,114,Organism/Species	BD,138,140,Disease/Disorder	"[{""token"": ""Shank3"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Organism/Species""}, {""token"": ""BD"", ""start_span"": 138, ""end_span"": 140, ""type"": ""Disease/Disorder""}]"	train
For example, an up - regulated GPR85 ( also called SREB2 for super - conserved receptor expressed in brain) gene, encoding a highly conserved G protein - coupled receptor, has been associated with SCZ ( Matsumoto et al ., 2008; Radulescu et al ., 2013 ).	GPR85,31,36,Gene/Protein	SREB2,51,56,Gene/Protein	super - conserved receptor expressed in brain,61,106,Gene/Protein	G protein - coupled receptor,142,170,Gene/Protein	SCZ,197,200,Disease/Disorder	"[{""token"": ""GPR85"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""SREB2"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""super - conserved receptor expressed in brain"", ""start_span"": 61, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""G protein - coupled receptor"", ""start_span"": 142, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""SCZ"", ""start_span"": 197, ""end_span"": 200, ""type"": ""Disease/Disorder""}]"	train
Notably, the Gpr85 TG mice mildly overexpressing GPR85 proteins display some abnormal behaviors including impaired prepulse inhibition and decreased social interaction ( Matsumoto et al ., 2008 ), which were also seen in the Shank3 TG mice ( Han et al ., 2013b ).	Gpr85,13,18,Gene/Protein	mice,22,26,Organism/Species	GPR85,49,54,Gene/Protein	Shank3,225,231,Gene/Protein	mice,235,239,Organism/Species	"[{""token"": ""Gpr85"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Organism/Species""}, {""token"": ""GPR85"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 225, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 235, ""end_span"": 239, ""type"": ""Organism/Species""}]"	train
It has been shown that mTORC1 and mTORC2 regulate motility and metastasis of colorectal cancer cells via modulating Ras homolog gene family, member A ( RhoA) and Rac1 signaling ( Gulhati et al ., 2011 ).	mTORC1,23,29,Gene/Protein	mTORC2,34,40,Gene/Protein	colorectal cancer,77,94,Disease/Disorder	RhoA,152,156,Gene/Protein	Rac1,162,166,Gene/Protein	"[{""token"": ""mTORC1"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""mTORC2"", ""start_span"": 34, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""colorectal cancer"", ""start_span"": 77, ""end_span"": 94, ""type"": ""Disease/Disorder""}, {""token"": ""RhoA"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""Rac1"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Gene/Protein""}]"	train
The CLK2 phosphorylates and activates the regulatory subunit of protein phosphatase 2A ( PP2A) which in turn inactivates Akt, a positive regulator of mTORC1.	CLK2,4,8,Gene/Protein	protein phosphatase 2A,64,86,Gene/Protein	PP2A,89,93,Gene/Protein	Akt,121,124,Gene/Protein	mTORC1,150,156,Gene/Protein	"[{""token"": ""CLK2"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""protein phosphatase 2A"", ""start_span"": 64, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""PP2A"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""Akt"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 150, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
Interestingly, it has been shown that intracerebroventricular injection of ouabain, an inhibitor of Na / K - ATPase, increases Akt and mTORC1 activities in the frontal cortex and causes manic - like behaviors in rats ( Yu et al ., 2010; Kim S.	ouabain,75,82,Chemical/Drug	Na / K - ATPase,100,115,Gene/Protein	Akt,127,130,Gene/Protein	mTORC1,135,141,Gene/Protein	rats,212,216,Organism/Species	"[{""token"": ""ouabain"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Chemical/Drug""}, {""token"": ""Na / K - ATPase"", ""start_span"": 100, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""Akt"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 135, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""rats"", ""start_span"": 212, ""end_span"": 216, ""type"": ""Organism/Species""}]"	train
In conclusion, our results suggest a decrease in mTORC1 activity in the striatum of Shank3 TG mice that may be potentially mediated by the PPI - dependent connectivity between Shank3 and several upstream regulators of mTORC1.	mTORC1,49,55,Gene/Protein	Shank3,84,90,Gene/Protein	mice,94,98,Organism/Species	Shank3,176,182,Gene/Protein	mTORC1,218,224,Gene/Protein	"[{""token"": ""mTORC1"", ""start_span"": 49, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""Shank3"", ""start_span"": 84, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Organism/Species""}, {""token"": ""Shank3"", ""start_span"": 176, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""mTORC1"", ""start_span"": 218, ""end_span"": 224, ""type"": ""Gene/Protein""}]"	train
Despite the clear age dependency of HF, there is presently a paucity of information regarding whether alterations to the neurohormonal axis that occur in aged animals with HF develop to the same degree, or with the same time dependency, as that which occurs in young animals with HF.	HF,36,38,Disease/Disorder	animals,159,166,Organism/Species	HF,172,174,Disease/Disorder	animals,267,274,Organism/Species	HF,280,282,Disease/Disorder	"[{""token"": ""HF"", ""start_span"": 36, ""end_span"": 38, ""type"": ""Disease/Disorder""}, {""token"": ""animals"", ""start_span"": 159, ""end_span"": 166, ""type"": ""Organism/Species""}, {""token"": ""HF"", ""start_span"": 172, ""end_span"": 174, ""type"": ""Disease/Disorder""}, {""token"": ""animals"", ""start_span"": 267, ""end_span"": 274, ""type"": ""Organism/Species""}, {""token"": ""HF"", ""start_span"": 280, ""end_span"": 282, ""type"": ""Disease/Disorder""}]"	train
Parasympathetic function in aging and HF was measured using sequential sympathetic ( 0. 5 mg · kg − 1 propranolol [ PPL ]; prepared as propranolol hydrochloride in 0. 9% NaCl solution, Sigma - Aldrich, UK) and parasympathetic ( 0. 05 mg · kg − 1 atropine; prepared as atropine sulfate in 0. 9% NaCl solution; Sigma - Aldrich) blockade via intravenous bolus with an additional 0. 05 mg · kg − 1 · minute − 1 atropine infused after 1 minute to maintain complete autonomic block ( AB) for the duration of the experiment.	HF,38,40,Disease/Disorder	propranolol,102,113,Chemical/Drug	propranolol hydrochloride,135,160,Chemical/Drug	atropine,246,254,Chemical/Drug	atropine,268,276,Chemical/Drug	"[{""token"": ""HF"", ""start_span"": 38, ""end_span"": 40, ""type"": ""Disease/Disorder""}, {""token"": ""propranolol"", ""start_span"": 102, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""propranolol hydrochloride"", ""start_span"": 135, ""end_span"": 160, ""type"": ""Chemical/Drug""}, {""token"": ""atropine"", ""start_span"": 246, ""end_span"": 254, ""type"": ""Chemical/Drug""}, {""token"": ""atropine"", ""start_span"": 268, ""end_span"": 276, ""type"": ""Chemical/Drug""}]"	train
The attenuated chronotropic and inotropic responses to dobutamine in HF were also associated with a significant interaction between HF and plasma noradrenaline levels increasing ( Figure 2H; p <. 05; two - way RM - ANOVA) with a directly observed increase in the aged cohort ( aged control, 557 ± 73 pg · mL − 1; aged HF, 1973 ± 937 pg · mL − 1; p <. 05 ).	dobutamine,55,65,Chemical/Drug	HF,69,71,Disease/Disorder	HF,132,134,Disease/Disorder	noradrenaline,146,159,Chemical/Drug	HF,318,320,Disease/Disorder	"[{""token"": ""dobutamine"", ""start_span"": 55, ""end_span"": 65, ""type"": ""Chemical/Drug""}, {""token"": ""HF"", ""start_span"": 69, ""end_span"": 71, ""type"": ""Disease/Disorder""}, {""token"": ""HF"", ""start_span"": 132, ""end_span"": 134, ""type"": ""Disease/Disorder""}, {""token"": ""noradrenaline"", ""start_span"": 146, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""HF"", ""start_span"": 318, ""end_span"": 320, ""type"": ""Disease/Disorder""}]"	train
Thus HRV was less in aged HF animals than in young HF animals at baseline ( no drug infusion) and following β - adrenergic receptor antagonism ( p <. 05 ).	HF,26,28,Disease/Disorder	animals,29,36,Organism/Species	HF,51,53,Disease/Disorder	animals,54,61,Organism/Species	β - adrenergic receptor,108,131,Gene/Protein	"[{""token"": ""HF"", ""start_span"": 26, ""end_span"": 28, ""type"": ""Disease/Disorder""}, {""token"": ""animals"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Organism/Species""}, {""token"": ""HF"", ""start_span"": 51, ""end_span"": 53, ""type"": ""Disease/Disorder""}, {""token"": ""animals"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Organism/Species""}, {""token"": ""\u03b2 - adrenergic receptor"", ""start_span"": 108, ""end_span"": 131, ""type"": ""Gene/Protein""}]"	train
ERBB2 ( HER2) is a well - characterized membrane receptor in the EGFR family and a therapeutic target in invasive breast carcinoma.	ERBB2,0,5,Gene/Protein	HER2,8,12,Gene/Protein	membrane receptor,40,57,Gene/Protein	EGFR,65,69,Gene/Protein	invasive breast carcinoma,105,130,Disease/Disorder	"[{""token"": ""ERBB2"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""HER2"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""membrane receptor"", ""start_span"": 40, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""EGFR"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""invasive breast carcinoma"", ""start_span"": 105, ""end_span"": 130, ""type"": ""Disease/Disorder""}]"	train
In studies performed on human breast carcinoma, the reported prevalence of HER4 over - expression ranges from 12% to 82% in tumors and has been linked to both improved and poor clinical outcome, depending on antibody and study design [ 16 - 18 ].	human,24,29,Organism/Species	breast carcinoma,30,46,Disease/Disorder	HER4,75,79,Gene/Protein	tumors,124,130,Disease/Disorder	antibody,208,216,Gene/Protein	"[{""token"": ""human"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Organism/Species""}, {""token"": ""breast carcinoma"", ""start_span"": 30, ""end_span"": 46, ""type"": ""Disease/Disorder""}, {""token"": ""HER4"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""tumors"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Disease/Disorder""}, {""token"": ""antibody"", ""start_span"": 208, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	train
The cleavage site contributes to the unique localization and function of HER4 and likely plays a critical role in regulating HER2 positive carcinomas and the therapeutic response to HER2 over - expressing tumors [ 11, 18, 19, 24 - 28 ].	HER4,73,77,Gene/Protein	HER2,125,129,Gene/Protein	carcinomas,139,149,Disease/Disorder	HER2,182,186,Gene/Protein	tumors,205,211,Disease/Disorder	"[{""token"": ""HER4"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""HER2"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""carcinomas"", ""start_span"": 139, ""end_span"": 149, ""type"": ""Disease/Disorder""}, {""token"": ""HER2"", ""start_span"": 182, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""tumors"", ""start_span"": 205, ""end_span"": 211, ""type"": ""Disease/Disorder""}]"	train
For PFS, there was a significant difference between patients that co - over - expressed both HER2 and HER4 vs. patients that lacked HER4 over - expression ( HER2 positive / HER4 negative) ( p = 0. 03) ( Figure 6A ).	HER2,93,97,Gene/Protein	HER4,102,106,Gene/Protein	HER4,132,136,Gene/Protein	HER2,157,161,Gene/Protein	HER4,173,177,Gene/Protein	"[{""token"": ""HER2"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""HER4"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""HER4"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""HER2"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""HER4"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
Evaluation of OS in this cohort revealed a clear separation in the survival curves between patients with co - over - expression of HER2 and HER4 vs. patients that lacked HER4 over - expression ( HER2 - Pos and HER4 - Neg ); this difference did not reach statistical significance ( p = 0. 47) ( Figure 6B ).	HER2,131,135,Gene/Protein	HER4,140,144,Gene/Protein	HER4,170,174,Gene/Protein	HER2,195,199,Gene/Protein	HER4,210,214,Gene/Protein	"[{""token"": ""HER2"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""HER4"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""HER4"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""HER2"", ""start_span"": 195, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""HER4"", ""start_span"": 210, ""end_span"": 214, ""type"": ""Gene/Protein""}]"	train
We accomplished this by first, utilizing a single HER4 antibody ( E200) which was recently stringently tested and validated in breast carcinoma and second, by developing a standardized semi - quantitative H - Score system for determining HER4 expression status in breast carcinoma.	HER4,50,54,Gene/Protein	antibody,55,63,Gene/Protein	breast carcinoma,127,143,Disease/Disorder	HER4,238,242,Gene/Protein	breast carcinoma,264,280,Disease/Disorder	"[{""token"": ""HER4"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 55, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""breast carcinoma"", ""start_span"": 127, ""end_span"": 143, ""type"": ""Disease/Disorder""}, {""token"": ""HER4"", ""start_span"": 238, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""breast carcinoma"", ""start_span"": 264, ""end_span"": 280, ""type"": ""Disease/Disorder""}]"	train
RT - qPCR was carried out in triplicate using a TaqMan ® RNA - to - CT ™ 1 - Step master mixtures Kit with primers and monocolor hydrolysis probes Hs01001580_m1 ( HER2 ), Hs00955525_m1 ( HER4 ), Hs00955525_m1 ( B2M ), Hs00984230_m1 ( GAPDH ), and Hs03929097_g1 ( TFRC) ( Applied Biosystems, Foster City, CA ).	HER2,163,167,Gene/Protein	HER4,187,191,Gene/Protein	B2M,211,214,Gene/Protein	GAPDH,234,239,Gene/Protein	TFRC,263,267,Gene/Protein	"[{""token"": ""HER2"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""HER4"", ""start_span"": 187, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""B2M"", ""start_span"": 211, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""GAPDH"", ""start_span"": 234, ""end_span"": 239, ""type"": ""Gene/Protein""}, {""token"": ""TFRC"", ""start_span"": 263, ""end_span"": 267, ""type"": ""Gene/Protein""}]"	train
Smad2 and Smad3 are activated by TGF - ß proteins, while Smad1, 5 and 8 are activated by BMP ligands.	Smad2,0,5,Gene/Protein	Smad3,10,15,Gene/Protein	TGF - ß,33,40,Gene/Protein	Smad1,57,62,Gene/Protein	BMP,89,92,Gene/Protein	"[{""token"": ""Smad2"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""Smad3"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""TGF - \u00df"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""Smad1"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""BMP"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene/Protein""}]"	train
Mouse models for lung cancer associate elevated BMP2 levels with increased malignancy [ 37 ], promoted lung tumor growth [ 38] and stimulated angiogenesis in developing tumors [ 39 ].	Mouse,0,5,Organism/Species	lung cancer,17,28,Disease/Disorder	BMP2,48,52,Gene/Protein	lung tumor,103,113,Disease/Disorder	tumors,169,175,Disease/Disorder	"[{""token"": ""Mouse"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism/Species""}, {""token"": ""lung cancer"", ""start_span"": 17, ""end_span"": 28, ""type"": ""Disease/Disorder""}, {""token"": ""BMP2"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""lung tumor"", ""start_span"": 103, ""end_span"": 113, ""type"": ""Disease/Disorder""}, {""token"": ""tumors"", ""start_span"": 169, ""end_span"": 175, ""type"": ""Disease/Disorder""}]"	train
Immunofluorescent staining was performed as previously described [ 45] using anti - Smad1 antibody ( Santa Cruz, sc - 9765 ), Alexa Fluor 488 secondary antibody ( Invitrogen ), Hoechst 33258 ( Molecular probes) for DNA staining and CellMask Orange ( Invitrogen) for cell membrane staining.	Smad1,84,89,Gene/Protein	antibody,90,98,Gene/Protein	sc,113,115,Chemical/Drug	antibody,152,160,Gene/Protein	Hoechst 33258,177,190,Chemical/Drug	"[{""token"": ""Smad1"", ""start_span"": 84, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 90, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""sc"", ""start_span"": 113, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""antibody"", ""start_span"": 152, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""Hoechst 33258"", ""start_span"": 177, ""end_span"": 190, ""type"": ""Chemical/Drug""}]"	train
Progression of absolute Gaussia Luciferase activity upon sustained stimulation with TNFα. c2c12 cells were seeded out in 6 - well plates, transiently transfected with a NFkb - binding site Luciferase reporter and starved over night.	Gaussia,24,31,Organism/Species	Luciferase,32,42,Gene/Protein	TNFα,84,88,Gene/Protein	NFkb,169,173,Gene/Protein	Luciferase,189,199,Gene/Protein	"[{""token"": ""Gaussia"", ""start_span"": 24, ""end_span"": 31, ""type"": ""Organism/Species""}, {""token"": ""Luciferase"", ""start_span"": 32, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""TNF\u03b1"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""NFkb"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""Luciferase"", ""start_span"": 189, ""end_span"": 199, ""type"": ""Gene/Protein""}]"	train
The qRT - PCR anaylsis of the BMP target genes id1 and smad6 as well as the housekeeping gene ef1a followed.	BMP,30,33,Gene/Protein	id1,47,50,Gene/Protein	smad6,55,60,Gene/Protein	housekeeping gene,76,93,Gene/Protein	ef1a,94,98,Gene/Protein	"[{""token"": ""BMP"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""id1"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""smad6"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""housekeeping gene"", ""start_span"": 76, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""ef1a"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene/Protein""}]"	train
The qRT - PCR anaylsis of the BMP target genes id1 and smad6 as well as the housekeeping gene ef1a followed.	BMP,30,33,Gene/Protein	id1,47,50,Gene/Protein	smad6,55,60,Gene/Protein	housekeeping gene,76,93,Gene/Protein	ef1a,94,98,Gene/Protein	"[{""token"": ""BMP"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""id1"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""smad6"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""housekeeping gene"", ""start_span"": 76, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""ef1a"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene/Protein""}]"	train
The qRT - PCR anaylsis of the BMP target genes id1 and smad6 as well as the housekeeping gene ef1a followed.	BMP,30,33,Gene/Protein	id1,47,50,Gene/Protein	smad6,55,60,Gene/Protein	housekeeping gene,76,93,Gene/Protein	ef1a,94,98,Gene/Protein	"[{""token"": ""BMP"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""id1"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""smad6"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""housekeeping gene"", ""start_span"": 76, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""ef1a"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene/Protein""}]"	train
Recently, Mayr et al. investigated Caucasian Sengers patients from Germany, Italy, The Netherlands and Switzerland and, using whole exome sequencing, identified AGK as the disease - causing gene in Sengers syndrome [ 4 ]. AGK encodes a mitochondrial transmembrane enzyme, acylglycerol kinase, a multisubstrate lipid with a likely role in cardiolipin biosynthesis.	AGK,161,164,Gene/Protein	Sengers syndrome,198,214,Disease/Disorder	AGK,222,225,Gene/Protein	acylglycerol kinase,272,291,Gene/Protein	cardiolipin,338,349,Chemical/Drug	"[{""token"": ""AGK"", ""start_span"": 161, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""Sengers syndrome"", ""start_span"": 198, ""end_span"": 214, ""type"": ""Disease/Disorder""}, {""token"": ""AGK"", ""start_span"": 222, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""acylglycerol kinase"", ""start_span"": 272, ""end_span"": 291, ""type"": ""Gene/Protein""}, {""token"": ""cardiolipin"", ""start_span"": 338, ""end_span"": 349, ""type"": ""Chemical/Drug""}]"	train
In the last decade many studies have shown that infection with high - risk ( HR) types of human papillomavirus ( HPV) is a necessary condition for the development of invasive cervical cancer ( CC) [ 1 ].	infection,48,57,Disease/Disorder	human papillomavirus,90,110,Organism/Species	HPV,113,116,Organism/Species	cervical cancer,175,190,Disease/Disorder	CC,193,195,Disease/Disorder	"[{""token"": ""infection"", ""start_span"": 48, ""end_span"": 57, ""type"": ""Disease/Disorder""}, {""token"": ""human papillomavirus"", ""start_span"": 90, ""end_span"": 110, ""type"": ""Organism/Species""}, {""token"": ""HPV"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Organism/Species""}, {""token"": ""cervical cancer"", ""start_span"": 175, ""end_span"": 190, ""type"": ""Disease/Disorder""}, {""token"": ""CC"", ""start_span"": 193, ""end_span"": 195, ""type"": ""Disease/Disorder""}]"	train
A specific protocol for 18 – 24 year - old women was adopted: colposcopy was offered to women with HSIL ( high squamous intraepithelial lesions) and ASCH ( atypical squamous cells that cannot exclude high - grade lesions ), while women with LSIL ( low squamous intraepithelial lesions) or less severe lesions were invited to repeat pap - test two years later and colposcopy was offered only if, after two years, the diagnosis was still LSIL or it progressed to a more severe lesion.	squamous intraepithelial lesions,111,143,Disease/Disorder	lesions,213,220,Disease/Disorder	squamous intraepithelial lesions,252,284,Disease/Disorder	lesions,301,308,Disease/Disorder	lesion,475,481,Disease/Disorder	"[{""token"": ""squamous intraepithelial lesions"", ""start_span"": 111, ""end_span"": 143, ""type"": ""Disease/Disorder""}, {""token"": ""lesions"", ""start_span"": 213, ""end_span"": 220, ""type"": ""Disease/Disorder""}, {""token"": ""squamous intraepithelial lesions"", ""start_span"": 252, ""end_span"": 284, ""type"": ""Disease/Disorder""}, {""token"": ""lesions"", ""start_span"": 301, ""end_span"": 308, ""type"": ""Disease/Disorder""}, {""token"": ""lesion"", ""start_span"": 475, ""end_span"": 481, ""type"": ""Disease/Disorder""}]"	train
Table 4 shows the distribution of HPV types in single and multiple infections; the proportion of single and co - infections by genotype is also reported: the proportion of infections occurring in conjunction with other types did not significantly differ by HPV type ( Fisher ’ s exact test: p = 0. 264 ).	HPV,34,37,Organism/Species	infections,67,77,Disease/Disorder	co - infections,108,123,Disease/Disorder	infections,172,182,Disease/Disorder	HPV,257,260,Organism/Species	"[{""token"": ""HPV"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Organism/Species""}, {""token"": ""infections"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Disease/Disorder""}, {""token"": ""co - infections"", ""start_span"": 108, ""end_span"": 123, ""type"": ""Disease/Disorder""}, {""token"": ""infections"", ""start_span"": 172, ""end_span"": 182, ""type"": ""Disease/Disorder""}, {""token"": ""HPV"", ""start_span"": 257, ""end_span"": 260, ""type"": ""Organism/Species""}]"	train
In fact HPV 73 and 82 were observed only in co - infection with other HR - HPV types, suggesting that they could have been found only because coexisted with HPV types detected by HR - HC2 probes B ( for this reason we excluded HR - HC2 not targeted types from the analysis of co - infections ).	HPV,8,11,Organism/Species	co - infection,44,58,Disease/Disorder	HPV,75,78,Organism/Species	HPV,157,160,Organism/Species	co - infections,276,291,Disease/Disorder	"[{""token"": ""HPV"", ""start_span"": 8, ""end_span"": 11, ""type"": ""Organism/Species""}, {""token"": ""co - infection"", ""start_span"": 44, ""end_span"": 58, ""type"": ""Disease/Disorder""}, {""token"": ""HPV"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Organism/Species""}, {""token"": ""HPV"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Organism/Species""}, {""token"": ""co - infections"", ""start_span"": 276, ""end_span"": 291, ""type"": ""Disease/Disorder""}]"	train
The analysis of the high quality trimmed reads revealed that the gut microbiota of baboons contained sequences from 18 different bacterial divisions / phyla, and most of the sequences belonged to Actinobacteria, followed by Firmicutes ( Fig. 1, Supplementary Table 1 ). Fusobacteria were only present in the stools of Bedouins and baboons.	baboons,83,90,Organism/Species	Actinobacteria,196,210,Organism/Species	Firmicutes,224,234,Organism/Species	Fusobacteria,270,282,Organism/Species	baboons,331,338,Organism/Species	"[{""token"": ""baboons"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Organism/Species""}, {""token"": ""Actinobacteria"", ""start_span"": 196, ""end_span"": 210, ""type"": ""Organism/Species""}, {""token"": ""Firmicutes"", ""start_span"": 224, ""end_span"": 234, ""type"": ""Organism/Species""}, {""token"": ""Fusobacteria"", ""start_span"": 270, ""end_span"": 282, ""type"": ""Organism/Species""}, {""token"": ""baboons"", ""start_span"": 331, ""end_span"": 338, ""type"": ""Organism/Species""}]"	train
For humans, the bacterial taxa Shewanella and Vibrio are significantly overrepresented in enterotype 3, Bifidobacterium in enterotype 2 and Collinsella in enterotype 1.	humans,4,10,Organism/Species	Shewanella,31,41,Organism/Species	Vibrio,46,52,Organism/Species	Bifidobacterium,104,119,Organism/Species	Collinsella,140,151,Organism/Species	"[{""token"": ""humans"", ""start_span"": 4, ""end_span"": 10, ""type"": ""Organism/Species""}, {""token"": ""Shewanella"", ""start_span"": 31, ""end_span"": 41, ""type"": ""Organism/Species""}, {""token"": ""Vibrio"", ""start_span"": 46, ""end_span"": 52, ""type"": ""Organism/Species""}, {""token"": ""Bifidobacterium"", ""start_span"": 104, ""end_span"": 119, ""type"": ""Organism/Species""}, {""token"": ""Collinsella"", ""start_span"": 140, ""end_span"": 151, ""type"": ""Organism/Species""}]"	train
A relationship, such as Toll - like receptors ( TLRs ), especially TLR9 and TLR4, was demonstrated between IgAN and pathogen - recognition molecules.	Toll - like receptors,24,45,Gene/Protein	TLRs,48,52,Gene/Protein	TLR9,67,71,Gene/Protein	TLR4,76,80,Gene/Protein	IgAN,107,111,Disease/Disorder	"[{""token"": ""Toll - like receptors"", ""start_span"": 24, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""TLRs"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""TLR9"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""TLR4"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""IgAN"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Disease/Disorder""}]"	train
Donadio et al. [ 11] proposed that dietary supplementation with fish oils could benefit patients with immune - related renal diseases, including IgAN, lupus nephritis, and cyclosporine - induced nephrotoxicity.	fish,64,68,Organism/Species	immune - related renal diseases,102,133,Disease/Disorder	IgAN,145,149,Disease/Disorder	lupus nephritis,151,166,Disease/Disorder	cyclosporine,172,184,Chemical/Drug	"[{""token"": ""fish"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Organism/Species""}, {""token"": ""immune - related renal diseases"", ""start_span"": 102, ""end_span"": 133, ""type"": ""Disease/Disorder""}, {""token"": ""IgAN"", ""start_span"": 145, ""end_span"": 149, ""type"": ""Disease/Disorder""}, {""token"": ""lupus nephritis"", ""start_span"": 151, ""end_span"": 166, ""type"": ""Disease/Disorder""}, {""token"": ""cyclosporine"", ""start_span"": 172, ""end_span"": 184, ""type"": ""Chemical/Drug""}]"	train
Serum IgA, IgG, IgM, and IgA – IgG IC concentrations were measured using a sandwich enzyme - linked immunosorbent assay ( ELISA) kit ( Bethyl Laboratories ).	IgA,6,9,Gene/Protein	IgG,11,14,Gene/Protein	IgM,16,19,Gene/Protein	IgA,25,28,Gene/Protein	IgG,31,34,Gene/Protein	"[{""token"": ""IgA"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""IgM"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""IgA"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene/Protein""}]"	train
In brief, the sections were washed with phosphate - buffered saline ( PBS ), blocked with a blocking agent ( DS Pharma Biomedical, Osaka, Japan) at room temperature for 30 min, and incubated with DyLight 488 - conjugated goat anti - murine IgA ( Bethyl laboratories, Texas, USA) and Alexa 555 - conjugated goat anti - murine IgG ( Invitrogen AG, Basel, Switzerland) antibodies at room temperature for 120 min.	goat,221,225,Organism/Species	IgA,240,243,Gene/Protein	goat,306,310,Organism/Species	IgG,325,328,Gene/Protein	antibodies,366,376,Gene/Protein	"[{""token"": ""goat"", ""start_span"": 221, ""end_span"": 225, ""type"": ""Organism/Species""}, {""token"": ""IgA"", ""start_span"": 240, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""goat"", ""start_span"": 306, ""end_span"": 310, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 325, ""end_span"": 328, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 366, ""end_span"": 376, ""type"": ""Gene/Protein""}]"	train
To evaluate the viability of B cells in each Zn condition, we cultured splenic B cells with anti - CD40 antibody ( 553721; BD Pharmingen, Tokyo, Japan) and anti - IgM antibody ( 115 - 006 - 020; Jackson ImmunoResearch Laboratories, Pennsylvania, USA) and then used the Cell Counting Kit - 8 ( Dojindo Laboratories, Tokyo, Japan) to quantify the cells.	CD40,99,103,Gene/Protein	antibody,104,112,Gene/Protein	553721,115,121,Chemical/Drug	IgM,163,166,Gene/Protein	antibody,167,175,Gene/Protein	"[{""token"": ""CD40"", ""start_span"": 99, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 104, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""553721"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Chemical/Drug""}, {""token"": ""IgM"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 167, ""end_span"": 175, ""type"": ""Gene/Protein""}]"	train
However, the serum concentrations of IgG, IgA, IgM, and IgA – IgG ICs in the low and normal Zn diet groups increased during the course of the disease.	IgG,37,40,Gene/Protein	IgA,42,45,Gene/Protein	IgM,47,50,Gene/Protein	IgA,56,59,Gene/Protein	IgG,62,65,Gene/Protein	"[{""token"": ""IgG"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IgA"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""IgM"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""IgA"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene/Protein""}]"	train
Dietary zinc intervention altered the serum concentrations of IgA and IgA – IgG immune complexes but not of IgG and IgM. * p < 0. 05.	IgA,62,65,Gene/Protein	IgA,70,73,Gene/Protein	IgG,76,79,Gene/Protein	IgG,108,111,Gene/Protein	IgM,116,119,Gene/Protein	"[{""token"": ""IgA"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""IgA"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""IgM"", ""start_span"": 116, ""end_span"": 119, ""type"": ""Gene/Protein""}]"	train
Although all mice in each dietary group showed an aggravation of IgAN after nasal LPS stimulation, increased albuminuria was more pronounced in the low Zn diet group ( p < 0. 05 ), with a greater increase in serum concentrations of IgA ( p < 0. 07) and IgA – IgG ICs ( p < 0. 05; Figure 5 ).	mice,13,17,Organism/Species	IgAN,65,69,Disease/Disorder	IgA,232,235,Gene/Protein	IgA,253,256,Gene/Protein	IgG,259,262,Gene/Protein	"[{""token"": ""mice"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Organism/Species""}, {""token"": ""IgAN"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Disease/Disorder""}, {""token"": ""IgA"", ""start_span"": 232, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""IgA"", ""start_span"": 253, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 259, ""end_span"": 262, ""type"": ""Gene/Protein""}]"	train
To confirm the functional alteration of the TLR4 / TRIF pathway caused by Zn, we examined the expression of interferon - β, which is specifically induced by the activation of the TRIF - dependent pathway following TLR4 activation [ 28 ], [ 29 ].	TLR4,44,48,Gene/Protein	TRIF,51,55,Gene/Protein	interferon - β,108,122,Gene/Protein	TRIF,179,183,Gene/Protein	TLR4,214,218,Gene/Protein	"[{""token"": ""TLR4"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""TRIF"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""interferon - \u03b2"", ""start_span"": 108, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""TRIF"", ""start_span"": 179, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""TLR4"", ""start_span"": 214, ""end_span"": 218, ""type"": ""Gene/Protein""}]"	train
We previously reported that, in ddY mice under conventional conditions the serum concentrations of IgA, but not those of IgG and IgM, were significantly elevated relative to mice maintained under specific pathogen - free ( SPF) conditions [ 8 ].	mice,36,40,Organism/Species	IgA,99,102,Gene/Protein	IgG,121,124,Gene/Protein	IgM,129,132,Gene/Protein	mice,174,178,Organism/Species	"[{""token"": ""mice"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Organism/Species""}, {""token"": ""IgA"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""IgM"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 174, ""end_span"": 178, ""type"": ""Organism/Species""}]"	train
We used these methods to characterize several covalent and non - covalent inhibitors ( Fig. 1) of prolyl oligopeptidase ( POP ), a post - proline cleaving enzyme implicated in cancer and neurodegenerative disorders19, 20.	prolyl oligopeptidase,98,119,Gene/Protein	POP,122,125,Gene/Protein	post - proline cleaving enzyme,131,161,Gene/Protein	cancer,176,182,Disease/Disorder	neurodegenerative disorders19,187,216,Disease/Disorder	"[{""token"": ""prolyl oligopeptidase"", ""start_span"": 98, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""POP"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""post - proline cleaving enzyme"", ""start_span"": 131, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""cancer"", ""start_span"": 176, ""end_span"": 182, ""type"": ""Disease/Disorder""}, {""token"": ""neurodegenerative disorders19"", ""start_span"": 187, ""end_span"": 216, ""type"": ""Disease/Disorder""}]"	train
The data shows that the genes encoding for heat shock proteins ( HSPs) that function to prevent further protein denaturation and aggregation, such as HSP40, HSP70 and HSP105, exhibit maximal expression immediately after exposure to hyperthermic stress.	heat shock proteins,43,62,Gene/Protein	HSPs,65,69,Gene/Protein	HSP40,150,155,Gene/Protein	HSP70,157,162,Gene/Protein	HSP105,167,173,Gene/Protein	"[{""token"": ""heat shock proteins"", ""start_span"": 43, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""HSPs"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""HSP40"", ""start_span"": 150, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""HSP70"", ""start_span"": 157, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""HSP105"", ""start_span"": 167, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
Macropinocytosis depends on signaling to the actin cytoskeleton, such as the Rac signaling pathway, which was also affected at 0 h post - heat, with eight deregulated genes, including the Rac activator, TIAM1 ( T - lymphoma invasion and metastasis 1 ).	actin,45,50,Gene/Protein	Rac,77,80,Gene/Protein	Rac,188,191,Gene/Protein	TIAM1,203,208,Gene/Protein	T - lymphoma invasion and metastasis 1,211,249,Gene/Protein	"[{""token"": ""actin"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""Rac"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""Rac"", ""start_span"": 188, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""TIAM1"", ""start_span"": 203, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""T - lymphoma invasion and metastasis 1"", ""start_span"": 211, ""end_span"": 249, ""type"": ""Gene/Protein""}]"	train
The 0 h time - point post - heat affected pathways playing roles in the regulation of cellular development and / or in cellular growth and proliferation comprised cell cycle G1 / S checkpoint regulation, the glucocorticoid receptor, IL - 9, NF - κB, April - mediated and growth hormone signaling.	glucocorticoid receptor,208,231,Gene/Protein	IL - 9,233,239,Gene/Protein	NF - κB,241,248,Gene/Protein	April,250,255,Gene/Protein	growth hormone,271,285,Gene/Protein	"[{""token"": ""glucocorticoid receptor"", ""start_span"": 208, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""IL - 9"", ""start_span"": 233, ""end_span"": 239, ""type"": ""Gene/Protein""}, {""token"": ""NF - \u03baB"", ""start_span"": 241, ""end_span"": 248, ""type"": ""Gene/Protein""}, {""token"": ""April"", ""start_span"": 250, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""growth hormone"", ""start_span"": 271, ""end_span"": 285, ""type"": ""Gene/Protein""}]"	train
In all cases the tsetse population was partitioned into four distinct classes: teneral ( unfed) flies, SV; non - teneral ( previously fed) and uninfected flies, GV; exposed ( infected but non - infective) flies, EV; and infective flies, IV.	tsetse,17,23,Organism/Species	flies,96,101,Organism/Species	flies,154,159,Organism/Species	flies,205,210,Organism/Species	flies,230,235,Organism/Species	"[{""token"": ""tsetse"", ""start_span"": 17, ""end_span"": 23, ""type"": ""Organism/Species""}, {""token"": ""flies"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Organism/Species""}, {""token"": ""flies"", ""start_span"": 154, ""end_span"": 159, ""type"": ""Organism/Species""}, {""token"": ""flies"", ""start_span"": 205, ""end_span"": 210, ""type"": ""Organism/Species""}, {""token"": ""flies"", ""start_span"": 230, ""end_span"": 235, ""type"": ""Organism/Species""}]"	train
T - helper type 2 cells [ Th2] are recognised as an important underlying mechanism of a specific asthma phenotype that is associated with high levels of circulating IgE and atopy, and eosinophilia [ 4, 5] The presence of eosinophils in sputum samples has been known to be associated with asthma and has been used to indicate a good therapeutic response to inhaled or oral corticosteroid therapy [ 6, 7 ].	asthma,97,103,Disease/Disorder	IgE,165,168,Gene/Protein	eosinophilia,184,196,Disease/Disorder	asthma,288,294,Disease/Disorder	corticosteroid,372,386,Chemical/Drug	"[{""token"": ""asthma"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Disease/Disorder""}, {""token"": ""IgE"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""eosinophilia"", ""start_span"": 184, ""end_span"": 196, ""type"": ""Disease/Disorder""}, {""token"": ""asthma"", ""start_span"": 288, ""end_span"": 294, ""type"": ""Disease/Disorder""}, {""token"": ""corticosteroid"", ""start_span"": 372, ""end_span"": 386, ""type"": ""Chemical/Drug""}]"	train
It is therefore extremely valid and important to examine the respiratory microbiota in patients with severe asthma and determine whether the airway microbiota is altered compared to mild - moderate asthma as these differences could be important in determining both the pathophysiology and treatment of severe asthma.	microbiota,73,83,Organism/Species	asthma,108,114,Disease/Disorder	microbiota,148,158,Organism/Species	asthma,198,204,Disease/Disorder	asthma,309,315,Disease/Disorder	"[{""token"": ""microbiota"", ""start_span"": 73, ""end_span"": 83, ""type"": ""Organism/Species""}, {""token"": ""asthma"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Disease/Disorder""}, {""token"": ""microbiota"", ""start_span"": 148, ""end_span"": 158, ""type"": ""Organism/Species""}, {""token"": ""asthma"", ""start_span"": 198, ""end_span"": 204, ""type"": ""Disease/Disorder""}, {""token"": ""asthma"", ""start_span"": 309, ""end_span"": 315, ""type"": ""Disease/Disorder""}]"	train
Atopy was defined by the presence of positive skin - prick tests to at least one common aeroallergen including house dust mite, grass and tree pollen, cat dander, dog dander and Aspergillus.	house dust mite,111,126,Organism/Species	tree,138,142,Organism/Species	cat,151,154,Organism/Species	dog,163,166,Organism/Species	Aspergillus,178,189,Organism/Species	"[{""token"": ""house dust mite"", ""start_span"": 111, ""end_span"": 126, ""type"": ""Organism/Species""}, {""token"": ""tree"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Organism/Species""}, {""token"": ""cat"", ""start_span"": 151, ""end_span"": 154, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Organism/Species""}, {""token"": ""Aspergillus"", ""start_span"": 178, ""end_span"": 189, ""type"": ""Organism/Species""}]"	train
( Odds Ratio ( OR) = 0. 62; 95% confidence interval ( CI) = 0. 54 – 0. 71) and Fusobacteria ( OR = 0. 50; 95% CI = 0. 40 – 0. 63) ( Fig 1 ), whereas Proteobacteria, containing potential respiratory pathogens such as, Neisseria and Moraxella spp ., were more common in the patients with non - severe asthma compared to controls ( OR = 2. 26; 95% CI = 1. 94 – 2. 64 ).	Fusobacteria,79,91,Organism/Species	Proteobacteria,149,163,Organism/Species	Neisseria,217,226,Organism/Species	Moraxella spp,231,244,Organism/Species	asthma,299,305,Disease/Disorder	"[{""token"": ""Fusobacteria"", ""start_span"": 79, ""end_span"": 91, ""type"": ""Organism/Species""}, {""token"": ""Proteobacteria"", ""start_span"": 149, ""end_span"": 163, ""type"": ""Organism/Species""}, {""token"": ""Neisseria"", ""start_span"": 217, ""end_span"": 226, ""type"": ""Organism/Species""}, {""token"": ""Moraxella spp"", ""start_span"": 231, ""end_span"": 244, ""type"": ""Organism/Species""}, {""token"": ""asthma"", ""start_span"": 299, ""end_span"": 305, ""type"": ""Disease/Disorder""}]"	train
In the study of Marri et al [ 38 ], who also used induced sputum samples from 10 non - asthmatic and 10 adults with asthma not taking inhaled or oral corticosteroid therapy at the time of the study, a greater abundance of Proteobacteria, particularly Haemophilus, and lower abundance of Firmicutes was reported.	asthma,87,93,Disease/Disorder	corticosteroid,150,164,Chemical/Drug	Proteobacteria,222,236,Organism/Species	Haemophilus,251,262,Organism/Species	Firmicutes,287,297,Organism/Species	"[{""token"": ""asthma"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Disease/Disorder""}, {""token"": ""corticosteroid"", ""start_span"": 150, ""end_span"": 164, ""type"": ""Chemical/Drug""}, {""token"": ""Proteobacteria"", ""start_span"": 222, ""end_span"": 236, ""type"": ""Organism/Species""}, {""token"": ""Haemophilus"", ""start_span"": 251, ""end_span"": 262, ""type"": ""Organism/Species""}, {""token"": ""Firmicutes"", ""start_span"": 287, ""end_span"": 297, ""type"": ""Organism/Species""}]"	train
The increase in Proteobacteria confirmed the results of earlier studies [ 12, 13] using bronchial brushings from asthma patients who were on inhaled corticosteroid treatment, where Haemophilus was particularly seen to be increased, with the former study also reporting a decrease in Prevotella.	Proteobacteria,16,30,Organism/Species	asthma,113,119,Disease/Disorder	corticosteroid,149,163,Chemical/Drug	Haemophilus,181,192,Organism/Species	Prevotella,283,293,Organism/Species	"[{""token"": ""Proteobacteria"", ""start_span"": 16, ""end_span"": 30, ""type"": ""Organism/Species""}, {""token"": ""asthma"", ""start_span"": 113, ""end_span"": 119, ""type"": ""Disease/Disorder""}, {""token"": ""corticosteroid"", ""start_span"": 149, ""end_span"": 163, ""type"": ""Chemical/Drug""}, {""token"": ""Haemophilus"", ""start_span"": 181, ""end_span"": 192, ""type"": ""Organism/Species""}, {""token"": ""Prevotella"", ""start_span"": 283, ""end_span"": 293, ""type"": ""Organism/Species""}]"	train
The other important observation is that the gut microbiota has been reported to completely metabolise corticosteroids such as prednisolone, beclomethasone dipropionate and budesonide, but the effect of the airway microbiota in this context remains unknown [ 42 ].	microbiota,48,58,Organism/Species	corticosteroids,102,117,Chemical/Drug	prednisolone,126,138,Chemical/Drug	budesonide,172,182,Chemical/Drug	microbiota,213,223,Organism/Species	"[{""token"": ""microbiota"", ""start_span"": 48, ""end_span"": 58, ""type"": ""Organism/Species""}, {""token"": ""corticosteroids"", ""start_span"": 102, ""end_span"": 117, ""type"": ""Chemical/Drug""}, {""token"": ""prednisolone"", ""start_span"": 126, ""end_span"": 138, ""type"": ""Chemical/Drug""}, {""token"": ""budesonide"", ""start_span"": 172, ""end_span"": 182, ""type"": ""Chemical/Drug""}, {""token"": ""microbiota"", ""start_span"": 213, ""end_span"": 223, ""type"": ""Organism/Species""}]"	train
Since our patients with severe asthma may be classified as being corticosteroid - insensitive as demonstrated by studies on peripheral blood mononuclear cells or alveolar macrophages [ 43, 44 ], the recent study by Goleva and colleagues on bronchoalveolar lavage microbiota of patients defined as corticosteroid - resistant and corticosteroid insensitive is of interest [ 23 ].	asthma,31,37,Disease/Disorder	corticosteroid,65,79,Chemical/Drug	microbiota,263,273,Organism/Species	corticosteroid,297,311,Chemical/Drug	corticosteroid,328,342,Chemical/Drug	"[{""token"": ""asthma"", ""start_span"": 31, ""end_span"": 37, ""type"": ""Disease/Disorder""}, {""token"": ""corticosteroid"", ""start_span"": 65, ""end_span"": 79, ""type"": ""Chemical/Drug""}, {""token"": ""microbiota"", ""start_span"": 263, ""end_span"": 273, ""type"": ""Organism/Species""}, {""token"": ""corticosteroid"", ""start_span"": 297, ""end_span"": 311, ""type"": ""Chemical/Drug""}, {""token"": ""corticosteroid"", ""start_span"": 328, ""end_span"": 342, ""type"": ""Chemical/Drug""}]"	train
In summary, we have shown that in severe asthma, there is a distinct alteration of the sputum microbiota with a greater prominence of Firmicutes ( including 2 Streptococcal OTUs, and a lower prominence of Bacteroidetes, particularly Prevotella spp.	asthma,41,47,Disease/Disorder	microbiota,94,104,Organism/Species	Firmicutes,134,144,Organism/Species	Bacteroidetes,205,218,Organism/Species	Prevotella spp,233,247,Organism/Species	"[{""token"": ""asthma"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Disease/Disorder""}, {""token"": ""microbiota"", ""start_span"": 94, ""end_span"": 104, ""type"": ""Organism/Species""}, {""token"": ""Firmicutes"", ""start_span"": 134, ""end_span"": 144, ""type"": ""Organism/Species""}, {""token"": ""Bacteroidetes"", ""start_span"": 205, ""end_span"": 218, ""type"": ""Organism/Species""}, {""token"": ""Prevotella spp"", ""start_span"": 233, ""end_span"": 247, ""type"": ""Organism/Species""}]"	train
It is worth noting, however, that of the 8 taxa that had high susceptibility to bleaching in June / July, five showed decreases in relative abundance after bleaching ( Pachyseris, Fungia, Pectinia, Hydnophora and Montipora) ( Supplementary Table S1 online ).	Pachyseris,168,178,Organism/Species	Fungia,180,186,Organism/Species	Pectinia,188,196,Organism/Species	Hydnophora,198,208,Organism/Species	Montipora,213,222,Organism/Species	"[{""token"": ""Pachyseris"", ""start_span"": 168, ""end_span"": 178, ""type"": ""Organism/Species""}, {""token"": ""Fungia"", ""start_span"": 180, ""end_span"": 186, ""type"": ""Organism/Species""}, {""token"": ""Pectinia"", ""start_span"": 188, ""end_span"": 196, ""type"": ""Organism/Species""}, {""token"": ""Hydnophora"", ""start_span"": 198, ""end_span"": 208, ""type"": ""Organism/Species""}, {""token"": ""Montipora"", ""start_span"": 213, ""end_span"": 222, ""type"": ""Organism/Species""}]"	train
An investigation of coral symbiont diversity using internal transcribed spacer region 2 ( ITS2) tag pyrosequencing ( Supplementary Table S3 online) from two coral species revealed that whilst sequences related to Symbiodinium clades C and D were both found, clade D predominated in the tissues of both Pocillopora damicornis and Platygyra sinensis.	coral,20,25,Organism/Species	coral,157,162,Organism/Species	Symbiodinium clades C,213,234,Organism/Species	Pocillopora damicornis,302,324,Organism/Species	Platygyra sinensis,329,347,Organism/Species	"[{""token"": ""coral"", ""start_span"": 20, ""end_span"": 25, ""type"": ""Organism/Species""}, {""token"": ""coral"", ""start_span"": 157, ""end_span"": 162, ""type"": ""Organism/Species""}, {""token"": ""Symbiodinium clades C"", ""start_span"": 213, ""end_span"": 234, ""type"": ""Organism/Species""}, {""token"": ""Pocillopora damicornis"", ""start_span"": 302, ""end_span"": 324, ""type"": ""Organism/Species""}, {""token"": ""Platygyra sinensis"", ""start_span"": 329, ""end_span"": 347, ""type"": ""Organism/Species""}]"	train
Opportunistic sampling of corals carried out in 2012 from reef sites in Singapore allowed us to assess the dominant clades of Symbiodinium found in two species of coral: Platygyra sinensis and Pocillopora damicornis.	corals,26,32,Organism/Species	Symbiodinium,126,138,Organism/Species	coral,163,168,Organism/Species	Platygyra sinensis,170,188,Organism/Species	Pocillopora damicornis,193,215,Organism/Species	"[{""token"": ""corals"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Organism/Species""}, {""token"": ""Symbiodinium"", ""start_span"": 126, ""end_span"": 138, ""type"": ""Organism/Species""}, {""token"": ""coral"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Organism/Species""}, {""token"": ""Platygyra sinensis"", ""start_span"": 170, ""end_span"": 188, ""type"": ""Organism/Species""}, {""token"": ""Pocillopora damicornis"", ""start_span"": 193, ""end_span"": 215, ""type"": ""Organism/Species""}]"	train
The reliability of the data recorded by this system was previously tested on Adélie penguins, great cormorants Phalacrocorax carbo hanedae and more recently on Cape gannets Morus bassanus.	Adélie penguins,77,92,Organism/Species	great cormorants,94,110,Organism/Species	Phalacrocorax carbo hanedae,111,138,Organism/Species	Cape gannets,160,172,Organism/Species	Morus bassanus,173,187,Organism/Species	"[{""token"": ""Ad\u00e9lie penguins"", ""start_span"": 77, ""end_span"": 92, ""type"": ""Organism/Species""}, {""token"": ""great cormorants"", ""start_span"": 94, ""end_span"": 110, ""type"": ""Organism/Species""}, {""token"": ""Phalacrocorax carbo hanedae"", ""start_span"": 111, ""end_span"": 138, ""type"": ""Organism/Species""}, {""token"": ""Cape gannets"", ""start_span"": 160, ""end_span"": 172, ""type"": ""Organism/Species""}, {""token"": ""Morus bassanus"", ""start_span"": 173, ""end_span"": 187, ""type"": ""Organism/Species""}]"	train
Morita et al. indicated that the true digestibility of rice protein extracted by alkaline treatment was higher than that treated by α - amylase, and showed that rice protein isolates produced by the two different methods ( alkaline treatment and α - amylase degradation) could lower serum cholesterol concentration in Sprague - Dawley rats compared with casein [ 5 ].	α - amylase,132,143,Gene/Protein	α - amylase,246,257,Gene/Protein	cholesterol,289,300,Chemical/Drug	Sprague - Dawley rats,318,339,Organism/Species	casein,354,360,Gene/Protein	"[{""token"": ""\u03b1 - amylase"", ""start_span"": 132, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""\u03b1 - amylase"", ""start_span"": 246, ""end_span"": 257, ""type"": ""Gene/Protein""}, {""token"": ""cholesterol"", ""start_span"": 289, ""end_span"": 300, ""type"": ""Chemical/Drug""}, {""token"": ""Sprague - Dawley rats"", ""start_span"": 318, ""end_span"": 339, ""type"": ""Organism/Species""}, {""token"": ""casein"", ""start_span"": 354, ""end_span"": 360, ""type"": ""Gene/Protein""}]"	train
The lipid fraction of protein samples ( CAS, RP - A, RP - E) was removed by chloroform - methanol ( 2: 1, v / v) extraction [ 19 ], and the in vitro digestion of CAS, RP - A and RP - E with pepsin and pancreatin was performed according to previous study [ 17 ].	CAS,40,43,Gene/Protein	chloroform,76,86,Chemical/Drug	CAS,162,165,Gene/Protein	pepsin,190,196,Gene/Protein	pancreatin,201,211,Gene/Protein	"[{""token"": ""CAS"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""chloroform"", ""start_span"": 76, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""CAS"", ""start_span"": 162, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""pepsin"", ""start_span"": 190, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""pancreatin"", ""start_span"": 201, ""end_span"": 211, ""type"": ""Gene/Protein""}]"	train
Cholesterol esterification ratio was described as: cholesterol esterification ratio (%) = ( total cholesterol − free cholesterol) × 100 / total cholesterol.	Cholesterol,0,11,Chemical/Drug	cholesterol,51,62,Chemical/Drug	cholesterol,98,109,Chemical/Drug	cholesterol,117,128,Chemical/Drug	cholesterol,144,155,Chemical/Drug	"[{""token"": ""Cholesterol"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 98, ""end_span"": 109, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 117, ""end_span"": 128, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 144, ""end_span"": 155, ""type"": ""Chemical/Drug""}]"	train
Glutamate is essential for excitatory synaptic transmission mediated by ionotropic glutamate receptors, which include NMDA receptors and non - NMDA receptors, α - amino - 3 - hydroxy - 5 - methyl - 4 - isoxazolepropionic acid ( AMPA) and kainate receptors [ 3 ].	Glutamate,0,9,Chemical/Drug	ionotropic glutamate receptors,72,102,Gene/Protein	NMDA receptors,118,132,Gene/Protein	NMDA receptors,143,157,Gene/Protein	kainate receptors,238,255,Gene/Protein	"[{""token"": ""Glutamate"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""ionotropic glutamate receptors"", ""start_span"": 72, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""NMDA receptors"", ""start_span"": 118, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""NMDA receptors"", ""start_span"": 143, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""kainate receptors"", ""start_span"": 238, ""end_span"": 255, ""type"": ""Gene/Protein""}]"	train
Two ataxic ( male and female) mice appeared spontaneously in the same litter from a mating pair of hetero mice with the knockout ( KO) allele for Salt - Inducible Kinase 3 ( Sik3: Sik3tm1Htake /+) [ 19] on a C57BL / 6J ( B6) genetic background.	mice,30,34,Organism/Species	mice,106,110,Organism/Species	Salt - Inducible Kinase 3,146,171,Gene/Protein	Sik3,174,178,Gene/Protein	Sik3tm1Htake,180,192,Gene/Protein	"[{""token"": ""mice"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Organism/Species""}, {""token"": ""Salt - Inducible Kinase 3"", ""start_span"": 146, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""Sik3"", ""start_span"": 174, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""Sik3tm1Htake"", ""start_span"": 180, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
Whereas, memantine ( 10 mg / kg ), an NMDA and 5HT3 receptor antagonist which is also reported to exert agonistic actions for the dopamine D2 receptor [ 21, 22 ], impaired balance in the mutant mice, but not normal mice ( Figure 1B and Supplementary Movie 1 ).	memantine,9,18,Chemical/Drug	5HT3 receptor,47,60,Gene/Protein	dopamine D2 receptor,130,150,Gene/Protein	mice,194,198,Organism/Species	mice,215,219,Organism/Species	"[{""token"": ""memantine"", ""start_span"": 9, ""end_span"": 18, ""type"": ""Chemical/Drug""}, {""token"": ""5HT3 receptor"", ""start_span"": 47, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""dopamine D2 receptor"", ""start_span"": 130, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 194, ""end_span"": 198, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 215, ""end_span"": 219, ""type"": ""Organism/Species""}]"	train
( R )- CPP also produced balance disturbances only in the mutant mice ( Supplementary Movie 2 ), whereas ifenprodil, Ro25 - 6981, or the AMPA receptor antagonist DNQX did not produce balance disturbances in the mutant or normal mice.	mice,65,69,Organism/Species	ifenprodil,105,115,Chemical/Drug	Ro25 - 6981,117,128,Chemical/Drug	AMPA receptor,137,150,Gene/Protein	mice,228,232,Organism/Species	"[{""token"": ""mice"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Organism/Species""}, {""token"": ""ifenprodil"", ""start_span"": 105, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""Ro25 - 6981"", ""start_span"": 117, ""end_span"": 128, ""type"": ""Chemical/Drug""}, {""token"": ""AMPA receptor"", ""start_span"": 137, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 228, ""end_span"": 232, ""type"": ""Organism/Species""}]"	train
Because serotonin reuptake inhibitors are used to treat vertigo [ 23 ], and the 5HT3 antagonist ondansetron causes headache and dizziness [ 24 ], we examined whether ondansetron affected the mutant mice.	serotonin,8,17,Chemical/Drug	vertigo,56,63,Disease/Disorder	ondansetron,96,107,Chemical/Drug	ondansetron,166,177,Chemical/Drug	mice,198,202,Organism/Species	"[{""token"": ""serotonin"", ""start_span"": 8, ""end_span"": 17, ""type"": ""Chemical/Drug""}, {""token"": ""vertigo"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Disease/Disorder""}, {""token"": ""ondansetron"", ""start_span"": 96, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""ondansetron"", ""start_span"": 166, ""end_span"": 177, ""type"": ""Chemical/Drug""}, {""token"": ""mice"", ""start_span"": 198, ""end_span"": 202, ""type"": ""Organism/Species""}]"	train
Moreover, in the Grid2Htake / Htake mice, co - treatment with AMPA and a low dose of memantine ( 5 mg / kg) caused more evident balance impairment than memantine treatment alone ( Supplementary Figure S3 ), suggesting that GRID2 deficiency may augment the synergistic action of AMPA and memantine.	mice,36,40,Organism/Species	memantine,85,94,Chemical/Drug	memantine,152,161,Chemical/Drug	GRID2,223,228,Gene/Protein	memantine,287,296,Chemical/Drug	"[{""token"": ""mice"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Organism/Species""}, {""token"": ""memantine"", ""start_span"": 85, ""end_span"": 94, ""type"": ""Chemical/Drug""}, {""token"": ""memantine"", ""start_span"": 152, ""end_span"": 161, ""type"": ""Chemical/Drug""}, {""token"": ""GRID2"", ""start_span"": 223, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""memantine"", ""start_span"": 287, ""end_span"": 296, ""type"": ""Chemical/Drug""}]"	train
Here, we report cross - talk between GRID2 signaling and memantine in mice, which may, in part, account for the adverse effects of memantine in patients with individual differences in congenital or acquired genetic factors, such as GRID2.	GRID2,37,42,Gene/Protein	memantine,57,66,Chemical/Drug	mice,70,74,Organism/Species	memantine,131,140,Chemical/Drug	GRID2,232,237,Gene/Protein	"[{""token"": ""GRID2"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""memantine"", ""start_span"": 57, ""end_span"": 66, ""type"": ""Chemical/Drug""}, {""token"": ""mice"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Organism/Species""}, {""token"": ""memantine"", ""start_span"": 131, ""end_span"": 140, ""type"": ""Chemical/Drug""}, {""token"": ""GRID2"", ""start_span"": 232, ""end_span"": 237, ""type"": ""Gene/Protein""}]"	train
GRID2 is located on the postsynaptic membrane of Purkinje cells and binds to cerebellin precursor protein 1 ( CBLN1) and neurexin 1 beta ( NRXN1b) [ 7, 8] on the parallel fibers of granule cells [ 7, 37 ].	GRID2,0,5,Gene/Protein	cerebellin precursor protein 1,77,107,Gene/Protein	CBLN1,110,115,Gene/Protein	neurexin 1 beta,121,136,Gene/Protein	NRXN1b,139,145,Gene/Protein	"[{""token"": ""GRID2"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""cerebellin precursor protein 1"", ""start_span"": 77, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""CBLN1"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""neurexin 1 beta"", ""start_span"": 121, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""NRXN1b"", ""start_span"": 139, ""end_span"": 145, ""type"": ""Gene/Protein""}]"	train
However, double - KO mice with disrupted Nr2A and Nr2C genes ( encoding two major NMDA receptor subunits in the adult mice cerebellum) demonstrate a mild impairment in motor coordination, but they do not exhibit an ataxic phenotype [ 43 ].	mice,21,25,Organism/Species	Nr2A,41,45,Gene/Protein	Nr2C,50,54,Gene/Protein	NMDA receptor,82,95,Gene/Protein	mice,118,122,Organism/Species	"[{""token"": ""mice"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Organism/Species""}, {""token"": ""Nr2A"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""Nr2C"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""NMDA receptor"", ""start_span"": 82, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Organism/Species""}]"	train
To map the end points of the Grid2 deletion, we used following primers: mGrid2 intron 2H F 5 '- GCT ACT TTG GTA CAA GTG GAC A and mGrid2 intron 2H R 5 '- GAC AAG TTG CTC TCT GTA TCT; mGrid2 Intron 2I F 5 '- CAT GCT CAC ATC AAA ATA CAT CAA and mGrid2 Intron 2I R 5 '- TGT AAT TGA GGAA AAT ACA TAA T.	Grid2,29,34,Gene/Protein	mGrid2,72,78,Gene/Protein	mGrid2,130,136,Gene/Protein	mGrid2,183,189,Gene/Protein	mGrid2,243,249,Gene/Protein	"[{""token"": ""Grid2"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""mGrid2"", ""start_span"": 72, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""mGrid2"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""mGrid2"", ""start_span"": 183, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""mGrid2"", ""start_span"": 243, ""end_span"": 249, ""type"": ""Gene/Protein""}]"	train
To identify the Grid2 deletion in Grid2Htake / Htake mice, we used the following primers for PCR amplification: mGrid2 Intron 2HIF 5 '- TGG ATC CTT CTA CGT GCA AC, mGrid2 Intron 8YF2 5 '- GGA CCA CAC TGA GGT TCG AAA GA, and mGrid2 Intron 8YR 5 '- ATC TCT TGG CAT GCA TTA GAC.	Grid2,16,21,Gene/Protein	mice,53,57,Organism/Species	mGrid2,112,118,Gene/Protein	mGrid2,164,170,Gene/Protein	mGrid2,224,230,Gene/Protein	"[{""token"": ""Grid2"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Organism/Species""}, {""token"": ""mGrid2"", ""start_span"": 112, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""mGrid2"", ""start_span"": 164, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""mGrid2"", ""start_span"": 224, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
Specifically, a gene expression analysis of HCC identified YAP as an important “ driver oncogene ” [ 26 ], and the Hippo pathway is a highly conserved protein kinase chain that plays a pivotal role in restricting tumor cell proliferation and promoting apoptosis.	HCC,44,47,Disease/Disorder	YAP,59,62,Gene/Protein	Hippo,115,120,Gene/Protein	kinase,159,165,Gene/Protein	tumor,213,218,Disease/Disorder	"[{""token"": ""HCC"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Disease/Disorder""}, {""token"": ""YAP"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""Hippo"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""kinase"", ""start_span"": 159, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 213, ""end_span"": 218, ""type"": ""Disease/Disorder""}]"	train
Moreover, ISH, IHC, and hematoxylin - eosin ( HE) staining were performed on paraffin - embedded samples of xenograft tumors formed by cells overexpressing EGFP - LV - uc. 134 or EGFP - LV - shRNA and the negative control cells.	hematoxylin,24,35,Chemical/Drug	eosin,38,43,Chemical/Drug	tumors,118,124,Disease/Disorder	EGFP,156,160,Gene/Protein	EGFP,179,183,Gene/Protein	"[{""token"": ""hematoxylin"", ""start_span"": 24, ""end_span"": 35, ""type"": ""Chemical/Drug""}, {""token"": ""eosin"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Chemical/Drug""}, {""token"": ""tumors"", ""start_span"": 118, ""end_span"": 124, ""type"": ""Disease/Disorder""}, {""token"": ""EGFP"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""EGFP"", ""start_span"": 179, ""end_span"": 183, ""type"": ""Gene/Protein""}]"	train
Previous studies have shown that inflammation - induced Jak - STAT3 signaling triggers the ubiquitination of DICER1 in cytoplasm by CUL4A to promote the development of colon cancer [ 33 ].	Jak,56,59,Gene/Protein	STAT3,62,67,Gene/Protein	DICER1,109,115,Gene/Protein	CUL4A,132,137,Gene/Protein	colon cancer,168,180,Disease/Disorder	"[{""token"": ""Jak"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""STAT3"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""DICER1"", ""start_span"": 109, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""CUL4A"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""colon cancer"", ""start_span"": 168, ""end_span"": 180, ""type"": ""Disease/Disorder""}]"	train
Notably, Western blotting showed that the overexpression of CUL4A inhibited the uc. 134 - mediated increases in LATS1 and YAPS127 phosphorylation, whereas the knockdown of CUL4A reversed the si - uc. 134 - mediated repression of LATS1 and inactivation of Hippo kinase signaling ( Fig. 5a, Additional file 5: Figure S4C ).	CUL4A,60,65,Gene/Protein	LATS1,112,117,Gene/Protein	CUL4A,172,177,Gene/Protein	LATS1,229,234,Gene/Protein	Hippo kinase,255,267,Gene/Protein	"[{""token"": ""CUL4A"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""LATS1"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""CUL4A"", ""start_span"": 172, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""LATS1"", ""start_span"": 229, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""Hippo kinase"", ""start_span"": 255, ""end_span"": 267, ""type"": ""Gene/Protein""}]"	train
Moreover, the serine / threonine kinase LATS1 is a core kinase of Hippo kinase signaling pathway and plays important roles in tumor proliferation, apoptosis, and stem cell differentiation.	serine / threonine kinase,14,39,Gene/Protein	LATS1,40,45,Gene/Protein	kinase,56,62,Gene/Protein	Hippo kinase,66,78,Gene/Protein	tumor,126,131,Disease/Disorder	"[{""token"": ""serine / threonine kinase"", ""start_span"": 14, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""LATS1"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""kinase"", ""start_span"": 56, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""Hippo kinase"", ""start_span"": 66, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Disease/Disorder""}]"	train
OSAS: obstructive sleep apnea syndrome; COPD: chronic obstructive pulmonary disease; GOLD: Global Initiative for Chronic Obstructive Lung Disease; AHI: apnea - hypopnea index; SpO2: blood oxygen saturation; RP: respiratory polygraphy; PSG: polysomnography; RPLAB: in - hospital respiratory polygraphy; RPHOME: respiratory polygraphy at home; ODI4: oxygen desaturation index of 4 %; MLPOX - LAB: multilayer perceptron artificial neural network trained with oximetric recordings from portable oximetry in the hospital; MLPOX - HOME: multilayer perceptron artificial neural network trained with oximetric recordings from portable oximetry at home.	OSAS,0,4,Disease/Disorder	obstructive sleep apnea syndrome,6,38,Disease/Disorder	COPD,40,44,Disease/Disorder	chronic obstructive pulmonary disease,46,83,Disease/Disorder	Chronic Obstructive Lung Disease,113,145,Disease/Disorder	"[{""token"": ""OSAS"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Disease/Disorder""}, {""token"": ""obstructive sleep apnea syndrome"", ""start_span"": 6, ""end_span"": 38, ""type"": ""Disease/Disorder""}, {""token"": ""COPD"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Disease/Disorder""}, {""token"": ""chronic obstructive pulmonary disease"", ""start_span"": 46, ""end_span"": 83, ""type"": ""Disease/Disorder""}, {""token"": ""Chronic Obstructive Lung Disease"", ""start_span"": 113, ""end_span"": 145, ""type"": ""Disease/Disorder""}]"	train
Mikocka - Walus et al. [ 40] compared psychological problems such as anxiety and depression and impairment of quality of life in IBD, IBS and Hepatitis C, and general population.	anxiety,69,76,Disease/Disorder	depression,81,91,Disease/Disorder	IBD,129,132,Disease/Disorder	IBS,134,137,Disease/Disorder	Hepatitis C,142,153,Disease/Disorder	"[{""token"": ""anxiety"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Disease/Disorder""}, {""token"": ""depression"", ""start_span"": 81, ""end_span"": 91, ""type"": ""Disease/Disorder""}, {""token"": ""IBD"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Disease/Disorder""}, {""token"": ""IBS"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Disease/Disorder""}, {""token"": ""Hepatitis C"", ""start_span"": 142, ""end_span"": 153, ""type"": ""Disease/Disorder""}]"	train
NLRs are recognized by the presence of three specific domains; an effector domain at the N - terminus that is involved in protein: protein interactions, a central NACHT ( or nucleotide binding oligomerization / NOD) domain and a C - terminal leucine - rich repeat ( LRR) domain.	NLRs,0,4,Gene/Protein	NACHT,163,168,Gene/Protein	nucleotide,174,184,Chemical/Drug	NOD,211,214,Gene/Protein	leucine,242,249,Chemical/Drug	"[{""token"": ""NLRs"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""NACHT"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""nucleotide"", ""start_span"": 174, ""end_span"": 184, ""type"": ""Chemical/Drug""}, {""token"": ""NOD"", ""start_span"": 211, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""leucine"", ""start_span"": 242, ""end_span"": 249, ""type"": ""Chemical/Drug""}]"	train
These two molecular pathways are fundamental to a molecular platform known as the inflammasome [ 7 ], which coordinates the production and processing of important inflammatory cytokines such as interleukin ( IL )- 1, IL - 18 and IL - 33 in mammals.	inflammatory cytokines,163,185,Gene/Protein	interleukin ( IL )- 1,194,215,Gene/Protein	IL - 18,217,224,Gene/Protein	IL - 33,229,236,Gene/Protein	mammals,240,247,Organism/Species	"[{""token"": ""inflammatory cytokines"", ""start_span"": 163, ""end_span"": 185, ""type"": ""Gene/Protein""}, {""token"": ""interleukin ( IL )- 1"", ""start_span"": 194, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""IL - 18"", ""start_span"": 217, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""IL - 33"", ""start_span"": 229, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""mammals"", ""start_span"": 240, ""end_span"": 247, ""type"": ""Organism/Species""}]"	train
NOD1 recognizes a molecule known as meso - DAP ( γ - D - glutamyl - meso - diaminopimelic acid ), which is a peptidoglycan ( PGN) component found in Gram - negative and Gram - positive bacteria [ 13 ], while NOD2 recognizes muramyl dipeptide, a peptidoglycan component found only in Gram - positive bacteria [ 14 ].	NOD1,0,4,Gene/Protein	Gram - positive bacteria,169,193,Organism/Species	NOD2,208,212,Gene/Protein	muramyl dipeptide,224,241,Chemical/Drug	Gram - positive bacteria,283,307,Organism/Species	"[{""token"": ""NOD1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""Gram - positive bacteria"", ""start_span"": 169, ""end_span"": 193, ""type"": ""Organism/Species""}, {""token"": ""NOD2"", ""start_span"": 208, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""muramyl dipeptide"", ""start_span"": 224, ""end_span"": 241, ""type"": ""Chemical/Drug""}, {""token"": ""Gram - positive bacteria"", ""start_span"": 283, ""end_span"": 307, ""type"": ""Organism/Species""}]"	train
In a distinct pathway, monosodium urate and calcium pyrophosphate dihydrate crystals have been shown to increase caspase - 1 activity in a NALP3 - dependent ( TLR - independent) manner [ 1 ], representing potential ' danger signal ' ligands for NALP3 [ 5] and defining a further role for NLRs in recognizing cellular stress.	caspase - 1,113,124,Gene/Protein	NALP3,139,144,Gene/Protein	TLR,159,162,Gene/Protein	NALP3,245,250,Gene/Protein	NLRs,288,292,Gene/Protein	"[{""token"": ""caspase - 1"", ""start_span"": 113, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""NALP3"", ""start_span"": 139, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""TLR"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""NALP3"", ""start_span"": 245, ""end_span"": 250, ""type"": ""Gene/Protein""}, {""token"": ""NLRs"", ""start_span"": 288, ""end_span"": 292, ""type"": ""Gene/Protein""}]"	train
Extending the knowledge of NLRs in ectotherms, this study reports an extensive overview of the NLR family in teleost fish, represented using information derived from the zebrafish Danio rerio.	NLRs,27,31,Gene/Protein	NLR,95,98,Gene/Protein	teleost fish,109,121,Organism/Species	zebrafish,170,179,Organism/Species	Danio rerio,180,191,Organism/Species	"[{""token"": ""NLRs"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""NLR"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""teleost fish"", ""start_span"": 109, ""end_span"": 121, ""type"": ""Organism/Species""}, {""token"": ""zebrafish"", ""start_span"": 170, ""end_span"": 179, ""type"": ""Organism/Species""}, {""token"": ""Danio rerio"", ""start_span"": 180, ""end_span"": 191, ""type"": ""Organism/Species""}]"	train
In the zebrafish genome, three distinct subfamilies were identified and highly supported by bootstrap analysis; some resembled mammalian NODs ( designated subfamily A; Table 2; Fig 1C ), some resembled mammalian NALPs ( designated subfamily B; Table 3; Fig 1B) and some formed a unique clade, closely related to NOD3, which was restricted to teleostei ( designated subfamily C; Table 4; Fig 1A ).	zebrafish,7,16,Organism/Species	NODs,137,141,Gene/Protein	NALPs,212,217,Gene/Protein	NOD3,312,316,Gene/Protein	teleostei,342,351,Organism/Species	"[{""token"": ""zebrafish"", ""start_span"": 7, ""end_span"": 16, ""type"": ""Organism/Species""}, {""token"": ""NODs"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""NALPs"", ""start_span"": 212, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""NOD3"", ""start_span"": 312, ""end_span"": 316, ""type"": ""Gene/Protein""}, {""token"": ""teleostei"", ""start_span"": 342, ""end_span"": 351, ""type"": ""Organism/Species""}]"	train
The N - terminal domains for NLR - A4 and NLR - A5, as with NLR - A3, were not identified within the CDD database set, but share some conserved features with the corresponding regions of mammalian NOD4 and NOD5.	NLR - A4,29,37,Gene/Protein	NLR - A5,42,50,Gene/Protein	NLR - A3,60,68,Gene/Protein	NOD4,197,201,Gene/Protein	NOD5,206,210,Gene/Protein	"[{""token"": ""NLR - A4"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""NLR - A5"", ""start_span"": 42, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""NLR - A3"", ""start_span"": 60, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""NOD4"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""NOD5"", ""start_span"": 206, ""end_span"": 210, ""type"": ""Gene/Protein""}]"	train
Several NALP - like sequences were also identified for Xenopus tropicalis ( Table 5) that similarly formed their own cluster distinct from the human and zebrafish NALPs ( Fig 1B ).	NALP - like,8,19,Gene/Protein	Xenopus tropicalis,55,73,Organism/Species	human,143,148,Organism/Species	zebrafish,153,162,Organism/Species	NALPs,163,168,Gene/Protein	"[{""token"": ""NALP - like"", ""start_span"": 8, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""Xenopus tropicalis"", ""start_span"": 55, ""end_span"": 73, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 143, ""end_span"": 148, ""type"": ""Organism/Species""}, {""token"": ""zebrafish"", ""start_span"": 153, ""end_span"": 162, ""type"": ""Organism/Species""}, {""token"": ""NALPs"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
Although the NACHT domains of the C - group NLRs are clearly homologous to NOD3, many of these genes were found to encode a conserved PYRIN domain at the N - terminus ( Figs 2, 3) showing some analogy to mammalian NALP genes.	NACHT,13,18,Gene/Protein	NLRs,44,48,Gene/Protein	NOD3,75,79,Gene/Protein	PYRIN,134,139,Gene/Protein	NALP,214,218,Gene/Protein	"[{""token"": ""NACHT"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""NLRs"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""NOD3"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""PYRIN"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""NALP"", ""start_span"": 214, ""end_span"": 218, ""type"": ""Gene/Protein""}]"	train
Further overlapping ESTs / TCs identified in the TIGR database provided additional confirmation for the NLR C - group, with an effector ( PYRIN or other) domain, NACHT domain, LRR domain and a C - terminal B30. 2 domain ( Fig 5) [ see Additional file 3] although, due to the high number of closely related sequences for this subfamily and the current stage of the zebrafish genome sequence, it was not possible to ascertain whether the overlapping ESTs were generated from the same gene or distinct genes within the NLR - C family.	NLR C,104,109,Gene/Protein	PYRIN,138,143,Gene/Protein	NACHT,162,167,Gene/Protein	zebrafish,364,373,Organism/Species	NLR - C,516,523,Gene/Protein	"[{""token"": ""NLR C"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""PYRIN"", ""start_span"": 138, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""NACHT"", ""start_span"": 162, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""zebrafish"", ""start_span"": 364, ""end_span"": 373, ""type"": ""Organism/Species""}, {""token"": ""NLR - C"", ""start_span"": 516, ""end_span"": 523, ""type"": ""Gene/Protein""}]"	train
Although the CIITA was evident in the genomes of the pufferfishes, frog and chicken, this molecule was not readily identifiable in zebrafish Zv6.	CIITA,13,18,Gene/Protein	pufferfishes,53,65,Organism/Species	frog,67,71,Organism/Species	chicken,76,83,Organism/Species	zebrafish,131,140,Organism/Species	"[{""token"": ""CIITA"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""pufferfishes"", ""start_span"": 53, ""end_span"": 65, ""type"": ""Organism/Species""}, {""token"": ""frog"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Organism/Species""}, {""token"": ""chicken"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Organism/Species""}, {""token"": ""zebrafish"", ""start_span"": 131, ""end_span"": 140, ""type"": ""Organism/Species""}]"	train
While an increasing amount of information exists for these molecules in mammals, this gene family is poorly studied in other vertebrates with little to no information available even at the gene level for birds, amphibians and fish.	mammals,72,79,Organism/Species	vertebrates,125,136,Organism/Species	birds,204,209,Organism/Species	amphibians,211,221,Organism/Species	fish,226,230,Organism/Species	"[{""token"": ""mammals"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Organism/Species""}, {""token"": ""vertebrates"", ""start_span"": 125, ""end_span"": 136, ""type"": ""Organism/Species""}, {""token"": ""birds"", ""start_span"": 204, ""end_span"": 209, ""type"": ""Organism/Species""}, {""token"": ""amphibians"", ""start_span"": 211, ""end_span"": 221, ""type"": ""Organism/Species""}, {""token"": ""fish"", ""start_span"": 226, ""end_span"": 230, ""type"": ""Organism/Species""}]"	train
Similar to the highest expression of NLR - A2 in zebrafish intestine, human NOD2 has a more restricted expression pattern, with predominant expression in cells of myeloid origin including monocytes [ 9] and Paneth cells [ 19] that are associated with the gut, although expression of NOD2 can also be induced in epithelial cells [ 20 ].	NLR - A2,37,45,Gene/Protein	zebrafish,49,58,Organism/Species	human,70,75,Organism/Species	NOD2,76,80,Gene/Protein	NOD2,283,287,Gene/Protein	"[{""token"": ""NLR - A2"", ""start_span"": 37, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""zebrafish"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Organism/Species""}, {""token"": ""NOD2"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""NOD2"", ""start_span"": 283, ""end_span"": 287, ""type"": ""Gene/Protein""}]"	train
Both NLR - A4 and NLR - A5 genes were constitutively expressed in intestine, spleen and liver of naïve zebrafish, although there is clearly some fish to fish variation preventing their detection in some individuals under the conditions used for RT - PCR.	NLR - A4,5,13,Gene/Protein	NLR - A5,18,26,Gene/Protein	zebrafish,103,112,Organism/Species	fish,145,149,Organism/Species	fish,153,157,Organism/Species	"[{""token"": ""NLR - A4"", ""start_span"": 5, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""NLR - A5"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""zebrafish"", ""start_span"": 103, ""end_span"": 112, ""type"": ""Organism/Species""}, {""token"": ""fish"", ""start_span"": 145, ""end_span"": 149, ""type"": ""Organism/Species""}, {""token"": ""fish"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Organism/Species""}]"	train
However, chickens do possess a NALP3 ortholog ( see below) representing another potential PRR for muramyl dipeptide [ 22] and may functionally replace NOD2 in this species.	chickens,9,17,Organism/Species	NALP3,31,36,Gene/Protein	PRR,90,93,Gene/Protein	muramyl dipeptide,98,115,Chemical/Drug	NOD2,151,155,Gene/Protein	"[{""token"": ""chickens"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Organism/Species""}, {""token"": ""NALP3"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""PRR"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""muramyl dipeptide"", ""start_span"": 98, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""NOD2"", ""start_span"": 151, ""end_span"": 155, ""type"": ""Gene/Protein""}]"	train
The closest human ortholog of the amphibian and fish NALPs appears to be NALP6.	human,12,17,Organism/Species	amphibian,34,43,Organism/Species	fish,48,52,Organism/Species	NALPs,53,58,Gene/Protein	NALP6,73,78,Gene/Protein	"[{""token"": ""human"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Organism/Species""}, {""token"": ""amphibian"", ""start_span"": 34, ""end_span"": 43, ""type"": ""Organism/Species""}, {""token"": ""fish"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Organism/Species""}, {""token"": ""NALPs"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""NALP6"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Gene/Protein""}]"	train
It should be pointed out that although chicken NLRP3 has an N - terminal PYRIN domain, the N - terminal domains for the Xenopus and zebrafish NALPs were not identified.	chicken,39,46,Organism/Species	PYRIN,73,78,Gene/Protein	Xenopus,120,127,Organism/Species	zebrafish,132,141,Organism/Species	NALPs,142,147,Gene/Protein	"[{""token"": ""chicken"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Organism/Species""}, {""token"": ""PYRIN"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""Xenopus"", ""start_span"": 120, ""end_span"": 127, ""type"": ""Organism/Species""}, {""token"": ""zebrafish"", ""start_span"": 132, ""end_span"": 141, ""type"": ""Organism/Species""}, {""token"": ""NALPs"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Gene/Protein""}]"	train
No PYRIN domains are observed for the Xenopus NALP - like sequences and, other than the PY - CARD protein ( prediction ENSXETT00000004042 ), no PYRIN domains were predicted in the Xenopus genome.	PYRIN,3,8,Gene/Protein	Xenopus,38,45,Organism/Species	NALP - like,46,57,Gene/Protein	PYRIN,144,149,Gene/Protein	Xenopus,180,187,Organism/Species	"[{""token"": ""PYRIN"", ""start_span"": 3, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""Xenopus"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Organism/Species""}, {""token"": ""NALP - like"", ""start_span"": 46, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""PYRIN"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""Xenopus"", ""start_span"": 180, ""end_span"": 187, ""type"": ""Organism/Species""}]"	train
TRIM5a has been shown to inhibit retroviral activity by directly binding the capsid of the HIV retrovirus [ 25 ], and PYRIN has been shown to inhibit the activity of caspase - 1 by directly binding to the active site of this enzyme [ 24 ], both using their B30. 2 domains for these interactions.	TRIM5a,0,6,Gene/Protein	HIV,91,94,Organism/Species	retrovirus,95,105,Organism/Species	PYRIN,118,123,Gene/Protein	caspase - 1,166,177,Gene/Protein	"[{""token"": ""TRIM5a"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Organism/Species""}, {""token"": ""retrovirus"", ""start_span"": 95, ""end_span"": 105, ""type"": ""Organism/Species""}, {""token"": ""PYRIN"", ""start_span"": 118, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""caspase - 1"", ""start_span"": 166, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
The latter function would reflect gene families of cell surface receptors such as killer immunoglobulin - like receptors ( KIRs) [ 26] or novel immune - type receptors ( NITRs) [ 27] that possess many inhibitory receptors and a small number of stimulatory receptors for controlling cellular activation.	cell surface receptors,51,73,Gene/Protein	killer immunoglobulin - like receptors,82,120,Gene/Protein	KIRs,123,127,Gene/Protein	novel immune - type receptors,138,167,Gene/Protein	NITRs,170,175,Gene/Protein	"[{""token"": ""cell surface receptors"", ""start_span"": 51, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""killer immunoglobulin - like receptors"", ""start_span"": 82, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""KIRs"", ""start_span"": 123, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""novel immune - type receptors"", ""start_span"": 138, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""NITRs"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Gene/Protein""}]"	train
Partial amino acid sequences from the NACHT domain ( from regions corresponding to the GxxGxGKS motif to the FAAFY sequence signature of human NOD2) were used in the analyses as this region was clearly identified in all NLRs.	amino acid,8,18,Chemical/Drug	NACHT,38,43,Gene/Protein	human,137,142,Organism/Species	NOD2,143,147,Gene/Protein	NLRs,220,224,Gene/Protein	"[{""token"": ""amino acid"", ""start_span"": 8, ""end_span"": 18, ""type"": ""Chemical/Drug""}, {""token"": ""NACHT"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Organism/Species""}, {""token"": ""NOD2"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""NLRs"", ""start_span"": 220, ""end_span"": 224, ""type"": ""Gene/Protein""}]"	train
Further analysis of the NLR - A and NLR - B subfamilies including frog and chicken NLRs were performed using the same methods.	NLR - A,24,31,Gene/Protein	NLR - B,36,43,Gene/Protein	frog,66,70,Organism/Species	chicken,75,82,Organism/Species	NLRs,83,87,Gene/Protein	"[{""token"": ""NLR - A"", ""start_span"": 24, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""NLR - B"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""frog"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Organism/Species""}, {""token"": ""chicken"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Organism/Species""}, {""token"": ""NLRs"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}]"	train
Blood samples were pipetted into 96 - well plates, followed by the addition of biotinylated anti - rat VEGF antibody, HRP - conjugated streptavidin and TMB substrate solution.	rat,99,102,Organism/Species	VEGF,103,107,Gene/Protein	antibody,108,116,Gene/Protein	HRP,118,121,Gene/Protein	streptavidin,135,147,Gene/Protein	"[{""token"": ""rat"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Organism/Species""}, {""token"": ""VEGF"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""HRP"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""streptavidin"", ""start_span"": 135, ""end_span"": 147, ""type"": ""Gene/Protein""}]"	train
Macrophage infiltration ( CD68) and activation status ( HLA - DRIIα, CD163) were evaluated in a large cohort of human primary breast tumors ( 562 tissue microarray samples ), by immunohistochemistry and scored by automated image analysis algorithms.	CD68,26,30,Gene/Protein	HLA - DRIIα,56,67,Gene/Protein	CD163,69,74,Gene/Protein	human,112,117,Organism/Species	breast tumors,126,139,Disease/Disorder	"[{""token"": ""CD68"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""HLA - DRII\u03b1"", ""start_span"": 56, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""CD163"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Organism/Species""}, {""token"": ""breast tumors"", ""start_span"": 126, ""end_span"": 139, ""type"": ""Disease/Disorder""}]"	train
TAMs, a macrophage population recruited and educated by tumor cells, which are therefore exposed to IL - 10, TGF - β, M - CSF ( monocyte colony stimulating factor) [ 6] and other immunosuppressive stimuli [ 7 ], are more closely related to the M2 type [ 8 ].	tumor,56,61,Disease/Disorder	IL - 10,100,107,Gene/Protein	TGF - β,109,116,Gene/Protein	M - CSF,118,125,Gene/Protein	monocyte colony stimulating factor,128,162,Gene/Protein	"[{""token"": ""tumor"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Disease/Disorder""}, {""token"": ""IL - 10"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""TGF - \u03b2"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""monocyte colony stimulating factor"", ""start_span"": 128, ""end_span"": 162, ""type"": ""Gene/Protein""}]"	train
Conversely, TAMs secrete epidermal growth factor ( EGF) and activate the EGF receptor ( EGFR) on the cancer cells.	epidermal growth factor,25,48,Gene/Protein	EGF,51,54,Gene/Protein	EGF receptor,73,85,Gene/Protein	EGFR,88,92,Gene/Protein	cancer,101,107,Disease/Disorder	"[{""token"": ""epidermal growth factor"", ""start_span"": 25, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""EGF"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""EGF receptor"", ""start_span"": 73, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""EGFR"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""cancer"", ""start_span"": 101, ""end_span"": 107, ""type"": ""Disease/Disorder""}]"	train
It showed that CD68 + cells in the tumor stroma but not in the tumor nest were an independent prognostic factor for decreased cancer - specific survival, accounting for the localization of TAMs in the tumors more than their mere presence.	CD68,15,19,Gene/Protein	tumor,35,40,Disease/Disorder	tumor,63,68,Disease/Disorder	cancer,126,132,Disease/Disorder	tumors,201,207,Disease/Disorder	"[{""token"": ""CD68"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Disease/Disorder""}, {""token"": ""tumor"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Disease/Disorder""}, {""token"": ""cancer"", ""start_span"": 126, ""end_span"": 132, ""type"": ""Disease/Disorder""}, {""token"": ""tumors"", ""start_span"": 201, ""end_span"": 207, ""type"": ""Disease/Disorder""}]"	train
The macrophages treated with IL - 10 and MDA - MB231 CM secreted more IL - 8, IL - 10 and MMP - 9 than the CTR IL - 10 - treated macrophages ( Fig. 3g - k ).	IL - 10,29,36,Gene/Protein	IL - 8,70,76,Gene/Protein	IL - 10,78,85,Gene/Protein	MMP - 9,90,97,Gene/Protein	IL - 10,111,118,Gene/Protein	"[{""token"": ""IL - 10"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 70, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""MMP - 9"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene/Protein""}]"	train
MDA - MB231 CM in the IL - 4 condition increased IL - 10 secretion ( Fig. 3f ), and increased IL - 6, IL - 8 ( Fig. 3d, e) and MMP - 9 secretion ( Fig. 3j, k ).	IL - 4,22,28,Gene/Protein	IL - 10,49,56,Gene/Protein	IL - 6,94,100,Gene/Protein	IL - 8,102,108,Gene/Protein	MMP - 9,127,134,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 49, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 94, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""MMP - 9"", ""start_span"": 127, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
If compared to MDA - MB231 CM alone, IL - 4 combined with MDA - MB231 CM decreased the secretion of IL - 6, IL - 8 and MMP - 9 and increased IL - 10 secretion ( Fig. 3a - c and Fig. 3j, k ).	IL - 4,37,43,Gene/Protein	IL - 6,100,106,Gene/Protein	IL - 8,108,114,Gene/Protein	MMP - 9,119,126,Gene/Protein	IL - 10,141,148,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""MMP - 9"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 141, ""end_span"": 148, ""type"": ""Gene/Protein""}]"	train
Additionally, TAMs secrete EGF, TNF - α, VEGF and basic fibroblast growth factor ( bFGF) and have reduced antigen presenting ability.	EGF,27,30,Gene/Protein	TNF - α,32,39,Gene/Protein	VEGF,41,45,Gene/Protein	basic fibroblast growth factor,50,80,Gene/Protein	bFGF,83,87,Gene/Protein	"[{""token"": ""EGF"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""TNF - \u03b1"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""VEGF"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""basic fibroblast growth factor"", ""start_span"": 50, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""bFGF"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}]"	train
A study of murine and human macrophage polarization profiles showed that M - CSF - differentiated human macrophages are pro - M2, meaning that LPS or IFN - γ stimulation can still induce an M1 response.	murine,11,17,Organism/Species	human,22,27,Organism/Species	M - CSF,73,80,Gene/Protein	human,98,103,Organism/Species	IFN - γ,150,157,Gene/Protein	"[{""token"": ""murine"", ""start_span"": 11, ""end_span"": 17, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Organism/Species""}, {""token"": ""M - CSF"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Organism/Species""}, {""token"": ""IFN - \u03b3"", ""start_span"": 150, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	train
M - CSF induces CD163 expression in macrophages which, when LPS - stimulated, secrete higher levels of IL - 12p40, TNF - α and IL - 6 [ 34 ].	M - CSF,0,7,Gene/Protein	CD163,16,21,Gene/Protein	IL - 12p40,103,113,Gene/Protein	TNF - α,115,122,Gene/Protein	IL - 6,127,133,Gene/Protein	"[{""token"": ""M - CSF"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""CD163"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12p40"", ""start_span"": 103, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""TNF - \u03b1"", ""start_span"": 115, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 127, ""end_span"": 133, ""type"": ""Gene/Protein""}]"	train
These include bisphosphonates [ 56 ]; M - CSF and M - CSFR inhibitors and targeting antibodies [ 57 ], NCT01316822, NCT01444404; anti - macrophage migration inhibitory factor, NCT01765790 and L - MTP - PE, NCT00631631.	bisphosphonates,14,29,Chemical/Drug	M - CSF,38,45,Gene/Protein	M - CSFR,50,58,Gene/Protein	antibodies,84,94,Gene/Protein	macrophage migration inhibitory factor,136,174,Gene/Protein	"[{""token"": ""bisphosphonates"", ""start_span"": 14, ""end_span"": 29, ""type"": ""Chemical/Drug""}, {""token"": ""M - CSF"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""M - CSFR"", ""start_span"": 50, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 84, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""macrophage migration inhibitory factor"", ""start_span"": 136, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	train
Flow cytometry analysis of CD14 + cells differentiated for 5 days in the presence of IFN - γ with or without 50% conditioned media ( CM) A mean fluorescence intensity ( MFI) of CD14 B CDC16 and C CD64 normalized to MFI of unstained cells; n = 3. ( PDF 2112 kb)	CD14,27,31,Gene/Protein	IFN - γ,85,92,Gene/Protein	CD14,177,181,Gene/Protein	CDC16,184,189,Gene/Protein	CD64,196,200,Gene/Protein	"[{""token"": ""CD14"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""IFN - \u03b3"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""CD14"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""CDC16"", ""start_span"": 184, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""CD64"", ""start_span"": 196, ""end_span"": 200, ""type"": ""Gene/Protein""}]"	train
Exclusion criteria included major cardiovascular disease, respiratory disease, cerebral vascular disease, gastric - esophageal reflux, or a full stomach, known obstructive sleep apnea, body mass index of greater than 35 kg / m2, and the need for emergency surgery.	cardiovascular disease,34,56,Disease/Disorder	respiratory disease,58,77,Disease/Disorder	cerebral vascular disease,79,104,Disease/Disorder	gastric - esophageal reflux,106,133,Disease/Disorder	obstructive sleep apnea,160,183,Disease/Disorder	"[{""token"": ""cardiovascular disease"", ""start_span"": 34, ""end_span"": 56, ""type"": ""Disease/Disorder""}, {""token"": ""respiratory disease"", ""start_span"": 58, ""end_span"": 77, ""type"": ""Disease/Disorder""}, {""token"": ""cerebral vascular disease"", ""start_span"": 79, ""end_span"": 104, ""type"": ""Disease/Disorder""}, {""token"": ""gastric - esophageal reflux"", ""start_span"": 106, ""end_span"": 133, ""type"": ""Disease/Disorder""}, {""token"": ""obstructive sleep apnea"", ""start_span"": 160, ""end_span"": 183, ""type"": ""Disease/Disorder""}]"	train
This is accomplished in two steps: emulsification of vitamin D3 in the intestinal lumen, through the action of bile salts, forming small droplets which are dispersed and incorporated into micelles - complex aggregates formed by the interaction of free fatty acids, monoglycerides, and bile salts.	vitamin D3,53,63,Chemical/Drug	bile salts,111,121,Chemical/Drug	fatty acids,252,263,Chemical/Drug	monoglycerides,265,279,Chemical/Drug	bile salts,285,295,Chemical/Drug	"[{""token"": ""vitamin D3"", ""start_span"": 53, ""end_span"": 63, ""type"": ""Chemical/Drug""}, {""token"": ""bile salts"", ""start_span"": 111, ""end_span"": 121, ""type"": ""Chemical/Drug""}, {""token"": ""fatty acids"", ""start_span"": 252, ""end_span"": 263, ""type"": ""Chemical/Drug""}, {""token"": ""monoglycerides"", ""start_span"": 265, ""end_span"": 279, ""type"": ""Chemical/Drug""}, {""token"": ""bile salts"", ""start_span"": 285, ""end_span"": 295, ""type"": ""Chemical/Drug""}]"	train
Safety parameters were evaluated including hematology analyses ( complete blood counts ), biochemical analyses ( serum creatinine, total bilirubin, urea, SGOT, SGPT, alkaline phosphates, calcium) and urine was collected for urine routine and microbiological analyses at screening visit ( day 0) and at the end of period II visit ( day 90 ).	creatinine,119,129,Chemical/Drug	bilirubin,137,146,Chemical/Drug	urea,148,152,Chemical/Drug	SGOT,154,158,Gene/Protein	SGPT,160,164,Gene/Protein	"[{""token"": ""creatinine"", ""start_span"": 119, ""end_span"": 129, ""type"": ""Chemical/Drug""}, {""token"": ""bilirubin"", ""start_span"": 137, ""end_span"": 146, ""type"": ""Chemical/Drug""}, {""token"": ""urea"", ""start_span"": 148, ""end_span"": 152, ""type"": ""Chemical/Drug""}, {""token"": ""SGOT"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""SGPT"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
For the detection of bone morphogenetic protein - 2 ( BMP - 2) in the growth plate, the dehydrated tibia sections were incubated overnight in 1% Triton X - 100 containing goat BMP - 2 antibody ( Santa Cruz Biotechnology, diluted 1: 500) at room temperature.	bone morphogenetic protein - 2,21,51,Gene/Protein	BMP - 2,54,61,Gene/Protein	goat,171,175,Organism/Species	BMP - 2,176,183,Gene/Protein	antibody,184,192,Gene/Protein	"[{""token"": ""bone morphogenetic protein - 2"", ""start_span"": 21, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""BMP - 2"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""goat"", ""start_span"": 171, ""end_span"": 175, ""type"": ""Organism/Species""}, {""token"": ""BMP - 2"", ""start_span"": 176, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 184, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
It is known that preosteoblastic cells produce proteins of the extracellular matrix including collagen at first and then to successively produce alkaline phosphatase ( ALP) and osteopontin / osteocalcin during mineralization phase [ 29 ].	collagen,94,102,Gene/Protein	alkaline phosphatase,145,165,Gene/Protein	ALP,168,171,Gene/Protein	osteopontin,177,188,Gene/Protein	osteocalcin,191,202,Gene/Protein	"[{""token"": ""collagen"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""alkaline phosphatase"", ""start_span"": 145, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""ALP"", ""start_span"": 168, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""osteopontin"", ""start_span"": 177, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""osteocalcin"", ""start_span"": 191, ""end_span"": 202, ""type"": ""Gene/Protein""}]"	train
Additionally, others from Pagrus caeruleostictus and Solea senegalensis belonged to an unknown apicomplexan group previously found in the Caribbean Sea, where it was sequenced from the water column, corals, and fish.	Pagrus caeruleostictus,26,48,Organism/Species	Solea senegalensis,53,71,Organism/Species	apicomplexan,95,107,Organism/Species	corals,199,205,Organism/Species	fish,211,215,Organism/Species	"[{""token"": ""Pagrus caeruleostictus"", ""start_span"": 26, ""end_span"": 48, ""type"": ""Organism/Species""}, {""token"": ""Solea senegalensis"", ""start_span"": 53, ""end_span"": 71, ""type"": ""Organism/Species""}, {""token"": ""apicomplexan"", ""start_span"": 95, ""end_span"": 107, ""type"": ""Organism/Species""}, {""token"": ""corals"", ""start_span"": 199, ""end_span"": 205, ""type"": ""Organism/Species""}, {""token"": ""fish"", ""start_span"": 211, ""end_span"": 215, ""type"": ""Organism/Species""}]"	train
These include Plasmodium species, the causative agents of malaria, and Toxoplasma gondii, which infects most warm - blooded vertebrates and has a high prevalence in humans [ 2 ].	Plasmodium,14,24,Organism/Species	malaria,58,65,Disease/Disorder	Toxoplasma gondii,71,88,Organism/Species	vertebrates,124,135,Organism/Species	humans,165,171,Organism/Species	"[{""token"": ""Plasmodium"", ""start_span"": 14, ""end_span"": 24, ""type"": ""Organism/Species""}, {""token"": ""malaria"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Disease/Disorder""}, {""token"": ""Toxoplasma gondii"", ""start_span"": 71, ""end_span"": 88, ""type"": ""Organism/Species""}, {""token"": ""vertebrates"", ""start_span"": 124, ""end_span"": 135, ""type"": ""Organism/Species""}, {""token"": ""humans"", ""start_span"": 165, ""end_span"": 171, ""type"": ""Organism/Species""}]"	train
There are only a few exceptions: Fundulus grandis collected from the Gulf coast of the Mississippi [ 7 ]), Taurulus bubalis from an unknown locality [ 6 ], and Selar crumenophthalmus, Lutjanus kasmira and Mulloidichthys sp. from Hawaii [ 8, 9 ].	Fundulus grandis,33,49,Organism/Species	Taurulus bubalis,107,123,Organism/Species	Selar crumenophthalmus,160,182,Organism/Species	Lutjanus kasmira,184,200,Organism/Species	Mulloidichthys sp,205,222,Organism/Species	"[{""token"": ""Fundulus grandis"", ""start_span"": 33, ""end_span"": 49, ""type"": ""Organism/Species""}, {""token"": ""Taurulus bubalis"", ""start_span"": 107, ""end_span"": 123, ""type"": ""Organism/Species""}, {""token"": ""Selar crumenophthalmus"", ""start_span"": 160, ""end_span"": 182, ""type"": ""Organism/Species""}, {""token"": ""Lutjanus kasmira"", ""start_span"": 184, ""end_span"": 200, ""type"": ""Organism/Species""}, {""token"": ""Mulloidichthys sp"", ""start_span"": 205, ""end_span"": 222, ""type"": ""Organism/Species""}]"	train
According to the genetic distances within this Goussia group ( where interspecific distances range between 0. 4 – 4. 4 %), the genotypes found in Scomber japonicus, Dicentrarchus labrax and Sparus aurata + Diplodus sargus could correspond to different species as genetic distances between them ranged between 0. 4 – 7. 3 %.	Goussia,47,54,Organism/Species	Scomber japonicus,146,163,Organism/Species	Dicentrarchus labrax,165,185,Organism/Species	Sparus aurata,190,203,Organism/Species	Diplodus sargus,206,221,Organism/Species	"[{""token"": ""Goussia"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Organism/Species""}, {""token"": ""Scomber japonicus"", ""start_span"": 146, ""end_span"": 163, ""type"": ""Organism/Species""}, {""token"": ""Dicentrarchus labrax"", ""start_span"": 165, ""end_span"": 185, ""type"": ""Organism/Species""}, {""token"": ""Sparus aurata"", ""start_span"": 190, ""end_span"": 203, ""type"": ""Organism/Species""}, {""token"": ""Diplodus sargus"", ""start_span"": 206, ""end_span"": 221, ""type"": ""Organism/Species""}]"	train
The morphology of this putative Goussia sp. is very similar to that of the coccidian infecting the kidney of S. aurata from the Red Sea ( originally reported as an haemogregarine [ 40 ]) and a Liza host species from Africa ( also reported as an haemogregarine [ 41 ]), suggesting that this putative Goussia sensu Whipps et al. [ 8 ], might have a wide host and geographical range.	Goussia sp,32,42,Organism/Species	haemogregarine,164,178,Organism/Species	Liza,193,197,Organism/Species	haemogregarine,245,259,Organism/Species	Goussia,299,306,Organism/Species	"[{""token"": ""Goussia sp"", ""start_span"": 32, ""end_span"": 42, ""type"": ""Organism/Species""}, {""token"": ""haemogregarine"", ""start_span"": 164, ""end_span"": 178, ""type"": ""Organism/Species""}, {""token"": ""Liza"", ""start_span"": 193, ""end_span"": 197, ""type"": ""Organism/Species""}, {""token"": ""haemogregarine"", ""start_span"": 245, ""end_span"": 259, ""type"": ""Organism/Species""}, {""token"": ""Goussia"", ""start_span"": 299, ""end_span"": 306, ""type"": ""Organism/Species""}]"	train
In the present study, the parasites found in Solea senegalensis and Pagrus caeruleostictus were close relatives of an apicomplexan from the blood of a Caribbean fish ( Ophioblennius macclurei, see [ 13 ]) and also of a parasite sequenced from an eDNA seawater sample from the Caribbean [ 54 ].	Solea senegalensis,45,63,Organism/Species	Pagrus caeruleostictus,68,90,Organism/Species	apicomplexan,118,130,Organism/Species	fish,161,165,Organism/Species	Ophioblennius macclurei,168,191,Organism/Species	"[{""token"": ""Solea senegalensis"", ""start_span"": 45, ""end_span"": 63, ""type"": ""Organism/Species""}, {""token"": ""Pagrus caeruleostictus"", ""start_span"": 68, ""end_span"": 90, ""type"": ""Organism/Species""}, {""token"": ""apicomplexan"", ""start_span"": 118, ""end_span"": 130, ""type"": ""Organism/Species""}, {""token"": ""fish"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Organism/Species""}, {""token"": ""Ophioblennius macclurei"", ""start_span"": 168, ""end_span"": 191, ""type"": ""Organism/Species""}]"	train
The phylogeny of Janouškovec et al. [ 4] identified these coral - dwelling lineages as sister to Sarcocystis and eimeriids, and the authors suggested that they remained undescribed because coral reefs are poorly surveyed for the Apicomplexa.	coral,58,63,Organism/Species	Sarcocystis,97,108,Organism/Species	eimeriids,113,122,Organism/Species	coral,189,194,Organism/Species	Apicomplexa,229,240,Organism/Species	"[{""token"": ""coral"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Organism/Species""}, {""token"": ""Sarcocystis"", ""start_span"": 97, ""end_span"": 108, ""type"": ""Organism/Species""}, {""token"": ""eimeriids"", ""start_span"": 113, ""end_span"": 122, ""type"": ""Organism/Species""}, {""token"": ""coral"", ""start_span"": 189, ""end_span"": 194, ""type"": ""Organism/Species""}, {""token"": ""Apicomplexa"", ""start_span"": 229, ""end_span"": 240, ""type"": ""Organism/Species""}]"	train
Additionally, our phylogenetic results suggest that the Apicomplexa recovered from elasmobranchs are basal, which is in line with the host ’ s phylogenetic relationships since elasmobranchs ( together with the holocephalans) are the oldest jawed vertebrates on earth ( e. g. [ 56 ]).	Apicomplexa,56,67,Organism/Species	elasmobranchs,83,96,Organism/Species	elasmobranchs,176,189,Organism/Species	holocephalans,210,223,Organism/Species	jawed vertebrates,240,257,Organism/Species	"[{""token"": ""Apicomplexa"", ""start_span"": 56, ""end_span"": 67, ""type"": ""Organism/Species""}, {""token"": ""elasmobranchs"", ""start_span"": 83, ""end_span"": 96, ""type"": ""Organism/Species""}, {""token"": ""elasmobranchs"", ""start_span"": 176, ""end_span"": 189, ""type"": ""Organism/Species""}, {""token"": ""holocephalans"", ""start_span"": 210, ""end_span"": 223, ""type"": ""Organism/Species""}, {""token"": ""jawed vertebrates"", ""start_span"": 240, ""end_span"": 257, ""type"": ""Organism/Species""}]"	train
Breeding of Rev - erbα −/− animals in our facility revealed reduced fertility of these animals, with the average number of pups per mating pair reduced in Rev - erbα −/− compared to the heterozygous Rev - erbα +/− breeding pairs ( Fig. 1A ).	Rev - erbα,12,22,Gene/Protein	animals,27,34,Organism/Species	animals,87,94,Organism/Species	Rev - erbα,155,165,Gene/Protein	Rev - erbα,199,209,Gene/Protein	"[{""token"": ""Rev - erb\u03b1"", ""start_span"": 12, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""animals"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Organism/Species""}, {""token"": ""animals"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Organism/Species""}, {""token"": ""Rev - erb\u03b1"", ""start_span"": 155, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""Rev - erb\u03b1"", ""start_span"": 199, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
Similarly, FGF21 protein levels were also increased in plasma of Rev - erbα −/− mice with pronounced elevation at Zeitgeber time ( ZT) 12 and ZT18 ( Fig. 1E ), but plasma FGF21 levels were not diurnal in wild - type animals ( Fig. 1E ).	FGF21,11,16,Gene/Protein	Rev - erbα,65,75,Gene/Protein	mice,80,84,Organism/Species	FGF21,171,176,Gene/Protein	animals,216,223,Organism/Species	"[{""token"": ""FGF21"", ""start_span"": 11, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""Rev - erb\u03b1"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Organism/Species""}, {""token"": ""FGF21"", ""start_span"": 171, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""animals"", ""start_span"": 216, ""end_span"": 223, ""type"": ""Organism/Species""}]"	train
Fgf21 is regulated by REV - ERBα / HNF6 and PPARα / RXRα	Fgf21,0,5,Gene/Protein	REV - ERBα,22,32,Gene/Protein	HNF6,35,39,Gene/Protein	PPARα,44,49,Gene/Protein	RXRα,52,56,Gene/Protein	"[{""token"": ""Fgf21"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""REV - ERB\u03b1"", ""start_span"": 22, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""HNF6"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""PPAR\u03b1"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""RXR\u03b1"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}]"	train
( B) Dose dependent repression by REV - ERBα on the Bmal1 :: luc reporter ( black bars) and the Fgf21 :: luc reporter ( white bars) in NIH3T3 cells ( n = 4 ).	REV - ERBα,34,44,Gene/Protein	Bmal1,52,57,Gene/Protein	luc,61,64,Gene/Protein	Fgf21,96,101,Gene/Protein	luc,105,108,Gene/Protein	"[{""token"": ""REV - ERB\u03b1"", ""start_span"": 34, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""Bmal1"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene/Protein""}]"	train
( D) Dose - dependent activating potential of RORα on the Bmal1 :: luc reporter ( black bars) but not on the Fgf21 :: luc reporter ( white bars) in NIH3T3 cells ( n = 3 ).	RORα,46,50,Gene/Protein	Bmal1,58,63,Gene/Protein	luc,67,70,Gene/Protein	Fgf21,109,114,Gene/Protein	luc,118,121,Gene/Protein	"[{""token"": ""ROR\u03b1"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""Bmal1"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 109, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene/Protein""}]"	train
( E) Repression of the Bmal1 :: luc ( white bars) and Fgf21 :: luc ( blue bars) reporters in Hepa - 1c1c7 cells involves Hnf6.	Bmal1,23,28,Gene/Protein	luc,32,35,Gene/Protein	Fgf21,54,59,Gene/Protein	luc,63,66,Gene/Protein	Hnf6,121,125,Gene/Protein	"[{""token"": ""Bmal1"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""Hnf6"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene/Protein""}]"	train
( G) Fold induction of the Fgf21 :: luc reporter by Pparα, Rxrα and Per2 in NIH3T3 cells ( n = 4 ).	Fgf21,27,32,Gene/Protein	luc,36,39,Gene/Protein	Pparα,52,57,Gene/Protein	Rxrα,59,63,Gene/Protein	Per2,68,72,Gene/Protein	"[{""token"": ""Fgf21"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""Ppar\u03b1"", ""start_span"": 52, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""Rxr\u03b1"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""Per2"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}]"	train
REV - ERBα repressed the Bmal1 :: luc reporter as expected, and also repressed the Fgf21 :: luc reporter ( Fig. 2B) in a dose - dependent manner.	REV - ERBα,0,10,Gene/Protein	Bmal1,25,30,Gene/Protein	luc,34,37,Gene/Protein	Fgf21,83,88,Gene/Protein	luc,92,95,Gene/Protein	"[{""token"": ""REV - ERB\u03b1"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""Bmal1"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}]"	train
Mutation of the R1 element in the Fgf21 :: luc reporter reduced the repressive potential of REV - ERBα ( Fig. 2C ), which is consistent with previous findings that REV - ERBα may repress Fgf21 expression via this RORE site ( Estall et al ., 2009 ).	Fgf21,34,39,Gene/Protein	luc,43,46,Gene/Protein	REV - ERBα,92,102,Gene/Protein	REV - ERBα,164,174,Gene/Protein	Fgf21,187,192,Gene/Protein	"[{""token"": ""Fgf21"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""REV - ERB\u03b1"", ""start_span"": 92, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""REV - ERB\u03b1"", ""start_span"": 164, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 187, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
Since the classical mechanism of REV - ERBα - mediated repression involves competition with the transcriptional activator RORα, we tested whether RORα activates the Fgf21 :: luc construct.	REV - ERBα,33,43,Gene/Protein	RORα,122,126,Gene/Protein	RORα,146,150,Gene/Protein	Fgf21,165,170,Gene/Protein	luc,174,177,Gene/Protein	"[{""token"": ""REV - ERB\u03b1"", ""start_span"": 33, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""ROR\u03b1"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""ROR\u03b1"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
Accordingly, the repression by REV - ERBα on this promoter only partially repressed activation and in absence of HNF6, REV - ERBα alone did not repress the Fgf21 :: luc reporter below baseline levels ( Fig. 2E ).	REV - ERBα,31,41,Gene/Protein	HNF6,113,117,Gene/Protein	REV - ERBα,119,129,Gene/Protein	Fgf21,156,161,Gene/Protein	luc,165,168,Gene/Protein	"[{""token"": ""REV - ERB\u03b1"", ""start_span"": 31, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""HNF6"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""REV - ERB\u03b1"", ""start_span"": 119, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 156, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
Because we identified a PPAR binding site ( P in Fig. 2C) between the RORE R1 and R2, we tested whether PPARα, together with its heterodimerizing partner RXRα, may modulate the Fgf21 :: luc reporter.	PPAR,24,28,Gene/Protein	PPARα,104,109,Gene/Protein	RXRα,154,158,Gene/Protein	Fgf21,177,182,Gene/Protein	luc,186,189,Gene/Protein	"[{""token"": ""PPAR"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""PPAR\u03b1"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""RXR\u03b1"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 177, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 186, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
Addition of Per2 increased this activation further ( Fig. 2G ), indicating that PPARα, RXRα and Per2 have an activating function on the Fgf21 promoter.	Per2,12,16,Gene/Protein	PPARα,80,85,Gene/Protein	RXRα,87,91,Gene/Protein	Per2,96,100,Gene/Protein	Fgf21,136,141,Gene/Protein	"[{""token"": ""Per2"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""PPAR\u03b1"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""RXR\u03b1"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""Per2"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Gene/Protein""}]"	train
Similar to HNF6, PPARα binding to the Fgf21 promoter was not time - of - day dependent, with strong binding at both ZT8 and ZT20 in both wild - type and Rev - erbα −/− mice ( Fig. 3C ).	HNF6,11,15,Gene/Protein	PPARα,17,22,Gene/Protein	Fgf21,38,43,Gene/Protein	Rev - erbα,153,163,Gene/Protein	mice,168,172,Organism/Species	"[{""token"": ""HNF6"", ""start_span"": 11, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""PPAR\u03b1"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""Rev - erb\u03b1"", ""start_span"": 153, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Organism/Species""}]"	train
( C) Binding of PPARα on the Bmal1 and Fgf21 promoters in the liver of wild - type ( black bars) and Rev - erbα −/− ( red bars) animals at ZT8 and ZT20.	PPARα,16,21,Gene/Protein	Bmal1,29,34,Gene/Protein	Fgf21,39,44,Gene/Protein	Rev - erbα,101,111,Gene/Protein	animals,128,135,Organism/Species	"[{""token"": ""PPAR\u03b1"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""Bmal1"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""Rev - erb\u03b1"", ""start_span"": 101, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""animals"", ""start_span"": 128, ""end_span"": 135, ""type"": ""Organism/Species""}]"	train
( D) Binding of PER2 on the Bmal1 and Fgf21 promoters in the liver of wild - type ( black bars) and Rev - erbα −/− ( red bars) animals at ZT8 and ZT20.	PER2,16,20,Gene/Protein	Bmal1,28,33,Gene/Protein	Fgf21,38,43,Gene/Protein	Rev - erbα,100,110,Gene/Protein	animals,127,134,Organism/Species	"[{""token"": ""PER2"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""Bmal1"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""Rev - erb\u03b1"", ""start_span"": 100, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""animals"", ""start_span"": 127, ""end_span"": 134, ""type"": ""Organism/Species""}]"	train
Because PER2 can bind to both REV - ERBα and PPARα ( Schmutz et al ., 2010 ), we tested PER2 binding to the Fgf21 promoter.	PER2,8,12,Gene/Protein	REV - ERBα,30,40,Gene/Protein	PPARα,45,50,Gene/Protein	PER2,88,92,Gene/Protein	Fgf21,108,113,Gene/Protein	"[{""token"": ""PER2"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""REV - ERB\u03b1"", ""start_span"": 30, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""PPAR\u03b1"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""PER2"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 108, ""end_span"": 113, ""type"": ""Gene/Protein""}]"	train
Hence, Rev - erbα −/− animals can be considered as Fgf21 overexpressors, although they overexpress Fgf21 to a much lesser extent compared to the transgenic mice described by Owen et al. ( 2013 ).	Rev - erbα,7,17,Gene/Protein	animals,22,29,Organism/Species	Fgf21,51,56,Gene/Protein	Fgf21,99,104,Gene/Protein	mice,156,160,Organism/Species	"[{""token"": ""Rev - erb\u03b1"", ""start_span"": 7, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""animals"", ""start_span"": 22, ""end_span"": 29, ""type"": ""Organism/Species""}, {""token"": ""Fgf21"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Organism/Species""}]"	train
This indicates that the Fgf21 promoter is most likely not activated by BMAL1 / CLOCK or BMAL1 / NPAS2 heterodimers in vivo.	Fgf21,24,29,Gene/Protein	BMAL1,71,76,Gene/Protein	CLOCK,79,84,Gene/Protein	BMAL1,88,93,Gene/Protein	NPAS2,96,101,Gene/Protein	"[{""token"": ""Fgf21"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""BMAL1"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""CLOCK"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""BMAL1"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""NPAS2"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Gene/Protein""}]"	train
Therefore, we tested whether RORα induces the Fgf21 :: luc reporter in a dose - dependent manner as it does for the Bmal1 :: luc reporter.	RORα,29,33,Gene/Protein	Fgf21,46,51,Gene/Protein	luc,55,58,Gene/Protein	Bmal1,116,121,Gene/Protein	luc,125,128,Gene/Protein	"[{""token"": ""ROR\u03b1"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""Fgf21"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""Bmal1"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""luc"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene/Protein""}]"	train
Whereas the direct competition mechanism between REV - ERBα and ROR transcription factors provides a universal mechanism for self - sustained control of the molecular clock across all tissues, REV - ERBα uses lineage - determining factors to convey a tissue - specific rhythm that regulates metabolism tailored to the specific need of that tissue ( Zhang et al ., 2015 ).	REV - ERBα,49,59,Gene/Protein	ROR,64,67,Gene/Protein	transcription factors,68,89,Gene/Protein	clock,167,172,Gene/Protein	REV - ERBα,193,203,Gene/Protein	"[{""token"": ""REV - ERB\u03b1"", ""start_span"": 49, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""ROR"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 68, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""clock"", ""start_span"": 167, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""REV - ERB\u03b1"", ""start_span"": 193, ""end_span"": 203, ""type"": ""Gene/Protein""}]"	train
Anti - rabbit and - mouse HRP conjugated antibody was used as a secondary antibody.	rabbit,7,13,Organism/Species	mouse,20,25,Organism/Species	HRP,26,29,Gene/Protein	antibody,41,49,Gene/Protein	antibody,74,82,Gene/Protein	"[{""token"": ""rabbit"", ""start_span"": 7, ""end_span"": 13, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 20, ""end_span"": 25, ""type"": ""Organism/Species""}, {""token"": ""HRP"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 41, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Gene/Protein""}]"	train
Here we analyze the gene families contained within the whole genomes of human, chimpanzee, mouse, rat, and dog.	human,72,77,Organism/Species	chimpanzee,79,89,Organism/Species	mouse,91,96,Organism/Species	rat,98,101,Organism/Species	dog,107,110,Organism/Species	"[{""token"": ""human"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Organism/Species""}, {""token"": ""chimpanzee"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Organism/Species""}, {""token"": ""rat"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Organism/Species""}]"	train
In this paper we analyze gene gain and loss at a genomic scale by studying the expansion and contraction of gene families in the whole genomes of human, chimpanzee, mouse, rat, and dog.	human,146,151,Organism/Species	chimpanzee,153,163,Organism/Species	mouse,165,170,Organism/Species	rat,172,175,Organism/Species	dog,181,184,Organism/Species	"[{""token"": ""human"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Organism/Species""}, {""token"": ""chimpanzee"", ""start_span"": 153, ""end_span"": 163, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Organism/Species""}, {""token"": ""rat"", ""start_span"": 172, ""end_span"": 175, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 181, ""end_span"": 184, ""type"": ""Organism/Species""}]"	train
Our estimate for the rate of gene gain and loss is similar to previously reported values for yeast [ 25] and is close to estimates for the birth rate of gene duplicates in mouse and rat ( 0. 0013 – 0. 0026 [ 27 ]), as well as several other non - human eukaryotes ( 0. 001 – 0. 016 [ 15 ]).	yeast,93,98,Organism/Species	mouse,172,177,Organism/Species	rat,182,185,Organism/Species	human,246,251,Organism/Species	eukaryotes,252,262,Organism/Species	"[{""token"": ""yeast"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 172, ""end_span"": 177, ""type"": ""Organism/Species""}, {""token"": ""rat"", ""start_span"": 182, ""end_span"": 185, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 246, ""end_span"": 251, ""type"": ""Organism/Species""}, {""token"": ""eukaryotes"", ""start_span"": 252, ""end_span"": 262, ""type"": ""Organism/Species""}]"	train
This particular golgin subfamily has 49 human genes, 23 chimpanzee genes, and only a single copy each in the rodents and dog.	golgin,16,22,Gene/Protein	human,40,45,Organism/Species	chimpanzee,56,66,Organism/Species	rodents,109,116,Organism/Species	dog,121,124,Organism/Species	"[{""token"": ""golgin"", ""start_span"": 16, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Organism/Species""}, {""token"": ""chimpanzee"", ""start_span"": 56, ""end_span"": 66, ""type"": ""Organism/Species""}, {""token"": ""rodents"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Organism/Species""}]"	train
This agrees with recent results showing that differences between humans and mice are a result of both accelerated loss in humans and addition of functional OR genes in mice [ 48 ].	humans,65,71,Organism/Species	mice,76,80,Organism/Species	humans,122,128,Organism/Species	OR,156,158,Gene/Protein	mice,168,172,Organism/Species	"[{""token"": ""humans"", ""start_span"": 65, ""end_span"": 71, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Organism/Species""}, {""token"": ""humans"", ""start_span"": 122, ""end_span"": 128, ""type"": ""Organism/Species""}, {""token"": ""OR"", ""start_span"": 156, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Organism/Species""}]"	train
To minimize this source of bias we focused only on mammalian genomes that were estimated to be > 90% complete ( rat > 90% [ 27 ], chimpanzee > 94% [ 1 ], mouse ≈ 96% [ 38 ], dog ≈ 99% [ 54 ], human ≈ 99% [ 39 ]).	rat,112,115,Organism/Species	chimpanzee,130,140,Organism/Species	mouse,154,159,Organism/Species	dog,174,177,Organism/Species	human,192,197,Organism/Species	"[{""token"": ""rat"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Organism/Species""}, {""token"": ""chimpanzee"", ""start_span"": 130, ""end_span"": 140, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 154, ""end_span"": 159, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 192, ""end_span"": 197, ""type"": ""Organism/Species""}]"	train
Gene tree for the forkhead box gene family ( ENSF00000000311 ), showing gene duplication events as red boxes ( H = human, C = chimp, M = mouse, R = rat, D = dog ).	human,115,120,Organism/Species	chimp,126,131,Organism/Species	mouse,137,142,Organism/Species	rat,148,151,Organism/Species	dog,157,160,Organism/Species	"[{""token"": ""human"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Organism/Species""}, {""token"": ""chimp"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Organism/Species""}, {""token"": ""rat"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Organism/Species""}]"	train
Therefore, given the role GABAARs may play in a number of disorders including autism, schizophrenia, Fragile X and Down syndrome ( Deidda et al ., 2014, Rudolph and Mohler, 2014 ), these findings may not only be important in better understanding how phasic GABAergic neurotransmission changes to accommodate the demands of neuronal network activity during development, but may additionally allow new insights into the pathology of certain neurodevelopmental disorders.	GABAARs,26,33,Gene/Protein	autism,78,84,Disease/Disorder	schizophrenia,86,99,Disease/Disorder	Down syndrome,115,128,Disease/Disorder	neurodevelopmental disorders,439,467,Disease/Disorder	"[{""token"": ""GABAARs"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""autism"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Disease/Disorder""}, {""token"": ""schizophrenia"", ""start_span"": 86, ""end_span"": 99, ""type"": ""Disease/Disorder""}, {""token"": ""Down syndrome"", ""start_span"": 115, ""end_span"": 128, ""type"": ""Disease/Disorder""}, {""token"": ""neurodevelopmental disorders"", ""start_span"": 439, ""end_span"": 467, ""type"": ""Disease/Disorder""}]"	train
In mouse cortex the staining for mRNA encoding for the 5α3α synthesising enzymes 5α - reductase Type I ( 5α - R I) and 3α - hydroxysteroid dehydrogenase ( 3α - HSD ), was co - located in layer 2 / 3 / 5 pyramidal neurons ( Agis - Balboa et al.	mouse,3,8,Organism/Species	5α - reductase Type I,81,102,Gene/Protein	5α - R I,105,113,Gene/Protein	3α - hydroxysteroid dehydrogenase,119,152,Gene/Protein	3α - HSD,155,163,Gene/Protein	"[{""token"": ""mouse"", ""start_span"": 3, ""end_span"": 8, ""type"": ""Organism/Species""}, {""token"": ""5\u03b1 - reductase Type I"", ""start_span"": 81, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""5\u03b1 - R I"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""3\u03b1 - hydroxysteroid dehydrogenase"", ""start_span"": 119, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""3\u03b1 - HSD"", ""start_span"": 155, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
The production of NO is both necessary and sufficient to trigger Ca2 + sparks, as stretch – induced Ca2 + sparks were not activated under conditions of NOS inhibition or in eNOS knockout smooth muscle, and exogenous NO restored stretch – induced Ca2 + release in eNOS knockout cells, indicating that, NO mediates stretch - induced Ca2 + release through activation of PI ( 3) K - Akt − endothelial NOS axis in smooth muscle.	NOS,152,155,Gene/Protein	eNOS,173,177,Gene/Protein	eNOS,263,267,Gene/Protein	Akt,379,382,Gene/Protein	endothelial NOS,385,400,Gene/Protein	"[{""token"": ""NOS"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""eNOS"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""eNOS"", ""start_span"": 263, ""end_span"": 267, ""type"": ""Gene/Protein""}, {""token"": ""Akt"", ""start_span"": 379, ""end_span"": 382, ""type"": ""Gene/Protein""}, {""token"": ""endothelial NOS"", ""start_span"": 385, ""end_span"": 400, ""type"": ""Gene/Protein""}]"	train
Moreover, phosphorylation assay of Akt and eNOS demonstrated that both phospho - Akt and phospho - eNOS levels were greatly up - regulated by stretch ( Fig. 8 ), suggesting the activation of PI ( 3) K / Akt pathway by stretch further.	Akt,35,38,Gene/Protein	eNOS,43,47,Gene/Protein	Akt,81,84,Gene/Protein	eNOS,99,103,Gene/Protein	Akt,203,206,Gene/Protein	"[{""token"": ""Akt"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""eNOS"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""Akt"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""eNOS"", ""start_span"": 99, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""Akt"", ""start_span"": 203, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	train
Although recent work in mouse embryo bladder myocytes demonstrated that RYR1 is required for depolarization - induced Ca2 + spark [ 29 ], our conclusion that stretch - induced Ca2 + spark was mediated by activation of RYR2 does not oppose the voltage depolarizing induced Ca2 + release through RYR1 in mouse embryo bladder smooth muscle.	mouse,24,29,Organism/Species	RYR1,72,76,Gene/Protein	RYR2,218,222,Gene/Protein	RYR1,294,298,Gene/Protein	mouse,302,307,Organism/Species	"[{""token"": ""mouse"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Organism/Species""}, {""token"": ""RYR1"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""RYR2"", ""start_span"": 218, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""RYR1"", ""start_span"": 294, ""end_span"": 298, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 302, ""end_span"": 307, ""type"": ""Organism/Species""}]"	train
The fatty acid composition in all seven strains is similar to the fatty acid composition found in plant oils and might be therefore utilized in biodiesel production. S. cerevisiae biomass is produced in high amounts in biotechnological applications, with very low lipid content ( less than 10 %) of which palmitoleic acid ( 16: 1) comprises 40 %. K. polysporus produced up to 60% of palmitoleic acid, but the total lipid and biomass yield was low in comparison with other strains ( Figure 1 ).	fatty acid,4,14,Chemical/Drug	fatty acid,66,76,Chemical/Drug	plant,98,103,Organism/Species	palmitoleic acid,305,321,Chemical/Drug	palmitoleic acid,383,399,Chemical/Drug	"[{""token"": ""fatty acid"", ""start_span"": 4, ""end_span"": 14, ""type"": ""Chemical/Drug""}, {""token"": ""fatty acid"", ""start_span"": 66, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""plant"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Organism/Species""}, {""token"": ""palmitoleic acid"", ""start_span"": 305, ""end_span"": 321, ""type"": ""Chemical/Drug""}, {""token"": ""palmitoleic acid"", ""start_span"": 383, ""end_span"": 399, ""type"": ""Chemical/Drug""}]"	train
In this work, glucose was chosen as a substrate; however, many other starting materials are studied, besides saccharides, such as lactose or sucrose [ 35] that can be also exploited as volatile fatty acids [ 21] or industrial fat derivatives composed of saturated free fatty acids [ 18 ].	glucose,14,21,Chemical/Drug	lactose,130,137,Chemical/Drug	sucrose,141,148,Chemical/Drug	fatty acids,194,205,Chemical/Drug	fatty acids,269,280,Chemical/Drug	"[{""token"": ""glucose"", ""start_span"": 14, ""end_span"": 21, ""type"": ""Chemical/Drug""}, {""token"": ""lactose"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Chemical/Drug""}, {""token"": ""sucrose"", ""start_span"": 141, ""end_span"": 148, ""type"": ""Chemical/Drug""}, {""token"": ""fatty acids"", ""start_span"": 194, ""end_span"": 205, ""type"": ""Chemical/Drug""}, {""token"": ""fatty acids"", ""start_span"": 269, ""end_span"": 280, ""type"": ""Chemical/Drug""}]"	train
The fatty acid profile determined in this study displayed preferential synthesis of unsaturated fatty acids ( palmitoleic acid ( 16: 1 ), oleic acid ( 18: 1 ), and linoleic acid ( 18: 2 )) in both oleaginous and nonoleaginous species.	fatty acid,4,14,Chemical/Drug	unsaturated fatty acids,84,107,Chemical/Drug	palmitoleic acid,110,126,Chemical/Drug	oleic acid,138,148,Chemical/Drug	linoleic acid,164,177,Chemical/Drug	"[{""token"": ""fatty acid"", ""start_span"": 4, ""end_span"": 14, ""type"": ""Chemical/Drug""}, {""token"": ""unsaturated fatty acids"", ""start_span"": 84, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""palmitoleic acid"", ""start_span"": 110, ""end_span"": 126, ""type"": ""Chemical/Drug""}, {""token"": ""oleic acid"", ""start_span"": 138, ""end_span"": 148, ""type"": ""Chemical/Drug""}, {""token"": ""linoleic acid"", ""start_span"": 164, ""end_span"": 177, ""type"": ""Chemical/Drug""}]"	train
In addition, we found that Aldehyde Dehydrogenase 1 ( ALDH1) is co - expressed with NIK in tumor cells from patients with breast cancer.	Aldehyde Dehydrogenase 1,27,51,Gene/Protein	ALDH1,54,59,Gene/Protein	NIK,84,87,Gene/Protein	tumor,91,96,Disease/Disorder	breast cancer,122,135,Disease/Disorder	"[{""token"": ""Aldehyde Dehydrogenase 1"", ""start_span"": 27, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""ALDH1"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""NIK"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Disease/Disorder""}, {""token"": ""breast cancer"", ""start_span"": 122, ""end_span"": 135, ""type"": ""Disease/Disorder""}]"	train
To isolate BCSCs, we used specific antibodies against surface markers ( CD44, CD24 or Epithelial Cell Adhesion Molecule ( ESA) in a luminal ( MCF7) and a triple negative ( MDA - MB - 231) breast cancer cell line.	CD44,72,76,Gene/Protein	CD24,78,82,Gene/Protein	Epithelial Cell Adhesion Molecule,86,119,Gene/Protein	ESA,122,125,Gene/Protein	breast cancer,188,201,Disease/Disorder	"[{""token"": ""CD44"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""CD24"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""Epithelial Cell Adhesion Molecule"", ""start_span"": 86, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""ESA"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""breast cancer"", ""start_span"": 188, ""end_span"": 201, ""type"": ""Disease/Disorder""}]"	train
Sorted ESA + MDA - MB - 231 cells were able to form tumors within 90 days while the majority of mice inoculated with ESA − did not form tumors ( Supplementary Table S1 ).	ESA,7,10,Gene/Protein	tumors,52,58,Disease/Disorder	mice,96,100,Organism/Species	ESA,117,120,Gene/Protein	tumors,136,142,Disease/Disorder	"[{""token"": ""ESA"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""tumors"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Disease/Disorder""}, {""token"": ""mice"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Organism/Species""}, {""token"": ""ESA"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""tumors"", ""start_span"": 136, ""end_span"": 142, ""type"": ""Disease/Disorder""}]"	train
For this reason, we examined the levels of this kinase in MDA - MB - 231 ( claudin low ), SKBR3 ( HER2 +) and MCF7 ( luminal) breast cancer cell lines and found that as expected, NIK is highly expressed in MDA - MB - 231 cells and barely detectable in MCF7 cells ( Supplementary Fig.	kinase,48,54,Gene/Protein	claudin,75,82,Gene/Protein	HER2,98,102,Gene/Protein	breast cancer,126,139,Disease/Disorder	NIK,179,182,Gene/Protein	"[{""token"": ""kinase"", ""start_span"": 48, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""claudin"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""HER2"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""breast cancer"", ""start_span"": 126, ""end_span"": 139, ""type"": ""Disease/Disorder""}, {""token"": ""NIK"", ""start_span"": 179, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	train
In addition, MDA - MB - 231 BCSCs also exhibited higher levels of NIK when compared to CD44 −/ ESA − cells ( Fig. 2B ); furthermore NIK is highly expressed in MDA - MB - 231 cells with ALDH activity ( Supplementary Fig.	NIK,66,69,Gene/Protein	CD44,87,91,Gene/Protein	ESA,95,98,Gene/Protein	NIK,132,135,Gene/Protein	ALDH,185,189,Gene/Protein	"[{""token"": ""NIK"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""CD44"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""ESA"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""NIK"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""ALDH"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Gene/Protein""}]"	train
In further support of these findings, NIK inhibition in MDA - MB - 231 cells also reduced the expression of SOX2, OCT4, ALDH1A3 and ALDH8A1 ( Fig. 2F ).	NIK,38,41,Gene/Protein	SOX2,108,112,Gene/Protein	OCT4,114,118,Gene/Protein	ALDH1A3,120,127,Gene/Protein	ALDH8A1,132,139,Gene/Protein	"[{""token"": ""NIK"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""SOX2"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""OCT4"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""ALDH1A3"", ""start_span"": 120, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""ALDH8A1"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Gene/Protein""}]"	train
NIK is an essential kinase that induces principally non - canonical NF - κB activation by phosphorylating p100 and IKKα10.	NIK,0,3,Gene/Protein	kinase,20,26,Gene/Protein	NF - κB,68,75,Gene/Protein	p100,106,110,Gene/Protein	IKKα10,115,121,Gene/Protein	"[{""token"": ""NIK"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""kinase"", ""start_span"": 20, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""NF - \u03baB"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""p100"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""IKK\u03b110"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Gene/Protein""}]"	train
It has been reported that NIK mediates the processing of p100 to p52 and promotes the nuclear translocation of p52: RelB dimer.	NIK,26,29,Gene/Protein	p100,57,61,Gene/Protein	p52,65,68,Gene/Protein	p52,111,114,Gene/Protein	RelB,116,120,Gene/Protein	"[{""token"": ""NIK"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""p100"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene/Protein""}]"	train
Western blotting assays revealed that NIK increased mainly the expression of p52, RelB and RelA / p65 ( Fig. 5C, D ).	NIK,38,41,Gene/Protein	p52,77,80,Gene/Protein	RelB,82,86,Gene/Protein	RelA,91,95,Gene/Protein	p65,98,101,Gene/Protein	"[{""token"": ""NIK"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""RelA"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""p65"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene/Protein""}]"	train
To determine the role of NIK in ERK activation, we analyzed the phosphorylation status of ERK in NIK - deficient and NIK - over - expressing cells.	NIK,25,28,Gene/Protein	ERK,32,35,Gene/Protein	ERK,90,93,Gene/Protein	NIK,97,100,Gene/Protein	NIK,117,120,Gene/Protein	"[{""token"": ""NIK"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""NIK"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""NIK"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}]"	train
HER2 appears to regulate self - renewal in breast tumors lacking HER2 amplification through the receptor activator of NF - κB ( RANK )- ligand41.	HER2,0,4,Gene/Protein	breast tumors,43,56,Disease/Disorder	HER2,65,69,Gene/Protein	receptor activator of NF - κB,96,125,Gene/Protein	RANK,128,132,Gene/Protein	"[{""token"": ""HER2"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""breast tumors"", ""start_span"": 43, ""end_span"": 56, ""type"": ""Disease/Disorder""}, {""token"": ""HER2"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""receptor activator of NF - \u03baB"", ""start_span"": 96, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""RANK"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}]"	train
In addition, it was recently shown that the induction of the non - canonical NF - κB pathway through NIK activation regulates Jagged1 ( JAG1) expression and expands the stem cell population in the basal - like breast cancer subtype21.	NF - κB,77,84,Gene/Protein	NIK,101,104,Gene/Protein	Jagged1,126,133,Gene/Protein	JAG1,136,140,Gene/Protein	breast cancer,210,223,Disease/Disorder	"[{""token"": ""NF - \u03baB"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""NIK"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""Jagged1"", ""start_span"": 126, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""JAG1"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""breast cancer"", ""start_span"": 210, ""end_span"": 223, ""type"": ""Disease/Disorder""}]"	train
We found that phosphorylation of ERK1 / 2 is regulated upstream by NIK, and that both NIK and ERK1 / 2 are required to regulate stemness in breast cancer cells.	ERK1,33,37,Gene/Protein	NIK,67,70,Gene/Protein	NIK,86,89,Gene/Protein	ERK1,94,98,Gene/Protein	breast cancer,140,153,Disease/Disorder	"[{""token"": ""ERK1"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""NIK"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""NIK"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""ERK1"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""breast cancer"", ""start_span"": 140, ""end_span"": 153, ""type"": ""Disease/Disorder""}]"	train
Supporting our results, Richmond Ann and Dhawan Punita, showed that NIK activates ERK1 / 2 via MEK1 / 2 in melanoma cell lines, which have high NIK basal expression.	NIK,68,71,Gene/Protein	ERK1,82,86,Gene/Protein	MEK1,95,99,Gene/Protein	melanoma,107,115,Disease/Disorder	NIK,144,147,Gene/Protein	"[{""token"": ""NIK"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""ERK1"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""MEK1"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""melanoma"", ""start_span"": 107, ""end_span"": 115, ""type"": ""Disease/Disorder""}, {""token"": ""NIK"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene/Protein""}]"	train
The enzymatic activities of both the firefly luciferase and the beta - galactosidase reporter genes were determined 48 h after transfection with a Dual - luciferase Reporter Assay kit ( Promega) and a Luminescent Beta - galactosidase Detection Kit ( Clontech ), respectively.	firefly,37,44,Organism/Species	luciferase,45,55,Gene/Protein	beta - galactosidase,64,84,Gene/Protein	luciferase,154,164,Gene/Protein	Beta - galactosidase,213,233,Gene/Protein	"[{""token"": ""firefly"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Organism/Species""}, {""token"": ""luciferase"", ""start_span"": 45, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""beta - galactosidase"", ""start_span"": 64, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""luciferase"", ""start_span"": 154, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""Beta - galactosidase"", ""start_span"": 213, ""end_span"": 233, ""type"": ""Gene/Protein""}]"	train
Treatment of LUTS - BPH, either alone or with coexisting erectile dysfunction ( ED ), with PDE - 5 inhibitors and notably tadalafil 5mg, has recently been added to EU - wide treatment guidelines for non - neurogenic LUTS [ 4 ].	BPH,20,23,Disease/Disorder	erectile dysfunction,57,77,Disease/Disorder	ED,80,82,Disease/Disorder	PDE - 5,91,98,Gene/Protein	tadalafil,122,131,Chemical/Drug	"[{""token"": ""BPH"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Disease/Disorder""}, {""token"": ""erectile dysfunction"", ""start_span"": 57, ""end_span"": 77, ""type"": ""Disease/Disorder""}, {""token"": ""ED"", ""start_span"": 80, ""end_span"": 82, ""type"": ""Disease/Disorder""}, {""token"": ""PDE - 5"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""tadalafil"", ""start_span"": 122, ""end_span"": 131, ""type"": ""Chemical/Drug""}]"	train
In pooled subgroup analyses, significant improvements in IPSS total score were observed regardless of baseline LUTS severity ( IPSS < 20 /≥ 20 ), age (≤ 65 /> 65 years ), recent use of α - blocking agents or PDE - 5 inhibitors, total testosterone level (< 300 /≥ 300ng / dl ), or prostate - specific antigen ( PSA) predicted prostate volume (≤ 40 /> 40ml ), while tadalafil was well tolerated across all subgroups [ 13 ].	PDE - 5,208,215,Gene/Protein	testosterone,234,246,Chemical/Drug	prostate - specific antigen,280,307,Gene/Protein	PSA,310,313,Gene/Protein	tadalafil,364,373,Chemical/Drug	"[{""token"": ""PDE - 5"", ""start_span"": 208, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""testosterone"", ""start_span"": 234, ""end_span"": 246, ""type"": ""Chemical/Drug""}, {""token"": ""prostate - specific antigen"", ""start_span"": 280, ""end_span"": 307, ""type"": ""Gene/Protein""}, {""token"": ""PSA"", ""start_span"": 310, ""end_span"": 313, ""type"": ""Gene/Protein""}, {""token"": ""tadalafil"", ""start_span"": 364, ""end_span"": 373, ""type"": ""Chemical/Drug""}]"	train
Patients were excluded if PSA was > 10ng / ml ( or for PSA 4 – 10ng / ml, prostate malignancy had to be excluded ), if post - void residual ( PVR) urine volume was ≥ 300ml, or if they had used finasteride or dutasteride within 3 or 6 months ( 12 months in one study ), respectively.	PSA,26,29,Gene/Protein	PSA,55,58,Gene/Protein	prostate malignancy,74,93,Disease/Disorder	finasteride,193,204,Chemical/Drug	dutasteride,208,219,Chemical/Drug	"[{""token"": ""PSA"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""PSA"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""prostate malignancy"", ""start_span"": 74, ""end_span"": 93, ""type"": ""Disease/Disorder""}, {""token"": ""finasteride"", ""start_span"": 193, ""end_span"": 204, ""type"": ""Chemical/Drug""}, {""token"": ""dutasteride"", ""start_span"": 208, ""end_span"": 219, ""type"": ""Chemical/Drug""}]"	train
Minor differences between the studies included the following: one enrolled patients with BPH and concomitant ED [ 7 ]; one was a dose - finding study in which tadalafil was administered at doses of 2. 5mg, 5mg, 10mg, 20mg once daily [ 16 ]; one included a tadalafil 2. 5mg treatment arm [ 7 ]; and one included an additional tamsulosin 0. 4mg treatment arm [ 8 ].	BPH,89,92,Disease/Disorder	ED,109,111,Disease/Disorder	tadalafil,159,168,Chemical/Drug	tadalafil,256,265,Chemical/Drug	tamsulosin,325,335,Chemical/Drug	"[{""token"": ""BPH"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Disease/Disorder""}, {""token"": ""ED"", ""start_span"": 109, ""end_span"": 111, ""type"": ""Disease/Disorder""}, {""token"": ""tadalafil"", ""start_span"": 159, ""end_span"": 168, ""type"": ""Chemical/Drug""}, {""token"": ""tadalafil"", ""start_span"": 256, ""end_span"": 265, ""type"": ""Chemical/Drug""}, {""token"": ""tamsulosin"", ""start_span"": 325, ""end_span"": 335, ""type"": ""Chemical/Drug""}]"	train
Table 6 details sensitivities and specificities on held - out test data from non - SDR models lying on the ROC surface when testosterone, alcohol intake, Qmax, SHBG, albumin, PGI - S and PSA were excluded.	testosterone,124,136,Chemical/Drug	alcohol,138,145,Chemical/Drug	SHBG,160,164,Gene/Protein	albumin,166,173,Gene/Protein	PSA,187,190,Gene/Protein	"[{""token"": ""testosterone"", ""start_span"": 124, ""end_span"": 136, ""type"": ""Chemical/Drug""}, {""token"": ""alcohol"", ""start_span"": 138, ""end_span"": 145, ""type"": ""Chemical/Drug""}, {""token"": ""SHBG"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""albumin"", ""start_span"": 166, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""PSA"", ""start_span"": 187, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
Models were generated on dataset excluding testosterone, alcohol frequency, Qmax, SHBG, Albumin, PGI, and PSA	testosterone,43,55,Chemical/Drug	alcohol,57,64,Chemical/Drug	SHBG,82,86,Gene/Protein	Albumin,88,95,Gene/Protein	PSA,106,109,Gene/Protein	"[{""token"": ""testosterone"", ""start_span"": 43, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""alcohol"", ""start_span"": 57, ""end_span"": 64, ""type"": ""Chemical/Drug""}, {""token"": ""SHBG"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""Albumin"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""PSA"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene/Protein""}]"	train
BII, BPH Impact Index; CI, confidence interval; DT, Decision Tree; IPSS, International Prostate Symptom Score; MCID, Minimally Clinically Important Differences; PGI - I, Patient Global Impression of Improvement; PSA, prostate specific antigen; Qmax, maximal flow rate; QoL, quality of life; RF, Random Forest; SHBG, sex hormone binding globulin.	BPH,5,8,Disease/Disorder	PSA,212,215,Gene/Protein	prostate specific antigen,217,242,Gene/Protein	SHBG,310,314,Gene/Protein	sex hormone binding globulin,316,344,Gene/Protein	"[{""token"": ""BPH"", ""start_span"": 5, ""end_span"": 8, ""type"": ""Disease/Disorder""}, {""token"": ""PSA"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Gene/Protein""}, {""token"": ""prostate specific antigen"", ""start_span"": 217, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""SHBG"", ""start_span"": 310, ""end_span"": 314, ""type"": ""Gene/Protein""}, {""token"": ""sex hormone binding globulin"", ""start_span"": 316, ""end_span"": 344, ""type"": ""Gene/Protein""}]"	train
In a four year single - centre retrospective analysis 225 patients with confirmed PH of various origins were enrolled to investigate the prevalence of AF, and to assess the clinical manifestation, 6 - minute walk distance, NT - proBNP levels, echocardiographic parameters and hemodynamics obtained by right heart catheterization in PH with AF.	PH,82,84,Disease/Disorder	AF,151,153,Disease/Disorder	NT - proBNP,223,234,Gene/Protein	PH,332,334,Disease/Disorder	AF,340,342,Disease/Disorder	"[{""token"": ""PH"", ""start_span"": 82, ""end_span"": 84, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 151, ""end_span"": 153, ""type"": ""Disease/Disorder""}, {""token"": ""NT - proBNP"", ""start_span"": 223, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""PH"", ""start_span"": 332, ""end_span"": 334, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 340, ""end_span"": 342, ""type"": ""Disease/Disorder""}]"	train
In the total PH cohort and in PH not related to left heart disease occurrence of AF was associated with an increase of right atrial pressure ( RAP) and right atrial dilatation.	PH,13,15,Disease/Disorder	PH,30,32,Disease/Disorder	heart disease,53,66,Disease/Disorder	AF,81,83,Disease/Disorder	right atrial dilatation,152,175,Disease/Disorder	"[{""token"": ""PH"", ""start_span"": 13, ""end_span"": 15, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 30, ""end_span"": 32, ""type"": ""Disease/Disorder""}, {""token"": ""heart disease"", ""start_span"": 53, ""end_span"": 66, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 81, ""end_span"": 83, ""type"": ""Disease/Disorder""}, {""token"": ""right atrial dilatation"", ""start_span"": 152, ""end_span"": 175, ""type"": ""Disease/Disorder""}]"	train
Targeted therapy for PAH such as prostacyclin analogues, endothelin receptor antagonists and phosphodiesterase - 5 inhibitors were equally prescribed in PAH patients with and without AF.	PAH,21,24,Disease/Disorder	endothelin receptor,57,76,Gene/Protein	phosphodiesterase - 5,93,114,Gene/Protein	PAH,153,156,Disease/Disorder	AF,183,185,Disease/Disorder	"[{""token"": ""PAH"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Disease/Disorder""}, {""token"": ""endothelin receptor"", ""start_span"": 57, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""phosphodiesterase - 5"", ""start_span"": 93, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""PAH"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 183, ""end_span"": 185, ""type"": ""Disease/Disorder""}]"	train
Consistently, the 6 - minute walk distance was significantly shorter in the PH - AF group ( PH - SR vs. PH - AF: 355. 55 ± 9. 86 m, n = 130 vs. 321. 98 ± 14. 1 m, n = 53; p < 0. 05, figure 1 ).	PH,76,78,Disease/Disorder	AF,81,83,Disease/Disorder	PH,92,94,Disease/Disorder	PH,104,106,Disease/Disorder	AF,109,111,Disease/Disorder	"[{""token"": ""PH"", ""start_span"": 76, ""end_span"": 78, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 81, ""end_span"": 83, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 92, ""end_span"": 94, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 104, ""end_span"": 106, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 109, ""end_span"": 111, ""type"": ""Disease/Disorder""}]"	train
Moreover, in patients with AF, the elevation of NT - proBNP serum levels was more pronounced ( PH - SR vs. PH - AF: 2128. 88 ± 429. 97 ng / l, n = 155 vs. 3252. 79 ± 401. 76 ng / l, n = 70; p < 0. 05, figure 1 ).	AF,27,29,Disease/Disorder	NT - proBNP,48,59,Gene/Protein	PH,95,97,Disease/Disorder	PH,107,109,Disease/Disorder	AF,112,114,Disease/Disorder	"[{""token"": ""AF"", ""start_span"": 27, ""end_span"": 29, ""type"": ""Disease/Disorder""}, {""token"": ""NT - proBNP"", ""start_span"": 48, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""PH"", ""start_span"": 95, ""end_span"": 97, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 107, ""end_span"": 109, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 112, ""end_span"": 114, ""type"": ""Disease/Disorder""}]"	train
PCWP and mean right atrial pressure ( RAPmean) were obtained by right heart catheterization in the presence ( PH - AF) or absence ( PH - SR) of AF in patients with PH. * p < 0. 05.	PH,110,112,Disease/Disorder	AF,115,117,Disease/Disorder	PH,132,134,Disease/Disorder	AF,144,146,Disease/Disorder	PH,164,166,Disease/Disorder	"[{""token"": ""PH"", ""start_span"": 110, ""end_span"": 112, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 115, ""end_span"": 117, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 132, ""end_span"": 134, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 144, ""end_span"": 146, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 164, ""end_span"": 166, ""type"": ""Disease/Disorder""}]"	train
Symptomatic heart failure has been reported in 30% of AF patients and AF is found in up to 30% of heart failure patients, depending on the underlying cause and severity of heart failure [ 9 ], [ 19 ].	heart failure,12,25,Disease/Disorder	AF,54,56,Disease/Disorder	AF,70,72,Disease/Disorder	heart failure,98,111,Disease/Disorder	heart failure,172,185,Disease/Disorder	"[{""token"": ""heart failure"", ""start_span"": 12, ""end_span"": 25, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 54, ""end_span"": 56, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 70, ""end_span"": 72, ""type"": ""Disease/Disorder""}, {""token"": ""heart failure"", ""start_span"": 98, ""end_span"": 111, ""type"": ""Disease/Disorder""}, {""token"": ""heart failure"", ""start_span"": 172, ""end_span"": 185, ""type"": ""Disease/Disorder""}]"	train
Compared to the cited populations mentioned above we observed a significantly higher prevalence of AF in patients with left heart disease combined with PH ( 57. 7 %), supporting the notion that our patients suffered from more severe heart failure, which was also indicated by the high prevalence of patients with NYHA III and markedly elevated NT - proBNP levels.	AF,99,101,Disease/Disorder	heart disease,124,137,Disease/Disorder	PH,152,154,Disease/Disorder	heart failure,233,246,Disease/Disorder	NT - proBNP,344,355,Gene/Protein	"[{""token"": ""AF"", ""start_span"": 99, ""end_span"": 101, ""type"": ""Disease/Disorder""}, {""token"": ""heart disease"", ""start_span"": 124, ""end_span"": 137, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 152, ""end_span"": 154, ""type"": ""Disease/Disorder""}, {""token"": ""heart failure"", ""start_span"": 233, ""end_span"": 246, ""type"": ""Disease/Disorder""}, {""token"": ""NT - proBNP"", ""start_span"": 344, ""end_span"": 355, ""type"": ""Gene/Protein""}]"	train
These results provide insight into the possible pathophysiology of AF in PH and indicate a different pathomechanism of AF induction in PH with versus without left heart disease.	AF,67,69,Disease/Disorder	PH,73,75,Disease/Disorder	AF,119,121,Disease/Disorder	PH,135,137,Disease/Disorder	heart disease,163,176,Disease/Disorder	"[{""token"": ""AF"", ""start_span"": 67, ""end_span"": 69, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 73, ""end_span"": 75, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 119, ""end_span"": 121, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 135, ""end_span"": 137, ""type"": ""Disease/Disorder""}, {""token"": ""heart disease"", ""start_span"": 163, ""end_span"": 176, ""type"": ""Disease/Disorder""}]"	train
As for the effect of age and duration of diabetes on CKD development, it appears that while the prevalence of CKD steadily increases along with age and duration of disease, the risk of developing CKD is relatively unaffected by duration of diabetes.	diabetes,41,49,Disease/Disorder	CKD,53,56,Disease/Disorder	CKD,110,113,Disease/Disorder	CKD,196,199,Disease/Disorder	diabetes,240,248,Disease/Disorder	"[{""token"": ""diabetes"", ""start_span"": 41, ""end_span"": 49, ""type"": ""Disease/Disorder""}, {""token"": ""CKD"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Disease/Disorder""}, {""token"": ""CKD"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Disease/Disorder""}, {""token"": ""CKD"", ""start_span"": 196, ""end_span"": 199, ""type"": ""Disease/Disorder""}, {""token"": ""diabetes"", ""start_span"": 240, ""end_span"": 248, ""type"": ""Disease/Disorder""}]"	train
Among these, arsC encodes an arsenate reductase and arsA and arsB encode an arsenite efflux pump.	arsC,13,17,Gene/Protein	arsenate reductase,29,47,Gene/Protein	arsA,52,56,Gene/Protein	arsB,61,65,Gene/Protein	arsenite efflux pump,76,96,Gene/Protein	"[{""token"": ""arsC"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""arsenate reductase"", ""start_span"": 29, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""arsA"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""arsB"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""arsenite efflux pump"", ""start_span"": 76, ""end_span"": 96, ""type"": ""Gene/Protein""}]"	train
We analyze several theropod eggshells from various localities, including oviraptorid Macroolithus yaotunensis eggshells from the Late Cretaceous deposits of Henan, Jiangxi, and Guangdong in China and alvarezsaurid Triprismatoolithus eggshell from the Two Medicine Formation of Montana, United States, with the scanning electron microscope ( SEM ), electron probe micro - analysis ( EPMA ), and Raman spectroscopy ( RS ).	theropod,19,27,Organism/Species	oviraptorid,73,84,Organism/Species	Macroolithus yaotunensis,85,109,Organism/Species	alvarezsaurid,200,213,Organism/Species	Triprismatoolithus,214,232,Organism/Species	"[{""token"": ""theropod"", ""start_span"": 19, ""end_span"": 27, ""type"": ""Organism/Species""}, {""token"": ""oviraptorid"", ""start_span"": 73, ""end_span"": 84, ""type"": ""Organism/Species""}, {""token"": ""Macroolithus yaotunensis"", ""start_span"": 85, ""end_span"": 109, ""type"": ""Organism/Species""}, {""token"": ""alvarezsaurid"", ""start_span"": 200, ""end_span"": 213, ""type"": ""Organism/Species""}, {""token"": ""Triprismatoolithus"", ""start_span"": 214, ""end_span"": 232, ""type"": ""Organism/Species""}]"	train
Among all dinosaurs, the nesting type of titanosaur, troodontid, and oviraptorid dinosaurs are comparatively well documented ( Jackson, 2007; Varricchio et al ., 2013; Wiemann et al ., 2017 ).	dinosaurs,10,19,Organism/Species	titanosaur,41,51,Organism/Species	troodontid,53,63,Organism/Species	oviraptorid,69,80,Organism/Species	dinosaurs,81,90,Organism/Species	"[{""token"": ""dinosaurs"", ""start_span"": 10, ""end_span"": 19, ""type"": ""Organism/Species""}, {""token"": ""titanosaur"", ""start_span"": 41, ""end_span"": 51, ""type"": ""Organism/Species""}, {""token"": ""troodontid"", ""start_span"": 53, ""end_span"": 63, ""type"": ""Organism/Species""}, {""token"": ""oviraptorid"", ""start_span"": 69, ""end_span"": 80, ""type"": ""Organism/Species""}, {""token"": ""dinosaurs"", ""start_span"": 81, ""end_span"": 90, ""type"": ""Organism/Species""}]"	train
Since ornithological research had suggested that P is an inhibitor of calcite growth during eggshell formation ( Fink et al ., 1993; Dennis et al ., 1996; Fraser, Bain & Solomon, 1999; Cusack, Fraser & Stachel, 2003 ), the similarity of P distribution between oviraptorid dinosaur and modern avian eggshells suggests that the oviraptorid dinosaurs studied by us already possessed a similar eggshell formation mechanism to that of extant birds.	oviraptorid,260,271,Organism/Species	dinosaur,272,280,Organism/Species	oviraptorid,326,337,Organism/Species	dinosaurs,338,347,Organism/Species	birds,437,442,Organism/Species	"[{""token"": ""oviraptorid"", ""start_span"": 260, ""end_span"": 271, ""type"": ""Organism/Species""}, {""token"": ""dinosaur"", ""start_span"": 272, ""end_span"": 280, ""type"": ""Organism/Species""}, {""token"": ""oviraptorid"", ""start_span"": 326, ""end_span"": 337, ""type"": ""Organism/Species""}, {""token"": ""dinosaurs"", ""start_span"": 338, ""end_span"": 347, ""type"": ""Organism/Species""}, {""token"": ""birds"", ""start_span"": 437, ""end_span"": 442, ""type"": ""Organism/Species""}]"	train
Most birds build open nests either on the tree or on the ground ( ostriches or emus ), while the megapode birds bury their eggs in a mound.	birds,5,10,Organism/Species	ostriches,66,75,Organism/Species	emus,79,83,Organism/Species	megapode,97,105,Organism/Species	birds,106,111,Organism/Species	"[{""token"": ""birds"", ""start_span"": 5, ""end_span"": 10, ""type"": ""Organism/Species""}, {""token"": ""ostriches"", ""start_span"": 66, ""end_span"": 75, ""type"": ""Organism/Species""}, {""token"": ""emus"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Organism/Species""}, {""token"": ""megapode"", ""start_span"": 97, ""end_span"": 105, ""type"": ""Organism/Species""}, {""token"": ""birds"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Organism/Species""}]"	train
Although no Mongolian oviraptorid eggshells were included in our study, it appears likely that Mongolian oviraptorid eggs were also cuticle - coated for the prevention of water loss as in Adélie penguin eggs ( Thompson & Goldie, 1990 ). Fanti, Currie & Demchig ( 2012) documented clutches of the oviraptorid Nemegtomaia from both the Nemegt and Baruungoyot formations, that represent mesic and xeric habitats, respectively.	oviraptorid,22,33,Organism/Species	oviraptorid,105,116,Organism/Species	Adélie penguin,188,202,Organism/Species	oviraptorid,296,307,Organism/Species	Nemegtomaia,308,319,Organism/Species	"[{""token"": ""oviraptorid"", ""start_span"": 22, ""end_span"": 33, ""type"": ""Organism/Species""}, {""token"": ""oviraptorid"", ""start_span"": 105, ""end_span"": 116, ""type"": ""Organism/Species""}, {""token"": ""Ad\u00e9lie penguin"", ""start_span"": 188, ""end_span"": 202, ""type"": ""Organism/Species""}, {""token"": ""oviraptorid"", ""start_span"": 296, ""end_span"": 307, ""type"": ""Organism/Species""}, {""token"": ""Nemegtomaia"", ""start_span"": 308, ""end_span"": 319, ""type"": ""Organism/Species""}]"	train
While it is uncertain that the alvarezsaurid eggshells were pigmented without further chemical studies, it is possible that alvarezsaurid dinosaur exploited similar nesting strategies as oviraptorid dinosaurs did.	alvarezsaurid,31,44,Organism/Species	alvarezsaurid,124,137,Organism/Species	dinosaur,138,146,Organism/Species	oviraptorid,187,198,Organism/Species	dinosaurs,199,208,Organism/Species	"[{""token"": ""alvarezsaurid"", ""start_span"": 31, ""end_span"": 44, ""type"": ""Organism/Species""}, {""token"": ""alvarezsaurid"", ""start_span"": 124, ""end_span"": 137, ""type"": ""Organism/Species""}, {""token"": ""dinosaur"", ""start_span"": 138, ""end_span"": 146, ""type"": ""Organism/Species""}, {""token"": ""oviraptorid"", ""start_span"": 187, ""end_span"": 198, ""type"": ""Organism/Species""}, {""token"": ""dinosaurs"", ""start_span"": 199, ""end_span"": 208, ""type"": ""Organism/Species""}]"	train
The membrane - associated RING - CH ( MARCH) proteins belong to the RING finger protein family of E3 ubiquitin ligases, consisting of 11 members in mammals.	membrane - associated RING - CH,4,35,Gene/Protein	MARCH,38,43,Gene/Protein	RING finger protein,68,87,Gene/Protein	E3 ubiquitin ligases,98,118,Gene/Protein	mammals,148,155,Organism/Species	"[{""token"": ""membrane - associated RING - CH"", ""start_span"": 4, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""MARCH"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""RING finger protein"", ""start_span"": 68, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""E3 ubiquitin ligases"", ""start_span"": 98, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""mammals"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Organism/Species""}]"	train
At the same time, we found that MARCH 7 could modulate nuclear factor kB ( NF - kB) and Wnt / β - catenin pathways.	MARCH,32,37,Gene/Protein	nuclear factor kB,55,72,Gene/Protein	NF - kB,75,82,Gene/Protein	Wnt,88,91,Gene/Protein	β - catenin,94,105,Gene/Protein	"[{""token"": ""MARCH"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor kB"", ""start_span"": 55, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""NF - kB"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""Wnt"", ""start_span"": 88, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 94, ""end_span"": 105, ""type"": ""Gene/Protein""}]"	train
Transforming growth factor ( TGF )- β1, tumor necrosis factor - alpha ( TNF - α) and Interleukin - 1β are expressed in ovarian cancer, which can promote ovarian tumorigenesis through an inflammatory response [ 6 - 8 ].	Transforming growth factor ( TGF )- β1,0,38,Gene/Protein	tumor necrosis factor - alpha,40,69,Gene/Protein	TNF - α,72,79,Gene/Protein	Interleukin - 1β,85,101,Gene/Protein	ovarian cancer,119,133,Disease/Disorder	"[{""token"": ""Transforming growth factor ( TGF )- \u03b21"", ""start_span"": 0, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor - alpha"", ""start_span"": 40, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""TNF - \u03b1"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""Interleukin - 1\u03b2"", ""start_span"": 85, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""ovarian cancer"", ""start_span"": 119, ""end_span"": 133, ""type"": ""Disease/Disorder""}]"	train
Ectopic expression of MARCH7 increased NF - κB and Wnt / β - catenin signal pathway luciferase reporter activity	MARCH7,22,28,Gene/Protein	NF - κB,39,46,Gene/Protein	Wnt,51,54,Gene/Protein	β - catenin,57,68,Gene/Protein	luciferase,84,94,Gene/Protein	"[{""token"": ""MARCH7"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""NF - \u03baB"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""Wnt"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 57, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""luciferase"", ""start_span"": 84, ""end_span"": 94, ""type"": ""Gene/Protein""}]"	train
Increase in nuclear translocation of NF kB p65 and P50 were observed after infection of A2780 cells with LV5 - MARCH7 as compared with that of LV5 - GFP ( P < 0. 05) ( Fig. 5A and 5B ).	NF kB p65,37,46,Gene/Protein	P50,51,54,Gene/Protein	infection,75,84,Disease/Disorder	MARCH7,111,117,Gene/Protein	GFP,149,152,Gene/Protein	"[{""token"": ""NF kB p65"", ""start_span"": 37, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""P50"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""infection"", ""start_span"": 75, ""end_span"": 84, ""type"": ""Disease/Disorder""}, {""token"": ""MARCH7"", ""start_span"": 111, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
C - myc, sp5, lef1 play key roles in the Wnt / β - catenin signaling pathway [ 9 - 11 ].	C - myc,0,7,Gene/Protein	sp5,9,12,Gene/Protein	lef1,14,18,Gene/Protein	Wnt,41,44,Gene/Protein	β - catenin,47,58,Gene/Protein	"[{""token"": ""C - myc"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""sp5"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""lef1"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""Wnt"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Gene/Protein""}]"	train
( A) The expression of NFkB P65, NFkB P50, and β - catenin was detected by immunofluorescence staining in ovarian cancer SKOV3 cells ( LV3 - shMARCH7 - 1 or LV3 - shMARCH7 - 2 infected) and A2780 cells ( LV5 - MARCH7 infected ).	NFkB P65,23,31,Gene/Protein	NFkB P50,33,41,Gene/Protein	β - catenin,47,58,Gene/Protein	ovarian cancer,106,120,Disease/Disorder	MARCH7,143,149,Gene/Protein	"[{""token"": ""NFkB P65"", ""start_span"": 23, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""NFkB P50"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""ovarian cancer"", ""start_span"": 106, ""end_span"": 120, ""type"": ""Disease/Disorder""}, {""token"": ""MARCH7"", ""start_span"": 143, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
IHC revealed that the expression of MARCH7, P50, P65 and β - catenin in tumors from LV3 - shMARCH7 - 1 infected group was lower than that in the LV3 - NC infected group ( P < 0. 05) ( Fig. 6C and S2A ).	MARCH7,36,42,Gene/Protein	P50,44,47,Gene/Protein	P65,49,52,Gene/Protein	β - catenin,57,68,Gene/Protein	tumors,72,78,Disease/Disorder	"[{""token"": ""MARCH7"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""P50"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""P65"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 57, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""tumors"", ""start_span"": 72, ""end_span"": 78, ""type"": ""Disease/Disorder""}]"	train
Immunohistochemical analysis of MARCH7, NFkB P65, NFkB P50, and β - catenin expression were performed on tumor xenografts.	MARCH7,32,38,Gene/Protein	NFkB P65,40,48,Gene/Protein	NFkB P50,50,58,Gene/Protein	β - catenin,64,75,Gene/Protein	tumor,105,110,Disease/Disorder	"[{""token"": ""MARCH7"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""NFkB P65"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""NFkB P50"", ""start_span"": 50, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 64, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Disease/Disorder""}]"	train
( F) Immunohistochemical analysis of MARCH7, NFkB P65, NFkB P50, and β - catenin expression were performed on tumor xenografts.	MARCH7,37,43,Gene/Protein	NFkB P65,45,53,Gene/Protein	NFkB P50,55,63,Gene/Protein	β - catenin,69,80,Gene/Protein	tumor,110,115,Disease/Disorder	"[{""token"": ""MARCH7"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""NFkB P65"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""NFkB P50"", ""start_span"": 55, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 69, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Disease/Disorder""}]"	train
These results suggest that elevated levels of MARCH7 aids in the progress of ovarian cancer, and promotes an aggressive behavior, indicating that MARCH7 may function as a novel tumor marker and a potential therapeutic target for ovarian cancer.	MARCH7,46,52,Gene/Protein	ovarian cancer,77,91,Disease/Disorder	MARCH7,146,152,Gene/Protein	tumor,177,182,Disease/Disorder	ovarian cancer,229,243,Disease/Disorder	"[{""token"": ""MARCH7"", ""start_span"": 46, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""ovarian cancer"", ""start_span"": 77, ""end_span"": 91, ""type"": ""Disease/Disorder""}, {""token"": ""MARCH7"", ""start_span"": 146, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 177, ""end_span"": 182, ""type"": ""Disease/Disorder""}, {""token"": ""ovarian cancer"", ""start_span"": 229, ""end_span"": 243, ""type"": ""Disease/Disorder""}]"	train
To further study the relation between MARCH7 and NF kB, we tried inhibiting NF kB with PDTC ( Ammonium pyrrolidinedithiocarbamate ), P50 siRNA or / and P65 siRNA.	MARCH7,38,44,Gene/Protein	NF kB,49,54,Gene/Protein	NF kB,76,81,Gene/Protein	P50,133,136,Gene/Protein	P65,152,155,Gene/Protein	"[{""token"": ""MARCH7"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""NF kB"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""NF kB"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""P50"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""P65"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene/Protein""}]"	train
Based on these findings, we concluded that MARCH7 participated in Wnt / β - catenin signaling in human ovarian cancer cells.	MARCH7,43,49,Gene/Protein	Wnt,66,69,Gene/Protein	β - catenin,72,83,Gene/Protein	human,97,102,Organism/Species	ovarian cancer,103,117,Disease/Disorder	"[{""token"": ""MARCH7"", ""start_span"": 43, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""Wnt"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 72, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Organism/Species""}, {""token"": ""ovarian cancer"", ""start_span"": 103, ""end_span"": 117, ""type"": ""Disease/Disorder""}]"	train
β - catenin involved in Wnt / β - catenin pathway and intercellular adhesion, which is causally correlated with the existence of E - cadherin and catenin complexes.	β - catenin,0,11,Gene/Protein	Wnt,24,27,Gene/Protein	β - catenin,30,41,Gene/Protein	E - cadherin,129,141,Gene/Protein	catenin,146,153,Gene/Protein	"[{""token"": ""\u03b2 - catenin"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""Wnt"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 30, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""E - cadherin"", ""start_span"": 129, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""catenin"", ""start_span"": 146, ""end_span"": 153, ""type"": ""Gene/Protein""}]"	train
The percentage of positive tumor cells was scored as follows: 0 ( absence of tumor cells ), 1 (< 33% tumor cells ), 2 ( 33 – 66% tumor cells) and 3 (> 66% tumor cells ).	tumor,27,32,Disease/Disorder	tumor,77,82,Disease/Disorder	tumor,101,106,Disease/Disorder	tumor,129,134,Disease/Disorder	tumor,155,160,Disease/Disorder	"[{""token"": ""tumor"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Disease/Disorder""}, {""token"": ""tumor"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Disease/Disorder""}, {""token"": ""tumor"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Disease/Disorder""}, {""token"": ""tumor"", ""start_span"": 129, ""end_span"": 134, ""type"": ""Disease/Disorder""}, {""token"": ""tumor"", ""start_span"": 155, ""end_span"": 160, ""type"": ""Disease/Disorder""}]"	train
The primers used for amplifying MARCH7, sp5, lef1, c - myc and GAPDH were synthesized by Guangzhou Funeng Co ., Ltd.	MARCH7,32,38,Gene/Protein	sp5,40,43,Gene/Protein	lef1,45,49,Gene/Protein	c - myc,51,58,Gene/Protein	GAPDH,63,68,Gene/Protein	"[{""token"": ""MARCH7"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""sp5"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""lef1"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""c - myc"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""GAPDH"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Gene/Protein""}]"	train
The frequency of epidermal growth factor receptor ( EGFR) mutation was significantly lower in ILD and IPF patients than in non - ILD patients ( 2 or 0 vs. 32 %, respectively ).	epidermal growth factor receptor,17,49,Gene/Protein	EGFR,52,56,Gene/Protein	ILD,94,97,Disease/Disorder	IPF,102,105,Disease/Disorder	ILD,129,132,Disease/Disorder	"[{""token"": ""epidermal growth factor receptor"", ""start_span"": 17, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""EGFR"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""ILD"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Disease/Disorder""}, {""token"": ""IPF"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Disease/Disorder""}, {""token"": ""ILD"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Disease/Disorder""}]"	train
Indeed, adverse events, including AEs, and PD were the main reasons for discontinuing first - line therapy within three cycles in patients with ILD / IPF, suggesting that AEs of ILD / IPF may have made an important contribution to the lower DCR and shorter survival.	PD,43,45,Disease/Disorder	ILD,144,147,Disease/Disorder	IPF,150,153,Disease/Disorder	ILD,178,181,Disease/Disorder	IPF,184,187,Disease/Disorder	"[{""token"": ""PD"", ""start_span"": 43, ""end_span"": 45, ""type"": ""Disease/Disorder""}, {""token"": ""ILD"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Disease/Disorder""}, {""token"": ""IPF"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Disease/Disorder""}, {""token"": ""ILD"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Disease/Disorder""}, {""token"": ""IPF"", ""start_span"": 184, ""end_span"": 187, ""type"": ""Disease/Disorder""}]"	train
However, in another study 4 / 15 patients with NSCLC and ILD who received carboplatin and paclitaxel developed grade 3 or higher pneumonitis ( 27 %) ( Shukuya et al. 2010 ); this high incidence cannot be ignored.	NSCLC,47,52,Disease/Disorder	ILD,57,60,Disease/Disorder	carboplatin,74,85,Chemical/Drug	paclitaxel,90,100,Chemical/Drug	pneumonitis,129,140,Disease/Disorder	"[{""token"": ""NSCLC"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Disease/Disorder""}, {""token"": ""ILD"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Disease/Disorder""}, {""token"": ""carboplatin"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Chemical/Drug""}, {""token"": ""paclitaxel"", ""start_span"": 90, ""end_span"": 100, ""type"": ""Chemical/Drug""}, {""token"": ""pneumonitis"", ""start_span"": 129, ""end_span"": 140, ""type"": ""Disease/Disorder""}]"	train
Currently, several clinical trials are assessing a combination of carboplatin and nab - paclitaxel for advanced NSCLC with ILD.	carboplatin,66,77,Chemical/Drug	nab,82,85,Chemical/Drug	paclitaxel,88,98,Chemical/Drug	NSCLC,112,117,Disease/Disorder	ILD,123,126,Disease/Disorder	"[{""token"": ""carboplatin"", ""start_span"": 66, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""nab"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Chemical/Drug""}, {""token"": ""paclitaxel"", ""start_span"": 88, ""end_span"": 98, ""type"": ""Chemical/Drug""}, {""token"": ""NSCLC"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Disease/Disorder""}, {""token"": ""ILD"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Disease/Disorder""}]"	train
MDA - MB - 231 - GFP and MDA - MB - 231 β1 - GFP cells were stably transduced with recombinant lentivirus for firefly luciferase ( AMS Biotechnology ).	GFP,17,20,Gene/Protein	GFP,45,48,Gene/Protein	lentivirus,95,105,Organism/Species	firefly,110,117,Organism/Species	luciferase,118,128,Gene/Protein	"[{""token"": ""GFP"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""lentivirus"", ""start_span"": 95, ""end_span"": 105, ""type"": ""Organism/Species""}, {""token"": ""firefly"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Organism/Species""}, {""token"": ""luciferase"", ""start_span"": 118, ""end_span"": 128, ""type"": ""Gene/Protein""}]"	train
Cultures were fixed in 4% paraformaldehyde and the cancer cells were visualized with anti - GFP ( 1: 1, 000; NeuroMab ), or anti - cytokeratin 18 ( 1: 500; BioLegend) followed by Alexa - 568 - conjugated goat anti - mouse ( 1: 500 ).	cancer,51,57,Disease/Disorder	GFP,92,95,Gene/Protein	cytokeratin 18,131,145,Gene/Protein	goat,204,208,Organism/Species	mouse,216,221,Organism/Species	"[{""token"": ""cancer"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Disease/Disorder""}, {""token"": ""GFP"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""cytokeratin 18"", ""start_span"": 131, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""goat"", ""start_span"": 204, ""end_span"": 208, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 216, ""end_span"": 221, ""type"": ""Organism/Species""}]"	train
We have previously shown that β1 mRNA / protein are expressed in BCa cell lines. 24 Here, we used Oncomine to study the expression of SCN1B mRNA in normal breast and BCa specimens across multiple microarrays. SCN1B was expressed at a significantly higher level in BCa compared with normal breast in two out of eight datasets in which differential data were available ( 1. 7 - fold, p < 0. 05; and > 2. 2 - fold, p < 0. 05; Figs.	BCa,65,68,Disease/Disorder	SCN1B,134,139,Gene/Protein	BCa,166,169,Disease/Disorder	SCN1B,209,214,Gene/Protein	BCa,264,267,Disease/Disorder	"[{""token"": ""BCa"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Disease/Disorder""}, {""token"": ""SCN1B"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""BCa"", ""start_span"": 166, ""end_span"": 169, ""type"": ""Disease/Disorder""}, {""token"": ""SCN1B"", ""start_span"": 209, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""BCa"", ""start_span"": 264, ""end_span"": 267, ""type"": ""Disease/Disorder""}]"	train
We orthotopically implanted luciferase - expressing MDA - MB - 231 or MDA - MB - 231 - β1 cells into the mammary fat pads of female Rag2 −/− Il2rg −/− mice and monitored tumour growth by bioluminescent imaging.	luciferase,28,38,Gene/Protein	Rag2,132,136,Gene/Protein	Il2rg,141,146,Gene/Protein	mice,151,155,Organism/Species	tumour,170,176,Disease/Disorder	"[{""token"": ""luciferase"", ""start_span"": 28, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""Rag2"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""Il2rg"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 151, ""end_span"": 155, ""type"": ""Organism/Species""}, {""token"": ""tumour"", ""start_span"": 170, ""end_span"": 176, ""type"": ""Disease/Disorder""}]"	train
Several classes of CAMs are known to promote angiogenesis, including integrins, cadherins, and immunoglobulin superfamily CAMs, 43 raising the possibility that β1 may contribute to promoting blood vessel development through heterophilic adhesion.	CAMs,19,23,Gene/Protein	integrins,69,78,Gene/Protein	cadherins,80,89,Gene/Protein	immunoglobulin,95,109,Gene/Protein	CAMs,122,126,Gene/Protein	"[{""token"": ""CAMs"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""integrins"", ""start_span"": 69, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""cadherins"", ""start_span"": 80, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulin"", ""start_span"": 95, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""CAMs"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Gene/Protein""}]"	train
Expression of the IL - 17 - receptor in bladder tumours, and functional effects and gene expression changes induced by IL - 17 in bladder tumour cells in vitro suggest a role in tumour behaviour.	IL - 17 - receptor,18,36,Gene/Protein	bladder tumours,40,55,Disease/Disorder	IL - 17,119,126,Gene/Protein	bladder tumour,130,144,Disease/Disorder	tumour,178,184,Disease/Disorder	"[{""token"": ""IL - 17 - receptor"", ""start_span"": 18, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""bladder tumours"", ""start_span"": 40, ""end_span"": 55, ""type"": ""Disease/Disorder""}, {""token"": ""IL - 17"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""bladder tumour"", ""start_span"": 130, ""end_span"": 144, ""type"": ""Disease/Disorder""}, {""token"": ""tumour"", ""start_span"": 178, ""end_span"": 184, ""type"": ""Disease/Disorder""}]"	train
Finally, we assessed the effects of IL - 17 in the context of patient outcome, following intravesical BCG immunotherapy which is the standard of care; higher numbers of IL - 17 + cells were associated with improved event - free survival ( p = 0. 0449, HR 0. 2918, 95% CI 0. 08762 – 0. 9721) in patients with primary and concomitant CIS ( n = 41 ), we propose a model of IL - 17 + Mast cells mechanism of action.	IL - 17,36,43,Gene/Protein	BCG,102,105,Organism/Species	IL - 17,169,176,Gene/Protein	CIS,332,335,Disease/Disorder	IL - 17,370,377,Gene/Protein	"[{""token"": ""IL - 17"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""BCG"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Organism/Species""}, {""token"": ""IL - 17"", ""start_span"": 169, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""CIS"", ""start_span"": 332, ""end_span"": 335, ""type"": ""Disease/Disorder""}, {""token"": ""IL - 17"", ""start_span"": 370, ""end_span"": 377, ""type"": ""Gene/Protein""}]"	train
Thus, in the context of bladder CIS, IL - 17 + mast cells predict favourable outcome following BCG immunotherapy indicative of a novel mechanism of BCG immunotherapy in UBC and could form the basis of a stratified approach to treatment.	bladder CIS,24,35,Disease/Disorder	IL - 17,37,44,Gene/Protein	BCG,95,98,Organism/Species	BCG,148,151,Organism/Species	UBC,169,172,Disease/Disorder	"[{""token"": ""bladder CIS"", ""start_span"": 24, ""end_span"": 35, ""type"": ""Disease/Disorder""}, {""token"": ""IL - 17"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""BCG"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Organism/Species""}, {""token"": ""BCG"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Organism/Species""}, {""token"": ""UBC"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Disease/Disorder""}]"	train
IL - 17 has been implicated in the response to BCG immunotherapy in a murine bladder cancer model [ 25 ]; however, there are no data from patients as to the role of IL - 17 in UBC.	IL - 17,0,7,Gene/Protein	BCG,47,50,Organism/Species	bladder cancer,77,91,Disease/Disorder	IL - 17,165,172,Gene/Protein	UBC,176,179,Disease/Disorder	"[{""token"": ""IL - 17"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""BCG"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Organism/Species""}, {""token"": ""bladder cancer"", ""start_span"": 77, ""end_span"": 91, ""type"": ""Disease/Disorder""}, {""token"": ""IL - 17"", ""start_span"": 165, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""UBC"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Disease/Disorder""}]"	train
Examining the stage of the tumours at time of diagnosis demonstrated that there was a significant increase in IL - 17 + cells in CIS patients ( p = < 0. 0001 ), although not all CIS patients have enhanced levels of IL - 17 + cells ( Fig 2B ).	tumours,27,34,Disease/Disorder	IL - 17,110,117,Gene/Protein	CIS,129,132,Disease/Disorder	CIS,178,181,Disease/Disorder	IL - 17,215,222,Gene/Protein	"[{""token"": ""tumours"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Disease/Disorder""}, {""token"": ""IL - 17"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""CIS"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Disease/Disorder""}, {""token"": ""CIS"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Disease/Disorder""}, {""token"": ""IL - 17"", ""start_span"": 215, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	train
The ΔCT values of mRNA transcripts of ( C) IL - 17A, ( D) IL - 17 - F, ( E) IL - 6 or ( F) IL - 23 are shown relative to GAPDH ( ΔCT = CTExperimental - CTGAPDH ).	IL - 17A,43,51,Gene/Protein	IL - 17 - F,58,69,Gene/Protein	IL - 6,76,82,Gene/Protein	IL - 23,91,98,Gene/Protein	GAPDH,121,126,Gene/Protein	"[{""token"": ""IL - 17A"", ""start_span"": 43, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""IL - 17 - F"", ""start_span"": 58, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 76, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""IL - 23"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""GAPDH"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Gene/Protein""}]"	train
Examining transcripts related to and downstream of IL - 17, we similarly measured increased mRNA levels of the related cytokine IL - 17F as well as IL - 6, the expression of which is upregulated by IL - 17 [ 26] ( Fig 2D and 2E ).	IL - 17,51,58,Gene/Protein	cytokine,119,127,Gene/Protein	IL - 17F,128,136,Gene/Protein	IL - 6,148,154,Gene/Protein	IL - 17,198,205,Gene/Protein	"[{""token"": ""IL - 17"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 119, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""IL - 17F"", ""start_span"": 128, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 148, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""IL - 17"", ""start_span"": 198, ""end_span"": 205, ""type"": ""Gene/Protein""}]"	train
As shown in Fig 4E, cells positive for both MCT and IL - 17 were observed in all cases confirming that MCs are the main source of IL - 17 in the tumour microenvironment of bladder CIS.	MCT,44,47,Gene/Protein	IL - 17,52,59,Gene/Protein	IL - 17,130,137,Gene/Protein	tumour,145,151,Disease/Disorder	bladder CIS,172,183,Disease/Disorder	"[{""token"": ""MCT"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""IL - 17"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""IL - 17"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""tumour"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Disease/Disorder""}, {""token"": ""bladder CIS"", ""start_span"": 172, ""end_span"": 183, ""type"": ""Disease/Disorder""}]"	train
However, IL - 17 has been implicated in the efficacy of BCG immunotherapy in a murine bladder cancer model [ 25 ]; although patients with high grade NMIBC should be offered intravesical BCG, not all patients actually receive this treatment.	IL - 17,9,16,Gene/Protein	BCG,56,59,Organism/Species	bladder cancer,86,100,Disease/Disorder	NMIBC,149,154,Disease/Disorder	BCG,186,189,Organism/Species	"[{""token"": ""IL - 17"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""BCG"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Organism/Species""}, {""token"": ""bladder cancer"", ""start_span"": 86, ""end_span"": 100, ""type"": ""Disease/Disorder""}, {""token"": ""NMIBC"", ""start_span"": 149, ""end_span"": 154, ""type"": ""Disease/Disorder""}, {""token"": ""BCG"", ""start_span"": 186, ""end_span"": 189, ""type"": ""Organism/Species""}]"	train
In this model, IL - 17 was required for BCG efficacy through IL - 8 production and increased neutrophil recruitment, in keeping with clinical data showing increased IL - 8, within the first few hours of BCG treatment is predictive of response [ 12, 55, 56 ].	IL - 17,15,22,Gene/Protein	BCG,40,43,Organism/Species	IL - 8,61,67,Gene/Protein	IL - 8,165,171,Gene/Protein	BCG,203,206,Organism/Species	"[{""token"": ""IL - 17"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""BCG"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Organism/Species""}, {""token"": ""IL - 8"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 165, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""BCG"", ""start_span"": 203, ""end_span"": 206, ""type"": ""Organism/Species""}]"	train
Recently, a urinary cytokine panel ( CyPRIT ), based on changes in levels of nine cytokines, correctly identified 85. 5% of BCG responders in initial tests in 130 high - risk BCG - treated patients, of whom almost half had concomitant CIS [ 57 ].	cytokine,20,28,Gene/Protein	cytokines,82,91,Gene/Protein	BCG,124,127,Organism/Species	BCG,175,178,Organism/Species	CIS,235,238,Disease/Disorder	"[{""token"": ""cytokine"", ""start_span"": 20, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 82, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""BCG"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Organism/Species""}, {""token"": ""BCG"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Organism/Species""}, {""token"": ""CIS"", ""start_span"": 235, ""end_span"": 238, ""type"": ""Disease/Disorder""}]"	train
The pcr1 + gene encodes an activating transcription factor / cAMP response element binding ( ATF / CREB) transcription factor family.	pcr1,4,8,Gene/Protein	activating transcription factor,27,58,Gene/Protein	ATF,93,96,Gene/Protein	CREB,99,103,Gene/Protein	transcription factor,105,125,Gene/Protein	"[{""token"": ""pcr1"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""activating transcription factor"", ""start_span"": 27, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""ATF"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 99, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 105, ""end_span"": 125, ""type"": ""Gene/Protein""}]"	train
It has been shown in the fission yeast Schizosaccharomyces pombe [ 5 - 8] and the budding yeast Saccharomyces cerevisiae [ 1, 9 - 12] that a number of transcription factors dramatically modulate the transcriptome to facilitate meiosis, thereby playing critical roles in meiotic progression and sporulation ( gametogenesis ).	fission yeast,25,38,Organism/Species	Schizosaccharomyces pombe,39,64,Organism/Species	yeast,90,95,Organism/Species	Saccharomyces cerevisiae,96,120,Organism/Species	transcription factors,151,172,Gene/Protein	"[{""token"": ""fission yeast"", ""start_span"": 25, ""end_span"": 38, ""type"": ""Organism/Species""}, {""token"": ""Schizosaccharomyces pombe"", ""start_span"": 39, ""end_span"": 64, ""type"": ""Organism/Species""}, {""token"": ""yeast"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Organism/Species""}, {""token"": ""Saccharomyces cerevisiae"", ""start_span"": 96, ""end_span"": 120, ""type"": ""Organism/Species""}, {""token"": ""transcription factors"", ""start_span"": 151, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	train
Pabp – GFP was found to localize in the cytoplasm in spo5 ∆ cells ( Figure 2E ), suggesting that Spo5 is not an mRNA export factor.	Pabp,0,4,Gene/Protein	GFP,7,10,Gene/Protein	spo5,53,57,Gene/Protein	Spo5,97,101,Gene/Protein	mRNA export factor,112,130,Gene/Protein	"[{""token"": ""Pabp"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""spo5"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""Spo5"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""mRNA export factor"", ""start_span"": 112, ""end_span"": 130, ""type"": ""Gene/Protein""}]"	train
However, Pcr1 suppressed the defect in spo5 ∆ cells less efficiently than Spo5, suggesting that Spo5 may also regulate factors important for meiotic progression and sporulation other than Pcr1.	Pcr1,9,13,Gene/Protein	spo5,39,43,Gene/Protein	Spo5,74,78,Gene/Protein	Spo5,96,100,Gene/Protein	Pcr1,188,192,Gene/Protein	"[{""token"": ""Pcr1"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""spo5"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""Spo5"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""Spo5"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""Pcr1"", ""start_span"": 188, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
h 90 spo5 ( S365P )- GFP - kan ade6 - M216 leu1 ura4	spo5,5,9,Gene/Protein	GFP,21,24,Gene/Protein	ade6,31,35,Gene/Protein	leu1,43,47,Gene/Protein	ura4,48,52,Gene/Protein	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene/Protein""}]"	train
h 90 spo5 ( F341L )- GFP - kan ade6 - M216 leu1 ura4	spo5,5,9,Gene/Protein	GFP,21,24,Gene/Protein	ade6,31,35,Gene/Protein	leu1,43,47,Gene/Protein	ura4,48,52,Gene/Protein	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene/Protein""}]"	train
h 90 spo5 - GFP - kan ade6 - M216 leu1 ura4	spo5,5,9,Gene/Protein	GFP,12,15,Gene/Protein	ade6,22,26,Gene/Protein	leu1,34,38,Gene/Protein	ura4,39,43,Gene/Protein	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene/Protein""}]"	train
h 90 spo5 ( 1 – 296 )- GFP - kan ade6 - M216 leu1 ura4	spo5,5,9,Gene/Protein	GFP,23,26,Gene/Protein	ade6,33,37,Gene/Protein	leu1,45,49,Gene/Protein	ura4,50,54,Gene/Protein	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}]"	train
h 90 spo5 ( 1 – 366 )- GFP - kan ade6 - M216 leu1 ura4	spo5,5,9,Gene/Protein	GFP,23,26,Gene/Protein	ade6,33,37,Gene/Protein	leu1,45,49,Gene/Protein	ura4,50,54,Gene/Protein	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}]"	train
h 90 spo5 ( 1 – 456 )- GFP - kan ade6 - M216 leu1 ura4	spo5,5,9,Gene/Protein	GFP,23,26,Gene/Protein	ade6,33,37,Gene/Protein	leu1,45,49,Gene/Protein	ura4,50,54,Gene/Protein	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}]"	train
h 90 spo5 ( 1 – 525 )- GFP - kan ade6 - M216 leu1 ura4	spo5,5,9,Gene/Protein	GFP,23,26,Gene/Protein	ade6,33,37,Gene/Protein	leu1,45,49,Gene/Protein	ura4,50,54,Gene/Protein	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}]"	train
h 90 spo5 :: ura4 + ade6 - M216 leu1 ura4	spo5,5,9,Gene/Protein	ura4,13,17,Gene/Protein	ade6,20,24,Gene/Protein	leu1,32,36,Gene/Protein	ura4,37,41,Gene/Protein	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 20, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}]"	train
h 90 spo5 + NLS - GFP - kan ade6 - M216 leu1 ura4	spo5,5,9,Gene/Protein	GFP,18,21,Gene/Protein	ade6,28,32,Gene/Protein	leu1,40,44,Gene/Protein	ura4,45,49,Gene/Protein	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene/Protein""}]"	train
The pREP1 plasmids carrying the atf1 +, atf21 +, and atf31 + genes were a gift from Takatomi Yamada [ 37 ], and we subsequently replaced their nmt1 promoters with the nmt81 promoter.	atf1,32,36,Gene/Protein	atf21,40,45,Gene/Protein	atf31,53,58,Gene/Protein	nmt1,143,147,Gene/Protein	nmt81,167,172,Gene/Protein	"[{""token"": ""atf1"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""atf21"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""atf31"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""nmt1"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""nmt81"", ""start_span"": 167, ""end_span"": 172, ""type"": ""Gene/Protein""}]"	train
The α - Melanocyte Stimulating Hormone ( αMSH )/ Melanocortin - 1 receptor ( MC1R) interaction promotes melanogenesis through the cAMP / PKA pathway.	α - Melanocyte Stimulating Hormone,4,38,Gene/Protein	αMSH,41,45,Gene/Protein	Melanocortin - 1 receptor,49,74,Gene/Protein	MC1R,77,81,Gene/Protein	PKA,137,140,Gene/Protein	"[{""token"": ""\u03b1 - Melanocyte Stimulating Hormone"", ""start_span"": 4, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""\u03b1MSH"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""Melanocortin - 1 receptor"", ""start_span"": 49, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""MC1R"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""PKA"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Gene/Protein""}]"	train
We employed B16 - F10 cell line, a human melanoma cell line ( Mel 13) and two primary cultures of human melanocytes ( NHM 1 and NHM 2, respectively ), all expressing a wild type MC1R and responding to the αMSH in terms of pigmentation.	human,35,40,Organism/Species	melanoma,41,49,Disease/Disorder	human,98,103,Organism/Species	MC1R,178,182,Gene/Protein	αMSH,205,209,Gene/Protein	"[{""token"": ""human"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Organism/Species""}, {""token"": ""melanoma"", ""start_span"": 41, ""end_span"": 49, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Organism/Species""}, {""token"": ""MC1R"", ""start_span"": 178, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""\u03b1MSH"", ""start_span"": 205, ""end_span"": 209, ""type"": ""Gene/Protein""}]"	train
Further experiments, treating melanoma cell lines with αMSH in the presence / absence of GW9662, as an inhibitor of PPARγ, confirmed the key role of this transcription factor in decreasing cell proliferation in response to the hormone exposure.	melanoma,30,38,Disease/Disorder	αMSH,55,59,Gene/Protein	GW9662,89,95,Chemical/Drug	PPARγ,116,121,Gene/Protein	transcription factor,154,174,Gene/Protein	"[{""token"": ""melanoma"", ""start_span"": 30, ""end_span"": 38, ""type"": ""Disease/Disorder""}, {""token"": ""\u03b1MSH"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""GW9662"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""PPAR\u03b3"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 154, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	train
The Melanocortin - 1 receptor ( MC1R ), expressed on the surface of melanocytes and melanoma cells, and its ligand, the α - Melanocyte Stimulating Hormone ( αMSH ), represent a key interaction in the control of melanogenesis [ 1 – 4 ].	Melanocortin - 1 receptor,4,29,Gene/Protein	MC1R,32,36,Gene/Protein	melanoma,84,92,Disease/Disorder	α - Melanocyte Stimulating Hormone,120,154,Gene/Protein	αMSH,157,161,Gene/Protein	"[{""token"": ""Melanocortin - 1 receptor"", ""start_span"": 4, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""MC1R"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""melanoma"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Disease/Disorder""}, {""token"": ""\u03b1 - Melanocyte Stimulating Hormone"", ""start_span"": 120, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""\u03b1MSH"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	train
MC1R activation stimulates cAMP synthesis via G - protein, which in turn mediates the phosphorylation of the cAMP responsive element - binding protein ( CREB) transcription factor.	MC1R,0,4,Gene/Protein	G - protein,46,57,Gene/Protein	cAMP responsive element - binding protein,109,150,Gene/Protein	CREB,153,157,Gene/Protein	transcription factor,159,179,Gene/Protein	"[{""token"": ""MC1R"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""G - protein"", ""start_span"": 46, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""cAMP responsive element - binding protein"", ""start_span"": 109, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""transcription factor"", ""start_span"": 159, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
We previously identified a new pathway between αMSH and Peroxisome Proliferator Activated Receptor ( PPARγ) on B16 - F10 mouse melanoma cell line [ 7 ].	αMSH,47,51,Gene/Protein	Peroxisome Proliferator Activated Receptor,56,98,Gene/Protein	PPARγ,101,106,Gene/Protein	mouse,121,126,Organism/Species	melanoma,127,135,Disease/Disorder	"[{""token"": ""\u03b1MSH"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""Peroxisome Proliferator Activated Receptor"", ""start_span"": 56, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""PPAR\u03b3"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Organism/Species""}, {""token"": ""melanoma"", ""start_span"": 127, ""end_span"": 135, ""type"": ""Disease/Disorder""}]"	train
Furthermore, we aimed to deepen the knowledge of the mechanism responsible for the down - proliferative response of melanoma cells after exposure to αMSH, by analyzing cell proliferation and protein levels of p27, p21, cyclin D1 and E, as typical proliferation modulators.	melanoma,116,124,Disease/Disorder	αMSH,149,153,Gene/Protein	p27,209,212,Gene/Protein	p21,214,217,Gene/Protein	cyclin D1,219,228,Gene/Protein	"[{""token"": ""melanoma"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Disease/Disorder""}, {""token"": ""\u03b1MSH"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""p27"", ""start_span"": 209, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""p21"", ""start_span"": 214, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""cyclin D1"", ""start_span"": 219, ""end_span"": 228, ""type"": ""Gene/Protein""}]"	train
The following doses of chemicals were employed: 10 − 7 M αMSH ( Sigma - Aldrich Srl, Milan, Italy ); 3 μM GW9662 ( Sigma - Aldrich Srl, Milan, Italy) a potent and irreversible antagonist of PPARγ [ 29 ]; 15 μM 3 M3 - FBS ( 3 M3) ( Merck KGaA, Darmstadt, Germany ), a PLC inducer [ 30 ]; 1 μM Forskolin ( FSK) ( Sigma - Sigma - Aldrich Srl, Milan, Italy ), a cAMP - stimulating agent [ 8 ].	αMSH,57,61,Gene/Protein	GW9662,106,112,Chemical/Drug	PPARγ,190,195,Gene/Protein	PLC,267,270,Gene/Protein	Forskolin,292,301,Chemical/Drug	"[{""token"": ""\u03b1MSH"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""GW9662"", ""start_span"": 106, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""PPAR\u03b3"", ""start_span"": 190, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""PLC"", ""start_span"": 267, ""end_span"": 270, ""type"": ""Gene/Protein""}, {""token"": ""Forskolin"", ""start_span"": 292, ""end_span"": 301, ""type"": ""Chemical/Drug""}]"	train
We investigated the capacity of αMSH to modulate proliferation in primary human melanocytes NHM 1 and NHM 2, in B16 - F10 murine melanoma cell line and in the Mel 13 human melanoma cell line.	αMSH,32,36,Gene/Protein	human,74,79,Organism/Species	melanoma,129,137,Disease/Disorder	human,166,171,Organism/Species	melanoma,172,180,Disease/Disorder	"[{""token"": ""\u03b1MSH"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Organism/Species""}, {""token"": ""melanoma"", ""start_span"": 129, ""end_span"": 137, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 166, ""end_span"": 171, ""type"": ""Organism/Species""}, {""token"": ""melanoma"", ""start_span"": 172, ""end_span"": 180, ""type"": ""Disease/Disorder""}]"	train
Thus, these results indicate that αMSH exerted a mitogenic effect in primary human melanocytes while it reduced melanoma cell proliferation. Fig. 1αMSH acts as a mitogenic agent in NHMs, whereas it determined a slow down of proliferation in B16 - F10 and Mel 13 melanoma cell lines. a Analysis of cell number performed on NHM 1 and NHM 2, after treatment with 10 − 7 M αMSH for 72 h and 6 days.	αMSH,34,38,Gene/Protein	human,77,82,Organism/Species	melanoma,112,120,Disease/Disorder	melanoma,262,270,Disease/Disorder	αMSH,369,373,Gene/Protein	"[{""token"": ""\u03b1MSH"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Organism/Species""}, {""token"": ""melanoma"", ""start_span"": 112, ""end_span"": 120, ""type"": ""Disease/Disorder""}, {""token"": ""melanoma"", ""start_span"": 262, ""end_span"": 270, ""type"": ""Disease/Disorder""}, {""token"": ""\u03b1MSH"", ""start_span"": 369, ""end_span"": 373, ""type"": ""Gene/Protein""}]"	train
Data are mean values ± SD of three independent experiments performed in duplicate. * p < 0. 01 ( vs untreated cells ). e Western blot analysis of p27 ( 4 h ), p21 ( 48 h ), cyclin D1 and cyclin E ( 6 h) protein expression on cell lysate of B16 - F10 and Mel 13, treated with 10 − 7 M αMSH.	p27,146,149,Gene/Protein	p21,159,162,Gene/Protein	cyclin D1,173,182,Gene/Protein	cyclin E,187,195,Gene/Protein	αMSH,284,288,Gene/Protein	"[{""token"": ""p27"", ""start_span"": 146, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""p21"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""cyclin D1"", ""start_span"": 173, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""cyclin E"", ""start_span"": 187, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""\u03b1MSH"", ""start_span"": 284, ""end_span"": 288, ""type"": ""Gene/Protein""}]"	train
The first series of experiments evidenced that while in primary cultures of human melanocytes the αMSH acted as a mitogenic agent [ 1, 3 ], in Mel 13 human melanoma cell line and in the B16 - F10 murine melanoma cell line, this hormone did not exert the same effect.	human,76,81,Organism/Species	αMSH,98,102,Gene/Protein	human,150,155,Organism/Species	melanoma,156,164,Disease/Disorder	melanoma,203,211,Disease/Disorder	"[{""token"": ""human"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Organism/Species""}, {""token"": ""\u03b1MSH"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 150, ""end_span"": 155, ""type"": ""Organism/Species""}, {""token"": ""melanoma"", ""start_span"": 156, ""end_span"": 164, ""type"": ""Disease/Disorder""}, {""token"": ""melanoma"", ""start_span"": 203, ""end_span"": 211, ""type"": ""Disease/Disorder""}]"	train
Subsequent experiments, carried out by stimulating the cells with 3 M3 ( or αMSH ), after inhibition of PPARγ with GW9662, led to similar results in the two conditions, thereby highlighting the role of PPARγ as an effector element ( triggered by the active PI ( 4, 5) P2 / PLC pathway) capable of mediating the phenomenon.	αMSH,76,80,Gene/Protein	PPARγ,104,109,Gene/Protein	GW9662,115,121,Chemical/Drug	PPARγ,202,207,Gene/Protein	PLC,273,276,Gene/Protein	"[{""token"": ""\u03b1MSH"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""PPAR\u03b3"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""GW9662"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Chemical/Drug""}, {""token"": ""PPAR\u03b3"", ""start_span"": 202, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""PLC"", ""start_span"": 273, ""end_span"": 276, ""type"": ""Gene/Protein""}]"	train
For example, Arabidopsis thaliana INDUCER OF CBF EXPRESSION1 ( ICE1) and ICE2 and their homologs in several different plants are reported to play key roles in mediating cold responses ( Chinnusamy et al ., 2003; Feng et al ., 2012; Huang et al ., 2013 ).	Arabidopsis thaliana,13,33,Organism/Species	INDUCER OF CBF EXPRESSION1,34,60,Gene/Protein	ICE1,63,67,Gene/Protein	ICE2,73,77,Gene/Protein	plants,118,124,Organism/Species	"[{""token"": ""Arabidopsis thaliana"", ""start_span"": 13, ""end_span"": 33, ""type"": ""Organism/Species""}, {""token"": ""INDUCER OF CBF EXPRESSION1"", ""start_span"": 34, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""ICE1"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""ICE2"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""plants"", ""start_span"": 118, ""end_span"": 124, ""type"": ""Organism/Species""}]"	train
To examine the subcellular distribution of the CsbHLH18 protein, the fusion vector ( CsbHLH18 – YFP) and the control vector ( YFP) were transiently expressed in tobacco leaves.	CsbHLH18,47,55,Gene/Protein	CsbHLH18,85,93,Gene/Protein	YFP,96,99,Gene/Protein	YFP,126,129,Gene/Protein	tobacco,161,168,Organism/Species	"[{""token"": ""CsbHLH18"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""CsbHLH18"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""YFP"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""YFP"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""tobacco"", ""start_span"": 161, ""end_span"": 168, ""type"": ""Organism/Species""}]"	train
First, trifoliate orange is closely related to sweet orange; CsbHLH18 shares > 98% nucleotide sequence identity with its counterpart gene of trifoliate orange ( Supplementary Fig.	trifoliate orange,7,24,Organism/Species	sweet orange,47,59,Organism/Species	CsbHLH18,61,69,Gene/Protein	nucleotide,83,93,Chemical/Drug	trifoliate orange,141,158,Organism/Species	"[{""token"": ""trifoliate orange"", ""start_span"": 7, ""end_span"": 24, ""type"": ""Organism/Species""}, {""token"": ""sweet orange"", ""start_span"": 47, ""end_span"": 59, ""type"": ""Organism/Species""}, {""token"": ""CsbHLH18"", ""start_span"": 61, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""nucleotide"", ""start_span"": 83, ""end_span"": 93, ""type"": ""Chemical/Drug""}, {""token"": ""trifoliate orange"", ""start_span"": 141, ""end_span"": 158, ""type"": ""Organism/Species""}]"	train
Nevertheless, the absence of interaction between CsbHLH18 and promoters of CsSOD and CsCAT genes is intriguing as their transcript levels were altered in the same manner as that of CsPOD in the transgenic plants.	CsbHLH18,49,57,Gene/Protein	CsSOD,75,80,Gene/Protein	CsCAT,85,90,Gene/Protein	CsPOD,181,186,Gene/Protein	plants,205,211,Organism/Species	"[{""token"": ""CsbHLH18"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""CsSOD"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""CsCAT"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""CsPOD"", ""start_span"": 181, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""plants"", ""start_span"": 205, ""end_span"": 211, ""type"": ""Organism/Species""}]"	train
Henoch — Schoenlein purpura is the one of most common types of systemic vasculitis that involves impaired renal function and Henoch - Schoenlein purpura nephritis ( HSPN ).	Henoch — Schoenlein purpura,0,27,Disease/Disorder	systemic vasculitis,63,82,Disease/Disorder	impaired renal function,97,120,Disease/Disorder	Henoch - Schoenlein purpura nephritis,125,162,Disease/Disorder	HSPN,165,169,Disease/Disorder	"[{""token"": ""Henoch \u2014 Schoenlein purpura"", ""start_span"": 0, ""end_span"": 27, ""type"": ""Disease/Disorder""}, {""token"": ""systemic vasculitis"", ""start_span"": 63, ""end_span"": 82, ""type"": ""Disease/Disorder""}, {""token"": ""impaired renal function"", ""start_span"": 97, ""end_span"": 120, ""type"": ""Disease/Disorder""}, {""token"": ""Henoch - Schoenlein purpura nephritis"", ""start_span"": 125, ""end_span"": 162, ""type"": ""Disease/Disorder""}, {""token"": ""HSPN"", ""start_span"": 165, ""end_span"": 169, ""type"": ""Disease/Disorder""}]"	train
Following treatment, the numbers of CD38 + CD19 + and CD86 + CD19 + B cells per microliter of blood were significantly reduced in HSPN patients.	CD38,36,40,Gene/Protein	CD19,43,47,Gene/Protein	CD86,54,58,Gene/Protein	CD19,61,65,Gene/Protein	HSPN,130,134,Disease/Disorder	"[{""token"": ""CD38"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""CD86"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""HSPN"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Disease/Disorder""}]"	train
Normal values: lymphocytes: 1. 10 – 3. 20 ( 109 / L ), serum albumin: 40. 00 – 55. 00 g / L, serum uric acid: 210 – 430 μmol / L, triglycerides: 0. 28 – 1. 6 mmol / L, cholesterol: 2. 6 – 6. 0 mmol / L, urinary protein: < 0. 2 g / 24 h, urea nitrogen: 3. 2 – 7. 0 mmol / L, eGFR: 80 – 120 ml / min.	albumin,61,68,Gene/Protein	uric acid,99,108,Chemical/Drug	triglycerides,130,143,Chemical/Drug	cholesterol,168,179,Chemical/Drug	urea,237,241,Chemical/Drug	"[{""token"": ""albumin"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""uric acid"", ""start_span"": 99, ""end_span"": 108, ""type"": ""Chemical/Drug""}, {""token"": ""triglycerides"", ""start_span"": 130, ""end_span"": 143, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 168, ""end_span"": 179, ""type"": ""Chemical/Drug""}, {""token"": ""urea"", ""start_span"": 237, ""end_span"": 241, ""type"": ""Chemical/Drug""}]"	train
We determined the concentrations of serum triglycerides, serum IgA cholesterol, albumin, uric acid, leukocytes and lymphocytes using ADVIA 1650 biochemical analyzer ( Bayer, Pittsburg, PA, USA ).	triglycerides,42,55,Chemical/Drug	IgA,63,66,Gene/Protein	cholesterol,67,78,Chemical/Drug	albumin,80,87,Gene/Protein	uric acid,89,98,Chemical/Drug	"[{""token"": ""triglycerides"", ""start_span"": 42, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""IgA"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""cholesterol"", ""start_span"": 67, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""albumin"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""uric acid"", ""start_span"": 89, ""end_span"": 98, ""type"": ""Chemical/Drug""}]"	train
There were also no significant differences in the serum albumin concentration, serum uric acid concentration, urea nitrogen concentration, triglycerides, cholesterol, and lymphocyte counts of experimental cases and HCs.	albumin,56,63,Gene/Protein	uric acid,85,94,Chemical/Drug	urea,110,114,Chemical/Drug	triglycerides,139,152,Chemical/Drug	cholesterol,154,165,Chemical/Drug	"[{""token"": ""albumin"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""uric acid"", ""start_span"": 85, ""end_span"": 94, ""type"": ""Chemical/Drug""}, {""token"": ""urea"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Chemical/Drug""}, {""token"": ""triglycerides"", ""start_span"": 139, ""end_span"": 152, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 154, ""end_span"": 165, ""type"": ""Chemical/Drug""}]"	train
However, there were no differences in the numbers of CD27 + CD19 + and CD27 + CD95 + CD19 + B cells ( data not shown ).	CD27,53,57,Gene/Protein	CD19,60,64,Gene/Protein	CD27,71,75,Gene/Protein	CD95,78,82,Gene/Protein	CD19,85,89,Gene/Protein	"[{""token"": ""CD27"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""CD27"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""CD95"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene/Protein""}]"	train
The cells were stained with anti - CD19, anti - CD5, anti - CD1d, and intracellular anti - IL - 10 or isotype - matched IgG.	CD19,35,39,Gene/Protein	CD5,48,51,Gene/Protein	CD1d,60,64,Gene/Protein	IL - 10,91,98,Gene/Protein	IgG,120,123,Gene/Protein	"[{""token"": ""CD19"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene/Protein""}]"	train
The fraction of CD38 + CD19 + B cells was negatively correlated with the serum IL - 10 concentration ( Fig 4A, P = 0. 0047, R = – 0. 6193) and the number of IL - 10 + CD19 + B cells per microliter of blood ( Fig 4B, P = 0. 0244, R = – 0. 514 ).	CD38,16,20,Gene/Protein	CD19,23,27,Gene/Protein	IL - 10,79,86,Gene/Protein	IL - 10,157,164,Gene/Protein	CD19,167,171,Gene/Protein	"[{""token"": ""CD38"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
In addition, the number of CD86 + CD19 + B cells was negatively correlated with the serum IL - 10 concentration ( Fig 4C, P = 0. 0226, R = – 0. 5195) and the number of IL - 10 + CD19 + B cells ( Fig 4D, P = 0. 0145, R = – 0. 5509 ).	CD86,27,31,Gene/Protein	CD19,34,38,Gene/Protein	IL - 10,90,97,Gene/Protein	IL - 10,168,175,Gene/Protein	CD19,178,182,Gene/Protein	"[{""token"": ""CD86"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 168, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 178, ""end_span"": 182, ""type"": ""Gene/Protein""}]"	train
( A - B) The number of CD38 + CD19 + B cells was negatively correlated with the serum IL - 10 level and the percentage of IL - 10 + CD19 + B cells.	CD38,23,27,Gene/Protein	CD19,30,34,Gene/Protein	IL - 10,86,93,Gene/Protein	IL - 10,122,129,Gene/Protein	CD19,132,136,Gene/Protein	"[{""token"": ""CD38"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene/Protein""}]"	train
( C - D) The number of CD86 + CD19 + B cells was negatively correlated with the serum IL - 10 level and the number of IL - 10 + CD19 + B cells.	CD86,23,27,Gene/Protein	CD19,30,34,Gene/Protein	IL - 10,86,93,Gene/Protein	IL - 10,118,125,Gene/Protein	CD19,128,132,Gene/Protein	"[{""token"": ""CD86"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}]"	train
Normal values: lymphocytes: 1. 10 – 3. 20 ( 109 / L ), serum albumin: 40. 00 – 55. 00 g / L, serum uric acid: 210 – 430 μmol / L, triglycerides: 0. 28 – 1. 6 mmol / L, cholesterol: 2. 6 – 6. 0 mmol / L, urinary proteins: < 0. 2 g / 24 h, urea nitrogen: 3. 2 – 7. 0 mmol / L, eGFR: 80 – 120 ml / min.	albumin,61,68,Gene/Protein	uric acid,99,108,Chemical/Drug	triglycerides,130,143,Chemical/Drug	cholesterol,168,179,Chemical/Drug	urea,238,242,Chemical/Drug	"[{""token"": ""albumin"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""uric acid"", ""start_span"": 99, ""end_span"": 108, ""type"": ""Chemical/Drug""}, {""token"": ""triglycerides"", ""start_span"": 130, ""end_span"": 143, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 168, ""end_span"": 179, ""type"": ""Chemical/Drug""}, {""token"": ""urea"", ""start_span"": 238, ""end_span"": 242, ""type"": ""Chemical/Drug""}]"	train
However, there were no significant differences in the numbers of CD27 + CD19 + and CD27 + CD95 + CD19 + B cells between the experimental and control groups.	CD27,65,69,Gene/Protein	CD19,72,76,Gene/Protein	CD27,83,87,Gene/Protein	CD95,90,94,Gene/Protein	CD19,97,101,Gene/Protein	"[{""token"": ""CD27"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""CD27"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""CD95"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}]"	train
Consequently, the number of circulating CD86 + CD19 + B cells, specifically CD38 + CD19 + B cells, may be associated with the pathogenesis of HSPN.	CD86,40,44,Gene/Protein	CD19,47,51,Gene/Protein	CD38,76,80,Gene/Protein	CD19,83,87,Gene/Protein	HSPN,142,146,Disease/Disorder	"[{""token"": ""CD86"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""CD38"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""HSPN"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Disease/Disorder""}]"	train
We have found that the number of CD38 + CD19 + B cells was negatively correlated with the serum IL - 10 concentration and the number of IL - 10 + CD19 + B cells per microliter of blood.	CD38,33,37,Gene/Protein	CD19,40,44,Gene/Protein	IL - 10,96,103,Gene/Protein	IL - 10,136,143,Gene/Protein	CD19,146,150,Gene/Protein	"[{""token"": ""CD38"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 136, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
Our findings suggest that CD38 + CD19 + B cells and Bregs may contribute to the pathogenesis of HSPN, and we also propose that CD38 + CD19 + B cells and Bregs can serve as biomarkers in the evaluation of the severity of disease.	CD38,26,30,Gene/Protein	CD19,33,37,Gene/Protein	HSPN,96,100,Disease/Disorder	CD38,127,131,Gene/Protein	CD19,134,138,Gene/Protein	"[{""token"": ""CD38"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""HSPN"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Disease/Disorder""}, {""token"": ""CD38"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Gene/Protein""}]"	train
Systematic review of the firefly genus Scissicauda ( Coleoptera, Lampyridae, Amydetinae) from Brazil	firefly,25,32,Organism/Species	Scissicauda,39,50,Organism/Species	Coleoptera,53,63,Organism/Species	Lampyridae,65,75,Organism/Species	Amydetinae,77,87,Organism/Species	"[{""token"": ""firefly"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Organism/Species""}, {""token"": ""Scissicauda"", ""start_span"": 39, ""end_span"": 50, ""type"": ""Organism/Species""}, {""token"": ""Coleoptera"", ""start_span"": 53, ""end_span"": 63, ""type"": ""Organism/Species""}, {""token"": ""Lampyridae"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Organism/Species""}, {""token"": ""Amydetinae"", ""start_span"": 77, ""end_span"": 87, ""type"": ""Organism/Species""}]"	train
Most of the females remain undescribed. McDermott ( 1966) assigned Amydetinae to subfamily level, keeping its subgroups as subtribes: Amydetina, Vestina and Psilocladina, the latter with five genera including Scissicauda.	Amydetinae,67,77,Organism/Species	Amydetina,134,143,Organism/Species	Vestina,145,152,Organism/Species	Psilocladina,157,169,Organism/Species	Scissicauda,209,220,Organism/Species	"[{""token"": ""Amydetinae"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Organism/Species""}, {""token"": ""Amydetina"", ""start_span"": 134, ""end_span"": 143, ""type"": ""Organism/Species""}, {""token"": ""Vestina"", ""start_span"": 145, ""end_span"": 152, ""type"": ""Organism/Species""}, {""token"": ""Psilocladina"", ""start_span"": 157, ""end_span"": 169, ""type"": ""Organism/Species""}, {""token"": ""Scissicauda"", ""start_span"": 209, ""end_span"": 220, ""type"": ""Organism/Species""}]"	train
Males with antennae flabellate ( Fig. 10) ( filiform in Scissicauda balena sp. n .), anterior pro and mesoclaws bifid ( Fig. 29) ( entire in Scissicauda balena sp. n .), phallus dorsal plate strongly rounded basally, phallic groove at apical one third, strongly curved ( subtruncate basally, phallic groove at half its length, moderately curved in Scissicauda balena sp. n .); ventral plate at least 2 × phallobase length ( slightly shorter than phallobase in Scissicauda balena sp. n .); parameres ventrobasal process rudimentary ( Figs 36 – 41) ( digitiform, extending slightly beyond ventral plate, shorter than paramere itself in Scissicauda balena sp. n ., Figs 63 – 66 ).	Scissicauda,56,67,Organism/Species	Scissicauda,141,152,Organism/Species	Scissicauda,348,359,Organism/Species	Scissicauda,460,471,Organism/Species	Scissicauda,634,645,Organism/Species	"[{""token"": ""Scissicauda"", ""start_span"": 56, ""end_span"": 67, ""type"": ""Organism/Species""}, {""token"": ""Scissicauda"", ""start_span"": 141, ""end_span"": 152, ""type"": ""Organism/Species""}, {""token"": ""Scissicauda"", ""start_span"": 348, ""end_span"": 359, ""type"": ""Organism/Species""}, {""token"": ""Scissicauda"", ""start_span"": 460, ""end_span"": 471, ""type"": ""Organism/Species""}, {""token"": ""Scissicauda"", ""start_span"": 634, ""end_span"": 645, ""type"": ""Organism/Species""}]"	train
Males with antennal lamellae absent ( Fig. 54) ( present in Scissicauda disjuncta, Fig. 10 ), anterior pro and mesoclaws entire ( bifid in Scissicauda disjuncta ), phallus dorsal plate subtruncate basally, phallic groove at half of its length, moderately curved ( strongly rounded basally, phallic groove at apical one third, strongly curved in Scissicauda disjuncta ); ventral plate at least 2 × phallobase length ( slightly shorter than phallobase in Scissicauda disjuncta ); parameres ventrobasal process digitiform, extending slightly beyond ventral plate, shorter than paramere itself ( Figs 63 – 66) ( process rudimentary in Scissicauda disjuncta, Figs 36 – 41 ).	Scissicauda,60,71,Organism/Species	Scissicauda,139,150,Organism/Species	Scissicauda,345,356,Organism/Species	Scissicauda,453,464,Organism/Species	Scissicauda,631,642,Organism/Species	"[{""token"": ""Scissicauda"", ""start_span"": 60, ""end_span"": 71, ""type"": ""Organism/Species""}, {""token"": ""Scissicauda"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Organism/Species""}, {""token"": ""Scissicauda"", ""start_span"": 345, ""end_span"": 356, ""type"": ""Organism/Species""}, {""token"": ""Scissicauda"", ""start_span"": 453, ""end_span"": 464, ""type"": ""Organism/Species""}, {""token"": ""Scissicauda"", ""start_span"": 631, ""end_span"": 642, ""type"": ""Organism/Species""}]"	train
In studies of infectious disease cohorts ( Chaussabel et al ., 2008 ), including Tuberculosis, Staphylococcus, and HIV, Axes 5, 6, and 7 are typically associated with active infection ( in preparation ).	infectious disease,14,32,Disease/Disorder	Tuberculosis,81,93,Disease/Disorder	Staphylococcus,95,109,Organism/Species	HIV,115,118,Organism/Species	infection,174,183,Disease/Disorder	"[{""token"": ""infectious disease"", ""start_span"": 14, ""end_span"": 32, ""type"": ""Disease/Disorder""}, {""token"": ""Tuberculosis"", ""start_span"": 81, ""end_span"": 93, ""type"": ""Disease/Disorder""}, {""token"": ""Staphylococcus"", ""start_span"": 95, ""end_span"": 109, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Organism/Species""}, {""token"": ""infection"", ""start_span"": 174, ""end_span"": 183, ""type"": ""Disease/Disorder""}]"	train
( A ‐ C) Real ‐ time quantitative PCR analysis of Collagen I ( A ), Collagen IV ( B) and TGF ‐ β1 ( C) mRNA levels in kidney tissues of wild ‐ type B6 and MD2 KO mice.	Collagen I,50,60,Gene/Protein	Collagen IV,68,79,Gene/Protein	TGF ‐ β1,89,97,Gene/Protein	MD2,155,158,Gene/Protein	mice,162,166,Organism/Species	"[{""token"": ""Collagen I"", ""start_span"": 50, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""Collagen IV"", ""start_span"": 68, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""TGF \u2010 \u03b21"", ""start_span"": 89, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""MD2"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Organism/Species""}]"	train
As these cytokines and adhesion molecule are elevated only in the B6 mice on HFD, the results clearly show inhibited inflammatory activity in the MD2 deficient mice.	cytokines,9,18,Gene/Protein	adhesion molecule,23,40,Gene/Protein	B6 mice,66,73,Organism/Species	MD2,146,149,Gene/Protein	mice,160,164,Organism/Species	"[{""token"": ""cytokines"", ""start_span"": 9, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""adhesion molecule"", ""start_span"": 23, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""B6 mice"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Organism/Species""}, {""token"": ""MD2"", ""start_span"": 146, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Organism/Species""}]"	train
Studies have shown that MAPK and NF ‐ κB are downstream of MD2 / TLR4 complex and these signalling pathways are also the predominant ones activated in renal tissue in mice on HFD 9, 11.	MAPK,24,28,Gene/Protein	NF ‐ κB,33,40,Gene/Protein	MD2,59,62,Gene/Protein	TLR4,65,69,Gene/Protein	mice,167,171,Organism/Species	"[{""token"": ""MAPK"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""NF \u2010 \u03baB"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""MD2"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""TLR4"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Organism/Species""}]"	train
( D ‐ F) Pro ‐ inflammatory cytokines in kidney tissues of PA ‐ challenged mice showing TNF ‐ α ( D ), IL ‐ 6 ( E) and chemotactic factor MCP ‐ 1 ( F ).	Pro ‐ inflammatory cytokines,9,37,Gene/Protein	mice,75,79,Organism/Species	TNF ‐ α,88,95,Gene/Protein	IL ‐ 6,103,109,Gene/Protein	MCP ‐ 1,138,145,Gene/Protein	"[{""token"": ""Pro \u2010 inflammatory cytokines"", ""start_span"": 9, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Organism/Species""}, {""token"": ""TNF \u2010 \u03b1"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""IL \u2010 6"", ""start_span"": 103, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""MCP \u2010 1"", ""start_span"": 138, ""end_span"": 145, ""type"": ""Gene/Protein""}]"	train
We next examined pro ‐ inflammatory factor expression in PA ‐ challenged mice and show increased TNF ‐ α, IL ‐ 6 and MCP ‐ 1 protein in B6 mice ( Fig. 4D – F ).	mice,73,77,Organism/Species	TNF ‐ α,97,104,Gene/Protein	IL ‐ 6,106,112,Gene/Protein	MCP ‐ 1,117,124,Gene/Protein	B6 mice,136,143,Organism/Species	"[{""token"": ""mice"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Organism/Species""}, {""token"": ""TNF \u2010 \u03b1"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""IL \u2010 6"", ""start_span"": 106, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""MCP \u2010 1"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Gene/Protein""}, {""token"": ""B6 mice"", ""start_span"": 136, ""end_span"": 143, ""type"": ""Organism/Species""}]"	train
PA also induced renal tissue mRNA expression of cytokines and adhesion molecules in B6 mice but not the MD2 KO mice ( Fig. S13C – G ).	cytokines,48,57,Gene/Protein	adhesion molecules,62,80,Gene/Protein	B6 mice,84,91,Organism/Species	MD2,104,107,Gene/Protein	mice,111,115,Organism/Species	"[{""token"": ""cytokines"", ""start_span"": 48, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""adhesion molecules"", ""start_span"": 62, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""B6 mice"", ""start_span"": 84, ""end_span"": 91, ""type"": ""Organism/Species""}, {""token"": ""MD2"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Organism/Species""}]"	train
Additionally, increases in IL - 6 - type cytokines and members of the JAK - STAT ( Janus kinase signal transducer and activator of transcription) signaling pathway were shown in early pressure - induced optic nerve head ( ONH) injury [ 23 ].	IL - 6 - type cytokines,27,50,Gene/Protein	JAK,70,73,Gene/Protein	STAT,76,80,Gene/Protein	Janus kinase,83,95,Gene/Protein	signal transducer and activator of transcription,96,144,Gene/Protein	"[{""token"": ""IL - 6 - type cytokines"", ""start_span"": 27, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""JAK"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""STAT"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""Janus kinase"", ""start_span"": 83, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""signal transducer and activator of transcription"", ""start_span"": 96, ""end_span"": 144, ""type"": ""Gene/Protein""}]"	train
As the DBA / 2J model has shown pathological variability in the literature, we based our age groups for comparison on previous work published by ours and other lab groups [ 4, 7, 8, 28] and included the following: 3 – 5 - month - old mice ( D3 – 5) representing pre - glaucomatous ages, 8 – 10 - month - old mice ( D8 – 10) representing early glaucomatous pathology where anterograde transport deficits and mild axonopathy are evident, and 12 – 15 - month - old mice ( D12 – 15) representing increasing transport deficits and axonopathy characteristic of late glaucomatous pathology [ 4, 7, 8, 28 ].	mice,234,238,Organism/Species	mice,308,312,Organism/Species	axonopathy,412,422,Disease/Disorder	mice,462,466,Organism/Species	axonopathy,526,536,Disease/Disorder	"[{""token"": ""mice"", ""start_span"": 234, ""end_span"": 238, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 308, ""end_span"": 312, ""type"": ""Organism/Species""}, {""token"": ""axonopathy"", ""start_span"": 412, ""end_span"": 422, ""type"": ""Disease/Disorder""}, {""token"": ""mice"", ""start_span"": 462, ""end_span"": 466, ""type"": ""Organism/Species""}, {""token"": ""axonopathy"", ""start_span"": 526, ""end_span"": 536, ""type"": ""Disease/Disorder""}]"	train
Following three 10 - min washes with PBS, secondary antibody cocktail was added for 2 h at room temperature, which contained donkey anti - rabbit Alexafluor 594 ( 1: 250, Jackson Laboratories, 711 - 586 - 152; West Grove, PA) and donkey anti - mouse Alexafluor 647 ( 1: 250, Invitrogen, A - 31571; Grand Island, NY ).	antibody,52,60,Gene/Protein	donkey,125,131,Organism/Species	rabbit,139,145,Organism/Species	donkey,230,236,Organism/Species	mouse,244,249,Organism/Species	"[{""token"": ""antibody"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""donkey"", ""start_span"": 125, ""end_span"": 131, ""type"": ""Organism/Species""}, {""token"": ""rabbit"", ""start_span"": 139, ""end_span"": 145, ""type"": ""Organism/Species""}, {""token"": ""donkey"", ""start_span"": 230, ""end_span"": 236, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 244, ""end_span"": 249, ""type"": ""Organism/Species""}]"	train
For all cytokines shown, with the exception of IL - 1β and MCP - 1, there was a significant age - dependent increase in D2G control mice that was not apparent in DBA / 2J mice.	cytokines,8,17,Gene/Protein	IL - 1β,47,54,Gene/Protein	MCP - 1,59,66,Gene/Protein	mice,132,136,Organism/Species	DBA / 2J mice,162,175,Organism/Species	"[{""token"": ""cytokines"", ""start_span"": 8, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1\u03b2"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""MCP - 1"", ""start_span"": 59, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Organism/Species""}, {""token"": ""DBA / 2J mice"", ""start_span"": 162, ""end_span"": 175, ""type"": ""Organism/Species""}]"	train
Pro - inflammatory cytokines and growth factors that showed a significant elevation in G12 – 15 compared to G3 – 5 mice were as follows: VEGF ( t ( 10) = 4. 025, p = 0. 002 ), MIG ( t ( 9) = 3. 572, p = 0. 006 ), and KC ( t ( 10) = 4. 698, p = 0. 001 ).	Pro - inflammatory cytokines,0,28,Gene/Protein	mice,115,119,Organism/Species	VEGF,137,141,Gene/Protein	MIG,176,179,Gene/Protein	KC,217,219,Gene/Protein	"[{""token"": ""Pro - inflammatory cytokines"", ""start_span"": 0, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Organism/Species""}, {""token"": ""VEGF"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""MIG"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""KC"", ""start_span"": 217, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
Differences in collicular IL - 6 levels emerged in 12 – 15 - month - old mice based on transport outcome, with transport absent regions ( CTB −) demonstrating significantly greater IL - 6 than transport intact ( CTB +) regions ( asterisk indicates p < 0. 05 ).	IL - 6,26,32,Gene/Protein	mice,73,77,Organism/Species	CTB,138,141,Gene/Protein	IL - 6,181,187,Gene/Protein	CTB,212,215,Gene/Protein	"[{""token"": ""IL - 6"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Organism/Species""}, {""token"": ""CTB"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 181, ""end_span"": 187, ""type"": ""Gene/Protein""}, {""token"": ""CTB"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Gene/Protein""}]"	train
This idea is supported by data in htau mice, a common neurodegenerative model for Alzheimer ’ s disease, which show elevated KC and MIG, among other pro - inflammatory mediators, within their cortex when compared to controls [ 40 ].	htau,34,38,Gene/Protein	mice,39,43,Organism/Species	Alzheimer ’ s disease,82,103,Disease/Disorder	KC,125,127,Gene/Protein	MIG,132,135,Gene/Protein	"[{""token"": ""htau"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Organism/Species""}, {""token"": ""Alzheimer \u2019 s disease"", ""start_span"": 82, ""end_span"": 103, ""type"": ""Disease/Disorder""}, {""token"": ""KC"", ""start_span"": 125, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""MIG"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene/Protein""}]"	train
Notably, IL - 1β was significantly elevated in both proximal and distal portions of the optic nerve in DBA / 2J mice compared to controls, indicating a possible role for this cytokine in distal axonopathy in glaucoma [ 4 ].	IL - 1β,9,16,Gene/Protein	DBA / 2J mice,103,116,Organism/Species	cytokine,175,183,Gene/Protein	distal axonopathy,187,204,Disease/Disorder	glaucoma,208,216,Disease/Disorder	"[{""token"": ""IL - 1\u03b2"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""DBA / 2J mice"", ""start_span"": 103, ""end_span"": 116, ""type"": ""Organism/Species""}, {""token"": ""cytokine"", ""start_span"": 175, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""distal axonopathy"", ""start_span"": 187, ""end_span"": 204, ""type"": ""Disease/Disorder""}, {""token"": ""glaucoma"", ""start_span"": 208, ""end_span"": 216, ""type"": ""Disease/Disorder""}]"	train
Schistosoma mansoni Soluble Egg Antigens Induce Expression of the Negative Regulators SOCS1 and SHP1 in Human Dendritic Cells via Interaction with the Mannose Receptor	Schistosoma mansoni,0,19,Organism/Species	SOCS1,86,91,Gene/Protein	SHP1,96,100,Gene/Protein	Human,104,109,Organism/Species	Mannose Receptor,151,167,Gene/Protein	"[{""token"": ""Schistosoma mansoni"", ""start_span"": 0, ""end_span"": 19, ""type"": ""Organism/Species""}, {""token"": ""SOCS1"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""SHP1"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""Human"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Organism/Species""}, {""token"": ""Mannose Receptor"", ""start_span"": 151, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
Schistosomiasis is a common debilitating human parasitic disease in ( sub) tropical areas, however, schistosome infections can also protect against a variety of inflammatory diseases.	Schistosomiasis,0,15,Disease/Disorder	human,41,46,Organism/Species	parasitic disease,47,64,Disease/Disorder	schistosome infections,100,122,Disease/Disorder	inflammatory diseases,161,182,Disease/Disorder	"[{""token"": ""Schistosomiasis"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Organism/Species""}, {""token"": ""parasitic disease"", ""start_span"": 47, ""end_span"": 64, ""type"": ""Disease/Disorder""}, {""token"": ""schistosome infections"", ""start_span"": 100, ""end_span"": 122, ""type"": ""Disease/Disorder""}, {""token"": ""inflammatory diseases"", ""start_span"": 161, ""end_span"": 182, ""type"": ""Disease/Disorder""}]"	train
Remarkably, interaction of SEA glycans with DCs results in a strongly increased expression of Suppressor Of Cytokine Signalling1 ( SOCS1) and SH2 - containing protein tyrosine Phosphatase - 1 ( SHP1 ), important negative regulators of TLR4 signalling.	Suppressor Of Cytokine Signalling1,94,128,Gene/Protein	SOCS1,131,136,Gene/Protein	SH2 - containing protein tyrosine Phosphatase - 1,142,191,Gene/Protein	SHP1,194,198,Gene/Protein	TLR4,235,239,Gene/Protein	"[{""token"": ""Suppressor Of Cytokine Signalling1"", ""start_span"": 94, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""SOCS1"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""SH2 - containing protein tyrosine Phosphatase - 1"", ""start_span"": 142, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""SHP1"", ""start_span"": 194, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""TLR4"", ""start_span"": 235, ""end_span"": 239, ""type"": ""Gene/Protein""}]"	train
Recent data show that SEA contains components that suppress TLR - induced proinflammatory cytokine expression via DC - SIGN by activation of NF - κB family member Bcl3 [ 33 ].	TLR,60,63,Gene/Protein	proinflammatory cytokine,74,98,Gene/Protein	DC - SIGN,114,123,Gene/Protein	NF - κB,141,148,Gene/Protein	Bcl3,163,167,Gene/Protein	"[{""token"": ""TLR"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""proinflammatory cytokine"", ""start_span"": 74, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""DC - SIGN"", ""start_span"": 114, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""NF - \u03baB"", ""start_span"": 141, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""Bcl3"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
Human IL - 4 and recombinant human GM - CSF were purchased from Immunotools ( Germany ). Escherichia coli LPS ( strain 0111: B4) was purchased from Sigma - Aldrich ( USA ).	Human,0,5,Organism/Species	IL - 4,6,12,Gene/Protein	human,29,34,Organism/Species	GM - CSF,35,43,Gene/Protein	Escherichia coli,89,105,Organism/Species	"[{""token"": ""Human"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism/Species""}, {""token"": ""IL - 4"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Organism/Species""}, {""token"": ""GM - CSF"", ""start_span"": 35, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""Escherichia coli"", ""start_span"": 89, ""end_span"": 105, ""type"": ""Organism/Species""}]"	train
For flow cytometric analysis PE - conjugated mouse anti - human OX40L ( Ik - 1, BD Pharmingen, 1: 50) and anti - human PD - L1 ( eBioscience, MIH1, 1: 50) were used.	mouse,45,50,Organism/Species	human,58,63,Organism/Species	OX40L,64,69,Gene/Protein	human,113,118,Organism/Species	PD - L1,119,126,Gene/Protein	"[{""token"": ""mouse"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Organism/Species""}, {""token"": ""OX40L"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Organism/Species""}, {""token"": ""PD - L1"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene/Protein""}]"	train
IgG2b and IgG1κ control antibodies, for anti - DC - SIGN and anti - MR antibodies respectively, were purchased from BD ( USA ).	IgG1κ,10,15,Gene/Protein	antibodies,24,34,Gene/Protein	DC - SIGN,47,56,Gene/Protein	MR,68,70,Gene/Protein	antibodies,71,81,Gene/Protein	"[{""token"": ""IgG1\u03ba"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 24, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""DC - SIGN"", ""start_span"": 47, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""MR"", ""start_span"": 68, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 71, ""end_span"": 81, ""type"": ""Gene/Protein""}]"	train
PI treatment caused loss of binding by the recombinant CLR - Fc hybrids MGL - Fc, DC - SIGN - Fc and MR - Fc to SEA ( Fig 1A ), indicating that the glycan ligands for these CLRs were destroyed by PI treatment.	CLR,55,58,Gene/Protein	MGL,72,75,Gene/Protein	DC - SIGN,82,91,Gene/Protein	MR,101,103,Gene/Protein	CLRs,173,177,Gene/Protein	"[{""token"": ""CLR"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""MGL"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""DC - SIGN"", ""start_span"": 82, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""MR"", ""start_span"": 101, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""CLRs"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
Binding of IgG - Fc hybrid molecules of the C - type lectin receptors DC - SIGN, MGL and MR to untreated ( U) SEA, SEA treated with 10 mM periodate ( PI ), or heated at 80 ° C for 20 min ( DN) ( coated at 5 μg / ml) was assessed by ELISA.	IgG,11,14,Gene/Protein	C - type lectin receptors,44,69,Gene/Protein	DC - SIGN,70,79,Gene/Protein	MGL,81,84,Gene/Protein	MR,89,91,Gene/Protein	"[{""token"": ""IgG"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""C - type lectin receptors"", ""start_span"": 44, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""DC - SIGN"", ""start_span"": 70, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""MGL"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""MR"", ""start_span"": 89, ""end_span"": 91, ""type"": ""Gene/Protein""}]"	train
In A, B, and E, respectively, the mRNA levels of SEA - induced SOCS1, SOCS2, and SOCS3 are shown, whereas the protein levels of SOCS1 and SOCS2 are shown in C and D, respectively.	SOCS1,63,68,Gene/Protein	SOCS2,70,75,Gene/Protein	SOCS3,81,86,Gene/Protein	SOCS1,128,133,Gene/Protein	SOCS2,138,143,Gene/Protein	"[{""token"": ""SOCS1"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""SOCS2"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""SOCS3"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""SOCS1"", ""start_span"": 128, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""SOCS2"", ""start_span"": 138, ""end_span"": 143, ""type"": ""Gene/Protein""}]"	train
In regard to the mechanism by which SEA negatively regulates TLR4 signaling, we hypothesized that S. mansoni SEA has to be recognized and internalized by lectin - receptors present on DCs to suppress the cytokine production from LPS - activated DCs, and / or to enhance expression levels of SOCS1 and SHP1.	TLR4,61,65,Gene/Protein	lectin - receptors,154,172,Gene/Protein	cytokine,204,212,Gene/Protein	SOCS1,291,296,Gene/Protein	SHP1,301,305,Gene/Protein	"[{""token"": ""TLR4"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""lectin - receptors"", ""start_span"": 154, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""cytokine"", ""start_span"": 204, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""SOCS1"", ""start_span"": 291, ""end_span"": 296, ""type"": ""Gene/Protein""}, {""token"": ""SHP1"", ""start_span"": 301, ""end_span"": 305, ""type"": ""Gene/Protein""}]"	train
These data show that a complete loss of induction of both SOCS1 and SHP1 expression is associated with a loss of suppression of TNFα, but not IL - 6 production, indicating a difference between the regulation of expression or secretion of these cytokines.	SOCS1,58,63,Gene/Protein	SHP1,68,72,Gene/Protein	TNFα,128,132,Gene/Protein	IL - 6,142,148,Gene/Protein	cytokines,244,253,Gene/Protein	"[{""token"": ""SOCS1"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""SHP1"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""TNF\u03b1"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 142, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 244, ""end_span"": 253, ""type"": ""Gene/Protein""}]"	train
S. mansoni SEA induces SOCS1 and SHP1 in human dendritic cells ( DCs) via the mannose receptor ( MR ).	SOCS1,23,28,Gene/Protein	SHP1,33,37,Gene/Protein	human,41,46,Organism/Species	mannose receptor,78,94,Gene/Protein	MR,97,99,Gene/Protein	"[{""token"": ""SOCS1"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""SHP1"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Organism/Species""}, {""token"": ""mannose receptor"", ""start_span"": 78, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""MR"", ""start_span"": 97, ""end_span"": 99, ""type"": ""Gene/Protein""}]"	train
The data indicate that the blocking antibodies to MR, but not isotype control antibodies, significantly inhibit SEA - induced SOCS1 and SHP1 expression.	antibodies,36,46,Gene/Protein	MR,50,52,Gene/Protein	antibodies,78,88,Gene/Protein	SOCS1,126,131,Gene/Protein	SHP1,136,140,Gene/Protein	"[{""token"": ""antibodies"", ""start_span"": 36, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""MR"", ""start_span"": 50, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 78, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""SOCS1"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""SHP1"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene/Protein""}]"	train
Our data also reveal that the capacity of SEA to induce SOCS1 and SHP1 is glycan - dependent, since both oxidation of SEA glycans and blocking the binding of SEA to DCs by adding the mannose - mimic AllMan inhibit the induction of SOCS1 and SHP1 expression.	SOCS1,56,61,Gene/Protein	SHP1,66,70,Gene/Protein	mannose,183,190,Chemical/Drug	SOCS1,231,236,Gene/Protein	SHP1,241,245,Gene/Protein	"[{""token"": ""SOCS1"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""SHP1"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""mannose"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Chemical/Drug""}, {""token"": ""SOCS1"", ""start_span"": 231, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""SHP1"", ""start_span"": 241, ""end_span"": 245, ""type"": ""Gene/Protein""}]"	train
The capacity of SEA to upregulate mRNA levels of SOCS1 and SHP1 via the MR is difficult to associate with RNase activity of Omega - 1.	SOCS1,49,54,Gene/Protein	SHP1,59,63,Gene/Protein	MR,72,74,Gene/Protein	RNase,106,111,Gene/Protein	Omega - 1,124,133,Gene/Protein	"[{""token"": ""SOCS1"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""SHP1"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""MR"", ""start_span"": 72, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""RNase"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""Omega - 1"", ""start_span"": 124, ""end_span"": 133, ""type"": ""Gene/Protein""}]"	train
Accordingly, we hypothesized that: i) the fetal primate skin would mount a pro - inflammatory response to preterm birth associated pro - inflammatory agents ( lipopolysaccharides from Escherichia coli, live Ureaplasma parvum, interleukin - 1β) and; ii) that inhibiting interleukin - 1 signaling would decrease the skin inflammatory response.	primate,48,55,Organism/Species	Escherichia coli,184,200,Organism/Species	Ureaplasma parvum,207,224,Organism/Species	interleukin - 1β,226,242,Gene/Protein	interleukin - 1,269,284,Gene/Protein	"[{""token"": ""primate"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Organism/Species""}, {""token"": ""Escherichia coli"", ""start_span"": 184, ""end_span"": 200, ""type"": ""Organism/Species""}, {""token"": ""Ureaplasma parvum"", ""start_span"": 207, ""end_span"": 224, ""type"": ""Organism/Species""}, {""token"": ""interleukin - 1\u03b2"", ""start_span"": 226, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""interleukin - 1"", ""start_span"": 269, ""end_span"": 284, ""type"": ""Gene/Protein""}]"	train
Using sheep models of chorioamnionitis induced by the intraamniotic ( IA) administration of E. coli lipopolysaccharide ( LPS) or live Ureaplasma parvum ( UP) we reported that the fetal skin responded with increased inflammatory cells and cytokine expression in the dermis [ 11 – 13 ].	sheep,6,11,Organism/Species	chorioamnionitis,22,38,Disease/Disorder	Ureaplasma parvum,134,151,Organism/Species	UP,154,156,Organism/Species	cytokine,238,246,Gene/Protein	"[{""token"": ""sheep"", ""start_span"": 6, ""end_span"": 11, ""type"": ""Organism/Species""}, {""token"": ""chorioamnionitis"", ""start_span"": 22, ""end_span"": 38, ""type"": ""Disease/Disorder""}, {""token"": ""Ureaplasma parvum"", ""start_span"": 134, ""end_span"": 151, ""type"": ""Organism/Species""}, {""token"": ""UP"", ""start_span"": 154, ""end_span"": 156, ""type"": ""Organism/Species""}, {""token"": ""cytokine"", ""start_span"": 238, ""end_span"": 246, ""type"": ""Gene/Protein""}]"	train
The cytokines TNF - α, IL - 1α, and MCP - 1 did not change with LPS exposure, and IL - 10 was undetectable in association with LPS exposure.	cytokines,4,13,Gene/Protein	TNF - α,14,21,Gene/Protein	IL - 1α,23,30,Gene/Protein	MCP - 1,36,43,Gene/Protein	IL - 10,82,89,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""TNF - \u03b1"", ""start_span"": 14, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1\u03b1"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""MCP - 1"", ""start_span"": 36, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Gene/Protein""}]"	train
In contrast to LPS exposure, TNF - α increased significantly 15 fold at 3 days and 9 fold at 7 days, but IL - 10, IL - 1α, and MCP - 1 did not change with UP exposure ( Table 3 ).	TNF - α,29,36,Gene/Protein	IL - 10,105,112,Gene/Protein	IL - 1α,114,121,Gene/Protein	MCP - 1,127,134,Gene/Protein	UP,155,157,Organism/Species	"[{""token"": ""TNF - \u03b1"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1\u03b1"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""MCP - 1"", ""start_span"": 127, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""UP"", ""start_span"": 155, ""end_span"": 157, ""type"": ""Organism/Species""}]"	train
We performed immunohistochemistry ( IHC) for IL - 6, IL - 8, CD3, CD68, MPO and pancytokeratin.	IL - 6,45,51,Gene/Protein	IL - 8,53,59,Gene/Protein	CD3,61,64,Gene/Protein	CD68,66,70,Gene/Protein	MPO,72,75,Gene/Protein	"[{""token"": ""IL - 6"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""CD68"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""MPO"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Gene/Protein""}]"	train
Although IL - 8 transcript expression in the fetal skin was increased significantly both 16 and 48 hours post - LPS stimulation, we did not observe infiltrating neutrophils ( MPO ), leukocytes ( CD3 +) or infiltrating macrophages ( CD68 +) in fetal rhesus skin as we anticipated.	IL - 8,9,15,Gene/Protein	MPO,175,178,Gene/Protein	CD3,195,198,Gene/Protein	CD68,232,236,Gene/Protein	rhesus,249,255,Organism/Species	"[{""token"": ""IL - 8"", ""start_span"": 9, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""MPO"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 195, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""CD68"", ""start_span"": 232, ""end_span"": 236, ""type"": ""Gene/Protein""}, {""token"": ""rhesus"", ""start_span"": 249, ""end_span"": 255, ""type"": ""Organism/Species""}]"	train
In the present study, an injection of IL - 1β sufficient to induce chorioamnionitis and fetal inflammatory response [ 16] did not cause skin inflammation in the non - human primate.	IL - 1β,38,45,Gene/Protein	chorioamnionitis,67,83,Disease/Disorder	skin inflammation,136,153,Disease/Disorder	human,167,172,Organism/Species	primate,173,180,Organism/Species	"[{""token"": ""IL - 1\u03b2"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""chorioamnionitis"", ""start_span"": 67, ""end_span"": 83, ""type"": ""Disease/Disorder""}, {""token"": ""skin inflammation"", ""start_span"": 136, ""end_span"": 153, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 167, ""end_span"": 172, ""type"": ""Organism/Species""}, {""token"": ""primate"", ""start_span"": 173, ""end_span"": 180, ""type"": ""Organism/Species""}]"	train
IL - 1 is well established as a critical mediator of skin inflammation, with both IL - 1α and IL - 1β acting via IL - 1 receptor 1.	IL - 1,0,6,Gene/Protein	skin inflammation,53,70,Disease/Disorder	IL - 1α,82,89,Gene/Protein	IL - 1β,94,101,Gene/Protein	IL - 1 receptor 1,113,130,Gene/Protein	"[{""token"": ""IL - 1"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""skin inflammation"", ""start_span"": 53, ""end_span"": 70, ""type"": ""Disease/Disorder""}, {""token"": ""IL - 1\u03b1"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1\u03b2"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1 receptor 1"", ""start_span"": 113, ""end_span"": 130, ""type"": ""Gene/Protein""}]"	train
It is tempting to speculate as to why 10 ug of IA IL - 1β failed to elicit skin inflammation in the macaque fetus, despite being associated with pulmonary inflammation and chorioamnionitis.	IL - 1β,50,57,Gene/Protein	skin inflammation,75,92,Disease/Disorder	macaque,100,107,Organism/Species	pulmonary inflammation,145,167,Disease/Disorder	chorioamnionitis,172,188,Disease/Disorder	"[{""token"": ""IL - 1\u03b2"", ""start_span"": 50, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""skin inflammation"", ""start_span"": 75, ""end_span"": 92, ""type"": ""Disease/Disorder""}, {""token"": ""macaque"", ""start_span"": 100, ""end_span"": 107, ""type"": ""Organism/Species""}, {""token"": ""pulmonary inflammation"", ""start_span"": 145, ""end_span"": 167, ""type"": ""Disease/Disorder""}, {""token"": ""chorioamnionitis"", ""start_span"": 172, ""end_span"": 188, ""type"": ""Disease/Disorder""}]"	train
In addition, these compounds significantly increased the survival of the nematode Caenorhabditis elegans infected with Vibrio anguillarum, Vibrio harveyi and Vibrio vulnificus.	nematode,73,81,Organism/Species	Caenorhabditis elegans,82,104,Organism/Species	Vibrio anguillarum,119,137,Organism/Species	Vibrio harveyi,139,153,Organism/Species	Vibrio vulnificus,158,175,Organism/Species	"[{""token"": ""nematode"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Organism/Species""}, {""token"": ""Caenorhabditis elegans"", ""start_span"": 82, ""end_span"": 104, ""type"": ""Organism/Species""}, {""token"": ""Vibrio anguillarum"", ""start_span"": 119, ""end_span"": 137, ""type"": ""Organism/Species""}, {""token"": ""Vibrio harveyi"", ""start_span"": 139, ""end_span"": 153, ""type"": ""Organism/Species""}, {""token"": ""Vibrio vulnificus"", ""start_span"": 158, ""end_span"": 175, ""type"": ""Organism/Species""}]"	train
In this way, nucleophilic amino acid side chains ( e. g. the thiol groups of cysteine residues) in LuxR possibly react with the electrophilic β - position to form irreversible cinnamaldehyde - receptor conjugates.	amino acid,26,36,Chemical/Drug	thiol,61,66,Chemical/Drug	cysteine,77,85,Chemical/Drug	LuxR,99,103,Gene/Protein	cinnamaldehyde,176,190,Chemical/Drug	"[{""token"": ""amino acid"", ""start_span"": 26, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""thiol"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Chemical/Drug""}, {""token"": ""cysteine"", ""start_span"": 77, ""end_span"": 85, ""type"": ""Chemical/Drug""}, {""token"": ""LuxR"", ""start_span"": 99, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""cinnamaldehyde"", ""start_span"": 176, ""end_span"": 190, ""type"": ""Chemical/Drug""}]"	train
GST - LuxR was purified using Glutathione Uniflow resins ( Clontech, Mountain view, CA, USA) and fractions containing GST - LuxR were identified by both SDS - PAGE and capillary electrophoresis ( Experion PRO260 chip; Bio - rad laboratories, Nazareth Eke, Belgium ).	GST,0,3,Gene/Protein	LuxR,6,10,Gene/Protein	Glutathione,30,41,Chemical/Drug	GST,118,121,Gene/Protein	LuxR,124,128,Gene/Protein	"[{""token"": ""GST"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""LuxR"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""Glutathione"", ""start_span"": 30, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""GST"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""LuxR"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Gene/Protein""}]"	train
Numerous genome - wide association ( GWA) studies have recently been performed on bipolar disorder ( BD ), but few signals were replicated and meta - analyses identified only a couple of associated genes, such as CACNA1C, ODZ4 and NCAN, with a small effect size [ 1 ]–[ 4 ].	bipolar disorder,82,98,Disease/Disorder	BD,101,103,Disease/Disorder	CACNA1C,213,220,Gene/Protein	ODZ4,222,226,Gene/Protein	NCAN,231,235,Gene/Protein	"[{""token"": ""bipolar disorder"", ""start_span"": 82, ""end_span"": 98, ""type"": ""Disease/Disorder""}, {""token"": ""BD"", ""start_span"": 101, ""end_span"": 103, ""type"": ""Disease/Disorder""}, {""token"": ""CACNA1C"", ""start_span"": 213, ""end_span"": 220, ""type"": ""Gene/Protein""}, {""token"": ""ODZ4"", ""start_span"": 222, ""end_span"": 226, ""type"": ""Gene/Protein""}, {""token"": ""NCAN"", ""start_span"": 231, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	train
The eggs of Rhodnius and of Panstrongylus whose parentals were collected in Manabí presented a significantly larger operculum ( Table 2 ). Table 2Size variation of the complete egg ( sqrA and Perimeter) and of the operculum ( Centroid size) SpeciessqrAPerimeterCentroid sizeMeanVarianceMeanVarianceMeanVariance R. ecuadoriensis L1. 070. 00194. 51c 0. 0380. 670. 0012M1. 090. 0024. 65b 0. 0370. 740. 0012 T. carrioni 1. 220. 00294. 64b 0. 0420. 680. 0013 P. chinai 1. 320. 00254. 91a 0. 0310. 720. 0018 P. howardi 1. 280. 00254. 71b 0. 0350. 780. 002 Abbreviations: R Rhodnius, L Loja Province, M Manabí Province, T Triatoma, P Panstrongylus, sqrA, mean square root of the area within the egg boundary Note: All pairwise comparisons of mean sqrA were significant ( permutation test, 1000 cycles, P ranging from P = 0. 015 to P < 0. 0001 ).	Rhodnius,12,20,Organism/Species	Panstrongylus,28,41,Organism/Species	Rhodnius,567,575,Organism/Species	Triatoma,615,623,Organism/Species	Panstrongylus,627,640,Organism/Species	"[{""token"": ""Rhodnius"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Organism/Species""}, {""token"": ""Panstrongylus"", ""start_span"": 28, ""end_span"": 41, ""type"": ""Organism/Species""}, {""token"": ""Rhodnius"", ""start_span"": 567, ""end_span"": 575, ""type"": ""Organism/Species""}, {""token"": ""Triatoma"", ""start_span"": 615, ""end_span"": 623, ""type"": ""Organism/Species""}, {""token"": ""Panstrongylus"", ""start_span"": 627, ""end_span"": 640, ""type"": ""Organism/Species""}]"	train
Generally speaking, in the datasets with small sample sizes such as those for Melanoma, Brain Cancer, Lung Cancer 1, Lymphoma and Pancreatic Cancer, the single gene classifiers showed better or comparable classification results compared with the standard methods.	Melanoma,78,86,Disease/Disorder	Brain Cancer,88,100,Disease/Disorder	Lung Cancer,102,113,Disease/Disorder	Lymphoma,117,125,Disease/Disorder	Pancreatic Cancer,130,147,Disease/Disorder	"[{""token"": ""Melanoma"", ""start_span"": 78, ""end_span"": 86, ""type"": ""Disease/Disorder""}, {""token"": ""Brain Cancer"", ""start_span"": 88, ""end_span"": 100, ""type"": ""Disease/Disorder""}, {""token"": ""Lung Cancer"", ""start_span"": 102, ""end_span"": 113, ""type"": ""Disease/Disorder""}, {""token"": ""Lymphoma"", ""start_span"": 117, ""end_span"": 125, ""type"": ""Disease/Disorder""}, {""token"": ""Pancreatic Cancer"", ""start_span"": 130, ""end_span"": 147, ""type"": ""Disease/Disorder""}]"	train
Clearly, in the Melanoma, Gastric Tumor, Lung Cancer 1, Lung Cancer 2 and Prostate Cancer dataset, there are many genes with large differences in expression between the classes so that it is not difficult to find a single gene on which to base a good classifier.	Melanoma,16,24,Disease/Disorder	Gastric Tumor,26,39,Disease/Disorder	Lung Cancer,41,52,Disease/Disorder	Lung Cancer,56,67,Disease/Disorder	Prostate Cancer,74,89,Disease/Disorder	"[{""token"": ""Melanoma"", ""start_span"": 16, ""end_span"": 24, ""type"": ""Disease/Disorder""}, {""token"": ""Gastric Tumor"", ""start_span"": 26, ""end_span"": 39, ""type"": ""Disease/Disorder""}, {""token"": ""Lung Cancer"", ""start_span"": 41, ""end_span"": 52, ""type"": ""Disease/Disorder""}, {""token"": ""Lung Cancer"", ""start_span"": 56, ""end_span"": 67, ""type"": ""Disease/Disorder""}, {""token"": ""Prostate Cancer"", ""start_span"": 74, ""end_span"": 89, ""type"": ""Disease/Disorder""}]"	train
As for the degree of classification difficulty, the Melanoma, Gastric Tumor, Lung Cancer 1, Lung Cancer 2 and Prostate Cancer are easily - classified datasets, while the others are more difficult.	Melanoma,52,60,Disease/Disorder	Gastric Tumor,62,75,Disease/Disorder	Lung Cancer,77,88,Disease/Disorder	Lung Cancer,92,103,Disease/Disorder	Prostate Cancer,110,125,Disease/Disorder	"[{""token"": ""Melanoma"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Disease/Disorder""}, {""token"": ""Gastric Tumor"", ""start_span"": 62, ""end_span"": 75, ""type"": ""Disease/Disorder""}, {""token"": ""Lung Cancer"", ""start_span"": 77, ""end_span"": 88, ""type"": ""Disease/Disorder""}, {""token"": ""Lung Cancer"", ""start_span"": 92, ""end_span"": 103, ""type"": ""Disease/Disorder""}, {""token"": ""Prostate Cancer"", ""start_span"": 110, ""end_span"": 125, ""type"": ""Disease/Disorder""}]"	train
Fluorescent cholesterol, including intrinsic fluorescent sterols such as dehydroergosterol ( DHE) and fluorophore - tagged analogs such as 7 - nitrobenz - 2 - oxa - 1, 3 - diazole ( NBD )- cholesterol and boron dipyrromethene difluoride ( BODIPY )- cholesterol are widely used in vitro and in vivo192021.	cholesterol,12,23,Chemical/Drug	sterols,57,64,Chemical/Drug	dehydroergosterol,73,90,Chemical/Drug	cholesterol,189,200,Chemical/Drug	cholesterol,249,260,Chemical/Drug	"[{""token"": ""cholesterol"", ""start_span"": 12, ""end_span"": 23, ""type"": ""Chemical/Drug""}, {""token"": ""sterols"", ""start_span"": 57, ""end_span"": 64, ""type"": ""Chemical/Drug""}, {""token"": ""dehydroergosterol"", ""start_span"": 73, ""end_span"": 90, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 189, ""end_span"": 200, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 249, ""end_span"": 260, ""type"": ""Chemical/Drug""}]"	train
Based on the above considerations, we have synthesized a series of tagged cholesterols – alkyne cholesterol ( A - Chol, 5 ), phenyl - alkyne cholesterol ( PhA - Chol, 6 ), phenyl - diyne cholesterol ( PhDY - Chol, 7 ), and cyano cholesterol ( CN - Chol, 8 ), as shown in Figure 1.	cholesterols,74,86,Chemical/Drug	alkyne,89,95,Chemical/Drug	cholesterol,96,107,Chemical/Drug	cholesterol,141,152,Chemical/Drug	cyano cholesterol,223,240,Chemical/Drug	"[{""token"": ""cholesterols"", ""start_span"": 74, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""alkyne"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 96, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 141, ""end_span"": 152, ""type"": ""Chemical/Drug""}, {""token"": ""cyano cholesterol"", ""start_span"": 223, ""end_span"": 240, ""type"": ""Chemical/Drug""}]"	train
ACAT - 1 inhibition was used to block cholesterol esterification either by adding a potent ACAT inhibitor, avasimibe, or by RNA interference with ACAT - 1 shRNA plasmid.	ACAT - 1,0,8,Gene/Protein	cholesterol,38,49,Chemical/Drug	ACAT,91,95,Gene/Protein	avasimibe,107,116,Chemical/Drug	ACAT - 1,146,154,Gene/Protein	"[{""token"": ""ACAT - 1"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""cholesterol"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""ACAT"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""avasimibe"", ""start_span"": 107, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""ACAT - 1"", ""start_span"": 146, ""end_span"": 154, ""type"": ""Gene/Protein""}]"	train
VS17 strain with hjIs9 [ ges - 1p :: glo - 1 :: GFP + unc - 119 (+)] genotype was used to study cholesterol storage in LROs.	ges - 1p,25,33,Gene/Protein	glo - 1,37,44,Gene/Protein	GFP,48,51,Gene/Protein	unc - 119,54,63,Gene/Protein	cholesterol,96,107,Chemical/Drug	"[{""token"": ""ges - 1p"", ""start_span"": 25, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""glo - 1"", ""start_span"": 37, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""unc - 119"", ""start_span"": 54, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""cholesterol"", ""start_span"": 96, ""end_span"": 107, ""type"": ""Chemical/Drug""}]"	train
F - actin ( phalloidin staining) is shown in green, EC - specific markers ( VECad, CD31, or vWF) in red, and nuclei in blue.	F - actin,0,9,Gene/Protein	phalloidin,12,22,Chemical/Drug	VECad,76,81,Gene/Protein	CD31,83,87,Gene/Protein	vWF,92,95,Gene/Protein	"[{""token"": ""F - actin"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""phalloidin"", ""start_span"": 12, ""end_span"": 22, ""type"": ""Chemical/Drug""}, {""token"": ""VECad"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""CD31"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""vWF"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}]"	train
ECFCs covered the microfiber surface continuously, and exhibited typical membrane expression of endothelial markers VEcad and CD31, and cytoplasmic expression of von Willebrand factor ( vWF, Fig. 1B – D ), demonstrating that fibrin microfibers support the adhesion and culture of ECFCs.	VEcad,116,121,Gene/Protein	CD31,126,130,Gene/Protein	von Willebrand factor,162,183,Gene/Protein	vWF,186,189,Gene/Protein	fibrin,225,231,Gene/Protein	"[{""token"": ""VEcad"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""CD31"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""von Willebrand factor"", ""start_span"": 162, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""vWF"", ""start_span"": 186, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""fibrin"", ""start_span"": 225, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
To probe if the aligned nanotopography of the fibrin microfibers is responsible for ECFC alignment and coordinated deposition of laminin, collagen IV, and fibronectin, we first examined their deposition on flat ( 2D) fibrin sheets with a similar aligned nanotopography ( Fig.	fibrin,46,52,Gene/Protein	laminin,129,136,Gene/Protein	collagen IV,138,149,Gene/Protein	fibronectin,155,166,Gene/Protein	fibrin,217,223,Gene/Protein	"[{""token"": ""fibrin"", ""start_span"": 46, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""laminin"", ""start_span"": 129, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""collagen IV"", ""start_span"": 138, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""fibronectin"", ""start_span"": 155, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""fibrin"", ""start_span"": 217, ""end_span"": 223, ""type"": ""Gene/Protein""}]"	train
F - Actin filaments ( phalloidin) are shown in green, collagen IV in red, fibronectin or laminin in magenta, and nuclei in blue.	F - Actin,0,9,Gene/Protein	phalloidin,22,32,Chemical/Drug	collagen IV,54,65,Gene/Protein	fibronectin,74,85,Gene/Protein	laminin,89,96,Gene/Protein	"[{""token"": ""F - Actin"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""phalloidin"", ""start_span"": 22, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""collagen IV"", ""start_span"": 54, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""fibronectin"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""laminin"", ""start_span"": 89, ""end_span"": 96, ""type"": ""Gene/Protein""}]"	train
siRNA transfection via exosomes resulted in a substantial decrease of the protein expression level and in suppression of RAD51 downstream activity. A, Western blot probed with RAD51 and RAD52 in HeLa cells direct transfected with specific siRNAs and with exosome carriers of siRNAs against RAD51 or RAD52.	RAD51,121,126,Gene/Protein	RAD51,176,181,Gene/Protein	RAD52,186,191,Gene/Protein	RAD51,290,295,Gene/Protein	RAD52,299,304,Gene/Protein	"[{""token"": ""RAD51"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""RAD51"", ""start_span"": 176, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""RAD52"", ""start_span"": 186, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""RAD51"", ""start_span"": 290, ""end_span"": 295, ""type"": ""Gene/Protein""}, {""token"": ""RAD52"", ""start_span"": 299, ""end_span"": 304, ""type"": ""Gene/Protein""}]"	train
We excluded from the study BC patients presenting T3 – T4 tumors, patients already treated for a BC, patients submitted to neoadjuvant therapy, or previously affected by a non BC tumor.	BC,27,29,Disease/Disorder	tumors,58,64,Disease/Disorder	BC,97,99,Disease/Disorder	BC,176,178,Disease/Disorder	tumor,179,184,Disease/Disorder	"[{""token"": ""BC"", ""start_span"": 27, ""end_span"": 29, ""type"": ""Disease/Disorder""}, {""token"": ""tumors"", ""start_span"": 58, ""end_span"": 64, ""type"": ""Disease/Disorder""}, {""token"": ""BC"", ""start_span"": 97, ""end_span"": 99, ""type"": ""Disease/Disorder""}, {""token"": ""BC"", ""start_span"": 176, ""end_span"": 178, ""type"": ""Disease/Disorder""}, {""token"": ""tumor"", ""start_span"": 179, ""end_span"": 184, ""type"": ""Disease/Disorder""}]"	train
In all the patients, ER, PgR, HER2 and Ki - 67 were evaluated on a core biopsy of the primary tumor before breast surgery and SLN biopsy.	ER,21,23,Gene/Protein	PgR,25,28,Gene/Protein	HER2,30,34,Gene/Protein	Ki - 67,39,46,Gene/Protein	primary tumor,86,99,Disease/Disorder	"[{""token"": ""ER"", ""start_span"": 21, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""PgR"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""HER2"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""Ki - 67"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""primary tumor"", ""start_span"": 86, ""end_span"": 99, ""type"": ""Disease/Disorder""}]"	train
Barley genomic data and gene annotations were downloaded from ftp :// ftpmips. helmholtz - muenchen. de / plants / barley / public_data / ( Mayer et al ., 2012) and ftp :// ftpmips. helmholtz - muenchen. de / plants / barley / public_data / ( Mascher et al ., 2013 ).	Barley,0,6,Organism/Species	plants,106,112,Organism/Species	barley,115,121,Organism/Species	plants,209,215,Organism/Species	barley,218,224,Organism/Species	"[{""token"": ""Barley"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 106, ""end_span"": 112, ""type"": ""Organism/Species""}, {""token"": ""barley"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 209, ""end_span"": 215, ""type"": ""Organism/Species""}, {""token"": ""barley"", ""start_span"": 218, ""end_span"": 224, ""type"": ""Organism/Species""}]"	train
Since 2006, several new targeted therapies have been approved for the treatment of mRCC such as sunitinib, sorafenib, pazopanib and everolimus.	mRCC,83,87,Disease/Disorder	sunitinib,96,105,Chemical/Drug	sorafenib,107,116,Chemical/Drug	pazopanib,118,127,Chemical/Drug	everolimus,132,142,Chemical/Drug	"[{""token"": ""mRCC"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Disease/Disorder""}, {""token"": ""sunitinib"", ""start_span"": 96, ""end_span"": 105, ""type"": ""Chemical/Drug""}, {""token"": ""sorafenib"", ""start_span"": 107, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""pazopanib"", ""start_span"": 118, ""end_span"": 127, ""type"": ""Chemical/Drug""}, {""token"": ""everolimus"", ""start_span"": 132, ""end_span"": 142, ""type"": ""Chemical/Drug""}]"	train
Metformin attenuated AngII - induced activation ( cleavage) of caspase 3, Bcl - 2 down - regulation and p53 up - regulation.	Metformin,0,9,Chemical/Drug	AngII,21,26,Gene/Protein	caspase 3,63,72,Gene/Protein	Bcl - 2,74,81,Gene/Protein	p53,104,107,Gene/Protein	"[{""token"": ""Metformin"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""AngII"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""caspase 3"", ""start_span"": 63, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}]"	train
AngII type 1 ( AT1R) and type 2 ( AT2R) G protein – coupled receptors have been shown to mediate the effects of circulating and local ( intracellular) AngII 9, 10.	AngII type 1,0,12,Gene/Protein	AT1R,15,19,Gene/Protein	AT2R,34,38,Gene/Protein	G protein – coupled receptors,40,69,Gene/Protein	AngII,151,156,Gene/Protein	"[{""token"": ""AngII type 1"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""AT1R"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""AT2R"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""G protein \u2013 coupled receptors"", ""start_span"": 40, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""AngII"", ""start_span"": 151, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
Metformin prevented cell death at all concentrations of AngII and, interestingly, demonstrated anti - apoptotic effects on cells treated with 200 nM AngII, preventing caspase 3 cleavage and Bcl - 2 down - regulation.	Metformin,0,9,Chemical/Drug	AngII,56,61,Gene/Protein	AngII,149,154,Gene/Protein	caspase 3,167,176,Gene/Protein	Bcl - 2,190,197,Gene/Protein	"[{""token"": ""Metformin"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""AngII"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""AngII"", ""start_span"": 149, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""caspase 3"", ""start_span"": 167, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 190, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
However, when the cells were treated with 1 μM AngII, the presence or absence of metformin did not alter caspase 3 or Bcl - 2 protein levels ( Fig. 2B and C ), suggesting that cell death occurs through necrosis, rather than apoptosis, at high concentrations of AngII.	AngII,47,52,Gene/Protein	metformin,81,90,Chemical/Drug	caspase 3,105,114,Gene/Protein	Bcl - 2,118,125,Gene/Protein	AngII,261,266,Gene/Protein	"[{""token"": ""AngII"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""metformin"", ""start_span"": 81, ""end_span"": 90, ""type"": ""Chemical/Drug""}, {""token"": ""caspase 3"", ""start_span"": 105, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""Bcl - 2"", ""start_span"": 118, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""AngII"", ""start_span"": 261, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	train
Metformin and losartan increase eNOS activation and reduce p53 in AngII - induced hypertrophy	Metformin,0,9,Chemical/Drug	losartan,14,22,Chemical/Drug	eNOS,32,36,Gene/Protein	p53,59,62,Gene/Protein	AngII,66,71,Gene/Protein	"[{""token"": ""Metformin"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""losartan"", ""start_span"": 14, ""end_span"": 22, ""type"": ""Chemical/Drug""}, {""token"": ""eNOS"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""AngII"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene/Protein""}]"	train
The effects of AngII on the level of p53 in cardiomyocytes in the presence or absence of losartan ( Los ), metformin ( Met ), Nω - nitro - L - arginine methyl ester ( L - NAME) and / or splitomicin ( SP ).	AngII,15,20,Gene/Protein	p53,37,40,Gene/Protein	losartan,89,97,Chemical/Drug	metformin,107,116,Chemical/Drug	splitomicin,186,197,Chemical/Drug	"[{""token"": ""AngII"", ""start_span"": 15, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""losartan"", ""start_span"": 89, ""end_span"": 97, ""type"": ""Chemical/Drug""}, {""token"": ""metformin"", ""start_span"": 107, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""splitomicin"", ""start_span"": 186, ""end_span"": 197, ""type"": ""Chemical/Drug""}]"	train
Furthermore, physical interaction between p53 and cyclophilin D ( CyP - D ), a regulatory protein of the mitochondrial PTP, was found in the mitochondria of cancer cells 24 and in brains subjected to ischaemia / reperfusion 25.	p53,42,45,Gene/Protein	cyclophilin D,50,63,Gene/Protein	CyP - D,66,73,Gene/Protein	mitochondrial PTP,105,122,Gene/Protein	cancer,157,163,Disease/Disorder	"[{""token"": ""p53"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""cyclophilin D"", ""start_span"": 50, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""CyP - D"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""mitochondrial PTP"", ""start_span"": 105, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""cancer"", ""start_span"": 157, ""end_span"": 163, ""type"": ""Disease/Disorder""}]"	train
However, our experiments with immunoprecipitation of p53 followed by immunoblotting of CyP - D revealed no physical interaction between these two proteins or other possible PTP components, such as adenine nucleotide translocase and voltage - dependent anion channels ( data not shown ).	p53,53,56,Gene/Protein	CyP - D,87,94,Gene/Protein	PTP,173,176,Gene/Protein	adenine nucleotide translocase,197,227,Gene/Protein	voltage - dependent anion channels,232,266,Gene/Protein	"[{""token"": ""p53"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""CyP - D"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""PTP"", ""start_span"": 173, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""adenine nucleotide translocase"", ""start_span"": 197, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""voltage - dependent anion channels"", ""start_span"": 232, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	train
Effects of losartan ( Los ), metformin ( Met ), Nω - nitro - L - arginine methyl ester ( L - NAME) or splitomicin ( SP) on the activity of ETC. complex I, in the presence or absence of AngII.	losartan,11,19,Chemical/Drug	metformin,29,38,Chemical/Drug	splitomicin,102,113,Chemical/Drug	complex I,144,153,Gene/Protein	AngII,185,190,Gene/Protein	"[{""token"": ""losartan"", ""start_span"": 11, ""end_span"": 19, ""type"": ""Chemical/Drug""}, {""token"": ""metformin"", ""start_span"": 29, ""end_span"": 38, ""type"": ""Chemical/Drug""}, {""token"": ""splitomicin"", ""start_span"": 102, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""complex I"", ""start_span"": 144, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""AngII"", ""start_span"": 185, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
It should be noted that beneficial effects of metformin may also be mediated through AT2R stimulation, which would counteract AT1R and abrogate AT1R - mediated growth responses in cardiac hypertrophy 32.	metformin,46,55,Chemical/Drug	AT2R,85,89,Gene/Protein	AT1R,126,130,Gene/Protein	AT1R,144,148,Gene/Protein	cardiac hypertrophy,180,199,Disease/Disorder	"[{""token"": ""metformin"", ""start_span"": 46, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""AT2R"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""AT1R"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""AT1R"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""cardiac hypertrophy"", ""start_span"": 180, ""end_span"": 199, ""type"": ""Disease/Disorder""}]"	train
Our data are consistent with previous studies, which show that administration of the AT1R blockers, telmisartan and candesartan stimulated AMPK activity in cultured myotubes 36 and rat hypothalamuses 37.	AT1R,85,89,Gene/Protein	telmisartan,100,111,Chemical/Drug	candesartan,116,127,Chemical/Drug	AMPK,139,143,Gene/Protein	rat,181,184,Organism/Species	"[{""token"": ""AT1R"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""telmisartan"", ""start_span"": 100, ""end_span"": 111, ""type"": ""Chemical/Drug""}, {""token"": ""candesartan"", ""start_span"": 116, ""end_span"": 127, ""type"": ""Chemical/Drug""}, {""token"": ""AMPK"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""rat"", ""start_span"": 181, ""end_span"": 184, ""type"": ""Organism/Species""}]"	train
Accordingly, in the presence of metformin, AMPK - induced p53 down - regulation may prevent AngII - induced AT1R up - regulation 38.	metformin,32,41,Chemical/Drug	AMPK,43,47,Gene/Protein	p53,58,61,Gene/Protein	AngII,92,97,Gene/Protein	AT1R,108,112,Gene/Protein	"[{""token"": ""metformin"", ""start_span"": 32, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""AMPK"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""AngII"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""AT1R"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}]"	train
Glucan phosphatases, a family of enzymes functionally conserved in animals and plants, are essential for normal starch or glycogen degradation in plants and mammals, respectively.	Glucan phosphatases,0,19,Gene/Protein	animals,67,74,Organism/Species	plants,79,85,Organism/Species	plants,146,152,Organism/Species	mammals,157,164,Organism/Species	"[{""token"": ""Glucan phosphatases"", ""start_span"": 0, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""animals"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 79, ""end_span"": 85, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 146, ""end_span"": 152, ""type"": ""Organism/Species""}, {""token"": ""mammals"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Organism/Species""}]"	train
The phosphorylation process is carried out by the glucan water dikinase ( GWD, which phosphorylates the C6 - position of glucosyl residues) and phosphoglucan water dikinase ( PWD, which phosphorylates the C3 position) enzymes [ 4 – 8 ].	glucan water dikinase,50,71,Gene/Protein	GWD,74,77,Gene/Protein	glucosyl,121,129,Chemical/Drug	phosphoglucan water dikinase,144,172,Gene/Protein	PWD,175,178,Gene/Protein	"[{""token"": ""glucan water dikinase"", ""start_span"": 50, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""GWD"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""glucosyl"", ""start_span"": 121, ""end_span"": 129, ""type"": ""Chemical/Drug""}, {""token"": ""phosphoglucan water dikinase"", ""start_span"": 144, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""PWD"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
Lafora disease is caused by mutations in either the gene encoding Laforin ( a glucan phosphatase) or Malin ( an E3 ubiquitin ligase) [ 12, 18, 19 ].	Lafora disease,0,14,Disease/Disorder	Laforin,66,73,Gene/Protein	glucan phosphatase,78,96,Gene/Protein	Malin,101,106,Gene/Protein	E3 ubiquitin ligase,112,131,Gene/Protein	"[{""token"": ""Lafora disease"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Disease/Disorder""}, {""token"": ""Laforin"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""glucan phosphatase"", ""start_span"": 78, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""Malin"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""E3 ubiquitin ligase"", ""start_span"": 112, ""end_span"": 131, ""type"": ""Gene/Protein""}]"	train
Based on this, we decided to explore the presence and function of glucan phosphatases in the picoalgae Ostreococcus tauri. O. tauri is the smallest known free - living eukaryote and has a very simple genome and cellular organization although exhibiting the same degree of complexity as that of vascular plants regards to the starch metabolism pathways [ 21 ].	glucan phosphatases,66,85,Gene/Protein	picoalgae,93,102,Organism/Species	Ostreococcus tauri,103,121,Organism/Species	eukaryote,168,177,Organism/Species	plants,303,309,Organism/Species	"[{""token"": ""glucan phosphatases"", ""start_span"": 66, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""picoalgae"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Organism/Species""}, {""token"": ""Ostreococcus tauri"", ""start_span"": 103, ""end_span"": 121, ""type"": ""Organism/Species""}, {""token"": ""eukaryote"", ""start_span"": 168, ""end_span"": 177, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 303, ""end_span"": 309, ""type"": ""Organism/Species""}]"	train
The alignment of the mature amino acidic sequence of XP_003075237 with mature LSF2 and SEX4 polypeptides showed that XP_003075237 shares a 41% identity and 58% similarity with LSF2 and a 26% identity and 41% similarity with SEX4.	amino acidic,28,40,Chemical/Drug	LSF2,78,82,Gene/Protein	SEX4,87,91,Gene/Protein	LSF2,176,180,Gene/Protein	SEX4,224,228,Gene/Protein	"[{""token"": ""amino acidic"", ""start_span"": 28, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""LSF2"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""SEX4"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""LSF2"", ""start_span"": 176, ""end_span"": 180, ""type"": ""Gene/Protein""}, {""token"": ""SEX4"", ""start_span"": 224, ""end_span"": 228, ""type"": ""Gene/Protein""}]"	train
SLT can cause oral cancer [ 4 ], [ 5] and nicotine addiction [ 6] and is associated with several other health conditions including oral pain [ 7 ], cardiovascular diseases [ 8 ], hypertension [ 9 ], diabetes [ 10 ], loss in bone density [ 11 ], and problems during pregnancy and following childbirth [ 12 ].	oral cancer,14,25,Disease/Disorder	nicotine addiction,42,60,Disease/Disorder	cardiovascular diseases,148,171,Disease/Disorder	hypertension,179,191,Disease/Disorder	diabetes,199,207,Disease/Disorder	"[{""token"": ""oral cancer"", ""start_span"": 14, ""end_span"": 25, ""type"": ""Disease/Disorder""}, {""token"": ""nicotine addiction"", ""start_span"": 42, ""end_span"": 60, ""type"": ""Disease/Disorder""}, {""token"": ""cardiovascular diseases"", ""start_span"": 148, ""end_span"": 171, ""type"": ""Disease/Disorder""}, {""token"": ""hypertension"", ""start_span"": 179, ""end_span"": 191, ""type"": ""Disease/Disorder""}, {""token"": ""diabetes"", ""start_span"": 199, ""end_span"": 207, ""type"": ""Disease/Disorder""}]"	train
Human PDHA2 is a testis - specific gene that codes for the E1α subunit of Pyruvate Dehydrogenase Complex ( PDC ), a crucial enzyme system in cell energy metabolism.	Human,0,5,Organism/Species	PDHA2,6,11,Gene/Protein	E1α subunit,59,70,Gene/Protein	Pyruvate Dehydrogenase Complex,74,104,Gene/Protein	PDC,107,110,Gene/Protein	"[{""token"": ""Human"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism/Species""}, {""token"": ""PDHA2"", ""start_span"": 6, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""E1\u03b1 subunit"", ""start_span"": 59, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""Pyruvate Dehydrogenase Complex"", ""start_span"": 74, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""PDC"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene/Protein""}]"	train
Secondly, the fact that PDHA2 promoter reporter constructs present high luciferase activity in somatic cell lines where the PDHA2 mRNA cannot be detected, and that there are no significant differences between the luciferase activities of the different deletion constructs, suggest an important role of epigenetic modifications in the regulation PDHA2 tissue - specific expression.	PDHA2,24,29,Gene/Protein	luciferase,72,82,Gene/Protein	PDHA2,124,129,Gene/Protein	luciferase,213,223,Gene/Protein	PDHA2,345,350,Gene/Protein	"[{""token"": ""PDHA2"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""luciferase"", ""start_span"": 72, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""PDHA2"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""luciferase"", ""start_span"": 213, ""end_span"": 223, ""type"": ""Gene/Protein""}, {""token"": ""PDHA2"", ""start_span"": 345, ""end_span"": 350, ""type"": ""Gene/Protein""}]"	train
Briefly, chromatin isolated from cell cultures was immunoprecipitated using the following antibodies: anti RNA pol II clone CTD4H8 (# 05 - 623, Millipore, Bedford, MA, USA ), H3K36me3 (# ab9050, Abcam, Cambridge, UK ), Sp1 ( PEP 2) X (# SC - 59X, Santa Cruz Biotechnology, Inc ., Santa Cruz, CA, USA) and normal rabbit immunoglobulin (# X0903, DakoCytomation, Denmark ).	antibodies,90,100,Gene/Protein	RNA pol II,107,117,Gene/Protein	Sp1,219,222,Gene/Protein	rabbit,312,318,Organism/Species	immunoglobulin,319,333,Gene/Protein	"[{""token"": ""antibodies"", ""start_span"": 90, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""RNA pol II"", ""start_span"": 107, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""Sp1"", ""start_span"": 219, ""end_span"": 222, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 312, ""end_span"": 318, ""type"": ""Organism/Species""}, {""token"": ""immunoglobulin"", ""start_span"": 319, ""end_span"": 333, ""type"": ""Gene/Protein""}]"	train
Dulbecco ’ s phosphate - buffered saline ( PBS, calcium and magnesium free ), ethylenediaminetetraacetic acid ( EDTA ), diethylenetriaminepentaacetic acid ( DETPA ), phenylmethylsulfonyl fluoride ( PMSF ), trifluoroacetic acid ( TFA ), 3, 4 - dichloroisocoumarin, molecular weight cut - off filters ( 30, 50 and 100 kDa) and endothelins ( BET - 1, ET - 1, ET - 2 and ET - 3) were purchased from Sigma ( St. Louis, MO ).	endothelins,325,336,Gene/Protein	BET - 1,339,346,Gene/Protein	ET - 1,348,354,Gene/Protein	ET - 2,356,362,Gene/Protein	ET - 3,367,373,Gene/Protein	"[{""token"": ""endothelins"", ""start_span"": 325, ""end_span"": 336, ""type"": ""Gene/Protein""}, {""token"": ""BET - 1"", ""start_span"": 339, ""end_span"": 346, ""type"": ""Gene/Protein""}, {""token"": ""ET - 1"", ""start_span"": 348, ""end_span"": 354, ""type"": ""Gene/Protein""}, {""token"": ""ET - 2"", ""start_span"": 356, ""end_span"": 362, ""type"": ""Gene/Protein""}, {""token"": ""ET - 3"", ""start_span"": 367, ""end_span"": 373, ""type"": ""Gene/Protein""}]"	train
Initial separation of endothelin isoforms ( Big ET - 1, ET - 1, ET - 2 and ET - 3) were carried out on a LC - 318 column ( 25 cm length, 4. 6 mm id, 5 μm particle size; Supelco, Oakville, ON) by gradient elution using water - acetonitrile mobile phase ( A - 30% acetonitrile ( aq ); B - 90% acetonitrile ( aq )) with 0. 19% of TFA used as the ion - pair reagent.	endothelin,22,32,Gene/Protein	ET - 1,48,54,Gene/Protein	ET - 1,56,62,Gene/Protein	ET - 2,64,70,Gene/Protein	ET - 3,75,81,Gene/Protein	"[{""token"": ""endothelin"", ""start_span"": 22, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""ET - 1"", ""start_span"": 48, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""ET - 1"", ""start_span"": 56, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""ET - 2"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""ET - 3"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Gene/Protein""}]"	train
Significant ( p < 0. 05) positive associations were seen among markers, namely ET - 1, ET - 3, ICAM - 1, VCAM - 1, MMP - 2 and thus were clustered together in the heatmap ( Figure 2 ).	ET - 1,79,85,Gene/Protein	ET - 3,87,93,Gene/Protein	ICAM - 1,95,103,Gene/Protein	VCAM - 1,105,113,Gene/Protein	MMP - 2,115,122,Gene/Protein	"[{""token"": ""ET - 1"", ""start_span"": 79, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""ET - 3"", ""start_span"": 87, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""ICAM - 1"", ""start_span"": 95, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""VCAM - 1"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""MMP - 2"", ""start_span"": 115, ""end_span"": 122, ""type"": ""Gene/Protein""}]"	train
In essence, regression analysis of all data collectively suggested that infant birth weight outcome can be associated with the third trimester maternal plasma markers endothelins, ISOP, cellular adhesion molecules, vascular endothelial growth factor ( VEGF) and MMP - 9.	endothelins,167,178,Gene/Protein	cellular adhesion molecules,186,213,Gene/Protein	vascular endothelial growth factor,215,249,Gene/Protein	VEGF,252,256,Gene/Protein	MMP - 9,262,269,Gene/Protein	"[{""token"": ""endothelins"", ""start_span"": 167, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""cellular adhesion molecules"", ""start_span"": 186, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 215, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""VEGF"", ""start_span"": 252, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""MMP - 9"", ""start_span"": 262, ""end_span"": 269, ""type"": ""Gene/Protein""}]"	train
Analysis of β - globin mRNA levels in chicken 3 - day and 9 - day embryonic red blood cells. The vertical axis shows the relative amounts of β - globin gene primary transcripts, as determined by RT - qPCR analysis of RNA samples prepared from the blood of 3 - and 9 - day old chicken embryos. ( A) Normalization of data to the level of β - actin mRNA. ( B) Normalization of data to the amount of cells used for RNA preparation.	β - globin,12,22,Gene/Protein	chicken,38,45,Organism/Species	β - globin,141,151,Gene/Protein	chicken,276,283,Organism/Species	β - actin,336,345,Gene/Protein	"[{""token"": ""\u03b2 - globin"", ""start_span"": 12, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""chicken"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Organism/Species""}, {""token"": ""\u03b2 - globin"", ""start_span"": 141, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""chicken"", ""start_span"": 276, ""end_span"": 283, ""type"": ""Organism/Species""}, {""token"": ""\u03b2 - actin"", ""start_span"": 336, ""end_span"": 345, ""type"": ""Gene/Protein""}]"	train
Hence, the regulation of chicken β - globin gene expression may differ from regulation of β - globin gene expression in the mouse and human.	chicken,25,32,Organism/Species	β - globin,33,43,Gene/Protein	β - globin,90,100,Gene/Protein	mouse,124,129,Organism/Species	human,134,139,Organism/Species	"[{""token"": ""chicken"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Organism/Species""}, {""token"": ""\u03b2 - globin"", ""start_span"": 33, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - globin"", ""start_span"": 90, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Organism/Species""}]"	train
The five tissue types were white skin tissue from non - pigmented sheep ( NOR ); black skin tissue from a piebald animal ( PBB ); white skin tissue from a piebald animal ( PBW ); black skin tissue from a recessive black animal ( RSB) and white skin tissue from the non - pigmented region of a recessive black animal ( RSW ).	sheep,66,71,Organism/Species	animal,114,120,Organism/Species	animal,163,169,Organism/Species	animal,220,226,Organism/Species	animal,309,315,Organism/Species	"[{""token"": ""sheep"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Organism/Species""}, {""token"": ""animal"", ""start_span"": 114, ""end_span"": 120, ""type"": ""Organism/Species""}, {""token"": ""animal"", ""start_span"": 163, ""end_span"": 169, ""type"": ""Organism/Species""}, {""token"": ""animal"", ""start_span"": 220, ""end_span"": 226, ""type"": ""Organism/Species""}, {""token"": ""animal"", ""start_span"": 309, ""end_span"": 315, ""type"": ""Organism/Species""}]"	train
A total of 20 hybridizations were performed to compare the following tissue types: white skin tissue from 4 pooled non - pigmented animals ( NOR ); black skin tissue from a piebald animal ( PBB ); white skin tissue from a piebald animal ( PBW ); black skin tissue from a recessive black animal ( RSB) and white skin tissue sampled from the inguinal, non - pigmented area from a recessive black animal ( RSW ).	animals,131,138,Organism/Species	animal,181,187,Organism/Species	animal,230,236,Organism/Species	animal,287,293,Organism/Species	animal,394,400,Organism/Species	"[{""token"": ""animals"", ""start_span"": 131, ""end_span"": 138, ""type"": ""Organism/Species""}, {""token"": ""animal"", ""start_span"": 181, ""end_span"": 187, ""type"": ""Organism/Species""}, {""token"": ""animal"", ""start_span"": 230, ""end_span"": 236, ""type"": ""Organism/Species""}, {""token"": ""animal"", ""start_span"": 287, ""end_span"": 293, ""type"": ""Organism/Species""}, {""token"": ""animal"", ""start_span"": 394, ""end_span"": 400, ""type"": ""Organism/Species""}]"	train
Importantly, SMAD4 inhibits PAX3 [ 13] which is a key regulator of MITF that regulates the degree of black spotting in both dog [ 14] and cattle [ 6 ].	SMAD4,13,18,Gene/Protein	PAX3,28,32,Gene/Protein	MITF,67,71,Gene/Protein	dog,124,127,Organism/Species	cattle,138,144,Organism/Species	"[{""token"": ""SMAD4"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""PAX3"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""MITF"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""dog"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Organism/Species""}, {""token"": ""cattle"", ""start_span"": 138, ""end_span"": 144, ""type"": ""Organism/Species""}]"	train
Gene expression was examined using five tissue types as follows: white skin tissue from a non - pigmented animal ( NOR ); black skin tissue from a piebald animal ( PBB ); white skin tissue from a piebald animal ( PBW ); black skin tissue from a self color black animal ( RSB) and white skin tissue from a self color black animal ( RSW ).	animal,106,112,Organism/Species	animal,155,161,Organism/Species	animal,204,210,Organism/Species	animal,262,268,Organism/Species	animal,322,328,Organism/Species	"[{""token"": ""animal"", ""start_span"": 106, ""end_span"": 112, ""type"": ""Organism/Species""}, {""token"": ""animal"", ""start_span"": 155, ""end_span"": 161, ""type"": ""Organism/Species""}, {""token"": ""animal"", ""start_span"": 204, ""end_span"": 210, ""type"": ""Organism/Species""}, {""token"": ""animal"", ""start_span"": 262, ""end_span"": 268, ""type"": ""Organism/Species""}, {""token"": ""animal"", ""start_span"": 322, ""end_span"": 328, ""type"": ""Organism/Species""}]"	train
Active ( WT - Cre) and inactive ( Δ - Cre) viruses, each linked to a GFP construct to establish localization, were then injected into five regions of the CNS of Ndufs4lox / lox mice ( Fig 1A and 1B ).	Cre,14,17,Gene/Protein	Cre,38,41,Gene/Protein	viruses,43,50,Organism/Species	GFP,69,72,Gene/Protein	mice,177,181,Organism/Species	"[{""token"": ""Cre"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""Cre"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""viruses"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Organism/Species""}, {""token"": ""GFP"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Organism/Species""}]"	train
The loss of NDUFS4 immunostaining in the GFP - expressing virus infected cells in the injected regions was quantified to confirm virus mediated knockdown of NDUFS4 ( Fig 1D ).	NDUFS4,12,18,Gene/Protein	GFP,41,44,Gene/Protein	virus,58,63,Organism/Species	virus,129,134,Organism/Species	NDUFS4,157,163,Gene/Protein	"[{""token"": ""NDUFS4"", ""start_span"": 12, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""virus"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Organism/Species""}, {""token"": ""virus"", ""start_span"": 129, ""end_span"": 134, ""type"": ""Organism/Species""}, {""token"": ""NDUFS4"", ""start_span"": 157, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
Reprinted from the Allen mouse brain atlas under a CC BY license, with permission from the Allen Institute, original copyright 2008. D. EC50s for ISO and HAL for the active ( n = 7, black bars) and sham ( n = 6, grey bars) virus injected mice in the LORR assay. E. EC50s for ISO and HAL for the active ( n = 7, black bars) and sham ( n = 6, grey bars) virus injected mice in the TC assay.	mouse,25,30,Organism/Species	virus,223,228,Organism/Species	mice,238,242,Organism/Species	virus,352,357,Organism/Species	mice,367,371,Organism/Species	"[{""token"": ""mouse"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Organism/Species""}, {""token"": ""virus"", ""start_span"": 223, ""end_span"": 228, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 238, ""end_span"": 242, ""type"": ""Organism/Species""}, {""token"": ""virus"", ""start_span"": 352, ""end_span"": 357, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 367, ""end_span"": 371, ""type"": ""Organism/Species""}]"	train
Reprinted from the Allen mouse brain atlas under a CC BY license, with permission from the Allen Institute, original copyright 2008. D. EC50s for ISO and HAL for the active ( n = 6, black bars) and sham ( n = 7, grey bars) virus injected mice in the LORR assay. E. EC50s for ISO and HAL for the active ( n = 6, black bars) and sham ( n = 7, grey bars) virus injected mice in the TC assay.	mouse,25,30,Organism/Species	virus,223,228,Organism/Species	mice,238,242,Organism/Species	virus,352,357,Organism/Species	mice,367,371,Organism/Species	"[{""token"": ""mouse"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Organism/Species""}, {""token"": ""virus"", ""start_span"": 223, ""end_span"": 228, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 238, ""end_span"": 242, ""type"": ""Organism/Species""}, {""token"": ""virus"", ""start_span"": 352, ""end_span"": 357, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 367, ""end_span"": 371, ""type"": ""Organism/Species""}]"	train
Reprinted from the Allen mouse brain atlas under a CC BY license, with permission from the Allen Institute, original copyright 2008. D. EC50s for ISO and HAL for the active ( n = 6, black bars) and sham ( n = 6, grey bars) virus injected mice in the LORR assay. E. EC50s for ISO and HAL for the active ( n = 6, black bars) and sham ( n = 6, grey bars) virus injected mice in the TC assay.	mouse,25,30,Organism/Species	virus,223,228,Organism/Species	mice,238,242,Organism/Species	virus,352,357,Organism/Species	mice,367,371,Organism/Species	"[{""token"": ""mouse"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Organism/Species""}, {""token"": ""virus"", ""start_span"": 223, ""end_span"": 228, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 238, ""end_span"": 242, ""type"": ""Organism/Species""}, {""token"": ""virus"", ""start_span"": 352, ""end_span"": 357, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 367, ""end_span"": 371, ""type"": ""Organism/Species""}]"	train
Reprinted from the Allen mouse brain atlas under a CC BY license, with permission from the Allen Institute, original copyright 2008. D. EC50s for ISO and HAL for the active ( n = 6, black bars) and sham ( n = 6, grey bars) virus injected mice in the LORR assay. E. EC50s for ISO and HAL for the active ( n = 6, black bars) and sham ( n = 6, grey bars) virus injected mice in the TC assay.	mouse,25,30,Organism/Species	virus,223,228,Organism/Species	mice,238,242,Organism/Species	virus,352,357,Organism/Species	mice,367,371,Organism/Species	"[{""token"": ""mouse"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Organism/Species""}, {""token"": ""virus"", ""start_span"": 223, ""end_span"": 228, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 238, ""end_span"": 242, ""type"": ""Organism/Species""}, {""token"": ""virus"", ""start_span"": 352, ""end_span"": 357, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 367, ""end_span"": 371, ""type"": ""Organism/Species""}]"	train
Reprinted from the Allen mouse brain atlas under a CC BY license, with permission from the Allen Institute, original copyright 2008. D. EC50s for ISO and HAL for the active ( n = 5, black bars) and sham ( n = 6, grey bars) virus injected mice in the LORR assay. E. EC50s for ISO and HAL for the active ( n = 5, black bars) and sham ( n = 6, grey bars) virus injected mice in the TC assay.	mouse,25,30,Organism/Species	virus,223,228,Organism/Species	mice,238,242,Organism/Species	virus,352,357,Organism/Species	mice,367,371,Organism/Species	"[{""token"": ""mouse"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Organism/Species""}, {""token"": ""virus"", ""start_span"": 223, ""end_span"": 228, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 238, ""end_span"": 242, ""type"": ""Organism/Species""}, {""token"": ""virus"", ""start_span"": 352, ""end_span"": 357, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 367, ""end_span"": 371, ""type"": ""Organism/Species""}]"	train
Secondary antibodies, rabbit anti - mouse Alexa Fluor 568 ( Life Technologies; dilution 1: 2000) and donkey anti - goat AlexaFluor 488 ( Life Technologies; dilution 1: 2000) were incubated for one hour at RT.	antibodies,10,20,Gene/Protein	rabbit,22,28,Organism/Species	mouse,36,41,Organism/Species	donkey,101,107,Organism/Species	goat,115,119,Organism/Species	"[{""token"": ""antibodies"", ""start_span"": 10, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Organism/Species""}, {""token"": ""donkey"", ""start_span"": 101, ""end_span"": 107, ""type"": ""Organism/Species""}, {""token"": ""goat"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Organism/Species""}]"	train
To assess the efficiency of the AAV - mediated knockdown, Alexa Fluor 568 tagged NDUFS4 expression ( red immunofluorescence) was quantified in the virus infected cells which co - expressed the Green Fluorescent Protein ( GFP, Alexa Fluor 488 tagged, green immunofluorescence ), and expressed as a percentage of total infected cells.	AAV,32,35,Organism/Species	NDUFS4,81,87,Gene/Protein	virus,147,152,Organism/Species	Green Fluorescent Protein,193,218,Gene/Protein	GFP,221,224,Gene/Protein	"[{""token"": ""AAV"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Organism/Species""}, {""token"": ""NDUFS4"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""virus"", ""start_span"": 147, ""end_span"": 152, ""type"": ""Organism/Species""}, {""token"": ""Green Fluorescent Protein"", ""start_span"": 193, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 221, ""end_span"": 224, ""type"": ""Gene/Protein""}]"	train
The trypanosome lytic factor ( TLF) is a minor subclass of high - density lipoprotein that contains two proteins found only in primates, apolipoprotein L - 1 and haptoglobin - related protein ( Hpr ).	trypanosome,4,15,Organism/Species	primates,127,135,Organism/Species	apolipoprotein L - 1,137,157,Gene/Protein	haptoglobin - related protein,162,191,Gene/Protein	Hpr,194,197,Gene/Protein	"[{""token"": ""trypanosome"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Organism/Species""}, {""token"": ""primates"", ""start_span"": 127, ""end_span"": 135, ""type"": ""Organism/Species""}, {""token"": ""apolipoprotein L - 1"", ""start_span"": 137, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""haptoglobin - related protein"", ""start_span"": 162, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""Hpr"", ""start_span"": 194, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
We postulate that trypanosome infection causes increased vascular levels of Hb, resulting in the formation of TLF – Hb complexes that may be important in “ arming ” the human innate immune system to clear the circulation of certain African trypanosomes.	trypanosome infection,18,39,Disease/Disorder	Hb,76,78,Gene/Protein	Hb,116,118,Gene/Protein	human,169,174,Organism/Species	trypanosomes,240,252,Organism/Species	"[{""token"": ""trypanosome infection"", ""start_span"": 18, ""end_span"": 39, ""type"": ""Disease/Disorder""}, {""token"": ""Hb"", ""start_span"": 76, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""Hb"", ""start_span"": 116, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 169, ""end_span"": 174, ""type"": ""Organism/Species""}, {""token"": ""trypanosomes"", ""start_span"": 240, ""end_span"": 252, ""type"": ""Organism/Species""}]"	train
African trypanosomes are blood parasites of mammals in sub - Saharan Africa that cause chronic wasting diseases in both humans and domestic animals [ 1 ].	trypanosomes,8,20,Organism/Species	mammals,44,51,Organism/Species	chronic wasting diseases,87,111,Disease/Disorder	humans,120,126,Organism/Species	animals,140,147,Organism/Species	"[{""token"": ""trypanosomes"", ""start_span"": 8, ""end_span"": 20, ""type"": ""Organism/Species""}, {""token"": ""mammals"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Organism/Species""}, {""token"": ""chronic wasting diseases"", ""start_span"": 87, ""end_span"": 111, ""type"": ""Disease/Disorder""}, {""token"": ""humans"", ""start_span"": 120, ""end_span"": 126, ""type"": ""Organism/Species""}, {""token"": ""animals"", ""start_span"": 140, ""end_span"": 147, ""type"": ""Organism/Species""}]"	train
Hpr is 91% identical to haptoglobin ( Hp ), an abundant (∼ 0. 45 – 3 mg / ml in normal human serum) acute phase serum protein, possessing very high affinity for Hb [ 31 ].	Hpr,0,3,Gene/Protein	haptoglobin,24,35,Gene/Protein	Hp,38,40,Gene/Protein	human,87,92,Organism/Species	Hb,161,163,Gene/Protein	"[{""token"": ""Hpr"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""haptoglobin"", ""start_span"": 24, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""Hp"", ""start_span"": 38, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Organism/Species""}, {""token"": ""Hb"", ""start_span"": 161, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
Complexes of Hp and Hb that form when Hb is released from erythrocytes undergoing intravascular hemolysis are removed from the circulation by the CD163 scavenger receptor [ 32 ].	Hp,13,15,Gene/Protein	Hb,20,22,Gene/Protein	Hb,38,40,Gene/Protein	CD163,146,151,Gene/Protein	scavenger receptor,152,170,Gene/Protein	"[{""token"": ""Hp"", ""start_span"": 13, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""Hb"", ""start_span"": 20, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""Hb"", ""start_span"": 38, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""CD163"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""scavenger receptor"", ""start_span"": 152, ""end_span"": 170, ""type"": ""Gene/Protein""}]"	train
( C) The same gel as in ( B) transferred to nitrocellulose and probed with antibodies to transferrin ( Tf ), Hpr, ApoL - 1, and ApoA - 1.	transferrin,89,100,Gene/Protein	Tf,103,105,Gene/Protein	Hpr,109,112,Gene/Protein	ApoL - 1,114,122,Gene/Protein	ApoA - 1,128,136,Gene/Protein	"[{""token"": ""transferrin"", ""start_span"": 89, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""Tf"", ""start_span"": 103, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""Hpr"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""ApoL - 1"", ""start_span"": 114, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""ApoA - 1"", ""start_span"": 128, ""end_span"": 136, ""type"": ""Gene/Protein""}]"	train
More recently, it has been shown that native and recombinant Hp and recombinant Hpr bind Hb with high affinity and that Hb - coupled Sepharose can precipitate Hpr - containing HDLs from plasma [ 31 ].	Hp,61,63,Gene/Protein	Hpr,80,83,Gene/Protein	Hb,89,91,Gene/Protein	Hb,120,122,Gene/Protein	Hpr,159,162,Gene/Protein	"[{""token"": ""Hp"", ""start_span"": 61, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""Hpr"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""Hb"", ""start_span"": 89, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""Hb"", ""start_span"": 120, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""Hpr"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Gene/Protein""}]"	train
Hpr binds human Hb with high affinity, and the formation of the TLF – Hb complex enhances binding to the trypanosome TLF receptor and triggers lysosome breakdown by an iron - dependent, free radical – mediated pathway.	Hpr,0,3,Gene/Protein	human,10,15,Organism/Species	Hb,16,18,Gene/Protein	Hb,70,72,Gene/Protein	trypanosome,105,116,Organism/Species	"[{""token"": ""Hpr"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Organism/Species""}, {""token"": ""Hb"", ""start_span"": 16, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""Hb"", ""start_span"": 70, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""trypanosome"", ""start_span"": 105, ""end_span"": 116, ""type"": ""Organism/Species""}]"	train
This analysis indicates that Hpr and ApoL - 1 are assembled into the same HDL particle and that the amount of Hpr or ApoL - 1 found free in the human circulatory system is extremely low.	Hpr,29,32,Gene/Protein	ApoL - 1,37,45,Gene/Protein	Hpr,110,113,Gene/Protein	ApoL - 1,117,125,Gene/Protein	human,144,149,Organism/Species	"[{""token"": ""Hpr"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""ApoL - 1"", ""start_span"": 37, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""Hpr"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""ApoL - 1"", ""start_span"": 117, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Organism/Species""}]"	train
The basis for the enhanced trypanosome receptor recognition of the TLF – Hb complex is unknown, but the mammalian CD163 receptor shows a similar binding preference for the Hp – Hb complex [ 32, 33 ].	trypanosome,27,38,Organism/Species	Hb,73,75,Gene/Protein	CD163 receptor,114,128,Gene/Protein	Hp,172,174,Gene/Protein	Hb,177,179,Gene/Protein	"[{""token"": ""trypanosome"", ""start_span"": 27, ""end_span"": 38, ""type"": ""Organism/Species""}, {""token"": ""Hb"", ""start_span"": 73, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""CD163 receptor"", ""start_span"": 114, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""Hp"", ""start_span"": 172, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""Hb"", ""start_span"": 177, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
After incubation with secondary antibodies ( goat anti - rabbit and goat anti - mouse at 1: 10, 000 in all cases except transferrin ), ( Pierce Biotechnology) proteins were detected following reaction with ECL Plus ( GE Healthcare, http :// www. gelifesciences. com /) and were visualized by autoradiography.	goat,45,49,Organism/Species	rabbit,57,63,Organism/Species	goat,68,72,Organism/Species	mouse,80,85,Organism/Species	transferrin,120,131,Gene/Protein	"[{""token"": ""goat"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Organism/Species""}, {""token"": ""rabbit"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Organism/Species""}, {""token"": ""goat"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organism/Species""}, {""token"": ""transferrin"", ""start_span"": 120, ""end_span"": 131, ""type"": ""Gene/Protein""}]"	train
Thy1 - CFP - 23 and CX3CR1 - eGFP transgenic mice were purchased from The Jackson Laboratory ( Bar Harbor, ME ).	Thy1,0,4,Gene/Protein	CFP,7,10,Gene/Protein	CX3CR1,20,26,Gene/Protein	eGFP,29,33,Gene/Protein	mice,45,49,Organism/Species	"[{""token"": ""Thy1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""CFP"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""CX3CR1"", ""start_span"": 20, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""eGFP"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Organism/Species""}]"	train
The inhibiting effects of MTAP expression on tumor growth, angiogenesis, and the induction of apoptosis by L - alanosine were validated using MTAP - reexpressing xenografts and reverted using RNA interference in MTAP - preserved cells.	MTAP,26,30,Gene/Protein	tumor,45,50,Disease/Disorder	L - alanosine,107,120,Chemical/Drug	MTAP,142,146,Gene/Protein	MTAP,212,216,Gene/Protein	"[{""token"": ""MTAP"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Disease/Disorder""}, {""token"": ""L - alanosine"", ""start_span"": 107, ""end_span"": 120, ""type"": ""Chemical/Drug""}, {""token"": ""MTAP"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""MTAP"", ""start_span"": 212, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	train
By using ultrahigh - resolution array comparative genomic hybridization ( aCGH ), we previously profiled the global copy - number alterations ( CNAs) in myxofibrosarcoma specimens and cell lines and characterized SKP2 on 5p and CDK6 and MET on 7q as amplified oncogenes of pathogenic relevance [ 6 – 8 ].	myxofibrosarcoma,153,169,Disease/Disorder	SKP2,213,217,Gene/Protein	CDK6,228,232,Gene/Protein	MET,237,240,Gene/Protein	oncogenes,260,269,Gene/Protein	"[{""token"": ""myxofibrosarcoma"", ""start_span"": 153, ""end_span"": 169, ""type"": ""Disease/Disorder""}, {""token"": ""SKP2"", ""start_span"": 213, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""CDK6"", ""start_span"": 228, ""end_span"": 232, ""type"": ""Gene/Protein""}, {""token"": ""MET"", ""start_span"": 237, ""end_span"": 240, ""type"": ""Gene/Protein""}, {""token"": ""oncogenes"", ""start_span"": 260, ""end_span"": 269, ""type"": ""Gene/Protein""}]"	train
Although the MTAP gene dosage was slightly decreased, a western blotting assay revealed MTAP - expressing NMFH - 1 cells. ( B) Stable exogenous MTAP reexpression was achieved in the OH931 ( left) and NMFH - 2 ( middle) myxofibrosarcoma cell lines, and the western blots exhibited the expected bands using anti - MTAP.	MTAP,13,17,Gene/Protein	MTAP,88,92,Gene/Protein	MTAP,144,148,Gene/Protein	myxofibrosarcoma,219,235,Disease/Disorder	MTAP,312,316,Gene/Protein	"[{""token"": ""MTAP"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""MTAP"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""MTAP"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""myxofibrosarcoma"", ""start_span"": 219, ""end_span"": 235, ""type"": ""Disease/Disorder""}, {""token"": ""MTAP"", ""start_span"": 312, ""end_span"": 316, ""type"": ""Gene/Protein""}]"	train
Depending on the MTAP expression status, only the expression level of cyclin D1 in western blots was consistently altered as expected among the MTAP - reexpressing NMFH - 2 cells and 2 MTAP - knockdown clones of the NMFH - 1 cells. ( D) Compared with the empty controls ( left ), the MTAP - reexpressing NMFH - 2 transfectants ( middle) formed fewer colonies on soft agar, as expressed in the histogram ( bottom ).	MTAP,17,21,Gene/Protein	cyclin D1,70,79,Gene/Protein	MTAP,144,148,Gene/Protein	MTAP,185,189,Gene/Protein	MTAP,284,288,Gene/Protein	"[{""token"": ""MTAP"", ""start_span"": 17, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""cyclin D1"", ""start_span"": 70, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""MTAP"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""MTAP"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""MTAP"", ""start_span"": 284, ""end_span"": 288, ""type"": ""Gene/Protein""}]"	train
Of these, CXCL - 9, CXCL - 10, and MMP - 9 proteins were concomitantly downregulated using western blots in both NMFH - 2 and OH931 MTAP - reexpressing cell lines, the conditioned media of which also consistently demonstrated decreased MMP - 9 protein concentration using ELISA ( Figure 4B ).	CXCL - 9,10,18,Gene/Protein	CXCL - 10,20,29,Gene/Protein	MMP - 9,35,42,Gene/Protein	MTAP,132,136,Gene/Protein	MMP - 9,236,243,Gene/Protein	"[{""token"": ""CXCL - 9"", ""start_span"": 10, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""CXCL - 10"", ""start_span"": 20, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""MMP - 9"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""MTAP"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""MMP - 9"", ""start_span"": 236, ""end_span"": 243, ""type"": ""Gene/Protein""}]"	train
In vivo tumor suppressive function of MTAP and the inhibition of L - alanosine in MTAP - deficient myxofibrosarcoma	tumor,8,13,Disease/Disorder	MTAP,38,42,Gene/Protein	L - alanosine,65,78,Chemical/Drug	MTAP,82,86,Gene/Protein	myxofibrosarcoma,99,115,Disease/Disorder	"[{""token"": ""tumor"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Disease/Disorder""}, {""token"": ""MTAP"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""L - alanosine"", ""start_span"": 65, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""MTAP"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""myxofibrosarcoma"", ""start_span"": 99, ""end_span"": 115, ""type"": ""Disease/Disorder""}]"	train
In a subset common cohort of 40 primary myxofibrosarcomas yielding informative scoring results ( Table S6, Figure S4 ), we further corroborated the in vitro findings in clinical samples that MTAP protein deficiency was highly associated with increased Ki - 67 labeling index ( p < 0. 001 ), microvessel density ( p = 0. 002) assessed by CD31 staining [ 18 ], and MMP - 9 expression levels ( p < 0. 001) evaluated by H - score method [ 19 ].	myxofibrosarcomas,40,57,Disease/Disorder	MTAP,191,195,Gene/Protein	Ki - 67,252,259,Gene/Protein	CD31,337,341,Gene/Protein	MMP - 9,363,370,Gene/Protein	"[{""token"": ""myxofibrosarcomas"", ""start_span"": 40, ""end_span"": 57, ""type"": ""Disease/Disorder""}, {""token"": ""MTAP"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""Ki - 67"", ""start_span"": 252, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""CD31"", ""start_span"": 337, ""end_span"": 341, ""type"": ""Gene/Protein""}, {""token"": ""MMP - 9"", ""start_span"": 363, ""end_span"": 370, ""type"": ""Gene/Protein""}]"	train
Because L - alanosine can completely abrogate AMP supply in MTAP - deficient cells, we investigated whether L - alanosine can effectively inhibit this aggressive subset of myxofibrosarcomas by targeting the methionine de novo pathway [ 13 ].	L - alanosine,8,21,Chemical/Drug	MTAP,60,64,Gene/Protein	L - alanosine,108,121,Chemical/Drug	myxofibrosarcomas,172,189,Disease/Disorder	methionine,207,217,Chemical/Drug	"[{""token"": ""L - alanosine"", ""start_span"": 8, ""end_span"": 21, ""type"": ""Chemical/Drug""}, {""token"": ""MTAP"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""L - alanosine"", ""start_span"": 108, ""end_span"": 121, ""type"": ""Chemical/Drug""}, {""token"": ""myxofibrosarcomas"", ""start_span"": 172, ""end_span"": 189, ""type"": ""Disease/Disorder""}, {""token"": ""methionine"", ""start_span"": 207, ""end_span"": 217, ""type"": ""Chemical/Drug""}]"	train
Compared with the equally indolent MTAP - hypermethylated and MTAP - expressing myxofibrosarcomas, MTAP - homozygously deleted tumors were often high - grade and clinically aggressive.	MTAP,35,39,Gene/Protein	MTAP,62,66,Gene/Protein	myxofibrosarcomas,80,97,Disease/Disorder	MTAP,99,103,Gene/Protein	tumors,127,133,Disease/Disorder	"[{""token"": ""MTAP"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""MTAP"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""myxofibrosarcomas"", ""start_span"": 80, ""end_span"": 97, ""type"": ""Disease/Disorder""}, {""token"": ""MTAP"", ""start_span"": 99, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""tumors"", ""start_span"": 127, ""end_span"": 133, ""type"": ""Disease/Disorder""}]"	train
Analogously, MMP - 9 overexpression in the ASS1 - deficient and MTAP - deficient myxofibrosarcomas is likely mediated by overexpressed ODC, which converges growth - promoting signals to orchestrate transcriptional regulation.	MMP - 9,13,20,Gene/Protein	ASS1,43,47,Gene/Protein	MTAP,64,68,Gene/Protein	myxofibrosarcomas,81,98,Disease/Disorder	ODC,135,138,Gene/Protein	"[{""token"": ""MMP - 9"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""ASS1"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""MTAP"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""myxofibrosarcomas"", ""start_span"": 81, ""end_span"": 98, ""type"": ""Disease/Disorder""}, {""token"": ""ODC"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}]"	train
In addition, we demonstrated that myxofibrosarcomas fundamentally depended on MTAP deficiency regarding their susceptibility to L - alanosine, which effectively inhibited the MTAP - deficient cell lines and derived xenografts and was well - tolerated by the mice.	myxofibrosarcomas,34,51,Disease/Disorder	MTAP,78,82,Gene/Protein	L - alanosine,128,141,Chemical/Drug	MTAP,175,179,Gene/Protein	mice,258,262,Organism/Species	"[{""token"": ""myxofibrosarcomas"", ""start_span"": 34, ""end_span"": 51, ""type"": ""Disease/Disorder""}, {""token"": ""MTAP"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""L - alanosine"", ""start_span"": 128, ""end_span"": 141, ""type"": ""Chemical/Drug""}, {""token"": ""MTAP"", ""start_span"": 175, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 258, ""end_span"": 262, ""type"": ""Organism/Species""}]"	train
Since several antimetabolites targeting purine synthesis are available and additional drugs are in development [ 32 – 34 ], the findings of this study suggest that MTAP - deficient myxofibrosarcomas may benefit from the chemoselective targeting of the defects in methionine - adenine recycling and AMP synthesis.	purine,40,46,Chemical/Drug	MTAP,164,168,Gene/Protein	myxofibrosarcomas,181,198,Disease/Disorder	methionine,263,273,Chemical/Drug	adenine,276,283,Chemical/Drug	"[{""token"": ""purine"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Chemical/Drug""}, {""token"": ""MTAP"", ""start_span"": 164, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""myxofibrosarcomas"", ""start_span"": 181, ""end_span"": 198, ""type"": ""Disease/Disorder""}, {""token"": ""methionine"", ""start_span"": 263, ""end_span"": 273, ""type"": ""Chemical/Drug""}, {""token"": ""adenine"", ""start_span"": 276, ""end_span"": 283, ""type"": ""Chemical/Drug""}]"	train
In summary, MTAP deficiency in myxofibrosarcomas, and particularly that caused by homozygous deletion, negatively affects prognosis. In vitro and in vivo, MTAP may act as a tumor suppressor, serving antiangiogenic, antiproliferative, and antimigratory or antiinvasive functions, and its deficiency represents a potential therapeutic target of myxofibrosarcomas.	MTAP,12,16,Gene/Protein	myxofibrosarcomas,31,48,Disease/Disorder	MTAP,155,159,Gene/Protein	tumor,173,178,Disease/Disorder	myxofibrosarcomas,343,360,Disease/Disorder	"[{""token"": ""MTAP"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""myxofibrosarcomas"", ""start_span"": 31, ""end_span"": 48, ""type"": ""Disease/Disorder""}, {""token"": ""MTAP"", ""start_span"": 155, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 173, ""end_span"": 178, ""type"": ""Disease/Disorder""}, {""token"": ""myxofibrosarcomas"", ""start_span"": 343, ""end_span"": 360, ""type"": ""Disease/Disorder""}]"	train
Regarding the 3 myxofibrosarcoma cell lines, homozygous deletion was determined when no MTAP gene copy was detected but PIK3R1 was amplifiable, i. e. the MTAP / PIK3R1 ratio approximating zero.	myxofibrosarcoma,16,32,Disease/Disorder	MTAP,88,92,Gene/Protein	PIK3R1,120,126,Gene/Protein	MTAP,154,158,Gene/Protein	PIK3R1,161,167,Gene/Protein	"[{""token"": ""myxofibrosarcoma"", ""start_span"": 16, ""end_span"": 32, ""type"": ""Disease/Disorder""}, {""token"": ""MTAP"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""PIK3R1"", ""start_span"": 120, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""MTAP"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""PIK3R1"", ""start_span"": 161, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
For viral infection, 3 × 106 NMFH - 1 cells were incubated with 8 mL of lentivirus in the presence of polybrene, followed by puromycin selection to produce stable clones of lentivirus - transduced cells.	viral infection,4,19,Disease/Disorder	lentivirus,72,82,Organism/Species	polybrene,102,111,Chemical/Drug	puromycin,125,134,Chemical/Drug	lentivirus,173,183,Organism/Species	"[{""token"": ""viral infection"", ""start_span"": 4, ""end_span"": 19, ""type"": ""Disease/Disorder""}, {""token"": ""lentivirus"", ""start_span"": 72, ""end_span"": 82, ""type"": ""Organism/Species""}, {""token"": ""polybrene"", ""start_span"": 102, ""end_span"": 111, ""type"": ""Chemical/Drug""}, {""token"": ""puromycin"", ""start_span"": 125, ""end_span"": 134, ""type"": ""Chemical/Drug""}, {""token"": ""lentivirus"", ""start_span"": 173, ""end_span"": 183, ""type"": ""Organism/Species""}]"	train
To elucidate the functional alterations associated with MTAP reexpression, MTAP knockdown, and L - alanosine treatment, various cancer phenotypes were evaluated using cell viability, bromodeoxyuridine ( BrdU ), electric cell - substrate impedance sensing ( ECIS ), cell cycle kinetics, soft - agar, HUVEC tube formation, and wound - healing, invasion, and apoptosis assays in Methods - S5 - S11.	MTAP,56,60,Gene/Protein	MTAP,75,79,Gene/Protein	L - alanosine,95,108,Chemical/Drug	cancer,128,134,Disease/Disorder	bromodeoxyuridine,183,200,Chemical/Drug	"[{""token"": ""MTAP"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""MTAP"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""L - alanosine"", ""start_span"": 95, ""end_span"": 108, ""type"": ""Chemical/Drug""}, {""token"": ""cancer"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Disease/Disorder""}, {""token"": ""bromodeoxyuridine"", ""start_span"": 183, ""end_span"": 200, ""type"": ""Chemical/Drug""}]"	train
Off all 13 pituitary tumors, six were a non - secreting adenoma, five a prolactinoma, and two were an ACTH producing adenoma.	pituitary tumors,11,27,Disease/Disorder	adenoma,56,63,Disease/Disorder	prolactinoma,72,84,Disease/Disorder	ACTH,102,106,Gene/Protein	adenoma,117,124,Disease/Disorder	"[{""token"": ""pituitary tumors"", ""start_span"": 11, ""end_span"": 27, ""type"": ""Disease/Disorder""}, {""token"": ""adenoma"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Disease/Disorder""}, {""token"": ""prolactinoma"", ""start_span"": 72, ""end_span"": 84, ""type"": ""Disease/Disorder""}, {""token"": ""ACTH"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""adenoma"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Disease/Disorder""}]"	train
Table 2 shows the different GH doses stratified by gender before and after follow up. Fig. 1Mean serum total IGF - 1 level in SD score (± SEM) at baseline, after 4 weeks of GH treatment and at end of follow up in the low dose ( LD) and high dose ( HD) female and male groupTable 2Different GH doses stratified by gender at baseline and after follow upLow DoseHigh DoseGH dose at baseline ( mg / day) Male0. 20 ( 0. 25) 0. 13 ( 0. 23) female0. 38 ( 0. 39) 0. 50 ( 0. 30) GH dose at week 24 ( mg / day) Male0. 08 ( 0. 06) 0. 40 ( 0. 28) female0. 15 ( 0. 21) 1. 00 ( 0. 83) Values are median ( interquartile range)	GH,28,30,Gene/Protein	IGF - 1,109,116,Gene/Protein	GH,173,175,Gene/Protein	GH,290,292,Gene/Protein	GH,368,370,Gene/Protein	"[{""token"": ""GH"", ""start_span"": 28, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""IGF - 1"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""GH"", ""start_span"": 173, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""GH"", ""start_span"": 290, ""end_span"": 292, ""type"": ""Gene/Protein""}, {""token"": ""GH"", ""start_span"": 368, ""end_span"": 370, ""type"": ""Gene/Protein""}]"	train
For example intramolecular Mannich reaction of tryptamine or a tryptophan - derived oxindole and an aldehyde, oxidative ring contraction of tetrahydro - β - carbolines, dipolar cycloaddition reactions of azomethineylides with oxindolylidene 3 - ylidene acetate and intramolecular Heck reaction followed by trapping of an η3 - allylpalladium species by a tethered nitrogen nucleophile16171819.	tryptamine,47,57,Chemical/Drug	tryptophan,63,73,Chemical/Drug	oxindole,84,92,Chemical/Drug	tetrahydro - β - carbolines,140,167,Chemical/Drug	azomethineylides,204,220,Chemical/Drug	"[{""token"": ""tryptamine"", ""start_span"": 47, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""tryptophan"", ""start_span"": 63, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""oxindole"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""tetrahydro - \u03b2 - carbolines"", ""start_span"": 140, ""end_span"": 167, ""type"": ""Chemical/Drug""}, {""token"": ""azomethineylides"", ""start_span"": 204, ""end_span"": 220, ""type"": ""Chemical/Drug""}]"	train
MCF - 7 cells were maintained as monolayer in 25 cm2 culture flasks ( T - 25) at 37 ° C in DMEM medium ( GIBCO, St. Louis, USA) supplemented with high glucose, L - glutamine, pyridoxine hydrochloride, 110 mg / L sodium pyruvate, 3. 7 g / L NaHCO3 and antibiotics ( Penicillin - 10, 000 units / mL, Streptomycin − 10, 000 μg / mL, GIBCO, USA ).	glucose,151,158,Chemical/Drug	L - glutamine,160,173,Chemical/Drug	pyridoxine hydrochloride,175,199,Chemical/Drug	Penicillin,265,275,Chemical/Drug	Streptomycin,298,310,Chemical/Drug	"[{""token"": ""glucose"", ""start_span"": 151, ""end_span"": 158, ""type"": ""Chemical/Drug""}, {""token"": ""L - glutamine"", ""start_span"": 160, ""end_span"": 173, ""type"": ""Chemical/Drug""}, {""token"": ""pyridoxine hydrochloride"", ""start_span"": 175, ""end_span"": 199, ""type"": ""Chemical/Drug""}, {""token"": ""Penicillin"", ""start_span"": 265, ""end_span"": 275, ""type"": ""Chemical/Drug""}, {""token"": ""Streptomycin"", ""start_span"": 298, ""end_span"": 310, ""type"": ""Chemical/Drug""}]"	train
Echinococcus granulosus is a flatworm and member of the Platyhelminthes, and is the causative agent of cystic echinococcosis ( CE ), a disease that is distributed throughout most areas of the world [ 10, 11 ].	Echinococcus granulosus,0,23,Organism/Species	flatworm,29,37,Organism/Species	Platyhelminthes,56,71,Organism/Species	cystic echinococcosis,103,124,Disease/Disorder	CE,127,129,Disease/Disorder	"[{""token"": ""Echinococcus granulosus"", ""start_span"": 0, ""end_span"": 23, ""type"": ""Organism/Species""}, {""token"": ""flatworm"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Organism/Species""}, {""token"": ""Platyhelminthes"", ""start_span"": 56, ""end_span"": 71, ""type"": ""Organism/Species""}, {""token"": ""cystic echinococcosis"", ""start_span"": 103, ""end_span"": 124, ""type"": ""Disease/Disorder""}, {""token"": ""CE"", ""start_span"": 127, ""end_span"": 129, ""type"": ""Disease/Disorder""}]"	train
The cycle is completed when a canine ( dog, wolf, fox) definitive host swallows PSC present in the hydatid cysts in infected offal, and the PSC develop into adult worms in the small intestine [ 15 ].	dog,39,42,Organism/Species	wolf,44,48,Organism/Species	fox,50,53,Organism/Species	hydatid cysts,99,112,Disease/Disorder	worms,163,168,Organism/Species	"[{""token"": ""dog"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Organism/Species""}, {""token"": ""wolf"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Organism/Species""}, {""token"": ""fox"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Organism/Species""}, {""token"": ""hydatid cysts"", ""start_span"": 99, ""end_span"": 112, ""type"": ""Disease/Disorder""}, {""token"": ""worms"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Organism/Species""}]"	train
Of these, 24 families had been expected in the flatworms [ 8, 9 ], including one which is characteristic for Eumetazoa, 14 from Bilateria, 8 from Protostomia and one from Lophotrochozoa ( Figure 3a ).	flatworms,47,56,Organism/Species	Eumetazoa,109,118,Organism/Species	Bilateria,128,137,Organism/Species	Protostomia,146,157,Organism/Species	Lophotrochozoa,171,185,Organism/Species	"[{""token"": ""flatworms"", ""start_span"": 47, ""end_span"": 56, ""type"": ""Organism/Species""}, {""token"": ""Eumetazoa"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Organism/Species""}, {""token"": ""Bilateria"", ""start_span"": 128, ""end_span"": 137, ""type"": ""Organism/Species""}, {""token"": ""Protostomia"", ""start_span"": 146, ""end_span"": 157, ""type"": ""Organism/Species""}, {""token"": ""Lophotrochozoa"", ""start_span"": 171, ""end_span"": 185, ""type"": ""Organism/Species""}]"	train
We then compared the presence or absence of the conserved miRNA families of E. granulosus ( Cestoda) with three other flatworms, S. mediterranea ( Turbellaria) [ 18 ], Gyrodactylus salaris ( Monogenea) [ 9] and S. japonicum ( Trematoda) [ 22 ].	Cestoda,92,99,Organism/Species	flatworms,118,127,Organism/Species	Turbellaria,147,158,Organism/Species	Monogenea,191,200,Organism/Species	Trematoda,226,235,Organism/Species	"[{""token"": ""Cestoda"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Organism/Species""}, {""token"": ""flatworms"", ""start_span"": 118, ""end_span"": 127, ""type"": ""Organism/Species""}, {""token"": ""Turbellaria"", ""start_span"": 147, ""end_span"": 158, ""type"": ""Organism/Species""}, {""token"": ""Monogenea"", ""start_span"": 191, ""end_span"": 200, ""type"": ""Organism/Species""}, {""token"": ""Trematoda"", ""start_span"": 226, ""end_span"": 235, ""type"": ""Organism/Species""}]"	train
Since the larval PSC is an important transition life cycle stage, capable of developing either into an adult worm in the dog gastrointestinal tract or a secondary hydatid cyst in the intermediate host, we compared the expression levels of miRNAs in adult worms or cyst membrane with those in the PSC.	worm,109,113,Organism/Species	dog,121,124,Organism/Species	hydatid cyst,163,175,Disease/Disorder	worms,255,260,Organism/Species	cyst,264,268,Disease/Disorder	"[{""token"": ""worm"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Organism/Species""}, {""token"": ""hydatid cyst"", ""start_span"": 163, ""end_span"": 175, ""type"": ""Disease/Disorder""}, {""token"": ""worms"", ""start_span"": 255, ""end_span"": 260, ""type"": ""Organism/Species""}, {""token"": ""cyst"", ""start_span"": 264, ""end_span"": 268, ""type"": ""Disease/Disorder""}]"	train
Thus, the observation of substantially increased expression of let - 7 in the PSC and cyst might be associated with the capability of E. granulosus for bi - directional development, differentiating into an adult worm in the definitive host dog gastrointestinal tract or into a secondary hydatid cyst in the intermediate ( or human) host [ 50 ].	cyst,86,90,Disease/Disorder	worm,212,216,Organism/Species	dog,240,243,Organism/Species	hydatid cyst,287,299,Disease/Disorder	human,325,330,Organism/Species	"[{""token"": ""cyst"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Disease/Disorder""}, {""token"": ""worm"", ""start_span"": 212, ""end_span"": 216, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 240, ""end_span"": 243, ""type"": ""Organism/Species""}, {""token"": ""hydatid cyst"", ""start_span"": 287, ""end_span"": 299, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 325, ""end_span"": 330, ""type"": ""Organism/Species""}]"	train
In most patients, preoperative levels of serum follicle - stimulating hormone ( FSH ), leutenizing hormone ( LH ), and total testosterone were measured.	follicle - stimulating hormone,47,77,Gene/Protein	FSH,80,83,Gene/Protein	leutenizing hormone,87,106,Gene/Protein	LH,109,111,Gene/Protein	testosterone,125,137,Chemical/Drug	"[{""token"": ""follicle - stimulating hormone"", ""start_span"": 47, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""FSH"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""leutenizing hormone"", ""start_span"": 87, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""LH"", ""start_span"": 109, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""testosterone"", ""start_span"": 125, ""end_span"": 137, ""type"": ""Chemical/Drug""}]"	train
MRC2 ( Mannose Receptor C Type 2) is a constitutively recycling endocytic receptor belonging to the mannose receptor family, which has been found to be closely involved with cancer metastasis.	MRC2,0,4,Gene/Protein	Mannose Receptor C Type 2,7,32,Gene/Protein	endocytic receptor,64,82,Gene/Protein	mannose receptor,100,116,Gene/Protein	cancer,174,180,Disease/Disorder	"[{""token"": ""MRC2"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""Mannose Receptor C Type 2"", ""start_span"": 7, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""endocytic receptor"", ""start_span"": 64, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""mannose receptor"", ""start_span"": 100, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""cancer"", ""start_span"": 174, ""end_span"": 180, ""type"": ""Disease/Disorder""}]"	train
These data suggest that MRC2 overexpression predicts poor prognosis of HCCs after liver resection and MRC2 potentially contributed to TGFβ1 - driven up - regulation of cell migration and invasion in HCC.	MRC2,24,28,Gene/Protein	HCCs,71,75,Disease/Disorder	MRC2,102,106,Gene/Protein	TGFβ1,134,139,Gene/Protein	HCC,199,202,Disease/Disorder	"[{""token"": ""MRC2"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""HCCs"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Disease/Disorder""}, {""token"": ""MRC2"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""TGF\u03b21"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 199, ""end_span"": 202, ""type"": ""Disease/Disorder""}]"	train
Among them, there are multiple functions of extracellular matrix degradation on tumor progression including: ( 1) providing tumor mass more space to spread; ( 2) liberating more latent growth factors from extracellular matrix and activating oncogenic cell signalings in neighboring tumor cells; ( 3) facilitating the formation of neovasculature within tumor mass; ( 4) abolishing the restrictions of tumor cell proliferation from extracellular matrix [ 4 ].	tumor,80,85,Disease/Disorder	tumor,124,129,Disease/Disorder	tumor,282,287,Disease/Disorder	tumor,352,357,Disease/Disorder	tumor,400,405,Disease/Disorder	"[{""token"": ""tumor"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Disease/Disorder""}, {""token"": ""tumor"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Disease/Disorder""}, {""token"": ""tumor"", ""start_span"": 282, ""end_span"": 287, ""type"": ""Disease/Disorder""}, {""token"": ""tumor"", ""start_span"": 352, ""end_span"": 357, ""type"": ""Disease/Disorder""}, {""token"": ""tumor"", ""start_span"": 400, ""end_span"": 405, ""type"": ""Disease/Disorder""}]"	train
To determine the relationship between TGFβ1 and MRC2 in HCC tissues, we also observed TGFβ1 expression in both HCC tissues and adjacent liver tissues by IHC staining.	TGFβ1,38,43,Gene/Protein	MRC2,48,52,Gene/Protein	HCC,56,59,Disease/Disorder	TGFβ1,86,91,Gene/Protein	HCC,111,114,Disease/Disorder	"[{""token"": ""TGF\u03b21"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""MRC2"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Disease/Disorder""}, {""token"": ""TGF\u03b21"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Disease/Disorder""}]"	train
To examine further whether TGFβ1 take part in aberrant MRC2 over - expression in HCC, we treated Huh7 cells with recombinant human TGFβ1 protein in vitro.	TGFβ1,27,32,Gene/Protein	MRC2,55,59,Gene/Protein	HCC,81,84,Disease/Disorder	human,125,130,Organism/Species	TGFβ1,131,136,Gene/Protein	"[{""token"": ""TGF\u03b21"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""MRC2"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Organism/Species""}, {""token"": ""TGF\u03b21"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Gene/Protein""}]"	train
To reveal the role of TGFβ1 on the transcriptional regulation of MRC2 in HCC, we identified several potential Smad binding sites in the gene promoter of MRC2 using MatInspector professional version 7. 2 ( shown in Figure 5a ).	TGFβ1,22,27,Gene/Protein	MRC2,65,69,Gene/Protein	HCC,73,76,Disease/Disorder	Smad,110,114,Gene/Protein	MRC2,153,157,Gene/Protein	"[{""token"": ""TGF\u03b21"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""MRC2"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Disease/Disorder""}, {""token"": ""Smad"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""MRC2"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	train
( a) Schematic diagram of the potential Smad binding sites in the promoter of MRC2 which shows there are six neighboring potential Smad binding sites in the − 955 /− 401 bp MRC2 promoter fragment; ( b) With the help of ChIP assay, we obtained the DNA fragments bound with Smad protein in the nucleus of Huh7 cells.	Smad,40,44,Gene/Protein	MRC2,78,82,Gene/Protein	Smad,131,135,Gene/Protein	MRC2,173,177,Gene/Protein	Smad,272,276,Gene/Protein	"[{""token"": ""Smad"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""MRC2"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""Smad"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""MRC2"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""Smad"", ""start_span"": 272, ""end_span"": 276, ""type"": ""Gene/Protein""}]"	train
After analyzing 169 prostate tissue sections including benign prostatic hyperplasia and prostate cancer by immunofluorescence assay, Kogianni et al. found that MRC2 expression was clearly increased in both stromal tissues and epithelial tissues of prostate cancer compared to benign prostatic hyperplasia [ 19 ].	benign prostatic hyperplasia,55,83,Disease/Disorder	prostate cancer,88,103,Disease/Disorder	MRC2,160,164,Gene/Protein	prostate cancer,248,263,Disease/Disorder	benign prostatic hyperplasia,276,304,Disease/Disorder	"[{""token"": ""benign prostatic hyperplasia"", ""start_span"": 55, ""end_span"": 83, ""type"": ""Disease/Disorder""}, {""token"": ""prostate cancer"", ""start_span"": 88, ""end_span"": 103, ""type"": ""Disease/Disorder""}, {""token"": ""MRC2"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""prostate cancer"", ""start_span"": 248, ""end_span"": 263, ""type"": ""Disease/Disorder""}, {""token"": ""benign prostatic hyperplasia"", ""start_span"": 276, ""end_span"": 304, ""type"": ""Disease/Disorder""}]"	train
In glioblastoma multiforme, it was found that MRC2 was over - expressed in tumor tissues and attributed to mediating tumor cells invasion via collagen - containing matrices [ 24 ].	glioblastoma multiforme,3,26,Disease/Disorder	MRC2,46,50,Gene/Protein	tumor,75,80,Disease/Disorder	tumor,117,122,Disease/Disorder	collagen,142,150,Gene/Protein	"[{""token"": ""glioblastoma multiforme"", ""start_span"": 3, ""end_span"": 26, ""type"": ""Disease/Disorder""}, {""token"": ""MRC2"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Disease/Disorder""}, {""token"": ""tumor"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Disease/Disorder""}, {""token"": ""collagen"", ""start_span"": 142, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
Moreover, we found 6 potential Smad protein binding sites in the promoter of MRC2 gene and verified the direct interaction between Smad protein and the MRC2 promoter in HCC cells by ChIP assay.	Smad,31,35,Gene/Protein	MRC2,77,81,Gene/Protein	Smad,131,135,Gene/Protein	MRC2,152,156,Gene/Protein	HCC,169,172,Disease/Disorder	"[{""token"": ""Smad"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""MRC2"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""Smad"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""MRC2"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Disease/Disorder""}]"	train
Therefore, it was demonstrated that TGFβ1 regulated MRC2 expression in HCC, which is consistent with the findings in prostate cancer [ 25] and glioblastoma multiforme [ 24 ].	TGFβ1,36,41,Gene/Protein	MRC2,52,56,Gene/Protein	HCC,71,74,Disease/Disorder	prostate cancer,117,132,Disease/Disorder	glioblastoma multiforme,143,166,Disease/Disorder	"[{""token"": ""TGF\u03b21"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""MRC2"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Disease/Disorder""}, {""token"": ""prostate cancer"", ""start_span"": 117, ""end_span"": 132, ""type"": ""Disease/Disorder""}, {""token"": ""glioblastoma multiforme"", ""start_span"": 143, ""end_span"": 166, ""type"": ""Disease/Disorder""}]"	train
It was demonstrated further that MRC2 was regulated directly by TGFβ1 / Smad3 and involved in the oncogenic effect of TGFβ1 in HCC.	MRC2,33,37,Gene/Protein	TGFβ1,64,69,Gene/Protein	Smad3,72,77,Gene/Protein	TGFβ1,118,123,Gene/Protein	HCC,127,130,Disease/Disorder	"[{""token"": ""MRC2"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""TGF\u03b21"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""Smad3"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""TGF\u03b21"", ""start_span"": 118, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Disease/Disorder""}]"	train
TaTypA, a Ribosome - Binding GTPase Protein, Positively Regulates Wheat Resistance to the Stripe Rust Fungus	TaTypA,0,6,Gene/Protein	Ribosome - Binding GTPase,10,35,Gene/Protein	Wheat,66,71,Organism/Species	Stripe Rust,90,101,Disease/Disorder	Fungus,102,108,Organism/Species	"[{""token"": ""TaTypA"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""Ribosome - Binding GTPase"", ""start_span"": 10, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""Wheat"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Organism/Species""}, {""token"": ""Stripe Rust"", ""start_span"": 90, ""end_span"": 101, ""type"": ""Disease/Disorder""}, {""token"": ""Fungus"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Organism/Species""}]"	train
Diverse mechanisms have been shown to be involved in pathogen - induced ROS production, including peroxidases and different oxidases ( oxalate oxidase, amine oxidase, and NADPH oxidase; Pugin et al ., 1997; Wojtaszek, 1997; Rea et al ., 1998 ).	peroxidases,98,109,Gene/Protein	oxidases,124,132,Gene/Protein	oxalate oxidase,135,150,Gene/Protein	amine oxidase,152,165,Gene/Protein	NADPH oxidase,171,184,Gene/Protein	"[{""token"": ""peroxidases"", ""start_span"": 98, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""oxidases"", ""start_span"": 124, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""oxalate oxidase"", ""start_span"": 135, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""amine oxidase"", ""start_span"": 152, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""NADPH oxidase"", ""start_span"": 171, ""end_span"": 184, ""type"": ""Gene/Protein""}]"	train
A few members of trGTPases family, such as EF - G, EF - Tu, IF2 and RF3, bind to an overlapping site on the ribosome ( Sergiev et al ., 2005 ).	trGTPases,17,26,Gene/Protein	EF - G,43,49,Gene/Protein	EF - Tu,51,58,Gene/Protein	IF2,60,63,Gene/Protein	RF3,68,71,Gene/Protein	"[{""token"": ""trGTPases"", ""start_span"": 17, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""EF - G"", ""start_span"": 43, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""EF - Tu"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""IF2"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""RF3"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene/Protein""}]"	train
TypA / BipA was firstly identified in Salmonella typhimurium as a protein induced by the antimicrobial peptide bactericidal permeability - increasing protein ( BPI; Qi et al ., 1995 ).	TypA / BipA,0,11,Gene/Protein	Salmonella typhimurium,38,60,Organism/Species	antimicrobial peptide,89,110,Gene/Protein	bactericidal permeability - increasing protein,111,157,Gene/Protein	BPI,160,163,Gene/Protein	"[{""token"": ""TypA / BipA"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""Salmonella typhimurium"", ""start_span"": 38, ""end_span"": 60, ""type"": ""Organism/Species""}, {""token"": ""antimicrobial peptide"", ""start_span"": 89, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""bactericidal permeability - increasing protein"", ""start_span"": 111, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""BPI"", ""start_span"": 160, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
TypA binding to ribosomes at a site in accordance with that of EF - G indicated that GTPase activity of TypA is sensitive to high GDP: GTP ratios ( Owens et al ., 2004 ).	TypA,0,4,Gene/Protein	at,26,28,Organism/Species	EF - G,63,69,Gene/Protein	GTPase,85,91,Gene/Protein	TypA,104,108,Gene/Protein	"[{""token"": ""TypA"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""at"", ""start_span"": 26, ""end_span"": 28, ""type"": ""Organism/Species""}, {""token"": ""EF - G"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""GTPase"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""TypA"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene/Protein""}]"	train
The transcript profile of TaTypA was analyzed in wheat seedlings inoculated with Pst and in plants subjected to environmental stimuli, and the subcellular localization of TaTypA was determined.	TaTypA,26,32,Gene/Protein	wheat,49,54,Organism/Species	Pst,81,84,Organism/Species	plants,92,98,Organism/Species	TaTypA,171,177,Gene/Protein	"[{""token"": ""TaTypA"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""wheat"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Organism/Species""}, {""token"": ""Pst"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 92, ""end_span"": 98, ""type"": ""Organism/Species""}, {""token"": ""TaTypA"", ""start_span"": 171, ""end_span"": 177, ""type"": ""Gene/Protein""}]"	train
A 433 - bp unisequence ( GenBank accession number EV253998) exhibiting high homology to a putative TypA Oryza sativa GTP - binding protein was obtained from the Pst - induced SSH cDNA library ( Yu et al ., 2010) and used as a query sequence to screen EST databases of wheat constructed in our laboratory ( Ma et al ., 2009 ).	TypA,99,103,Gene/Protein	Oryza sativa,104,116,Organism/Species	GTP - binding protein,117,138,Gene/Protein	Pst,161,164,Organism/Species	wheat,268,273,Organism/Species	"[{""token"": ""TypA"", ""start_span"": 99, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""Oryza sativa"", ""start_span"": 104, ""end_span"": 116, ""type"": ""Organism/Species""}, {""token"": ""GTP - binding protein"", ""start_span"": 117, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""Pst"", ""start_span"": 161, ""end_span"": 164, ""type"": ""Organism/Species""}, {""token"": ""wheat"", ""start_span"": 268, ""end_span"": 273, ""type"": ""Organism/Species""}]"	train
To better understand TaTypA characteristics in the wheat genome, the exon of each sub - genomic sequence was selected and assembled artificially, designated TaTypA - 6A, TaTypA - 6B, and TaTypA - 6D, respectively ( Supplementary Figure S1 ).	TaTypA,21,27,Gene/Protein	wheat,51,56,Organism/Species	TaTypA,157,163,Gene/Protein	TaTypA,170,176,Gene/Protein	TaTypA,187,193,Gene/Protein	"[{""token"": ""TaTypA"", ""start_span"": 21, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""wheat"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Organism/Species""}, {""token"": ""TaTypA"", ""start_span"": 157, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""TaTypA"", ""start_span"": 170, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""TaTypA"", ""start_span"": 187, ""end_span"": 193, ""type"": ""Gene/Protein""}]"	train
TaTypA - 6A and TaTypA - 6D contain only a few amino acid variations relative to TaTypA from Su11, whereas TaTypA - 6B contains 101 - and 48 - aa deletions ( Supplementary Figure S2 ).	TaTypA,0,6,Gene/Protein	TaTypA,16,22,Gene/Protein	amino acid,47,57,Chemical/Drug	TaTypA,81,87,Gene/Protein	TaTypA,107,113,Gene/Protein	"[{""token"": ""TaTypA"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""TaTypA"", ""start_span"": 16, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""amino acid"", ""start_span"": 47, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""TaTypA"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""TaTypA"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Gene/Protein""}]"	train
TaTypA, together with OsTypA from Oryza sativa and BdTypA from B. distachyon, constituted a monocot subgroup.	TaTypA,0,6,Gene/Protein	OsTypA,22,28,Gene/Protein	Oryza sativa,34,46,Organism/Species	BdTypA,51,57,Gene/Protein	monocot,92,99,Organism/Species	"[{""token"": ""TaTypA"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""OsTypA"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""Oryza sativa"", ""start_span"": 34, ""end_span"": 46, ""type"": ""Organism/Species""}, {""token"": ""BdTypA"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""monocot"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Organism/Species""}]"	train
pCaMV35S :: TaTypA :: GFP and pCaMV35S :: TaTypA - N1 - 80 :: GFP fusion proteins were mainly targeted to the chloroplasts of wheat cells ( Figure 2 ).	TaTypA,12,18,Gene/Protein	GFP,22,25,Gene/Protein	TaTypA,42,48,Gene/Protein	GFP,62,65,Gene/Protein	wheat,126,131,Organism/Species	"[{""token"": ""TaTypA"", ""start_span"": 12, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""TaTypA"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""wheat"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Organism/Species""}]"	train
Bands of 28 -, 107 -, and 35 - kDa were detected, suggesting that GFP, TapA - GFP and TaTypA - N1 - 80 - GFP was expressed in wheat cells ( Supplementary Figure S4 ).	GFP,66,69,Gene/Protein	GFP,78,81,Gene/Protein	TaTypA,86,92,Gene/Protein	GFP,105,108,Gene/Protein	wheat,126,131,Organism/Species	"[{""token"": ""GFP"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""TaTypA"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""wheat"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Organism/Species""}]"	train
The presence of non - symptomatic new leaves in plants treated with Fes buffer under the same conditions indicated that silencing of TaPDS occurred specifically in BSMV: TaPDS - as infected plants.	plants,48,54,Organism/Species	TaPDS,133,138,Gene/Protein	BSMV,164,168,Organism/Species	TaPDS,170,175,Gene/Protein	plants,190,196,Organism/Species	"[{""token"": ""plants"", ""start_span"": 48, ""end_span"": 54, ""type"": ""Organism/Species""}, {""token"": ""TaPDS"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""BSMV"", ""start_span"": 164, ""end_span"": 168, ""type"": ""Organism/Species""}, {""token"": ""TaPDS"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""plants"", ""start_span"": 190, ""end_span"": 196, ""type"": ""Organism/Species""}]"	train
The areas were significantly less in TaTypA knock - down plants than in BSMV: γ - infected plants at 48 and 120 hpi ( Figure 6B ).	TaTypA,37,43,Gene/Protein	plants,57,63,Organism/Species	BSMV,72,76,Organism/Species	plants,91,97,Organism/Species	at,98,100,Organism/Species	"[{""token"": ""TaTypA"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""plants"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Organism/Species""}, {""token"": ""BSMV"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 91, ""end_span"": 97, ""type"": ""Organism/Species""}, {""token"": ""at"", ""start_span"": 98, ""end_span"": 100, ""type"": ""Organism/Species""}]"	train
H2O2 accumulation was significantly decreased in TaTypA knock - down plants compared to BSMV: γ infected plants at 48 and 120 hpi ( Figures 7A, B ).	TaTypA,49,55,Gene/Protein	plants,69,75,Organism/Species	BSMV,88,92,Organism/Species	plants,105,111,Organism/Species	at,112,114,Organism/Species	"[{""token"": ""TaTypA"", ""start_span"": 49, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""plants"", ""start_span"": 69, ""end_span"": 75, ""type"": ""Organism/Species""}, {""token"": ""BSMV"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 105, ""end_span"": 111, ""type"": ""Organism/Species""}, {""token"": ""at"", ""start_span"": 112, ""end_span"": 114, ""type"": ""Organism/Species""}]"	train
( A) Wheat leaves previously treated with recombinant BSMV: γ or BSMV: TaTypA were inoculated with Pst race CYR23.	Wheat,5,10,Organism/Species	BSMV,54,58,Organism/Species	BSMV,65,69,Organism/Species	TaTypA,71,77,Gene/Protein	Pst race CYR23,99,113,Organism/Species	"[{""token"": ""Wheat"", ""start_span"": 5, ""end_span"": 10, ""type"": ""Organism/Species""}, {""token"": ""BSMV"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Organism/Species""}, {""token"": ""BSMV"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Organism/Species""}, {""token"": ""TaTypA"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""Pst race CYR23"", ""start_span"": 99, ""end_span"": 113, ""type"": ""Organism/Species""}]"	train
Phylogenetic analysis indicated that TypA proteins in plants form a monophyletic group, within which TaTypA and rice OsTypA constitute a subgroup ( Figure 1 ).	TypA,37,41,Gene/Protein	plants,54,60,Organism/Species	TaTypA,101,107,Gene/Protein	rice,112,116,Organism/Species	OsTypA,117,123,Gene/Protein	"[{""token"": ""TypA"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""plants"", ""start_span"": 54, ""end_span"": 60, ""type"": ""Organism/Species""}, {""token"": ""TaTypA"", ""start_span"": 101, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""rice"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Organism/Species""}, {""token"": ""OsTypA"", ""start_span"": 117, ""end_span"": 123, ""type"": ""Gene/Protein""}]"	train
In contrast, the hyphae of Pst rapidly colonized host tissues during the compatible interaction without any detectable O2 ⋅- and H2O2 accumulation or HR. TaTypA expression was induced as early as 36 hpi and peaked at 96 hpi in the incompatible interaction, suggesting that TaTypA may be responsible for ROS accumulation and protection of host cells from Pst infection.	Pst,27,30,Organism/Species	TaTypA,154,160,Gene/Protein	at,214,216,Organism/Species	TaTypA,273,279,Gene/Protein	Pst infection,354,367,Disease/Disorder	"[{""token"": ""Pst"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Organism/Species""}, {""token"": ""TaTypA"", ""start_span"": 154, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""at"", ""start_span"": 214, ""end_span"": 216, ""type"": ""Organism/Species""}, {""token"": ""TaTypA"", ""start_span"": 273, ""end_span"": 279, ""type"": ""Gene/Protein""}, {""token"": ""Pst infection"", ""start_span"": 354, ""end_span"": 367, ""type"": ""Disease/Disorder""}]"	train
Superoxide dismutase ( SOD) and catalase ( CAT) are major ROS - scavenging enzymes ( Mittler et al ., 2004 ).	Superoxide dismutase,0,20,Gene/Protein	SOD,23,26,Gene/Protein	catalase,32,40,Gene/Protein	CAT,43,46,Gene/Protein	ROS - scavenging enzymes,58,82,Gene/Protein	"[{""token"": ""Superoxide dismutase"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""SOD"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""catalase"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""CAT"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""ROS - scavenging enzymes"", ""start_span"": 58, ""end_span"": 82, ""type"": ""Gene/Protein""}]"	train
Eukaryotic photosynthetic microorganisms, such as Chlorella vulgaris, Dunaliella tertiolecta, Chlamydomonas reinhardtii, Phaeodactylum tricornutum, and Thalassiosira pseudonana, have also been studied [ 13, 14, 15 ].	microorganisms,26,40,Organism/Species	Dunaliella tertiolecta,70,92,Organism/Species	Chlamydomonas reinhardtii,94,119,Organism/Species	Phaeodactylum tricornutum,121,146,Organism/Species	Thalassiosira pseudonana,152,176,Organism/Species	"[{""token"": ""microorganisms"", ""start_span"": 26, ""end_span"": 40, ""type"": ""Organism/Species""}, {""token"": ""Dunaliella tertiolecta"", ""start_span"": 70, ""end_span"": 92, ""type"": ""Organism/Species""}, {""token"": ""Chlamydomonas reinhardtii"", ""start_span"": 94, ""end_span"": 119, ""type"": ""Organism/Species""}, {""token"": ""Phaeodactylum tricornutum"", ""start_span"": 121, ""end_span"": 146, ""type"": ""Organism/Species""}, {""token"": ""Thalassiosira pseudonana"", ""start_span"": 152, ""end_span"": 176, ""type"": ""Organism/Species""}]"	train
In this work, a host – guest approach in which the N - terminal fragment of Moloney murine leukemia virus reverse transcriptase ( MMLV RT) serves as the host and DNA as the guest was used to determine the crystal structures of complexes including 16 bp oligo ­ nucleotides with and without the SP lesion at 2. 14 and 1. 72 Å resolution, respectively.	Moloney murine leukemia virus,76,105,Organism/Species	reverse transcriptase,106,127,Gene/Protein	MMLV,130,134,Organism/Species	RT,135,137,Gene/Protein	oligo ­ nucleotides,253,272,Chemical/Drug	"[{""token"": ""Moloney murine leukemia virus"", ""start_span"": 76, ""end_span"": 105, ""type"": ""Organism/Species""}, {""token"": ""reverse transcriptase"", ""start_span"": 106, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""MMLV"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Organism/Species""}, {""token"": ""RT"", ""start_span"": 135, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""oligo \u00ad nucleotides"", ""start_span"": 253, ""end_span"": 272, ""type"": ""Chemical/Drug""}]"	train
The N - terminal fragment ( amino - acid residues 24 – 278) of Moloney murine leukemia virus reverse transcriptase ( MMLV RT) was purified as described previously ( Sun et al ., 1998 ▶).	amino - acid,28,40,Chemical/Drug	Moloney murine leukemia virus,63,92,Organism/Species	reverse transcriptase,93,114,Gene/Protein	MMLV,117,121,Organism/Species	RT,122,124,Gene/Protein	"[{""token"": ""amino - acid"", ""start_span"": 28, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""Moloney murine leukemia virus"", ""start_span"": 63, ""end_span"": 92, ""type"": ""Organism/Species""}, {""token"": ""reverse transcriptase"", ""start_span"": 93, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""MMLV"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Organism/Species""}, {""token"": ""RT"", ""start_span"": 122, ""end_span"": 124, ""type"": ""Gene/Protein""}]"	train
Handed behavior has also been frequently reported in fish, e. g ., with respect to eye usage preference ( i. e. visual lateralization) in a poeciliid fish [ 9 ], [ 10 ], swimming - turns in zebra - and goldfish [ 11] and foraging in a freshwater goby [ 12] and in some African cichlid fishes [ 13 ], [ 14 ].	fish,53,57,Organism/Species	poeciliid fish,140,154,Organism/Species	goldfish,202,210,Organism/Species	freshwater goby,235,250,Organism/Species	cichlid fishes,277,291,Organism/Species	"[{""token"": ""fish"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Organism/Species""}, {""token"": ""poeciliid fish"", ""start_span"": 140, ""end_span"": 154, ""type"": ""Organism/Species""}, {""token"": ""goldfish"", ""start_span"": 202, ""end_span"": 210, ""type"": ""Organism/Species""}, {""token"": ""freshwater goby"", ""start_span"": 235, ""end_span"": 250, ""type"": ""Organism/Species""}, {""token"": ""cichlid fishes"", ""start_span"": 277, ""end_span"": 291, ""type"": ""Organism/Species""}]"	train
In Uganda, THETA ( Traditional and modern health practitioners together against AIDS and other diseases ), is promoting collaboration between traditional and biomedical health workers in the prevention and care of sexually transmitted infections ( STIs) including HIV / AIDS.	AIDS,80,84,Disease/Disorder	sexually transmitted infections,214,245,Disease/Disorder	STIs,248,252,Disease/Disorder	HIV,264,267,Disease/Disorder	AIDS,270,274,Disease/Disorder	"[{""token"": ""AIDS"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Disease/Disorder""}, {""token"": ""sexually transmitted infections"", ""start_span"": 214, ""end_span"": 245, ""type"": ""Disease/Disorder""}, {""token"": ""STIs"", ""start_span"": 248, ""end_span"": 252, ""type"": ""Disease/Disorder""}, {""token"": ""HIV"", ""start_span"": 264, ""end_span"": 267, ""type"": ""Disease/Disorder""}, {""token"": ""AIDS"", ""start_span"": 270, ""end_span"": 274, ""type"": ""Disease/Disorder""}]"	train
TH need to be educated on other practices that can transmit the virus and should also be trained in HIV counseling, condom distribution, community HIV / AIDS and STI education.	virus,64,69,Organism/Species	HIV,100,103,Disease/Disorder	HIV,147,150,Disease/Disorder	AIDS,153,157,Disease/Disorder	STI,162,165,Disease/Disorder	"[{""token"": ""virus"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Disease/Disorder""}, {""token"": ""HIV"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Disease/Disorder""}, {""token"": ""AIDS"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Disease/Disorder""}, {""token"": ""STI"", ""start_span"": 162, ""end_span"": 165, ""type"": ""Disease/Disorder""}]"	train
Knockdown of the catalytic subunit of PP1 ( PP1Cα ), but not PP2A ( PP2ACα ), increased pS137 - PFN1 levels.	PP1,38,41,Gene/Protein	PP1Cα,44,49,Gene/Protein	PP2A,61,65,Gene/Protein	PP2ACα,68,74,Gene/Protein	PFN1,96,100,Gene/Protein	"[{""token"": ""PP1"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""PP1C\u03b1"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""PP2A"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""PP2AC\u03b1"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene/Protein""}]"	train
Profilin - 1 ( PFN1) and profilin - 2a ( PFN2a ), the classic “ somatic ” isoforms, are 65% identical in amino acid sequence, and highly conserved in 3D structure [ 3 ].	Profilin - 1,0,12,Gene/Protein	PFN1,15,19,Gene/Protein	profilin - 2a,25,38,Gene/Protein	PFN2a,41,46,Gene/Protein	amino acid,105,115,Chemical/Drug	"[{""token"": ""Profilin - 1"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""profilin - 2a"", ""start_span"": 25, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""PFN2a"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""amino acid"", ""start_span"": 105, ""end_span"": 115, ""type"": ""Chemical/Drug""}]"	train
Two testis - specific profilins, PFN3 and PFN4, are recently described, and differ substantially from PFN1 and PFN2a in their primary sequences [ 5 ].	profilins,22,31,Gene/Protein	PFN3,33,37,Gene/Protein	PFN4,42,46,Gene/Protein	PFN1,102,106,Gene/Protein	PFN2a,111,116,Gene/Protein	"[{""token"": ""profilins"", ""start_span"": 22, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""PFN3"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""PFN4"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""PFN2a"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Gene/Protein""}]"	train
Both PFN3 and PFN4 bind G - actin with lower affinity than PFN1 and PFN2a.	PFN3,5,9,Gene/Protein	PFN4,14,18,Gene/Protein	G - actin,24,33,Gene/Protein	PFN1,59,63,Gene/Protein	PFN2a,68,73,Gene/Protein	"[{""token"": ""PFN3"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""PFN4"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""G - actin"", ""start_span"": 24, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""PFN2a"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Gene/Protein""}]"	train
By exploiting a highly sensitive and specific PFN1 antibody against pSer - 137, we now provide pharmacological, genetic and biochemical evidence that protein phosphatase - 1 ( PP1) exists in the same protein complex with PFN1 and dephosphorylates Ser - 137.	PFN1,46,50,Gene/Protein	antibody,51,59,Gene/Protein	protein phosphatase - 1,150,173,Gene/Protein	PP1,176,179,Gene/Protein	PFN1,221,225,Gene/Protein	"[{""token"": ""PFN1"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 51, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""protein phosphatase - 1"", ""start_span"": 150, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""PP1"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 221, ""end_span"": 225, ""type"": ""Gene/Protein""}]"	train
The RhoA activator lysophosphatidic acid ( LPA) mildly increased pS137 - PFN1 levels in cultured cells, which was blocked by the ROCK inhibitor Y - 27632 [ 6 ].	RhoA,4,8,Gene/Protein	lysophosphatidic acid,19,40,Chemical/Drug	PFN1,73,77,Gene/Protein	ROCK,129,133,Gene/Protein	Y - 27632,144,153,Chemical/Drug	"[{""token"": ""RhoA"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""lysophosphatidic acid"", ""start_span"": 19, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""PFN1"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""ROCK"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""Y - 27632"", ""start_span"": 144, ""end_span"": 153, ""type"": ""Chemical/Drug""}]"	train
In situ staining of mammalian cells by pSer - 137 - PFN1 antibody P3490 is responsive to RhoA / ROCK signaling.	PFN1,52,56,Gene/Protein	antibody,57,65,Gene/Protein	P3490,66,71,Chemical/Drug	RhoA,89,93,Gene/Protein	ROCK,96,100,Gene/Protein	"[{""token"": ""PFN1"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""P3490"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Chemical/Drug""}, {""token"": ""RhoA"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""ROCK"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene/Protein""}]"	train
In serum - starved NIH 3T3 cells, the RhoA activator lysophosphatidic acid ( LPA) markedly increased the number of P3490 - positive cells, and this was blocked by ROCK inhibition with Y - 27632 ( Fig. 1D ).	RhoA,38,42,Gene/Protein	lysophosphatidic acid,53,74,Chemical/Drug	P3490,115,120,Chemical/Drug	ROCK,163,167,Gene/Protein	Y - 27632,184,193,Chemical/Drug	"[{""token"": ""RhoA"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""lysophosphatidic acid"", ""start_span"": 53, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""P3490"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Chemical/Drug""}, {""token"": ""ROCK"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""Y - 27632"", ""start_span"": 184, ""end_span"": 193, ""type"": ""Chemical/Drug""}]"	train
Data are mean ± SEM of three independent experiments. D, HEK293 cells were transiently transfected with Myc - tagged PFN1 ( wt, S137A or S137D ), treated with 50 µM hydroxyfasudil for 16 hr, and double stained with an anti - Myc ( red) and P3490 ( green) antibodies.	Myc,104,107,Gene/Protein	PFN1,117,121,Gene/Protein	Myc,225,228,Gene/Protein	P3490,240,245,Chemical/Drug	antibodies,255,265,Gene/Protein	"[{""token"": ""Myc"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""Myc"", ""start_span"": 225, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""P3490"", ""start_span"": 240, ""end_span"": 245, ""type"": ""Chemical/Drug""}, {""token"": ""antibodies"", ""start_span"": 255, ""end_span"": 265, ""type"": ""Gene/Protein""}]"	train
Okadaic acid ( OA) inhibits the serine / threonine - specific phosphoprotein phosphatase ( PPP) family, in particular its two most abundant members, PP1 and PP2A [ 15 ].	Okadaic acid,0,12,Chemical/Drug	serine / threonine - specific phosphoprotein phosphatase,32,88,Gene/Protein	PPP,91,94,Gene/Protein	PP1,149,152,Gene/Protein	PP2A,157,161,Gene/Protein	"[{""token"": ""Okadaic acid"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Chemical/Drug""}, {""token"": ""serine / threonine - specific phosphoprotein phosphatase"", ""start_span"": 32, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""PPP"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""PP1"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""PP2A"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	train
Nearly all cells expressing wild type PP1Cα stained negative for pS137 - PFN1, while many cells expressing the inactive PP1Cα ( H125A) mutant or wild type PP2ACα stained positive for pS137 - PFN1 ( Fig. 4D ).	PP1Cα,38,43,Gene/Protein	PFN1,73,77,Gene/Protein	PP1Cα,120,125,Gene/Protein	PP2ACα,155,161,Gene/Protein	PFN1,191,195,Gene/Protein	"[{""token"": ""PP1C\u03b1"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""PP1C\u03b1"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""PP2AC\u03b1"", ""start_span"": 155, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
Silencing PP1Cα, but not PP2ACα, increased the number of P3490 - positive cells and their staining intensities, while having no effect on total PFN1 levels. B, effects of PP1Cα and PP2ACα knockdown on P3490 staining were quantified using the fluorescence plate reader, normalized vs. DAPI, and represented as change relative to control siRNA.	PP1Cα,10,15,Gene/Protein	PP2ACα,25,31,Gene/Protein	PFN1,144,148,Gene/Protein	PP1Cα,171,176,Gene/Protein	PP2ACα,181,187,Gene/Protein	"[{""token"": ""PP1C\u03b1"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""PP2AC\u03b1"", ""start_span"": 25, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""PP1C\u03b1"", ""start_span"": 171, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""PP2AC\u03b1"", ""start_span"": 181, ""end_span"": 187, ""type"": ""Gene/Protein""}]"	train
Neither Myc - PP1Cα ( H125A) nor Myc - PP2ACα over - expression affected P3490 staining of the transfected cells ( as indicated by the presence of cells that were both red and green ).	Myc,8,11,Gene/Protein	PP1Cα,14,19,Gene/Protein	Myc,33,36,Gene/Protein	PP2ACα,39,45,Gene/Protein	P3490,73,78,Chemical/Drug	"[{""token"": ""Myc"", ""start_span"": 8, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""PP1C\u03b1"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""Myc"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""PP2AC\u03b1"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""P3490"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Chemical/Drug""}]"	train
The preceding experiments correlated PP1 activity with pS137 - PFN1 dephosphorylation, but left uncertain whether the dephosphorylation is carried out directly by PP1, or by an unknown phosphatase whose activity is regulated by PP1.	PP1,37,40,Gene/Protein	PFN1,63,67,Gene/Protein	PP1,163,166,Gene/Protein	phosphatase,185,196,Gene/Protein	PP1,228,231,Gene/Protein	"[{""token"": ""PP1"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""PP1"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""phosphatase"", ""start_span"": 185, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""PP1"", ""start_span"": 228, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
We next tested for preferential binding of PP1Cα to pS137 - PFN1 vs. unphosphorylated PFN1 by using the phosphomimetic PFN1 ( S137D) vs. phospho - resistant PFN1 ( S137A) mutant.	PP1Cα,43,48,Gene/Protein	PFN1,60,64,Gene/Protein	PFN1,86,90,Gene/Protein	PFN1,119,123,Gene/Protein	PFN1,157,161,Gene/Protein	"[{""token"": ""PP1C\u03b1"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	train
PP1Cα bound more phosphomimetic PFN1 ( S137D) and less phospho - resistant PFN1 ( S137A) in comparison to PFN1 ( wt ), with all PFN1 variants expressed at a similar level ( Fig. 5B ).	PP1Cα,0,5,Gene/Protein	PFN1,32,36,Gene/Protein	PFN1,75,79,Gene/Protein	PFN1,106,110,Gene/Protein	PFN1,128,132,Gene/Protein	"[{""token"": ""PP1C\u03b1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Gene/Protein""}]"	train
Ser - 137 phosphorylation abolishes PFN1 ' s binding to polyproline - containing ligands, e. g. huntingtin, which reduces its ability to inhibit polyglutamine - dependent huntingtin aggregation [ 6 ].	PFN1,36,40,Gene/Protein	polyproline,56,67,Chemical/Drug	huntingtin,96,106,Gene/Protein	polyglutamine,145,158,Chemical/Drug	huntingtin,171,181,Gene/Protein	"[{""token"": ""PFN1"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""polyproline"", ""start_span"": 56, ""end_span"": 67, ""type"": ""Chemical/Drug""}, {""token"": ""huntingtin"", ""start_span"": 96, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""polyglutamine"", ""start_span"": 145, ""end_span"": 158, ""type"": ""Chemical/Drug""}, {""token"": ""huntingtin"", ""start_span"": 171, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	train
This effectively rules out the vast majority of PFN1 - interacting proteins as the candidate, and focuses our future efforts on the limited number of non - polyproline ligands of PFN1 ( e. g. actin and gephyrin) [ 3 ].	PFN1,48,52,Gene/Protein	polyproline,156,167,Chemical/Drug	PFN1,179,183,Gene/Protein	actin,192,197,Gene/Protein	gephyrin,202,210,Gene/Protein	"[{""token"": ""PFN1"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""polyproline"", ""start_span"": 156, ""end_span"": 167, ""type"": ""Chemical/Drug""}, {""token"": ""PFN1"", ""start_span"": 179, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""actin"", ""start_span"": 192, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""gephyrin"", ""start_span"": 202, ""end_span"": 210, ""type"": ""Gene/Protein""}]"	train
HA - tagged human PFN1 ( wt, S137A and S137D) was PCR amplified and cloned into the EcoRI ( 5 ′) and XhoI ( 3 ′) sites of pcDNA3. 1.	HA,0,2,Gene/Protein	human,12,17,Organism/Species	PFN1,18,22,Gene/Protein	EcoRI,84,89,Gene/Protein	XhoI,101,105,Gene/Protein	"[{""token"": ""HA"", ""start_span"": 0, ""end_span"": 2, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Organism/Species""}, {""token"": ""PFN1"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""EcoRI"", ""start_span"": 84, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""XhoI"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene/Protein""}]"	train
HEK293 cells over - expressing Myc - PP1Cα ( wt or H125A) or Myc - PP2ACα were lysed with buffer containing 50 mM Tris - HCl ( pH 7. 4 ), 150 mM NaCl, 0. 1% Triton X - 100, and protease inhibitors.	Myc,31,34,Gene/Protein	PP1Cα,37,42,Gene/Protein	Myc,61,64,Gene/Protein	PP2ACα,67,73,Gene/Protein	protease,177,185,Gene/Protein	"[{""token"": ""Myc"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""PP1C\u03b1"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""Myc"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""PP2AC\u03b1"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""protease"", ""start_span"": 177, ""end_span"": 185, ""type"": ""Gene/Protein""}]"	train
After 2 hr of mixing at 4 ° C, beads were washed 4 times with lysis buffer, and analyzed by Western blot for co - immunoprecitation of untagged or HA - tagged PFN1 via antibodies against PFN1 ( 1 ∶ 1000) or the HA tag ( 1 ∶ 1000 ).	HA,147,149,Gene/Protein	PFN1,159,163,Gene/Protein	antibodies,168,178,Gene/Protein	PFN1,187,191,Gene/Protein	HA,211,213,Gene/Protein	"[{""token"": ""HA"", ""start_span"": 147, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 159, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 168, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 187, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""HA"", ""start_span"": 211, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
P3490 was first diluted 1 ∶ 5000 in the blocking buffers for immunofluorescence ( PBS / 0. 1% Triton X - 100 / 2% BSA) or Western blot ( TBS / 0. 05% Tween 20 / 5% skim milk ), and then mixed at 1 ∶ 200 molar ratio ( antibody / peptide) with PFN1 peptides containing ( Ac - CMASHLRR ( pS) QY - OH) or lacking a phosphate on Ser - 137 ( Ac - CMASHLRRSQY - OH) for 30 min at room temperature.	P3490,0,5,Chemical/Drug	BSA,114,117,Gene/Protein	Tween 20,150,158,Chemical/Drug	antibody,217,225,Gene/Protein	PFN1,242,246,Gene/Protein	"[{""token"": ""P3490"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Chemical/Drug""}, {""token"": ""BSA"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""Tween 20"", ""start_span"": 150, ""end_span"": 158, ""type"": ""Chemical/Drug""}, {""token"": ""antibody"", ""start_span"": 217, ""end_span"": 225, ""type"": ""Gene/Protein""}, {""token"": ""PFN1"", ""start_span"": 242, ""end_span"": 246, ""type"": ""Gene/Protein""}]"	train
Some important transcription factors ( TF) regulating lipid metabolism and seed maturation have been reported, including basic leucine zipper ( bZIP) and DNA binding with one finger ( DOF) TF families [ 11, 12 ].	transcription factors,15,36,Gene/Protein	TF,39,41,Gene/Protein	leucine,127,134,Chemical/Drug	bZIP,144,148,Gene/Protein	TF,189,191,Gene/Protein	"[{""token"": ""transcription factors"", ""start_span"": 15, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""TF"", ""start_span"": 39, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""leucine"", ""start_span"": 127, ""end_span"": 134, ""type"": ""Chemical/Drug""}, {""token"": ""bZIP"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""TF"", ""start_span"": 189, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
ATCNGC4 ( CYCLIC NUCLEOTIDE - GATED CATION CHANNEL 4 ); calmodulin binding / cation channel / cation transmembrane transporter / cyclic nucleotide binding	ATCNGC4,0,7,Gene/Protein	CYCLIC NUCLEOTIDE - GATED CATION CHANNEL 4,10,52,Gene/Protein	calmodulin,56,66,Gene/Protein	transmembrane transporter,101,126,Gene/Protein	cyclic nucleotide,129,146,Chemical/Drug	"[{""token"": ""ATCNGC4"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""CYCLIC NUCLEOTIDE - GATED CATION CHANNEL 4"", ""start_span"": 10, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""calmodulin"", ""start_span"": 56, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""transmembrane transporter"", ""start_span"": 101, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""cyclic nucleotide"", ""start_span"": 129, ""end_span"": 146, ""type"": ""Chemical/Drug""}]"	train
KAS III ( 3 - KETOACYL - ACYL CARRIER PROTEIN SYNTHASE III ); 3 - oxoacyl -[ acyl - carrier - protein] synthase / catalytic / transferase, transferring acyl groups other than amino - acyl groups	KAS III,0,7,Gene/Protein	3 - KETOACYL - ACYL CARRIER PROTEIN SYNTHASE III,10,58,Gene/Protein	catalytic / transferase,114,137,Gene/Protein	acyl,152,156,Chemical/Drug	amino - acyl,175,187,Chemical/Drug	"[{""token"": ""KAS III"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""3 - KETOACYL - ACYL CARRIER PROTEIN SYNTHASE III"", ""start_span"": 10, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""catalytic / transferase"", ""start_span"": 114, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""acyl"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Chemical/Drug""}, {""token"": ""amino - acyl"", ""start_span"": 175, ""end_span"": 187, ""type"": ""Chemical/Drug""}]"	train
Individuals with mental health problems ( bipolar disorder, psychosis, schizophrenia, Alzheimer ' s disease, or other forms of dementia) or other health problems, that might have affected their ability to participate in the study, were excluded.	bipolar disorder,42,58,Disease/Disorder	psychosis,60,69,Disease/Disorder	schizophrenia,71,84,Disease/Disorder	Alzheimer ' s disease,86,107,Disease/Disorder	dementia,127,135,Disease/Disorder	"[{""token"": ""bipolar disorder"", ""start_span"": 42, ""end_span"": 58, ""type"": ""Disease/Disorder""}, {""token"": ""psychosis"", ""start_span"": 60, ""end_span"": 69, ""type"": ""Disease/Disorder""}, {""token"": ""schizophrenia"", ""start_span"": 71, ""end_span"": 84, ""type"": ""Disease/Disorder""}, {""token"": ""Alzheimer ' s disease"", ""start_span"": 86, ""end_span"": 107, ""type"": ""Disease/Disorder""}, {""token"": ""dementia"", ""start_span"": 127, ""end_span"": 135, ""type"": ""Disease/Disorder""}]"	train
No history of 3 or more episodes of otitis media in last 12 months, focal brain lesions, traumatic brain injury, cerebral palsy, seizure disorder, severely impaired reciprocal social interaction or severely restricted activities in DSM - IV criteria for autism.	otitis media,36,48,Disease/Disorder	brain lesions,74,87,Disease/Disorder	cerebral palsy,113,127,Disease/Disorder	seizure disorder,129,145,Disease/Disorder	autism,254,260,Disease/Disorder	"[{""token"": ""otitis media"", ""start_span"": 36, ""end_span"": 48, ""type"": ""Disease/Disorder""}, {""token"": ""brain lesions"", ""start_span"": 74, ""end_span"": 87, ""type"": ""Disease/Disorder""}, {""token"": ""cerebral palsy"", ""start_span"": 113, ""end_span"": 127, ""type"": ""Disease/Disorder""}, {""token"": ""seizure disorder"", ""start_span"": 129, ""end_span"": 145, ""type"": ""Disease/Disorder""}, {""token"": ""autism"", ""start_span"": 254, ""end_span"": 260, ""type"": ""Disease/Disorder""}]"	train
We curated 32 human microarray datasets ( 1, 764 expression profiles in total) measuring cancers of 12 tissues, and 23 datasets ( 1, 158 expression profiles) not related to cancer ( e. g. normal tissues, chronic granulomatous disease, Huntington ' s disease, inflammatory response ).	human,14,19,Organism/Species	cancers,89,96,Disease/Disorder	cancer,173,179,Disease/Disorder	chronic granulomatous disease,204,233,Disease/Disorder	Huntington ' s disease,235,257,Disease/Disorder	"[{""token"": ""human"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Organism/Species""}, {""token"": ""cancers"", ""start_span"": 89, ""end_span"": 96, ""type"": ""Disease/Disorder""}, {""token"": ""cancer"", ""start_span"": 173, ""end_span"": 179, ""type"": ""Disease/Disorder""}, {""token"": ""chronic granulomatous disease"", ""start_span"": 204, ""end_span"": 233, ""type"": ""Disease/Disorder""}, {""token"": ""Huntington ' s disease"", ""start_span"": 235, ""end_span"": 257, ""type"": ""Disease/Disorder""}]"	train
Recently, two new PDGF ligands were discovered that have a N - terminal complement subcomponent C1R / C1S, UEGf, BMP1 ( CUB) domain [ 23 ].	PDGF,18,22,Gene/Protein	C1R,96,99,Gene/Protein	C1S,102,105,Gene/Protein	UEGf,107,111,Gene/Protein	BMP1,113,117,Gene/Protein	"[{""token"": ""PDGF"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""C1R"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""C1S"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""UEGf"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""BMP1"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Gene/Protein""}]"	train
Hearing curves were typically U - shaped ( five out of six species) with best hearing sensitivity located at 0. 5 or 1 kHz ( Fig. 3, Table 2 ). Oxydoras niger and Amblydoras affinis showed lowest thresholds at 0. 5 kHz, whereas Acanthodoras spinosissimus, Agamyxis pectinifrons and Megalodoras uranoscopus had best hearing sensitivity at 1 kHz.	Oxydoras niger,144,158,Organism/Species	Amblydoras affinis,163,181,Organism/Species	Acanthodoras spinosissimus,228,254,Organism/Species	Agamyxis pectinifrons,256,277,Organism/Species	Megalodoras uranoscopus,282,305,Organism/Species	"[{""token"": ""Oxydoras niger"", ""start_span"": 144, ""end_span"": 158, ""type"": ""Organism/Species""}, {""token"": ""Amblydoras affinis"", ""start_span"": 163, ""end_span"": 181, ""type"": ""Organism/Species""}, {""token"": ""Acanthodoras spinosissimus"", ""start_span"": 228, ""end_span"": 254, ""type"": ""Organism/Species""}, {""token"": ""Agamyxis pectinifrons"", ""start_span"": 256, ""end_span"": 277, ""type"": ""Organism/Species""}, {""token"": ""Megalodoras uranoscopus"", ""start_span"": 282, ""end_span"": 305, ""type"": ""Organism/Species""}]"	train
Ladich ( 1999) [ 34] determined that callichthyids had lower auditory sensitivities than pimelodids ( Pimelodus blochii and P. pictus) and doradids ( Platydoras armatulus ), whereas there was no difference between the latter two families.	callichthyids,37,50,Organism/Species	pimelodids,89,99,Organism/Species	Pimelodus blochii,102,119,Organism/Species	doradids,139,147,Organism/Species	Platydoras armatulus,150,170,Organism/Species	"[{""token"": ""callichthyids"", ""start_span"": 37, ""end_span"": 50, ""type"": ""Organism/Species""}, {""token"": ""pimelodids"", ""start_span"": 89, ""end_span"": 99, ""type"": ""Organism/Species""}, {""token"": ""Pimelodus blochii"", ""start_span"": 102, ""end_span"": 119, ""type"": ""Organism/Species""}, {""token"": ""doradids"", ""start_span"": 139, ""end_span"": 147, ""type"": ""Organism/Species""}, {""token"": ""Platydoras armatulus"", ""start_span"": 150, ""end_span"": 170, ""type"": ""Organism/Species""}]"	train
The Hawaiian squirrelfish Myripristis kuntee showed lower auditory thresholds and detected a wider frequency range than Adioryx xantherythrus [ 6 ], [ 8 ]. Myripristis kuntee possesses anterior swim bladder horns, which directly contact the ear, whereas the distance between bladder and inner ear in Adioryx xantherythrus is significant larger.	Hawaiian squirrelfish,4,25,Organism/Species	Myripristis kuntee,26,44,Organism/Species	Adioryx xantherythrus,120,141,Organism/Species	Myripristis kuntee,156,174,Organism/Species	Adioryx xantherythrus,300,321,Organism/Species	"[{""token"": ""Hawaiian squirrelfish"", ""start_span"": 4, ""end_span"": 25, ""type"": ""Organism/Species""}, {""token"": ""Myripristis kuntee"", ""start_span"": 26, ""end_span"": 44, ""type"": ""Organism/Species""}, {""token"": ""Adioryx xantherythrus"", ""start_span"": 120, ""end_span"": 141, ""type"": ""Organism/Species""}, {""token"": ""Myripristis kuntee"", ""start_span"": 156, ""end_span"": 174, ""type"": ""Organism/Species""}, {""token"": ""Adioryx xantherythrus"", ""start_span"": 300, ""end_span"": 321, ""type"": ""Organism/Species""}]"	train
They also showed that thresholds of species with anterior extensions of their swim bladders ( e. g. Atlantic croaker, spotted seatrout) were not significantly lower than those of fishes lacking these projections ( e. g. northern kingfish, red drum) [ 50 ].	Atlantic croaker,100,116,Organism/Species	spotted seatrout,118,134,Organism/Species	fishes,179,185,Organism/Species	northern kingfish,220,237,Organism/Species	red drum,239,247,Organism/Species	"[{""token"": ""Atlantic croaker"", ""start_span"": 100, ""end_span"": 116, ""type"": ""Organism/Species""}, {""token"": ""spotted seatrout"", ""start_span"": 118, ""end_span"": 134, ""type"": ""Organism/Species""}, {""token"": ""fishes"", ""start_span"": 179, ""end_span"": 185, ""type"": ""Organism/Species""}, {""token"": ""northern kingfish"", ""start_span"": 220, ""end_span"": 237, ""type"": ""Organism/Species""}, {""token"": ""red drum"", ""start_span"": 239, ""end_span"": 247, ""type"": ""Organism/Species""}]"	train
Fe ( II) is transported by the divalent metal transporter - 1 ( DMT - 1) and Fe ( III) is proposed to undergo enzymatic reduction to Fe ( II ), perhaps by duodenal cytochrome B ( DcytB ), prior to transport by DMT - 1 [ 9 – 13 ].	divalent metal transporter - 1,31,61,Gene/Protein	DMT - 1,64,71,Gene/Protein	duodenal cytochrome B,155,176,Gene/Protein	DcytB,179,184,Gene/Protein	DMT - 1,210,217,Gene/Protein	"[{""token"": ""divalent metal transporter - 1"", ""start_span"": 31, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""DMT - 1"", ""start_span"": 64, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""duodenal cytochrome B"", ""start_span"": 155, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""DcytB"", ""start_span"": 179, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""DMT - 1"", ""start_span"": 210, ""end_span"": 217, ""type"": ""Gene/Protein""}]"	train
The elegant study of Gunshin et al. [ 69 ], utilizing an intestinal - specific DMT - 1 knock - out model termed Slc11a2int / int ( which is a cross of Slc11a2flox / flox mice with mice carrying a Villin - Cre transgene ), proved essentiality of this transporter for intestinal non - haem iron absorption after birth [ 69 ].	DMT - 1,79,86,Gene/Protein	mice,170,174,Organism/Species	mice,180,184,Organism/Species	Villin,196,202,Gene/Protein	Cre,205,208,Gene/Protein	"[{""token"": ""DMT - 1"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Organism/Species""}, {""token"": ""Villin"", ""start_span"": 196, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""Cre"", ""start_span"": 205, ""end_span"": 208, ""type"": ""Gene/Protein""}]"	train
Finally, of particular note, is a paper by Theil and colleagues [ 75 ], published during preparation of this manuscript, where they show that the Fe derived from dietary ferritin - protein ( i. e. protein - encapsulated ferrihydrite - like nanostructures) is absorbed differently in rats and humans to that of DMT - 1 - dependent Fe ( II ).	ferritin,170,178,Gene/Protein	ferrihydrite,220,232,Chemical/Drug	rats,283,287,Organism/Species	humans,292,298,Organism/Species	DMT - 1,310,317,Gene/Protein	"[{""token"": ""ferritin"", ""start_span"": 170, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""ferrihydrite"", ""start_span"": 220, ""end_span"": 232, ""type"": ""Chemical/Drug""}, {""token"": ""rats"", ""start_span"": 283, ""end_span"": 287, ""type"": ""Organism/Species""}, {""token"": ""humans"", ""start_span"": 292, ""end_span"": 298, ""type"": ""Organism/Species""}, {""token"": ""DMT - 1"", ""start_span"": 310, ""end_span"": 317, ""type"": ""Gene/Protein""}]"	train
The nanoform of TiO2 for example titanate nanoSheets ( TNS) and titanate nano tubes ( TNT) have also been synthesized and used as additives for removing harmful compounds from cigarette smoke [ 11] including nicotine, tar, ammonia, hydrogen cyanide, selected carbonyls and phenolic compounds.	titanate,33,41,Chemical/Drug	titanate,64,72,Chemical/Drug	nicotine,208,216,Chemical/Drug	carbonyls,259,268,Chemical/Drug	phenolic,273,281,Chemical/Drug	"[{""token"": ""titanate"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""titanate"", ""start_span"": 64, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine"", ""start_span"": 208, ""end_span"": 216, ""type"": ""Chemical/Drug""}, {""token"": ""carbonyls"", ""start_span"": 259, ""end_span"": 268, ""type"": ""Chemical/Drug""}, {""token"": ""phenolic"", ""start_span"": 273, ""end_span"": 281, ""type"": ""Chemical/Drug""}]"	train
The mechanism of NAT - mediated N - acetylation has been studied in humans and laboratory mammals, as well as in prokaryotes, including mycobacteria16.	NAT,17,20,Gene/Protein	humans,68,74,Organism/Species	mammals,90,97,Organism/Species	prokaryotes,113,124,Organism/Species	mycobacteria16,136,150,Organism/Species	"[{""token"": ""NAT"", ""start_span"": 17, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""humans"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Organism/Species""}, {""token"": ""mammals"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Organism/Species""}, {""token"": ""prokaryotes"", ""start_span"": 113, ""end_span"": 124, ""type"": ""Organism/Species""}, {""token"": ""mycobacteria16"", ""start_span"": 136, ""end_span"": 150, ""type"": ""Organism/Species""}]"	train
Irrespectively of their kingdom of origin, all characterized NAT homologues appear to perform their enzyme function via a conserved “ catalytic triad ” ( typically formed by residues cysteine - histidine - aspartate) similar to that of cysteine proteases1718.	NAT,61,64,Gene/Protein	cysteine,183,191,Chemical/Drug	histidine,194,203,Chemical/Drug	aspartate,206,215,Chemical/Drug	cysteine proteases1718,236,258,Gene/Protein	"[{""token"": ""NAT"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""cysteine"", ""start_span"": 183, ""end_span"": 191, ""type"": ""Chemical/Drug""}, {""token"": ""histidine"", ""start_span"": 194, ""end_span"": 203, ""type"": ""Chemical/Drug""}, {""token"": ""aspartate"", ""start_span"": 206, ""end_span"": 215, ""type"": ""Chemical/Drug""}, {""token"": ""cysteine proteases1718"", ""start_span"": 236, ""end_span"": 258, ""type"": ""Gene/Protein""}]"	train
The method was applicable with all recombinant NAT proteins in our panel, except the NAT3 of F. oxysporum [( FUSO4) NAT3] and the NAT1 of A. nidulans [( EMENI) NAT1] which were recovered at less optimal levels of yield and purity ( Supplementary Fig.	NAT,47,50,Gene/Protein	NAT3,85,89,Gene/Protein	NAT3,116,120,Gene/Protein	NAT1,130,134,Gene/Protein	NAT1,160,164,Gene/Protein	"[{""token"": ""NAT"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""NAT3"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""NAT3"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""NAT1"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""NAT1"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
Interference with the BOA detoxification pathway, either via deletion of the NAT1 gene926 or co - culture with antagonistic Bacillus bacteria27, has been shown to compromise the BOA tolerance of endophytic Fusaria infecting cereal plants.	NAT1,77,81,Gene/Protein	Bacillus,124,132,Organism/Species	bacteria27,133,143,Organism/Species	Fusaria,206,213,Organism/Species	plants,231,237,Organism/Species	"[{""token"": ""NAT1"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""Bacillus"", ""start_span"": 124, ""end_span"": 132, ""type"": ""Organism/Species""}, {""token"": ""bacteria27"", ""start_span"": 133, ""end_span"": 143, ""type"": ""Organism/Species""}, {""token"": ""Fusaria"", ""start_span"": 206, ""end_span"": 213, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 231, ""end_span"": 237, ""type"": ""Organism/Species""}]"	train
In actinobacteria, some NAT genes have been localized within operons regulating cholesterol catabolism to propionyl - CoA3233, an acyl - group donor substrate of NATs, as shown by this and previous studies2334.	actinobacteria,3,17,Organism/Species	NAT,24,27,Gene/Protein	cholesterol,80,91,Chemical/Drug	acyl,130,134,Chemical/Drug	NATs,162,166,Gene/Protein	"[{""token"": ""actinobacteria"", ""start_span"": 3, ""end_span"": 17, ""type"": ""Organism/Species""}, {""token"": ""NAT"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""cholesterol"", ""start_span"": 80, ""end_span"": 91, ""type"": ""Chemical/Drug""}, {""token"": ""acyl"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Chemical/Drug""}, {""token"": ""NATs"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Gene/Protein""}]"	train
These data are consistent with the quantification of dipeptides ( composed of branched - chain amino acids, predominantly leucine and isoleucine) in Arabidopsis roots, where they were abundant with significantly higher amounts in the epidermis and endodermis compared with other root cell types44.	dipeptides,53,63,Chemical/Drug	amino acids,95,106,Chemical/Drug	leucine,122,129,Chemical/Drug	isoleucine,134,144,Chemical/Drug	Arabidopsis,149,160,Organism/Species	"[{""token"": ""dipeptides"", ""start_span"": 53, ""end_span"": 63, ""type"": ""Chemical/Drug""}, {""token"": ""amino acids"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Chemical/Drug""}, {""token"": ""leucine"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Chemical/Drug""}, {""token"": ""isoleucine"", ""start_span"": 134, ""end_span"": 144, ""type"": ""Chemical/Drug""}, {""token"": ""Arabidopsis"", ""start_span"": 149, ""end_span"": 160, ""type"": ""Organism/Species""}]"	train
The most similar orthologue of the PKS gene defining the postulated NAT3 - containing cluster in Aspergillus is found on the gene cluster responsible for production of the red pigment bikaverin in Fusarium50.	PKS,35,38,Gene/Protein	NAT3,68,72,Gene/Protein	Aspergillus,97,108,Organism/Species	bikaverin,184,193,Chemical/Drug	Fusarium50,197,207,Organism/Species	"[{""token"": ""PKS"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""NAT3"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""Aspergillus"", ""start_span"": 97, ""end_span"": 108, ""type"": ""Organism/Species""}, {""token"": ""bikaverin"", ""start_span"": 184, ""end_span"": 193, ""type"": ""Chemical/Drug""}, {""token"": ""Fusarium50"", ""start_span"": 197, ""end_span"": 207, ""type"": ""Organism/Species""}]"	train
The bikaverin cluster does not bear any NAT orthologue; however, recent bioinformatics analyses suggest that certain NAT genes in Fusarium are contained within subtelomeric chromosomal regions which are known to be highly variable and harbour genes involved in secondary metabolism and adaptation of fungi to environmental stimuli51.	bikaverin,4,13,Chemical/Drug	NAT,40,43,Gene/Protein	NAT,117,120,Gene/Protein	Fusarium,130,138,Organism/Species	fungi,300,305,Organism/Species	"[{""token"": ""bikaverin"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Chemical/Drug""}, {""token"": ""NAT"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""NAT"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""Fusarium"", ""start_span"": 130, ""end_span"": 138, ""type"": ""Organism/Species""}, {""token"": ""fungi"", ""start_span"": 300, ""end_span"": 305, ""type"": ""Organism/Species""}]"	train
Amplified products of the complete ORFs of fungal NAT genes ( generated from cDNA or, in the case of intronless NAT genes, from genomic DNA) were A - tailed at the 3 ′- ends with Taq - DNA polymerase, then ligated to EcoRV - digested and T - tailed pGEM - 5zf (+) cloning vector.	NAT,50,53,Gene/Protein	NAT,112,115,Gene/Protein	Taq,179,182,Organism/Species	DNA polymerase,185,199,Gene/Protein	EcoRV,217,222,Gene/Protein	"[{""token"": ""NAT"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""NAT"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""Taq"", ""start_span"": 179, ""end_span"": 182, ""type"": ""Organism/Species""}, {""token"": ""DNA polymerase"", ""start_span"": 185, ""end_span"": 199, ""type"": ""Gene/Protein""}, {""token"": ""EcoRV"", ""start_span"": 217, ""end_span"": 222, ""type"": ""Gene/Protein""}]"	train
These findings help elucidate the genetic interplay between Rad54 and Parp - 1 by suggesting that p53 / p21 - mediated apoptosis and / or senescence may be involved in synthetic lethal interactions occurring during development and inhibition of tumor growth.	Rad54,60,65,Gene/Protein	Parp - 1,70,78,Gene/Protein	p53,98,101,Gene/Protein	p21,104,107,Gene/Protein	tumor,245,250,Disease/Disorder	"[{""token"": ""Rad54"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""p21"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 245, ""end_span"": 250, ""type"": ""Disease/Disorder""}]"	train
The Rad54 gene encodes a dsDNA - dependent ATPase of the Swi2 / Snf2 family [ 9 ], which interacts directly with Rad51 [ 10, 11 ], and stimulates its DNA exchange activity [ 12 ].	Rad54,4,9,Gene/Protein	ATPase,43,49,Gene/Protein	Swi2,57,61,Gene/Protein	Snf2,64,68,Gene/Protein	Rad51,113,118,Gene/Protein	"[{""token"": ""Rad54"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""ATPase"", ""start_span"": 43, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""Swi2"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""Snf2"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""Rad51"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Gene/Protein""}]"	train
Interestingly, several point mutations in conserved regions of the Rad54 gene family have been found in primary tumors ( e. g ., breast and colon carcinomas and lymphomas) [ 14, 15 ], and approximately half of epithelial ovarian cancers have alterations in genes regulating HR repair [ 16 ].	Rad54,67,72,Gene/Protein	primary tumors,104,118,Disease/Disorder	colon carcinomas,140,156,Disease/Disorder	lymphomas,161,170,Disease/Disorder	epithelial ovarian cancers,210,236,Disease/Disorder	"[{""token"": ""Rad54"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""primary tumors"", ""start_span"": 104, ""end_span"": 118, ""type"": ""Disease/Disorder""}, {""token"": ""colon carcinomas"", ""start_span"": 140, ""end_span"": 156, ""type"": ""Disease/Disorder""}, {""token"": ""lymphomas"", ""start_span"": 161, ""end_span"": 170, ""type"": ""Disease/Disorder""}, {""token"": ""epithelial ovarian cancers"", ""start_span"": 210, ""end_span"": 236, ""type"": ""Disease/Disorder""}]"	train
We also showed that combined loss of Ptc1 and Rad54 or of Ptc1 and Parp - 1 increased radiation induced MB [ 21, 22 ].	Ptc1,37,41,Gene/Protein	Rad54,46,51,Gene/Protein	Ptc1,58,62,Gene/Protein	Parp - 1,67,75,Gene/Protein	MB,104,106,Disease/Disorder	"[{""token"": ""Ptc1"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""MB"", ""start_span"": 104, ""end_span"": 106, ""type"": ""Disease/Disorder""}]"	train
Here, we analyzed the effects of combined loss of Rad54 and Parp - 1 in the Ptc1 mouse model of spontaneous and radiation - induced cancer, highlighting novel synthetic lethal interactions during development and tumorigenesis, and dissecting the underlying cellular and molecular mechanisms.	Rad54,50,55,Gene/Protein	Parp - 1,60,68,Gene/Protein	Ptc1,76,80,Gene/Protein	mouse,81,86,Organism/Species	radiation - induced cancer,112,138,Disease/Disorder	"[{""token"": ""Rad54"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 60, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Organism/Species""}, {""token"": ""radiation - induced cancer"", ""start_span"": 112, ""end_span"": 138, ""type"": ""Disease/Disorder""}]"	train
Although no significant differences were detected between Rad54 and Parp - 1 single and compound mutants in phosphorylation of p53 at Ser18 [ 27 ], we observed a significant increase in total p53 expression ( 3 - fold) only in compound mutants, indicating marked p53 activation ( Figure 6A ), which is consistent with persistent genetic damage.	Rad54,58,63,Gene/Protein	Parp - 1,68,76,Gene/Protein	p53,127,130,Gene/Protein	p53,192,195,Gene/Protein	p53,263,266,Gene/Protein	"[{""token"": ""Rad54"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 68, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 263, ""end_span"": 266, ""type"": ""Gene/Protein""}]"	train
The difference in growth rate become significant at 72 and 96 h after seeding, with a 1. 5 - 2 fold reduction in cell numbers and an increase in doubling times ( 23 vs 35 h) in MEFs from Rad54 -/-/ Parp - 1 -/-/ Ptc1 +/- compared to those from Ptc1 +/- mice ( Figure 6C ).	Rad54,187,192,Gene/Protein	Parp - 1,198,206,Gene/Protein	Ptc1,212,216,Gene/Protein	Ptc1,244,248,Gene/Protein	mice,253,257,Organism/Species	"[{""token"": ""Rad54"", ""start_span"": 187, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 198, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 212, ""end_span"": 216, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 244, ""end_span"": 248, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 253, ""end_span"": 257, ""type"": ""Organism/Species""}]"	train
We observed not only that the combination is active in vivo, but could also clarify that Parp - 1 is not strictly necessary for HR during early embryogenesis, as combined deletions of Parp - 1 and Rad54 caused significantly reduced birth rate and growth retardation - resulting in early death of Rad54 -/-/ Parp - 1 -/- pups - not full embryonic lethality.	Parp - 1,89,97,Gene/Protein	Parp - 1,184,192,Gene/Protein	Rad54,197,202,Gene/Protein	Rad54,296,301,Gene/Protein	Parp - 1,307,315,Gene/Protein	"[{""token"": ""Parp - 1"", ""start_span"": 89, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 184, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 197, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 296, ""end_span"": 301, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 307, ""end_span"": 315, ""type"": ""Gene/Protein""}]"	train
Notably, combined loss of Atm and DNA - PKcs cause embryonic lethality in mice [ 35, 36 ], suggesting that their downregulation may be central to the perinatal lethality of Rad54 -/-/ Parp - 1 -/- mutants.	Atm,26,29,Gene/Protein	DNA - PKcs,34,44,Gene/Protein	mice,74,78,Organism/Species	Rad54,173,178,Gene/Protein	Parp - 1,184,192,Gene/Protein	"[{""token"": ""Atm"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""DNA - PKcs"", ""start_span"": 34, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Organism/Species""}, {""token"": ""Rad54"", ""start_span"": 173, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 184, ""end_span"": 192, ""type"": ""Gene/Protein""}]"	train
Our results of p53 expression in P1 - cerebellum and MEFs are in line with the fact that deficiency in several DNA repair genes such as DNA Lig4, XRCC4 and Rad51 cause increased level of genotoxic stress, triggering a p53 - dependent DNA damage response leading to embryonic lethality [ 40 – 42 ].	p53,15,18,Gene/Protein	Lig4,140,144,Gene/Protein	XRCC4,146,151,Gene/Protein	Rad51,156,161,Gene/Protein	p53,218,221,Gene/Protein	"[{""token"": ""p53"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""Lig4"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""XRCC4"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""Rad51"", ""start_span"": 156, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""p53"", ""start_span"": 218, ""end_span"": 221, ""type"": ""Gene/Protein""}]"	train
In fact, some haemosporidians like Haemoproteus ( Parahaemoproteus) handai, H. ( P .) psittaci, and H. ( P .) homohandai have been originally described from captive Psittaciformes [ 24, 80, 81 ].	haemosporidians,14,29,Organism/Species	Haemoproteus,35,47,Organism/Species	Parahaemoproteus,50,66,Organism/Species	handai,68,74,Organism/Species	Psittaciformes,165,179,Organism/Species	"[{""token"": ""haemosporidians"", ""start_span"": 14, ""end_span"": 29, ""type"": ""Organism/Species""}, {""token"": ""Haemoproteus"", ""start_span"": 35, ""end_span"": 47, ""type"": ""Organism/Species""}, {""token"": ""Parahaemoproteus"", ""start_span"": 50, ""end_span"": 66, ""type"": ""Organism/Species""}, {""token"": ""handai"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Organism/Species""}, {""token"": ""Psittaciformes"", ""start_span"": 165, ""end_span"": 179, ""type"": ""Organism/Species""}]"	train
In addition to fruits, flowers and unripe seeds, red - fronted parakeets consume invertebrates and marine molluscs and occasionally scavenged animal carrion, including birds ( omnivorous - carrion diet ).	red - fronted parakeets,49,72,Organism/Species	invertebrates,81,94,Organism/Species	molluscs,106,114,Organism/Species	animal,142,148,Organism/Species	birds,168,173,Organism/Species	"[{""token"": ""red - fronted parakeets"", ""start_span"": 49, ""end_span"": 72, ""type"": ""Organism/Species""}, {""token"": ""invertebrates"", ""start_span"": 81, ""end_span"": 94, ""type"": ""Organism/Species""}, {""token"": ""molluscs"", ""start_span"": 106, ""end_span"": 114, ""type"": ""Organism/Species""}, {""token"": ""animal"", ""start_span"": 142, ""end_span"": 148, ""type"": ""Organism/Species""}, {""token"": ""birds"", ""start_span"": 168, ""end_span"": 173, ""type"": ""Organism/Species""}]"	train
Austral parakeets include in their diet larvae of Homoptera, Lepidoptera and Hymenoptera ( Aditrochus fagicolus) ( omnivorous - insectivorous diet; Additional file 3: Table S2 ).	Austral parakeets,0,17,Organism/Species	Homoptera,50,59,Organism/Species	Lepidoptera,61,72,Organism/Species	Hymenoptera,77,88,Organism/Species	Aditrochus fagicolus,91,111,Organism/Species	"[{""token"": ""Austral parakeets"", ""start_span"": 0, ""end_span"": 17, ""type"": ""Organism/Species""}, {""token"": ""Homoptera"", ""start_span"": 50, ""end_span"": 59, ""type"": ""Organism/Species""}, {""token"": ""Lepidoptera"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Organism/Species""}, {""token"": ""Hymenoptera"", ""start_span"": 77, ""end_span"": 88, ""type"": ""Organism/Species""}, {""token"": ""Aditrochus fagicolus"", ""start_span"": 91, ""end_span"": 111, ""type"": ""Organism/Species""}]"	train
Our results are in fully agreement with a previous wide - ranging study including 246 species of wild Neotropical birds, which found that species with omnivorous diets had higher prevalence of Plasmodium, whereas insectivores had higher prevalence of microfilariae than birds with a different feeding behaviour [ 20 ].	birds,114,119,Organism/Species	Plasmodium,193,203,Organism/Species	insectivores,213,225,Organism/Species	microfilariae,251,264,Organism/Species	birds,270,275,Organism/Species	"[{""token"": ""birds"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Organism/Species""}, {""token"": ""Plasmodium"", ""start_span"": 193, ""end_span"": 203, ""type"": ""Organism/Species""}, {""token"": ""insectivores"", ""start_span"": 213, ""end_span"": 225, ""type"": ""Organism/Species""}, {""token"": ""microfilariae"", ""start_span"": 251, ""end_span"": 264, ""type"": ""Organism/Species""}, {""token"": ""birds"", ""start_span"": 270, ""end_span"": 275, ""type"": ""Organism/Species""}]"	train
Let us consider the experiment that consists in comparing the phosphorylation of ERK induced by the FSH between untreated cells and cells treated with an inhibitor of protein kinase A ( PKA) ( for example, with the H89 inhibitor23 ).	ERK,81,84,Gene/Protein	FSH,100,103,Gene/Protein	protein kinase A,167,183,Gene/Protein	PKA,186,189,Gene/Protein	H89,215,218,Gene/Protein	"[{""token"": ""ERK"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""FSH"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase A"", ""start_span"": 167, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""PKA"", ""start_span"": 186, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""H89"", ""start_span"": 215, ""end_span"": 218, ""type"": ""Gene/Protein""}]"	train
The result of the experiment is that the phosphorylation of ERK induced by FSH is hampered by the inhibitor, from which an expert can make the hypothesis that PKA might be an intermediary of the activation of ERK by FSH.	ERK,60,63,Gene/Protein	FSH,75,78,Gene/Protein	PKA,159,162,Gene/Protein	ERK,209,212,Gene/Protein	FSH,216,219,Gene/Protein	"[{""token"": ""ERK"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""FSH"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""PKA"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 209, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""FSH"", ""start_span"": 216, ""end_span"": 219, ""type"": ""Gene/Protein""}]"	train
From this first conclusion, two alternatives appear: either Ya can influence Za independently from Xa ( activated PKA stimulates the phosphorylation of ERK independently of FSH) and no other additional conclusion has to be made, or Ya is an intermediary of the induction of Za by Xa, meaning that additionally, Xa stimulates the transformation of Y into Ya ( FSH stimulates the activation of PKA ).	PKA,114,117,Gene/Protein	ERK,152,155,Gene/Protein	FSH,173,176,Gene/Protein	FSH,359,362,Gene/Protein	PKA,392,395,Gene/Protein	"[{""token"": ""PKA"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""FSH"", ""start_span"": 173, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""FSH"", ""start_span"": 359, ""end_span"": 362, ""type"": ""Gene/Protein""}, {""token"": ""PKA"", ""start_span"": 392, ""end_span"": 395, ""type"": ""Gene/Protein""}]"	train
The results obtained show that p38MAPK stimulates the phosphorylation of MEK in an FSHR - induced system, as MEK activation is significantly lower in the presence of p38MAPK inhibitor.	p38MAPK,31,38,Gene/Protein	MEK,73,76,Gene/Protein	FSHR,83,87,Gene/Protein	MEK,109,112,Gene/Protein	p38MAPK,166,173,Gene/Protein	"[{""token"": ""p38MAPK"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""MEK"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""FSHR"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""MEK"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""p38MAPK"", ""start_span"": 166, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
Distribution of both bullous pemphigoid ( BP) patients with ( white column) and without ( gray column) mucosal involvement according to erythema / urticaria BP Disease Area Index ( BPDAI) values ( A) and blisters / erosions BPDAI values ( B) at the time of diagnosis.	bullous pemphigoid,21,39,Disease/Disorder	BP,42,44,Disease/Disorder	erythema,136,144,Disease/Disorder	urticaria,147,156,Disease/Disorder	BP,157,159,Disease/Disorder	"[{""token"": ""bullous pemphigoid"", ""start_span"": 21, ""end_span"": 39, ""type"": ""Disease/Disorder""}, {""token"": ""BP"", ""start_span"": 42, ""end_span"": 44, ""type"": ""Disease/Disorder""}, {""token"": ""erythema"", ""start_span"": 136, ""end_span"": 144, ""type"": ""Disease/Disorder""}, {""token"": ""urticaria"", ""start_span"": 147, ""end_span"": 156, ""type"": ""Disease/Disorder""}, {""token"": ""BP"", ""start_span"": 157, ""end_span"": 159, ""type"": ""Disease/Disorder""}]"	train
Subgroup analysis of BP patients with and without mucosal involvement showed no significant difference both within the number of BP patients who produced anti - BP180 antibodies and within the mean serum titer for this autoantibody ( Table 3 ).	BP,21,23,Disease/Disorder	BP,129,131,Disease/Disorder	BP180,161,166,Gene/Protein	antibodies,167,177,Gene/Protein	autoantibody,219,231,Gene/Protein	"[{""token"": ""BP"", ""start_span"": 21, ""end_span"": 23, ""type"": ""Disease/Disorder""}, {""token"": ""BP"", ""start_span"": 129, ""end_span"": 131, ""type"": ""Disease/Disorder""}, {""token"": ""BP180"", ""start_span"": 161, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 167, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""autoantibody"", ""start_span"": 219, ""end_span"": 231, ""type"": ""Gene/Protein""}]"	train
Correlation of serum anti - BP180 NC16A titers with total BP Disease Area Index ( BPDAI) ( A, E ), total skin BPDAI ( B, F ), blister / erosion BPDAI ( C, G ), and erythema / urticaria BPDAI ( D, H) scores in bullous pemphigoid patients without ( A – D) or with ( E – H) mucosal involvement.	BP180,28,33,Gene/Protein	BP,58,60,Disease/Disorder	erythema,164,172,Disease/Disorder	urticaria,175,184,Disease/Disorder	bullous pemphigoid,209,227,Disease/Disorder	"[{""token"": ""BP180"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""BP"", ""start_span"": 58, ""end_span"": 60, ""type"": ""Disease/Disorder""}, {""token"": ""erythema"", ""start_span"": 164, ""end_span"": 172, ""type"": ""Disease/Disorder""}, {""token"": ""urticaria"", ""start_span"": 175, ""end_span"": 184, ""type"": ""Disease/Disorder""}, {""token"": ""bullous pemphigoid"", ""start_span"": 209, ""end_span"": 227, ""type"": ""Disease/Disorder""}]"	train
Although the analysis of skin BPDAI highlighted an increase in the blisters / erosions activity in BP patients with mucosal involvement, serum titers of autoantibodies directed against BP180 - NC16A, the dominant autoantigen in BP, were not different between patients with and without mucosal involvement.	BP,30,32,Disease/Disorder	autoantibodies,153,167,Gene/Protein	BP180,185,190,Gene/Protein	autoantigen,213,224,Gene/Protein	BP,228,230,Disease/Disorder	"[{""token"": ""BP"", ""start_span"": 30, ""end_span"": 32, ""type"": ""Disease/Disorder""}, {""token"": ""autoantibodies"", ""start_span"": 153, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""BP180"", ""start_span"": 185, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""autoantigen"", ""start_span"": 213, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""BP"", ""start_span"": 228, ""end_span"": 230, ""type"": ""Disease/Disorder""}]"	train
Semi - quantitative RT - PCR analysis of total mRNA excluded the possibility of a severe drop in transcription of CDC19, PFK1 or ACT1 genes in the elp3uba4 double mutant, strongly suggesting the significantly reduced abundance of Cdc19 and Pfk1 in this strain results from a translational rather than a transcriptional defect or a combination of a translational defect with the induction cell death ( Fig. 3F ).	CDC19,114,119,Gene/Protein	PFK1,121,125,Gene/Protein	ACT1,129,133,Gene/Protein	Cdc19,230,235,Gene/Protein	Pfk1,240,244,Gene/Protein	"[{""token"": ""CDC19"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""PFK1"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""ACT1"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""Cdc19"", ""start_span"": 230, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""Pfk1"", ""start_span"": 240, ""end_span"": 244, ""type"": ""Gene/Protein""}]"	train
To analyze genetic interaction of elp3 and urm1 / uba4 with respect to TS and its suppression by excess of tRNA, we transformed the elp3uba4 double mutant with the above mentioned tRNA overexpression plasmids and studied the resulting strains phenotypically for growth at 30 ° C and at 37 ° C along with the wild type control and the single elp3 and uba4 mutants.	elp3,34,38,Gene/Protein	urm1,43,47,Gene/Protein	uba4,50,54,Gene/Protein	elp3,132,136,Gene/Protein	uba4,136,140,Gene/Protein	"[{""token"": ""elp3"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""urm1"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""uba4"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""elp3"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""uba4"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene/Protein""}]"	train
However, combined loss of wobble uridine mcm5 modification and thiolation is tolerated in Caenorhabditis elegans grown at 15 ° C [ 34] and also in fission yeast, an elp3ctu1 ( ortholog of ncs6) double deletion is viable [ 35 ], arguing against an absolute requirement of mcm5s2U for life in eukaryotes.	uridine,33,40,Chemical/Drug	Caenorhabditis elegans,90,112,Organism/Species	fission yeast,147,160,Organism/Species	ncs6,188,192,Gene/Protein	eukaryotes,291,301,Organism/Species	"[{""token"": ""uridine"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""Caenorhabditis elegans"", ""start_span"": 90, ""end_span"": 112, ""type"": ""Organism/Species""}, {""token"": ""fission yeast"", ""start_span"": 147, ""end_span"": 160, ""type"": ""Organism/Species""}, {""token"": ""ncs6"", ""start_span"": 188, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""eukaryotes"", ""start_span"": 291, ""end_span"": 301, ""type"": ""Organism/Species""}]"	train
However, compared to the more comprehensively studied human [ 1 ], mouse [ 2 ], maize [ 3] and cow [ 4] transcriptomes, sheep transcriptomic research remains at a low level.	human,54,59,Organism/Species	mouse,67,72,Organism/Species	maize,80,85,Organism/Species	cow,95,98,Organism/Species	sheep,120,125,Organism/Species	"[{""token"": ""human"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Organism/Species""}, {""token"": ""maize"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organism/Species""}, {""token"": ""cow"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Organism/Species""}, {""token"": ""sheep"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Organism/Species""}]"	train
First, using BLASTN, we compared our transcripts to the NCBI Refseq database ( human, cow and sheep ), UTRdb [ 28] ( human only) and Gnomon ( sheep only) to find highly similar sequences.	human,79,84,Organism/Species	cow,86,89,Organism/Species	sheep,94,99,Organism/Species	human,117,122,Organism/Species	sheep,142,147,Organism/Species	"[{""token"": ""human"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Organism/Species""}, {""token"": ""cow"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Organism/Species""}, {""token"": ""sheep"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Organism/Species""}, {""token"": ""sheep"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Organism/Species""}]"	train
Analysis of MLL expression patterns revealed a negative relationship with cellular metabolism, proliferation and anti - apoptotic transcriptional networks. In silico analysis of published data demonstrated that reduced levels of MLL mRNA are associated with relapse and prednisolone resistance in T - ALL patients and adverse clinical outcome in children with MLL - rearranged ALL.	MLL,12,15,Gene/Protein	MLL,229,232,Gene/Protein	ALL,301,304,Disease/Disorder	MLL,360,363,Gene/Protein	ALL,377,380,Disease/Disorder	"[{""token"": ""MLL"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""MLL"", ""start_span"": 229, ""end_span"": 232, ""type"": ""Gene/Protein""}, {""token"": ""ALL"", ""start_span"": 301, ""end_span"": 304, ""type"": ""Disease/Disorder""}, {""token"": ""MLL"", ""start_span"": 360, ""end_span"": 363, ""type"": ""Gene/Protein""}, {""token"": ""ALL"", ""start_span"": 377, ""end_span"": 380, ""type"": ""Disease/Disorder""}]"	train
Rearrangement of the mixed lineage leukemia gene ( MLL) gene affects 80% of ALL in infants and is associated with a particularly poor prognosis [ 2, 3 ]. MLL is located at 11q23 and encodes a histone methyltransferase that through its regulation of HOX genes is essential for normal mammalian development and hematopoiesis [ 4 ].	MLL,51,54,Gene/Protein	ALL,76,79,Disease/Disorder	MLL,154,157,Gene/Protein	histone methyltransferase,192,217,Gene/Protein	HOX,249,252,Gene/Protein	"[{""token"": ""MLL"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""ALL"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Disease/Disorder""}, {""token"": ""MLL"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""histone methyltransferase"", ""start_span"": 192, ""end_span"": 217, ""type"": ""Gene/Protein""}, {""token"": ""HOX"", ""start_span"": 249, ""end_span"": 252, ""type"": ""Gene/Protein""}]"	train
For assessment of GILZ induction, MLL - KD and MLL - Scr cells in exponential growth were incubated with 1 μM dexamethasone ( Mayne Pharma Pty Ltd, VIC, Australia) for four hours prior to RNA extraction and measurement by qRT - PCR.	GILZ,18,22,Gene/Protein	MLL,34,37,Gene/Protein	MLL,47,50,Gene/Protein	dexamethasone,110,123,Chemical/Drug	Mayne,126,131,Chemical/Drug	"[{""token"": ""GILZ"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""MLL"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""MLL"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""dexamethasone"", ""start_span"": 110, ""end_span"": 123, ""type"": ""Chemical/Drug""}, {""token"": ""Mayne"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Chemical/Drug""}]"	train
MAP2K2 - ERK, JNK, p38, NFkB, and apoptosis pathways	MAP2K2,0,6,Gene/Protein	ERK,9,12,Gene/Protein	JNK,14,17,Gene/Protein	p38,19,22,Gene/Protein	NFkB,24,28,Gene/Protein	"[{""token"": ""MAP2K2"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""ERK"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""JNK"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""p38"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""NFkB"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene/Protein""}]"	train
( A) Difference in MLL expression in pediatric T - ALL patient specimens with ex vivo sensitivity or resistance to prednisolone [ 17 ]; ( B) Difference in MLL expression in pediatric T - ALL patient specimens measured at diagnosis or relapse [ 14 ].	MLL,19,22,Gene/Protein	ALL,51,54,Disease/Disorder	prednisolone,115,127,Chemical/Drug	MLL,155,158,Gene/Protein	ALL,187,190,Disease/Disorder	"[{""token"": ""MLL"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""ALL"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Disease/Disorder""}, {""token"": ""prednisolone"", ""start_span"": 115, ""end_span"": 127, ""type"": ""Chemical/Drug""}, {""token"": ""MLL"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""ALL"", ""start_span"": 187, ""end_span"": 190, ""type"": ""Disease/Disorder""}]"	train
Figure 3A shows that of all the pediatric ALL subtypes, the widest variations in MLL expression levels are found in patients with T - lineage ALL and those with MLL - rearrangements.	all,24,27,Disease/Disorder	ALL,42,45,Disease/Disorder	MLL,81,84,Gene/Protein	ALL,142,145,Disease/Disorder	MLL,161,164,Gene/Protein	"[{""token"": ""all"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Disease/Disorder""}, {""token"": ""ALL"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Disease/Disorder""}, {""token"": ""MLL"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""ALL"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Disease/Disorder""}, {""token"": ""MLL"", ""start_span"": 161, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
There was no significant difference in the induction of GILZ mRNA between MLL - KD and MLL - Scr cell lines following a 4 hour incubation with dexamethasone ( Figure 5D ), indicating that GC - transcriptional responses in MLL - KD cells appeared to be intact.	GILZ,56,60,Gene/Protein	MLL,74,77,Gene/Protein	MLL,87,90,Gene/Protein	dexamethasone,143,156,Chemical/Drug	MLL,222,225,Gene/Protein	"[{""token"": ""GILZ"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""MLL"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""MLL"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""dexamethasone"", ""start_span"": 143, ""end_span"": 156, ""type"": ""Chemical/Drug""}, {""token"": ""MLL"", ""start_span"": 222, ""end_span"": 225, ""type"": ""Gene/Protein""}]"	train
Although there are conflicting reports of the effect of MLL - rearrangements on steroid resistance [ 7, 8 ], it is clear that all infants with MLL - rearrangements have significantly worse prognosis than those with non - rearranged MLL regardless of the type of translocation involved [ 3, 27 ].	MLL,56,59,Gene/Protein	steroid,80,87,Chemical/Drug	all,126,129,Disease/Disorder	MLL,143,146,Gene/Protein	MLL,232,235,Gene/Protein	"[{""token"": ""MLL"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""steroid"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Chemical/Drug""}, {""token"": ""all"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Disease/Disorder""}, {""token"": ""MLL"", ""start_span"": 143, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""MLL"", ""start_span"": 232, ""end_span"": 235, ""type"": ""Gene/Protein""}]"	train
Although loss - of heterozygosity ( LOH) at the MLL locus has been reported to be a relatively frequent event in childhood ALL, consistent with a potential role as a tumor suppressor [ 38 ], this is not the case in patients with MLL - disease where one wild - type copy of MLL appears to be retained [ 38 - 40 ].	MLL,48,51,Gene/Protein	ALL,123,126,Disease/Disorder	tumor,166,171,Disease/Disorder	MLL,229,232,Gene/Protein	MLL,273,276,Gene/Protein	"[{""token"": ""MLL"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""ALL"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Disease/Disorder""}, {""token"": ""tumor"", ""start_span"": 166, ""end_span"": 171, ""type"": ""Disease/Disorder""}, {""token"": ""MLL"", ""start_span"": 229, ""end_span"": 232, ""type"": ""Gene/Protein""}, {""token"": ""MLL"", ""start_span"": 273, ""end_span"": 276, ""type"": ""Gene/Protein""}]"	train
Other workers have recently demonstrated down - regulation of wild - type MLL in myeloid leukemia patients with different types of rearranged - MLL [ 42] suggesting that it may be a common feature of MLL - related leukemia.	MLL,74,77,Gene/Protein	myeloid leukemia,81,97,Disease/Disorder	MLL,144,147,Gene/Protein	MLL,200,203,Gene/Protein	leukemia,214,222,Disease/Disorder	"[{""token"": ""MLL"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""myeloid leukemia"", ""start_span"": 81, ""end_span"": 97, ""type"": ""Disease/Disorder""}, {""token"": ""MLL"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""MLL"", ""start_span"": 200, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""leukemia"", ""start_span"": 214, ""end_span"": 222, ""type"": ""Disease/Disorder""}]"	train
Importantly, HBV - HCV co - infection is associated with more severe liver disease and with a higher prevalence of liver cancer [ 4 ].	HBV,13,16,Organism/Species	HCV,19,22,Organism/Species	co - infection,23,37,Disease/Disorder	liver disease,69,82,Disease/Disorder	liver cancer,115,127,Disease/Disorder	"[{""token"": ""HBV"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Organism/Species""}, {""token"": ""co - infection"", ""start_span"": 23, ""end_span"": 37, ""type"": ""Disease/Disorder""}, {""token"": ""liver disease"", ""start_span"": 69, ""end_span"": 82, ""type"": ""Disease/Disorder""}, {""token"": ""liver cancer"", ""start_span"": 115, ""end_span"": 127, ""type"": ""Disease/Disorder""}]"	train
While liver disease activity and fibrosis progression are generally more severe in cases of HBV - HCV co - infection, an inverse relationship between the replication of each virus within some co - infected patients has been noted, suggesting direct or indirect viral interference [ 10, 11 ].	liver disease,6,19,Disease/Disorder	HBV,92,95,Organism/Species	HCV,98,101,Organism/Species	co - infection,102,116,Disease/Disorder	virus,174,179,Organism/Species	"[{""token"": ""liver disease"", ""start_span"": 6, ""end_span"": 19, ""type"": ""Disease/Disorder""}, {""token"": ""HBV"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Organism/Species""}, {""token"": ""co - infection"", ""start_span"": 102, ""end_span"": 116, ""type"": ""Disease/Disorder""}, {""token"": ""virus"", ""start_span"": 174, ""end_span"": 179, ""type"": ""Organism/Species""}]"	train
Furthermore, HBsAg serum titers are significantly lower during HBV - HCV co - infection, potentially due to decreased HBV replication [ 16 ].	HBsAg,13,18,Gene/Protein	HBV,63,66,Organism/Species	HCV,69,72,Organism/Species	co - infection,73,87,Disease/Disorder	HBV,118,121,Organism/Species	"[{""token"": ""HBsAg"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""HBV"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Organism/Species""}, {""token"": ""co - infection"", ""start_span"": 73, ""end_span"": 87, ""type"": ""Disease/Disorder""}, {""token"": ""HBV"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Organism/Species""}]"	train
HCV core antigen and HCV RNA are positively correlated and appear almost simultaneously in patients ’ peripheral blood, suggesting HCV core antigen may be an additional useful diagnostic marker [ 17 – 19 ].	HCV,0,3,Organism/Species	core antigen,4,16,Gene/Protein	HCV,21,24,Organism/Species	HCV,131,134,Organism/Species	core antigen,135,147,Gene/Protein	"[{""token"": ""HCV"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Organism/Species""}, {""token"": ""core antigen"", ""start_span"": 4, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""HCV"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Organism/Species""}, {""token"": ""core antigen"", ""start_span"": 135, ""end_span"": 147, ""type"": ""Gene/Protein""}]"	train
Other tests included assays for detecting serum HCV antibody, HBV serological markers, HCV RNA, and HBV DNA.	HCV,48,51,Organism/Species	antibody,52,60,Gene/Protein	HBV,62,65,Organism/Species	HCV,87,90,Organism/Species	HBV,100,103,Organism/Species	"[{""token"": ""HCV"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Organism/Species""}, {""token"": ""antibody"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""HBV"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Organism/Species""}, {""token"": ""HBV"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Organism/Species""}]"	train
Comparison of Virological Characteristics between Patients with HBV - HCV Co - Infection and HCV Mono - Infection	HBV,64,67,Organism/Species	HCV,70,73,Organism/Species	Co - Infection,74,88,Disease/Disorder	HCV,93,96,Organism/Species	Infection,104,113,Disease/Disorder	"[{""token"": ""HBV"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Organism/Species""}, {""token"": ""Co - Infection"", ""start_span"": 74, ""end_span"": 88, ""type"": ""Disease/Disorder""}, {""token"": ""HCV"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Organism/Species""}, {""token"": ""Infection"", ""start_span"": 104, ""end_span"": 113, ""type"": ""Disease/Disorder""}]"	train
The median HCV RNA levels of HBV - HCV co - infected patients was significantly lower than those of mono - infected HCV patients, ( 1. 18 [ Interquartile range ( IQR) 0 – 5. 57] versus 5. 87 [ IQR, 3. 54 – 6. 71] Log10 IU / ml, respectively; P < 0. 001) as was the percentage of patients with HCV RNA level ≥ 4 × 105 IU / mL ( 23. 4% versus 56. 5 %, P < 0. 001) ( Table 2 ).	HCV,11,14,Organism/Species	HBV,29,32,Organism/Species	HCV,35,38,Organism/Species	HCV,116,119,Organism/Species	HCV,293,296,Organism/Species	"[{""token"": ""HCV"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Organism/Species""}, {""token"": ""HBV"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 116, ""end_span"": 119, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 293, ""end_span"": 296, ""type"": ""Organism/Species""}]"	train
Comparison of serum HCV core Ag levels in HBV - HCV co - infection patients.	HCV,20,23,Organism/Species	core Ag,24,31,Gene/Protein	HBV,42,45,Organism/Species	HCV,48,51,Organism/Species	co - infection,52,66,Disease/Disorder	"[{""token"": ""HCV"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Organism/Species""}, {""token"": ""core Ag"", ""start_span"": 24, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""HBV"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Organism/Species""}, {""token"": ""co - infection"", ""start_span"": 52, ""end_span"": 66, ""type"": ""Disease/Disorder""}]"	train
We found no significant differences in APRI and FIB - 4 levels between the 107 HBV - HCV co - infected patients and 107 matched HCV controls, or between these two groups of patients with HCV RNA viremia.	HBV,79,82,Organism/Species	HCV,85,88,Organism/Species	HCV,128,131,Organism/Species	HCV,187,190,Organism/Species	viremia,195,202,Disease/Disorder	"[{""token"": ""HBV"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 187, ""end_span"": 190, ""type"": ""Organism/Species""}, {""token"": ""viremia"", ""start_span"": 195, ""end_span"": 202, ""type"": ""Disease/Disorder""}]"	train
Comparison of Virological Characteristics between Patients with HBV - HCV Co - Infection and HBV Mono - Infection	HBV,64,67,Organism/Species	HCV,70,73,Organism/Species	Co - Infection,74,88,Disease/Disorder	HBV,93,96,Organism/Species	Infection,104,113,Disease/Disorder	"[{""token"": ""HBV"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Organism/Species""}, {""token"": ""Co - Infection"", ""start_span"": 74, ""end_span"": 88, ""type"": ""Disease/Disorder""}, {""token"": ""HBV"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Organism/Species""}, {""token"": ""Infection"", ""start_span"": 104, ""end_span"": 113, ""type"": ""Disease/Disorder""}]"	train
Furthermore, 6. 5% ( 7 / 107) of patients with HBV - HCV co - infection had undetectable HBV DNA and HCV RNA levels.	HBV,47,50,Organism/Species	HCV,53,56,Organism/Species	co - infection,57,71,Disease/Disorder	HBV,89,92,Organism/Species	HCV,101,104,Organism/Species	"[{""token"": ""HBV"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Organism/Species""}, {""token"": ""co - infection"", ""start_span"": 57, ""end_span"": 71, ""type"": ""Disease/Disorder""}, {""token"": ""HBV"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Organism/Species""}]"	train
Baseline Characteristics of HBV and HCV Replication in Patients with HBV - HCV Co - Infection	HBV,28,31,Organism/Species	HCV,36,39,Organism/Species	HBV,69,72,Organism/Species	HCV,75,78,Organism/Species	Co - Infection,79,93,Disease/Disorder	"[{""token"": ""HBV"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Organism/Species""}, {""token"": ""HBV"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Organism/Species""}, {""token"": ""Co - Infection"", ""start_span"": 79, ""end_span"": 93, ""type"": ""Disease/Disorder""}]"	train
Baseline characteristics of HBV / HCV replication with HBV - HCV co - infection.	HBV,28,31,Organism/Species	HCV,34,37,Organism/Species	HBV,55,58,Organism/Species	HCV,61,64,Organism/Species	co - infection,65,79,Disease/Disorder	"[{""token"": ""HBV"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Organism/Species""}, {""token"": ""HBV"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Organism/Species""}, {""token"": ""co - infection"", ""start_span"": 65, ""end_span"": 79, ""type"": ""Disease/Disorder""}]"	train
Quantitative variables are displayed as interquartile range ( range ), and HBsAg, HCV core Ag, HCV - RNA and HBV - DNA which are displayed as interquartile range ( IQR ), except age and BMI are displayed as interquartile mean ± SD	HBsAg,75,80,Gene/Protein	HCV,82,85,Organism/Species	core Ag,86,93,Gene/Protein	HCV,95,98,Organism/Species	HBV,109,112,Organism/Species	"[{""token"": ""HBsAg"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""HCV"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Organism/Species""}, {""token"": ""core Ag"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""HCV"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Organism/Species""}, {""token"": ""HBV"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Organism/Species""}]"	train
Because HBsAg did not correlate with HBV DNA and HCV RNA in the overall cohort, we analyzed patterns of HBV and HCV dominance in co - infected patients.	HBsAg,8,13,Gene/Protein	HBV,37,40,Organism/Species	HCV,49,52,Organism/Species	HBV,104,107,Organism/Species	HCV,112,115,Organism/Species	"[{""token"": ""HBsAg"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""HBV"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Organism/Species""}, {""token"": ""HBV"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Organism/Species""}]"	train
The majority of HBV - HCV co - infected patients ( n = 39, 36. 45 %) were HCV dominant ( Group a) ( HBV DNA < 2000 IU / mL and HCV RNA > 15 IU / mL ).	HBV,16,19,Organism/Species	HCV,22,25,Organism/Species	HCV,74,77,Organism/Species	HBV,100,103,Organism/Species	HCV,127,130,Organism/Species	"[{""token"": ""HBV"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Organism/Species""}, {""token"": ""HBV"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Organism/Species""}]"	train
We found a marked difference in the severity of liver disease among the HCV mono - infected, HBV mono - infected, and HBV - HCV co - infected groups ( Table 1 ).	liver disease,48,61,Disease/Disorder	HCV,72,75,Organism/Species	HBV,93,96,Organism/Species	HBV,118,121,Organism/Species	HCV,124,127,Organism/Species	"[{""token"": ""liver disease"", ""start_span"": 48, ""end_span"": 61, ""type"": ""Disease/Disorder""}, {""token"": ""HCV"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Organism/Species""}, {""token"": ""HBV"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Organism/Species""}, {""token"": ""HBV"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Organism/Species""}]"	train
The frequency of HBeAg negativity is significantly higher in patients with HBV - HCV co - infected patients compared to those with HBV mono - infection.	HBeAg,17,22,Gene/Protein	HBV,75,78,Organism/Species	HCV,81,84,Organism/Species	HBV,131,134,Organism/Species	infection,142,151,Disease/Disorder	"[{""token"": ""HBeAg"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""HBV"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Organism/Species""}, {""token"": ""HBV"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Organism/Species""}, {""token"": ""infection"", ""start_span"": 142, ""end_span"": 151, ""type"": ""Disease/Disorder""}]"	train
If HBV and HCV infect the same hepatocyte, HCV structural or functional proteins may directly influence HBV replication and HBsAg expression, or vice versa [ 39 ].	HBV,3,6,Organism/Species	HCV,11,14,Organism/Species	HCV,43,46,Organism/Species	HBV,104,107,Organism/Species	HBsAg,124,129,Gene/Protein	"[{""token"": ""HBV"", ""start_span"": 3, ""end_span"": 6, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Organism/Species""}, {""token"": ""HBV"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Organism/Species""}, {""token"": ""HBsAg"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Gene/Protein""}]"	train
Because HBV - HCV viremia is a dynamic process [ 7 ], long - term follow - up will be critical to understanding the complex interactions between HBV and HCV in co - infected patients.	HBV,8,11,Organism/Species	HCV,14,17,Organism/Species	viremia,18,25,Disease/Disorder	HBV,145,148,Organism/Species	HCV,153,156,Organism/Species	"[{""token"": ""HBV"", ""start_span"": 8, ""end_span"": 11, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Organism/Species""}, {""token"": ""viremia"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Disease/Disorder""}, {""token"": ""HBV"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Organism/Species""}]"	train
Caring for the dog is making responsible decisions about what is best for the dog; for example, providing care by being close to the dog, giving it one ’ s attention, wanting to be useful to the dog, and saying that one always wants to be at the dog ’ s side as a friend.	dog,15,18,Organism/Species	dog,78,81,Organism/Species	dog,133,136,Organism/Species	dog,195,198,Organism/Species	dog,246,249,Organism/Species	"[{""token"": ""dog"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 195, ""end_span"": 198, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 246, ""end_span"": 249, ""type"": ""Organism/Species""}]"	train
Being concerned for the dog by protecting it, such as putting one ’ s arms around the dog as a shield when realizing that certain situations may be threatening to the dog; providing care by observing and commenting on any health problems in order to be considerate; showing concern for the dog by understanding that it is not behaving as before — realizing perhaps that something is wrong with the dog. Mr Edgar: Are you limping, my friend?	dog,24,27,Organism/Species	dog,86,89,Organism/Species	dog,167,170,Organism/Species	dog,290,293,Organism/Species	dog,398,401,Organism/Species	"[{""token"": ""dog"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 290, ""end_span"": 293, ""type"": ""Organism/Species""}, {""token"": ""dog"", ""start_span"": 398, ""end_span"": 401, ""type"": ""Organism/Species""}]"	train
Drugs used to clear infections or cure cancer often target enzymes in bacteria or cancer cells, but the drugs can interfere with the proper function of human enzymes as well.	infections,20,30,Disease/Disorder	cancer,39,45,Disease/Disorder	bacteria,70,78,Organism/Species	cancer,82,88,Disease/Disorder	human,152,157,Organism/Species	"[{""token"": ""infections"", ""start_span"": 20, ""end_span"": 30, ""type"": ""Disease/Disorder""}, {""token"": ""cancer"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Disease/Disorder""}, {""token"": ""bacteria"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Organism/Species""}, {""token"": ""cancer"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Organism/Species""}]"	train
Example ligand sets include the thymidylate synthase reaction set, composed of the reaction substrates and products, and the nucleotide reverse transcriptase inhibitor ( NRTI) drug set, which includes known inhibitors of the nucleoside reverse transcriptase enzyme.	thymidylate synthase,32,52,Gene/Protein	nucleotide,125,135,Chemical/Drug	reverse transcriptase,136,157,Gene/Protein	nucleoside,225,235,Chemical/Drug	reverse transcriptase,236,257,Gene/Protein	"[{""token"": ""thymidylate synthase"", ""start_span"": 32, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""nucleotide"", ""start_span"": 125, ""end_span"": 135, ""type"": ""Chemical/Drug""}, {""token"": ""reverse transcriptase"", ""start_span"": 136, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""nucleoside"", ""start_span"": 225, ""end_span"": 235, ""type"": ""Chemical/Drug""}, {""token"": ""reverse transcriptase"", ""start_span"": 236, ""end_span"": 257, ""type"": ""Gene/Protein""}]"	train
For example, the glycinamide ribonucleotide formyltransferase ( GART) inhibitor drug set hits both the GART reaction set ( E = 1. 55 × 10 − 82) and the off - pathway but pharmacologically related antifolate target dihydrofolate reductase ( DHFR) ( E = 1. 02 × 10 − 134 ).	glycinamide ribonucleotide formyltransferase,17,61,Gene/Protein	GART,64,68,Gene/Protein	GART,103,107,Gene/Protein	dihydrofolate reductase,214,237,Gene/Protein	DHFR,240,244,Gene/Protein	"[{""token"": ""glycinamide ribonucleotide formyltransferase"", ""start_span"": 17, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""GART"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""GART"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""dihydrofolate reductase"", ""start_span"": 214, ""end_span"": 237, ""type"": ""Gene/Protein""}, {""token"": ""DHFR"", ""start_span"": 240, ""end_span"": 244, ""type"": ""Gene/Protein""}]"	train
The top three hits yielded by the NRTI drug set queried against human metabolism – thymidine kinase ( E = 3. 48 × 10 − 26 ), thymidylate kinase ( E = 7. 48 × 10 − 28 ), and deoxythymidine diphosphate kinase ( E = 1. 54 × 10 − 24) ( Figure 3 reaction numbers 2, 3, and 4; additional results in Table 2) – successively phosphorylate the NRTI pro - drugs into the pharmacologically active NRTI triphosphates [ 38 ],[ 39 ].	human,64,69,Organism/Species	thymidine kinase,83,99,Gene/Protein	thymidylate kinase,125,143,Gene/Protein	deoxythymidine diphosphate kinase,173,206,Gene/Protein	triphosphates,391,404,Chemical/Drug	"[{""token"": ""human"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Organism/Species""}, {""token"": ""thymidine kinase"", ""start_span"": 83, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""thymidylate kinase"", ""start_span"": 125, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""deoxythymidine diphosphate kinase"", ""start_span"": 173, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""triphosphates"", ""start_span"": 391, ""end_span"": 404, ""type"": ""Chemical/Drug""}]"	train
Accordingly, SEA finds additional links between the DHFR drug set and established antifolate targets outside the pyrimidine and folate biosynthesis pathways such as serine hydroxymethyltransferase ( SHMT, E = 2. 68 × 10 − 44 ), phosphoribosyl - aminoimidazole - carboxamide formyltransferase ( AICAR transformylase, E = 2. 21 × 10 − 39 ), and phosphoribosyl - glycinamide formyltransferase ( GART, E = 2. 21 × 10 − 39) ( Table 2 ).	DHFR,52,56,Gene/Protein	folate,86,92,Chemical/Drug	serine,165,171,Chemical/Drug	SHMT,199,203,Gene/Protein	GART,392,396,Gene/Protein	"[{""token"": ""DHFR"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""folate"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""serine"", ""start_span"": 165, ""end_span"": 171, ""type"": ""Chemical/Drug""}, {""token"": ""SHMT"", ""start_span"": 199, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""GART"", ""start_span"": 392, ""end_span"": 396, ""type"": ""Gene/Protein""}]"	train
The TS inhibitors link not only to the reactions of deoxyribonucleotide biosynthesis including thymidylate synthase ( E = 2. 54 × 10 − 75 ), but also the GART ( E = 1. 50 × 10 − 60) and DHFR ( E = 1. 96 × 10 − 123) reactions ( Figure 3 and Table 2 ).	TS,4,6,Gene/Protein	deoxyribonucleotide,52,71,Chemical/Drug	thymidylate synthase,95,115,Gene/Protein	GART,154,158,Gene/Protein	DHFR,186,190,Gene/Protein	"[{""token"": ""TS"", ""start_span"": 4, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""deoxyribonucleotide"", ""start_span"": 52, ""end_span"": 71, ""type"": ""Chemical/Drug""}, {""token"": ""thymidylate synthase"", ""start_span"": 95, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""GART"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""DHFR"", ""start_span"": 186, ""end_span"": 190, ""type"": ""Gene/Protein""}]"	train
Mutagenesis of RpoE - like sigma factor genes in Bdellovibrio reveals differential control of groEL and two groES genes	RpoE - like,15,26,Gene/Protein	sigma factor,27,39,Gene/Protein	Bdellovibrio,49,61,Organism/Species	groEL,94,99,Gene/Protein	groES,108,113,Gene/Protein	"[{""token"": ""RpoE - like"", ""start_span"": 15, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""sigma factor"", ""start_span"": 27, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""Bdellovibrio"", ""start_span"": 49, ""end_span"": 61, ""type"": ""Organism/Species""}, {""token"": ""groEL"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""groES"", ""start_span"": 108, ""end_span"": 113, ""type"": ""Gene/Protein""}]"	train
RpoE - like sigma factors in other bacteria mediate gene expression in response to changes in host / external environment and bacteria with mutations in rpoEs can be defective in virulence or other host interactions [ 5 ].	RpoE - like,0,11,Gene/Protein	sigma factors,12,25,Gene/Protein	bacteria,35,43,Organism/Species	bacteria,126,134,Organism/Species	rpoEs,153,158,Gene/Protein	"[{""token"": ""RpoE - like"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""sigma factors"", ""start_span"": 12, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""bacteria"", ""start_span"": 35, ""end_span"": 43, ""type"": ""Organism/Species""}, {""token"": ""bacteria"", ""start_span"": 126, ""end_span"": 134, ""type"": ""Organism/Species""}, {""token"": ""rpoEs"", ""start_span"": 153, ""end_span"": 158, ""type"": ""Gene/Protein""}]"	train
Alignment of the RpoE protein from E. coli with the predicted gene products from bd0743 and bd0881 gave another indication that these Bdellovibrio proteins may have different roles from that of E. coli RpoE.	RpoE,17,21,Gene/Protein	bd0743,81,87,Gene/Protein	bd0881,92,98,Gene/Protein	Bdellovibrio,134,146,Organism/Species	RpoE,202,206,Gene/Protein	"[{""token"": ""RpoE"", ""start_span"": 17, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""bd0743"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""bd0881"", ""start_span"": 92, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""Bdellovibrio"", ""start_span"": 134, ""end_span"": 146, ""type"": ""Organism/Species""}, {""token"": ""RpoE"", ""start_span"": 202, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	train
Additionally bd0881 is conserved in the genome of Bacteriovorax marinus, a marine Bdellovibrio - like bacterium but bd0743 does not have a strong homologue in that genome.	bd0881,13,19,Gene/Protein	Bacteriovorax marinus,50,71,Organism/Species	Bdellovibrio,82,94,Organism/Species	bacterium,102,111,Organism/Species	bd0743,116,122,Gene/Protein	"[{""token"": ""bd0881"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""Bacteriovorax marinus"", ""start_span"": 50, ""end_span"": 71, ""type"": ""Organism/Species""}, {""token"": ""Bdellovibrio"", ""start_span"": 82, ""end_span"": 94, ""type"": ""Organism/Species""}, {""token"": ""bacterium"", ""start_span"": 102, ""end_span"": 111, ""type"": ""Organism/Species""}, {""token"": ""bd0743"", ""start_span"": 116, ""end_span"": 122, ""type"": ""Gene/Protein""}]"	train
Top hits from a BLAST search for Bd3314 are sigma - 70 genes from many delta - proteobacteria, ( outwith the predatory Bdellovibrio) further supporting its possible role as an alternative sigma 70 protein.	Bd3314,33,39,Gene/Protein	sigma - 70,44,54,Gene/Protein	delta - proteobacteria,71,93,Organism/Species	Bdellovibrio,119,131,Organism/Species	sigma 70,188,196,Gene/Protein	"[{""token"": ""Bd3314"", ""start_span"": 33, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""sigma - 70"", ""start_span"": 44, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""delta - proteobacteria"", ""start_span"": 71, ""end_span"": 93, ""type"": ""Organism/Species""}, {""token"": ""Bdellovibrio"", ""start_span"": 119, ""end_span"": 131, ""type"": ""Organism/Species""}, {""token"": ""sigma 70"", ""start_span"": 188, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
This suggests that Bd0881 controls, or optimises, the transcription of some genes involved in the predatory lifestyle while Bd0743 does not and thus Bd0881 is the first experimentally identified Bdellovibrio transcriptional regulator of predation genes.	Bd0881,19,25,Gene/Protein	Bd0743,124,130,Gene/Protein	Bd0881,149,155,Gene/Protein	Bdellovibrio,195,207,Organism/Species	transcriptional regulator,208,233,Gene/Protein	"[{""token"": ""Bd0881"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""Bd0743"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""Bd0881"", ""start_span"": 149, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""Bdellovibrio"", ""start_span"": 195, ""end_span"": 207, ""type"": ""Organism/Species""}, {""token"": ""transcriptional regulator"", ""start_span"": 208, ""end_span"": 233, ""type"": ""Gene/Protein""}]"	train
Thus the similarity in expression patterns of fliC3 gene and bd0881 during predation may imply that Bd0881 protein is involved in regulatory events to do with the timepoints where flagella are being synthesised, i. e. around septation, but the fact that ΔBd0881 mutants are not immotile shows that Bd0881 is not required for the “ all or nothing ” induction of the fliC3 gene expression itself.	fliC3,46,51,Gene/Protein	bd0881,61,67,Gene/Protein	Bd0881,100,106,Gene/Protein	Bd0881,255,261,Gene/Protein	fliC3,365,370,Gene/Protein	"[{""token"": ""fliC3"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""bd0881"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""Bd0881"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""Bd0881"", ""start_span"": 255, ""end_span"": 261, ""type"": ""Gene/Protein""}, {""token"": ""fliC3"", ""start_span"": 365, ""end_span"": 370, ""type"": ""Gene/Protein""}]"	train
Recent work [ 16] has demonstrated different roles for multiple chaperone groEL gene products in the predatory Myxococcus including differential roles in predation and so it is possible that a similar situation exists with the duplicate groES gene products of Bdellovibrio.	chaperone,64,73,Gene/Protein	groEL,74,79,Gene/Protein	Myxococcus,111,121,Organism/Species	groES,237,242,Gene/Protein	Bdellovibrio,260,272,Organism/Species	"[{""token"": ""chaperone"", ""start_span"": 64, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""groEL"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""Myxococcus"", ""start_span"": 111, ""end_span"": 121, ""type"": ""Organism/Species""}, {""token"": ""groES"", ""start_span"": 237, ""end_span"": 242, ""type"": ""Gene/Protein""}, {""token"": ""Bdellovibrio"", ""start_span"": 260, ""end_span"": 272, ""type"": ""Organism/Species""}]"	train
In previous studies on the six different flagellins that are incorporated into the flagellar propeller of Bdellovibrio [ 11, 17 ], we found that different flagellin compositions of a single Bdellovibrio flagellum are possible, and that in the case of a fliC4 mutant, for example, an apparently wild type - length flagellum gave a lower swimming speed than wild type [ 11] suggesting an altered filament rigidity.	flagellins,41,51,Gene/Protein	Bdellovibrio,106,118,Organism/Species	flagellin,155,164,Gene/Protein	Bdellovibrio,190,202,Organism/Species	fliC4,253,258,Gene/Protein	"[{""token"": ""flagellins"", ""start_span"": 41, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""Bdellovibrio"", ""start_span"": 106, ""end_span"": 118, ""type"": ""Organism/Species""}, {""token"": ""flagellin"", ""start_span"": 155, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""Bdellovibrio"", ""start_span"": 190, ""end_span"": 202, ""type"": ""Organism/Species""}, {""token"": ""fliC4"", ""start_span"": 253, ""end_span"": 258, ""type"": ""Gene/Protein""}]"	train
BSE cases have arisen without any known exposure to other infectious prion agents, the possibility remains that they represent a type of inherited BSE that occurs in older cattle with certain Prnp haplotypes.	BSE,0,3,Disease/Disorder	prion,69,74,Gene/Protein	BSE,147,150,Disease/Disorder	cattle,172,178,Organism/Species	Prnp,192,196,Gene/Protein	"[{""token"": ""BSE"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Disease/Disorder""}, {""token"": ""prion"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""BSE"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Disease/Disorder""}, {""token"": ""cattle"", ""start_span"": 172, ""end_span"": 178, ""type"": ""Organism/Species""}, {""token"": ""Prnp"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
The strain Hansenula polymorpha RB11 - pC10 - FMD - GFP expresses GFP under the control of the FMD promoter [ 18 ].	Hansenula polymorpha RB11,11,36,Organism/Species	FMD,46,49,Gene/Protein	GFP,52,55,Gene/Protein	GFP,66,69,Gene/Protein	FMD,95,98,Gene/Protein	"[{""token"": ""Hansenula polymorpha RB11"", ""start_span"": 11, ""end_span"": 36, ""type"": ""Organism/Species""}, {""token"": ""FMD"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""FMD"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}]"	train
Two of these chromate reductases have been well studied: ChrR in Pseudomonas putida ( Park et al ., 2000) and YieF in Escherichia coli ( Barak et al ., 2006 ).	chromate reductases,13,32,Gene/Protein	ChrR,57,61,Gene/Protein	Pseudomonas putida,65,83,Organism/Species	YieF,110,114,Gene/Protein	Escherichia coli,118,134,Organism/Species	"[{""token"": ""chromate reductases"", ""start_span"": 13, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""ChrR"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""Pseudomonas putida"", ""start_span"": 65, ""end_span"": 83, ""type"": ""Organism/Species""}, {""token"": ""YieF"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene/Protein""}, {""token"": ""Escherichia coli"", ""start_span"": 118, ""end_span"": 134, ""type"": ""Organism/Species""}]"	train
To ease data analysis, metabolites were grouped into 6 guilds ( Zak et al ., 1994 ): ( 1) carbohydrates, ( 2) carboxylic acids, ( 3) amino acids, ( 4) amines and amides, ( 5) polymers and ( 6) miscellaneous.	carbohydrates,90,103,Chemical/Drug	carboxylic acids,110,126,Chemical/Drug	amino acids,133,144,Chemical/Drug	amines,151,157,Chemical/Drug	amides,162,168,Chemical/Drug	"[{""token"": ""carbohydrates"", ""start_span"": 90, ""end_span"": 103, ""type"": ""Chemical/Drug""}, {""token"": ""carboxylic acids"", ""start_span"": 110, ""end_span"": 126, ""type"": ""Chemical/Drug""}, {""token"": ""amino acids"", ""start_span"": 133, ""end_span"": 144, ""type"": ""Chemical/Drug""}, {""token"": ""amines"", ""start_span"": 151, ""end_span"": 157, ""type"": ""Chemical/Drug""}, {""token"": ""amides"", ""start_span"": 162, ""end_span"": 168, ""type"": ""Chemical/Drug""}]"	train
For example, a proteomics study of Arthobacter FB 24 demonstrated that, when the bacterium was exposed to chromate, a large number of proteins involved in metabolism ( e. g ., carbohydrate, energy production, and amino acid transport and metabolism) had altered expression ( Henne et al ., 2009b ).	Arthobacter FB 24,35,52,Organism/Species	bacterium,81,90,Organism/Species	chromate,106,114,Chemical/Drug	carbohydrate,176,188,Chemical/Drug	amino acid,213,223,Chemical/Drug	"[{""token"": ""Arthobacter FB 24"", ""start_span"": 35, ""end_span"": 52, ""type"": ""Organism/Species""}, {""token"": ""bacterium"", ""start_span"": 81, ""end_span"": 90, ""type"": ""Organism/Species""}, {""token"": ""chromate"", ""start_span"": 106, ""end_span"": 114, ""type"": ""Chemical/Drug""}, {""token"": ""carbohydrate"", ""start_span"": 176, ""end_span"": 188, ""type"": ""Chemical/Drug""}, {""token"": ""amino acid"", ""start_span"": 213, ""end_span"": 223, ""type"": ""Chemical/Drug""}]"	train
While past studies have found that the efflux pump gene, chrA, can provide chromate resistance ( e. g ., Diaz - Perez et al ., 2007; Henne et al ., 2009a; Ramirez - Diaz et al ., 2008 ), the lack of this gene could suggest that other efflux pumps may be exporting chromate.	efflux pump,39,50,Gene/Protein	chrA,57,61,Gene/Protein	chromate resistance,75,94,Disease/Disorder	efflux pumps,234,246,Gene/Protein	chromate,264,272,Chemical/Drug	"[{""token"": ""efflux pump"", ""start_span"": 39, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""chrA"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""chromate resistance"", ""start_span"": 75, ""end_span"": 94, ""type"": ""Disease/Disorder""}, {""token"": ""efflux pumps"", ""start_span"": 234, ""end_span"": 246, ""type"": ""Gene/Protein""}, {""token"": ""chromate"", ""start_span"": 264, ""end_span"": 272, ""type"": ""Chemical/Drug""}]"	train
The exclusion criteria were severe mental illness ( ongoing mania, psychosis or suicidal ideation ), substance abuse and addiction or pregnancy.	mental illness,35,49,Disease/Disorder	mania,60,65,Disease/Disorder	psychosis,67,76,Disease/Disorder	substance abuse,101,116,Disease/Disorder	addiction,121,130,Disease/Disorder	"[{""token"": ""mental illness"", ""start_span"": 35, ""end_span"": 49, ""type"": ""Disease/Disorder""}, {""token"": ""mania"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Disease/Disorder""}, {""token"": ""psychosis"", ""start_span"": 67, ""end_span"": 76, ""type"": ""Disease/Disorder""}, {""token"": ""substance abuse"", ""start_span"": 101, ""end_span"": 116, ""type"": ""Disease/Disorder""}, {""token"": ""addiction"", ""start_span"": 121, ""end_span"": 130, ""type"": ""Disease/Disorder""}]"	train
To test whether maladaptive metacognitive beliefs ( MCQ - 30) was associated with subjective cognitive impairments ( EMQ) controlling for levels of fatigue, pain, insomnia, depression, and anxiety, we performed a hierarchical linear regression using subjective cognitive impairments at treatment termination as the dependent variable.	cognitive impairments,93,114,Disease/Disorder	insomnia,163,171,Disease/Disorder	depression,173,183,Disease/Disorder	anxiety,189,196,Disease/Disorder	cognitive impairments,261,282,Disease/Disorder	"[{""token"": ""cognitive impairments"", ""start_span"": 93, ""end_span"": 114, ""type"": ""Disease/Disorder""}, {""token"": ""insomnia"", ""start_span"": 163, ""end_span"": 171, ""type"": ""Disease/Disorder""}, {""token"": ""depression"", ""start_span"": 173, ""end_span"": 183, ""type"": ""Disease/Disorder""}, {""token"": ""anxiety"", ""start_span"": 189, ""end_span"": 196, ""type"": ""Disease/Disorder""}, {""token"": ""cognitive impairments"", ""start_span"": 261, ""end_span"": 282, ""type"": ""Disease/Disorder""}]"	train
To test whether the subscales of the maladaptive metacognitive beliefs ( MCQ - 30) questionnaire were associated with subjective cognitive impairments ( EMQ) controlling for levels of fatigue, pain, insomnia, depression, and anxiety, we performed a hierarchical linear regression using subjective cognitive impairments at treatment termination as the dependent variable.	cognitive impairments,129,150,Disease/Disorder	insomnia,199,207,Disease/Disorder	depression,209,219,Disease/Disorder	anxiety,225,232,Disease/Disorder	cognitive impairments,297,318,Disease/Disorder	"[{""token"": ""cognitive impairments"", ""start_span"": 129, ""end_span"": 150, ""type"": ""Disease/Disorder""}, {""token"": ""insomnia"", ""start_span"": 199, ""end_span"": 207, ""type"": ""Disease/Disorder""}, {""token"": ""depression"", ""start_span"": 209, ""end_span"": 219, ""type"": ""Disease/Disorder""}, {""token"": ""anxiety"", ""start_span"": 225, ""end_span"": 232, ""type"": ""Disease/Disorder""}, {""token"": ""cognitive impairments"", ""start_span"": 297, ""end_span"": 318, ""type"": ""Disease/Disorder""}]"	train
Human Papillomaviruses ( HPVs) are major human pathogens and the causative agents of a number of important human malignancies, with cervical cancer being the most important1, 2.	Human Papillomaviruses,0,22,Organism/Species	HPVs,25,29,Organism/Species	human,41,46,Organism/Species	human,107,112,Organism/Species	cervical cancer,132,147,Disease/Disorder	"[{""token"": ""Human Papillomaviruses"", ""start_span"": 0, ""end_span"": 22, ""type"": ""Organism/Species""}, {""token"": ""HPVs"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Organism/Species""}, {""token"": ""cervical cancer"", ""start_span"": 132, ""end_span"": 147, ""type"": ""Disease/Disorder""}]"	train
Cells were fixed 3 days post - transfection and neutralising antibody was visualised using secondary goat anti - mouse rhodamine antibody ( Molecular Probes ).	antibody,61,69,Gene/Protein	goat,101,105,Organism/Species	mouse,113,118,Organism/Species	rhodamine,119,128,Chemical/Drug	antibody,129,137,Gene/Protein	"[{""token"": ""antibody"", ""start_span"": 61, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""goat"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Organism/Species""}, {""token"": ""rhodamine"", ""start_span"": 119, ""end_span"": 128, ""type"": ""Chemical/Drug""}, {""token"": ""antibody"", ""start_span"": 129, ""end_span"": 137, ""type"": ""Gene/Protein""}]"	train
These assays were then repeated in the presence of p53 siRNA, and as can be seen from Fig. 2c, this renders the late passage cells susceptible to HPV - 16 infection and promotes transduction of the reporter construct, consistent with reactivation of cell division, allowing the incoming viruses to gain access to the nucleus during mitosis. Figure 2HPV - 16 PsV infection of senescent cells is restored following transfection of p53 siRNA.	p53,51,54,Gene/Protein	HPV - 16 infection,146,164,Disease/Disorder	viruses,287,294,Organism/Species	infection,362,371,Disease/Disorder	p53,429,432,Gene/Protein	"[{""token"": ""p53"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""HPV - 16 infection"", ""start_span"": 146, ""end_span"": 164, ""type"": ""Disease/Disorder""}, {""token"": ""viruses"", ""start_span"": 287, ""end_span"": 294, ""type"": ""Organism/Species""}, {""token"": ""infection"", ""start_span"": 362, ""end_span"": 371, ""type"": ""Disease/Disorder""}, {""token"": ""p53"", ""start_span"": 429, ""end_span"": 432, ""type"": ""Gene/Protein""}]"	train
The anti - L1 neutralising antibody ( H16. V5) was added to the cells at 12 days post - infection, and at 13 days post - infection cells were transfected with the p53 siRNA.	L1,11,13,Gene/Protein	antibody,27,35,Gene/Protein	infection,88,97,Disease/Disorder	infection,121,130,Disease/Disorder	p53,163,166,Gene/Protein	"[{""token"": ""L1"", ""start_span"": 11, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 27, ""end_span"": 35, ""type"": ""Gene/Protein""}, {""token"": ""infection"", ""start_span"": 88, ""end_span"": 97, ""type"": ""Disease/Disorder""}, {""token"": ""infection"", ""start_span"": 121, ""end_span"": 130, ""type"": ""Disease/Disorder""}, {""token"": ""p53"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Gene/Protein""}]"	train
In contrast, in cells transfected with the p53 siRNA there is clear evidence of virus co - localisation with EEA1 and LAMP1, demonstrating that stimulation of cell cycle re - entry also stimulates endocytic uptake of the HPV - 16 PsVs. Figure 6HPV - 16 PsVs trafficking to early and late endosomes is affected in senescent cells.	p53,43,46,Gene/Protein	virus,80,85,Organism/Species	EEA1,109,113,Gene/Protein	LAMP1,118,123,Gene/Protein	HPV - 16,221,229,Organism/Species	"[{""token"": ""p53"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""virus"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organism/Species""}, {""token"": ""EEA1"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""LAMP1"", ""start_span"": 118, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""HPV - 16"", ""start_span"": 221, ""end_span"": 229, ""type"": ""Organism/Species""}]"	train
In view of the high levels of antimalarial drug resistance exhibited by both P. falciparum and P. vivax, antimalarial policy for uncomplicated malaria due to any Plasmodium species was changed in March 2006 from oral quinine to dihydroartemisinin - piperaquine, an artemisinin combination therapy ( ACT ).	malaria,34,41,Disease/Disorder	Plasmodium,162,172,Organism/Species	quinine,217,224,Chemical/Drug	piperaquine,249,260,Chemical/Drug	artemisinin,265,276,Chemical/Drug	"[{""token"": ""malaria"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Disease/Disorder""}, {""token"": ""Plasmodium"", ""start_span"": 162, ""end_span"": 172, ""type"": ""Organism/Species""}, {""token"": ""quinine"", ""start_span"": 217, ""end_span"": 224, ""type"": ""Chemical/Drug""}, {""token"": ""piperaquine"", ""start_span"": 249, ""end_span"": 260, ""type"": ""Chemical/Drug""}, {""token"": ""artemisinin"", ""start_span"": 265, ""end_span"": 276, ""type"": ""Chemical/Drug""}]"	train
Severe anemia was defined as a hemoglobin less than 5g / dL but in accordance with 2014 World Health Organization severe malarial anemia definitions, we also conducted subanalyses in which severe anemia was defined as a hemoglobin < 5g / dL in children under 12 years of age and < 7g / dL in adults ≥ 12 years of age [ 26 ].	anemia,7,13,Disease/Disorder	hemoglobin,31,41,Gene/Protein	anemia,130,136,Disease/Disorder	anemia,196,202,Disease/Disorder	hemoglobin,220,230,Gene/Protein	"[{""token"": ""anemia"", ""start_span"": 7, ""end_span"": 13, ""type"": ""Disease/Disorder""}, {""token"": ""hemoglobin"", ""start_span"": 31, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""anemia"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Disease/Disorder""}, {""token"": ""anemia"", ""start_span"": 196, ""end_span"": 202, ""type"": ""Disease/Disorder""}, {""token"": ""hemoglobin"", ""start_span"": 220, ""end_span"": 230, ""type"": ""Gene/Protein""}]"	train
Prior to March 2006 ( 401 cases ), the majority of patients received either oral quinine ( n = 212; 52. 9 %), chloroquine ( n = 76; 19. 0 %) or doxycycline ( n = 71, 17. 7 %) with small numbers receiving sulphadoxine - pyrimethamine ( n = 21, 5. 2 %).	quinine,81,88,Chemical/Drug	chloroquine,110,121,Chemical/Drug	doxycycline,144,155,Chemical/Drug	sulphadoxine,204,216,Chemical/Drug	pyrimethamine,219,232,Chemical/Drug	"[{""token"": ""quinine"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""chloroquine"", ""start_span"": 110, ""end_span"": 121, ""type"": ""Chemical/Drug""}, {""token"": ""doxycycline"", ""start_span"": 144, ""end_span"": 155, ""type"": ""Chemical/Drug""}, {""token"": ""sulphadoxine"", ""start_span"": 204, ""end_span"": 216, ""type"": ""Chemical/Drug""}, {""token"": ""pyrimethamine"", ""start_span"": 219, ""end_span"": 232, ""type"": ""Chemical/Drug""}]"	train
We have demonstrated that amide - based dendrimers functionalized with the membrane - interacting peptide gH625 derived from the herpes simplex virus type 1 ( HSV - 1) envelope glycoprotein H enter cells mainly through a non - active translocation mechanism.	amide,26,31,Chemical/Drug	gH625,106,111,Chemical/Drug	herpes simplex virus type 1,129,156,Organism/Species	HSV - 1,159,166,Organism/Species	envelope glycoprotein H,168,191,Gene/Protein	"[{""token"": ""amide"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""gH625"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Chemical/Drug""}, {""token"": ""herpes simplex virus type 1"", ""start_span"": 129, ""end_span"": 156, ""type"": ""Organism/Species""}, {""token"": ""HSV - 1"", ""start_span"": 159, ""end_span"": 166, ""type"": ""Organism/Species""}, {""token"": ""envelope glycoprotein H"", ""start_span"": 168, ""end_span"": 191, ""type"": ""Gene/Protein""}]"	train
In contrast, MMTV - Wnt1 induced canonical signaling in K14 + basal cells with CD24 / CD49f profiles characteristic of two distinct stem / progenitor cell - types.	MMTV,13,17,Organism/Species	Wnt1,20,24,Gene/Protein	K14,56,59,Gene/Protein	CD24,79,83,Gene/Protein	CD49f,86,91,Gene/Protein	"[{""token"": ""MMTV"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Organism/Species""}, {""token"": ""Wnt1"", ""start_span"": 20, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""K14"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""CD24"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""CD49f"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Gene/Protein""}]"	train
Mice expressing Wnt inhibitors, or deficient in Lef - 1, show defective embryonic mammary development, and loss of the Wnt coreceptor, LRP5 / 6, impairs postnatal development [ 6 ]–[ 9 ].	Mice,0,4,Organism/Species	Wnt,16,19,Gene/Protein	Lef - 1,48,55,Gene/Protein	Wnt coreceptor,119,133,Gene/Protein	LRP5,135,139,Gene/Protein	"[{""token"": ""Mice"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Organism/Species""}, {""token"": ""Wnt"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""Lef - 1"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""Wnt coreceptor"", ""start_span"": 119, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""LRP5"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Gene/Protein""}]"	train
Recently the connection between the physiological role of Wnt signaling in stem cells and its capacity to induce cancer when upregulated has been exploited to identify intestinal stem cells by virtue of their expression of a Wnt - responsive gene, Lgr5, that was initially found to be upregulated in colonic tumors [ 31 ].	Wnt,58,61,Gene/Protein	cancer,113,119,Disease/Disorder	Wnt,225,228,Gene/Protein	Lgr5,248,252,Gene/Protein	colonic tumors,300,314,Disease/Disorder	"[{""token"": ""Wnt"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""cancer"", ""start_span"": 113, ""end_span"": 119, ""type"": ""Disease/Disorder""}, {""token"": ""Wnt"", ""start_span"": 225, ""end_span"": 228, ""type"": ""Gene/Protein""}, {""token"": ""Lgr5"", ""start_span"": 248, ""end_span"": 252, ""type"": ""Gene/Protein""}, {""token"": ""colonic tumors"", ""start_span"": 300, ""end_span"": 314, ""type"": ""Disease/Disorder""}]"	train
Tumors from MMTV - ΔN89β - catenin mice contained many more K18 + than K14 + cells and were hormone receptor - negative ( Fig. 2A – C ).	Tumors,0,6,Disease/Disorder	MMTV,12,16,Organism/Species	mice,35,39,Organism/Species	K18,60,63,Gene/Protein	K14,71,74,Gene/Protein	"[{""token"": ""Tumors"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Disease/Disorder""}, {""token"": ""MMTV"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Organism/Species""}, {""token"": ""K18"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""K14"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene/Protein""}]"	train
Mammary glands from 12 week - old virgin MMTV - ΔN89β - catenin ( MMTV - ΔN89β - cat) ( A – E) and MMTV - Wnt1 ( F – J) mice.	MMTV,41,45,Organism/Species	MMTV,66,70,Organism/Species	MMTV,99,103,Organism/Species	Wnt1,106,110,Gene/Protein	mice,120,124,Organism/Species	"[{""token"": ""MMTV"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Organism/Species""}, {""token"": ""MMTV"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Organism/Species""}, {""token"": ""MMTV"", ""start_span"": 99, ""end_span"": 103, ""type"": ""Organism/Species""}, {""token"": ""Wnt1"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Organism/Species""}]"	train
In contrast, mammary glands from MMTV - Wnt1 mice showed a strikingly uniform Conductin - lacZ expression pattern along the entire mammary ductal system ( Fig. 3D and F) and the reporter was found exclusively within basal cells ( Fig. 3E ).	MMTV,33,37,Organism/Species	Wnt1,40,44,Gene/Protein	mice,45,49,Organism/Species	Conductin,78,87,Gene/Protein	lacZ,90,94,Gene/Protein	"[{""token"": ""MMTV"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Organism/Species""}, {""token"": ""Wnt1"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Organism/Species""}, {""token"": ""Conductin"", ""start_span"": 78, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""lacZ"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene/Protein""}]"	train
K18 + luminal epithelial cells from MMTV - Wnt1 mice fail to respond, suggesting they lack a Wnt1 receptor, or that autocrine canonical pathway activity is suppressed by non - canonical antagonism within this cell - type.	K18,0,3,Gene/Protein	MMTV,36,40,Organism/Species	Wnt1,43,47,Gene/Protein	mice,48,52,Organism/Species	Wnt1 receptor,93,106,Gene/Protein	"[{""token"": ""K18"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""MMTV"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Organism/Species""}, {""token"": ""Wnt1"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Organism/Species""}, {""token"": ""Wnt1 receptor"", ""start_span"": 93, ""end_span"": 106, ""type"": ""Gene/Protein""}]"	train
In contrast to the even distribution of EGFP − cells from MMTV - ΔN89β - catenin mice between the two major CD24 / CD49f cell populations ( Fig. 5B ), cells expressing high levels of EGFPhi ( top 15 %) ( Fig. 5C) fell exclusively within the CD24highCD49flow subpopulation and showed an upward rightward shift in mean fluorescence intensity, suggestive of CFCs.	EGFP,40,44,Gene/Protein	MMTV,58,62,Organism/Species	mice,81,85,Organism/Species	CD24,108,112,Gene/Protein	CD49f,115,120,Gene/Protein	"[{""token"": ""EGFP"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""MMTV"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Organism/Species""}, {""token"": ""CD24"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""CD49f"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Gene/Protein""}]"	train
CD24 / CD49f marker profile of ( A) total, ( B) EGFP - and ( C) EGFPhi cells from MMTV - ΔN89β - catenin tumors.	CD24,0,4,Gene/Protein	CD49f,7,12,Gene/Protein	EGFP,48,52,Gene/Protein	MMTV,82,86,Organism/Species	tumors,105,111,Disease/Disorder	"[{""token"": ""CD24"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""CD49f"", ""start_span"": 7, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""EGFP"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""MMTV"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Organism/Species""}, {""token"": ""tumors"", ""start_span"": 105, ""end_span"": 111, ""type"": ""Disease/Disorder""}]"	train
These β - catenin - responsive cells display a hormone - receptor - negative [ 38 ], K18 + CD24highCD49flow profile, and generate colonies containing both K8 + and K14 + cells.	β - catenin,6,17,Gene/Protein	hormone - receptor,47,65,Gene/Protein	K18,85,88,Gene/Protein	K8,155,157,Gene/Protein	K14,164,167,Gene/Protein	"[{""token"": ""\u03b2 - catenin"", ""start_span"": 6, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""hormone - receptor"", ""start_span"": 47, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""K18"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""K8"", ""start_span"": 155, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""K14"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
However the most prominent site of Hh pathway activity in MMTV - Wnt1 mice occurs in stromal cells exclusively within the tumor microenvironment.	Hh,35,37,Gene/Protein	MMTV,58,62,Organism/Species	Wnt1,65,69,Gene/Protein	mice,70,74,Organism/Species	tumor,122,127,Disease/Disorder	"[{""token"": ""Hh"", ""start_span"": 35, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""MMTV"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Organism/Species""}, {""token"": ""Wnt1"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Organism/Species""}, {""token"": ""tumor"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Disease/Disorder""}]"	train
Given that MMTV - Wnt1 tumors are enriched in cells with stem / progenitor characteristics, we speculate that stromal Hh pathway activity may be indicative of the step when CSCs co - opt bystanders to become complicit in tumor formation by forming a supportive CSC niche.	MMTV,11,15,Organism/Species	Wnt1,18,22,Gene/Protein	tumors,23,29,Disease/Disorder	Hh,118,120,Gene/Protein	tumor,221,226,Disease/Disorder	"[{""token"": ""MMTV"", ""start_span"": 11, ""end_span"": 15, ""type"": ""Organism/Species""}, {""token"": ""Wnt1"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""tumors"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Disease/Disorder""}, {""token"": ""Hh"", ""start_span"": 118, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 221, ""end_span"": 226, ""type"": ""Disease/Disorder""}]"	train
PO meal resulted in lower total cholesterol ( P = 0 · 021 ), LDL - cholesterol ( P = 0 · 046 ), soluble intracellular adhesion molecule ( P = 0 · 005) and insulin ( P = 0 · 005) incremental AUC, and increased IL - 10 ( P = 0 · 013 ).	cholesterol,32,43,Chemical/Drug	cholesterol,67,78,Chemical/Drug	intracellular adhesion molecule,104,135,Gene/Protein	insulin,155,162,Gene/Protein	IL - 10,209,216,Gene/Protein	"[{""token"": ""cholesterol"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 67, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""intracellular adhesion molecule"", ""start_span"": 104, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""insulin"", ""start_span"": 155, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 209, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	train
Postprandial inflammatory and lipaemic responses are pronounced in individuals with obesity, the metabolic syndrome ( MetS) and type 2 diabetes ( 2 – 5 ), in part because the magnitude of the postprandial inflammatory response is correlated with insulin resistance ( 6, 7 ).	obesity,84,91,Disease/Disorder	metabolic syndrome,97,115,Disease/Disorder	MetS,118,122,Disease/Disorder	type 2 diabetes,128,143,Disease/Disorder	insulin,246,253,Gene/Protein	"[{""token"": ""obesity"", ""start_span"": 84, ""end_span"": 91, ""type"": ""Disease/Disorder""}, {""token"": ""metabolic syndrome"", ""start_span"": 97, ""end_span"": 115, ""type"": ""Disease/Disorder""}, {""token"": ""MetS"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Disease/Disorder""}, {""token"": ""type 2 diabetes"", ""start_span"": 128, ""end_span"": 143, ""type"": ""Disease/Disorder""}, {""token"": ""insulin"", ""start_span"": 246, ""end_span"": 253, ""type"": ""Gene/Protein""}]"	train
The six highest abundant MFGM - derived proteins reported in BPC50 include: fatty acid - binding protein, butyrophilin, lactadherin, adipophilin, xanthine oxidase and mucin ( 35 ).	fatty acid - binding protein,76,104,Gene/Protein	butyrophilin,106,118,Gene/Protein	lactadherin,120,131,Gene/Protein	adipophilin,133,144,Gene/Protein	xanthine,146,154,Chemical/Drug	"[{""token"": ""fatty acid - binding protein"", ""start_span"": 76, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""butyrophilin"", ""start_span"": 106, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""lactadherin"", ""start_span"": 120, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""adipophilin"", ""start_span"": 133, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""xanthine"", ""start_span"": 146, ""end_span"": 154, ""type"": ""Chemical/Drug""}]"	train
Only incidental bacterial and parasitic infections were detected, including Campylobacter sp ., Syngamus trachea infection, and intestinal cestodes and nematodes.	parasitic infections,30,50,Disease/Disorder	Campylobacter sp,76,92,Organism/Species	Syngamus trachea infection,96,122,Disease/Disorder	cestodes,139,147,Organism/Species	nematodes,152,161,Organism/Species	"[{""token"": ""parasitic infections"", ""start_span"": 30, ""end_span"": 50, ""type"": ""Disease/Disorder""}, {""token"": ""Campylobacter sp"", ""start_span"": 76, ""end_span"": 92, ""type"": ""Organism/Species""}, {""token"": ""Syngamus trachea infection"", ""start_span"": 96, ""end_span"": 122, ""type"": ""Disease/Disorder""}, {""token"": ""cestodes"", ""start_span"": 139, ""end_span"": 147, ""type"": ""Organism/Species""}, {""token"": ""nematodes"", ""start_span"": 152, ""end_span"": 161, ""type"": ""Organism/Species""}]"	train
RRT - PCR for WNV and other flaviviruses was performed on tissue samples collected from birds from four incidents, and for influenza A virus on tissues from birds from five incidents.	WNV,14,17,Organism/Species	flaviviruses,28,40,Organism/Species	birds,88,93,Organism/Species	influenza A virus,123,140,Organism/Species	birds,157,162,Organism/Species	"[{""token"": ""WNV"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Organism/Species""}, {""token"": ""flaviviruses"", ""start_span"": 28, ""end_span"": 40, ""type"": ""Organism/Species""}, {""token"": ""birds"", ""start_span"": 88, ""end_span"": 93, ""type"": ""Organism/Species""}, {""token"": ""influenza A virus"", ""start_span"": 123, ""end_span"": 140, ""type"": ""Organism/Species""}, {""token"": ""birds"", ""start_span"": 157, ""end_span"": 162, ""type"": ""Organism/Species""}]"	train
As with all other species apart from starlings, both reports of blackbird drowning were of individual birds which may be explained by the fact that blackbirds are less gregarious than starlings and generally only associate loosely with conspecifics when foraging47.	starlings,37,46,Organism/Species	blackbird,64,73,Organism/Species	birds,102,107,Organism/Species	blackbirds,148,158,Organism/Species	starlings,184,193,Organism/Species	"[{""token"": ""starlings"", ""start_span"": 37, ""end_span"": 46, ""type"": ""Organism/Species""}, {""token"": ""blackbird"", ""start_span"": 64, ""end_span"": 73, ""type"": ""Organism/Species""}, {""token"": ""birds"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Organism/Species""}, {""token"": ""blackbirds"", ""start_span"": 148, ""end_span"": 158, ""type"": ""Organism/Species""}, {""token"": ""starlings"", ""start_span"": 184, ""end_span"": 193, ""type"": ""Organism/Species""}]"	train
A review of the BTO ring recovery dataset showed that probable drowning incidents occur across a range of wild bird species, but most commonly involve blackbirds and starlings; drowned starlings were, however, reported significantly more frequently than drowned blackbirds.	bird,111,115,Organism/Species	blackbirds,151,161,Organism/Species	starlings,166,175,Organism/Species	starlings,185,194,Organism/Species	blackbirds,262,272,Organism/Species	"[{""token"": ""bird"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Organism/Species""}, {""token"": ""blackbirds"", ""start_span"": 151, ""end_span"": 161, ""type"": ""Organism/Species""}, {""token"": ""starlings"", ""start_span"": 166, ""end_span"": 175, ""type"": ""Organism/Species""}, {""token"": ""starlings"", ""start_span"": 185, ""end_span"": 194, ""type"": ""Organism/Species""}, {""token"": ""blackbirds"", ""start_span"": 262, ""end_span"": 272, ""type"": ""Organism/Species""}]"	train
Most human infections generate antibodies of the IgG1 subclass, with significant levels of both IgM and IgE ( Smith, 1993 ).	human,5,10,Organism/Species	infections,11,21,Disease/Disorder	IgG1,49,53,Gene/Protein	IgM,96,99,Gene/Protein	IgE,104,107,Gene/Protein	"[{""token"": ""human"", ""start_span"": 5, ""end_span"": 10, ""type"": ""Organism/Species""}, {""token"": ""infections"", ""start_span"": 11, ""end_span"": 21, ""type"": ""Disease/Disorder""}, {""token"": ""IgG1"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""IgM"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""IgE"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Gene/Protein""}]"	train
The IgG4 isotype, which can be predominant in other, more intense, tissue helminth infections such as filariasis and schistosomiasis ( Maizels et al ., 1995) is less prominent, although reportedly more evident in active cases of visceral larva migrans ( Obwaller et al ., 1998 ).	IgG4,4,8,Gene/Protein	helminth infections,74,93,Disease/Disorder	filariasis,102,112,Disease/Disorder	schistosomiasis,117,132,Disease/Disorder	visceral larva migrans,229,251,Disease/Disorder	"[{""token"": ""IgG4"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""helminth infections"", ""start_span"": 74, ""end_span"": 93, ""type"": ""Disease/Disorder""}, {""token"": ""filariasis"", ""start_span"": 102, ""end_span"": 112, ""type"": ""Disease/Disorder""}, {""token"": ""schistosomiasis"", ""start_span"": 117, ""end_span"": 132, ""type"": ""Disease/Disorder""}, {""token"": ""visceral larva migrans"", ""start_span"": 229, ""end_span"": 251, ""type"": ""Disease/Disorder""}]"	train
Intestinal immunity to ascarid worms is poorly understood; taking a comparative approach, based on animal models of taxonomically distant nematodes ( e. g. Nippostrongylus brasiliensis, Trichuris muris ), it would be predicted that Th2 - dependent mechanisms act to expel the parasites, but the cell types and molecular mediators participating in expulsion are as yet unknown.	animal,99,105,Organism/Species	nematodes,138,147,Organism/Species	Nippostrongylus brasiliensis,156,184,Organism/Species	Trichuris muris,186,201,Organism/Species	parasites,276,285,Organism/Species	"[{""token"": ""animal"", ""start_span"": 99, ""end_span"": 105, ""type"": ""Organism/Species""}, {""token"": ""nematodes"", ""start_span"": 138, ""end_span"": 147, ""type"": ""Organism/Species""}, {""token"": ""Nippostrongylus brasiliensis"", ""start_span"": 156, ""end_span"": 184, ""type"": ""Organism/Species""}, {""token"": ""Trichuris muris"", ""start_span"": 186, ""end_span"": 201, ""type"": ""Organism/Species""}, {""token"": ""parasites"", ""start_span"": 276, ""end_span"": 285, ""type"": ""Organism/Species""}]"	train
The Tcn - 2 and Tcn - 8 monoclonal antibodies which bind the surface coat, recognise related but distinct trisaccharide glycan side - chains ( Schabussova et al ., 2007 ), which are expressed on the family of mucin polypeptides, principally MUC - 1, - 2 and - 3 collectively termed TES - 120 ( Loukas et al ., 2000b ).	Tcn - 2,4,11,Gene/Protein	Tcn - 8,16,23,Gene/Protein	mucin,209,214,Gene/Protein	MUC - 1,241,248,Gene/Protein	TES - 120,282,291,Gene/Protein	"[{""token"": ""Tcn - 2"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""Tcn - 8"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""mucin"", ""start_span"": 209, ""end_span"": 214, ""type"": ""Gene/Protein""}, {""token"": ""MUC - 1"", ""start_span"": 241, ""end_span"": 248, ""type"": ""Gene/Protein""}, {""token"": ""TES - 120"", ""start_span"": 282, ""end_span"": 291, ""type"": ""Gene/Protein""}]"	train
While the T. canis PEB protein is similar to homologues from other species in functionally binding PE, its structure differs markedly in including a 72 - aa N - terminal extension, containing a tandemly repeated six - cysteine motif homologous to the potassium channel toxin of the sea anemone, Stocihactis helianthus ( Gems et al ., 1995 ).	PEB,19,22,Gene/Protein	cysteine,218,226,Chemical/Drug	potassium channel toxin,251,274,Gene/Protein	sea anemone,282,293,Organism/Species	Stocihactis helianthus,295,317,Organism/Species	"[{""token"": ""PEB"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""cysteine"", ""start_span"": 218, ""end_span"": 226, ""type"": ""Chemical/Drug""}, {""token"": ""potassium channel toxin"", ""start_span"": 251, ""end_span"": 274, ""type"": ""Gene/Protein""}, {""token"": ""sea anemone"", ""start_span"": 282, ""end_span"": 293, ""type"": ""Organism/Species""}, {""token"": ""Stocihactis helianthus"", ""start_span"": 295, ""end_span"": 317, ""type"": ""Organism/Species""}]"	train
The principal mucins are MUC - 1 ( Gems and Maizels, 1996 ), - 2 and - 3 ( Loukas et al ., 2000b) with less abundant components MUC - 4 and - 5 ( Doedens et al ., 2001 ), differing in structure and the relative proportions of Serine or Threonine residues ( Loukas et al ., 2000b ).	mucins,14,20,Gene/Protein	MUC - 1,25,32,Gene/Protein	MUC - 4,128,135,Gene/Protein	Serine,226,232,Chemical/Drug	Threonine,236,245,Chemical/Drug	"[{""token"": ""mucins"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""MUC - 1"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""MUC - 4"", ""start_span"": 128, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""Serine"", ""start_span"": 226, ""end_span"": 232, ""type"": ""Chemical/Drug""}, {""token"": ""Threonine"", ""start_span"": 236, ""end_span"": 245, ""type"": ""Chemical/Drug""}]"	train
The blood group - like antigens are more abundant on higher molecular - weight TES components ( TES - 120 and TES - 400 ), and therefore a Western blotting procedure to assay human antibodies to the lower molecular weight TES components ( TES - 26 and TES - 32) has also been developed ( Magnaval et al ., 1991, 2002 ).	TES - 120,96,105,Gene/Protein	TES - 400,110,119,Gene/Protein	human,175,180,Organism/Species	TES - 26,239,247,Gene/Protein	TES - 32,252,260,Gene/Protein	"[{""token"": ""TES - 120"", ""start_span"": 96, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""TES - 400"", ""start_span"": 110, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 175, ""end_span"": 180, ""type"": ""Organism/Species""}, {""token"": ""TES - 26"", ""start_span"": 239, ""end_span"": 247, ""type"": ""Gene/Protein""}, {""token"": ""TES - 32"", ""start_span"": 252, ""end_span"": 260, ""type"": ""Gene/Protein""}]"	train
We considered children with AOM / woP, AOM / wiP, or CSOM to have suppurative otitis media ( presence of a pus producing infection ).	AOM,28,31,Disease/Disorder	AOM,39,42,Disease/Disorder	CSOM,53,57,Disease/Disorder	suppurative otitis media,66,90,Disease/Disorder	infection,121,130,Disease/Disorder	"[{""token"": ""AOM"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Disease/Disorder""}, {""token"": ""AOM"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Disease/Disorder""}, {""token"": ""CSOM"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Disease/Disorder""}, {""token"": ""suppurative otitis media"", ""start_span"": 66, ""end_span"": 90, ""type"": ""Disease/Disorder""}, {""token"": ""infection"", ""start_span"": 121, ""end_span"": 130, ""type"": ""Disease/Disorder""}]"	train
Unfortunately, the rates of OM ( all types ), TM perforation, and suppurative OM ( AOM / woP, AOM / wiP or CSOM) remain extremely high.	OM,28,30,Disease/Disorder	suppurative OM,66,80,Disease/Disorder	AOM,83,86,Disease/Disorder	AOM,94,97,Disease/Disorder	CSOM,107,111,Disease/Disorder	"[{""token"": ""OM"", ""start_span"": 28, ""end_span"": 30, ""type"": ""Disease/Disorder""}, {""token"": ""suppurative OM"", ""start_span"": 66, ""end_span"": 80, ""type"": ""Disease/Disorder""}, {""token"": ""AOM"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Disease/Disorder""}, {""token"": ""AOM"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Disease/Disorder""}, {""token"": ""CSOM"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Disease/Disorder""}]"	train
Upon activation, glycoprotein ( Gp) IIb / IIIa ( αIIbβ3 integrin) mediates platelet aggregation and spreading by means of fibrinogen bridges, which, once converted to fibrin, ultimately contribute to thrombus stabilization ( 4 ).	glycoprotein,17,29,Gene/Protein	Gp,32,34,Gene/Protein	αIIbβ3 integrin,49,64,Gene/Protein	fibrinogen,122,132,Gene/Protein	fibrin,167,173,Gene/Protein	"[{""token"": ""glycoprotein"", ""start_span"": 17, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""Gp"", ""start_span"": 32, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""\u03b1IIb\u03b23 integrin"", ""start_span"": 49, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""fibrinogen"", ""start_span"": 122, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""fibrin"", ""start_span"": 167, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
The transduction of the ADP signal involves its interaction with two platelet receptors belonging to the P2 purinergic family, the Gαq - coupled receptor P2Y1 and the Gαi - coupled receptor P2Y12.	platelet receptors,69,87,Gene/Protein	Gαq - coupled receptor,131,153,Gene/Protein	P2Y1,154,158,Gene/Protein	Gαi - coupled receptor,167,189,Gene/Protein	P2Y12,190,195,Gene/Protein	"[{""token"": ""platelet receptors"", ""start_span"": 69, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""G\u03b1q - coupled receptor"", ""start_span"": 131, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""P2Y1"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""G\u03b1i - coupled receptor"", ""start_span"": 167, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""P2Y12"", ""start_span"": 190, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
Gαq is linked to a signaling pathway involving PLC activation, resulting in a rise in the intracellular calcium concentration ([ Ca + 2] i) and protein kinase C ( PKC) activation, leading to GP IIb / IIIa activation and transient platelet aggregation.	Gαq,0,3,Gene/Protein	PLC,47,50,Gene/Protein	protein kinase C,144,160,Gene/Protein	PKC,163,166,Gene/Protein	GP IIb,191,197,Gene/Protein	"[{""token"": ""G\u03b1q"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene/Protein""}, {""token"": ""PLC"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase C"", ""start_span"": 144, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""PKC"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""GP IIb"", ""start_span"": 191, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
P2Y12 is linked to Gai - coupled signaling cascades associated with adenylcyclase ( Ac) down - regulation and decreased cyclic - 3 ', 5 '- monophosphate ( cAMP) production, which mediates GP IIb / IIIa receptor activation, leading to sustained platelet aggregation.	P2Y12,0,5,Gene/Protein	Gai,19,22,Gene/Protein	adenylcyclase,68,81,Gene/Protein	Ac,84,86,Gene/Protein	GP IIb,188,194,Gene/Protein	"[{""token"": ""P2Y12"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""Gai"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""adenylcyclase"", ""start_span"": 68, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""Ac"", ""start_span"": 84, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""GP IIb"", ""start_span"": 188, ""end_span"": 194, ""type"": ""Gene/Protein""}]"	train
The CURE ( 19) and the CREDO ( 20) studies established the superiority of clopidogrel in combination with aspirin versus aspirin alone in ACS and in ACS with PCI, respectively.	clopidogrel,74,85,Chemical/Drug	aspirin,106,113,Chemical/Drug	aspirin,121,128,Chemical/Drug	ACS,138,141,Disease/Disorder	ACS,149,152,Disease/Disorder	"[{""token"": ""clopidogrel"", ""start_span"": 74, ""end_span"": 85, ""type"": ""Chemical/Drug""}, {""token"": ""aspirin"", ""start_span"": 106, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""aspirin"", ""start_span"": 121, ""end_span"": 128, ""type"": ""Chemical/Drug""}, {""token"": ""ACS"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Disease/Disorder""}, {""token"": ""ACS"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Disease/Disorder""}]"	train
Whereas a vasodilator - stimulated phosphoprotein ( VASP )- tailored clopidogrel loading dose has been found to improve the clinical outcome ( 37) and to reduce the rate of early stent thrombosis after PCI ( 38 ), the GRAVITAS trial has been designed to evaluate only the efficacy and safety of VASP - tailored clopidogrel - maintaining regimens ( 39 ).	vasodilator - stimulated phosphoprotein,10,49,Gene/Protein	VASP,52,56,Gene/Protein	clopidogrel,69,80,Chemical/Drug	VASP,295,299,Gene/Protein	clopidogrel,311,322,Chemical/Drug	"[{""token"": ""vasodilator - stimulated phosphoprotein"", ""start_span"": 10, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""VASP"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""clopidogrel"", ""start_span"": 69, ""end_span"": 80, ""type"": ""Chemical/Drug""}, {""token"": ""VASP"", ""start_span"": 295, ""end_span"": 299, ""type"": ""Gene/Protein""}, {""token"": ""clopidogrel"", ""start_span"": 311, ""end_span"": 322, ""type"": ""Chemical/Drug""}]"	train
In the SILOAM phase IV study ( Clini - calTrials. gov Identifier: NCT01261832 ), a triple antiplatelet therapy ( cilostazol plus aspirin and clopidogrel) is compared ( at 1 month and at 6 months) with the standard dual antiplatelet treatment ( ASA and clopidogrel) in 951 ACS subjects ( expected number) undergoing PCI and drug eluting - stent implantation.	cilostazol,113,123,Chemical/Drug	aspirin,129,136,Chemical/Drug	clopidogrel,141,152,Chemical/Drug	clopidogrel,252,263,Chemical/Drug	ACS,272,275,Disease/Disorder	"[{""token"": ""cilostazol"", ""start_span"": 113, ""end_span"": 123, ""type"": ""Chemical/Drug""}, {""token"": ""aspirin"", ""start_span"": 129, ""end_span"": 136, ""type"": ""Chemical/Drug""}, {""token"": ""clopidogrel"", ""start_span"": 141, ""end_span"": 152, ""type"": ""Chemical/Drug""}, {""token"": ""clopidogrel"", ""start_span"": 252, ""end_span"": 263, ""type"": ""Chemical/Drug""}, {""token"": ""ACS"", ""start_span"": 272, ""end_span"": 275, ""type"": ""Disease/Disorder""}]"	train
Vitamin K - dependent protein; a polyclonal anti - Gas6 antibody lowers platelet thromboembolism induced by the intravenous injection of collagen plus epinephrine and aggregation by ADP	Vitamin K - dependent protein,0,29,Gene/Protein	Gas6,51,55,Gene/Protein	thromboembolism,81,96,Disease/Disorder	collagen,137,145,Gene/Protein	epinephrine,151,162,Chemical/Drug	"[{""token"": ""Vitamin K - dependent protein"", ""start_span"": 0, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""Gas6"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""thromboembolism"", ""start_span"": 81, ""end_span"": 96, ""type"": ""Disease/Disorder""}, {""token"": ""collagen"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""epinephrine"", ""start_span"": 151, ""end_span"": 162, ""type"": ""Chemical/Drug""}]"	train
Whether prasugrel is safer and better than clopidogrel in reducing the risk of cardiovascular death, MI, or stroke, in patients with ACS who are medically managed, and in whom no revascularization is planned, will be evaluated in the TRILOGY ACS study, a phase III multicenter, double - blind, randomized, controlled trial including approximately 10, 000 patients ( 50 ).	prasugrel,8,17,Chemical/Drug	clopidogrel,43,54,Chemical/Drug	stroke,108,114,Disease/Disorder	ACS,133,136,Disease/Disorder	ACS,242,245,Disease/Disorder	"[{""token"": ""prasugrel"", ""start_span"": 8, ""end_span"": 17, ""type"": ""Chemical/Drug""}, {""token"": ""clopidogrel"", ""start_span"": 43, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""stroke"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Disease/Disorder""}, {""token"": ""ACS"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Disease/Disorder""}, {""token"": ""ACS"", ""start_span"": 242, ""end_span"": 245, ""type"": ""Disease/Disorder""}]"	train
In 174 subjects with a recent coronary artery disease receiving 75 - 100 mg / day aspirin ( 92 also under ticagrelor 180 - mg load and 90 mg / twice daily maintenance dose, and 82 also under clopidogrel 600 - mg load and 75 mg / d maintenance dose) the genotyping of the cytochrome P450 ( CYP) 2C19 (* 1 ,* 2 ,* 3 ,* 4 ,* 5 ,* 6 ,* 7 ,* 8 ,* 17) was performed.	coronary artery disease,30,53,Disease/Disorder	aspirin,82,89,Chemical/Drug	ticagrelor,106,116,Chemical/Drug	clopidogrel,191,202,Chemical/Drug	cytochrome P450,271,286,Gene/Protein	"[{""token"": ""coronary artery disease"", ""start_span"": 30, ""end_span"": 53, ""type"": ""Disease/Disorder""}, {""token"": ""aspirin"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""ticagrelor"", ""start_span"": 106, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""clopidogrel"", ""start_span"": 191, ""end_span"": 202, ""type"": ""Chemical/Drug""}, {""token"": ""cytochrome P450"", ""start_span"": 271, ""end_span"": 286, ""type"": ""Gene/Protein""}]"	train
To evaluate further the safety and efficacy parameters, in a phase III study ( NCT01294462) 90 mg / twice daily ticagrelor ( on top of 100 mg aspirin) will be compared to 75 mg clopidogrel ( on top of 100 mg aspirin as well) in ACS subjects with a planned PCI.	ticagrelor,112,122,Chemical/Drug	aspirin,142,149,Chemical/Drug	clopidogrel,177,188,Chemical/Drug	aspirin,208,215,Chemical/Drug	ACS,228,231,Disease/Disorder	"[{""token"": ""ticagrelor"", ""start_span"": 112, ""end_span"": 122, ""type"": ""Chemical/Drug""}, {""token"": ""aspirin"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Chemical/Drug""}, {""token"": ""clopidogrel"", ""start_span"": 177, ""end_span"": 188, ""type"": ""Chemical/Drug""}, {""token"": ""aspirin"", ""start_span"": 208, ""end_span"": 215, ""type"": ""Chemical/Drug""}, {""token"": ""ACS"", ""start_span"": 228, ""end_span"": 231, ""type"": ""Disease/Disorder""}]"	train
The rate of major cardiovascular adverse events in the atopaxar group was similar to placebo ( ACS 6. 6% and 5. 0% in placebo or E5555, respectively, P = 0. 73; CAD 4. 5% placebo versus 1. 0% E5555, P = 0. 066 ).	atopaxar,55,63,Chemical/Drug	ACS,95,98,Disease/Disorder	E5555,129,134,Chemical/Drug	CAD,161,164,Disease/Disorder	E5555,192,197,Chemical/Drug	"[{""token"": ""atopaxar"", ""start_span"": 55, ""end_span"": 63, ""type"": ""Chemical/Drug""}, {""token"": ""ACS"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Disease/Disorder""}, {""token"": ""E5555"", ""start_span"": 129, ""end_span"": 134, ""type"": ""Chemical/Drug""}, {""token"": ""CAD"", ""start_span"": 161, ""end_span"": 164, ""type"": ""Disease/Disorder""}, {""token"": ""E5555"", ""start_span"": 192, ""end_span"": 197, ""type"": ""Chemical/Drug""}]"	train
Vorapaxar blocks the platelet PAR - 1 receptor, inhibiting thrombin - induced activation and aggregation of platelets without affecting thrombin - induced fibrin production.	Vorapaxar,0,9,Chemical/Drug	PAR - 1 receptor,30,46,Gene/Protein	thrombin,59,67,Gene/Protein	thrombin,136,144,Gene/Protein	fibrin,155,161,Gene/Protein	"[{""token"": ""Vorapaxar"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""PAR - 1 receptor"", ""start_span"": 30, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""thrombin"", ""start_span"": 59, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""thrombin"", ""start_span"": 136, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""fibrin"", ""start_span"": 155, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	train
Inhibition of Gas6 function can be achieved by Gas6 - neutralizing antibodies, by proteases cleaving the extracellular domain of Gas6 receptors, or by inactivation of RNA for Gas6 or Gas6 receptors.	Gas6,14,18,Gene/Protein	Gas6,47,51,Gene/Protein	Gas6 receptors,129,143,Gene/Protein	Gas6,175,179,Gene/Protein	Gas6 receptors,183,197,Gene/Protein	"[{""token"": ""Gas6"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""Gas6"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""Gas6 receptors"", ""start_span"": 129, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""Gas6"", ""start_span"": 175, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""Gas6 receptors"", ""start_span"": 183, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
Choroidal circulation is known to be associated with retinal diseases such as age - related macular degeneration ( AMD) and diabetic retinopathy ( DR) [ 2 ], [ 3 ], which are major causes of vision loss or impairment.	retinal diseases,53,69,Disease/Disorder	age - related macular degeneration,78,112,Disease/Disorder	AMD,115,118,Disease/Disorder	diabetic retinopathy,124,144,Disease/Disorder	DR,147,149,Disease/Disorder	"[{""token"": ""retinal diseases"", ""start_span"": 53, ""end_span"": 69, ""type"": ""Disease/Disorder""}, {""token"": ""age - related macular degeneration"", ""start_span"": 78, ""end_span"": 112, ""type"": ""Disease/Disorder""}, {""token"": ""AMD"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Disease/Disorder""}, {""token"": ""diabetic retinopathy"", ""start_span"": 124, ""end_span"": 144, ""type"": ""Disease/Disorder""}, {""token"": ""DR"", ""start_span"": 147, ""end_span"": 149, ""type"": ""Disease/Disorder""}]"	train
The decreases in IL - 12, TNF - α and CCL5 were statistically significant, while the IL - 13 decrease was statistically significant in the severe keratoconus group only.	IL - 12,17,24,Gene/Protein	TNF - α,26,33,Gene/Protein	CCL5,38,42,Gene/Protein	IL - 13,85,92,Gene/Protein	keratoconus,146,157,Disease/Disorder	"[{""token"": ""IL - 12"", ""start_span"": 17, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""TNF - \u03b1"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""CCL5"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""keratoconus"", ""start_span"": 146, ""end_span"": 157, ""type"": ""Disease/Disorder""}]"	train
After correcting for age and contact lens use, IL - 12, TNF - α, and RANTES / CCL5 were significantly lower in KC than in controls.	IL - 12,47,54,Gene/Protein	TNF - α,56,63,Gene/Protein	RANTES,69,75,Gene/Protein	CCL5,78,82,Gene/Protein	KC,111,113,Disease/Disorder	"[{""token"": ""IL - 12"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""TNF - \u03b1"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""RANTES"", ""start_span"": 69, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""CCL5"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""KC"", ""start_span"": 111, ""end_span"": 113, ""type"": ""Disease/Disorder""}]"	train
Based on the commercial availability of high sensitivity ELISA kits, we selected TNF - α and IFN - γ as TH1, IL - 4 as TH2 and IL - 17 as TH17 representative cytokines.	TNF - α,81,88,Gene/Protein	IFN - γ,93,100,Gene/Protein	IL - 4,109,115,Gene/Protein	IL - 17,127,134,Gene/Protein	cytokines,158,167,Gene/Protein	"[{""token"": ""TNF - \u03b1"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""IFN - \u03b3"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 109, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""IL - 17"", ""start_span"": 127, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 158, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
Others have examined isolated cytokines by conventional sandwich ELISA and reported concentrations of IL - 6, TNF - α and IL - 10 in control and keratoconus subjects [ 8 ], [ 13 ].	cytokines,30,39,Gene/Protein	IL - 6,102,108,Gene/Protein	TNF - α,110,117,Gene/Protein	IL - 10,122,129,Gene/Protein	keratoconus,145,156,Disease/Disorder	"[{""token"": ""cytokines"", ""start_span"": 30, ""end_span"": 39, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""TNF - \u03b1"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""keratoconus"", ""start_span"": 145, ""end_span"": 156, ""type"": ""Disease/Disorder""}]"	train
IL - 12 promotes the differentiation of TH1 cells; its decrease in keratoconus is consistent with decreases in two signature TH1 cytokines, IFN - γ and TNF - α.	IL - 12,0,7,Gene/Protein	keratoconus,67,78,Disease/Disorder	cytokines,129,138,Gene/Protein	IFN - γ,140,147,Gene/Protein	TNF - α,152,159,Gene/Protein	"[{""token"": ""IL - 12"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""keratoconus"", ""start_span"": 67, ""end_span"": 78, ""type"": ""Disease/Disorder""}, {""token"": ""cytokines"", ""start_span"": 129, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""IFN - \u03b3"", ""start_span"": 140, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""TNF - \u03b1"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
Both IL - 4 and IL - 13 cytokines were also reduced in keratoconus, and the decrease in IL - 4, as measured by conventional ELISA, was statistically significant.	IL - 4,5,11,Gene/Protein	IL - 13,16,23,Gene/Protein	cytokines,24,33,Gene/Protein	keratoconus,55,66,Disease/Disorder	IL - 4,88,94,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 5, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 24, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""keratoconus"", ""start_span"": 55, ""end_span"": 66, ""type"": ""Disease/Disorder""}, {""token"": ""IL - 4"", ""start_span"": 88, ""end_span"": 94, ""type"": ""Gene/Protein""}]"	train
IL - 4 and IL - 4 receptor engagement through the JAK - STAT and the IRS1 / 2 pathways regulate cell proliferation and tissue homeostasis [ 17 ].	IL - 4,0,6,Gene/Protein	IL - 4 receptor,11,26,Gene/Protein	JAK,50,53,Gene/Protein	STAT,56,60,Gene/Protein	IRS1,69,73,Gene/Protein	"[{""token"": ""IL - 4"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4 receptor"", ""start_span"": 11, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""JAK"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""STAT"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""IRS1"", ""start_span"": 69, ""end_span"": 73, ""type"": ""Gene/Protein""}]"	train
In vitro and in vivo studies indicate reciprocal interactions between IFN - γ and IL - 17, and between IL - 4 and IL - 17, and that these cytokines restrict undue amplification of the TH17 response [ 24 ].	IFN - γ,70,77,Gene/Protein	IL - 17,82,89,Gene/Protein	IL - 4,103,109,Gene/Protein	IL - 17,114,121,Gene/Protein	cytokines,138,147,Gene/Protein	"[{""token"": ""IFN - \u03b3"", ""start_span"": 70, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""IL - 17"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 103, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""IL - 17"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 138, ""end_span"": 147, ""type"": ""Gene/Protein""}]"	train
We have investigated the invasiveness of primary chicken embryo intestinal cells ( CEICs) by C. jejuni strains of human and chicken origins and the production of pro - inflammatory cytokines as well as the expression of the bacterial virulence - associated genes during co - cultivation.	chicken,49,56,Organism/Species	human,114,119,Organism/Species	chicken,124,131,Organism/Species	pro - inflammatory cytokines,162,190,Gene/Protein	virulence - associated genes,234,262,Gene/Protein	"[{""token"": ""chicken"", ""start_span"": 49, ""end_span"": 56, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Organism/Species""}, {""token"": ""chicken"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Organism/Species""}, {""token"": ""pro - inflammatory cytokines"", ""start_span"": 162, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""virulence - associated genes"", ""start_span"": 234, ""end_span"": 262, ""type"": ""Gene/Protein""}]"	train
Furthermore, incubation of bacteria with conditioned cell - and bacteria - free media from another co - cultivation experiment also increased the expression of the virulence - associated genes in the C. jejuni chicken isolate, indicating that the expression of bacterial genes is regulated by component ( s) secreted upon co - cultivation of bacteria and CEICs.	bacteria,27,35,Organism/Species	bacteria,64,72,Organism/Species	virulence - associated genes,164,192,Gene/Protein	chicken,210,217,Organism/Species	bacteria,261,269,Organism/Species	"[{""token"": ""bacteria"", ""start_span"": 27, ""end_span"": 35, ""type"": ""Organism/Species""}, {""token"": ""bacteria"", ""start_span"": 64, ""end_span"": 72, ""type"": ""Organism/Species""}, {""token"": ""virulence - associated genes"", ""start_span"": 164, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""chicken"", ""start_span"": 210, ""end_span"": 217, ""type"": ""Organism/Species""}, {""token"": ""bacteria"", ""start_span"": 261, ""end_span"": 269, ""type"": ""Organism/Species""}]"	train
Previous studies have shown that C. jejuni can invade human - derived epithelial cell cultures [ 8, 9] and induce the production of a number of cytokines and chemokines during the course of experimental infections [ 10 - 15 ], as well as in clinical Campylobacter infections [ 16 ].	human,54,59,Organism/Species	cytokines,144,153,Gene/Protein	chemokines,158,168,Gene/Protein	infections,203,213,Disease/Disorder	Campylobacter infections,250,274,Disease/Disorder	"[{""token"": ""human"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Organism/Species""}, {""token"": ""cytokines"", ""start_span"": 144, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""chemokines"", ""start_span"": 158, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""infections"", ""start_span"": 203, ""end_span"": 213, ""type"": ""Disease/Disorder""}, {""token"": ""Campylobacter infections"", ""start_span"": 250, ""end_span"": 274, ""type"": ""Disease/Disorder""}]"	train
Therefore, we used primary chicken embryo intestinal cells ( CEICs) as a model to compare the cytokine responses of CEICs elicited by C. jejuni strains of human and chicken origin, as well as the concomitant expression of the virulence - associated genes of C. jejuni.	chicken,27,34,Organism/Species	cytokine,94,102,Gene/Protein	human,155,160,Organism/Species	chicken,165,172,Organism/Species	virulence - associated genes,226,254,Gene/Protein	"[{""token"": ""chicken"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Organism/Species""}, {""token"": ""cytokine"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 155, ""end_span"": 160, ""type"": ""Organism/Species""}, {""token"": ""chicken"", ""start_span"": 165, ""end_span"": 172, ""type"": ""Organism/Species""}, {""token"": ""virulence - associated genes"", ""start_span"": 226, ""end_span"": 254, ""type"": ""Gene/Protein""}]"	train
Figure 2 shows that both bacterial strains induced the production of IL - 1β, IL - 6, CXCLi1 and CXCLi2, but not of TGF - β4.	IL - 1β,69,76,Gene/Protein	IL - 6,78,84,Gene/Protein	CXCLi1,86,92,Gene/Protein	CXCLi2,97,103,Gene/Protein	TGF - β4,116,124,Gene/Protein	"[{""token"": ""IL - 1\u03b2"", ""start_span"": 69, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""CXCLi1"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""CXCLi2"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""TGF - \u03b24"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Gene/Protein""}]"	train
Inducible NOS, IL - 1β, IL - 6, and CXCLi2 are major markers of inflammatory disease.	Inducible NOS,0,13,Gene/Protein	IL - 1β,15,22,Gene/Protein	IL - 6,24,30,Gene/Protein	CXCLi2,36,42,Gene/Protein	inflammatory disease,64,84,Disease/Disorder	"[{""token"": ""Inducible NOS"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1\u03b2"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 24, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""CXCLi2"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""inflammatory disease"", ""start_span"": 64, ""end_span"": 84, ""type"": ""Disease/Disorder""}]"	train
Interleukin - 8 is a pro - inflammatory cytokine, a potent chemotactic factor for many immune effector cells, and a mediator of localized inflammatory responses [ 28 ]. Campylobacter strains have exhibited variability in the induction of CXCL8, and those strains with a high ability to invade intestinal epithelial cells frequently induce the high levels of CXCL8 [ 12 ].	Interleukin - 8,0,15,Gene/Protein	pro - inflammatory cytokine,21,48,Gene/Protein	Campylobacter,169,182,Organism/Species	CXCL8,238,243,Gene/Protein	CXCL8,358,363,Gene/Protein	"[{""token"": ""Interleukin - 8"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""pro - inflammatory cytokine"", ""start_span"": 21, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""Campylobacter"", ""start_span"": 169, ""end_span"": 182, ""type"": ""Organism/Species""}, {""token"": ""CXCL8"", ""start_span"": 238, ""end_span"": 243, ""type"": ""Gene/Protein""}, {""token"": ""CXCL8"", ""start_span"": 358, ""end_span"": 363, ""type"": ""Gene/Protein""}]"	train
The medium of non - inoculated CEICs suppressed the expression of the virulence - associated genes in chicken strain SC11, especially for genes ciaB and dnaJ ( p ≤ 0. 081 ), while slightly increased in human strain HM5040 ( Figure 5 ).	virulence - associated genes,70,98,Gene/Protein	chicken,102,109,Organism/Species	ciaB,144,148,Gene/Protein	dnaJ,153,157,Gene/Protein	human,202,207,Organism/Species	"[{""token"": ""virulence - associated genes"", ""start_span"": 70, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""chicken"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Organism/Species""}, {""token"": ""ciaB"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""dnaJ"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 202, ""end_span"": 207, ""type"": ""Organism/Species""}]"	train
The transcripts of bacterial virulence - associated genes ciaB, dnaJ and racR in invaded / adhered, suspended and those bacteria treated with various media were quantitatively determined by qPCR relative to 16S rRNA, by use of the 2 - ΔΔCt method previously described [ 41 ].	virulence - associated genes,29,57,Gene/Protein	ciaB,58,62,Gene/Protein	dnaJ,64,68,Gene/Protein	racR,73,77,Gene/Protein	bacteria,120,128,Organism/Species	"[{""token"": ""virulence - associated genes"", ""start_span"": 29, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""ciaB"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""dnaJ"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""racR"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""bacteria"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Organism/Species""}]"	train
IL - 8 / CXCL8 was the first described angiogenic, mitogenic, and motogenic chemokine in various cancer models and is the prototype of ELR + CXC chemokines [ 8, 10 - 13 ].	IL - 8,0,6,Gene/Protein	CXCL8,9,14,Gene/Protein	chemokine,76,85,Gene/Protein	cancer,97,103,Disease/Disorder	CXC chemokines,141,155,Gene/Protein	"[{""token"": ""IL - 8"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene/Protein""}, {""token"": ""CXCL8"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Gene/Protein""}, {""token"": ""chemokine"", ""start_span"": 76, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""cancer"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Disease/Disorder""}, {""token"": ""CXC chemokines"", ""start_span"": 141, ""end_span"": 155, ""type"": ""Gene/Protein""}]"	train
In recent years, several studies have shown that IL - 8 and CXCR2 are overexpressed in a range of human cancers including renal, prostate, pancreatic, colon, nasopharyngeal, and gastric cancers [ 37 - 41 ].	IL - 8,49,55,Gene/Protein	CXCR2,60,65,Gene/Protein	human,98,103,Organism/Species	cancers,104,111,Disease/Disorder	gastric cancers,178,193,Disease/Disorder	"[{""token"": ""IL - 8"", ""start_span"": 49, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""CXCR2"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Organism/Species""}, {""token"": ""cancers"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Disease/Disorder""}, {""token"": ""gastric cancers"", ""start_span"": 178, ""end_span"": 193, ""type"": ""Disease/Disorder""}]"	train
The assessment of the prognostic value of IL - 8 genetic marker in breast carcinoma confirmed the results of our previous study and indicated that IL - 8 (- 251) A allele is highly associated with aggressive forms of breast carcinoma as defined by large tumor size, high grade and lymph node metastases.	IL - 8,42,48,Gene/Protein	breast carcinoma,67,83,Disease/Disorder	IL - 8,147,153,Gene/Protein	breast carcinoma,217,233,Disease/Disorder	tumor,254,259,Disease/Disorder	"[{""token"": ""IL - 8"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""breast carcinoma"", ""start_span"": 67, ""end_span"": 83, ""type"": ""Disease/Disorder""}, {""token"": ""IL - 8"", ""start_span"": 147, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""breast carcinoma"", ""start_span"": 217, ""end_span"": 233, ""type"": ""Disease/Disorder""}, {""token"": ""tumor"", ""start_span"": 254, ""end_span"": 259, ""type"": ""Disease/Disorder""}]"	train
Given the importance of IL - 8 and CXCR2 in angiogenesis, we investigated the relationship between polymorphisms - 251 T / A in IL - 8 gene and (+ 1208) C / T in CXCR2 gene and breast carcinoma.	IL - 8,24,30,Gene/Protein	CXCR2,35,40,Gene/Protein	IL - 8,128,134,Gene/Protein	CXCR2,162,167,Gene/Protein	breast carcinoma,177,193,Disease/Disorder	"[{""token"": ""IL - 8"", ""start_span"": 24, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""CXCR2"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""CXCR2"", ""start_span"": 162, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""breast carcinoma"", ""start_span"": 177, ""end_span"": 193, ""type"": ""Disease/Disorder""}]"	train
There is now convincing evidence that these correlations between IL - 8 A allele and cancer risk result from an increased level of IL - 8 protein, which may have an impact on cancer development and progression via the regulation of immune response and pathways of tumor angiogenesis.	IL - 8,65,71,Gene/Protein	cancer,85,91,Disease/Disorder	IL - 8,131,137,Gene/Protein	cancer,175,181,Disease/Disorder	tumor,264,269,Disease/Disorder	"[{""token"": ""IL - 8"", ""start_span"": 65, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""cancer"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Disease/Disorder""}, {""token"": ""IL - 8"", ""start_span"": 131, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""cancer"", ""start_span"": 175, ""end_span"": 181, ""type"": ""Disease/Disorder""}, {""token"": ""tumor"", ""start_span"": 264, ""end_span"": 269, ""type"": ""Disease/Disorder""}]"	train
Overexpression of IL - 8 is associated with increasing tumor stage, disease progression and recurrence in human bladder, prostate, breast, lung, gastric, hepatic cancers, and melanoma [ 11, 14 - 16, 43, 50, 51 ].	IL - 8,18,24,Gene/Protein	tumor,55,60,Disease/Disorder	human,106,111,Organism/Species	hepatic cancers,154,169,Disease/Disorder	melanoma,175,183,Disease/Disorder	"[{""token"": ""IL - 8"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 55, ""end_span"": 60, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Organism/Species""}, {""token"": ""hepatic cancers"", ""start_span"": 154, ""end_span"": 169, ""type"": ""Disease/Disorder""}, {""token"": ""melanoma"", ""start_span"": 175, ""end_span"": 183, ""type"": ""Disease/Disorder""}]"	train
Since CXCR2 binds to all ELR + CXC chemokines that induce angiogenesis, including IL - 8, it may be safe to say that CXCR2 is a mediator of the proangiogenic effects of IL - 8.	CXCR2,6,11,Gene/Protein	CXC chemokines,31,45,Gene/Protein	IL - 8,82,88,Gene/Protein	CXCR2,117,122,Gene/Protein	IL - 8,169,175,Gene/Protein	"[{""token"": ""CXCR2"", ""start_span"": 6, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""CXC chemokines"", ""start_span"": 31, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""CXCR2"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 169, ""end_span"": 175, ""type"": ""Gene/Protein""}]"	train
In some types of primary neurons and in endothelial cells, proneurotrophin binding to the p75NTR - sortilin receptor complex is a potent apoptotic stimulus [ 7, 9, 10] and several studies have demonstrated the importance of proNGF and proBDNF for inducing apoptosis in vivo [ 7, 10 – 15 ].	proneurotrophin,59,74,Gene/Protein	p75NTR,90,96,Gene/Protein	sortilin,99,107,Gene/Protein	proNGF,224,230,Gene/Protein	proBDNF,235,242,Gene/Protein	"[{""token"": ""proneurotrophin"", ""start_span"": 59, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""p75NTR"", ""start_span"": 90, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""sortilin"", ""start_span"": 99, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""proNGF"", ""start_span"": 224, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""proBDNF"", ""start_span"": 235, ""end_span"": 242, ""type"": ""Gene/Protein""}]"	train
Cells were seeded on poly - D - lysin coated coverslips and fed Neurobasal media supplemented with 2% B27 ( Invitrogen ), 1% L - glutamine ( Wisent) and 1% penicillin / streptomicyin ( Wisent )] and astrocyte conditioned media for 10 days in vitro, prior to treatment with BDNF, proBDNF or HBpFproBDNF.	L - glutamine,125,138,Chemical/Drug	penicillin,156,166,Chemical/Drug	streptomicyin,169,182,Chemical/Drug	BDNF,273,277,Gene/Protein	proBDNF,279,286,Gene/Protein	"[{""token"": ""L - glutamine"", ""start_span"": 125, ""end_span"": 138, ""type"": ""Chemical/Drug""}, {""token"": ""penicillin"", ""start_span"": 156, ""end_span"": 166, ""type"": ""Chemical/Drug""}, {""token"": ""streptomicyin"", ""start_span"": 169, ""end_span"": 182, ""type"": ""Chemical/Drug""}, {""token"": ""BDNF"", ""start_span"": 273, ""end_span"": 277, ""type"": ""Gene/Protein""}, {""token"": ""proBDNF"", ""start_span"": 279, ""end_span"": 286, ""type"": ""Gene/Protein""}]"	train
The anti - biotin antibody was from Jackson Immunoresearch, anti - Flag and anti - beta III - tubulin were from Sigma, anti - BDNF ( N - 20) was from Santa - Cruz Biotechnology, Inc. and anti phospho - TrkA ( Tyr490) was from Cell Signaling Technology.	biotin,11,17,Chemical/Drug	antibody,18,26,Gene/Protein	beta III - tubulin,83,101,Gene/Protein	BDNF,126,130,Gene/Protein	TrkA,202,206,Gene/Protein	"[{""token"": ""biotin"", ""start_span"": 11, ""end_span"": 17, ""type"": ""Chemical/Drug""}, {""token"": ""antibody"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Gene/Protein""}, {""token"": ""beta III - tubulin"", ""start_span"": 83, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""TrkA"", ""start_span"": 202, ""end_span"": 206, ""type"": ""Gene/Protein""}]"	train
Anti - Sortilin and anti - SorCS2 were gifts from Dr. Barbara Hempstead, Rhodamine - tagged phalloidin was from Life technologies and Hoechst 33342 was obtained from Molecular Probes.	Sortilin,7,15,Gene/Protein	SorCS2,27,33,Gene/Protein	Rhodamine,73,82,Chemical/Drug	phalloidin,92,102,Chemical/Drug	Hoechst 33342,134,147,Chemical/Drug	"[{""token"": ""Sortilin"", ""start_span"": 7, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""SorCS2"", ""start_span"": 27, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""Rhodamine"", ""start_span"": 73, ""end_span"": 82, ""type"": ""Chemical/Drug""}, {""token"": ""phalloidin"", ""start_span"": 92, ""end_span"": 102, ""type"": ""Chemical/Drug""}, {""token"": ""Hoechst 33342"", ""start_span"": 134, ""end_span"": 147, ""type"": ""Chemical/Drug""}]"	train
To confirm that HBpF - proBDNF binds to p75NTR, we overexpressed p75NTR and sortilin either alone or together in HEK293 cells, with and without HBpF - proBDNF.	proBDNF,23,30,Gene/Protein	p75NTR,40,46,Gene/Protein	p75NTR,65,71,Gene/Protein	sortilin,76,84,Gene/Protein	proBDNF,151,158,Gene/Protein	"[{""token"": ""proBDNF"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""p75NTR"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""p75NTR"", ""start_span"": 65, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""sortilin"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""proBDNF"", ""start_span"": 151, ""end_span"": 158, ""type"": ""Gene/Protein""}]"	train
Homologous sequences are found in animals, fungi, and prokaryotes, but not in protozoans or plants [ 2 ].	animals,34,41,Organism/Species	fungi,43,48,Organism/Species	prokaryotes,54,65,Organism/Species	protozoans,78,88,Organism/Species	plants,92,98,Organism/Species	"[{""token"": ""animals"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Organism/Species""}, {""token"": ""fungi"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Organism/Species""}, {""token"": ""prokaryotes"", ""start_span"": 54, ""end_span"": 65, ""type"": ""Organism/Species""}, {""token"": ""protozoans"", ""start_span"": 78, ""end_span"": 88, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 92, ""end_span"": 98, ""type"": ""Organism/Species""}]"	train
Urochordata ( Ciona intestinalis [ Ci] and Ciona savigny [ Cs ]) were used as out - group.	Urochordata,0,11,Organism/Species	Ciona intestinalis,14,32,Organism/Species	Ci,35,37,Organism/Species	Ciona savigny,43,56,Organism/Species	Cs,59,61,Organism/Species	"[{""token"": ""Urochordata"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Organism/Species""}, {""token"": ""Ciona intestinalis"", ""start_span"": 14, ""end_span"": 32, ""type"": ""Organism/Species""}, {""token"": ""Ci"", ""start_span"": 35, ""end_span"": 37, ""type"": ""Organism/Species""}, {""token"": ""Ciona savigny"", ""start_span"": 43, ""end_span"": 56, ""type"": ""Organism/Species""}, {""token"": ""Cs"", ""start_span"": 59, ""end_span"": 61, ""type"": ""Organism/Species""}]"	train
To further investigate whether amino acid substitutions in the highly conserved N - termini of the bestrophins could have caused adaptive functional diversification, amino acid residues 1 – 367 from 53 vertebrate bestrophins ( Table 1) were used for posterior analysis by the DIVERGE program algorithms [ 27, 28 ].	amino acid,31,41,Chemical/Drug	bestrophins,99,110,Gene/Protein	amino acid,166,176,Chemical/Drug	vertebrate,202,212,Organism/Species	bestrophins,213,224,Gene/Protein	"[{""token"": ""amino acid"", ""start_span"": 31, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""bestrophins"", ""start_span"": 99, ""end_span"": 110, ""type"": ""Gene/Protein""}, {""token"": ""amino acid"", ""start_span"": 166, ""end_span"": 176, ""type"": ""Chemical/Drug""}, {""token"": ""vertebrate"", ""start_span"": 202, ""end_span"": 212, ""type"": ""Organism/Species""}, {""token"": ""bestrophins"", ""start_span"": 213, ""end_span"": 224, ""type"": ""Gene/Protein""}]"	train
Human and mouse bestrophin 3, heterologously expressed in HEK - 293 cells, produce no chloride currents in a physiological range [ 16, 36 ], in contrast for example to mouse bestrophin 2 [ 13, 14 ].	Human,0,5,Organism/Species	mouse,10,15,Organism/Species	bestrophin 3,16,28,Gene/Protein	mouse,168,173,Organism/Species	bestrophin 2,174,186,Gene/Protein	"[{""token"": ""Human"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Organism/Species""}, {""token"": ""bestrophin 3"", ""start_span"": 16, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 168, ""end_span"": 173, ""type"": ""Organism/Species""}, {""token"": ""bestrophin 2"", ""start_span"": 174, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
Due to gaps and a shorter length of bestrophin 2 and 4, a total of 15 residues from human bestrophin 4 ( codons 264 – 278) and one ( codon 356) from human bestrophin 2 were excluded from the analysis.	bestrophin 2,36,48,Gene/Protein	human,84,89,Organism/Species	bestrophin 4,90,102,Gene/Protein	human,149,154,Organism/Species	bestrophin 2,155,167,Gene/Protein	"[{""token"": ""bestrophin 2"", ""start_span"": 36, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 84, ""end_span"": 89, ""type"": ""Organism/Species""}, {""token"": ""bestrophin 4"", ""start_span"": 90, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 149, ""end_span"": 154, ""type"": ""Organism/Species""}, {""token"": ""bestrophin 2"", ""start_span"": 155, ""end_span"": 167, ""type"": ""Gene/Protein""}]"	train
Presence of IgG Anti - gp160 / 120 Antibodies Confers Higher HIV Capture Capacity to Erythrocytes from HIV - Positive Individuals	IgG,12,15,Gene/Protein	gp160,23,28,Gene/Protein	Antibodies,35,45,Gene/Protein	HIV,61,64,Organism/Species	HIV,103,106,Organism/Species	"[{""token"": ""IgG"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene/Protein""}, {""token"": ""gp160"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""Antibodies"", ""start_span"": 35, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Organism/Species""}]"	train
However, the presence of immunoglobulins G anti - HIV ( IgG anti - HIV) in erythrocytes from HIV - positive individuals is still to be elucidated.	immunoglobulins G,25,42,Gene/Protein	HIV,50,53,Organism/Species	IgG,56,59,Gene/Protein	HIV,67,70,Organism/Species	HIV,93,96,Organism/Species	"[{""token"": ""immunoglobulins G"", ""start_span"": 25, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Organism/Species""}]"	train
Results suggest that in HIV - positive individuals, erythrocytes are capable of capturing high amounts of HIV by the presence of IgGs anti - gp160 / 120 on their membranes and this may produce a reduction in the available free virus.	HIV,24,27,Organism/Species	HIV,106,109,Organism/Species	IgGs,129,133,Gene/Protein	gp160,141,146,Gene/Protein	virus,227,232,Organism/Species	"[{""token"": ""HIV"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Organism/Species""}, {""token"": ""IgGs"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""gp160"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""virus"", ""start_span"": 227, ""end_span"": 232, ""type"": ""Organism/Species""}]"	train
Immune complexes, namely antigens opsonized by antibodies and complement, are bound to erythrocytes through specific interactions of the complement protein C3b with the erythrocyte complement receptor 1 ( CR1 or CD35 ).	antibodies,47,57,Gene/Protein	complement protein C3b,137,159,Gene/Protein	complement receptor 1,181,202,Gene/Protein	CR1,205,208,Gene/Protein	CD35,212,216,Gene/Protein	"[{""token"": ""antibodies"", ""start_span"": 47, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""complement protein C3b"", ""start_span"": 137, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""complement receptor 1"", ""start_span"": 181, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""CR1"", ""start_span"": 205, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""CD35"", ""start_span"": 212, ""end_span"": 216, ""type"": ""Gene/Protein""}]"	train
However, the presence and pattern of immunoglobulins G anti HIV ( IgG anti - HIV) in erythrocytes from HIV - positive individuals is still to be demonstrated.	immunoglobulins G,37,54,Gene/Protein	HIV,60,63,Organism/Species	IgG,66,69,Gene/Protein	HIV,77,80,Organism/Species	HIV,103,106,Organism/Species	"[{""token"": ""immunoglobulins G"", ""start_span"": 37, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Organism/Species""}]"	train
Determinations showed presence of anti - gp160 in 11 out of the 12 individuals, 6 presented IgG anti - p24 and 6 IgG anti - p34 ( Table S1 ).	gp160,41,46,Gene/Protein	IgG,92,95,Gene/Protein	p24,103,106,Gene/Protein	IgG,113,116,Gene/Protein	p34,124,127,Gene/Protein	"[{""token"": ""gp160"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""p24"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""p34"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene/Protein""}]"	train
Besides, presence of HIV - RNA [ 1 ], [ 11 ], p24 - antigen [ 1] and IgG anti - HIV was shown on erythrocytes from HIV - positive individuals.	HIV,21,24,Organism/Species	p24,46,49,Gene/Protein	IgG,69,72,Gene/Protein	HIV,80,83,Organism/Species	HIV,115,118,Organism/Species	"[{""token"": ""HIV"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Organism/Species""}, {""token"": ""p24"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 80, ""end_span"": 83, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Organism/Species""}]"	train
In order to address this issue, plasma dilutions from 14 HIV - positive individuals were used as source of HIV - specific antibodies and then incubated with CXCR4 - tropic strains of HIV IIIB.	HIV,57,60,Organism/Species	HIV,107,110,Organism/Species	antibodies,122,132,Gene/Protein	CXCR4,157,162,Gene/Protein	HIV IIIB,183,191,Organism/Species	"[{""token"": ""HIV"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Organism/Species""}, {""token"": ""antibodies"", ""start_span"": 122, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""CXCR4"", ""start_span"": 157, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""HIV IIIB"", ""start_span"": 183, ""end_span"": 191, ""type"": ""Organism/Species""}]"	train
Each of these was exposed to erythrocytes from HIV - negative individuals ( E) ( HIV - Ig - C + E or HIV - Ig - Ci + E ).	HIV,47,50,Organism/Species	HIV,81,84,Organism/Species	Ig,87,89,Gene/Protein	HIV,101,104,Organism/Species	Ig,107,109,Gene/Protein	"[{""token"": ""HIV"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Organism/Species""}, {""token"": ""Ig"", ""start_span"": 87, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Organism/Species""}, {""token"": ""Ig"", ""start_span"": 107, ""end_span"": 109, ""type"": ""Gene/Protein""}]"	train
Since gp160 is the precursor of gp120 and gp41, a possible explanation is that such antibodies are present but they are not detected due to higher affinity to gp160.	gp160,6,11,Gene/Protein	gp120,32,37,Gene/Protein	gp41,42,46,Gene/Protein	antibodies,84,94,Gene/Protein	gp160,159,164,Gene/Protein	"[{""token"": ""gp160"", ""start_span"": 6, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""gp120"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""gp41"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 84, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""gp160"", ""start_span"": 159, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
This therefore, suggests that the association of IgGs anti - HIV to erythrocytes has a relevant role in HIV availability in plasma but it is not enough to significantly modify the quantification of IgGs anti - HIV.	IgGs,49,53,Gene/Protein	HIV,61,64,Organism/Species	HIV,104,107,Organism/Species	IgGs,198,202,Gene/Protein	HIV,210,213,Organism/Species	"[{""token"": ""IgGs"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Organism/Species""}, {""token"": ""IgGs"", ""start_span"": 198, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 210, ""end_span"": 213, ""type"": ""Organism/Species""}]"	train
Therefore, plasma was diluted at a final concentration equal to the extent in IgG in erythrocytes ( IgG anti HIV - Pd) and IgG anti - HIV were evaluated by western blot.	IgG,78,81,Gene/Protein	IgG,100,103,Gene/Protein	HIV,109,112,Organism/Species	IgG,123,126,Gene/Protein	HIV,134,137,Organism/Species	"[{""token"": ""IgG"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""IgG"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Organism/Species""}]"	train
An aliquot of each of these samples were exposed to 2. 5 108 erythrocytes from HIV - negative individuals ( E) 30 minutes at 37 ° C ( viral capture) ( HIV - Ig - C + E or HIV - Ig - Ci + E ).	HIV,79,82,Organism/Species	HIV,151,154,Organism/Species	Ig,157,159,Gene/Protein	HIV,171,174,Organism/Species	Ig,177,179,Gene/Protein	"[{""token"": ""HIV"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 151, ""end_span"": 154, ""type"": ""Organism/Species""}, {""token"": ""Ig"", ""start_span"": 157, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 171, ""end_span"": 174, ""type"": ""Organism/Species""}, {""token"": ""Ig"", ""start_span"": 177, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
Virus alone without treatment, virus with complement and without antibodies and virus with inactivated complement without antibodies were used as controls.	Virus,0,5,Organism/Species	virus,31,36,Organism/Species	antibodies,65,75,Gene/Protein	virus,80,85,Organism/Species	antibodies,122,132,Gene/Protein	"[{""token"": ""Virus"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism/Species""}, {""token"": ""virus"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Organism/Species""}, {""token"": ""antibodies"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""virus"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organism/Species""}, {""token"": ""antibodies"", ""start_span"": 122, ""end_span"": 132, ""type"": ""Gene/Protein""}]"	train
Detection of IgGs anti - HIV, plasma viral load, p24 - antigen and HIV capture by erythrocytes in HIV - positive individuals.	IgGs,13,17,Gene/Protein	HIV,25,28,Organism/Species	p24,49,52,Gene/Protein	HIV,67,70,Organism/Species	HIV,98,101,Organism/Species	"[{""token"": ""IgGs"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Organism/Species""}, {""token"": ""p24"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Organism/Species""}]"	train
UCB CD34 + cells were seeded at a concentration of 1 × 103 cells per each well in the 48 - well plate in the hematopoietic stem cell expansion medium ( StemSpan supplemented by 3 cocktail cytokines: Flt3 - L, SCF, TPO ).	CD34,4,8,Gene/Protein	cytokines,188,197,Gene/Protein	Flt3 - L,199,207,Gene/Protein	SCF,209,212,Gene/Protein	TPO,214,217,Gene/Protein	"[{""token"": ""CD34"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 188, ""end_span"": 197, ""type"": ""Gene/Protein""}, {""token"": ""Flt3 - L"", ""start_span"": 199, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""SCF"", ""start_span"": 209, ""end_span"": 212, ""type"": ""Gene/Protein""}, {""token"": ""TPO"", ""start_span"": 214, ""end_span"": 217, ""type"": ""Gene/Protein""}]"	train
This problem can partly explain the high levels of secreted factors attributed myeloid line distinction, such as GM - CSF, M - CSF, IL - 6, IL - 11 and SCF.	GM - CSF,113,121,Gene/Protein	M - CSF,123,130,Gene/Protein	IL - 6,132,138,Gene/Protein	IL - 11,140,147,Gene/Protein	SCF,152,155,Gene/Protein	"[{""token"": ""GM - CSF"", ""start_span"": 113, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""M - CSF"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""IL - 11"", ""start_span"": 140, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""SCF"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene/Protein""}]"	train
A) enumeration of CD34 + at isolation day was 89. 57 percentage. B) CD34 + cells were labeled with FITC - conjugated antibody and B) with IgG1 as the control antibody	CD34,18,22,Gene/Protein	CD34,68,72,Gene/Protein	antibody,117,125,Gene/Protein	IgG1,138,142,Gene/Protein	antibody,158,166,Gene/Protein	"[{""token"": ""CD34"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""CD34"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 117, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""IgG1"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 158, ""end_span"": 166, ""type"": ""Gene/Protein""}]"	train
It is becoming increasingly supported by experimental evidence that some human bacterial pathogens can colonize plants and cause disease ( Kirzinger et al ., 2011 ). Salmonella is one of these bacterial species with extremely broad host range that infects not only animals, but also plants ( Hernandez - Reyes and Schikora, 2013 ).	human,73,78,Organism/Species	plants,112,118,Organism/Species	Salmonella,166,176,Organism/Species	animals,265,272,Organism/Species	plants,283,289,Organism/Species	"[{""token"": ""human"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 112, ""end_span"": 118, ""type"": ""Organism/Species""}, {""token"": ""Salmonella"", ""start_span"": 166, ""end_span"": 176, ""type"": ""Organism/Species""}, {""token"": ""animals"", ""start_span"": 265, ""end_span"": 272, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 283, ""end_span"": 289, ""type"": ""Organism/Species""}]"	train
However, the infection of plants by Salmonella is only a nascent field, so there are no known PPIs for Salmonella with any plant reported yet.	infection,13,22,Disease/Disorder	plants,26,32,Organism/Species	Salmonella,36,46,Organism/Species	Salmonella,103,113,Organism/Species	plant,123,128,Organism/Species	"[{""token"": ""infection"", ""start_span"": 13, ""end_span"": 22, ""type"": ""Disease/Disorder""}, {""token"": ""plants"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Organism/Species""}, {""token"": ""Salmonella"", ""start_span"": 36, ""end_span"": 46, ""type"": ""Organism/Species""}, {""token"": ""Salmonella"", ""start_span"": 103, ""end_span"": 113, ""type"": ""Organism/Species""}, {""token"": ""plant"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Organism/Species""}]"	train
Only 62 interactions between Salmonella and mostly human proteins ( some Salmonella interactions involve other mammalian species, such as mouse and rat) are known to date.	Salmonella,29,39,Organism/Species	human,51,56,Organism/Species	Salmonella,73,83,Organism/Species	mouse,138,143,Organism/Species	rat,148,151,Organism/Species	"[{""token"": ""Salmonella"", ""start_span"": 29, ""end_span"": 39, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Organism/Species""}, {""token"": ""Salmonella"", ""start_span"": 73, ""end_span"": 83, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 138, ""end_span"": 143, ""type"": ""Organism/Species""}, {""token"": ""rat"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Organism/Species""}]"	train
Interestingly they involve mouse proteins whose human homologs also interact with the same Salmonella proteins — i. e ., these 14 PPIs have interologs in the human - Salmonella dataset.	mouse,27,32,Organism/Species	human,48,53,Organism/Species	Salmonella,91,101,Organism/Species	human,158,163,Organism/Species	Salmonella,166,176,Organism/Species	"[{""token"": ""mouse"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Organism/Species""}, {""token"": ""Salmonella"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Organism/Species""}, {""token"": ""Salmonella"", ""start_span"": 166, ""end_span"": 176, ""type"": ""Organism/Species""}]"	train
The mutational profile of HNSCC is characterized by recurrent alterations in tumor suppressor genes ( of the 15 most common HNSCC mutated genes only HRAS and PIK3CA are oncogenes) where singular hot spots are infrequent and the mutational spectra covers various exon regions and / or specific functional protein coding domains [ 25 ].	HNSCC,26,31,Disease/Disorder	tumor suppressor genes,77,99,Gene/Protein	HNSCC,124,129,Disease/Disorder	HRAS,149,153,Gene/Protein	PIK3CA,158,164,Gene/Protein	"[{""token"": ""HNSCC"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Disease/Disorder""}, {""token"": ""tumor suppressor genes"", ""start_span"": 77, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""HNSCC"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Disease/Disorder""}, {""token"": ""HRAS"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""PIK3CA"", ""start_span"": 158, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
HPV positivity was defined based on HPV16 E6 status, which has been shown to be a highly sensitive and specific marker of HPV16 - related oropharyngeal tumours [ 43, 45, 46 ].	HPV,0,3,Organism/Species	HPV16,36,41,Organism/Species	E6,42,44,Gene/Protein	HPV16,122,127,Organism/Species	oropharyngeal tumours,138,159,Disease/Disorder	"[{""token"": ""HPV"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Organism/Species""}, {""token"": ""HPV16"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Organism/Species""}, {""token"": ""E6"", ""start_span"": 42, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""HPV16"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Organism/Species""}, {""token"": ""oropharyngeal tumours"", ""start_span"": 138, ""end_span"": 159, ""type"": ""Disease/Disorder""}]"	train
Likewise, three subunits of the urea active transporter were upregulated between 52 - and 72 - fold, representing one of the many enzymes whose expression are known to increase to harvest nitrogen from nitrogen - containing compounds such as ammonium, nitrate, nitrite, urea, purines, pyrimidines and amino acids38.	urea active transporter,32,55,Gene/Protein	urea,270,274,Chemical/Drug	purines,276,283,Chemical/Drug	pyrimidines,285,296,Chemical/Drug	amino acids38,301,314,Chemical/Drug	"[{""token"": ""urea active transporter"", ""start_span"": 32, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""urea"", ""start_span"": 270, ""end_span"": 274, ""type"": ""Chemical/Drug""}, {""token"": ""purines"", ""start_span"": 276, ""end_span"": 283, ""type"": ""Chemical/Drug""}, {""token"": ""pyrimidines"", ""start_span"": 285, ""end_span"": 296, ""type"": ""Chemical/Drug""}, {""token"": ""amino acids38"", ""start_span"": 301, ""end_span"": 314, ""type"": ""Chemical/Drug""}]"	train
The increased transcript levels of TCA cycle genes and genes contributing to reducing power such as G6PDH and ME were correspondingly observed in heterotrophic fungi such as Mortierella alpina48 and Mucor circinelloides4950 to be critical determinants of lipid synthesis.	G6PDH,100,105,Gene/Protein	ME,110,112,Gene/Protein	fungi,160,165,Organism/Species	Mortierella alpina48,174,194,Organism/Species	Mucor circinelloides4950,199,223,Organism/Species	"[{""token"": ""G6PDH"", ""start_span"": 100, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""ME"", ""start_span"": 110, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""fungi"", ""start_span"": 160, ""end_span"": 165, ""type"": ""Organism/Species""}, {""token"": ""Mortierella alpina48"", ""start_span"": 174, ""end_span"": 194, ""type"": ""Organism/Species""}, {""token"": ""Mucor circinelloides4950"", ""start_span"": 199, ""end_span"": 223, ""type"": ""Organism/Species""}]"	train
The latter comprised; ( i) epithelium - off, 0. 1% iso - osmolar riboflavin, 9 mW UVA irradiation for 10 min, ( ii) disrupted epithelium, 0. 1% hypo - osmolar riboflavin, 9 mW UVA for 10 min, ( iii) epithelium - on, 0. 25% hypo - osmolar riboflavin with 0. 01% benzylalkonium chloride ( BACS ), 9 mW UVA for 10 min, ( iv) epithelium - on, 5 min iontophoresis at 0. 1 mA for 5 min with 0. 1% riboflavin solution, 9 mW UVA for 10 min or ( v) 12. 5 min, ( vi) epithelium - on, prolonged iontophoresis protocol of 25 min with 1. 0 mA for 5 min and 0. 5 mA for 5 min with 0. 25% riboflavin with 0. 01% BACS, 9 mW UVA for 10 min or ( vii) 12. 5 min.	riboflavin,65,75,Chemical/Drug	riboflavin,159,169,Chemical/Drug	riboflavin,238,248,Chemical/Drug	riboflavin,391,401,Chemical/Drug	riboflavin,574,584,Chemical/Drug	"[{""token"": ""riboflavin"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Chemical/Drug""}, {""token"": ""riboflavin"", ""start_span"": 159, ""end_span"": 169, ""type"": ""Chemical/Drug""}, {""token"": ""riboflavin"", ""start_span"": 238, ""end_span"": 248, ""type"": ""Chemical/Drug""}, {""token"": ""riboflavin"", ""start_span"": 391, ""end_span"": 401, ""type"": ""Chemical/Drug""}, {""token"": ""riboflavin"", ""start_span"": 574, ""end_span"": 584, ""type"": ""Chemical/Drug""}]"	train
A total of 35. 1 - kilobase noncoding sequences of neo - Y and neo - X alleles in the black muntjac and the orthologous sequences in the Indian muntjac as the outgroup were used to construct the dentrogram. ' BM ' stands for ' male black muntjac '; ' IM ' stands for ' Indian muntjac '; ' 1 ' and ' 2 ' represent the two male black muntjac individuals separately. ( a) Tree constructed by neighbor - joining method.	black muntjac,86,99,Organism/Species	Indian muntjac,137,151,Organism/Species	black muntjac,232,245,Organism/Species	Indian muntjac,269,283,Organism/Species	black muntjac,326,339,Organism/Species	"[{""token"": ""black muntjac"", ""start_span"": 86, ""end_span"": 99, ""type"": ""Organism/Species""}, {""token"": ""Indian muntjac"", ""start_span"": 137, ""end_span"": 151, ""type"": ""Organism/Species""}, {""token"": ""black muntjac"", ""start_span"": 232, ""end_span"": 245, ""type"": ""Organism/Species""}, {""token"": ""Indian muntjac"", ""start_span"": 269, ""end_span"": 283, ""type"": ""Organism/Species""}, {""token"": ""black muntjac"", ""start_span"": 326, ""end_span"": 339, ""type"": ""Organism/Species""}]"	train
IL - 1a induces MSC production of IL - 1a, leukemia - inhibiting factor, G - CSF, and GM - CSF [ 18 ]. In vitro evaluations have provided detailed evidence that these factors, as well as other members of the MSC secretome ( the array of proteins produced and secreted by MSCs ), support the growth of hematopoietic stem cells ( HSCs) and their progeny in an ex vivo environment.	IL - 1a,0,7,Gene/Protein	IL - 1a,34,41,Gene/Protein	leukemia - inhibiting factor,43,71,Gene/Protein	G - CSF,73,80,Gene/Protein	GM - CSF,86,94,Gene/Protein	"[{""token"": ""IL - 1a"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1a"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""leukemia - inhibiting factor"", ""start_span"": 43, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""G - CSF"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""GM - CSF"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Gene/Protein""}]"	train
The ASD group consisted of 14 men and 3 women, ranging in age from 18 to 27 ( mean age = 21. 06, SD = 3. 44 ), and the TD group consisted of eight men and nine women, ranging in age from 18 to 25 ( mean age = 22. 71, SD = 2. 02 ).	ASD,4,7,Disease/Disorder	men,30,33,Organism/Species	women,40,45,Organism/Species	men,147,150,Organism/Species	women,160,165,Organism/Species	"[{""token"": ""ASD"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Disease/Disorder""}, {""token"": ""men"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Organism/Species""}, {""token"": ""women"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Organism/Species""}, {""token"": ""men"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Organism/Species""}, {""token"": ""women"", ""start_span"": 160, ""end_span"": 165, ""type"": ""Organism/Species""}]"	train
The membrane was incubated with 5% skim milk in phosphate - buffered saline containing 0. 1% Tween - 20 ( PBS - T) for 1 hour at room temperature, primary antibody overnight at 4 ° C, and horseradish peroxidase - conjugated secondary antibody for 1 hour at room temperature.	Tween - 20,93,103,Chemical/Drug	antibody,155,163,Gene/Protein	horseradish,188,199,Organism/Species	peroxidase,200,210,Gene/Protein	antibody,234,242,Gene/Protein	"[{""token"": ""Tween - 20"", ""start_span"": 93, ""end_span"": 103, ""type"": ""Chemical/Drug""}, {""token"": ""antibody"", ""start_span"": 155, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""horseradish"", ""start_span"": 188, ""end_span"": 199, ""type"": ""Organism/Species""}, {""token"": ""peroxidase"", ""start_span"": 200, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 234, ""end_span"": 242, ""type"": ""Gene/Protein""}]"	train
Chronic imipramine treatment alters the protein level of adrenergic receptors. Imipramine ( 30 mg / kg) was chronically administered at ZT1 or ZT13, and the protein levels of α1AR and α2AR were analyzed with western blotting.	imipramine,8,18,Chemical/Drug	adrenergic receptors,57,77,Gene/Protein	Imipramine,79,89,Chemical/Drug	α1AR,175,179,Gene/Protein	α2AR,184,188,Gene/Protein	"[{""token"": ""imipramine"", ""start_span"": 8, ""end_span"": 18, ""type"": ""Chemical/Drug""}, {""token"": ""adrenergic receptors"", ""start_span"": 57, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""Imipramine"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""\u03b11AR"", ""start_span"": 175, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""\u03b12AR"", ""start_span"": 184, ""end_span"": 188, ""type"": ""Gene/Protein""}]"	train
Plasmodium parasites cycle between a vertebrate host and mosquito vector, experiencing changing environmental conditions as they develop from invasive to intracellular forms in the vertebrate, and invasive, intracellular and extracellular forms in the mosquito.	Plasmodium,0,10,Organism/Species	vertebrate,37,47,Organism/Species	mosquito,57,65,Organism/Species	vertebrate,181,191,Organism/Species	mosquito,252,260,Organism/Species	"[{""token"": ""Plasmodium"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Organism/Species""}, {""token"": ""vertebrate"", ""start_span"": 37, ""end_span"": 47, ""type"": ""Organism/Species""}, {""token"": ""mosquito"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Organism/Species""}, {""token"": ""vertebrate"", ""start_span"": 181, ""end_span"": 191, ""type"": ""Organism/Species""}, {""token"": ""mosquito"", ""start_span"": 252, ""end_span"": 260, ""type"": ""Organism/Species""}]"	train
Matrigel, an extracellular matrix derived from Engelbreth – Holm – Swarm mouse sarcoma, is comprised of laminin ( 56 %), collagen IV ( 31 %), enactin ( 8 %), heparan sulfate proteoglycans and growth factors ( BD Biosciences ).	Engelbreth – Holm – Swarm mouse sarcoma,47,86,Disease/Disorder	laminin,104,111,Gene/Protein	collagen IV,121,132,Gene/Protein	enactin,142,149,Gene/Protein	heparan sulfate proteoglycans,158,187,Gene/Protein	"[{""token"": ""Engelbreth \u2013 Holm \u2013 Swarm mouse sarcoma"", ""start_span"": 47, ""end_span"": 86, ""type"": ""Disease/Disorder""}, {""token"": ""laminin"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""collagen IV"", ""start_span"": 121, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""enactin"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""heparan sulfate proteoglycans"", ""start_span"": 158, ""end_span"": 187, ""type"": ""Gene/Protein""}]"	train
CD mice were treated with phenylhydrazine 2 days prior to infection by i. p. inoculation with P. berghei ( clone 259cl2 expressing green fluorescent protein ( Franke - Fayard et al ., 2004 )) obtained from a donor mouse between the second and sixth passage from cryopreserved stock.	mice,3,7,Organism/Species	phenylhydrazine,26,41,Chemical/Drug	infection,58,67,Disease/Disorder	green fluorescent protein,131,156,Gene/Protein	mouse,214,219,Organism/Species	"[{""token"": ""mice"", ""start_span"": 3, ""end_span"": 7, ""type"": ""Organism/Species""}, {""token"": ""phenylhydrazine"", ""start_span"": 26, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""infection"", ""start_span"": 58, ""end_span"": 67, ""type"": ""Disease/Disorder""}, {""token"": ""green fluorescent protein"", ""start_span"": 131, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 214, ""end_span"": 219, ""type"": ""Organism/Species""}]"	train
Drosophila melanogaster S2 cells were maintained in T25 culture flasks ( Griener Bio - One) at 27 ° C in supplemented Schneider ’ s insect cell culture medium ( ICM) with 10% heat - inactivated insect cell culture tested FBS, penicillin ( 50 U / ml) and streptomycin ( 50 μg / ml ).	Drosophila melanogaster,0,23,Organism/Species	insect,132,138,Organism/Species	insect,194,200,Organism/Species	penicillin,226,236,Chemical/Drug	streptomycin,254,266,Chemical/Drug	"[{""token"": ""Drosophila melanogaster"", ""start_span"": 0, ""end_span"": 23, ""type"": ""Organism/Species""}, {""token"": ""insect"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Organism/Species""}, {""token"": ""insect"", ""start_span"": 194, ""end_span"": 200, ""type"": ""Organism/Species""}, {""token"": ""penicillin"", ""start_span"": 226, ""end_span"": 236, ""type"": ""Chemical/Drug""}, {""token"": ""streptomycin"", ""start_span"": 254, ""end_span"": 266, ""type"": ""Chemical/Drug""}]"	train
For visualisation of nuclear material, ookinetes were fixed for 10 min in 1: 1 ice cold acetone: methanol, washed and then incubated with anti - P28 monoclonal antibody for 1 h at room temperature before further washing and incubation with an anti - mouse IgG antibody diluted 1: 200 for 1 h.	P28,145,148,Gene/Protein	antibody,160,168,Gene/Protein	mouse,250,255,Organism/Species	IgG,256,259,Gene/Protein	antibody,260,268,Gene/Protein	"[{""token"": ""P28"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 160, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 250, ""end_span"": 255, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 256, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 260, ""end_span"": 268, ""type"": ""Gene/Protein""}]"	train
In contrast to the majority of parasites that infect mosquitoes, both Hepatozoon caiman ( Lainson et al ., 2003) and Plasmodium spp. develop underneath the BL on the midgut of their respective vectors, namely Culex fatigans and Anopheles spp ., and do not enter the haemocoel immediately after exiting the gut lumen.	mosquitoes,53,63,Organism/Species	Hepatozoon caiman,70,87,Organism/Species	Plasmodium spp,117,131,Organism/Species	Culex fatigans,209,223,Organism/Species	Anopheles spp,228,241,Organism/Species	"[{""token"": ""mosquitoes"", ""start_span"": 53, ""end_span"": 63, ""type"": ""Organism/Species""}, {""token"": ""Hepatozoon caiman"", ""start_span"": 70, ""end_span"": 87, ""type"": ""Organism/Species""}, {""token"": ""Plasmodium spp"", ""start_span"": 117, ""end_span"": 131, ""type"": ""Organism/Species""}, {""token"": ""Culex fatigans"", ""start_span"": 209, ""end_span"": 223, ""type"": ""Organism/Species""}, {""token"": ""Anopheles spp"", ""start_span"": 228, ""end_span"": 241, ""type"": ""Organism/Species""}]"	train
Within the Clostridiaceae, sequences belonging to the genera Clostridium and Sedimentibacter dominated ( Fig. S2 ). Clostridium was detected in all sampling points ( 0. 7 – 4. 4 %). Sedimentibacter was absent in R52SS but detected in the other samples, with a slightly higher level in digesters receiving straw ( 3. 0 – 6. 9 %).	Clostridiaceae,11,25,Organism/Species	Clostridium,61,72,Organism/Species	Sedimentibacter,77,92,Organism/Species	Clostridium,116,127,Organism/Species	Sedimentibacter,182,197,Organism/Species	"[{""token"": ""Clostridiaceae"", ""start_span"": 11, ""end_span"": 25, ""type"": ""Organism/Species""}, {""token"": ""Clostridium"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Organism/Species""}, {""token"": ""Sedimentibacter"", ""start_span"": 77, ""end_span"": 92, ""type"": ""Organism/Species""}, {""token"": ""Clostridium"", ""start_span"": 116, ""end_span"": 127, ""type"": ""Organism/Species""}, {""token"": ""Sedimentibacter"", ""start_span"": 182, ""end_span"": 197, ""type"": ""Organism/Species""}]"	train
Moreover, a sharp increase in the relative abundance of hydrogenotrophic methanogens Methanobacterium, Methanoculleus and Methanothermobacter has been observed in biogas digesters co - digesting cattle excreta and olive mill wastes during a temperature shift from 37 ° C to 55 ° C, likely induced by an increase in H2 partial pressure ( Goberna et al ., 2010 ).	hydrogenotrophic methanogens,56,84,Organism/Species	Methanobacterium,85,101,Organism/Species	Methanoculleus,103,117,Organism/Species	Methanothermobacter,122,141,Organism/Species	cattle,195,201,Organism/Species	"[{""token"": ""hydrogenotrophic methanogens"", ""start_span"": 56, ""end_span"": 84, ""type"": ""Organism/Species""}, {""token"": ""Methanobacterium"", ""start_span"": 85, ""end_span"": 101, ""type"": ""Organism/Species""}, {""token"": ""Methanoculleus"", ""start_span"": 103, ""end_span"": 117, ""type"": ""Organism/Species""}, {""token"": ""Methanothermobacter"", ""start_span"": 122, ""end_span"": 141, ""type"": ""Organism/Species""}, {""token"": ""cattle"", ""start_span"": 195, ""end_span"": 201, ""type"": ""Organism/Species""}]"	train
Multivariable logistic regression showed that the likelihood of acquiring T. gondii infection was significantly higher in camels in the Ilala pastoral association [ PA] ( 82. 26 %) ( Adjusted Odds ratio [ aOR] = 10. 8; P < 0. 001) than camels in the Galcha PA ( 31. 43 %), in camels of ≥ 8 years old ( 56. 52 %; aOR = 1. 88; P = 0, 033) than camels of ≤ 4 years old ( 34. 26 %) and in areas where domestic cats are present ( aOR = 4. 16; P = 0. 006 ).	camels,122,128,Organism/Species	camels,236,242,Organism/Species	camels,276,282,Organism/Species	camels,342,348,Organism/Species	cats,406,410,Organism/Species	"[{""token"": ""camels"", ""start_span"": 122, ""end_span"": 128, ""type"": ""Organism/Species""}, {""token"": ""camels"", ""start_span"": 236, ""end_span"": 242, ""type"": ""Organism/Species""}, {""token"": ""camels"", ""start_span"": 276, ""end_span"": 282, ""type"": ""Organism/Species""}, {""token"": ""camels"", ""start_span"": 342, ""end_span"": 348, ""type"": ""Organism/Species""}, {""token"": ""cats"", ""start_span"": 406, ""end_span"": 410, ""type"": ""Organism/Species""}]"	train
Isolation of viable parasites from edible tissues of camels and the very poor knowledge of pastoralists about toxoplasmosis suggest the need for prevention of toxoplasmosis through bio - security measures, education and further investigation to unravel the impact of camel toxoplasmosis deserves consideration.	camels,53,59,Organism/Species	toxoplasmosis,110,123,Disease/Disorder	toxoplasmosis,159,172,Disease/Disorder	camel,267,272,Organism/Species	toxoplasmosis,273,286,Disease/Disorder	"[{""token"": ""camels"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Organism/Species""}, {""token"": ""toxoplasmosis"", ""start_span"": 110, ""end_span"": 123, ""type"": ""Disease/Disorder""}, {""token"": ""toxoplasmosis"", ""start_span"": 159, ""end_span"": 172, ""type"": ""Disease/Disorder""}, {""token"": ""camel"", ""start_span"": 267, ""end_span"": 272, ""type"": ""Organism/Species""}, {""token"": ""toxoplasmosis"", ""start_span"": 273, ""end_span"": 286, ""type"": ""Disease/Disorder""}]"	train
Studies done in different parts of Ethiopia over the last 24 years indicated high seroprevalence of T. gondii infection in sheep [ 21 - 23 ], goats [ 21, 22, 24, 25 ], cattle [ 21 ], chicken [ 26] and cats [ 27 ].	sheep,123,128,Organism/Species	goats,142,147,Organism/Species	cattle,168,174,Organism/Species	chicken,183,190,Organism/Species	cats,201,205,Organism/Species	"[{""token"": ""sheep"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Organism/Species""}, {""token"": ""goats"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Organism/Species""}, {""token"": ""cattle"", ""start_span"": 168, ""end_span"": 174, ""type"": ""Organism/Species""}, {""token"": ""chicken"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Organism/Species""}, {""token"": ""cats"", ""start_span"": 201, ""end_span"": 205, ""type"": ""Organism/Species""}]"	train
It has also been reported that the success of isolation of T. gondii cysts as well as the number of tissue cysts produced vary considerably with the intermediate hosts, being higher in sheep, goats and pigs [ 49, 57 ].	cysts,69,74,Disease/Disorder	cysts,107,112,Disease/Disorder	sheep,185,190,Organism/Species	goats,192,197,Organism/Species	pigs,202,206,Organism/Species	"[{""token"": ""cysts"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Disease/Disorder""}, {""token"": ""cysts"", ""start_span"": 107, ""end_span"": 112, ""type"": ""Disease/Disorder""}, {""token"": ""sheep"", ""start_span"": 185, ""end_span"": 190, ""type"": ""Organism/Species""}, {""token"": ""goats"", ""start_span"": 192, ""end_span"": 197, ""type"": ""Organism/Species""}, {""token"": ""pigs"", ""start_span"": 202, ""end_span"": 206, ""type"": ""Organism/Species""}]"	train
The P30 ELISA test we used in the current study employs non - species specific conjugate and was recommended by the manufacturer to detect anti - T. gondii antibodies in ruminant, cat or pig sera, plasma or meat juice.	P30,4,7,Gene/Protein	antibodies,156,166,Gene/Protein	ruminant,170,178,Organism/Species	cat,180,183,Organism/Species	pig,187,190,Organism/Species	"[{""token"": ""P30"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 156, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""ruminant"", ""start_span"": 170, ""end_span"": 178, ""type"": ""Organism/Species""}, {""token"": ""cat"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Organism/Species""}, {""token"": ""pig"", ""start_span"": 187, ""end_span"": 190, ""type"": ""Organism/Species""}]"	train
Moreover, the absence of precautions in handling aborted materials and poor knowledge of pastoralists about toxoplasmosis and the role of cats in the transmission of the disease are additional suggestive evidences for the spread of toxoplasmosis to humans and among camels in the study district.	toxoplasmosis,108,121,Disease/Disorder	cats,138,142,Organism/Species	toxoplasmosis,232,245,Disease/Disorder	humans,249,255,Organism/Species	camels,266,272,Organism/Species	"[{""token"": ""toxoplasmosis"", ""start_span"": 108, ""end_span"": 121, ""type"": ""Disease/Disorder""}, {""token"": ""cats"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Organism/Species""}, {""token"": ""toxoplasmosis"", ""start_span"": 232, ""end_span"": 245, ""type"": ""Disease/Disorder""}, {""token"": ""humans"", ""start_span"": 249, ""end_span"": 255, ""type"": ""Organism/Species""}, {""token"": ""camels"", ""start_span"": 266, ""end_span"": 272, ""type"": ""Organism/Species""}]"	train
Since all four commonly recognized human malaria species are present in the southwest Pacific [ 15 ], and our molecular techniques specifically targeted template DNA from P. falciparum, it is likely that the rates of malaria infections in these archival samples were higher than reported here, especially in the PNG highlands, where unstable malaria transmission has historically favored the predominance of P. vivax [ 18 ], [ 19 ].	human,35,40,Organism/Species	malaria,41,48,Disease/Disorder	malaria,217,224,Disease/Disorder	infections,225,235,Disease/Disorder	malaria,342,349,Disease/Disorder	"[{""token"": ""human"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Organism/Species""}, {""token"": ""malaria"", ""start_span"": 41, ""end_span"": 48, ""type"": ""Disease/Disorder""}, {""token"": ""malaria"", ""start_span"": 217, ""end_span"": 224, ""type"": ""Disease/Disorder""}, {""token"": ""infections"", ""start_span"": 225, ""end_span"": 235, ""type"": ""Disease/Disorder""}, {""token"": ""malaria"", ""start_span"": 342, ""end_span"": 349, ""type"": ""Disease/Disorder""}]"	train
To test the hypothesis, double staining of GFP and von Willebrand factor ( vWF) was performed to determine whether the injected GFP + C2C12 cells are localized with vWF + blood vessels for improved cell survival.	GFP,43,46,Gene/Protein	von Willebrand factor,51,72,Gene/Protein	vWF,75,78,Gene/Protein	GFP,128,131,Gene/Protein	vWF,165,168,Gene/Protein	"[{""token"": ""GFP"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene/Protein""}, {""token"": ""von Willebrand factor"", ""start_span"": 51, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""vWF"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""vWF"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
To examine the vascularization and neuronal ingrowth by the injected hMPCs, vWF / α - SMA and NF / AChR / MHC immunostaining were performed, and double - and triple - positive staining was visualized, respectively.	vWF,76,79,Gene/Protein	α - SMA,82,89,Gene/Protein	NF,94,96,Gene/Protein	AChR,99,103,Gene/Protein	MHC,106,109,Gene/Protein	"[{""token"": ""vWF"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""\u03b1 - SMA"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""NF"", ""start_span"": 94, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""AChR"", ""start_span"": 99, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""MHC"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene/Protein""}]"	train
To form the fibrin gel, 40 mg ml − 1 of fibrinogen solution and 40 U ml − 1 of thrombin solution ( Sigma, St. Louis, MO) were prepared by dissolving fibrinogen from bovine plasma ( Sigma) in 0. 9% sodium chloride saline solution, and bovine thrombin ( Sigma) in 25 mM CaCl2 in saline solution, respectively.	fibrin,12,18,Gene/Protein	fibrinogen,40,50,Gene/Protein	thrombin,79,87,Gene/Protein	fibrinogen,149,159,Gene/Protein	thrombin,241,249,Gene/Protein	"[{""token"": ""fibrin"", ""start_span"": 12, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""fibrinogen"", ""start_span"": 40, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""thrombin"", ""start_span"": 79, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""fibrinogen"", ""start_span"": 149, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""thrombin"", ""start_span"": 241, ""end_span"": 249, ""type"": ""Gene/Protein""}]"	train
Muscle differentiation was examined by immunostaining for mouse anti - MHC ( MF20; 1: 30 dilution; Developmental Studies Hybridoma Bank, Iowa City, IA) or mouse or rabbit anti - Myogenin ( ab1835; 1: 100 dilution, ab124800; 1: 200 Abcam ).	mouse,58,63,Organism/Species	MHC,71,74,Gene/Protein	mouse,155,160,Organism/Species	rabbit,164,170,Organism/Species	Myogenin,178,186,Gene/Protein	"[{""token"": ""mouse"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Organism/Species""}, {""token"": ""MHC"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 155, ""end_span"": 160, ""type"": ""Organism/Species""}, {""token"": ""rabbit"", ""start_span"": 164, ""end_span"": 170, ""type"": ""Organism/Species""}, {""token"": ""Myogenin"", ""start_span"": 178, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
For vascular integration, the tissue sections were stained with rabbit anti - vWF ( A0082; 1: 400 dilution; DAKO) and mouse anti - α - SMA ( sc - 32251; 1: 50 dilution; Santa Cruz ).	rabbit,64,70,Organism/Species	vWF,78,81,Gene/Protein	mouse,118,123,Organism/Species	α - SMA,131,138,Gene/Protein	sc - 32251,141,151,Chemical/Drug	"[{""token"": ""rabbit"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Organism/Species""}, {""token"": ""vWF"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 118, ""end_span"": 123, ""type"": ""Organism/Species""}, {""token"": ""\u03b1 - SMA"", ""start_span"": 131, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""sc - 32251"", ""start_span"": 141, ""end_span"": 151, ""type"": ""Chemical/Drug""}]"	train
To identify whether the infused cells contributed to formation of muscle fibers in vivo, GFP / MHC and HLA / MHC staining was performed on the GFP + - C2C12 - and hMPC - injected TA muscles, respectively.	GFP,89,92,Gene/Protein	MHC,95,98,Gene/Protein	HLA,103,106,Gene/Protein	MHC,109,112,Gene/Protein	GFP,143,146,Gene/Protein	"[{""token"": ""GFP"", ""start_span"": 89, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""MHC"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""HLA"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""MHC"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 143, ""end_span"": 146, ""type"": ""Gene/Protein""}]"	train
Methyl CpG binding protein 2 ( MeCP2) was first identified and characterized as a DNA binding protein that specifically binds to methyl - CpG dinucleotides [ 1 ].	Methyl CpG binding protein 2,0,28,Gene/Protein	MeCP2,31,36,Gene/Protein	as,39,41,Disease/Disorder	DNA binding protein,82,101,Gene/Protein	methyl - CpG dinucleotides,129,155,Chemical/Drug	"[{""token"": ""Methyl CpG binding protein 2"", ""start_span"": 0, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""MeCP2"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""as"", ""start_span"": 39, ""end_span"": 41, ""type"": ""Disease/Disorder""}, {""token"": ""DNA binding protein"", ""start_span"": 82, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""methyl - CpG dinucleotides"", ""start_span"": 129, ""end_span"": 155, ""type"": ""Chemical/Drug""}]"	train
In approximately 90% of RTT cases, the disease is due to MECP2 gene mutations [ 61 ]. MECP2 mutations that cause classical RTT in females typically result in neonatal encephalopathy and death in the first year of life in males.	RTT,24,27,Disease/Disorder	MECP2,57,62,Gene/Protein	MECP2,86,91,Gene/Protein	RTT,123,126,Disease/Disorder	neonatal encephalopathy,158,181,Disease/Disorder	"[{""token"": ""RTT"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Disease/Disorder""}, {""token"": ""MECP2"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""MECP2"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""RTT"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Disease/Disorder""}, {""token"": ""neonatal encephalopathy"", ""start_span"": 158, ""end_span"": 181, ""type"": ""Disease/Disorder""}]"	train
MECP2 duplication syndrome was predicted by the observation that mice engineered to overexpress MECP2 develop a progressive neurological disorder including stereotyped and repetitive movements, epilepsy, spasticity, hypoactivity, and early death [ 81, 82 ].	MECP2,0,5,Gene/Protein	mice,65,69,Organism/Species	MECP2,96,101,Gene/Protein	neurological disorder,124,145,Disease/Disorder	epilepsy,194,202,Disease/Disorder	"[{""token"": ""MECP2"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Organism/Species""}, {""token"": ""MECP2"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""neurological disorder"", ""start_span"": 124, ""end_span"": 145, ""type"": ""Disease/Disorder""}, {""token"": ""epilepsy"", ""start_span"": 194, ""end_span"": 202, ""type"": ""Disease/Disorder""}]"	train
Prenatal exposure to alcohol is associated with adverse effects on neurodevelopment, and results in a set of severe neurodevelopmental disorders known as fetal alcohol spectrum disorders ( FASD) [ 107, 108 ].	alcohol,21,28,Chemical/Drug	neurodevelopmental disorders,116,144,Disease/Disorder	as,151,153,Disease/Disorder	fetal alcohol spectrum disorders,154,186,Disease/Disorder	FASD,189,193,Disease/Disorder	"[{""token"": ""alcohol"", ""start_span"": 21, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""neurodevelopmental disorders"", ""start_span"": 116, ""end_span"": 144, ""type"": ""Disease/Disorder""}, {""token"": ""as"", ""start_span"": 151, ""end_span"": 153, ""type"": ""Disease/Disorder""}, {""token"": ""fetal alcohol spectrum disorders"", ""start_span"": 154, ""end_span"": 186, ""type"": ""Disease/Disorder""}, {""token"": ""FASD"", ""start_span"": 189, ""end_span"": 193, ""type"": ""Disease/Disorder""}]"	train
The incidence of FASD is estimated to be as high as 1 in 100 births and this disorder commonly manifests as cognitive and intellectual disabilities [ 108 ].	FASD,17,21,Disease/Disorder	as,41,43,Disease/Disorder	as,49,51,Disease/Disorder	as,105,107,Disease/Disorder	intellectual disabilities,122,147,Disease/Disorder	"[{""token"": ""FASD"", ""start_span"": 17, ""end_span"": 21, ""type"": ""Disease/Disorder""}, {""token"": ""as"", ""start_span"": 41, ""end_span"": 43, ""type"": ""Disease/Disorder""}, {""token"": ""as"", ""start_span"": 49, ""end_span"": 51, ""type"": ""Disease/Disorder""}, {""token"": ""as"", ""start_span"": 105, ""end_span"": 107, ""type"": ""Disease/Disorder""}, {""token"": ""intellectual disabilities"", ""start_span"": 122, ""end_span"": 147, ""type"": ""Disease/Disorder""}]"	train
MeCP2 has been also shown to modulate the alcohol intake and sensitivity to alcohol, demonstrating the role of MeCP2 in alcoholism [ 113 ].	MeCP2,0,5,Gene/Protein	alcohol,42,49,Chemical/Drug	alcohol,76,83,Chemical/Drug	MeCP2,111,116,Gene/Protein	alcoholism,120,130,Disease/Disorder	"[{""token"": ""MeCP2"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""alcohol"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""alcohol"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Chemical/Drug""}, {""token"": ""MeCP2"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""alcoholism"", ""start_span"": 120, ""end_span"": 130, ""type"": ""Disease/Disorder""}]"	train
Huntington ’ s disease ( HD) is a progressive neurodegenerative disorder that affects muscle coordination and results in cognitive decline and psychiatric disorders [ 114, 115 ].	Huntington ’ s disease,0,22,Disease/Disorder	HD,25,27,Disease/Disorder	neurodegenerative disorder,46,72,Disease/Disorder	cognitive decline,121,138,Disease/Disorder	psychiatric disorders,143,164,Disease/Disorder	"[{""token"": ""Huntington \u2019 s disease"", ""start_span"": 0, ""end_span"": 22, ""type"": ""Disease/Disorder""}, {""token"": ""HD"", ""start_span"": 25, ""end_span"": 27, ""type"": ""Disease/Disorder""}, {""token"": ""neurodegenerative disorder"", ""start_span"": 46, ""end_span"": 72, ""type"": ""Disease/Disorder""}, {""token"": ""cognitive decline"", ""start_span"": 121, ""end_span"": 138, ""type"": ""Disease/Disorder""}, {""token"": ""psychiatric disorders"", ""start_span"": 143, ""end_span"": 164, ""type"": ""Disease/Disorder""}]"	train
Aberrant interactions between Htt and MeCP2 is suggested to contribute to aberrant transcription in Huntington ’ s disease by regulating brain - derived neurotrophic factor ( BDNF) levels [ 117 ].	Htt,30,33,Gene/Protein	MeCP2,38,43,Gene/Protein	Huntington ’ s disease,100,122,Disease/Disorder	brain - derived neurotrophic factor,137,172,Gene/Protein	BDNF,175,179,Gene/Protein	"[{""token"": ""Htt"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""MeCP2"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""Huntington \u2019 s disease"", ""start_span"": 100, ""end_span"": 122, ""type"": ""Disease/Disorder""}, {""token"": ""brain - derived neurotrophic factor"", ""start_span"": 137, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""BDNF"", ""start_span"": 175, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
Apart from to its role in neurological disorders, MeCP2 has also been shown to play a role in many cancers such as breast, colorectal, lung, liver, and prostate cancer [ 118 – 123 ].	neurological disorders,26,48,Disease/Disorder	MeCP2,50,55,Gene/Protein	cancers,99,106,Disease/Disorder	as,112,114,Disease/Disorder	prostate cancer,152,167,Disease/Disorder	"[{""token"": ""neurological disorders"", ""start_span"": 26, ""end_span"": 48, ""type"": ""Disease/Disorder""}, {""token"": ""MeCP2"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""cancers"", ""start_span"": 99, ""end_span"": 106, ""type"": ""Disease/Disorder""}, {""token"": ""as"", ""start_span"": 112, ""end_span"": 114, ""type"": ""Disease/Disorder""}, {""token"": ""prostate cancer"", ""start_span"": 152, ""end_span"": 167, ""type"": ""Disease/Disorder""}]"	train
A recent study implicating MeCP2 in the pathogenesis of HSCR suggests that aberrant reduced levels of MeCP2 may play an important role in suppressing the proliferative ability of cells in patients with Hirschsprung ’ s disease [ 147 ]. Table 1 represents a list of MeCP2 - associated diseases and the genders that are mostly affected.	MeCP2,27,32,Gene/Protein	HSCR,56,60,Disease/Disorder	MeCP2,102,107,Gene/Protein	Hirschsprung ’ s disease,202,226,Disease/Disorder	MeCP2,265,270,Gene/Protein	"[{""token"": ""MeCP2"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""HSCR"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Disease/Disorder""}, {""token"": ""MeCP2"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Gene/Protein""}, {""token"": ""Hirschsprung \u2019 s disease"", ""start_span"": 202, ""end_span"": 226, ""type"": ""Disease/Disorder""}, {""token"": ""MeCP2"", ""start_span"": 265, ""end_span"": 270, ""type"": ""Gene/Protein""}]"	train
These include mostly rodent models ( particularly mouse models) as well as zebrafish and Drosophila models.	mouse,50,55,Organism/Species	as,64,66,Disease/Disorder	as,72,74,Disease/Disorder	zebrafish,75,84,Organism/Species	Drosophila,89,99,Organism/Species	"[{""token"": ""mouse"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Organism/Species""}, {""token"": ""as"", ""start_span"": 64, ""end_span"": 66, ""type"": ""Disease/Disorder""}, {""token"": ""as"", ""start_span"": 72, ""end_span"": 74, ""type"": ""Disease/Disorder""}, {""token"": ""zebrafish"", ""start_span"": 75, ""end_span"": 84, ""type"": ""Organism/Species""}, {""token"": ""Drosophila"", ""start_span"": 89, ""end_span"": 99, ""type"": ""Organism/Species""}]"	train
The reactivation of Mecp2 in the brains of Mecp2 null mice rescued many RTT - phenotypes seen in the null mice, including delayed disease progression, increased life span, deceased mortality, and restored neurological functions [ 153, 154 ].	Mecp2,20,25,Gene/Protein	Mecp2,43,48,Gene/Protein	mice,54,58,Organism/Species	RTT,72,75,Disease/Disorder	mice,106,110,Organism/Species	"[{""token"": ""Mecp2"", ""start_span"": 20, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""Mecp2"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Organism/Species""}, {""token"": ""RTT"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Disease/Disorder""}, {""token"": ""mice"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Organism/Species""}]"	train
Mecp2 mutant mice differ from the above - mentioned knockout mice as they express a truncated / mutant MeCP2 protein.	Mecp2,0,5,Gene/Protein	mice,13,17,Organism/Species	mice,61,65,Organism/Species	as,66,68,Disease/Disorder	MeCP2,103,108,Gene/Protein	"[{""token"": ""Mecp2"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Organism/Species""}, {""token"": ""as"", ""start_span"": 66, ""end_span"": 68, ""type"": ""Disease/Disorder""}, {""token"": ""MeCP2"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Gene/Protein""}]"	train
Loss of Mecp2 from cultured neuronal cell populations obtained from embryonic or postnatal Mecp2 - deficient mice indicate biochemical and morphological abnormalities similar to Mecp2 null animals [ 49, 159, 169 ].	Mecp2,8,13,Gene/Protein	Mecp2,91,96,Gene/Protein	mice,109,113,Organism/Species	Mecp2,178,183,Gene/Protein	animals,189,196,Organism/Species	"[{""token"": ""Mecp2"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""Mecp2"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Organism/Species""}, {""token"": ""Mecp2"", ""start_span"": 178, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""animals"", ""start_span"": 189, ""end_span"": 196, ""type"": ""Organism/Species""}]"	train
Moreover, other studies have revealed putative roles of MeCP2 in astrocytes and microglia despite the low levels of MeCP2 in these cell types. Mecp2 - deficient astrocytes and microglia have been demonstrated to produce aberrant levels of soluble factors, such as glutamate, which inhibit dendrite branching from co - cultured neurons in vitro [ 47, 48, 170 ].	MeCP2,56,61,Gene/Protein	MeCP2,116,121,Gene/Protein	Mecp2,143,148,Gene/Protein	as,161,163,Disease/Disorder	glutamate,264,273,Chemical/Drug	"[{""token"": ""MeCP2"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""MeCP2"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""Mecp2"", ""start_span"": 143, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""as"", ""start_span"": 161, ""end_span"": 163, ""type"": ""Disease/Disorder""}, {""token"": ""glutamate"", ""start_span"": 264, ""end_span"": 273, ""type"": ""Chemical/Drug""}]"	train
Of 734 index patients, 83 ( 11 %) were diagnosed with LS; 23 MLH1, 17 MSH2, 31 MSH6 and 12 PMS2 mutation carriers.	LS,54,56,Disease/Disorder	MLH1,61,65,Gene/Protein	MSH2,70,74,Gene/Protein	MSH6,79,83,Gene/Protein	PMS2,91,95,Gene/Protein	"[{""token"": ""LS"", ""start_span"": 54, ""end_span"": 56, ""type"": ""Disease/Disorder""}, {""token"": ""MLH1"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""MSH2"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""MSH6"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""PMS2"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene/Protein""}]"	train
Lynch syndrome ( LS) is a hereditary predisposition to colorectal cancer, endometrial cancer and other extra - colonic cancers at a young age [ 1, 2 ].	Lynch syndrome,0,14,Disease/Disorder	LS,17,19,Disease/Disorder	colorectal cancer,55,72,Disease/Disorder	endometrial cancer,74,92,Disease/Disorder	colonic cancers,111,126,Disease/Disorder	"[{""token"": ""Lynch syndrome"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Disease/Disorder""}, {""token"": ""LS"", ""start_span"": 17, ""end_span"": 19, ""type"": ""Disease/Disorder""}, {""token"": ""colorectal cancer"", ""start_span"": 55, ""end_span"": 72, ""type"": ""Disease/Disorder""}, {""token"": ""endometrial cancer"", ""start_span"": 74, ""end_span"": 92, ""type"": ""Disease/Disorder""}, {""token"": ""colonic cancers"", ""start_span"": 111, ""end_span"": 126, ""type"": ""Disease/Disorder""}]"	train
In a retrospective, clinic - based cohort we assessed the performance of MMRpredict and PREMM5 in predicting LS mutations in general and for MLH1, MSH2, MSH6 and PMS2 mutations specifically.	LS,109,111,Disease/Disorder	MLH1,141,145,Gene/Protein	MSH2,147,151,Gene/Protein	MSH6,153,157,Gene/Protein	PMS2,162,166,Gene/Protein	"[{""token"": ""LS"", ""start_span"": 109, ""end_span"": 111, ""type"": ""Disease/Disorder""}, {""token"": ""MLH1"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""MSH2"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""MSH6"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""PMS2"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Gene/Protein""}]"	train
The PREMM5 model contains four linear predictors, each contributing weights to the probability of carrying a mutation in MLH1, MSH2 ( or TACSTD1 ), MSH6 and PMS2.	MLH1,121,125,Gene/Protein	MSH2,127,131,Gene/Protein	TACSTD1,137,144,Gene/Protein	MSH6,148,152,Gene/Protein	PMS2,157,161,Gene/Protein	"[{""token"": ""MLH1"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""MSH2"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""TACSTD1"", ""start_span"": 137, ""end_span"": 144, ""type"": ""Gene/Protein""}, {""token"": ""MSH6"", ""start_span"": 148, ""end_span"": 152, ""type"": ""Gene/Protein""}, {""token"": ""PMS2"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	train
Of the 734 index patients, 83 ( 11 %) were diagnosed with a LS mutation; 23 MLH1, 17 MSH2, 31 MSH6 and 12 PMS2 mutation carriers.	LS,60,62,Disease/Disorder	MLH1,76,80,Gene/Protein	MSH2,85,89,Gene/Protein	MSH6,94,98,Gene/Protein	PMS2,106,110,Gene/Protein	"[{""token"": ""LS"", ""start_span"": 60, ""end_span"": 62, ""type"": ""Disease/Disorder""}, {""token"": ""MLH1"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""MSH2"", ""start_span"": 85, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""MSH6"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""PMS2"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene/Protein""}]"	train
Both PREMM5 and MMRpredict were far more accurate for MLH1 and MSH2 mutation carriers than for LS patients carrying a mutation in MSH6 or PMS2.	MLH1,54,58,Gene/Protein	MSH2,63,67,Gene/Protein	LS,95,97,Disease/Disorder	MSH6,130,134,Gene/Protein	PMS2,138,142,Gene/Protein	"[{""token"": ""MLH1"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""MSH2"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""LS"", ""start_span"": 95, ""end_span"": 97, ""type"": ""Disease/Disorder""}, {""token"": ""MSH6"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""PMS2"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene/Protein""}]"	train
Among the 88 differentially expressed transcription factor ( TF) genes, five showed a high degree of conservation ( 77. 7 – 88. 0% amino acid identity) of their conserved domains with genes associated with carpel fusion deficiency in Arabidopsis thaliana, suggesting that these five genes might control carpel fusion in maize.	transcription factor,38,58,Gene/Protein	TF,61,63,Gene/Protein	amino acid,131,141,Chemical/Drug	Arabidopsis thaliana,234,254,Organism/Species	maize,320,325,Organism/Species	"[{""token"": ""transcription factor"", ""start_span"": 38, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""TF"", ""start_span"": 61, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""amino acid"", ""start_span"": 131, ""end_span"": 141, ""type"": ""Chemical/Drug""}, {""token"": ""Arabidopsis thaliana"", ""start_span"": 234, ""end_span"": 254, ""type"": ""Organism/Species""}, {""token"": ""maize"", ""start_span"": 320, ""end_span"": 325, ""type"": ""Organism/Species""}]"	train
Moreover, other hormones, including gibberellin ( GA) 23, cytokinin ( CK) 24, and brassinosteroids ( BRs) 25, have been implicated in Arabidopsis carpel development, but detailed knowledge of their activity and related patterns of gene expression associated with maize carpel fusion are limited.	gibberellin,36,47,Chemical/Drug	cytokinin,58,67,Chemical/Drug	brassinosteroids,82,98,Chemical/Drug	Arabidopsis,134,145,Organism/Species	maize,263,268,Organism/Species	"[{""token"": ""gibberellin"", ""start_span"": 36, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""cytokinin"", ""start_span"": 58, ""end_span"": 67, ""type"": ""Chemical/Drug""}, {""token"": ""brassinosteroids"", ""start_span"": 82, ""end_span"": 98, ""type"": ""Chemical/Drug""}, {""token"": ""Arabidopsis"", ""start_span"": 134, ""end_span"": 145, ""type"": ""Organism/Species""}, {""token"": ""maize"", ""start_span"": 263, ""end_span"": 268, ""type"": ""Organism/Species""}]"	train
One of these TFs, GRMZM2G094892, showed a predicted amino acid sequence similarity of 78. 12% in the HLH superfamily DNA binding domain with the HECATE1 protein, a known regulator of carpel development in Arabidopsis37.	TFs,13,16,Gene/Protein	GRMZM2G094892,18,31,Gene/Protein	amino acid,52,62,Chemical/Drug	HLH,101,104,Gene/Protein	HECATE1,145,152,Gene/Protein	"[{""token"": ""TFs"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""GRMZM2G094892"", ""start_span"": 18, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""amino acid"", ""start_span"": 52, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""HLH"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""HECATE1"", ""start_span"": 145, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
One C2H2 family member, GRMZM2G058868, a homolog of Arabidopsis ZFP10, showed 88% similarity to the SUPERMAN protein in the single zinc finger domain.	C2H2,4,8,Gene/Protein	GRMZM2G058868,24,37,Gene/Protein	Arabidopsis,52,63,Organism/Species	ZFP10,64,69,Gene/Protein	SUPERMAN,100,108,Gene/Protein	"[{""token"": ""C2H2"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Gene/Protein""}, {""token"": ""GRMZM2G058868"", ""start_span"": 24, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""Arabidopsis"", ""start_span"": 52, ""end_span"": 63, ""type"": ""Organism/Species""}, {""token"": ""ZFP10"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""SUPERMAN"", ""start_span"": 100, ""end_span"": 108, ""type"": ""Gene/Protein""}]"	train
For instance, five members of the NAC, bHLH, C2H2, and MYB TF families were found to accumulate preferentially in the ifc ovary.	NAC,34,37,Gene/Protein	bHLH,39,43,Gene/Protein	C2H2,45,49,Gene/Protein	MYB,55,58,Gene/Protein	TF,59,61,Gene/Protein	"[{""token"": ""NAC"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene/Protein""}, {""token"": ""bHLH"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""C2H2"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""MYB"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""TF"", ""start_span"": 59, ""end_span"": 61, ""type"": ""Gene/Protein""}]"	train
In sand lizards, increased number of mates correlated with increased egg - hatching success and survival of young [ 45 ], while, female blue tits ( Parus caeruleus) and tree swallows ( Tachycineta bicolor) increase the heterozygosity and thus the potential fitness and reproductive success of their offspring through additional extra - pair matings [ 46, 47 ].	sand lizards,3,15,Organism/Species	blue tits,136,145,Organism/Species	Parus caeruleus,148,163,Organism/Species	tree swallows,169,182,Organism/Species	Tachycineta bicolor,185,204,Organism/Species	"[{""token"": ""sand lizards"", ""start_span"": 3, ""end_span"": 15, ""type"": ""Organism/Species""}, {""token"": ""blue tits"", ""start_span"": 136, ""end_span"": 145, ""type"": ""Organism/Species""}, {""token"": ""Parus caeruleus"", ""start_span"": 148, ""end_span"": 163, ""type"": ""Organism/Species""}, {""token"": ""tree swallows"", ""start_span"": 169, ""end_span"": 182, ""type"": ""Organism/Species""}, {""token"": ""Tachycineta bicolor"", ""start_span"": 185, ""end_span"": 204, ""type"": ""Organism/Species""}]"	train
In addition to TLR3, dsRNA sensors include two cytoplasmic receptors, retinoic acid - inducible gene I ( RIG - I) and melanoma differentiation - associated gene 5 ( MDA5) [ 7 ].	TLR3,15,19,Gene/Protein	retinoic acid - inducible gene I,70,102,Gene/Protein	RIG - I,105,112,Gene/Protein	melanoma differentiation - associated gene 5,118,162,Gene/Protein	MDA5,165,169,Gene/Protein	"[{""token"": ""TLR3"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""retinoic acid - inducible gene I"", ""start_span"": 70, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""RIG - I"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""melanoma differentiation - associated gene 5"", ""start_span"": 118, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""MDA5"", ""start_span"": 165, ""end_span"": 169, ""type"": ""Gene/Protein""}]"	train
NFκB and IRF3 / 7 are the dominant nuclear factors involved in the control of the expression of inflammatory cytokines and chemokines and Type I IFN, respectively, upon activation by dsRNA [ 8 ].	NFκB,0,4,Gene/Protein	IRF3,9,13,Gene/Protein	cytokines,109,118,Gene/Protein	chemokines,123,133,Gene/Protein	Type I IFN,138,148,Gene/Protein	"[{""token"": ""NF\u03baB"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""IRF3"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""chemokines"", ""start_span"": 123, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""Type I IFN"", ""start_span"": 138, ""end_span"": 148, ""type"": ""Gene/Protein""}]"	train
Transgenic mice that express HLA - DQ8 in an endogenous MHC class II - deficient background were backcrossed to NOD mice for 10 generations and intercrossed to produce congenic NOD AB ° DQ8 mice [ 16 ].	mice,11,15,Organism/Species	HLA,29,32,Gene/Protein	MHC class II,56,68,Gene/Protein	NOD mice,112,120,Organism/Species	NOD AB ° DQ8 mice,177,194,Organism/Species	"[{""token"": ""mice"", ""start_span"": 11, ""end_span"": 15, ""type"": ""Organism/Species""}, {""token"": ""HLA"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""MHC class II"", ""start_span"": 56, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""NOD mice"", ""start_span"": 112, ""end_span"": 120, ""type"": ""Organism/Species""}, {""token"": ""NOD AB \u00b0 DQ8 mice"", ""start_span"": 177, ""end_span"": 194, ""type"": ""Organism/Species""}]"	train
Real Time - PCR analysis of the IFNβ, CXCL10, TLR3, MDA5, and RIG - I mRNA expression at 3 and 12 h post - treatment with poly I: C ( black bar) or PBS ( white bar ).	IFNβ,32,36,Gene/Protein	CXCL10,38,44,Gene/Protein	TLR3,46,50,Gene/Protein	MDA5,52,56,Gene/Protein	RIG - I,62,69,Gene/Protein	"[{""token"": ""IFN\u03b2"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""CXCL10"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""TLR3"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""MDA5"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""RIG - I"", ""start_span"": 62, ""end_span"": 69, ""type"": ""Gene/Protein""}]"	train
However the percentage increase was higher in mice receiving gliadin gavages than in those on gluten - free chow ( mean value for each treatment: PBS - GFD: 0. 095 %, poly I: C - GFD: 0. 22 %, PBS - gliadin: 0, 17 %, poly I: C - Gliadin: 0, 56% Hot / h / cm2 ).	mice,46,50,Organism/Species	gliadin,61,68,Gene/Protein	gluten,94,100,Gene/Protein	gliadin,199,206,Gene/Protein	Gliadin,229,236,Gene/Protein	"[{""token"": ""mice"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Organism/Species""}, {""token"": ""gliadin"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""gluten"", ""start_span"": 94, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""gliadin"", ""start_span"": 199, ""end_span"": 206, ""type"": ""Gene/Protein""}, {""token"": ""Gliadin"", ""start_span"": 229, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
Stats: N = 4 - 5 mice per group, Two way ANOVA and Bonferroni post - test, * P < 0. 05, ** P < 0. 01 gliadin versus GFD mice; # P < 0. 05 poly I: C versus PBS in Gliadin - gavaged mice ( B ).	mice,17,21,Organism/Species	gliadin,101,108,Gene/Protein	mice,120,124,Organism/Species	Gliadin,162,169,Gene/Protein	mice,180,184,Organism/Species	"[{""token"": ""mice"", ""start_span"": 17, ""end_span"": 21, ""type"": ""Organism/Species""}, {""token"": ""gliadin"", ""start_span"": 101, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Organism/Species""}, {""token"": ""Gliadin"", ""start_span"": 162, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Organism/Species""}]"	train
During viral enteric infections, intermediates of replication, such as dsRNA, are produced in infected cells [ 6] and trigger a rapid inflammatory cascade, which involves the activation of TLR3 and RNA helicases such as RIG - I and MDA5 [ 7 ].	infections,21,31,Disease/Disorder	TLR3,189,193,Gene/Protein	RNA helicases,198,211,Gene/Protein	RIG - I,220,227,Gene/Protein	MDA5,232,236,Gene/Protein	"[{""token"": ""infections"", ""start_span"": 21, ""end_span"": 31, ""type"": ""Disease/Disorder""}, {""token"": ""TLR3"", ""start_span"": 189, ""end_span"": 193, ""type"": ""Gene/Protein""}, {""token"": ""RNA helicases"", ""start_span"": 198, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""RIG - I"", ""start_span"": 220, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""MDA5"", ""start_span"": 232, ""end_span"": 236, ""type"": ""Gene/Protein""}]"	train
A novel association of potential biological interest involved a SNP effect on insulin levels with variation in the CHN2 locus ( rs3793275, P = 5. 8 × 10 − 9 ), a beta - chimerin that has recently been described as part of a fusion gene also containing the insulin receptor that was shown to be responsible for severe insulin deficiency [ 15 ].	insulin,78,85,Gene/Protein	CHN2,115,119,Gene/Protein	beta - chimerin,162,177,Gene/Protein	insulin receptor,256,272,Gene/Protein	insulin,317,324,Gene/Protein	"[{""token"": ""insulin"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""CHN2"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""beta - chimerin"", ""start_span"": 162, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""insulin receptor"", ""start_span"": 256, ""end_span"": 272, ""type"": ""Gene/Protein""}, {""token"": ""insulin"", ""start_span"": 317, ""end_span"": 324, ""type"": ""Gene/Protein""}]"	train
Lead poisoning mainly caused brain and neurology defects, namely cognitive disorder, movement and coordination impairment, hearing and visual disturbance [ 5 ]. Recent studies have suggested Pb as an endocrine disrupting chemical.	Lead poisoning,0,14,Disease/Disorder	brain and neurology defects,29,56,Disease/Disorder	cognitive disorder,65,83,Disease/Disorder	movement and coordination impairment,85,121,Disease/Disorder	visual disturbance,135,153,Disease/Disorder	"[{""token"": ""Lead poisoning"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Disease/Disorder""}, {""token"": ""brain and neurology defects"", ""start_span"": 29, ""end_span"": 56, ""type"": ""Disease/Disorder""}, {""token"": ""cognitive disorder"", ""start_span"": 65, ""end_span"": 83, ""type"": ""Disease/Disorder""}, {""token"": ""movement and coordination impairment"", ""start_span"": 85, ""end_span"": 121, ""type"": ""Disease/Disorder""}, {""token"": ""visual disturbance"", ""start_span"": 135, ""end_span"": 153, ""type"": ""Disease/Disorder""}]"	train
PEPCK ( 1. 45 multiple) and G6pase ( 1. 18 multiple) related with gluconeogenesis were also hypermethylated, as well as cholesterol metabolism genes such as CYP51 and ACAT.	PEPCK,0,5,Gene/Protein	G6pase,28,34,Gene/Protein	cholesterol,120,131,Chemical/Drug	CYP51,157,162,Gene/Protein	ACAT,167,171,Gene/Protein	"[{""token"": ""PEPCK"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene/Protein""}, {""token"": ""G6pase"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""cholesterol"", ""start_span"": 120, ""end_span"": 131, ""type"": ""Chemical/Drug""}, {""token"": ""CYP51"", ""start_span"": 157, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""ACAT"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Gene/Protein""}]"	train
Developmental Pb exposure not only altered DNA methylation in both specific gene level and global genome level in brain of Alzheimer ’ s disease model [ 25 – 28 ], but also could affect the expression of DNA methyltransferase 1 ( DNMT1) and DNA methyltransferase 3a ( DNMT3a) in hippocampus [ 29 ].	Alzheimer ’ s disease,123,144,Disease/Disorder	DNA methyltransferase 1,204,227,Gene/Protein	DNMT1,230,235,Gene/Protein	DNA methyltransferase 3a,241,265,Gene/Protein	DNMT3a,268,274,Gene/Protein	"[{""token"": ""Alzheimer \u2019 s disease"", ""start_span"": 123, ""end_span"": 144, ""type"": ""Disease/Disorder""}, {""token"": ""DNA methyltransferase 1"", ""start_span"": 204, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""DNMT1"", ""start_span"": 230, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""DNA methyltransferase 3a"", ""start_span"": 241, ""end_span"": 265, ""type"": ""Gene/Protein""}, {""token"": ""DNMT3a"", ""start_span"": 268, ""end_span"": 274, ""type"": ""Gene/Protein""}]"	train
In addition, Pb exposure could enhance the mean DNA methylation level and epigenetic drift of several imprinted genes like IGF - 2, Igf2r, H19 in both cell model and animal tissues [ 30, 31 ], although others revealed that increased blood or patella lead levels were associated with hypomethylation of LINE - 1 in both cell model and population study [ 32, 33 ].	IGF - 2,123,130,Gene/Protein	Igf2r,132,137,Gene/Protein	H19,139,142,Gene/Protein	animal,166,172,Organism/Species	LINE - 1,302,310,Gene/Protein	"[{""token"": ""IGF - 2"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""Igf2r"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""H19"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""animal"", ""start_span"": 166, ""end_span"": 172, ""type"": ""Organism/Species""}, {""token"": ""LINE - 1"", ""start_span"": 302, ""end_span"": 310, ""type"": ""Gene/Protein""}]"	train
The hypermethylation of genes involved in fatty acid oxidation such as CPT - 2, MCAD, and ACO could result in reduced fatty acid oxidation rate and in turn elevated lipid synthesis in liver.	fatty acid,42,52,Chemical/Drug	CPT - 2,71,78,Gene/Protein	MCAD,80,84,Gene/Protein	ACO,90,93,Gene/Protein	fatty acid,118,128,Chemical/Drug	"[{""token"": ""fatty acid"", ""start_span"": 42, ""end_span"": 52, ""type"": ""Chemical/Drug""}, {""token"": ""CPT - 2"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""MCAD"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""ACO"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""fatty acid"", ""start_span"": 118, ""end_span"": 128, ""type"": ""Chemical/Drug""}]"	train
During its development the malaria parasite digests the major part of host RBC hemoglobin and polymerizes the undigested and prooxidant heme to HZ ( hemozoin, malaria pigment) in close contact with the membrane of the digestive vacuole of the parasite [ 47 ].	malaria,27,34,Disease/Disorder	hemoglobin,79,89,Gene/Protein	heme,136,140,Chemical/Drug	hemozoin,149,157,Chemical/Drug	malaria,159,166,Disease/Disorder	"[{""token"": ""malaria"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Disease/Disorder""}, {""token"": ""hemoglobin"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Gene/Protein""}, {""token"": ""heme"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Chemical/Drug""}, {""token"": ""hemozoin"", ""start_span"": 149, ""end_span"": 157, ""type"": ""Chemical/Drug""}, {""token"": ""malaria"", ""start_span"": 159, ""end_span"": 166, ""type"": ""Disease/Disorder""}]"	train
Parasitized RBCs generate 4 - HNE that conjugates with membrane skeleton proteins such as spectrin and actin and the integral membrane protein band 3 [ 51, 70] that contributes to anchoring the cytoskeleton to the membrane.	membrane skeleton proteins,55,81,Gene/Protein	spectrin,90,98,Gene/Protein	actin,103,108,Gene/Protein	integral membrane protein,117,142,Gene/Protein	band 3,143,149,Gene/Protein	"[{""token"": ""membrane skeleton proteins"", ""start_span"": 55, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""spectrin"", ""start_span"": 90, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""actin"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""integral membrane protein"", ""start_span"": 117, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""band 3"", ""start_span"": 143, ""end_span"": 149, ""type"": ""Gene/Protein""}]"	train
A number of neurodevelopmental conditions, such as autism spectrum disorder, attention - deficit hyperactive disorder, human X monosomy, fetal alcohol spectrum disorder, and William ’ s syndrome show a wide variety of CT abnormalities ( 35 – 42 ), which are typically attributed to defects in neuronal migration or cortical layering ( 43, 44 ).	autism spectrum disorder,51,75,Disease/Disorder	attention - deficit hyperactive disorder,77,117,Disease/Disorder	human,119,124,Organism/Species	fetal alcohol spectrum disorder,137,168,Disease/Disorder	William ’ s syndrome,174,194,Disease/Disorder	"[{""token"": ""autism spectrum disorder"", ""start_span"": 51, ""end_span"": 75, ""type"": ""Disease/Disorder""}, {""token"": ""attention - deficit hyperactive disorder"", ""start_span"": 77, ""end_span"": 117, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 119, ""end_span"": 124, ""type"": ""Organism/Species""}, {""token"": ""fetal alcohol spectrum disorder"", ""start_span"": 137, ""end_span"": 168, ""type"": ""Disease/Disorder""}, {""token"": ""William \u2019 s syndrome"", ""start_span"": 174, ""end_span"": 194, ""type"": ""Disease/Disorder""}]"	train
Because HYPO was compared against controls ( i. e ., Control minus HYPO ), red clusters signify regions of significant thinning in HYPO ( Controls > HYPO as per heat bars) while blue clusters signify regions of significant thickening ( Controls < HYPO ).	HYPO,8,12,Disease/Disorder	HYPO,67,71,Disease/Disorder	HYPO,131,135,Disease/Disorder	HYPO,149,153,Disease/Disorder	HYPO,247,251,Disease/Disorder	"[{""token"": ""HYPO"", ""start_span"": 8, ""end_span"": 12, ""type"": ""Disease/Disorder""}, {""token"": ""HYPO"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Disease/Disorder""}, {""token"": ""HYPO"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Disease/Disorder""}, {""token"": ""HYPO"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Disease/Disorder""}, {""token"": ""HYPO"", ""start_span"": 247, ""end_span"": 251, ""type"": ""Disease/Disorder""}]"	train
Sample regions showing significant correlations between CT and second - and third - trimester maternal TSH. ( A) Right medial - view spatial map showing increased thickening ( red) in right cuneus as maternal second - trimester TSH increased. ( B) Correlation plot between individual CT values and second - trimester maternal TSH levels in right cuneus. ( C) Right lateral - view spatial map showing increased thinning ( blue) in right inferior parietal angular gyrus ( circled) as third - trimester maternal TSH increased. ( D) Correlation plot between individual CT values and third - trimester maternal TSH levels in right inferior parietal angular gyrus.	TSH,103,106,Gene/Protein	TSH,228,231,Gene/Protein	TSH,326,329,Gene/Protein	TSH,509,512,Gene/Protein	TSH,606,609,Gene/Protein	"[{""token"": ""TSH"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""TSH"", ""start_span"": 228, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""TSH"", ""start_span"": 326, ""end_span"": 329, ""type"": ""Gene/Protein""}, {""token"": ""TSH"", ""start_span"": 509, ""end_span"": 512, ""type"": ""Gene/Protein""}, {""token"": ""TSH"", ""start_span"": 606, ""end_span"": 609, ""type"": ""Gene/Protein""}]"	train
Sample regions showing significant correlations between CT and first - trimester maternal TSH. ( A) Right lateral - view spatial map showing two nearby regions, indicating significant ( p < 0. 001) thickening ( red) as first - trimester maternal TSH levels increased. ( B) Correlation plots between individual CT values and first - trimester maternal TSH levels in two regions of right supramarginal gyrus. ( C) Right lateral - view spatial map showing significant thickening ( red) as first - trimester maternal TSH levels increased with M12 removed from FreeSurfer analysis. ( D) Correlation plot between individual CT values and first - trimester maternal TSH levels in right supramarginal gyrus with M12 removed from FreeSurfer analysis.	TSH,90,93,Gene/Protein	TSH,246,249,Gene/Protein	TSH,351,354,Gene/Protein	TSH,513,516,Gene/Protein	TSH,659,662,Gene/Protein	"[{""token"": ""TSH"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""TSH"", ""start_span"": 246, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""TSH"", ""start_span"": 351, ""end_span"": 354, ""type"": ""Gene/Protein""}, {""token"": ""TSH"", ""start_span"": 513, ""end_span"": 516, ""type"": ""Gene/Protein""}, {""token"": ""TSH"", ""start_span"": 659, ""end_span"": 662, ""type"": ""Gene/Protein""}]"	train
PM yields a risk reducing effect of more than 90 - 100% in healthy BRCA1 and BRCA2 mutation carriers [ 25 - 27] and PBSO decreases breast cancer risk in BRCA mutation carriers without prior breast cancer approximately by 50% [ 26, 28, 29 ].	BRCA1,67,72,Gene/Protein	BRCA2,77,82,Gene/Protein	breast cancer,131,144,Disease/Disorder	BRCA,153,157,Gene/Protein	breast cancer,190,203,Disease/Disorder	"[{""token"": ""BRCA1"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""BRCA2"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""breast cancer"", ""start_span"": 131, ""end_span"": 144, ""type"": ""Disease/Disorder""}, {""token"": ""BRCA"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene/Protein""}, {""token"": ""breast cancer"", ""start_span"": 190, ""end_span"": 203, ""type"": ""Disease/Disorder""}]"	train
We next investigated the preventive effect of ID cisplatin in a mouse model for BRCA1 - associated human breast cancer.	cisplatin,49,58,Chemical/Drug	mouse,64,69,Organism/Species	BRCA1,80,85,Gene/Protein	human,99,104,Organism/Species	breast cancer,105,118,Disease/Disorder	"[{""token"": ""cisplatin"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""mouse"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Organism/Species""}, {""token"": ""BRCA1"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Organism/Species""}, {""token"": ""breast cancer"", ""start_span"": 105, ""end_span"": 118, ""type"": ""Disease/Disorder""}]"	train
Dual therapy using ID cisplatin and olaparib led to a longer tumor - free latency compared to olaparib monotherapy ( p = 0. 004) but not compared to cisplatin monotherapy ( p = 0. 506 ).	cisplatin,22,31,Chemical/Drug	olaparib,36,44,Chemical/Drug	tumor,61,66,Disease/Disorder	olaparib,94,102,Chemical/Drug	cisplatin,149,158,Chemical/Drug	"[{""token"": ""cisplatin"", ""start_span"": 22, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""olaparib"", ""start_span"": 36, ""end_span"": 44, ""type"": ""Chemical/Drug""}, {""token"": ""tumor"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Disease/Disorder""}, {""token"": ""olaparib"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Chemical/Drug""}, {""token"": ""cisplatin"", ""start_span"": 149, ""end_span"": 158, ""type"": ""Chemical/Drug""}]"	train
Since Brca1 inactivation and subsequent tumor formation in the WAPcre - driven model occurs during the first estrus cycle ( independent of pregnancy - induced WAP activation) [ 43 ], we anticipate that this is probably due to the fact that prior to treatment, WAPcre; Brca1F / F; Trp53F / F female mice contain Brca1 - deficient mammary epithelial cells.	Brca1,6,11,Gene/Protein	tumor,40,45,Disease/Disorder	WAP,63,66,Gene/Protein	mice,298,302,Organism/Species	Brca1,311,316,Gene/Protein	"[{""token"": ""Brca1"", ""start_span"": 6, ""end_span"": 11, ""type"": ""Gene/Protein""}, {""token"": ""tumor"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Disease/Disorder""}, {""token"": ""WAP"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 298, ""end_span"": 302, ""type"": ""Organism/Species""}, {""token"": ""Brca1"", ""start_span"": 311, ""end_span"": 316, ""type"": ""Gene/Protein""}]"	train
In contrast to our findings in mice, it was shown that long - term testicular and ovarian cancer survivors have no increased lung cancer risk [ 51 - 53 ], and testicular cancer patients treated with chemotherapy only do not develop more lung tumors during follow - up [ 54 ].	mice,31,35,Organism/Species	ovarian cancer,82,96,Disease/Disorder	lung cancer,125,136,Disease/Disorder	testicular cancer,159,176,Disease/Disorder	lung tumors,237,248,Disease/Disorder	"[{""token"": ""mice"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Organism/Species""}, {""token"": ""ovarian cancer"", ""start_span"": 82, ""end_span"": 96, ""type"": ""Disease/Disorder""}, {""token"": ""lung cancer"", ""start_span"": 125, ""end_span"": 136, ""type"": ""Disease/Disorder""}, {""token"": ""testicular cancer"", ""start_span"": 159, ""end_span"": 176, ""type"": ""Disease/Disorder""}, {""token"": ""lung tumors"", ""start_span"": 237, ""end_span"": 248, ""type"": ""Disease/Disorder""}]"	train
Olaparib was already shown to be effective in breast cancer treatment [ 17 - 21, 23, 24 ], but now we also demonstrate the prophylactic effect of systemic PARP - inhibition in Brca1 - associated breast cancer.	Olaparib,0,8,Chemical/Drug	breast cancer,46,59,Disease/Disorder	PARP,155,159,Gene/Protein	Brca1,176,181,Gene/Protein	breast cancer,195,208,Disease/Disorder	"[{""token"": ""Olaparib"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical/Drug""}, {""token"": ""breast cancer"", ""start_span"": 46, ""end_span"": 59, ""type"": ""Disease/Disorder""}, {""token"": ""PARP"", ""start_span"": 155, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""Brca1"", ""start_span"": 176, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""breast cancer"", ""start_span"": 195, ""end_span"": 208, ""type"": ""Disease/Disorder""}]"	train
The Iressa Pan - Asia Study ( IPASS) trial indicated that gefitinib was superior to carboplatin plus paclitaxel as an initial treatment for patients with advanced NSCLC harboring an EGFR mutation [ 8 ].	gefitinib,58,67,Chemical/Drug	carboplatin,84,95,Chemical/Drug	paclitaxel,101,111,Chemical/Drug	NSCLC,163,168,Disease/Disorder	EGFR,182,186,Gene/Protein	"[{""token"": ""gefitinib"", ""start_span"": 58, ""end_span"": 67, ""type"": ""Chemical/Drug""}, {""token"": ""carboplatin"", ""start_span"": 84, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""paclitaxel"", ""start_span"": 101, ""end_span"": 111, ""type"": ""Chemical/Drug""}, {""token"": ""NSCLC"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Disease/Disorder""}, {""token"": ""EGFR"", ""start_span"": 182, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
Cells were exposed to the IC50 dose of gefitinib and paclitaxel using different sequences. * Paclitaxel significantly activated the EGFR pathway compared with control after paclitaxel exposure for 24 h ( p < 0. 05 ). # p < 0. 05.	gefitinib,39,48,Chemical/Drug	paclitaxel,53,63,Chemical/Drug	Paclitaxel,93,103,Chemical/Drug	EGFR,132,136,Gene/Protein	paclitaxel,173,183,Chemical/Drug	"[{""token"": ""gefitinib"", ""start_span"": 39, ""end_span"": 48, ""type"": ""Chemical/Drug""}, {""token"": ""paclitaxel"", ""start_span"": 53, ""end_span"": 63, ""type"": ""Chemical/Drug""}, {""token"": ""Paclitaxel"", ""start_span"": 93, ""end_span"": 103, ""type"": ""Chemical/Drug""}, {""token"": ""EGFR"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""paclitaxel"", ""start_span"": 173, ""end_span"": 183, ""type"": ""Chemical/Drug""}]"	train
As EGFR - TKIs gefitinib and erlotinib are active in patients with NSCLC harboring EGFR mutations, combining them in treatment with chemotherapy was deemed promising [ 8, 9 ].	EGFR,3,7,Gene/Protein	gefitinib,15,24,Chemical/Drug	erlotinib,29,38,Chemical/Drug	NSCLC,67,72,Disease/Disorder	EGFR,83,87,Gene/Protein	"[{""token"": ""EGFR"", ""start_span"": 3, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""gefitinib"", ""start_span"": 15, ""end_span"": 24, ""type"": ""Chemical/Drug""}, {""token"": ""erlotinib"", ""start_span"": 29, ""end_span"": 38, ""type"": ""Chemical/Drug""}, {""token"": ""NSCLC"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Disease/Disorder""}, {""token"": ""EGFR"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene/Protein""}]"	train
Ciardiello, et al. found that a TGFα - EGFR autocrine growth pathway is active in cancer cell lines, and gefitinib produced a dose - dependent inhibition of the secretion of TGFα [ 48 ].	TGFα,32,36,Gene/Protein	EGFR,39,43,Gene/Protein	cancer,82,88,Disease/Disorder	gefitinib,105,114,Chemical/Drug	TGFα,174,178,Gene/Protein	"[{""token"": ""TGF\u03b1"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""EGFR"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene/Protein""}, {""token"": ""cancer"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Disease/Disorder""}, {""token"": ""gefitinib"", ""start_span"": 105, ""end_span"": 114, ""type"": ""Chemical/Drug""}, {""token"": ""TGF\u03b1"", ""start_span"": 174, ""end_span"": 178, ""type"": ""Gene/Protein""}]"	train
Furthermore, miR - 148 was shown to affect Mitf mRNA expression in melanoma cells through a conserved binding site in the 3 ′ UTR sequence of mouse and human Mitf.	Mitf,43,47,Gene/Protein	melanoma,67,75,Disease/Disorder	mouse,142,147,Organism/Species	human,152,157,Organism/Species	Mitf,158,162,Gene/Protein	"[{""token"": ""Mitf"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""melanoma"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Disease/Disorder""}, {""token"": ""mouse"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Organism/Species""}, {""token"": ""Mitf"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Gene/Protein""}]"	train
Continued expression of MITF has been shown to be essential for melanoma cell proliferation and survival and, in fact, MITF has been proposed to act as a lineage survival oncogene in melanoma [ 23 ].	MITF,24,28,Gene/Protein	melanoma,64,72,Disease/Disorder	MITF,119,123,Gene/Protein	oncogene,171,179,Gene/Protein	melanoma,183,191,Disease/Disorder	"[{""token"": ""MITF"", ""start_span"": 24, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""melanoma"", ""start_span"": 64, ""end_span"": 72, ""type"": ""Disease/Disorder""}, {""token"": ""MITF"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""oncogene"", ""start_span"": 171, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""melanoma"", ""start_span"": 183, ""end_span"": 191, ""type"": ""Disease/Disorder""}]"	train
Here we show expression of an orphan immune regulator, death receptor 6 ( DR6 / TNFRSF21 ), on a population of Tfh cells that are highly expanded in lupus - like disease progression in mice.	death receptor 6,55,71,Gene/Protein	DR6,74,77,Gene/Protein	TNFRSF21,80,88,Gene/Protein	lupus,149,154,Disease/Disorder	mice,185,189,Organism/Species	"[{""token"": ""death receptor 6"", ""start_span"": 55, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""DR6"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""TNFRSF21"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Gene/Protein""}, {""token"": ""lupus"", ""start_span"": 149, ""end_span"": 154, ""type"": ""Disease/Disorder""}, {""token"": ""mice"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Organism/Species""}]"	train
The expression of costimulatory ligands such as inducible T cell co - stimulator ligand ( ICOSL) and programmed cell death - 1 ligand1 / 2 ( PD - L1 / 2) on GC B cells regulates TCR signal activation, both positively and negatively12.	inducible T cell co - stimulator ligand,48,87,Gene/Protein	ICOSL,90,95,Gene/Protein	programmed cell death - 1 ligand1,101,134,Gene/Protein	PD - L1,141,148,Gene/Protein	TCR,178,181,Gene/Protein	"[{""token"": ""inducible T cell co - stimulator ligand"", ""start_span"": 48, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""ICOSL"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""programmed cell death - 1 ligand1"", ""start_span"": 101, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""PD - L1"", ""start_span"": 141, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Gene/Protein""}]"	train
Notably, a functional blockade or defect in negative costimulatory molecules, including programmed cell death 1 ( PD1) or cytotoxic T - lymphocyte - associated protein 4 ( CTLA4 ), induces an aberrant GC reaction and systemic autoimmunological disease13141516.	programmed cell death 1,88,111,Gene/Protein	PD1,114,117,Gene/Protein	cytotoxic T - lymphocyte - associated protein 4,122,169,Gene/Protein	CTLA4,172,177,Gene/Protein	systemic autoimmunological disease13141516,217,259,Disease/Disorder	"[{""token"": ""programmed cell death 1"", ""start_span"": 88, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""PD1"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene/Protein""}, {""token"": ""cytotoxic T - lymphocyte - associated protein 4"", ""start_span"": 122, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""CTLA4"", ""start_span"": 172, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""systemic autoimmunological disease13141516"", ""start_span"": 217, ""end_span"": 259, ""type"": ""Disease/Disorder""}]"	train
To identify the DR6 ligand ( s ), we generated a soluble fusion protein consisting of an extracellular domain of murine DR6 and the Fc portion of human IgG ( DR6 - Fc ).	DR6,16,19,Gene/Protein	DR6,120,123,Gene/Protein	human,146,151,Organism/Species	IgG,152,155,Gene/Protein	DR6,158,161,Gene/Protein	"[{""token"": ""DR6"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene/Protein""}, {""token"": ""DR6"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""DR6"", ""start_span"": 158, ""end_span"": 161, ""type"": ""Gene/Protein""}]"	train
These findings demonstrate that syndecan - 1 is a specific binding partner for DR6 and the interaction negatively regulates NFAT and NFκB activation during TCR activation.	syndecan - 1,32,44,Gene/Protein	DR6,79,82,Gene/Protein	NFAT,124,128,Gene/Protein	NFκB,133,137,Gene/Protein	TCR,156,159,Gene/Protein	"[{""token"": ""syndecan - 1"", ""start_span"": 32, ""end_span"": 44, ""type"": ""Gene/Protein""}, {""token"": ""DR6"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""NF\u03baB"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 156, ""end_span"": 159, ""type"": ""Gene/Protein""}]"	train
As expected, the level of syndecan - 1 expression on GL7 + CD19 + GC B cells of NZB mice was higher than that of BWF1 mice ( Fig. 4c, upper panel ).	syndecan - 1,26,38,Gene/Protein	GL7,53,56,Gene/Protein	CD19,59,63,Gene/Protein	NZB mice,80,88,Organism/Species	BWF1 mice,113,122,Organism/Species	"[{""token"": ""syndecan - 1"", ""start_span"": 26, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""GL7"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""NZB mice"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Organism/Species""}, {""token"": ""BWF1 mice"", ""start_span"": 113, ""end_span"": 122, ""type"": ""Organism/Species""}]"	train
While GL7 + CD19 + GC B cells hardly developed in healthy non - immunized B6 mice, the cells expanded in lupus - prone NZB and BWF1 mice ( Fig. 4d, upper panel ).	GL7,6,9,Gene/Protein	CD19,12,16,Gene/Protein	B6 mice,74,81,Organism/Species	lupus,105,110,Disease/Disorder	BWF1 mice,127,136,Organism/Species	"[{""token"": ""GL7"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""B6 mice"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Organism/Species""}, {""token"": ""lupus"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Disease/Disorder""}, {""token"": ""BWF1 mice"", ""start_span"": 127, ""end_span"": 136, ""type"": ""Organism/Species""}]"	train
Meanwhile, syndecan - 1 / DR6 interaction dramatically suppressed the activation of TCR signalling, which activates NFκB and NFAT in the present study.	syndecan - 1,11,23,Gene/Protein	DR6,26,29,Gene/Protein	TCR,84,87,Gene/Protein	NFκB,116,120,Gene/Protein	NFAT,125,129,Gene/Protein	"[{""token"": ""syndecan - 1"", ""start_span"": 11, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""DR6"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""TCR"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""NF\u03baB"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Gene/Protein""}]"	train
Importantly, DR6 is also associated with negative regulation of peripheral lymphocyte activation in syndecan - 1 - associated immunological disease models such as EAE21, lung inflammation22, and lupus - like disease ( the present study ).	DR6,13,16,Gene/Protein	syndecan - 1,100,112,Gene/Protein	immunological disease,126,147,Disease/Disorder	lung inflammation22,170,189,Disease/Disorder	lupus,195,200,Disease/Disorder	"[{""token"": ""DR6"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""syndecan - 1"", ""start_span"": 100, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""immunological disease"", ""start_span"": 126, ""end_span"": 147, ""type"": ""Disease/Disorder""}, {""token"": ""lung inflammation22"", ""start_span"": 170, ""end_span"": 189, ""type"": ""Disease/Disorder""}, {""token"": ""lupus"", ""start_span"": 195, ""end_span"": 200, ""type"": ""Disease/Disorder""}]"	train
Two days after the infection, the cells were stained with biotinylated DR6 - Fc plus streptavidin - allophycocyanin ( APC ).	infection,19,28,Disease/Disorder	DR6,71,74,Gene/Protein	streptavidin,85,97,Gene/Protein	allophycocyanin,100,115,Gene/Protein	APC,118,121,Gene/Protein	"[{""token"": ""infection"", ""start_span"": 19, ""end_span"": 28, ""type"": ""Disease/Disorder""}, {""token"": ""DR6"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""streptavidin"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""allophycocyanin"", ""start_span"": 100, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""APC"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene/Protein""}]"	train
Anti - dsDNA Ab in serum sample was detected by ELISA using double - stranded deoxyribonucleic acid coated plate and horse radish peroxidase conjugated goat anti - mouse IgG ( H + L) antibody ( 1 / 5, 000 diluted, Jackson Immuno Research, West Grove, PA ).	horse radish,117,129,Organism/Species	peroxidase,130,140,Gene/Protein	goat,152,156,Organism/Species	mouse,164,169,Organism/Species	IgG,170,173,Gene/Protein	"[{""token"": ""horse radish"", ""start_span"": 117, ""end_span"": 129, ""type"": ""Organism/Species""}, {""token"": ""peroxidase"", ""start_span"": 130, ""end_span"": 140, ""type"": ""Gene/Protein""}, {""token"": ""goat"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 164, ""end_span"": 169, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 170, ""end_span"": 173, ""type"": ""Gene/Protein""}]"	train
Results: Both AA and EA patients with positive anti - RBP antibodies showed over - expression of similar IFN - related canonical pathways, such as IFN Signaling ( P = 1. 3 × 10 − 7 and 6. 3 × 10 − 11 in AA vs. EA respectively ), Antigen Presenting Pathway ( P = 1. 8 × 10 − 5 and 2. 5 × 10 − 6 ), and a number of pattern recognition receptor pathways.	RBP,54,57,Gene/Protein	antibodies,58,68,Gene/Protein	IFN,105,108,Gene/Protein	IFN,147,150,Gene/Protein	pattern recognition receptor,313,341,Gene/Protein	"[{""token"": ""RBP"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 58, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""IFN"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""IFN"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""pattern recognition receptor"", ""start_span"": 313, ""end_span"": 341, ""type"": ""Gene/Protein""}]"	train
In anti - RBP negative ( RBP −) patients, EA subjects demonstrated similar IFN - related pathway activation, whereas no IFN - related pathways were detected in RBP − AA patients.	RBP,10,13,Gene/Protein	RBP,25,28,Gene/Protein	IFN,75,78,Gene/Protein	IFN,120,123,Gene/Protein	RBP,160,163,Gene/Protein	"[{""token"": ""RBP"", ""start_span"": 10, ""end_span"": 13, ""type"": ""Gene/Protein""}, {""token"": ""RBP"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene/Protein""}, {""token"": ""IFN"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""IFN"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene/Protein""}, {""token"": ""RBP"", ""start_span"": 160, ""end_span"": 163, ""type"": ""Gene/Protein""}]"	train
Multiple candidate gene association studies and genome wide association studies have led to discovery of more than 30 susceptibility loci throughout the whole genome, most of which are involved in three main pathways in lupus pathogenesis: abnormal clearance of nuclear debris and immune complexes, over - activation of innate immune system through Toll - like receptor ( TLR) and type I interferon ( IFN) signaling, and aberrant adaptive immune response through B and T cell signaling ( 6, 7 ).	lupus,220,225,Disease/Disorder	Toll - like receptor,349,369,Gene/Protein	TLR,372,375,Gene/Protein	type I interferon,381,398,Gene/Protein	IFN,401,404,Gene/Protein	"[{""token"": ""lupus"", ""start_span"": 220, ""end_span"": 225, ""type"": ""Disease/Disorder""}, {""token"": ""Toll - like receptor"", ""start_span"": 349, ""end_span"": 369, ""type"": ""Gene/Protein""}, {""token"": ""TLR"", ""start_span"": 372, ""end_span"": 375, ""type"": ""Gene/Protein""}, {""token"": ""type I interferon"", ""start_span"": 381, ""end_span"": 398, ""type"": ""Gene/Protein""}, {""token"": ""IFN"", ""start_span"": 401, ""end_span"": 404, ""type"": ""Gene/Protein""}]"	train
Antibodies to Ro, La, Sm, and RNP for all samples were measured by ELISA methods ( INOVA Diagnostics, San Diego, CA, USA) at UCMC at the time of serum and RNA sampling, and standard clinical laboratory cutoff points were used to categorize them as positive or negative.	Antibodies,0,10,Gene/Protein	Ro,14,16,Gene/Protein	La,18,20,Gene/Protein	Sm,22,24,Gene/Protein	RNP,30,33,Gene/Protein	"[{""token"": ""Antibodies"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""Ro"", ""start_span"": 14, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""La"", ""start_span"": 18, ""end_span"": 20, ""type"": ""Gene/Protein""}, {""token"": ""Sm"", ""start_span"": 22, ""end_span"": 24, ""type"": ""Gene/Protein""}, {""token"": ""RNP"", ""start_span"": 30, ""end_span"": 33, ""type"": ""Gene/Protein""}]"	train
There was lower prevalence in anti - dsDNA antibodies in RBP − AA patients ( 77% of RBP + vs. 31% of RBP − had anti - dsDNA antibodies, P = 0. 005 ).	antibodies,43,53,Gene/Protein	RBP,57,60,Gene/Protein	RBP,84,87,Gene/Protein	RBP,101,104,Gene/Protein	antibodies,124,134,Gene/Protein	"[{""token"": ""antibodies"", ""start_span"": 43, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""RBP"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""RBP"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""RBP"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 124, ""end_span"": 134, ""type"": ""Gene/Protein""}]"	train
In the RBP − patients, there is essentially no increase in IFN - induced gene expression in AA patients, while the expression of these genes, in particular PKR, is increased in the RBP − EA SLE patients.	RBP,7,10,Gene/Protein	IFN,59,62,Gene/Protein	PKR,156,159,Gene/Protein	RBP,181,184,Gene/Protein	SLE,190,193,Disease/Disorder	"[{""token"": ""RBP"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""IFN"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""PKR"", ""start_span"": 156, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""RBP"", ""start_span"": 181, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""SLE"", ""start_span"": 190, ""end_span"": 193, ""type"": ""Disease/Disorder""}]"	train
Because anti - dsDNA antibodies have been associated with high IFN - α ( 25, 26 ), it is important to determine whether anti - dsDNA antibodies are contributing to the induction of IFN - induced gene expression we observe in our RBP − EA patients.	antibodies,21,31,Gene/Protein	IFN - α,63,70,Gene/Protein	antibodies,133,143,Gene/Protein	IFN,181,184,Gene/Protein	RBP,229,232,Gene/Protein	"[{""token"": ""antibodies"", ""start_span"": 21, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""IFN - \u03b1"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 133, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""IFN"", ""start_span"": 181, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""RBP"", ""start_span"": 229, ""end_span"": 232, ""type"": ""Gene/Protein""}]"	train
When we looked at the RBP negative patients in the qPCR replication cohorts with regard to presence or absence of anti - dsDNA antibodies, there was no significant difference in IFIT1, MX1, or PKR over - expression in the AA subjects.	RBP,22,25,Gene/Protein	antibodies,127,137,Gene/Protein	IFIT1,178,183,Gene/Protein	MX1,185,188,Gene/Protein	PKR,193,196,Gene/Protein	"[{""token"": ""RBP"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 127, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""IFIT1"", ""start_span"": 178, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""MX1"", ""start_span"": 185, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""PKR"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
Thus, in RBP − EA subjects, the anti - dsDNA antibody status did have an effect on expression of IFIGs, and thus anti - dsDNA antibodies are contributing to the IFN - induced gene expression in this group.	RBP,9,12,Gene/Protein	antibody,45,53,Gene/Protein	IFIGs,97,102,Gene/Protein	antibodies,126,136,Gene/Protein	IFN,161,164,Gene/Protein	"[{""token"": ""RBP"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""IFIGs"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 126, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""IFN"", ""start_span"": 161, ""end_span"": 164, ""type"": ""Gene/Protein""}]"	train
Expression of three genes ( IFIT1, MX1, and PKR) are shown in both patients with anti - dsDNA antibodies ( DNA +), and those who lack those antibodies ( DNA −).	IFIT1,28,33,Gene/Protein	MX1,35,38,Gene/Protein	PKR,44,47,Gene/Protein	antibodies,94,104,Gene/Protein	antibodies,140,150,Gene/Protein	"[{""token"": ""IFIT1"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Gene/Protein""}, {""token"": ""MX1"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""PKR"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 94, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 140, ""end_span"": 150, ""type"": ""Gene/Protein""}]"	train
Autoantibody immune complexes present in SLE patients have been implicated as major endogenous IFN - inducers, likely via the endosomal TLR and IFN regulatory factor pathways ( 43 – 45 ).	Autoantibody,0,12,Gene/Protein	SLE,41,44,Disease/Disorder	IFN,95,98,Gene/Protein	TLR,136,139,Gene/Protein	IFN regulatory factor,144,165,Gene/Protein	"[{""token"": ""Autoantibody"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""SLE"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Disease/Disorder""}, {""token"": ""IFN"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""TLR"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""IFN regulatory factor"", ""start_span"": 144, ""end_span"": 165, ""type"": ""Gene/Protein""}]"	train
Anti - RBP antibodies would be expected to activate the RNA - sensing TLRs, while anti - dsDNA antibody immune complexes would be expected to activate TLR 9.	RBP,7,10,Gene/Protein	antibodies,11,21,Gene/Protein	TLRs,70,74,Gene/Protein	antibody,95,103,Gene/Protein	TLR 9,151,156,Gene/Protein	"[{""token"": ""RBP"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""antibodies"", ""start_span"": 11, ""end_span"": 21, ""type"": ""Gene/Protein""}, {""token"": ""TLRs"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""antibody"", ""start_span"": 95, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""TLR 9"", ""start_span"": 151, ""end_span"": 156, ""type"": ""Gene/Protein""}]"	train
Genetic variations in the TLR pathway genes such as IRF5 and IRF7 have been associated with risk of SLE, and with gain of function within the type I IFN pathway ( 46, 47 ).	TLR,26,29,Gene/Protein	IRF5,52,56,Gene/Protein	IRF7,61,65,Gene/Protein	SLE,100,103,Disease/Disorder	type I IFN,142,152,Gene/Protein	"[{""token"": ""TLR"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""IRF5"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""IRF7"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""SLE"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Disease/Disorder""}, {""token"": ""type I IFN"", ""start_span"": 142, ""end_span"": 152, ""type"": ""Gene/Protein""}]"	train
All patients in our study had ANA, and it may be that other nuclear antigen / autoantibody complexes could have triggered the TLR / RLR system leading to IFN - pathway activation in these subjects.	nuclear antigen,60,75,Gene/Protein	autoantibody,78,90,Gene/Protein	TLR,126,129,Gene/Protein	RLR,132,135,Gene/Protein	IFN,154,157,Gene/Protein	"[{""token"": ""nuclear antigen"", ""start_span"": 60, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""autoantibody"", ""start_span"": 78, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""TLR"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""RLR"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""IFN"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene/Protein""}]"	train
The remaining three OSN / odour pairs ( Or24a / propyl acetate, Or74a / octanol, and Or74a / 2 - heptanone) showed significant increases in the firing rate for the full 5 min exposure, with two OSN / odour pairs showing significant declines in the level of activity following the first 60 s ( Or24a / propyl acetate: 41 spikes s − 1 at the beginning of odour exposure and only 20 spikes s − 1 after 60 s, p = 0. 019, Mann – Whitney; Or74a / octanol: 35 spikes s − 1 at the beginning and 14 spikes s − 1 after 60 s, p = 0. 0001, Mann – Whitney ).	Or24a,40,45,Gene/Protein	Or74a,64,69,Gene/Protein	Or74a,85,90,Gene/Protein	Or24a,293,298,Gene/Protein	Or74a,433,438,Gene/Protein	"[{""token"": ""Or24a"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""Or74a"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""Or74a"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""Or24a"", ""start_span"": 293, ""end_span"": 298, ""type"": ""Gene/Protein""}, {""token"": ""Or74a"", ""start_span"": 433, ""end_span"": 438, ""type"": ""Gene/Protein""}]"	train
Burkholderia cenocepacia is a virulent pathogen that causes significant morbidity and mortality in patients with cystic fibrosis ( CF ), survives intracellularly in macrophages, and uniquely causes systemic infections in CF.	Burkholderia cenocepacia,0,24,Organism/Species	cystic fibrosis,113,128,Disease/Disorder	CF,131,133,Disease/Disorder	systemic infections,198,217,Disease/Disorder	CF,221,223,Disease/Disorder	"[{""token"": ""Burkholderia cenocepacia"", ""start_span"": 0, ""end_span"": 24, ""type"": ""Organism/Species""}, {""token"": ""cystic fibrosis"", ""start_span"": 113, ""end_span"": 128, ""type"": ""Disease/Disorder""}, {""token"": ""CF"", ""start_span"": 131, ""end_span"": 133, ""type"": ""Disease/Disorder""}, {""token"": ""systemic infections"", ""start_span"": 198, ""end_span"": 217, ""type"": ""Disease/Disorder""}, {""token"": ""CF"", ""start_span"": 221, ""end_span"": 223, ""type"": ""Disease/Disorder""}]"	train
Basal serum levels of IFN - γ were similar between CF and non - CF patients, however after B. cenocepacia infection there is deficient IFN - γ production in CF MDMs.	IFN - γ,22,29,Gene/Protein	CF,51,53,Disease/Disorder	CF,64,66,Disease/Disorder	IFN - γ,135,142,Gene/Protein	CF,157,159,Disease/Disorder	"[{""token"": ""IFN - \u03b3"", ""start_span"": 22, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""CF"", ""start_span"": 51, ""end_span"": 53, ""type"": ""Disease/Disorder""}, {""token"": ""CF"", ""start_span"": 64, ""end_span"": 66, ""type"": ""Disease/Disorder""}, {""token"": ""IFN - \u03b3"", ""start_span"": 135, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""CF"", ""start_span"": 157, ""end_span"": 159, ""type"": ""Disease/Disorder""}]"	train
Bacteria survive in CF macrophages despite successful phagocytosis due to links between CF transmembrane conductance regulator ( CFTR) dysfunction and impaired phagolysosomal killing [ 17 ], [ 20 ], [ 21 ]. B. cenocepacia is also specifically able to evade degradation in CF macrophages leading to severe and persistent inflammation [ 19 ], [ 22 ], [ 23 ].	Bacteria,0,8,Organism/Species	CF,20,22,Disease/Disorder	CF transmembrane conductance regulator,88,126,Gene/Protein	CFTR,129,133,Gene/Protein	CF,272,274,Disease/Disorder	"[{""token"": ""Bacteria"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Organism/Species""}, {""token"": ""CF"", ""start_span"": 20, ""end_span"": 22, ""type"": ""Disease/Disorder""}, {""token"": ""CF transmembrane conductance regulator"", ""start_span"": 88, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""CFTR"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""CF"", ""start_span"": 272, ""end_span"": 274, ""type"": ""Disease/Disorder""}]"	train
Autophagy stimulation with rapamycin also enhances clearance of other major CF pathogens such as Pseudomonas aeruginosa [ 27] and Staphylococcus aureus [ 28 ], but autophagy has not been studied in human CF macrophages.	rapamycin,27,36,Chemical/Drug	CF,76,78,Disease/Disorder	Pseudomonas aeruginosa,97,119,Organism/Species	human,198,203,Organism/Species	CF,204,206,Disease/Disorder	"[{""token"": ""rapamycin"", ""start_span"": 27, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""CF"", ""start_span"": 76, ""end_span"": 78, ""type"": ""Disease/Disorder""}, {""token"": ""Pseudomonas aeruginosa"", ""start_span"": 97, ""end_span"": 119, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 198, ""end_span"": 203, ""type"": ""Organism/Species""}, {""token"": ""CF"", ""start_span"": 204, ""end_span"": 206, ""type"": ""Disease/Disorder""}]"	train
Although rapamycin was effective in murine CF studies, systemic side effects of rapamycin in CF [ 31] and increased development of interstitial lung disease [ 32] prevent clinical trials.	rapamycin,9,18,Chemical/Drug	CF,43,45,Disease/Disorder	rapamycin,80,89,Chemical/Drug	CF,93,95,Disease/Disorder	interstitial lung disease,131,156,Disease/Disorder	"[{""token"": ""rapamycin"", ""start_span"": 9, ""end_span"": 18, ""type"": ""Chemical/Drug""}, {""token"": ""CF"", ""start_span"": 43, ""end_span"": 45, ""type"": ""Disease/Disorder""}, {""token"": ""rapamycin"", ""start_span"": 80, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""CF"", ""start_span"": 93, ""end_span"": 95, ""type"": ""Disease/Disorder""}, {""token"": ""interstitial lung disease"", ""start_span"": 131, ""end_span"": 156, ""type"": ""Disease/Disorder""}]"	train
Azithromycin has been show to block autophagy in CF macrophages in vitro [ 44 ], but CF Patient Registry data does not support an increased risk of mycobacterial infections for those on chronic azithromycin as proposed in the study by Renna and colleagues [ 45 ].	Azithromycin,0,12,Chemical/Drug	CF,49,51,Disease/Disorder	CF,85,87,Disease/Disorder	mycobacterial infections,148,172,Disease/Disorder	azithromycin,194,206,Chemical/Drug	"[{""token"": ""Azithromycin"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Chemical/Drug""}, {""token"": ""CF"", ""start_span"": 49, ""end_span"": 51, ""type"": ""Disease/Disorder""}, {""token"": ""CF"", ""start_span"": 85, ""end_span"": 87, ""type"": ""Disease/Disorder""}, {""token"": ""mycobacterial infections"", ""start_span"": 148, ""end_span"": 172, ""type"": ""Disease/Disorder""}, {""token"": ""azithromycin"", ""start_span"": 194, ""end_span"": 206, ""type"": ""Chemical/Drug""}]"	train
To determine if IFN - γ is differentially produced in CF in response to B. cenocepacia, IFN - γ was measured in the serum of CF and non - CF subjects prior to macrophage isolation and in PBMC culture supernatants with and without 24 hour B. cenocepacia infection.	IFN - γ,16,23,Gene/Protein	CF,54,56,Disease/Disorder	IFN - γ,88,95,Gene/Protein	CF,125,127,Disease/Disorder	CF,138,140,Disease/Disorder	"[{""token"": ""IFN - \u03b3"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Gene/Protein""}, {""token"": ""CF"", ""start_span"": 54, ""end_span"": 56, ""type"": ""Disease/Disorder""}, {""token"": ""IFN - \u03b3"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""CF"", ""start_span"": 125, ""end_span"": 127, ""type"": ""Disease/Disorder""}, {""token"": ""CF"", ""start_span"": 138, ""end_span"": 140, ""type"": ""Disease/Disorder""}]"	train
Altogether, this data suggested that p62 is either sequestered or inefficiently utilized by human CF MDMs, and IFN - γ can alleviate this undesirable phenotype in CF cells.	p62,37,40,Gene/Protein	human,92,97,Organism/Species	CF,98,100,Disease/Disorder	IFN - γ,111,118,Gene/Protein	CF,163,165,Disease/Disorder	"[{""token"": ""p62"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Organism/Species""}, {""token"": ""CF"", ""start_span"": 98, ""end_span"": 100, ""type"": ""Disease/Disorder""}, {""token"": ""IFN - \u03b3"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""CF"", ""start_span"": 163, ""end_span"": 165, ""type"": ""Disease/Disorder""}]"	train
2C) Immunoblot for non - CF and CF macrophages demonstrating p62 accumulation in CF with reduction during IFN - y therapy, representative of 5 subjects.	CF,25,27,Disease/Disorder	CF,32,34,Disease/Disorder	p62,61,64,Gene/Protein	CF,81,83,Disease/Disorder	IFN - y,106,113,Gene/Protein	"[{""token"": ""CF"", ""start_span"": 25, ""end_span"": 27, ""type"": ""Disease/Disorder""}, {""token"": ""CF"", ""start_span"": 32, ""end_span"": 34, ""type"": ""Disease/Disorder""}, {""token"": ""p62"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""CF"", ""start_span"": 81, ""end_span"": 83, ""type"": ""Disease/Disorder""}, {""token"": ""IFN - y"", ""start_span"": 106, ""end_span"": 113, ""type"": ""Gene/Protein""}]"	train
During basal, uninfected conditions ( NT ), CF macrophages demonstrated persistence of increased LC3 - 1 over 24 hours compared to non CF as evidence by high proportion of LC31 relative to total LC3 ( Figures 3A, 3B ).	CF,44,46,Disease/Disorder	LC3 - 1,97,104,Gene/Protein	CF,135,137,Disease/Disorder	LC31,172,176,Gene/Protein	LC3,195,198,Gene/Protein	"[{""token"": ""CF"", ""start_span"": 44, ""end_span"": 46, ""type"": ""Disease/Disorder""}, {""token"": ""LC3 - 1"", ""start_span"": 97, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""CF"", ""start_span"": 135, ""end_span"": 137, ""type"": ""Disease/Disorder""}, {""token"": ""LC31"", ""start_span"": 172, ""end_span"": 176, ""type"": ""Gene/Protein""}, {""token"": ""LC3"", ""start_span"": 195, ""end_span"": 198, ""type"": ""Gene/Protein""}]"	train
LC31 levels are seen to decrease in CF similar to non CF levels by 24 hours with the use of either IFN - γ or rapamycin ( Figure 3B ).	LC31,0,4,Gene/Protein	CF,36,38,Disease/Disorder	CF,54,56,Disease/Disorder	IFN - γ,99,106,Gene/Protein	rapamycin,110,119,Chemical/Drug	"[{""token"": ""LC31"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""CF"", ""start_span"": 36, ""end_span"": 38, ""type"": ""Disease/Disorder""}, {""token"": ""CF"", ""start_span"": 54, ""end_span"": 56, ""type"": ""Disease/Disorder""}, {""token"": ""IFN - \u03b3"", ""start_span"": 99, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""rapamycin"", ""start_span"": 110, ""end_span"": 119, ""type"": ""Chemical/Drug""}]"	train
Therefore, we measured IL - 1β production in human CF macrophages after autophagy stimulation as a primary source of excess inflammatory cytokine production during infection.	IL - 1β,23,30,Gene/Protein	human,45,50,Organism/Species	CF,51,53,Disease/Disorder	inflammatory cytokine,124,145,Gene/Protein	infection,164,173,Disease/Disorder	"[{""token"": ""IL - 1\u03b2"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene/Protein""}, {""token"": ""human"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Organism/Species""}, {""token"": ""CF"", ""start_span"": 51, ""end_span"": 53, ""type"": ""Disease/Disorder""}, {""token"": ""inflammatory cytokine"", ""start_span"": 124, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""infection"", ""start_span"": 164, ""end_span"": 173, ""type"": ""Disease/Disorder""}]"	train
After 4 hours of autophagy stimulation, IL - 1β levels were similar between treated and untreated CF macrophages, but CF macrophages had significantly more IL - 1β than non - CF macrophages ( p = 0. 0012, Figure 7A ).	IL - 1β,40,47,Gene/Protein	CF,98,100,Disease/Disorder	CF,118,120,Disease/Disorder	IL - 1β,156,163,Gene/Protein	CF,175,177,Disease/Disorder	"[{""token"": ""IL - 1\u03b2"", ""start_span"": 40, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""CF"", ""start_span"": 98, ""end_span"": 100, ""type"": ""Disease/Disorder""}, {""token"": ""CF"", ""start_span"": 118, ""end_span"": 120, ""type"": ""Disease/Disorder""}, {""token"": ""IL - 1\u03b2"", ""start_span"": 156, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""CF"", ""start_span"": 175, ""end_span"": 177, ""type"": ""Disease/Disorder""}]"	train
However, in CF macrophages treated with IFN - γ, IL - 1β levels diminished by 24 hours of treatment ( p = 0. 045 ), while untreated CF macrophages infected with B. cenocepacia perpetuate elevated IL - 1β production ( Figure 7B ).	CF,12,14,Disease/Disorder	IFN - γ,40,47,Gene/Protein	IL - 1β,49,56,Gene/Protein	CF,132,134,Disease/Disorder	IL - 1β,196,203,Gene/Protein	"[{""token"": ""CF"", ""start_span"": 12, ""end_span"": 14, ""type"": ""Disease/Disorder""}, {""token"": ""IFN - \u03b3"", ""start_span"": 40, ""end_span"": 47, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1\u03b2"", ""start_span"": 49, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""CF"", ""start_span"": 132, ""end_span"": 134, ""type"": ""Disease/Disorder""}, {""token"": ""IL - 1\u03b2"", ""start_span"": 196, ""end_span"": 203, ""type"": ""Gene/Protein""}]"	train
After 24 of infection CF macrophages remained with slightly higher cell death than non - CF, except for IFN - γ treated CF MDMs.	infection,12,21,Disease/Disorder	CF,22,24,Disease/Disorder	CF,89,91,Disease/Disorder	IFN - γ,104,111,Gene/Protein	CF,120,122,Disease/Disorder	"[{""token"": ""infection"", ""start_span"": 12, ""end_span"": 21, ""type"": ""Disease/Disorder""}, {""token"": ""CF"", ""start_span"": 22, ""end_span"": 24, ""type"": ""Disease/Disorder""}, {""token"": ""CF"", ""start_span"": 89, ""end_span"": 91, ""type"": ""Disease/Disorder""}, {""token"": ""IFN - \u03b3"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""CF"", ""start_span"": 120, ""end_span"": 122, ""type"": ""Disease/Disorder""}]"	train
This result was not unexpected given the possibility of inflammasome dependent IFN - γ signaling [ 63 ], as well as the observed reduction in bacteria with IFN - γ treatment in the CF macrophages.	inflammasome,56,68,Gene/Protein	IFN - γ,79,86,Gene/Protein	bacteria,142,150,Organism/Species	IFN - γ,156,163,Gene/Protein	CF,181,183,Disease/Disorder	"[{""token"": ""inflammasome"", ""start_span"": 56, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""IFN - \u03b3"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""bacteria"", ""start_span"": 142, ""end_span"": 150, ""type"": ""Organism/Species""}, {""token"": ""IFN - \u03b3"", ""start_span"": 156, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""CF"", ""start_span"": 181, ""end_span"": 183, ""type"": ""Disease/Disorder""}]"	train
S1C) IL - 1β levels in macrophage supernatants after infection with k56 - 2 and either a 24 hour treatment with IFN - γ or a control diluent and separated by patients with (+ azithromycin) and without chronic azithromycin prophylaxis.	IL - 1β,5,12,Gene/Protein	infection,53,62,Disease/Disorder	IFN - γ,112,119,Gene/Protein	azithromycin,175,187,Chemical/Drug	azithromycin,209,221,Chemical/Drug	"[{""token"": ""IL - 1\u03b2"", ""start_span"": 5, ""end_span"": 12, ""type"": ""Gene/Protein""}, {""token"": ""infection"", ""start_span"": 53, ""end_span"": 62, ""type"": ""Disease/Disorder""}, {""token"": ""IFN - \u03b3"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""azithromycin"", ""start_span"": 175, ""end_span"": 187, ""type"": ""Chemical/Drug""}, {""token"": ""azithromycin"", ""start_span"": 209, ""end_span"": 221, ""type"": ""Chemical/Drug""}]"	train
( B) Co - injection of control GFP - expressing and mCherry - expressing viruses ( equal titer) into the dentate gyrus of adult mice results in roughly equal infection rates; sections counter - stained with DAPI.	GFP,31,34,Gene/Protein	mCherry,52,59,Gene/Protein	viruses,73,80,Organism/Species	mice,128,132,Organism/Species	infection,158,167,Disease/Disorder	"[{""token"": ""GFP"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""mCherry"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""viruses"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Organism/Species""}, {""token"": ""mice"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Organism/Species""}, {""token"": ""infection"", ""start_span"": 158, ""end_span"": 167, ""type"": ""Disease/Disorder""}]"	train
To generate the miR - 338 - 3p overexpressor virus, the mature miR - 338 - 3p sequence with a canonical stem loop ( 5 ’- TTCAAGAGA - 3 ’) was cloned into the BbsI / BglII site of pCMVU6, and the U6 promoter and miR338 - 3p sequence was excised and placed into the PacI / BstB1 site of the lentiviral FUGW vector.	virus,45,50,Organism/Species	BbsI,158,162,Gene/Protein	BglII,165,170,Gene/Protein	PacI,264,268,Gene/Protein	BstB1,271,276,Gene/Protein	"[{""token"": ""virus"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Organism/Species""}, {""token"": ""BbsI"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""BglII"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""PacI"", ""start_span"": 264, ""end_span"": 268, ""type"": ""Gene/Protein""}, {""token"": ""BstB1"", ""start_span"": 271, ""end_span"": 276, ""type"": ""Gene/Protein""}]"	train
However, partner proteins that interact with cassava HSP70 are different from those that interact with Arabidopsis and rice HSP70.	cassava,45,52,Organism/Species	HSP70,53,58,Gene/Protein	Arabidopsis,103,114,Organism/Species	rice,119,123,Organism/Species	HSP70,124,129,Gene/Protein	"[{""token"": ""cassava"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Organism/Species""}, {""token"": ""HSP70"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""Arabidopsis"", ""start_span"": 103, ""end_span"": 114, ""type"": ""Organism/Species""}, {""token"": ""rice"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Organism/Species""}, {""token"": ""HSP70"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Gene/Protein""}]"	train
These results suggested that cassava, Arabidopsis and rice may use these core proteins to respond to stress, but how these plants react are different since they use different mechanisms through different protein activities. Figure 6Interaction of the cassava heat shock protein 90. 1 ( HSP90. 1; cassava4. 1_002708m) and its partner proteins in MePPI - In.	cassava,29,36,Organism/Species	Arabidopsis,38,49,Organism/Species	rice,54,58,Organism/Species	plants,123,129,Organism/Species	cassava,251,258,Organism/Species	"[{""token"": ""cassava"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Organism/Species""}, {""token"": ""Arabidopsis"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Organism/Species""}, {""token"": ""rice"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Organism/Species""}, {""token"": ""cassava"", ""start_span"": 251, ""end_span"": 258, ""type"": ""Organism/Species""}]"	train
The nodes represent the proteins; ubiquitin - conjugating protein ( yellow ); ubiquitin ligases ( green ); F - box family proteins ( purple ); galactose oxidase / kelch repeat superfamily proteins ( pink ); other proteins ( orange ).	ubiquitin - conjugating protein,34,65,Gene/Protein	ubiquitin ligases,78,95,Gene/Protein	F - box family proteins,107,130,Gene/Protein	galactose oxidase,143,160,Gene/Protein	kelch repeat superfamily proteins,163,196,Gene/Protein	"[{""token"": ""ubiquitin - conjugating protein"", ""start_span"": 34, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""ubiquitin ligases"", ""start_span"": 78, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""F - box family proteins"", ""start_span"": 107, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""galactose oxidase"", ""start_span"": 143, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""kelch repeat superfamily proteins"", ""start_span"": 163, ""end_span"": 196, ""type"": ""Gene/Protein""}]"	train
The Wnt pathway is frequently activated in HCC. 3 4 Various attempts have been made to develop therapeutics targeting the Wnt pathway components, and some of these are now under clinical evaluation. 5 However, the challenges faced in the development of Wnt inhibitors, such as specificity and toxicity, demand a better understanding of the molecular mechanisms involved in Wnt deregulation, in order to inform the design of more specific and more effective compounds.	Wnt,4,7,Gene/Protein	HCC,43,46,Disease/Disorder	Wnt,122,125,Gene/Protein	Wnt,253,256,Gene/Protein	Wnt,373,376,Gene/Protein	"[{""token"": ""Wnt"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""HCC"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Disease/Disorder""}, {""token"": ""Wnt"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""Wnt"", ""start_span"": 253, ""end_span"": 256, ""type"": ""Gene/Protein""}, {""token"": ""Wnt"", ""start_span"": 373, ""end_span"": 376, ""type"": ""Gene/Protein""}]"	train
Mice were sacrificed at 36 weeks after DEN injection; liver was assessed for macroscopic tumour number and size, and normal liver and tumour samples were placed into RNA later, snap - frozen in liquid nitrogen or fixed in neutral buffered formalin overnight at 4 ° C for the assessment of β - catenin.	Mice,0,4,Organism/Species	tumour,89,95,Disease/Disorder	tumour,134,140,Disease/Disorder	formalin,239,247,Chemical/Drug	β - catenin,289,300,Gene/Protein	"[{""token"": ""Mice"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Organism/Species""}, {""token"": ""tumour"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Disease/Disorder""}, {""token"": ""tumour"", ""start_span"": 134, ""end_span"": 140, ""type"": ""Disease/Disorder""}, {""token"": ""formalin"", ""start_span"": 239, ""end_span"": 247, ""type"": ""Chemical/Drug""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 289, ""end_span"": 300, ""type"": ""Gene/Protein""}]"	train
To investigate the phenotype of conditional deletion of Apc, AhCre + Apcfl / fl and AhCre + Apc +/+ progeny were used as previously described. 29 Mice were given daily intraperitoneal injections of β - napthoflavone ( 80 mg / kg) as previously reported. 30 After 4 days, mice were killed and liver removed, weighed and placed into RNA later ( Sigma, St Louis, Missouri, USA) or fixed in formalin.	Apc,56,59,Gene/Protein	Apc,69,72,Gene/Protein	Mice,146,150,Organism/Species	β - napthoflavone,198,215,Chemical/Drug	mice,271,275,Organism/Species	"[{""token"": ""Apc"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""Apc"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""Mice"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Organism/Species""}, {""token"": ""\u03b2 - napthoflavone"", ""start_span"": 198, ""end_span"": 215, ""type"": ""Chemical/Drug""}, {""token"": ""mice"", ""start_span"": 271, ""end_span"": 275, ""type"": ""Organism/Species""}]"	train
To verify if these T - UCRs were specifically altered by Wnt / β - catenin or just affected by the malignant transformation, we profiled T - UCR expression in the livers of mice treated with DEN, which developed a median of 17 ( range: 13 – 36) tumours per liver with no nuclear activation of β - catenin ( see online supplementary figure S1 ).	Wnt,57,60,Gene/Protein	β - catenin,63,74,Gene/Protein	mice,173,177,Organism/Species	tumours,245,252,Disease/Disorder	β - catenin,293,304,Gene/Protein	"[{""token"": ""Wnt"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Organism/Species""}, {""token"": ""tumours"", ""start_span"": 245, ""end_span"": 252, ""type"": ""Disease/Disorder""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 293, ""end_span"": 304, ""type"": ""Gene/Protein""}]"	train
HepG2 cells are known to harbour mutations in exon 3 of the β - catenin gene ( CTNNB1 ), while Huh - 7 cells are known to be wild type ( WT) for CTNNB1 and other genes of the Wnt pathway. 6 The Wnt pathway is activated in HepG2 cell lines, but not in Huh - 7, in line with the mutational status of these cells ( see online supplementary table S4 and figure S2A, B ).	β - catenin,60,71,Gene/Protein	CTNNB1,79,85,Gene/Protein	CTNNB1,145,151,Gene/Protein	Wnt,175,178,Gene/Protein	Wnt,194,197,Gene/Protein	"[{""token"": ""\u03b2 - catenin"", ""start_span"": 60, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""CTNNB1"", ""start_span"": 79, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""CTNNB1"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""Wnt"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""Wnt"", ""start_span"": 194, ""end_span"": 197, ""type"": ""Gene/Protein""}]"	train
Next, we studied a second cohort of human frozen HCCs where CTNNB1, APC and AXIN1 genes were analysed by sequencing ( as previously described34 ).	human,36,41,Organism/Species	HCCs,49,53,Disease/Disorder	CTNNB1,60,66,Gene/Protein	APC,68,71,Gene/Protein	AXIN1,76,81,Gene/Protein	"[{""token"": ""human"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Organism/Species""}, {""token"": ""HCCs"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Disease/Disorder""}, {""token"": ""CTNNB1"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Gene/Protein""}, {""token"": ""APC"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""AXIN1"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Gene/Protein""}]"	train
To further investigate these findings, we studied a rat model of thiocetamide ( TAA )- induced CCA, which appropriately models ICC on a background of inflammation and activation of β - catenin, as previously shown. 27 uc. 158 − expression was increased in tumour tissues compared with control livers, confirming that uc. 158 − deregulation is conserved across species along with the sequence ( figure 5D ).	rat,52,55,Organism/Species	CCA,95,98,Disease/Disorder	ICC,127,130,Disease/Disorder	β - catenin,181,192,Gene/Protein	tumour,256,262,Disease/Disorder	"[{""token"": ""rat"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Organism/Species""}, {""token"": ""CCA"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Disease/Disorder""}, {""token"": ""ICC"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Disease/Disorder""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 181, ""end_span"": 192, ""type"": ""Gene/Protein""}, {""token"": ""tumour"", ""start_span"": 256, ""end_span"": 262, ""type"": ""Disease/Disorder""}]"	train
Patients with low circulating miR - 193b had mainly alpha - fetoprotein ( AFP) negative tumours, in line with previous reports of observed lower levels of AFP in CTNNB1 - mutated HCC41 ( figure 7E ).	alpha - fetoprotein,52,71,Gene/Protein	AFP,74,77,Gene/Protein	tumours,88,95,Disease/Disorder	AFP,155,158,Gene/Protein	CTNNB1,162,168,Gene/Protein	"[{""token"": ""alpha - fetoprotein"", ""start_span"": 52, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""AFP"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene/Protein""}, {""token"": ""tumours"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Disease/Disorder""}, {""token"": ""AFP"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""CTNNB1"", ""start_span"": 162, ""end_span"": 168, ""type"": ""Gene/Protein""}]"	train
The 10 - item inventory covers the following symptoms: delusion, hallucination, euphoria, agitation / aggression, disinhibition, irritability / lability, depression / dysphoria, anxiety, apathy / indifference, and aberrant motor behavior ( no / yes ).	delusion,55,63,Disease/Disorder	hallucination,65,78,Disease/Disorder	depression,154,164,Disease/Disorder	dysphoria,167,176,Disease/Disorder	anxiety,178,185,Disease/Disorder	"[{""token"": ""delusion"", ""start_span"": 55, ""end_span"": 63, ""type"": ""Disease/Disorder""}, {""token"": ""hallucination"", ""start_span"": 65, ""end_span"": 78, ""type"": ""Disease/Disorder""}, {""token"": ""depression"", ""start_span"": 154, ""end_span"": 164, ""type"": ""Disease/Disorder""}, {""token"": ""dysphoria"", ""start_span"": 167, ""end_span"": 176, ""type"": ""Disease/Disorder""}, {""token"": ""anxiety"", ""start_span"": 178, ""end_span"": 185, ""type"": ""Disease/Disorder""}]"	train
Based on a previous principal component analysis, psychosis ( delusions, hallucination ), agitation ( agitation / aggression, disinhibition, irritability ), and affective ( depression, anxiety) sub - syndrome scores were formed by summing the score of the included items [ 76 – 79 ].	psychosis,50,59,Disease/Disorder	delusions,62,71,Disease/Disorder	hallucination,73,86,Disease/Disorder	depression,173,183,Disease/Disorder	anxiety,185,192,Disease/Disorder	"[{""token"": ""psychosis"", ""start_span"": 50, ""end_span"": 59, ""type"": ""Disease/Disorder""}, {""token"": ""delusions"", ""start_span"": 62, ""end_span"": 71, ""type"": ""Disease/Disorder""}, {""token"": ""hallucination"", ""start_span"": 73, ""end_span"": 86, ""type"": ""Disease/Disorder""}, {""token"": ""depression"", ""start_span"": 173, ""end_span"": 183, ""type"": ""Disease/Disorder""}, {""token"": ""anxiety"", ""start_span"": 185, ""end_span"": 192, ""type"": ""Disease/Disorder""}]"	train
